Citrus Sinensis ID: 037780

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-----
Protein Sequence
GGQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG
Secondary Structure (PSIPRED)
cccccccccEEEEEEcccccccccccccccccHHHHHHHHHccccEEEEEEccccEEEEccccccccccccccccEEEEEEcccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccccccEEEEEEcccccccHHHHHHHHHHHHHHHcccccccEEEEccccccEEEEEEccccccHHHHccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEccccccccccccccccccccccccccccccccEEEEcccccccccccHHccccccccccccccHHHHHHHHHcccccccccccccHHcHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccEEEEccccccccccHHHccccHHHHHHHHHHcccEEEEEEEcccccccccccccccccEEEEccccEEHHHcccccccEEEEEcccHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEcHHHHHHHHHcHHHcccccccccEEEEEcccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEcccccccHHHHHHHHHHHHHHHHHHHHcccEEEEcccccHHHEEEcccccEEEccccccHEcccccccccccEEEEEcccccHHHHHcccEEEcccHEEHHEEEEEEEccccccccccccccccHHHHHHHHHHccccHHHccHHHcccccHHHHHHHHHHHHHHHcccccccccHHHEEEEccccccccccccccEEcc
Coil and Loop (DISEMBL)
ggqgynkelfdfhevknidwpqsdyerfkpynevqcknsclsdcfcaavifeddsccfkklplsngmtdsriTSKAFIKYknkgddppsvprppdpddkkkrkmMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKkkwirnspgdgtvetnlrCFSYKALEEATDNfkeeagrgsfgIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNngtlasflfgnlkpswnlrTNIAFQIARGLLYLhedcssqiihcdikpqnillddhynarisDFGLAKLLTLNQSKTIKTAIrgtkgyvapewyrkstitakvdVYSFGVLLLEIISCRKsfdiemgeEYAILTDWAFdcyrngklddlvegdmeAMNDIKCVEKLLMVSIWCiqedpslrptMRKVSQMLEGVvevdvppnpspfsg
Flexible Loop (DISEMBL)
ggqgynkelfdfhevknidwpqsdYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLplsngmtdsriTSKAFIkyknkgddppsvprppdpddkkKRKMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWirnspgdgtveTNLRCFSYKALEEATDnfkeeagrgsfGIVYKGViettrtsttavavKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLltlnqsktiktairgtkgyvapewyrkstitakvdvYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEgvvevdvppnpspfsg
Low Complexity Region (SEG)
GGQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMTDSRITSKAFIKYKNkgddppsvprppdpddkkkrkMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG
Disordered region (IsUnstruct)
*******ELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMT**RIT*KAFI******************************GSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQE********************************
Disordered Region (DISOPRED)
***********FHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMTDSRITSKAFIKYKNKGD*********************ATGSVLLGSSVFVNFAMVCGVGLGFFFIYKK***************LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS*******E**ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN******
Disordered Region (DISEMBL)
GGQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMTDSRITSKAFIKYKN********************KMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG
Disordered Region (DISPRO)
*********FDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIR********ETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
GGQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFSG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	455	2.2.26 [Sep-21-2011]
Q39202	832	G-type lectin S-receptor-	yes	no	0.958	0.524	0.550	1e-136
Q9XID3	829	G-type lectin S-receptor-	no	no	0.881	0.483	0.378	3e-78
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.690	0.382	0.470	4e-77
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.896	0.467	0.376	3e-72
O64477	828	G-type lectin S-receptor-	no	no	0.650	0.357	0.456	2e-70
Q39203	797	G-type lectin S-receptor-	no	no	0.635	0.362	0.454	1e-66
P17801	817	Putative receptor protein	N/A	no	0.931	0.518	0.357	5e-66
O65238	872	G-type lectin S-receptor-	no	no	0.628	0.327	0.407	2e-63
Q8H199	658	Cysteine-rich receptor-li	no	no	0.753	0.521	0.379	1e-60
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.646	0.455	0.411	4e-59

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  484 bits (1247), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 251/456 (55%), Positives = 313/456 (68%), Gaps = 20/456 (4%)

Query: 9   LFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIF---EDDSCCFKKLPLSN 65
           L++F  ++  +WP  DYE +  Y+E +CK SCLSDC CAAVIF    D  C  KK PLS+
Sbjct: 370 LYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSH 429

Query: 66  GMTDSRITSKAFIKYKNK--GDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAM 123
           G    R  S  FIK +N+   D P +  R       KK   +    SVLLG+S FV F  
Sbjct: 430 GERSPRGDSDTFIKVRNRSIADVPVTGNR------AKKLDWLIIACSVLLGTSAFVIFDT 483

Query: 124 VCGV-----GLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFG 178
            C                +   R +      E NLR F+Y  L EAT +F EE GRG+FG
Sbjct: 484 SCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFG 543

Query: 179 IVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN 238
           IVYKG +E    S   VAVKKLDR+  D EKEFKNEV VIGQ HHKNLVRL+GFC+EGQ+
Sbjct: 544 IVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQS 603

Query: 239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +++VYEFL  GTLA+FLF   +PSW  R NIA  IARG+LYLHE+CS QIIHCDIKPQNI
Sbjct: 604 QMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNI 663

Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVL 358
           LLD++Y  RISDFGLAKLL +NQ+ T+ T IRGTKGYVAPEW+R S IT+KVDVYS+GV+
Sbjct: 664 LLDEYYTPRISDFGLAKLLLMNQTYTL-TNIRGTKGYVAPEWFRNSPITSKVDVYSYGVM 722

Query: 359 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSI 418
           LLEI+ C+K+ D+   E+  IL +WA+DC+R G+L+DL E D EAMND++ VE+ + ++I
Sbjct: 723 LLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAI 779

Query: 419 WCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 454
           WCIQE+  +RP MR V+QMLEGV++V  PPNPSP+S
Sbjct: 780 WCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPYS 815

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  292 bits (748), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 167/441 (37%), Positives = 252/441 (57%), Gaps = 40/441 (9%)

Query: 36  CKNSCLSDCFCAAVIFEDDSC--CFKKLPLS--NGMTDSRITSKAFIKYKNKGDDPPSVP 91
           C+ +CLS   C A +   D    C++K P S   G     + S +++K         ++ 
Sbjct: 350 CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGP-VVANTLE 408

Query: 92  RPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKW---IRNSPGDGT 148
           R    DD   +  +             V  A++ G+ LG   +    W    R +P  GT
Sbjct: 409 RATKGDDNNSKVHL-----------WIVAVAVIAGL-LGLVAVEIGLWWCCCRKNPRFGT 456

Query: 149 VETNLRC----------FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK 198
           + ++             F+YK L+  T +FKE+ G G FG VY+GV+    T+ T VAVK
Sbjct: 457 LSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVK 512

Query: 199 KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN 258
           +L+ + Q GEK+F+ EV  I  THH NLVRL+GFC +G++RLLVYEF+ NG+L +FLF  
Sbjct: 513 QLEGIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTT 571

Query: 259 LKP---SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
                 +W  R NIA   A+G+ YLHE+C   I+HCDIKP+NIL+DD++ A++SDFGLAK
Sbjct: 572 DSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAK 631

Query: 316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 375
           LL    ++   +++RGT+GY+APEW     IT+K DVYS+G++LLE++S +++FD+    
Sbjct: 632 LLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKT 691

Query: 376 EYAILTDWAFDCYRNGKLDDLVEGDM--EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
            +   + WA++ +  G    +++  +  +   D++ V +++  S WCIQE P  RPTM K
Sbjct: 692 NHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGK 751

Query: 434 VSQMLEGVVEVDVPPNPSPFS 454
           V QMLEG+ E+  P  P   S
Sbjct: 752 VVQMLEGITEIKNPLCPKTIS 772

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  289 bits (739), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 157/334 (47%), Positives = 217/334 (64%), Gaps = 20/334 (5%)

Query: 132 FFIYK-KKWIRNSPGDGTVETNLR--------CFSYKALEEATDNFKEEAGRGSFGIVYK 182
           F I+K KK I  +P + + E N           F+YK L+ AT+NF  + G+G FG VY+
Sbjct: 450 FRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYE 509

Query: 183 GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV 242
           G    T    + +AVKKL+ + Q G+KEF+ EV +IG  HH +LVRL GFC EG +RLL 
Sbjct: 510 G----TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLA 564

Query: 243 YEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           YEFL+ G+L  ++F    G++   W+ R NIA   A+GL YLHEDC ++I+HCDIKP+NI
Sbjct: 565 YEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENI 624

Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVL 358
           LLDD++NA++SDFGLAKL+T  QS    T +RGT+GY+APEW     I+ K DVYS+G++
Sbjct: 625 LLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYGMV 683

Query: 359 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI-KCVEKLLMVS 417
           LLE+I  RK++D     E      +AF     GKL D+V+G M+ ++   + V++ +  +
Sbjct: 684 LLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKTA 743

Query: 418 IWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 451
           +WCIQED   RP+M KV QMLEGV  V  PP+ S
Sbjct: 744 LWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSS 777

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  273 bits (697), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 162/430 (37%), Positives = 240/430 (55%), Gaps = 22/430 (5%)

Query: 32  NEVQCKNSCLSDCFCAAVIF----EDDSCCFKKLPLSNGMTDSRITSKAFIKYKNKGDDP 87
           N  +C   CLSDC C A ++    E   C   K     G  D    S  F+K +     P
Sbjct: 396 NVRKCGEMCLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDP--GSTLFVKTRANESYP 453

Query: 88  PSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVCGVGLGFFF-IYKKKWIRNSPGD 146
            +       +D K RK       VL+   V     +V  +G+  ++ + +K+ ++ +  +
Sbjct: 454 SNSNN----NDSKSRKSHGLRQKVLVIPIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKN 509

Query: 147 GTVETNLRC-FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ 205
             +  +    F+Y+ L+  T+NF +  G G FG VYKG +       T VAVK+LDR   
Sbjct: 510 SLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTV----AGETLVAVKRLDRALS 565

Query: 206 DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS--- 262
            GE+EF  EV  IG  HH NLVRL G+C E  +RLLVYE++ NG+L  ++F + + +   
Sbjct: 566 HGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLL 625

Query: 263 -WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ 321
            W  R  IA   A+G+ Y HE C ++IIHCDIKP+NILLDD++  ++SDFGLAK++    
Sbjct: 626 DWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREH 685

Query: 322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT 381
           S  + T IRGT+GY+APEW     IT K DVYS+G+LLLEI+  R++ D+    E     
Sbjct: 686 SHVV-TMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYP 744

Query: 382 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
            WA+    NG     V+  ++ + + + V K L V+ WCIQ++ S+RP+M +V ++LEG 
Sbjct: 745 GWAYKELTNGTSLKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGT 804

Query: 442 V-EVDVPPNP 450
             E+++PP P
Sbjct: 805 SDEINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  266 bits (681), Expect = 2e-70,   Method: Compositional matrix adjust.
 Identities = 143/313 (45%), Positives = 200/313 (63%), Gaps = 17/313 (5%)

Query: 145 GDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF 204
           GDGT    L  FSY+ L+ AT NF ++ G G FG V+KG +      ++ +AVK+L+ + 
Sbjct: 476 GDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALP----DSSDIAVKRLEGIS 527

Query: 205 QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----L 259
           Q GEK+F+ EVV IG   H NLVRL GFC EG  +LLVY+++ NG+L S LF N     +
Sbjct: 528 Q-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKI 586

Query: 260 KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 319
              W LR  IA   ARGL YLH++C   IIHCDIKP+NILLD  +  +++DFGLAKL+  
Sbjct: 587 VLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR 646

Query: 320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 379
           + S+ + T +RGT+GY+APEW     ITAK DVYS+G++L E++S R++ +    E+   
Sbjct: 647 DFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRF 705

Query: 380 LTDWAFDCY-RNGKLDDLVEGDMEA-MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
              WA     ++G +  LV+  +E    DI+ V +   V+ WCIQ++ S RP M +V Q+
Sbjct: 706 FPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQI 765

Query: 438 LEGVVEVDVPPNP 450
           LEGV+EV+ PP P
Sbjct: 766 LEGVLEVNPPPFP 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  254 bits (648), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 139/306 (45%), Positives = 188/306 (61%), Gaps = 17/306 (5%)

Query: 146 DGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ 205
           DG    NL+ FS+K L+ AT+ F ++ G G FG V+KG +     S+T VAVK+L+R   
Sbjct: 441 DGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPG---SSTFVAVKRLERP-G 496

Query: 206 DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---S 262
            GE EF+ EV  IG   H NLVRL GFC E  +RLLVY+++  G+L+S+L     P   S
Sbjct: 497 SGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL-SRTSPKLLS 555

Query: 263 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
           W  R  IA   A+G+ YLHE C   IIHCDIKP+NILLD  YNA++SDFGLAKLL  + S
Sbjct: 556 WETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFS 615

Query: 323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIE---MGEEYAI 379
           + + T +RGT GYVAPEW     IT K DVYSFG+ LLE+I  R++  +    +GE+   
Sbjct: 616 RVLAT-MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETE 674

Query: 380 LTDWAFDCYR-----NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
              W F  +       G +D +V+  +    + + V ++  V+IWCIQ++  +RP M  V
Sbjct: 675 PEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTV 734

Query: 435 SQMLEG 440
            +MLEG
Sbjct: 735 VKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  252 bits (643), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 171/478 (35%), Positives = 253/478 (52%), Gaps = 54/478 (11%)

Query: 5   YNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDS-CCFKKLPL 63
           Y+K    F  + N D+  SD +     +   C++ C+SDC C    +++ +  C+ K  L
Sbjct: 345 YDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYL 404

Query: 64  SNGMT----DSRI----------TSKAFIKYKNKGDDPPSVPRPPDPD--DKKKRKMMNA 107
            +G T    D R            S A I   +  D   SVPR  D D  +K  R+    
Sbjct: 405 FSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFD---SVPRRLDCDRMNKSIREPFPD 461

Query: 108 TGSVLLGSSVFVNF---------AMVCGVGLGFFFIYKKK------WIRNSPGDGTVETN 152
                 G S +  F           V  +   +FF+ K++      W  +  G   + +N
Sbjct: 462 VHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWA-SEKGYKAMTSN 520

Query: 153 LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK 212
            R +SY+ L +AT  FK E GRG  G VYKGV+E  R     VAVKKL+ V Q G++ F+
Sbjct: 521 FRRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDR----HVAVKKLENVRQ-GKEVFQ 575

Query: 213 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNI 269
            E+ VIG+ +H NLVR+ GFC EG +RLLV E++ NG+LA+ LF   GN+   W  R NI
Sbjct: 576 AELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNI 635

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           A  +A+GL YLH +C   +IHCD+KP+NILLD  +  +I+DFGL KLL    S    + +
Sbjct: 636 ALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHV 695

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTDWA--F 385
           RGT GY+APEW     ITAKVDVYS+GV+LLE+++  +  ++  G  E +++L       
Sbjct: 696 RGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRML 755

Query: 386 DCYRNGKLDDLVEGDMEA-----MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
                G+    ++G +++     +N ++    L+ +++ C++ED S RPTM    Q L
Sbjct: 756 SAKLEGEEQSWIDGYLDSKLNRPVNYVQA-RTLIKLAVSCLEEDRSKRPTMEHAVQTL 812

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  243 bits (621), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 128/314 (40%), Positives = 183/314 (58%), Gaps = 28/314 (8%)

Query: 156 FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV 215
           F ++ LE+AT+NFK + G G FG VYKG    T    T +AVKK+      G +EF  E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560

Query: 216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQI 273
            +IG   H NLV+L GFC  G+  LLVYE++N+G+L   LF    P   W  R +IA   
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
           ARGL YLH  C  +IIHCD+KP+NILL DH+  +ISDFGL+KLL   +S ++ T +RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTR 679

Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD----------- 382
           GY+APEW   + I+ K DVYS+G++LLE++S RK+         ++  D           
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFR-SRSNSVTEDNNQNHSSTTTT 738

Query: 383 ---------WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
                    +A D +  G+  +L +  +E     +  EKL+ +++ C+ E+P+LRPTM  
Sbjct: 739 STGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAA 798

Query: 434 VSQMLEGVVEVDVP 447
           V  M EG + +  P
Sbjct: 799 VVGMFEGSIPLGNP 812

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  234 bits (596), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 137/361 (37%), Positives = 212/361 (58%), Gaps = 18/361 (4%)

Query: 88  PSVPRPPDPDDK--KKRKMMNATGSV--LLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNS 143
           P+ P  P   +   KK  +  + G V  ++  +V V F ++  + LGF    ++K  + S
Sbjct: 256 PAFPTLPAVTNTATKKGSITISIGIVWAIIIPTVIVVFLVL--LALGFVVYRRRKSYQGS 313

Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEE--AGRGSFGIVYKGVIETTRTSTTAVAVKKLD 201
             D T+  +L+ F +KA+E+AT+ F E    GRG FG V+ GV+  T      VA+K+L 
Sbjct: 314 STDITITHSLQ-FDFKAIEDATNKFSESNIIGRGGFGEVFMGVLNGTE-----VAIKRLS 367

Query: 202 RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP 261
           +  + G +EFKNEVVV+ + HH+NLV+LLGFC EG+ ++LVYEF+ N +L  FLF   K 
Sbjct: 368 KASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLFDPTKQ 427

Query: 262 S---WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
               W  R NI   I RG+LYLH+D    IIH D+K  NILLD   N +I+DFG+A++  
Sbjct: 428 GQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFG 487

Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
           ++QS      I GT+GY+ PE+ R+   + + DVYSFGVL+LEII  R +  I   +   
Sbjct: 488 IDQSGANTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICGRNNRFIHQSDTTV 547

Query: 379 I-LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
             L  +A+  +RN    +LV+  +    + + V + + +++ C+Q +P+ RP++  ++ M
Sbjct: 548 ENLVTYAWRLWRNDSPLELVDPTISENCETEEVTRCIHIALLCVQHNPTDRPSLSTINMM 607

Query: 438 L 438
           L
Sbjct: 608 L 608

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  229 bits (583), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 125/304 (41%), Positives = 182/304 (59%), Gaps = 10/304 (3%)

Query: 156 FSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN 213
           F +KA+E AT+ F    + G+G FG VYKG    T +S   VAVK+L +    GEKEF+N
Sbjct: 314 FDFKAIEAATNCFLPINKLGQGGFGEVYKG----TLSSGLQVAVKRLSKTSGQGEKEFEN 369

Query: 214 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIA 270
           EVVV+ +  H+NLV+LLG+C EG+ ++LVYEF+ N +L  FLF +   +K  W  R  I 
Sbjct: 370 EVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKII 429

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
             IARG+LYLH+D    IIH D+K  NILLDD  N +I+DFG+A++  ++Q++ +   + 
Sbjct: 430 GGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVV 489

Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDI-EMGEEYAILTDWAFDCYR 389
           GT GY++PE+      + K DVYSFGVL+LEIIS  K+  + +M E    L  + +  + 
Sbjct: 490 GTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWS 549

Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN 449
           NG   +LV+           + + + +++ C+QED   RPTM  + QML   +     P 
Sbjct: 550 NGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPR 609

Query: 450 PSPF 453
           P  F
Sbjct: 610 PPGF 613

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
224099309	801	predicted protein [Populus trichocarpa]	0.940	0.534	0.614	1e-153
356575025	800	PREDICTED: G-type lectin S-receptor-like	0.971	0.552	0.597	1e-150
255544746	800	ATP binding protein, putative [Ricinus c	0.949	0.54	0.610	1e-149
224103119	799	predicted protein [Populus trichocarpa]	0.964	0.549	0.599	1e-148
224143661	691	predicted protein [Populus trichocarpa]	0.870	0.573	0.603	1e-147
109676362	2037	CCHC-type integrase [Populus trichocarpa	0.896	0.200	0.640	1e-146
356528738	816	PREDICTED: G-type lectin S-receptor-like	0.971	0.541	0.591	1e-143
356555135	815	PREDICTED: G-type lectin S-receptor-like	0.969	0.541	0.589	1e-142
356503089	807	PREDICTED: G-type lectin S-receptor-like	0.956	0.539	0.582	1e-142
356503095	807	PREDICTED: G-type lectin S-receptor-like	0.956	0.539	0.58	1e-141

>gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 268/436 (61%), Positives = 330/436 (75%), Gaps = 8/436 (1%)

Query: 7   KELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFED-DSCCFKKLPLSN 65
           ++L+DF E+ N DWP SDY   KP+ E +C+ SCL+DC CA  IF   D C  KKLPLSN
Sbjct: 355 EDLYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSN 414

Query: 66  GMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVC 125
           G   + +  KA +K +    +P S   P  P++KK R  +   GSV LG SVFVNF +VC
Sbjct: 415 GRVQTNLDGKALLKVRRSNVNPRS---PYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVC 471

Query: 126 GVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVI 185
            + + FFFIY+++  R    DG VETNLRCF+Y+ L EAT+ FKEE GRG+FG+VYKGV+
Sbjct: 472 AIFMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVV 531

Query: 186 ETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 245
                S+  VAVKKL+ V +D  +EFK EV VIGQTHHKNLVRLLGFC+EG  RLLVYEF
Sbjct: 532 HIG--SSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEF 589

Query: 246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN 305
           ++NG+L+SF+F + KP W +R  IAF +ARGLLYLHE+CS+QIIHCDIKPQNILLD++YN
Sbjct: 590 MSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYN 649

Query: 306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISC 365
           ARISDFGLAKLL L+QS+T  TAIRGTKGYVAPEW+R   +T KVDVYS+GVLLLEII C
Sbjct: 650 ARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICC 708

Query: 366 RKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQED 424
           R++ D +   EE AILTDWA+DCYR G LD LV  D  A++DI+ +E+ LM++ WCIQED
Sbjct: 709 RRNVDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQED 768

Query: 425 PSLRPTMRKVSQMLEG 440
           PSLRPTMRKV+QMLEG
Sbjct: 769 PSLRPTMRKVTQMLEG 784

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  538 bits (1385), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 272/455 (59%), Positives = 333/455 (73%), Gaps = 13/455 (2%)

Query: 2   GQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKL 61
           GQ    +L+   E+ N DWP SDYE +KPYN   CK SCL DC CA  IF DDSC  KKL
Sbjct: 350 GQSLQGDLYFMKEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKL 409

Query: 62  PLSNGMTDSRITSKAFIK-YKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVN 120
           PLSNG  D  + + AFIK  KN     P  P   +   KK +  +    SVLLG SVF  
Sbjct: 410 PLSNGRRDRAVGASAFIKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVF-- 467

Query: 121 FAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIV 180
           F +V  V +GF+F Y KK   +S      E+NL  F++  L +ATDNFKEE GRGS GIV
Sbjct: 468 FNLVSAVWVGFYFYYNKK---SSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIV 524

Query: 181 YKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL 240
           YKG      T+   +AVKKLD+V +D +KEFK EV VIGQTHHK+LVRLLG+CDE Q+R+
Sbjct: 525 YKGT-----TNLATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRI 579

Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LVYEFL+NGTLA+FLFG+ KP+WN R  IAF IARGL+YLHE+C +QIIHCDIKPQNILL
Sbjct: 580 LVYEFLSNGTLANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILL 639

Query: 301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLL 360
           D+ YNARISDFGL+KLL +N+S T +T IRGTKGYVAP+W+R + IT KVDVYSFGVLLL
Sbjct: 640 DEQYNARISDFGLSKLLKINESHT-ETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLL 698

Query: 361 EIISCRKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW 419
           EII CR++ D E+G EE AILTDWA+DCYR G++D L+E D EA++D   +E+ +MV+IW
Sbjct: 699 EIICCRRNVDGEVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIW 758

Query: 420 CIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 454
           C+QEDPSLRP M+KV  MLEG+  V +PP+PSP++
Sbjct: 759 CLQEDPSLRPPMKKVMLMLEGIAPVTIPPSPSPYT 793

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis]

 Score =  533 bits (1373), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 268/439 (61%), Positives = 327/439 (74%), Gaps = 7/439 (1%)

Query: 8   ELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKLPLSNGM 67
           E +DF E+ N DWP SDYER+  YN  +C+ +C+ DCFC  V+F   SC  KKLPLSNG 
Sbjct: 356 EDYDFLELTNTDWPTSDYERYDSYNIEECQKACIQDCFCNVVVFRG-SCWKKKLPLSNGR 414

Query: 68  TDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVCGV 127
              ++  +AFIK +        +P  P P+ K+ +  +    SVLLGSSVF+NF ++  V
Sbjct: 415 QSEKVNGRAFIKVRKDDYMGRGLPPRPFPNAKEDQDSLVLVISVLLGSSVFINFILIGLV 474

Query: 128 GLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIET 187
              F F Y KK      G+   ++NLRCFSYK L EAT  FKEE GRGSFGIVYKG+IE 
Sbjct: 475 TFCFLFFYHKKSTGIPQGE---KSNLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEM 531

Query: 188 TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 247
              +T  VAVKKLDRV + GEKE+K EV  IGQTHHKNLV+LLGFCDEGQ +LLVYE L+
Sbjct: 532 G--TTVPVAVKKLDRVVEYGEKEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLS 589

Query: 248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR 307
           NGTLA+FLFG+ K SW  RT IAF IARGL+YLHE+C++QIIHCDIKPQNIL+D++Y+A+
Sbjct: 590 NGTLANFLFGDTKLSWKQRTQIAFGIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAK 649

Query: 308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRK 367
           ISDFGLAKLL L+QS+T  T IRGTKGYVAPEW+R   IT KVD YSFGVLLLEII  R+
Sbjct: 650 ISDFGLAKLLLLDQSQTF-TTIRGTKGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRR 708

Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
           S D E+  E AILTDWA+DCY  G++DDLVE D EA++D+K VE+ LMV+IWCIQEDP+L
Sbjct: 709 SVDTEISGERAILTDWAYDCYMEGRIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTL 768

Query: 428 RPTMRKVSQMLEGVVEVDV 446
           RPTM+ V  MLEG+++V V
Sbjct: 769 RPTMKTVILMLEGIIQVAV 787

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 269/449 (59%), Positives = 334/449 (74%), Gaps = 10/449 (2%)

Query: 7   KELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFED-DSCCFKKLPLSN 65
           ++L+DF E+ N DWP SDY   +P+ E +C+ SCL+DC CA  IF   D C  KKLPLSN
Sbjct: 355 EDLYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSN 414

Query: 66  GMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMVC 125
           G   + + +KA +K +    +P S   P  P++KK R  +   GSV LG SVFVNF +VC
Sbjct: 415 GRVQTIVDAKALLKVRRSNVNPRS---PYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVC 471

Query: 126 GVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVI 185
            + +GFFFIY+++  R    DG VETNLRCF+Y+ L EAT+ FKEE GRG+FG+VY+GV+
Sbjct: 472 AICMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVV 531

Query: 186 ETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 245
                S+  VAVKKL+ V +D  +EFK EV VIGQTHHKNLVRLLGFC+EG  RLLVYEF
Sbjct: 532 HIG--SSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEF 589

Query: 246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN 305
           ++NG+L+SF+F + KP W +R  IAF +ARGLLYLHED  SQIIHCDIKPQNILLD+  N
Sbjct: 590 MSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLDESLN 647

Query: 306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISC 365
           ARISDFGLAKLL  +Q+KT  TAIRGTKGYVAPEW++   +T KVD YSFG+LLLE++ C
Sbjct: 648 ARISDFGLAKLLKTDQTKT-TTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCC 706

Query: 366 RKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQED 424
           RK+F+I  M E   +L DWA DC + GKL+ LVE D EAM D+K VE+ +MV+IWCIQED
Sbjct: 707 RKNFEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQED 766

Query: 425 PSLRPTMRKVSQMLEGVVEVDVPPNPSPF 453
           PSLRP M+KV QMLEG V+V VPP+PS F
Sbjct: 767 PSLRPGMKKVVQMLEGGVQVSVPPDPSSF 795

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa]

 Score =  526 bits (1355), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 274/454 (60%), Positives = 319/454 (70%), Gaps = 58/454 (12%)

Query: 2   GQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKL 61
           G    ++ +DF E+ N+DWP SDYER+KP NE +C+ SCL+DC C+  IF D  C  KKL
Sbjct: 292 GLNSTEDQYDFVELINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRD-GCWKKKL 350

Query: 62  PLSNGMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNF 121
           PLSNG  D  +  KAF+K+               P   K  K+                 
Sbjct: 351 PLSNGRFDIGMNGKAFLKF---------------PKGYKTEKVKEG-------------- 381

Query: 122 AMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVY 181
               G GL                    ETNLR F+YK L EAT++FK+E GRG FG+VY
Sbjct: 382 ----GSGL--------------------ETNLRYFTYKELAEATNDFKDEVGRGGFGVVY 417

Query: 182 KGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 241
           KG I+    ST  VAVKKLD+V QDGEKEFK EV VIGQTHHKNLVRLLGFCDEGQNRLL
Sbjct: 418 KGTIQAG--STRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLL 475

Query: 242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD 301
           VYEFL+NGTLA+FLFG  KP+W  RT IAF IARGLLYLHE+C +QIIHCDIKPQNILLD
Sbjct: 476 VYEFLSNGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLD 535

Query: 302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
           ++YNARISDFGLAKLL ++QSKT +TAIRGTKGYVAPEW+R   IT KVDVYSFGV+LLE
Sbjct: 536 NYYNARISDFGLAKLLVMDQSKT-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLE 594

Query: 362 IISCRKSFDIEMGE-EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWC 420
           II CR++ D+E+GE E  +LTDWA+DCY +G LD L+  D EA NDI  +E+LL V IWC
Sbjct: 595 IICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKVGIWC 654

Query: 421 IQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 454
           IQEDPSLRPTMRKV+QMLEGVVEV   PNP P+S
Sbjct: 655 IQEDPSLRPTMRKVTQMLEGVVEVPAAPNPFPYS 688

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa]

 Score =  524 bits (1349), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 265/414 (64%), Positives = 315/414 (76%), Gaps = 6/414 (1%)

Query: 2   GQGYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDSCCFKKL 61
           G    ++ +DF E+ N+DWP SDYER+KP NE +C+ SCL+DC C+  IF D  C  KKL
Sbjct: 387 GLNSTEDQYDFVELINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRD-GCWKKKL 445

Query: 62  PLSNGMTDSRITSKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNF 121
           PLSNG  D  +  KAF+K+  KG  P   P P  P +KKK  +   TGSV+LG+SVFVNF
Sbjct: 446 PLSNGRFDIGMNGKAFLKFP-KGYVPLDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNF 504

Query: 122 AMVCGVGLGFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVY 181
            +V    L   FIY+KK  +   G   +ETNLR F+YK L EAT++FK+E GRG FG+VY
Sbjct: 505 VLVGAFCLTSSFIYRKKTEKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVY 564

Query: 182 KGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 241
           KG I+    ST  VAVKKLD+V QDGEKEFK EV VIGQTHHKNLVRLLGFCDEGQNRLL
Sbjct: 565 KGTIQAG--STRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLL 622

Query: 242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD 301
           VYEFL+NGTLA+FLFG  KP+W  RT IAF IARGLLYLHE+C +QIIHCDIKPQNILLD
Sbjct: 623 VYEFLSNGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLD 682

Query: 302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
           ++YNARISDFGLAKLL ++QSKT +TAIRGTKGYVAPEW+R   IT KVDVYSFGV+LLE
Sbjct: 683 NYYNARISDFGLAKLLVMDQSKT-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLE 741

Query: 362 IISCRKSFDIEMGE-EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL 414
           II CR++ D+E+GE E  +LTDWA+DCY +G LD L+  D EA NDI  +E+LL
Sbjct: 742 IICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLL 795

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528738|ref|XP_003532956.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  516 bits (1328), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 269/455 (59%), Positives = 334/455 (73%), Gaps = 13/455 (2%)

Query: 7   KELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFE-DDSCCFKKLPLSN 65
           ++L+DF  + + DWPQSDY   +P+NE QC+ SC+ DC C+  IF   DSC  KKLPLSN
Sbjct: 364 QDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDSCWKKKLPLSN 423

Query: 66  GMTDSRIT-SKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMV 124
           G  D+ +  +KAF+K +    D  S+  PP   +K  +      GSVLLGSS F+N  +V
Sbjct: 424 GRVDATLNGAKAFMKVRK---DNSSLIVPPIIVNKNNKNTSILVGSVLLGSSAFLNLILV 480

Query: 125 CGVGLG--FFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYK 182
             + L   + F YKKK       D  VETNLR F+Y+ L++AT++F +  G+G+FGIVY+
Sbjct: 481 GAICLSTSYVFRYKKKLRSIGRSDTIVETNLRRFTYEELKKATNDFDKVLGKGAFGIVYE 540

Query: 183 GVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 241
           GVI     S T VAVK+L+  + +D  KEFKNE+  IG THHKNLVRLLGFC+  + RLL
Sbjct: 541 GVINMC--SDTRVAVKRLNTFLMEDVHKEFKNELNAIGLTHHKNLVRLLGFCETEEKRLL 598

Query: 242 VYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           VYE+++NGTLAS LF  + KPSW LR  IA  IARGLLYLHE+CS+QIIHCDIKPQNILL
Sbjct: 599 VYEYMSNGTLASLLFNIVEKPSWKLRLQIAIGIARGLLYLHEECSTQIIHCDIKPQNILL 658

Query: 301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLL 360
           DD+YNARISDFGLAKLL +NQS+T  TAIRGTKGYVA EW++   ITAKVDVYS+GVLLL
Sbjct: 659 DDYYNARISDFGLAKLLNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLL 717

Query: 361 EIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW 419
           EI+SCRKS + E   EE AIL +WA+DCY  G L  LVEGD EA++D+K  EKL+M+++W
Sbjct: 718 EIVSCRKSVEFEAEDEEKAILAEWAYDCYIEGTLHALVEGDKEALDDMKTFEKLVMIALW 777

Query: 420 CIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 454
           C+QEDPSLRPTMR V+QMLEGVVEV +PP PS FS
Sbjct: 778 CVQEDPSLRPTMRNVTQMLEGVVEVKMPPCPSQFS 812

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555135|ref|XP_003545892.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  511 bits (1315), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 268/455 (58%), Positives = 332/455 (72%), Gaps = 14/455 (3%)

Query: 7   KELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFE-DDSCCFKKLPLSN 65
           K+L+DF  + + DWPQSDY   +P+NE QC+ SC+ DC C+  IF   DSC  KKLPLSN
Sbjct: 364 KDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDSCWKKKLPLSN 423

Query: 66  GMTDSRIT-SKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMV 124
           G  D+ +  +KAF+K +    D  S+  P    +K +   +   GSVLLGSS F+N  ++
Sbjct: 424 GRVDATLNGAKAFMKVRK---DNSSLIVPTIIVNKNRNTSI-LVGSVLLGSSAFLNLILL 479

Query: 125 CGVGLG--FFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYK 182
             + L   + F YKKK       D  VETNLRCF+YK LE+ATD F +  G+G+FGIVY+
Sbjct: 480 GAICLSTSYVFRYKKKLRSIGRSDTIVETNLRCFTYKELEKATDGFDKVLGKGAFGIVYE 539

Query: 183 GVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 241
           GVI     S T VAVK+L+  + +D  KEFKNE+  IG THHKNLVR+LGFC+  + RLL
Sbjct: 540 GVINMG--SDTRVAVKRLNTFLLEDVHKEFKNELNAIGLTHHKNLVRILGFCETEEKRLL 597

Query: 242 VYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           VYE+++NGTLAS LF  L KPSW LR  IA  +ARGLLYLHE+CS+QIIHCDIKPQNILL
Sbjct: 598 VYEYMSNGTLASLLFNILEKPSWELRLQIAIGVARGLLYLHEECSTQIIHCDIKPQNILL 657

Query: 301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLL 360
           DD+YNARISDFGLAKLL +NQS+T  TAIRGTKGYVA EW++   ITAKVDVYS+GVLLL
Sbjct: 658 DDYYNARISDFGLAKLLNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLL 716

Query: 361 EIISCRKSFDIEMGE-EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW 419
           EI+SCRKS + E  + E AIL +WA+DCY    L  LVEGD EA++D+K +EKL+M+++W
Sbjct: 717 EIVSCRKSVEFETEDKEKAILAEWAYDCYTERTLHALVEGDKEALDDMKNLEKLVMIALW 776

Query: 420 CIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 454
           C+QEDP LRPTMR V+QMLEGVVEV VPP PS  S
Sbjct: 777 CVQEDPDLRPTMRNVTQMLEGVVEVKVPPCPSQIS 811

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356503089|ref|XP_003520344.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  509 bits (1312), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 262/450 (58%), Positives = 328/450 (72%), Gaps = 15/450 (3%)

Query: 7   KELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFE-DDSCCFKKLPLSN 65
           ++L+DF  + + DWP SDY   KP+ E QC+ SC+ DC C+  IF   DSC  KKLPLSN
Sbjct: 358 EDLYDFEVLIDTDWPLSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKKLPLSN 417

Query: 66  GMTDSRIT-SKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMV 124
           G  D+ +  +KAF+K +    D  S+  PP    K  R  +     VLL  S  +N  +V
Sbjct: 418 GRVDATLNGAKAFMKVRK---DNSSLVVPPIIVKKNSRNTL----IVLLSGSACLNLILV 470

Query: 125 CGVGLGFFFIY--KKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYK 182
             + L  F+++  KKK  R       VETNLRCF+Y+ LEEAT+ F++  G+G+FGIVY+
Sbjct: 471 GAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGAFGIVYE 530

Query: 183 GVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 241
           GVI     S T VAVK+L+  + ++ +KEFKNE+ VIG THHKNLVRLLGFC+    RLL
Sbjct: 531 GVINMG--SLTLVAVKRLNTFLLEEVQKEFKNELNVIGLTHHKNLVRLLGFCETQDERLL 588

Query: 242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD 301
           VYE+++NGTLAS +F   KPSW LR  IA  +ARGLLYLHE+CS+QIIHCDIKPQNILLD
Sbjct: 589 VYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKPQNILLD 648

Query: 302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
           D+YNARISDFGLAK+L +NQS+T  TAIRGTKGYVA EW++   ITAKVDVYS+GVLLLE
Sbjct: 649 DYYNARISDFGLAKILNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLLE 707

Query: 362 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCI 421
           I+SCRKS + E  EE AILT+WAFDCY  G L DLVE D EA++D+K +EKL+M+++WC+
Sbjct: 708 IVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVMIALWCV 767

Query: 422 QEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 451
           QEDP LRPTMR V+QMLEGVVEV +PP PS
Sbjct: 768 QEDPGLRPTMRNVTQMLEGVVEVQIPPCPS 797

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356503095|ref|XP_003520347.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max]

 Score =  509 bits (1310), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 261/450 (58%), Positives = 327/450 (72%), Gaps = 15/450 (3%)

Query: 7   KELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFE-DDSCCFKKLPLSN 65
           ++L+DF  + + DWP SDY   KP+ E QC+ SC+ DC C+  IF   DSC  KKLPLSN
Sbjct: 358 EDLYDFEVLIDTDWPSSDYVLQKPFTEEQCRQSCMEDCLCSVAIFRLGDSCWKKKLPLSN 417

Query: 66  GMTDSRIT-SKAFIKYKNKGDDPPSVPRPPDPDDKKKRKMMNATGSVLLGSSVFVNFAMV 124
           G  D+ +  +KAF+K +    D  S+  PP    K  R  +     VLL  S  +N  +V
Sbjct: 418 GRVDATLNGAKAFMKVRK---DNSSLVVPPIIVKKNSRNTL----IVLLSGSACLNLILV 470

Query: 125 CGVGLGFFFIY--KKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYK 182
             + L  F+++  KKK  R       VETNLRCF+Y+ LEEAT+ F++  G+G+FGIVY+
Sbjct: 471 GAICLSSFYVFWCKKKLRRVGKSGTNVETNLRCFTYEELEEATNGFEKVLGKGAFGIVYE 530

Query: 183 GVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL 241
           GVI     S T VAVK+L+  + ++ +KEFKNE+  IG THHKNLVRLLGFC+    RLL
Sbjct: 531 GVINMG--SLTLVAVKRLNTFLLEEVQKEFKNELNAIGLTHHKNLVRLLGFCETQDERLL 588

Query: 242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD 301
           VYE+++NGTLAS +F   KPSW LR  IA  +ARGLLYLHE+CS+QIIHCDIKPQNILLD
Sbjct: 589 VYEYMSNGTLASLVFNVEKPSWKLRLQIATGVARGLLYLHEECSTQIIHCDIKPQNILLD 648

Query: 302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
           D+YNARISDFGLAK+L +NQS+T  TAIRGTKGYVA EW++   ITAKVDVYS+GVLLLE
Sbjct: 649 DYYNARISDFGLAKILNMNQSRT-NTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLLE 707

Query: 362 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCI 421
           I+SCRKS + E  EE AILT+WAFDCY  G L DLVE D EA++D+K +EKL+M+++WC+
Sbjct: 708 IVSCRKSVEFEADEEKAILTEWAFDCYTEGVLHDLVENDKEALDDMKTLEKLVMIALWCV 767

Query: 422 QEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 451
           QEDP LRPTMR V+QMLEGVVEV +PP PS
Sbjct: 768 QEDPGLRPTMRNVTQMLEGVVEVQIPPCPS 797

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.874	0.484	0.406	1.1e-73
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.887	0.487	0.378	5.3e-72
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.874	0.480	0.386	2.1e-68
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.457	0.238	0.493	1.1e-63
TAIR|locus:2019367	1078	AT1G29740 [Arabidopsis thalian	0.683	0.288	0.427	1.1e-56
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.731	0.500	0.392	3.3e-56
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.736	0.392	0.375	4.8e-56
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.663	0.355	0.402	6e-56
TAIR|locus:2197649	821	AT1G61360 [Arabidopsis thalian	0.648	0.359	0.373	1.1e-55
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.679	0.479	0.405	1.1e-55

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
 Identities = 176/433 (40%), Positives = 254/433 (58%)

Query:    36 CKNSCLSDCFCAAVIFEDDSC-CFKKLPLSNGMTDSRITSKAFIKYKNXXXXXXXXXXXX 94
             CK  C ++C C  + F++ S  CF    + +  T     S  F+ Y              
Sbjct:   363 CKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGS-GFVSYIKIASTGSGGGDNG 421

Query:    95 XXXXXXXXXMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYK-KKWIRNSPGDGTVETN- 152
                      ++     +++  +VF+  A++  V    F I+K KK I  +P + + E N 
Sbjct:   422 EDDGKHFPYVV-----IIVVVTVFI-IAVLIFVA---FRIHKRKKMILEAPQESSEEDNF 472

Query:   153 --------LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF 204
                     +R F+YK L+ AT+NF  + G+G FG VY+G    T    + +AVKKL+ + 
Sbjct:   473 LENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVYEG----TLPDGSRLAVKKLEGIG 527

Query:   205 QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----GNLK 260
             Q G+KEF+ EV +IG  HH +LVRL GFC EG +RLL YEFL+ G+L  ++F    G++ 
Sbjct:   528 Q-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVL 586

Query:   261 PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
               W+ R NIA   A+GL YLHEDC ++I+HCDIKP+NILLDD++NA++SDFGLAKL+T  
Sbjct:   587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646

Query:   321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
             QS    T +RGT+GY+APEW     I+ K DVYS+G++LLE+I  RK++D     E    
Sbjct:   647 QSHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHF 705

Query:   381 TDWAFDCYRNGKLDDLVEGDMEAMNDI--KCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
               +AF     GKL D+V+G M+ + D+  + V++ +  ++WCIQED   RP+M KV QML
Sbjct:   706 PSFAFKKMEEGKLMDIVDGKMKNV-DVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQML 764

Query:   439 EGVVEVDVPPNPS 451
             EGV  V  PP+ S
Sbjct:   765 EGVFPVVQPPSSS 777

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 728 (261.3 bits), Expect = 5.3e-72, P = 5.3e-72
 Identities = 166/438 (37%), Positives = 251/438 (57%)

Query:    36 CKNSCLSDCFC-AAVIFEDDSC-CFKKLPLS--NGMTDSRITSKAFIKYKNXXXXXXXXX 91
             C+ +CLS   C A+V   D S  C++K P S   G     + S +++K            
Sbjct:   350 CRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVANTLER 409

Query:    92 XXXXXXXXXXXXMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVET 151
                         +     +V+ G    V       V +G ++   +K    +P  GT+ +
Sbjct:   410 ATKGDDNNSKVHLWIVAVAVIAGLLGLV------AVEIGLWWCCCRK----NPRFGTLSS 459

Query:   152 NLRC----------FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD 201
             +             F+YK L+  T +FKE+ G G FG VY+GV+    T+ T VAVK+L+
Sbjct:   460 HYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVKQLE 515

Query:   202 RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNL 259
              + Q GEK+F+ EV  I  THH NLVRL+GFC +G++RLLVYEF+ NG+L +FLF   + 
Sbjct:   516 GIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSA 574

Query:   260 K-PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
             K  +W  R NIA   A+G+ YLHE+C   I+HCDIKP+NIL+DD++ A++SDFGLAKLL 
Sbjct:   575 KFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLN 634

Query:   319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
                ++   +++RGT+GY+APEW     IT+K DVYS+G++LLE++S +++FD+     + 
Sbjct:   635 PKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHK 694

Query:   379 ILTDWAFDCYRNGKLDDLVEGDM--EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
               + WA++ +  G    +++  +  +   D++ V +++  S WCIQE P  RPTM KV Q
Sbjct:   695 KFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQ 754

Query:   437 MLEGVVEVDVPPNPSPFS 454
             MLEG+ E+  P  P   S
Sbjct:   755 MLEGITEIKNPLCPKTIS 772

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 694 (249.4 bits), Expect = 2.1e-68, P = 2.1e-68
 Identities = 164/424 (38%), Positives = 235/424 (55%)

Query:    36 CKNSCLSDCFCAAVIFEDDS--CCFKKLPLSNGMTDSRITSKAFIKYKNXXXXXXXXXXX 93
             C ++C  DC C A  +++ S  C      + N        S+  I Y             
Sbjct:   372 CASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNVGA 431

Query:    94 XXXXXXXXXXMMNATGSVLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVETNL 153
                            G+VL    V V   +V  + L +    ++K +R   GDGT    L
Sbjct:   432 SGKSNNKGLIF----GAVLGSLGVIVLVLLVVILILRY---RRRKRMRGEKGDGT----L 480

Query:   154 RCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN 213
               FSY+ L+ AT NF ++ G G FG V+KG +      ++ +AVK+L+ + Q GEK+F+ 
Sbjct:   481 SAFSYRELQNATKNFSDKLGGGGFGSVFKGALP----DSSDIAVKRLEGISQ-GEKQFRT 535

Query:   214 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTN 268
             EVV IG   H NLVRL GFC EG  +LLVY+++ NG+L S LF N     +   W LR  
Sbjct:   536 EVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQ 595

Query:   269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
             IA   ARGL YLH++C   IIHCDIKP+NILLD  +  +++DFGLAKL+  + S+ + T 
Sbjct:   596 IALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL-TT 654

Query:   329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
             +RGT+GY+APEW     ITAK DVYS+G++L E++S R++ +    E+      WA    
Sbjct:   655 MRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATIL 714

Query:   389 -RNGKLDDLVEGDMEA-MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
              ++G +  LV+  +E    DI+ V +   V+ WCIQ++ S RP M +V Q+LEGV+EV+ 
Sbjct:   715 TKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNP 774

Query:   447 PPNP 450
             PP P
Sbjct:   775 PPFP 778

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 542 (195.9 bits), Expect = 1.1e-63, Sum P(3) = 1.1e-63
 Identities = 106/215 (49%), Positives = 143/215 (66%)

Query:   156 FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV 215
             F ++ LE+AT+NFK + G G FG VYKG    T    T +AVKK+      G +EF  E+
Sbjct:   505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560

Query:   216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQI 273
              +IG   H NLV+L GFC  G+  LLVYE++N+G+L   LF    P   W  R +IA   
Sbjct:   561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620

Query:   274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
             ARGL YLH  C  +IIHCD+KP+NILL DH+  +ISDFGL+KLL   +S ++ T +RGT+
Sbjct:   621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTR 679

Query:   334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS 368
             GY+APEW   + I+ K DVYS+G++LLE++S RK+
Sbjct:   680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)]

 Score = 592 (213.5 bits), Expect = 1.1e-56, P = 1.1e-56
 Identities = 139/325 (42%), Positives = 189/325 (58%)

Query:   127 VGLGFFFIYKKKW-IRNSPGDGTVETNLRCFSYKALEEATDNFK--EEAGRGSFGIVYKG 183
             V L F  +    W I  S  DG    +   FS + L+ ATD+F    + G G FG VYKG
Sbjct:   638 VSLSFLILGALYWRICVSNADGEKRGS---FSLRQLKVATDDFNPLNKIGEGGFGSVYKG 694

Query:   184 VIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY 243
              +     + T +AVKKL      G KEF NE+ +I    H NLV+L G C E    LLVY
Sbjct:   695 RLP----NGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEKTQLLLVY 750

Query:   244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD 301
             E+L N  LA  LFG   LK  W  R  I   IARGL +LHED + +IIH DIK  NILLD
Sbjct:   751 EYLENNCLADALFGRSGLKLDWRTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNILLD 810

Query:   302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
                N++ISDFGLA+L   +QS  I T + GT GY+APE+  +  +T K DVYSFGV+ +E
Sbjct:   811 KDLNSKISDFGLARLHEDDQSH-ITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAME 869

Query:   362 IISCRKSFDIEMGEEYAI-LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWC 420
             I+S + + +     E  + L DWAF   + G  D++++  +E + D+   E+++ VS+ C
Sbjct:   870 IVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLEGVFDVMEAERMIKVSLLC 929

Query:   421 IQEDPSLRPTMRKVSQMLEGVVEVD 445
               + P+LRPTM +V +MLEG  E++
Sbjct:   930 SSKSPTLRPTMSEVVKMLEGETEIE 954

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 579 (208.9 bits), Expect = 3.3e-56, P = 3.3e-56
 Identities = 137/349 (39%), Positives = 206/349 (59%)

Query:   117 VFVNFAMVCGVGLGFFFIYKKKWIRNSP-GDGTVET--NLRCFSYKALEEATDNFKEEAG 173
             V V+ A+   + +    I + K +RNS   D  VE    L+ +SY  +++ T++F    G
Sbjct:   279 VGVSAALTLMILIVVVIIVRTKNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFAHVLG 338

Query:   174 RGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC 233
             +G FG VYKG +     S   VAVK L +V +   +EF NEV  + +T H N+V LLGFC
Sbjct:   339 KGGFGTVYKGKLAD---SGRDVAVKIL-KVSEGNGEEFINEVASMSRTSHVNIVSLLGFC 394

Query:   234 DEGQNRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC 291
              E   R ++YEF+ NG+L  ++  N+  K  W    ++A  I+RGL YLH  C ++I+H 
Sbjct:   395 YEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHF 454

Query:   292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS--TITAK 349
             DIKPQNIL+D++   +ISDFGLAKL    +S      +RGT GY+APE + K+   ++ K
Sbjct:   455 DIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHK 514

Query:   350 VDVYSFGVLLLEIISCRKSFDIEM-GEEYAIL--TDWAFDCYRNGKLDDLVEGDMEAMND 406
              DVYS+G+++LE+I  +    +E  G     +   +W +  +  G++  +  GD     +
Sbjct:   515 SDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYKDFEKGEITRIF-GDSITDEE 573

Query:   407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE-VDVPPNPSPFS 454
              K  +KL++V++WCIQ +PS RP M KV +MLEG +E + VPPNP  FS
Sbjct:   574 EKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLFS 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 563 (203.2 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
 Identities = 132/352 (37%), Positives = 200/352 (56%)

Query:   111 VLLGSSVFVNFAMVCGVGLGFFFIYKKKWIRNSPGDGTVET--NLRCFSYKALEEATDNF 168
             +L GS+  +    +  + L     + K+  ++   D  +E    L+ +S++ +++ T++F
Sbjct:   464 ILGGSAALIVLISIVVIALVVRARHAKR--KSELNDENIEAVVMLKRYSFEKVKKMTNSF 521

Query:   169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
                 G+G FG VYKG +     S   +A+K L     +GE EF NE+V + +  H N+V 
Sbjct:   522 DHVIGKGGFGTVYKGKLPDA--SGRDIALKILKESKGNGE-EFINELVSMSRASHVNIVS 578

Query:   229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSS 286
             L GFC EG  R ++YEF+ NG+L  F+  N+  K  W    NIA  +ARGL YLH  C S
Sbjct:   579 LFGFCYEGSQRAIIYEFMPNGSLDKFISENMSTKIEWKTLYNIAVGVARGLEYLHNSCVS 638

Query:   287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST- 345
             +I+H DIKPQNIL+D+    +ISDFGLAKL    +S       RGT GY+APE + K+  
Sbjct:   639 KIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYG 698

Query:   346 -ITAKVDVYSFGVLLLEIISCRKSFDIEMG---EEYAILTDWAF-DCYRNGKLDDLVEGD 400
              ++ K DVYS+G+++LE+I   K  ++E     +      DW + D  R   +  L +  
Sbjct:   699 GVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHI 758

Query:   401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG--VVEVDVPPNP 450
             +E   + K V+++ +V +WCIQ +PS RP MRKV +MLEG  +  + VPP P
Sbjct:   759 IEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLEALQVPPKP 810

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 553 (199.7 bits), Expect = 6.0e-56, Sum P(2) = 6.0e-56
 Identities = 126/313 (40%), Positives = 185/313 (59%)

Query:   145 GDGTVETNLRCFSYKALEEATDNF-KE-EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR 202
             G     + L  FS  A+  AT++F KE E GRG FG VYKGV+E  R     +AVK+L  
Sbjct:   506 GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE----IAVKRLSG 561

Query:   203 VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS 262
                 G  EFKNE+++I +  H+NLVRLLG C EG+ ++LVYE++ N +L  FLF   K +
Sbjct:   562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621

Query:   263 ---WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 319
                W LR +I   IARGLLYLH D   +IIH D+K  N+LLD   N +ISDFG+A++   
Sbjct:   622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681

Query:   320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 379
             NQ++     + GT GY++PE+  +   + K DVYSFGVLLLEI+S +++  +    E+  
Sbjct:   682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGS 740

Query:   380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             L  +A+  Y +G+ ++LV+  +      +   + + V++ C+Q+  + RP M  V  MLE
Sbjct:   741 LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800

Query:   440 G-VVEVDVPPNPS 451
                  +  P  P+
Sbjct:   801 SDTATLAAPRQPT 813

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)]

 Score = 519 (187.8 bits), Expect = 1.1e-55, Sum P(2) = 1.1e-55
 Identities = 115/308 (37%), Positives = 181/308 (58%)

Query:   151 TNLRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE 208
             + L  F    L+ AT+NF    + G+G FG VYKG ++  +     +AVK+L      G 
Sbjct:   481 SGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKE----IAVKRLTSSSVQGT 536

Query:   209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNL 265
             +EF NE+ +I +  H+NL+RLLG C +G+ +LLVYE++ N +L  F+F     L+  W  
Sbjct:   537 EEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWAT 596

Query:   266 RTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
             R NI   IARGLLYLH D   +++H D+K  NILLD+  N +ISDFGLA+L   NQ +  
Sbjct:   597 RFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDS 656

Query:   326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 385
               ++ GT GY++PE+    T + K D+YSFGVL+LEII+ ++      G++   L  +A+
Sbjct:   657 TGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAW 716

Query:   386 DCY-RNGKLDDLVEGDMEAMNDIKCVE--KLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
             D +  NG ++ L++ D++  + +  VE  + + + + C+Q     RP +++V  ML    
Sbjct:   717 DSWSENGGVN-LLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTT 775

Query:   443 EVDVPPNP 450
             ++  P  P
Sbjct:   776 DLPKPTQP 783

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
 Identities = 133/328 (40%), Positives = 196/328 (59%)

Query:   136 KKKWIRNSPGDGTVETNLRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTT 193
             +K+ +     D T   +L+ F +KA+E AT+ F    + G+G FG VYKG    T +S  
Sbjct:   295 EKEPVAEDGNDITTAGSLQ-FDFKAIEAATNCFLPINKLGQGGFGEVYKG----TLSSGL 349

Query:   194 AVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
              VAVK+L +    GEKEF+NEVVV+ +  H+NLV+LLG+C EG+ ++LVYEF+ N +L  
Sbjct:   350 QVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDH 409

Query:   254 FLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD 310
             FLF +   +K  W  R  I   IARG+LYLH+D    IIH D+K  NILLDD  N +I+D
Sbjct:   410 FLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIAD 469

Query:   311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
             FG+A++  ++Q++ +   + GT GY++PE+      + K DVYSFGVL+LEIIS  K+  
Sbjct:   470 FGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSS 529

Query:   371 I-EMGEEYAILTDWAFDCYRNGKLDDLVE---GDMEAMNDI-KCVEKLLMVSIWCIQEDP 425
             + +M E    L  + +  + NG   +LV+   GD    ++I +C+     +++ C+QED 
Sbjct:   530 LYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIH----IALLCVQEDA 585

Query:   426 SLRPTMRKVSQMLEGVVEVDVPPNPSPF 453
               RPTM  + QML   +     P P  F
Sbjct:   586 EDRPTMSSIVQMLTTSLIALAEPRPPGF 613

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	455
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-39
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-31
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-28
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-22
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-22
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-12
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	6e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (432), Expect = 2e-50
 Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG VY    + T      VA+K + +       E    E+ ++ + +H N+V+L G
Sbjct: 2   GEGGFGTVYLARDKKTGKK---VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
             ++  +  LV E+   G+L   L  N    S +    I  QI  GL YLH   S+ IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 291 CDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKSTITA 348
            D+KP+NILLD D+   +++DFGL+KLLT    K++   I GT  Y+APE    K   + 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 349 KVDVYSFGVLLLEIISCRK 367
           K D++S GV+L E+   + 
Sbjct: 174 KSDIWSLGVILYELPELKD 192

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (434), Expect = 3e-50
 Identities = 87/277 (31%), Positives = 129/277 (46%), Gaps = 41/277 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRLL 230
           G GSFG VYK   + T      VAVK L +  +  +K+   + E+ ++ +  H N+VRL+
Sbjct: 8   GSGSFGTVYKAKHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
              ++  +  LV E+   G L  +L      S +    IA QI RGL YLH +    IIH
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIH 121

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST-ITAK 349
            D+KP+NILLD++   +I+DFGLAK L  + S    T   GT  Y+APE          K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 350 VDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
           VDV+S GV+L E+++ +  F           I       +  D       + +  DL++ 
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK- 238

Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
                               C+ +DPS RPT  ++ Q
Sbjct: 239 -------------------KCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  164 bits (417), Expect = 1e-47
 Identities = 74/272 (27%), Positives = 120/272 (44%), Gaps = 35/272 (12%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 230
           G GSFG VY     +T +     VA+K + +     ++E    E+ ++ +  H N+VRL 
Sbjct: 8   GEGSFGKVYLARDKKTGKL----VAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
              ++     LV E+   G L   L   G L            QI   L YLH   S  I
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH---SKGI 118

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           +H D+KP+NILLD+  + +++DFGLA+   L+  + + T + GT  Y+APE         
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175

Query: 349 KVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDC-YRNGKLDDLVEGDMEAMN 405
            VD++S GV+L E+++ +  F  D ++ E +  +             +        EA +
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP------EAKD 229

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
            I+            + +DP  R T  +  Q 
Sbjct: 230 LIRK----------LLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  164 bits (417), Expect = 1e-47
 Identities = 86/281 (30%), Positives = 141/281 (50%), Gaps = 35/281 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 225
             ++ G G+FG VYKG ++         VAVK L +   +   +EF  E  ++ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHE 282
           +V+LLG C E +  ++V E++  G L  +L    +P   S +   + A QIARG+ YL  
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA---IRGTKGYVAPE 339
             S   IH D+  +N L+ ++   +ISDFGL++ L  +    +K     IR    ++APE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 398
             ++   T+K DV+SFGVLL EI +        +GEE Y  +++   +         L +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMSN--AEVLE-----YLKK 219

Query: 399 GD-MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           G  +    +  C  +L  + + C  EDP  RPT  ++ ++L
Sbjct: 220 GYRLPKPPN--CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (416), Expect = 2e-47
 Identities = 85/280 (30%), Positives = 138/280 (49%), Gaps = 34/280 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 225
             ++ G G+FG VYKG ++         VAVK L +   +   +EF  E  ++ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           +V+LLG C E +   +V E++  G L S+L    +P  +L    + A QIARG+ YL   
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA---IRGTKGYVAPEW 340
            S   IH D+  +N L+ ++   +ISDFGL++ L  +     +     IR    ++APE 
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPES 174

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
            ++   T+K DV+SFGVLL EI +        +GE+ Y  +++   +         L  G
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEQPYPGMSN--EEVLE-----YLKNG 219

Query: 400 D-MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
             +       C  +L  + + C  EDP  RPT  ++ ++L
Sbjct: 220 YRLPQPP--NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (409), Expect = 2e-46
 Identities = 91/285 (31%), Positives = 136/285 (47%), Gaps = 44/285 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLG 231
           G G+FG VYKG ++     TT VAVK L     + E K+F  E  V+ +  H N+VRLLG
Sbjct: 4   GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 232 FCDEGQNRLLVYEFLNNGTLASFL------FGNLKP---SWNLRTNIAFQIARGLLYLHE 282
            C E +   LV E++  G L  +L      F + +    S     + A QIA+G+ YL  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA- 122

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA----IRGTKGYVAP 338
             S + +H D+  +N L+ +    +ISDFGL++ +  +     KT     IR    ++AP
Sbjct: 123 --SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WMAP 176

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDL 396
           E  +    T+K DV+SFGVLL EI +        +G      +  +   +  R G     
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLEYLRKGYR--- 225

Query: 397 VEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
               +       C ++L  LM+S W  Q DP  RPT  ++ + LE
Sbjct: 226 ----LPKP--EYCPDELYELMLSCW--QLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  160 bits (407), Expect = 3e-46
 Identities = 86/282 (30%), Positives = 135/282 (47%), Gaps = 37/282 (13%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKN 225
             ++ G G+FG VYKG ++     T T VAVK L     + E+ EF  E  ++ +  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHE 282
           +VRLLG C +G+   +V E++  G L  FL      L         +A QIA+G+ YL  
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE- 119

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG---YVAPE 339
             S   +H D+  +N L+ ++   +ISDFGL++ +  +     +    G K    ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPE 174

Query: 340 WYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 398
             +    T+K DV+SFGVLL EI +   + +     EE   + +   D YR         
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYR--------- 222

Query: 399 GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQML 438
             +    +  C ++L  LM+   C   DP  RPT  ++ + L
Sbjct: 223 --LPRPEN--CPDELYELMLQ--CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 1e-39
 Identities = 80/274 (29%), Positives = 133/274 (48%), Gaps = 33/274 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           GRGSFG VY       + +   +AVK   L    ++  +  + E+ ++    H N+VR  
Sbjct: 9   GRGSFGSVYLA---LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 231 GFC-DEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           G   DE +N L ++ E+++ G+L+S L  FG L     +R     QI  GL YLH   S+
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLH---SN 120

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            I+H DIK  NIL+D     +++DFG AK L   ++     ++RGT  ++APE  R    
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG-DMEAMN 405
               D++S G  ++E+ + +  +  E+G   A L         +G+  ++ E    EA +
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWS-ELGNPMAALYKIGS----SGEPPEIPEHLSEEAKD 235

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            ++           C++ DP  RPT     ++L+
Sbjct: 236 FLRK----------CLRRDPKKRPT---ADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 9e-31
 Identities = 80/287 (27%), Positives = 122/287 (42%), Gaps = 41/287 (14%)

Query: 160 ALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 219
           A+           G+G FG V  G     +     VAVK L        + F  E  V+ 
Sbjct: 2   AINSKELKLGATIGKGEFGDVMLGDYRGQK-----VAVKCLKDD-STAAQAFLAEASVMT 55

Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGL 277
              H NLV+LLG   +G    +V E++  G+L  +L    +    L   +  A  +  G+
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            YL E      +H D+  +N+L+ +   A++SDFGLAK  +  Q  + K  ++ T    A
Sbjct: 116 EYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWT----A 167

Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           PE  R+   + K DV+SFG+LL EI S  +                    Y    L D+V
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVV 209

Query: 398 EG-----DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                   MEA     C  ++  V   C + DP+ RPT +++ + L 
Sbjct: 210 PHVEKGYRMEAPE--GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  125 bits (315), Expect = 1e-30
 Identities = 96/341 (28%), Positives = 155/341 (45%), Gaps = 36/341 (10%)

Query: 115 SSVFVNFAMVCGVGLGFFFIYKKKWI---RNSPGDGTVETNLRCFSYKALEEATDN---- 167
           +     F ++  V  GF FI  +  +   R    DGT E     F  K  +  T N    
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF--FDSKVSKSITINDILS 690

Query: 168 -FKEE--AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 224
             KEE    RG  G  YKG    +  +     VK+++ V      E  +    +G+  H 
Sbjct: 691 SLKEENVISRGKKGASYKG---KSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHP 743

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           N+V+L+G C   +   L++E++    L+  L      SW  R  IA  IA+ L +LH  C
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRC 800

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  ++  ++ P+ I++D      +    L  LL  +    I +A      YVAPE     
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETK 853

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL----DDLVEGD 400
            IT K D+Y FG++L+E+++ +   D E G   +I+ +WA  CY +  L    D  + GD
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV-EWARYCYSDCHLDMWIDPSIRGD 912

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
           + ++N  + VE ++ +++ C   DP+ RP    V + LE  
Sbjct: 913 V-SVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLESA 951

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 82/287 (28%), Positives = 123/287 (42%), Gaps = 42/287 (14%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ-TH 222
               + G GSFG VY             VA+K L +  +   KE   F  E+ ++    H
Sbjct: 3   RILRKLGEGSFGEVYLAR------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRTNIAFQIARGL 277
             N+V+L  F  +  +  LV E+++ G+L   L      G L  S  L   I  QI   L
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSAL 114

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTI----KTAIRGT 332
            YLH      IIH DIKP+NILLD      ++ DFGLAKLL    S +      +   GT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 333 KGYVAPEWYRKST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWA 384
            GY+APE     +    ++  D++S G+ L E+++    F+ E           I+ +  
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTM 431
                +       E   +A +D+  ++KLL        +DP  R + 
Sbjct: 232 TPSLASPLSPSNPELISKAASDL--LKKLL-------AKDPKNRLSS 269

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
            E+ G+G FG VYK      + +   VA+K +    ++ +++  NE+ ++ +  H N+V+
Sbjct: 5   LEKIGKGGFGEVYKA---RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YLHEDC 284
             G   +     +V EF + G+L   L  +   +    + IA+ + + LL    YLH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTE-SQIAY-VCKELLKGLEYLH--- 115

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S+ IIH DIK  NILL      ++ DFGL+    L+ +K   T + GT  ++APE     
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMV-GTPYWMAPEVINGK 172

Query: 345 TITAKVDVYSFGVLLLE 361
               K D++S G+  +E
Sbjct: 173 PYDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 36/273 (13%)

Query: 168 FKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 224
             +  GRG+FG+VYKG+ +ET       VA+K++   ++ ++  K    E+ ++    H 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDF----VAIKQISLEKIKEEALKSIMQEIDLLKNLKHP 59

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHE 282
           N+V+ +G  +   +  ++ E+  NG+L   +  FG      +L     +Q+ +GL YLHE
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHE 117

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
                +IH DIK  NIL       +++DFG+A    LN       ++ GT  ++APE   
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIE 172

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKS-FDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGD 400
            S  +   D++S G  ++E+++     +D+  M   + I+ D   D         L EG 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPP------LPEGI 223

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
              + D       LM    C Q+DP+LRPT ++
Sbjct: 224 SPELKD------FLMQ---CFQKDPNLRPTAKQ 247

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (291), Expect = 2e-29
 Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDGE----KEFKNEVVVIGQTHHKNLV 227
           G G FG V     +    +T   VAVK L+     GE     +F+ E+ ++    H+N+V
Sbjct: 13  GEGHFGKVELCRYDPLGDNTGEQVAVKSLNH---SGEEQHRSDFEREIEILRTLDHENIV 69

Query: 228 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHED 283
           +  G C++  G++  L+ E+L +G+L  +L  + +   NL+  +  + QI +G+ YL   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG-- 126

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYR 342
            S + IH D+  +NIL++     +ISDFGLAK+L  ++    +K        + APE  R
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 343 KSTITAKVDVYSFGVLLLEIIS-CRKS 368
            S  ++  DV+SFGV L E+ +    S
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  113 bits (284), Expect = 2e-28
 Identities = 74/223 (33%), Positives = 111/223 (49%), Gaps = 36/223 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 224
           F EE G G+FG VYKG +     R S T+VA+K L +      ++EF+ E  ++    H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------------------LKPSWNLR 266
           N+V LLG C + Q   +++E+L +G L  FL  N                  L  S  L 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL- 127

Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-----Q 321
            +IA QIA G+ YL    S   +H D+  +N L+ +    +ISDFGL++ +        Q
Sbjct: 128 -HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           SK++   +R    ++ PE       T + D++SFGV+L EI S
Sbjct: 184 SKSL-LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  111 bits (280), Expect = 4e-28
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 36/274 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G+GSFG VY   +           +K++D +    EKE +   NEV ++ + +H N+++ 
Sbjct: 9   GKGSFGKVYL--VRRKSDGKL-YVLKEID-LSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
               +E     +V E+ + G L+  +                +   Q+   L YLH   S
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---S 121

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +I+H DIKPQNI L  +   ++ DFG++K+L+       KT + GT  Y++PE  +   
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPELCQNKP 179

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR--NGKLDDLVEGDMEA 403
              K D++S G +L E+ + +  F+   GE    L        +   G+   +       
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFE---GENLLEL------ALKILKGQYPPIPSQYSSE 230

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
           + ++  V  LL       Q+DP  RP++ ++ Q 
Sbjct: 231 LRNL--VSSLL-------QKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 7e-27
 Identities = 67/197 (34%), Positives = 97/197 (49%), Gaps = 6/197 (3%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           +E G G+FG V KGV          VAVK L       G+KEF  E  V+ Q  H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L+G C +G+  +LV E    G L  +L    +   +    +A Q+A G+ YL        
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHF 116

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWYRKSTIT 347
           +H D+  +N+LL + + A+ISDFG+++ L          TA R    + APE       +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 348 AKVDVYSFGVLLLEIIS 364
           +K DV+S+GV L E  S
Sbjct: 177 SKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 86/287 (29%), Positives = 133/287 (46%), Gaps = 40/287 (13%)

Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIG 219
           E TD   K + G G +G VY+GV +  + S T VAVK L    +D    +EF  E  V+ 
Sbjct: 4   ERTDITMKHKLGGGQYGEVYEGVWK--KYSLT-VAVKTLK---EDTMEVEEFLKEAAVMK 57

Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGL 277
           +  H NLV+LLG C       ++ EF+  G L  +L    +   N      +A QI+  +
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---G 334
            YL        IH D+  +N L+ +++  +++DFGL++L+T        TA  G K    
Sbjct: 118 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIK 170

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGK 392
           + APE    +  + K DV++FGVLL EI +        I++ + Y +L          G 
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------EKGY 222

Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             +  EG         C  K+  +   C Q +PS RP+  ++ Q  E
Sbjct: 223 RMERPEG---------CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 70/203 (34%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           + + G G FG V+ G    T   TT VAVK L       E  F  E  ++ +  H  LV+
Sbjct: 11  ERKLGAGQFGEVWMG----TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQ 65

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 284
           L   C E +   +V E+++ G+L  FL         LR      +A QIA G+ YL    
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLE--- 120

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWY 341
           S   IH D+  +NIL+ ++   +I+DFGLA+L+  +      TA  G K    + APE  
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEAA 176

Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
                T K DV+SFG+LL EI++
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 6e-26
 Identities = 81/289 (28%), Positives = 136/289 (47%), Gaps = 45/289 (15%)

Query: 171 EAGRGSFGIVYKGVIETTRTST--TAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G+ +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLK--PSWNLRTNIAFQIARGL 277
           RLLG    GQ  L+V E +  G L S+L               P+      +A +IA G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL      + +H D+  +N ++ +    +I DFG+ +   + ++   +   +G KG   
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYR---KGGKGLLP 184

Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILT-DWAFDCYRN 390
             ++APE  +    T K DV+SFGV+L E+ +        + E+ Y  L+ +       +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------LAEQPYQGLSNEEVLKFVID 236

Query: 391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           G   DL E          C +KLL +   C Q +P +RPT  ++   L+
Sbjct: 237 GGHLDLPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (265), Expect = 1e-25
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THH 223
           F +  G GSF  V        + +    A+K LD+     +   K  K E  V+ +   H
Sbjct: 5   FGKIIGEGSFSTVVLA---KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 224 KNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 280
             +++L   F DE +N   V E+  NG L  ++  +G+L          A +I   L YL
Sbjct: 62  PGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYL 118

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS---------KTIKTAIR- 330
           H   S  IIH D+KP+NILLD   + +I+DFG AK+L  N S                + 
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 331 --------GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
                   GT  YV+PE   +       D+++ G ++ ++++ +  F 
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 32/277 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
              + G G FG V++G+      +TT VAVK L     D  K+F  E  ++ +  H  L+
Sbjct: 10  LLRKLGAGQFGEVWEGLW----NNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLI 64

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L   C   +   +V E +  G+L  +L G    +  L    ++A Q+A G+ YL    +
Sbjct: 65  QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---A 121

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYR 342
              IH D+  +N+L+ ++   +++DFGLA+++  +    I  A  G K    + APE   
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKWTAPEAAL 177

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 402
            +  + K DV+SFG+LL EI++  +         Y  +T        N ++   V+    
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRM-------PYPGMT--------NAEVLQQVDQGYR 222

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                 C ++L  + + C +EDP  RPT   +   LE
Sbjct: 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 3e-25
 Identities = 75/274 (27%), Positives = 120/274 (43%), Gaps = 44/274 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHHKNLVR 228
           G G+FG VY  V      +   +AVK++    QD +    KE  +E+ V+    H NLV+
Sbjct: 9   GGGTFGKVYTAV---NLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
             G     +   +  E+ + GTL   L  G +     +R     Q+  GL YLH   S  
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SHG 119

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI---RGTKGYVAPEWYRKS 344
           I+H DIKP NI LD +   ++ DFG A  L  N + T+   +    GT  Y+APE     
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 345 TITAK---VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----KLDDL 396
                    D++S G ++LE+ + ++ +  E+  E+ I+       +  G      + D 
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIM-------FHVGAGHKPPIPDS 230

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT 430
           ++   E  + +            C++ DP  RPT
Sbjct: 231 LQLSPEGKDFLD----------RCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (258), Expect = 5e-25
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
            + G G FG V++G+ +        VA+K L       +++F+ EV  + +  HK+L+ L
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
              C  G+   ++ E +  G+L +FL    G + P  +L  ++A Q+A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-IDMACQVAEGMAYLEE---Q 123

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLT----LNQSKTIKTAIRGTKGYVAPEWYR 342
             IH D+  +NIL+ +    +++DFGLA+L+     L+  K I         + APE   
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAAS 177

Query: 343 KSTITAKVDVYSFGVLLLEIIS 364
             T + K DV+SFG+LL E+ +
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 1e-24
 Identities = 75/269 (27%), Positives = 126/269 (46%), Gaps = 28/269 (10%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKGV I         VA+K L +       KE  +E  V+    H ++VRLL
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C       L+ + +  G L  ++     N+   + L  N   QIA+G+ YL E    +
Sbjct: 76  GIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLL--NWCVQIAKGMSYLEE---KR 129

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL +++ +      +    ++A E       T
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEAMND 406
            K DV+S+GV + E+++         G +        ++     ++ DL+E G+      
Sbjct: 190 HKSDVWSYGVTVWELMT--------FGAK-------PYEGIPAVEIPDLLEKGERLPQPP 234

Query: 407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
           I C   + MV + C   D   RPT +++ 
Sbjct: 235 I-CTIDVYMVLVKCWMIDAESRPTFKELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 22/204 (10%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
              E+ G G+ G VYK    T R +   VA+KK+ R+ +  ++   NE++++    H N+
Sbjct: 22  KNLEKIGEGASGEVYKA---TDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77

Query: 227 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN---IAF---QIARGLLY 279
           V          + L +V E+++ G+L   +  N      +R N   IA+   ++ +GL Y
Sbjct: 78  VDYYD-SYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEY 131

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH   S  +IH DIK  NILL    + +++DFG A  LT  +SK  + ++ GT  ++APE
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPE 186

Query: 340 WYRKSTITAKVDVYSFGVLLLEII 363
             ++     KVD++S G++ +E+ 
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 80/279 (28%), Positives = 133/279 (47%), Gaps = 34/279 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 228
           +  G G FG V +G ++        VA+K L     D ++ +F  E  ++GQ  H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           L G   + +  +++ E++ NG+L  FL  N  K +      +   IA G+ YL E     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS----KTIKTAIRGTKGYVAPE--WY 341
            +H D+  +NIL++ +   ++SDFGL++ L  +++    K  K  IR T    APE   Y
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182

Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 400
           RK   T+  DV+SFG+++ E++S         GE  Y    D +     N  +   VE  
Sbjct: 183 RK--FTSASDVWSFGIVMWEVMS--------YGERPYW---DMS-----NQDVIKAVEDG 224

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                 + C   L  + + C Q+D + RPT  ++   L+
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 10/191 (5%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G+GS G+VYK      + +    A+KK+      +  K+   E+  +       +V+  G
Sbjct: 10  GQGSSGVVYKVR---HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 232 -FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
            F  EG+  + V E+++ G+LA  L    K    +   IA QI +GL YLH      IIH
Sbjct: 67  AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            DIKP N+L++     +I+DFG++K   L  +        GT  Y++PE  +  + +   
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181

Query: 351 DVYSFGVLLLE 361
           D++S G+ LLE
Sbjct: 182 DIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 49/284 (17%)

Query: 168 FKEEAGRGSFGIV----YKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQ 220
           F +E G G FG+V    ++G I+        VA+K +    ++G   E +F  E  V+ +
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID--------VAIKMI----REGAMSEDDFIEEAKVMMK 55

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGL 277
             H NLV+L G C + +   +V E++ NG L ++L    G L   W L  ++   +   +
Sbjct: 56  LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAM 113

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---G 334
            YL     +  IH D+  +N L+ +    ++SDFGLA+ +  +Q     T+ +GTK    
Sbjct: 114 EYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVK 166

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           +  PE +  S  ++K DV+SFGVL+ E+ S  K                 ++ + N ++ 
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM---------------PYERFSNSEVV 211

Query: 395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           + V              ++  +   C  E P  RP  +K+   L
Sbjct: 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.5 bits (243), Expect = 5e-23
 Identities = 78/280 (27%), Positives = 129/280 (46%), Gaps = 47/280 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-----KEFKNEVVVIGQTHHKNLV 227
           G GSFG VY+G+           AVK++             K+ + E+ ++ +  H N+V
Sbjct: 9   GSGSFGSVYEGL---NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           + LG   E  N  +  E +  G+LA  L  +G+      +      QI  GL YLH    
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP--VIRLYTRQILLGLEYLH---D 120

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPE-WYRK 343
              +H DIK  NIL+D +   +++DFG+AK ++  + +K+ K    G+  ++APE   ++
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEVIAQQ 176

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL----DDLVEG 399
                  D++S G  +LE+ + +  +     E  A +    F   R+ +L    D L   
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQL--EGVAAV----FKIGRSKELPPIPDHL--- 227

Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             EA + I          + C+Q DPSLRPT    +++LE
Sbjct: 228 SDEAKDFI----------LKCLQRDPSLRPT---AAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 96.6 bits (240), Expect = 9e-23
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             +E G G FG+V+ G     R     VA+K +       E++F  E  V+ +  H  LV
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLV 62

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L G C E     LV+EF+ +G L+ +L    +  ++  T   +   +  G+ YL     
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN- 120

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYR 342
             +IH D+  +N L+ ++   ++SDFG+ + +  +Q     T+  GTK    + +PE + 
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----TSSTGTKFPVKWSSPEVFS 174

Query: 343 KSTITAKVDVYSFGVLLLEIIS 364
            S  ++K DV+SFGVL+ E+ S
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 97.3 bits (242), Expect = 9e-23
 Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 28/269 (10%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V+KG+ I    +    VA+K + DR  +   +E  + ++ +G   H  +VRLL
Sbjct: 16  GSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLL 75

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C  G +  LV +    G+L   +     +L P      N   QIA+G+ YL E     
Sbjct: 76  GIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEEHR--- 129

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H ++  +NILL      +I+DFG+A LL  +  K   +  +    ++A E       T
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEAMND 406
            + DV+S+GV + E++S          E YA +        R  ++ DL+E G+  A   
Sbjct: 190 HQSDVWSYGVTVWEMMSYG-------AEPYAGM--------RPHEVPDLLEKGERLAQPQ 234

Query: 407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
           I C   + MV + C   D ++RPT ++++
Sbjct: 235 I-CTIDVYMVMVKCWMIDENVRPTFKELA 262

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 58/283 (20%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAV-AVKKLD-RVFQDGEKEFK-NEVVVIGQTHHKNLVR- 228
           G+GS+G VYK      R S     A+K++D       E+E   NE+ ++   +H N++  
Sbjct: 9   GKGSYGSVYK----VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 229 ----LLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPS---WNLRTNIAFQIAR 275
               L G      N+L +V E+   G L+  +        L P    W     I  Q+ R
Sbjct: 65  KEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLR 114

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL  LHE    +I+H D+K  NILL  +   +I D G++K+L  N +KT      GT  Y
Sbjct: 115 GLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHY 167

Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKL 393
           +APE ++    + K D++S G LL E+ +    F+    ++  Y +           GK 
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---------GKY 218

Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
             +     + + +         +    +Q  P LRP   K+  
Sbjct: 219 PPIPPIYSQDLQN--------FIR-SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 44/285 (15%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV-KKLD-RVFQDGEKE-FKNEVVVIGQTHHKNL 226
           E  G+GSFG V K V    R S   + V K++D     + EK+   +EV ++ +  H N+
Sbjct: 6   ETIGKGSFGTVRK-VR---RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 227 VRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--------NIAFQIARG 276
           VR      D     L +V E+   G LA  +    +     R          I  Q+   
Sbjct: 62  VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI----QKCKKERKYIEEEFIWRILTQLLLA 117

Query: 277 LLYLH--EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           L   H   D  + ++H D+KP NI LD + N ++ DFGLAK+L  + S   KT + GT  
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYV-GTPY 175

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           Y++PE     +   K D++S G L+ E+ +    F          L        + GK  
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI----KEGKFR 228

Query: 395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +       +N++  ++ +L V       DP  RP+     ++L+
Sbjct: 229 RIPYRYSSELNEV--IKSMLNV-------DPDKRPS---TEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 67/199 (33%), Positives = 96/199 (48%), Gaps = 19/199 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G+GSFG V     + T       A+K L   ++ +  E E    E  ++ + +H  +V+L
Sbjct: 2   GKGSFGKVLLVRKKDTGK---LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 230 L-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
              F  E   +L LV E+   G L S L   G            A +I   L YLH   S
Sbjct: 59  HYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERARF--YAAEIVLALEYLH---S 111

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             II+ D+KP+NILLD   + +++DFGLAK L+   S+T      GT  Y+APE      
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVLLGKG 169

Query: 346 ITAKVDVYSFGVLLLEIIS 364
               VD +S GVLL E+++
Sbjct: 170 YGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 23/204 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E+ G+G+FG VYKGV++      T VAVK     +  D +++F  E  ++ Q  H N+V+
Sbjct: 1   EKIGKGNFGDVYKGVLKGN----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI----ARGLLYLHEDC 284
           L+G C + Q   +V E +  G+L +FL    K    L      Q+    A G+ YL    
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEW 340
               IH D+  +N L+ ++   +ISDFG+++     +   I T   G K     + APE 
Sbjct: 114 C---IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 341 YRKSTITAKVDVYSFGVLLLEIIS 364
                 T++ DV+S+G+LL E  S
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 41/291 (14%)

Query: 167 NFKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHH 223
               E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+     
Sbjct: 9   TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQI 273
            ++VRLLG   +GQ  L+V E + +G L S+L           G   P+      +A +I
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
           A G+ YL+   + + +H D+  +N ++   +  +I DFG+ +   + ++   +   +G K
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGK 180

Query: 334 G-----YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
           G     ++APE  +    T   D++SFGV+L EI S               L +  +   
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGL 225

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            N ++   V           C E++  +   C Q +P +RPT  ++  +L+
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 81/274 (29%), Positives = 127/274 (46%), Gaps = 37/274 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           E  G G FG V +G     +     VAVK  K D   Q     F  E  V+ + HHKNLV
Sbjct: 12  EIIGEGEFGAVLQGEYTGQK-----VAVKNIKCDVTAQ----AFLEETAVMTKLHHKNLV 62

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCS 285
           RLLG         +V E ++ G L +FL    +   ++   + F   +A G+ YL    S
Sbjct: 63  RLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---S 118

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +++H D+  +NIL+ +   A++SDFGLA++     S  +  +    K + APE  +   
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK-WTAPEALKHKK 173

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            ++K DV+S+GVLL E+ S  ++   +M  +   + +     YR           ME   
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGYR-----------MEPPE 220

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  +LM S W  + +P  RP+  K+ + LE
Sbjct: 221 GCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 84/297 (28%), Positives = 129/297 (43%), Gaps = 52/297 (17%)

Query: 173 GRGSFGIVYKGVIETT--RTSTTAVAVKKL--DRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V K           T+ VAVK L  D      EK+  + V       +IG+  
Sbjct: 21  GEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMKMIGK-- 74

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPSWNLR---- 266
           HKN++ LLG C +     +V E+  +G L  FL                 P   L     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
            + A+Q+ARG+ +L    S + IH D+  +N+L+ + +  +I+DFGLA+ +         
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  I  +  F
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------GSPYPGIPVEELF 244

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G         ME      C ++L  +   C  E PS RPT +++ + L+ ++
Sbjct: 245 KLLKEGY-------RME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 65/213 (30%), Positives = 116/213 (54%), Gaps = 25/213 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKE-------FKNEVVVIGQTHH 223
           G GSFG VY G+     +S   +AVK+  L  V    +            E+ ++ +  H
Sbjct: 9   GSGSFGSVYLGM---NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 224 KNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 280
           +N+V+ LG      + L ++ E++  G++A+ L  +G  + +  L  N   QI +GL YL
Sbjct: 66  ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEET--LVRNFVRQILKGLNYL 122

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN----QSKTIKTAIRGTKGYV 336
           H   +  IIH DIK  NIL+D+    +ISDFG++K L  N    ++   + +++G+  ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE  ++++ T K D++S G L++E+++ +  F
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 28/206 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+++       AVA+K L   + + ++ +F +E  ++GQ  H N++RL G
Sbjct: 14  GAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEG 73

Query: 232 FCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
              + +  +++ E++ NG L  +L      F + +    LR      IA G+ YL +   
Sbjct: 74  VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGMKYLSD--- 125

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVAPEW 340
              +H D+  +NIL++ +   ++SDFGL+++L  +   T  T+     IR T    APE 
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT----APEA 181

Query: 341 --YRKSTITAKVDVYSFGVLLLEIIS 364
             YRK   T+  DV+SFG+++ E++S
Sbjct: 182 IAYRK--FTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 94.6 bits (235), Expect = 5e-22
 Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 12/199 (6%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHHKNL 226
           E G G+FG V KG+ +  ++  T VAVK L     + +   K+E++    V+ Q  +  +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKT-VAVKILKN--DNNDPALKDELLREANVMQQLDNPYI 58

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VR++G C E ++ +LV E    G L  FL  N   +    T +  Q++ G+ YL E   +
Sbjct: 59  VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---T 114

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKST 345
             +H D+  +N+LL   + A+ISDFGL+K L  +++    KT  +    + APE      
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 346 ITAKVDVYSFGVLLLEIIS 364
            ++K DV+SFGVL+ E  S
Sbjct: 175 FSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 76/283 (26%), Positives = 136/283 (48%), Gaps = 43/283 (15%)

Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G+ +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L++ E +  G L S+L               PS      +A +IA G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 184

Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             +++PE  +    T   DV+SFGV+L EI               A L +  +    N +
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSNEQ 229

Query: 393 -LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 230 VLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 77/288 (26%), Positives = 137/288 (47%), Gaps = 41/288 (14%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLV 227
           +E  G G FG V +G ++        VA+K L   + + + ++F +E  ++GQ  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
            L G   + +  +++ EF+ NG L SFL      F  ++    LR      IA G+ YL 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAP 338
           E      +H D+  +NIL++ +   ++SDFGL++ L  + S    T+  G K    + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 339 E--WYRKSTITAKVDVYSFGVLLLEIISC--RKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           E   YRK   T+  DV+S+G+++ E++S   R  +D+                  N  + 
Sbjct: 181 EAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVI 221

Query: 395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
           + +E D      + C   L  + + C Q+D + RP   ++   L+ ++
Sbjct: 222 NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 8/199 (4%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           ++ G GSFG+V +G   T+      VAVK L      D   +F  E  ++    H+NL+R
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSS 286
           L G        ++V E    G+L   L  +    + + T  + A QIA G+ YL    S 
Sbjct: 61  LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVAPEWYRKST 345
           + IH D+  +NILL      +I DFGL + L  N+   +          + APE  R  T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 346 ITAKVDVYSFGVLLLEIIS 364
            +   DV+ FGV L E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 34/213 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLVRL 229
           G+G+FG V    I   R +    A+K +++     +   +N   E  ++ + +H  LV L
Sbjct: 9   GKGAFGKVC---IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 230 -LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ----------IARGLL 278
              F DE +N  LV + L  G L           ++L   + F           I   L 
Sbjct: 66  WYSFQDE-ENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YLH   S  IIH DIKP NILLD+  +  I+DF +A  +T   + T  T+  GT GY+AP
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTS--GTPGYMAP 168

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDI 371
           E   +   +  VD +S GV   E +  ++ +  
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 34/214 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTT--AVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G+            VAVK L     +  E +F  E +++ + +H+N+VRL
Sbjct: 15  GHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRL 74

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--------NIAFQIARGLLYLH 281
           +G   E   R ++ E +  G L SFL  N +P     +          A  +A+G  YL 
Sbjct: 75  IGVSFERLPRFILLELMAGGDLKSFLREN-RPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNAR---ISDFGLAKLLTLNQSKTIKTAIRGTKG---- 334
           E   +  IH DI  +N LL      R   I+DFG+A        + I  A    KG    
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRAM 182

Query: 335 ----YVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
               ++ PE +     T+K DV+SFGVLL EI S
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 16/201 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLG 231
           G+G FG VY G +  +       AVK L+R+    E ++F  E +++    H N++ LLG
Sbjct: 4   GKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLG 63

Query: 232 FC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAF--QIARGLLYLHEDCS 285
            C   EG   L+V  ++ +G L +F+      + N  ++  I F  Q+A+G+ YL    S
Sbjct: 64  ICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYL---AS 116

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWYRK 343
            + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++   T  +    ++A E  + 
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 344 STITAKVDVYSFGVLLLEIIS 364
              T K DV+SFGVLL E+++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 92.2 bits (229), Expect = 3e-21
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 14/205 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           GRG+FGIV+   +   +     V +K++  +++ +D     +NE  V+    H N++   
Sbjct: 9   GRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQI 288
               E +  ++V E+   GTLA ++        +  T + F  QI   LL LH   +  I
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKLI 122

Query: 289 IHCDIKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +H D+K QNILLD H    +I DFG++K+L+   SK+    + GT  Y++PE        
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE 372
            K D+++ G +L E+ S +++F+  
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 12/208 (5%)

Query: 169 KEEAGRGSFGIVYKGVIETTRT--STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             + G+GSFG+V+K V +  +   +   + + K++R  ++   E  +E  V+ +     +
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE---EAIDEARVLAKLDSSYI 61

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDC 284
           +R      +     +V E+  NG L   L          +       QI  GL +LH   
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--- 118

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S +I+H DIK  N+ LD + N +I D G+AKL  L+ +      I GT  Y++PE     
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIE 372
               K DV++ GV+L E  + +  FD  
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN--EVVVIGQTHHKNLVRLL 230
           G G++G+VYK      + +   VA+KK+   F+          E+ ++ + +H N+++LL
Sbjct: 8   GEGTYGVVYKA---RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSSQII 289
                  +  LV+EF++   L   +    +    +L  +  +Q+ +GL + H   S  I+
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGIL 120

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI--- 346
           H D+KP+N+L++     +++DFGLA+           + +R    YV   WYR   +   
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF--------GSPVRPYTHYVVTRWYRAPELLLG 172

Query: 347 ----TAKVDVYSFGVLLLEIISCRKSF 369
               +  VD++S G +  E++S R  F
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.8 bits (230), Expect = 6e-21
 Identities = 71/229 (31%), Positives = 110/229 (48%), Gaps = 33/229 (14%)

Query: 158 YKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 217
           Y  LE     F++  G G+FG V K  I+       A   +  +   +D  ++F  E+ V
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 218 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 274
           + +  HH N++ LLG C+      L  E+  +G L  FL    + S  L T+ AF IA  
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116

Query: 275 ------------------RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
                             RG+ YL +    Q IH D+  +NIL+ ++Y A+I+DFGL++ 
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 173

Query: 317 LTLNQSKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
             +   KT+ +  +R    ++A E    S  T   DV+S+GVLL EI+S
Sbjct: 174 QEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 18/200 (9%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           ++ G G FG V+ G         T VA+K L +     E  F  E  ++ Q  H  LVRL
Sbjct: 12  KKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL 66

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++       
Sbjct: 67  YAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KN 122

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ +    +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 178

Query: 345 TITAKVDVYSFGVLLLEIIS 364
           T T K DV+SFG+LL EI++
Sbjct: 179 TFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 78/291 (26%), Positives = 137/291 (47%), Gaps = 24/291 (8%)

Query: 162 EEATDNFKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDGEKEFKNEVVVIGQ 220
           EE    F ++ G+G+FG V     +  + +T   VAVKKL     +  ++F+ E+ ++  
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61

Query: 221 THHKNLVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARG 276
             H N+V+  G C   G+  L LV E+L  G+L  +L  + +   + R  + +  QI +G
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKG 120

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 335
           + YL    S + +H D+  +NIL++     +I DFGL K+L  ++    ++        +
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKS------FDIEMGEEYAILTDWAFDCY 388
            APE   +S  +   DV+SFGV+L E+ +   KS      F   MG +           Y
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND----KQGQMIVY 233

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               L +L++ +        C  ++  +   C   DPS RP+  +++  +E
Sbjct: 234 H---LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 32/220 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 224
            K E G G+FG V+ G             VAVK L +    D  K+F+ E  ++    H+
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------IA 270
           N+V+  G C EG   ++V+E++ +G L  FL  +   +  L++               IA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-- 328
            QIA G++YL    S   +H D+  +N L+      +I DFG+++ +       +     
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 329 --IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIIS 364
             IR    ++ PE   YRK T  +  DV+SFGV+L EI +
Sbjct: 186 LPIR----WMPPESIMYRKFTTES--DVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 44/287 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V +G +     S   VAVK  KLD       +EF +E   +    H N+++L+
Sbjct: 8   GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLI 67

Query: 231 GFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGLL 278
           G C E  +       +++  F+ +G L SFL     G L     L+T + F   IA G+ 
Sbjct: 68  GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL----TLNQSKTIKTAIRGTKG 334
           YL    +   IH D+  +N +L +     ++DFGL+K +       Q +  K  ++    
Sbjct: 128 YL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---- 180

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           ++A E       T+K DV++FGV + EI +         G+         +    N ++ 
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RGQT-------PYPGVENHEIY 225

Query: 395 DLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           D +           C+++L  LM S W  + DP  RPT  K+ ++LE
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCW--RADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNL 226
           E  G+GSFG VYK +    + +   VA+K +D   ++ E E    + E+  + Q     +
Sbjct: 7   ECIGKGSFGEVYKAID---KRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 283
            +  G   +G    ++ E+   G+    L    KP     T IAF   ++  GL YLHE+
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
                IH DIK  NILL +  + +++DFG++  LT   SK       GT  ++APE  ++
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEVIKQ 172

Query: 344 STITAKVDVYSFGVLLLEII 363
           S    K D++S G+  +E+ 
Sbjct: 173 SGYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 47/295 (15%)

Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRL 229
           G G FG V K        R   T VAVK L       E ++  +E  ++ Q +H ++++L
Sbjct: 9   GEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKL 68

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL-------------FGNLKPSW---------NLRT 267
            G C +    LL+ E+   G+L SFL              GN   S+          +  
Sbjct: 69  YGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128

Query: 268 NIAF--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
            I+F  QI+RG+ YL E    +++H D+  +N+L+ +    +ISDFGL++ +    S   
Sbjct: 129 LISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA 384
           ++  R    ++A E       T + DV+SFGVLL EI++         G  Y  I  +  
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG-------GNPYPGIAPERL 238

Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           F+  + G   +  E          C E++  + + C +++P  RPT   +S+ LE
Sbjct: 239 FNLLKTGYRMERPE---------NCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G++GIVY     +T+     +A+K++        +    E+ +     H+N+V+ LG 
Sbjct: 17  GKGTYGIVYAARDLSTQVR---IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSSQII 289
             E     +  E +  G+L++ L     P  +    I F   QI  GL YLH++   QI+
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIV 130

Query: 290 HCDIKPQNILLDDHYNA-RISDFGLAKLLT-LNQSKTIKTAIRGTKGYVAPEWYRKST-- 345
           H DIK  N+L++ +    +ISDFG +K L  +N      T   GT  Y+APE   K    
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPRG 187

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
             A  D++S G  ++E+ + +  F IE+GE  A
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF-IELGEPQA 219

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 75/276 (27%), Positives = 120/276 (43%), Gaps = 33/276 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E  GRG+FG V+ G +   R   T VAVK   + +  D + +F  E  ++ Q  H N+VR
Sbjct: 1   ERIGRGNFGEVFSGRL---RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSS 286
           L+G C + Q   +V E +  G   +FL     P   ++  I      A G+ YL      
Sbjct: 58  LIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEWYR 342
             IH D+  +N L+ +    +ISDFG+++     +   +  +  G K     + APE   
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 402
               +++ DV+SFG+LL E  S            YA L+        N +  + +E  + 
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAV-------PYANLS--------NQQTREAIEQGVR 214

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
                 C + +  +   C + DP  RP+   V Q L
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 70/203 (34%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG V    ++ T       A KKLD+     + GE+   NE  ++ +   + +V L
Sbjct: 2   GKGGFGEVCACQVKAT---GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
             +  E ++ L LV   +N G L   ++   +P +     I  A QI  GL +LH+    
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +I++ D+KP+N+LLDDH N RISD GLA  + L   K IK    GT GY+APE  +    
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRA-GTPGYMAPEVLQGEVY 171

Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
              VD ++ G  L E+I+ R  F
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 15  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 70  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 181

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 182 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 226

Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 14/196 (7%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 226
           E  G+GSFG V+KG+   T+     VA+K +D   ++ E E ++   E+ V+ Q     +
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQ---VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
            +  G   +G    ++ E+L  G+    L       + + T +  +I +GL YLH   S 
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH---SE 120

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           + IH DIK  N+LL +  + +++DFG+A  LT  Q K  +    GT  ++APE  ++S  
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAY 178

Query: 347 TAKVDVYSFGVLLLEI 362
            +K D++S G+  +E+
Sbjct: 179 DSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 36/219 (16%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL----------DRVFQDGEKEFKNEVVVIG 219
           E  G+G++G VY  +  TT      +AVK++          D   +D  K  ++E+  + 
Sbjct: 7   ELIGKGTYGRVYLALNVTT---GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63

Query: 220 QTHHKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARG 276
              H N+V+ LGF +  +  L ++ E++  G++ S L  +G  +    L      Q+  G
Sbjct: 64  DLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFTEQVLEG 120

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-----KTAIRG 331
           L YLH   S  I+H D+K  N+L+D     +ISDFG++K     +S  I       +++G
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQG 172

Query: 332 TKGYVAPEW---YRKSTITAKVDVYSFGVLLLEIISCRK 367
           +  ++APE    Y +   +AKVD++S G ++LE+ + R+
Sbjct: 173 SVFWMAPEVIHSYSQG-YSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.9 bits (219), Expect = 2e-19
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 169 KEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKE--FKN---EVVVIGQTH 222
            E+ G G++G+VYK    +T       VA+KK   +  D E+E        E+ ++ +  
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEI----VALKK---IRLDNEEEGIPSTALREISLLKELK 56

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYL 280
           H N+V+LL      +   LV+E+ +   L  +L        +     +I +Q+ RGL Y 
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S +I+H D+KPQNIL++     +++DFGLA+   +                V   W
Sbjct: 115 H---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE--------VVTLW 163

Query: 341 YRKSTI-------TAKVDVYSFGVLLLEII 363
           YR   I       +  VD++S G +  E+I
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)

Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T +++   VAVKK+D   Q   +   NEVV++    H N
Sbjct: 22  DNFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +         + T +   + + L +LH   +
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSFLH---A 133

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  + ++ GT  ++APE   +  
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLP 191

Query: 346 ITAKVDVYSFGVLLLEII 363
              +VD++S G++++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 20/199 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 226
           E  G+GSFG VYKG+   T+     VA+K +D   ++ E E ++   E+ V+ Q     +
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKE---VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 283
            R  G   +G    ++ E+L  G+    L    KP     T IA    +I +GL YLH  
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH-- 118

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            S + IH DIK  N+LL +  + +++DFG+A  LT  Q K  +    GT  ++APE  ++
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQ 175

Query: 344 STITAKVDVYSFGVLLLEI 362
           S    K D++S G+  +E+
Sbjct: 176 SAYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 76/292 (26%), Positives = 121/292 (41%), Gaps = 53/292 (18%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL---DRVFQDGEKE-------FKNEVVVIG 219
           E  G G+FG VYK  +         +A+K++   +  F   ++E         +EV +I 
Sbjct: 6   EHLGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63

Query: 220 -QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS---------WNLRTNI 269
            Q  H N+VR      E     +V + +    L    F +LK           WN    I
Sbjct: 64  EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWN----I 118

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
             Q+   L YLH++   +I+H D+ P NI+L +     I+DFGLAK     Q ++  T++
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
            GT  Y  PE  +      K DV++FG +L ++ + +  F                  Y 
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------------YS 215

Query: 390 NGKLD---DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
              L     +VE   E + +    E +  V   C+  D   RP + +VS M+
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 173 GRGSFGIVYKG-VIETTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIGQTHHKNLV 227
           G G++G+V K     T       VA+KK      + +++ K     EV V+ Q  H+N+V
Sbjct: 10  GEGAYGVVLKCRNKATGEI----VAIKKFKES--EDDEDVKKTALREVKVLRQLRHENIV 63

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            L           LV+E++   TL   L    G L P         +Q+ + + Y H   
Sbjct: 64  NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH--- 117

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-- 342
           S  IIH DIKP+NIL+ +    ++ DFG A+ L    +  +         YVA  WYR  
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYRAP 170

Query: 343 ----KSTITAK-VDVYSFGVLLLEIISCRKSF 369
                 T   K VDV++ G ++ E++     F
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 47/295 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTS-TTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           F EE G  +FG +YKG +          VA+K L  +    +  EF+ E  ++ + HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---------------GNLKPSWNLRT--N 268
           +V LLG   + Q   +++E+LN G L  FL                G +K S +     +
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-----QSK 323
           IA QIA G+ YL    S   +H D+  +NIL+ +  + +ISD GL++ +        Q K
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 383
           ++   IR    ++ PE       ++  D++SFGV+L EI      F   +   Y      
Sbjct: 186 SL-LPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQPYYGFSNQE 234

Query: 384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
             +  R  +L    E          C  ++  +   C QE PS RP  + +   L
Sbjct: 235 VIEMVRKRQLLPCSE---------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 49/303 (16%)

Query: 156 FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTST--TAVAVKKLDRV-FQDGEKEFK 212
           F    L+E T       GRG FG V+    +        T V VK L +   ++ + EF+
Sbjct: 2   FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56

Query: 213 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------LKP---SW 263
            E+ +  +  HKN+VRLLG C E +   ++ E+ + G L  FL         LKP   S 
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 264 NLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS- 322
             +  +  QIA G+ +L    +++ +H D+  +N L+      ++S   L+K    N   
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEY 172

Query: 323 ---KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YA 378
              +     +R    ++APE  ++   + K DV+SFGVL+ E+ +         GE  + 
Sbjct: 173 YKLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--------QGELPFY 220

Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQ 436
            L+D          L+ L  G +E      C  +L  LM   W +  +P  RP+  ++  
Sbjct: 221 GLSDEEV-------LNRLQAGKLELPVPEGCPSRLYKLMTRCWAV--NPKDRPSFSELVS 271

Query: 437 MLE 439
            L 
Sbjct: 272 ALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 74/293 (25%), Positives = 121/293 (41%), Gaps = 43/293 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L    +   ++F+ E  ++    H++
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----------------FGNLKPSWNLRTN 268
           +VR  G C EG+  L+V+E++ +G L  FL                  G L     L   
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA-- 126

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           IA QIA G++YL    S   +H D+  +N L+      +I DFG+++ +       +   
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 183

Query: 329 IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 386
                 ++ PE   YRK   T + D++SFGV+L EI +  K         Y +    A +
Sbjct: 184 TMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQ------PWYQLSNTEAIE 235

Query: 387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           C   G+         E      C  ++  +   C Q +P  R  ++ +   L+
Sbjct: 236 CITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)

Query: 163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           E  D+F +  G GS GIV    I T + +   VAVKK+D   Q   +   NEVV++   H
Sbjct: 22  EYLDSFIK-IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H+N+V +      G    +V EFL  G L   +         + T +   + R L YLH 
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYLH- 135

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             +  +IH DIK  +ILL      ++SDFG    ++    K  + ++ GT  ++APE   
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVIS 191

Query: 343 KSTITAKVDVYSFGVLLLEII 363
           +     +VD++S G++++E+I
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 20/199 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 226
           E+ G+GSFG V+KG+   T+     VA+K +D   ++ E E ++   E+ V+ Q     +
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQK---VVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHED 283
            +  G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH  
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH-- 118

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            S + IH DIK  N+LL +H   +++DFG+A  LT  Q K  +    GT  ++APE  ++
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQ 175

Query: 344 STITAKVDVYSFGVLLLEI 362
           S   +K D++S G+  +E+
Sbjct: 176 SAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 78/284 (27%), Positives = 134/284 (47%), Gaps = 36/284 (12%)

Query: 173 GRGSFGIVYKGV---IETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 228
           G G+FG VY+G    I    +    VAVK L +   D EK EF  E  ++   +H N+V+
Sbjct: 4   GSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVK 63

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRT-----NIAFQIARGLLYLH 281
           LLG C   + + ++ E +  G L S+L       +   L T     +I   +A+G +YL 
Sbjct: 64  LLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123

Query: 282 EDCSSQIIHCDIKPQNILLDDH-YNAR----ISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           +      IH D+  +N L+ +  Y+A     I DFGLA+ +  +     +        ++
Sbjct: 124 Q---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDD 395
           APE       T + DV+SFGVL+ EI++        +G++ Y  L +   +  ++     
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILT--------LGQQPYPALNN--QEVLQHVT--- 227

Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
              G ++   +  C +K+  +   C  +DPS RPT  ++ ++L+
Sbjct: 228 -AGGRLQKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.4 bits (219), Expect = 2e-18
 Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 25/185 (13%)

Query: 194 AVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVRLLGFCDEGQ---NRLL-VYEFL 246
            VA+K L     + E +   F+ E  +  + +H N+V LL   D G+     L  V+E++
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61

Query: 247 NNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---D 301
              TL   L   G L      R  +  Q+   L   H      I+H D+KPQNI++    
Sbjct: 62  PGRTLREVLAADGALPAGETGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116

Query: 302 DHYNARISDFGLAKLL-----TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFG 356
              +A++ DFG+  LL         + T  T + GT  Y APE  R   +T   D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 357 VLLLE 361
           ++ LE
Sbjct: 177 LIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 31/225 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 226
           E+ G G++G+VYK      R +   +A+KK+ R+ Q+ E        E+ ++ +  H N+
Sbjct: 8   EKIGEGTYGVVYKA---RDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDC 284
           VRL       +   LV+E+L+   L   +  +   + N R      +QI RG+ Y H   
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119

Query: 285 SSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
           S +++H D+KPQN+L+D   NA +++DFGLA+   +         +R     V   WYR 
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--------PVRTFTHEVVTLWYRA 171

Query: 344 STI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 379
             I       +  VD++S G +  E+++ +  F  D E+ E + I
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216

Length = 294

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 73/268 (27%), Positives = 127/268 (47%), Gaps = 26/268 (9%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLVR 228
           G G+FG VYKG+ +    T    VA+K L+     G K   EF +E +++    H +LVR
Sbjct: 16  GSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLVR 73

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSSQ 287
           LLG C     +L V + + +G L  ++  +       L  N   QIA+G++YL E    +
Sbjct: 74  LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 129

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLA+LL  ++ +      +    ++A E       T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G+ Y        D     ++ DL+E         
Sbjct: 190 HQSDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEKGERLPQPP 234

Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            C   + MV + C   D   RP  ++++
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKELA 262

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 31/271 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           F +E G G FG+V  G           VA+K + +     E EF  E  V+ +  H+ LV
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD----VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLV 62

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSS 286
           +L G C + +   +V E+++NG L ++L  + K    +    +   +  G+ YL    S 
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SK 119

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APEWYRK 343
           Q IH D+  +N L+DD    ++SDFGL++ +  ++     T+  G+K  V    PE    
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLLY 175

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
           S  ++K DV++FGVL+ E+ S               L    ++ + N +  + V   +  
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYS---------------LGKMPYERFNNSETVEKVSQGLRL 220

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                  EK+  +   C  E    RPT +++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK----NL 226
           E G G+FG V KGV +  R     VA+K L     + EK  ++E++   +  H+     +
Sbjct: 2   ELGSGNFGCVKKGVYKM-RKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYI 57

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---FQIARGLLYLHED 283
           VR++G C E +  +LV E  + G L  FL G  K      +N+     Q++ G+ YL   
Sbjct: 58  VRMIGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG- 113

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYR 342
                +H D+  +N+LL + + A+ISDFGL+K L  + S    ++A +    + APE   
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 343 KSTITAKVDVYSFGVLLLEIIS 364
               +++ DV+S+G+ + E  S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 10/198 (5%)

Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T ++S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 23  DNFIK-IGEGSTGIV---CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +         +   +   + + L  LH   +
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLH---A 134

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG      +++    + ++ GT  ++APE   +  
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLP 192

Query: 346 ITAKVDVYSFGVLLLEII 363
              +VD++S G++++E++
Sbjct: 193 YGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             +  G G++G VYK     T     A+ V KL+    D  +  + E+ ++ +  H N+V
Sbjct: 7   LIQRIGSGTYGDVYKARDIATGELV-AIKVIKLEP--GDDFEIIQQEISMLKECRHPNIV 63

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLA---SFLFGNLKPSWNLRTNIAF---QIARGLLYLH 281
              G         +V E+   G+L        G L         IA+   +  +GL YLH
Sbjct: 64  AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAYVCRETLKGLAYLH 118

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           E   +  IH DIK  NILL +  + +++DFG++  LT   +K  K+ I GT  ++APE  
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR-KSFI-GTPYWMAPEVA 173

Query: 342 ---RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 375
              RK     K D+++ G      I+      IE+ E
Sbjct: 174 AVERKGGYDGKCDIWALG------ITA-----IELAE 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 78/275 (28%), Positives = 122/275 (44%), Gaps = 33/275 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           ++ G G FG V+ G    T    T VAVK L       E  F  E  ++ +  H  LV+L
Sbjct: 12  KKLGNGQFGEVWMG----TWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL 66

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQ 287
                E +   +V E+++ G+L  FL      +  L    ++A Q+A G+ Y+       
Sbjct: 67  YAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MN 122

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D    +I+DFGLA+L+  N+     TA +G K    + APE     
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYG 178

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             T K DV+SFG+LL E+++  +                 +    N ++ + VE      
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRV---------------PYPGMNNREVLEQVERGYRMP 223

Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C   L  + + C ++DP  RPT   +   LE
Sbjct: 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ-THHKNLV 227
           ++ G G+FG VY       + +   VA+KK+ + F   E+     EV  + +   H N+V
Sbjct: 5   KQLGDGTFGSVYLAR---NKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIV 61

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSS 286
           +L     E      V+E++             KP S ++  +I +QI +GL ++H     
Sbjct: 62  KLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KH 118

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST- 345
              H D+KP+N+L+      +I+DFGLA+ +   +S+   T    T+ Y APE   +ST 
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
            ++ VD+++ G ++ E+ + R  F
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 18/201 (8%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKNL 226
           G+G+FG VY    ++T R     +AVK++  D    + +KE    + E+ ++    H+ +
Sbjct: 11  GQGAFGRVYLCYDVDTGRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+  G   + +   +  E++  G++   L  +G L  +  +      QI  G+ YLH   
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--TETVTRKYTRQILEGVEYLH--- 121

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
           S+ I+H DIK  NIL D   N ++ DFG +K L T+  S T   ++ GT  +++PE    
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 344 STITAKVDVYSFGVLLLEIIS 364
                K DV+S G  ++E+++
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 23/203 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDG-EKEFKN---EVVVIGQTHHKNL 226
           G+G++G VY G+    +     +AVK+  LD       EKE++    EV ++    H N+
Sbjct: 9   GKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPSWNLRTNIAFQIARGLLYLHED 283
           V+ LG C +     +  EF+  G+++S L  FG L +P +   T    QI  G+ YLH +
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---QILDGVAYLHNN 121

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL---TLNQSKT-IKTAIRGTKGYVAPE 339
           C   ++H DIK  N++L  +   ++ DFG A+ L    L+ + + +  ++ GT  ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 340 WYRKSTITAKVDVYSFGVLLLEI 362
              +S    K D++S G  + E+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 37/293 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L     +  K+F  E  ++    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRT--------NIAFQ 272
           +V+  G C EG   ++V+E++ +G L  FL  +     L    N           +IA Q
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
           IA G++YL    S   +H D+  +N L+ ++   +I DFG+++ +       +       
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 333 KGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 390
             ++ PE   YRK   T + DV+S GV+L EI +  K         Y +  +   +C   
Sbjct: 186 IRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQ 237

Query: 391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           G++               C +++  + + C Q +P +R  ++++  +L+ + +
Sbjct: 238 GRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 79/274 (28%), Positives = 123/274 (44%), Gaps = 44/274 (16%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
               G G FG VY+GV  +      AVAVK  K        EK F  E  ++ Q  H ++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDC 284
           V+L+G   E     +V E    G L S+L  N K S +L + I  ++Q++  L YL    
Sbjct: 70  VKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE--- 124

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLL---TLNQSKTIKTAIRGTKGYVAPEWY 341
           S + +H DI  +N+L+      ++ DFGL++ L   +  ++   K  I+    ++APE  
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESI 180

Query: 342 RKSTITAKVDVYSFGVLLLEIISC-RKSFD----------IEMGEE-----------YAI 379
                T+  DV+ FGV + EI+    K F           IE GE            Y++
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240

Query: 380 LTD-WAFDCYRNGKLDDLVEGDMEAMNDIKCVEK 412
           +T  WA+D  +  +  +L       ++DI   EK
Sbjct: 241 MTKCWAYDPSKRPRFTELK----AQLSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 17/170 (10%)

Query: 208 EKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNL 265
           +K+   E+ +        +V+  G F DE  + + +  E+   G+L S ++  +K     
Sbjct: 43  QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVK-KRGG 100

Query: 266 RTN------IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 319
           R        IA  + +GL YLH   S +IIH DIKP NILL      ++ DFG++  L  
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157

Query: 320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           + + T      GT  Y+APE  +    +   DV+S G+ LLE+   R  F
Sbjct: 158 SLAGTFT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 24/205 (11%)

Query: 170 EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHH---K 224
           E  GRG++G VY+G  + T R     VA+K ++    D +  + + EV ++ Q       
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRV----VALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YL 280
           N+ +  G   +G    ++ E+   G++ + +    K        I+  I R +L    Y+
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIREVLVALKYI 117

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H      +IH DIK  NIL+ +  N ++ DFG+A LL  N SK  ++   GT  ++APE 
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEV 172

Query: 341 YRK-STITAKVDVYSFGVLLLEIIS 364
             +      K D++S G+ + E+ +
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 65/303 (21%)

Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           G+G+FG V++    G++       T VAVK L +    D + +F+ E  ++ +  H N+V
Sbjct: 14  GQGAFGRVFQARAPGLLPYE--PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN----------------------- 264
           +LLG C  G+   L++E++  G L  FL     P                          
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL------AKLLT 318
            +  IA Q+A G+ YL E    + +H D+  +N L+ ++   +I+DFGL      A    
Sbjct: 131 EQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
            +++  I   IR    ++ PE    +  T + DV+++GV+L EI      F   M   Y 
Sbjct: 188 ASENDAI--PIR----WMPPESIFYNRYTTESDVWAYGVVLWEI------FSYGMQPYYG 235

Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQ 436
           +  +      R+G +    +          C  +L  LM   W   + PS RP+   +++
Sbjct: 236 MAHEEVIYYVRDGNVLSCPDN---------CPLELYNLMRLCW--SKLPSDRPSFASINR 284

Query: 437 MLE 439
           +L+
Sbjct: 285 ILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 42/216 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T      VA+KKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 24  GSGAYGQVCSAFDTKTGRK---VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 231 G-FC-----DEGQNRLLVYEF----LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             F      ++ Q+  LV       LNN      +    K S +    + +QI RGL Y+
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGADLNN------IVKCQKLSDDHIQFLVYQILRGLKYI 134

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S+ IIH D+KP NI +++    +I DFGLA+    +   T         GYVA  W
Sbjct: 135 H---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEMT---------GYVATRW 180

Query: 341 YRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           YR   I          VD++S G ++ E+++ +  F
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 83.2 bits (206), Expect = 8e-18
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 21/200 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKN----EVVVIGQTHHKNL 226
           G GS+G+V K      + +   VA+KK    F + E  K  K     E+ ++ Q  H+NL
Sbjct: 10  GEGSYGMVMKC---KHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASF-LFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           V L+      +   LV+EF+++  L     + N      +R  + FQI RG+ + H   S
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQILRGIEFCH---S 118

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             IIH DIKP+NIL+      ++ DFG A+  TL     + T    T+ Y APE     T
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 346 ITAK-VDVYSFGVLLLEIIS 364
              + VD+++ G L+ E+++
Sbjct: 177 KYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 41/211 (19%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             E+ G GS+G VYK      + +   VA+K +  V +D + E   E+ ++ Q     +V
Sbjct: 7   ILEKLGEGSYGSVYKA---IHKETGQVVAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIV 61

Query: 228 RLLGFCDEGQNRLLVYEF----------------LNNGTLASFLFGNLKPSWNLRTNIAF 271
           +  G   +  +  +V E+                L    +A+ L+  LK           
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK----------- 110

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
               GL YLH   S++ IH DIK  NILL++   A+++DFG++  LT   +K   T I G
Sbjct: 111 ----GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVI-G 161

Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEI 362
           T  ++APE  ++     K D++S G+  +E+
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 28/288 (9%)

Query: 170 EEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLV 227
              G G FG V     +     T   VAVK L R   Q     +K E+ ++   +H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 228 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHED 283
           +  G C E  G+   L+ E++  G+L  +L    K   NL   + F  QI  G+ YLH  
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH-- 124

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWYR 342
            S   IH D+  +N+LLD+    +I DFGLAK +   ++   ++        + A E  +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 343 KSTITAKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
           ++  +   DV+SFGV L E++       S  K F+  +G +   +T          +L +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV--------RLIE 235

Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           L+E  M       C +++ ++   C + +   RPT R +  +L+ +  
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 73/282 (25%), Positives = 133/282 (47%), Gaps = 39/282 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLG 231
           G G FG V  G ++        VA+K L   + + ++ +F +E  ++GQ  H N++ L G
Sbjct: 13  GAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEG 72

Query: 232 FCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
              + +  ++V E++ NG+L +FL      F  ++    LR      IA G+ YL +   
Sbjct: 73  VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-----IASGMKYLSD--- 124

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPE--W 340
              +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG K    + APE   
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGKIPIRWTAPEAIA 182

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           YRK   T+  DV+S+G+++ E++S  +    EM  +  I                 +E  
Sbjct: 183 YRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA---------------IEEG 225

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                 + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 31/275 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           F +E G G FG+V+ G       +   VA+K +       E++F  E  V+ +  H  LV
Sbjct: 8   FMKELGSGQFGVVHLG----KWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           +L G C + +   +V EF+ NG L ++L    G L     L  ++   +  G+ YL    
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLER-- 118

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
            +  IH D+  +N L+      ++SDFG+ + + L+   T  +  +    +  PE +  S
Sbjct: 119 -NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 345 TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
             ++K DV+SFGVL+ E+ +  +  F+ +   E   +    F  YR  KL         A
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP-KL---------A 226

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
              +  V    M S W   E P  RPT  ++ + +
Sbjct: 227 SMTVYEV----MYSCW--HEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G FG V+ G       ++T VAVK L +      + F  E  ++    H  LVRL   
Sbjct: 15  GAGQFGEVWMGYYN----NSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQIIH 290
             + +   ++ E++  G+L  FL  +      L   I F  QIA G+ Y+        IH
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  N+L+ +    +I+DFGLA+++  N+     TA  G K    + APE     + T
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGSFT 182

Query: 348 AKVDVYSFGVLLLEIIS 364
            K DV+SFG+LL EI++
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 167 NFKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHK 224
              E  G G+  +VY  + +         VA+K++D    Q    E + EV  + Q +H 
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEK----VAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLH 281
           N+V+       G    LV  +L+ G+L   +  +          IA    ++ +GL YLH
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL---TLNQSKTIKTAIRGTKGYVAP 338
              S+  IH DIK  NILL +  + +I+DFG++  L        K  KT + GT  ++AP
Sbjct: 120 ---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAP 175

Query: 339 EWYRKST-ITAKVDVYSFGVLLLEII 363
           E   +      K D++SFG+  +E+ 
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 31/213 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQ-THHKNLVR 228
           G+G++GIV+K +    R +   VA+KK+   F+   D ++ F+ E++ + +   H N+V+
Sbjct: 16  GKGAYGIVWKAI---DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 229 LLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           LL     +  ++  LV+E++     A      L+     +  I +Q+ + L Y+H   S 
Sbjct: 72  LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KRYIMYQLLKALKYIH---SG 126

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPEWYRK 343
            +IH D+KP NILL+     +++DFGLA+ L+    N    + T       YVA  WYR 
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD------YVATRWYRA 180

Query: 344 STI-------TAKVDVYSFGVLLLEIISCRKSF 369
             I       T  VD++S G +L E++  +  F
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 18/195 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V  G     R +  AV   K D   Q     F  E  V+ Q  H NLV+LLG 
Sbjct: 15  GKGEFGDVMLG---DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 67

Query: 233 CDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             E +  L +V E++  G+L  +L   G      +     +  +   + YL    ++  +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R+   + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFSTK 179

Query: 350 VDVYSFGVLLLEIIS 364
            DV+SFG+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 28/208 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQT---H 222
            E G G++G VYK        +   VA+KK+       E+        E+ ++ Q     
Sbjct: 5   AEIGEGAYGTVYKA---RDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESFE 59

Query: 223 HKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIA 274
           H N+VRLL  C     D      LV+E ++   LA++L    KP      ++ ++  Q+ 
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DLMRQLL 117

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           RG+ +LH   S +I+H D+KPQNIL+      +I+DFGLA++ +   +    T++  T  
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLW 171

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEI 362
           Y APE   +S+    VD++S G +  E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 62/276 (22%), Positives = 118/276 (42%), Gaps = 40/276 (14%)

Query: 173 GRGSFG--IVYKGVIETTRTSTTAVAVKK---LDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           G+G+FG   +Y+      RT   ++ V K   L R+ +   ++  NE+V++    H N++
Sbjct: 9   GKGAFGEATLYR------RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--FQIARGLLYLHEDCS 285
                  +    L+  E+ N GTL   +       +     +   FQI   + Y+H+   
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--- 119

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
           + I+H DIK  NI L      ++ DFG++K+  L    ++   + GT  Y++PE  +   
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME--- 402
              K D+++ G +L E+++ +++FD                        +LV   ++   
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDAT-------------------NPLNLVVKIVQGNY 218

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
                    +L+ +    +Q+DP  RPT  +V    
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 16/208 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+ GIV+K      R +   VA+KK  L R+      +   E+  +    H  +V+LL
Sbjct: 9   GEGAHGIVFKAKD---RETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-IAFQIARGLLYLHEDCSSQII 289
                G   +LV E++    L+  L    +P    +       + +G+ Y+H    + I+
Sbjct: 66  DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIM 121

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKSTITA 348
           H D+KP N+L+      +I+DFGLA+L +  +   + +    T+ Y APE  Y       
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGARKYDP 180

Query: 349 KVDVYSFGVLLLEIISCRKSF----DIE 372
            VD+++ G +  E+++    F    DIE
Sbjct: 181 GVDLWAVGCIFAELLNGSPLFPGENDIE 208

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 36/220 (16%)

Query: 167 NFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIG 219
           NF+  E+ G G++G+VYK      + +   VA+KK+ R+  D E E        E+ ++ 
Sbjct: 1   NFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKI-RL--DTETEGVPSTAIREISLLK 54

Query: 220 QTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARG 276
           + +H N+V+LL      +N+L LV+EFL+   L  F+  +        L  +  FQ+ +G
Sbjct: 55  ELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG 112

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L + H   S +++H D+KPQN+L++     +++DFGLA+   +         +R     V
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--------PVRTYTHEV 161

Query: 337 APEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              WYR   I       +  VD++S G +  E+++ R  F
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL-G 231
            +G++G V+    ++T        +KK D + ++   +   E  ++ Q     +V+L   
Sbjct: 2   SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 232 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           F  + +N  LV E+L  G LAS L   G+L            +I   L YLH   S+ II
Sbjct: 62  FQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDV--ARIYIAEIVLALEYLH---SNGII 115

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI------KTAIRGTKGYVAPEWYRK 343
           H D+KP NIL+D + + +++DFGL+K+  + +   +         I GT  Y+APE    
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 344 STITAKVDVYSFGVLLLEIIS 364
              +  VD +S G +L E + 
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 48/295 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTA----VAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
            K E G G+FG V+  + E    S T     VAVK L        K+F+ E  ++    H
Sbjct: 9   LKRELGEGAFGKVF--LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------------------GNLKPSWNL 265
           +++V+  G C +G   ++V+E++ +G L  FL                   G L  S  L
Sbjct: 67  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 266 RTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
             +IA QIA G++YL    S   +H D+  +N L+  +   +I DFG+++ +       +
Sbjct: 127 --HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 326 KTAIRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 383
                    ++ PE   YRK   T + DV+SFGV+L EI +  K    ++     I    
Sbjct: 182 GGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---- 235

Query: 384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
             +C   G++ +             C +++  + + C Q +P  R  ++++ ++L
Sbjct: 236 --ECITQGRVLERPR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 174 RGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIGQTHHKNLVRL 229
           +G+FG VY   +   R++    A+K L +     + +  N      +++ Q     + +L
Sbjct: 6   KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                      LV E+LN G  AS +   G L   W  +  IA ++  G+  LH+     
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR---G 117

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH DIKP+N+L+D   + +++DFGL++    N+         GT  Y+APE        
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDD 171

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
              D +S G ++ E +     F  E  + 
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 32/210 (15%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 224
            + G G++G VYK      +T    VA+KK+     + EKE        E+ ++ +  H 
Sbjct: 5   AQIGEGTYGQVYKA--RNKKTGEL-VALKKIR---MENEKEGFPITAIREIKLLQKLRHP 58

Query: 225 NLVRLLGFC-DEGQNRL-LVYEFLN---NGTLAS----FLFGNLKPSWNLRTNIAFQIAR 275
           N+VRL      +G+  + +V+E+++    G L S    F    +K           Q+  
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-------CYMKQLLE 111

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL YLH   S+ I+H DIK  NIL+++    +++DFGLA+  T  ++    T    T  Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLWY 167

Query: 336 VAPEWYRKSTI-TAKVDVYSFGVLLLEIIS 364
             PE    +T    +VD++S G +L E+  
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 33/239 (13%)

Query: 168 FKEEAGRGSFGIVY----KGVIETTRTSTTA-------VAVKKL-DRVFQDGEKEFKNEV 215
            KE+ G G FG V+    +G+ E               VAVK L   V +    +F  E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPSWNL 265
            ++ +  + N++RLLG C       ++ E++ NG L  FL            N  PS ++
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 266 RT--NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK 323
                +A QIA G+ YL    S   +H D+  +N L+ +HY  +I+DFG+++ L      
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 382
            I+        ++A E       T   DV++FGV L E+ +  K       + Y++L+D
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE------QPYSLLSD 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 81/272 (29%), Positives = 120/272 (44%), Gaps = 33/272 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  ++ +  H  LV L   
Sbjct: 15  GQGCFGEVWMG----TWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAV 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V EF+  G+L  FL         L    ++A QIA G+ Y+        IH
Sbjct: 70  VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIH 125

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ D+   +I+DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 181

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+++  +                 +    N ++ + VE         
Sbjct: 182 IKSDVWSFGILLTELVTKGRV---------------PYPGMVNREVLEQVERGYRMPCPQ 226

Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            C E L  +   C ++DP  RPT   +   LE
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.7 bits (199), Expect = 5e-17
 Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV---VIGQTHHKNLVRL 229
           G+G FG V        R +    A KKL++      K ++  +V   ++ + H + +V L
Sbjct: 2   GKGGFGEVSAC---QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL---KPSWNLRTNIAF--QIARGLLYLHEDC 284
                   +  LV   +N G L   ++ N+    P +       +  QI  GL +LH+  
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ-- 115

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
             +II+ D+KP+N+LLD+  N RISD GLA  L   QSKT   A  GT G++APE  +  
Sbjct: 116 -RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPELLQGE 172

Query: 345 TITAKVDVYSFGVLLLEIISCRKSF 369
                VD ++ GV L E+I+ R  F
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 29/220 (13%)

Query: 161 LEEATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           L + T  F   E  G G++G VYK   + T      VA+K +D + +D E+E K E  ++
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQ---LVAIKIMD-IIEDEEEEIKEEYNIL 56

Query: 219 GQ-THHKNLVRLLG-------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-I 269
            + ++H N+    G         ++ Q   LV E    G++   + G  K    L+   I
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115

Query: 270 AF---QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
           A+   +  RGL YLHE   +++IH DIK QNILL  +   ++ DFG++  L     +   
Sbjct: 116 AYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR-N 171

Query: 327 TAIRGTKGYVAPE-----WYRKSTITAKVDVYSFGVLLLE 361
           T I GT  ++APE         ++  A+ DV+S G+  +E
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 35/273 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G FG V+      T    T VAVK +       E  F  E  V+    H  LV+L   
Sbjct: 15  GAGQFGEVWMA----TYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             + +   ++ EF+  G+L  FL    G+ +P   L  + + QIA G+ ++ +      I
Sbjct: 70  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFIEQ---RNYI 124

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTI 346
           H D++  NIL+      +I+DFGLA+++  N+     TA  G K    + APE     + 
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGSF 180

Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
           T K DV+SFG+LL+EI++  +         Y  ++        N ++   +E        
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRI-------PYPGMS--------NPEVIRALERGYRMPRP 225

Query: 407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             C E+L  + + C +  P  RPT   +  +L+
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 19/202 (9%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 227
           E G G+ G+V K +    R +   +AVK + R+  + E   K    E+ ++ + +   +V
Sbjct: 8   ELGAGNSGVVSKVLH---RPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIV 62

Query: 228 RLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 284
              G F + G   + + E+++ G+L   L          R    IA  + +GL YLHE  
Sbjct: 63  GFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEK- 119

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
             +IIH D+KP NIL++     ++ DFG++  L  + +KT      GT  Y+APE  + +
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGN 174

Query: 345 TITAKVDVYSFGVLLLEIISCR 366
             + K D++S G+ L+E+ + R
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 40/212 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRL 229
           G G++G+V   V + T      VA+KK+  VF    D ++  + E+ ++    H+N++ L
Sbjct: 9   GSGAYGVVCSAVDKRTGRK---VAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64

Query: 230 LG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPSWNLRTN----IAFQIARGLLY 279
           L               +V E +   T L   +    K    L  +      +QI RGL Y
Sbjct: 65  LDILRPPSPEDFNDVYIVTELM--ETDLHKVI----KSPQPLTDDHIQYFLYQILRGLKY 118

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAP 338
           LH   S+ +IH D+KP NIL++ + + +I DFGLA+ +  ++  K   T       YV  
Sbjct: 119 LH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVVT 169

Query: 339 EWYRK-------STITAKVDVYSFGVLLLEII 363
            WYR        S  T  +D++S G +  E++
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 14/178 (7%)

Query: 195 VAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLVRLLGFCDEGQNR--LLVYEFLNNG 249
           VAVK L    + G     + K E+ ++   +H+N+V+  G C E       L+ EFL +G
Sbjct: 36  VAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93

Query: 250 TLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR 307
           +L  +L  N K   NL+     A QI +G+ YL    S Q +H D+  +N+L++  +  +
Sbjct: 94  SLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149

Query: 308 ISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           I DFGL K +  ++   T+K  +     + APE   +S      DV+SFGV L E+++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E  G+G+FG V+KG ++      T VAVK   + + Q+ + +F +E  ++ Q  H N+V+
Sbjct: 1   ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 284
           L+G C + Q   +V E +  G   SFL    K    L+T      A   A G+ YL    
Sbjct: 57  LIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLE--- 110

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEW 340
           S   IH D+  +N L+ ++   +ISDFG+++     Q      +  G K     + APE 
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEA 165

Query: 341 YRKSTITAKVDVYSFGVLLLEIIS 364
                 +++ DV+S+G+LL E  S
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 35/220 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKN 225
           F++  G G+FG V + +I+       A A+K L +   ++  ++F  E+ V+ +  HH N
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNA-AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-------------- 271
           ++ LLG C+      +  E+   G L  FL    + S  L T+ AF              
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 272 ------QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
                  +A G+ YL E    Q IH D+  +N+L+ ++  ++I+DFGL++   +   KT+
Sbjct: 121 LLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177

Query: 326 -KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            +  +R    ++A E    S  T K DV+SFGVLL EI+S
Sbjct: 178 GRLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 48/298 (16%)

Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-----DRVFQDGEKEFKNEVVVIGQTHH 223
           G G FG V      G+ +        VAVK L     D+   D   E +  + +IG+  H
Sbjct: 21  GEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGK--H 77

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----------------T 267
           KN++ LLG C +     ++ E+ + G L  +L     P  +                   
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
           + A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFD 386
             R    ++APE       T + DV+SFGVLL EI +         G  Y  I  +  F 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG-------GSPYPGIPVEELFK 247

Query: 387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
             + G   D             C  +L M+   C    PS RPT +++ + L+ V+ V
Sbjct: 248 LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 14/200 (7%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHH 223
            F +  G GSFG V    +   + S    A+K L +   V     +   NE  ++    H
Sbjct: 4   EFIKTLGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
             LV L G   +  N  LV E++  G L S L  + +    +    A Q+   L YLH  
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH-- 118

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            S  I++ D+KP+N+LLD     +I+DFG AK +         T + GT  Y+APE    
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGTPEYLAPEIILS 172

Query: 344 STITAKVDVYSFGVLLLEII 363
                 VD ++ G+L+ E++
Sbjct: 173 KGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 74/299 (24%), Positives = 142/299 (47%), Gaps = 61/299 (20%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 226
           E+ G G++G+VYKG     + +   VA+KK+ R+  + E        E+ ++ +  H N+
Sbjct: 6   EKIGEGTYGVVYKGR---NKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 227 VRLLGFCDEGQNRL-LVYEFLN---NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           V L     + ++RL L++EFL+      L S   G    +  +++ + +QI +G+L+ H 
Sbjct: 62  VCLQDVLMQ-ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-YQILQGILFCH- 118

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S +++H D+KPQN+L+D+    +++DFGLA        +     +R     V   WYR
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLA--------RAFGIPVRVYTHEVVTLWYR 168

Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI-------------- 379
              +       +  VD++S G +  E+ + +  F  D E+ + + I              
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228

Query: 380 ---LTDW--AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
              L D+   F  ++ G L   V+ +++  + +  +EK+L+        DP+ R + +K
Sbjct: 229 VTSLPDYKNTFPKWKKGSLRSAVK-NLDE-DGLDLLEKMLIY-------DPAKRISAKK 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG V    ++ T       A KKLD+     + GEK    E  ++ + +   +V L
Sbjct: 2   GKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQ 287
               +   +  LV   +N G L   ++   +    +   I +  QI  G+L+LH   S  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I++ D+KP+N+LLDD  N R+SD GLA  + L   KTI T   GT GY+APE  ++   +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPYS 172

Query: 348 AKVDVYSFGVLLLEIISCRKSF 369
             VD ++ G  + E+++ R  F
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 65/293 (22%)

Query: 175 GSFGIVYKGV-IETTRTSTTAVAVK---------KLDRVFQDGEKEFKNEVVVIGQTHHK 224
           G+FG ++ G+ I+        V VK         ++  + Q+          + G   H+
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL-------LYG-LSHQ 68

Query: 225 NLVRLLGFCDEGQNRLLV-YEFLNNGTLASFL----FGNLKPSWNLRT----NIAFQIAR 275
           N++ +L  C E      V Y ++N G L  FL     G       L T    ++A QIA 
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK--------LLTLNQSKTIKT 327
           G+ YLH      +IH DI  +N ++D+    +I+D  L++         L  N+++ +K 
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 385
                  ++A E       ++  DV+SFGVLL E+++  ++   +I+  E  A L D   
Sbjct: 185 -------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
             YR  +              I C ++L  V   C   DP  RP+  ++ Q L
Sbjct: 236 --YRLAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 43/234 (18%)

Query: 167 NFKEEAGRGSFGIVY----KGVIETTR---------TSTTAVAVKKL-DRVFQDGEKEFK 212
           NF E+ G G FG V+     G+ + +           +   VAVK L      +  ++F 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 213 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----------FGNLKP 261
            EV ++ +    N+ RLLG C       ++ E++ NG L  FL             +   
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 262 SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLN 320
           S++    +A QIA G+ YL    S   +H D+  +N L+  +Y  +I+DFG+++ L + +
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 321 QSKTIKTAIRGTKGYVAP-EWYRKSTI-----TAKVDVYSFGVLLLEIIS-CRK 367
             +     ++G      P  W    ++     T K DV++FGV L EI++ CR+
Sbjct: 185 YYR-----VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 38/228 (16%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 224
           E+ G G++G+VYK      + +   VA+KK+ R+  + E E        E+ ++ + +H 
Sbjct: 5   EKIGEGTYGVVYKA---RDKLTGEIVALKKI-RL--ETEDEGVPSTAIREISLLKELNHP 58

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----AFQIARGLLYL 280
           N+VRLL          LV+EFL+   L  ++  +  P   L   +     +Q+ +G+ Y 
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S +++H D+KPQN+L+D     +++DFGLA+   +         +R     V   W
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV--------PVRTYTHEVVTLW 164

Query: 341 YRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAI 379
           YR   I       +  VD++S G +  E+++ R  F  D E+ + + I
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 10/159 (6%)

Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLR 266
           +  + E+ ++ + +H +++R+LG   E  +  L  E++  G+++  L  +G  K    + 
Sbjct: 48  EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVI 105

Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLT--LNQSK 323
            N   Q+ RGL YLHE+   QIIH D+K  N+L+D      RI+DFG A  L      + 
Sbjct: 106 INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162

Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEI 362
             +  + GT  ++APE  R        DV+S G +++E+
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQT-HHKNL 226
           G G+FG V +    G+ ++   +   VAVK L       E+E   +E+ ++    +H+N+
Sbjct: 44  GAGAFGKVVEATAYGLSKSD--AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V LLG C  G   L++ E+   G L +FL    +    L   ++F  Q+A+G+ +L    
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S   IH D+  +N+LL      +I DFGLA+ +  + +  +K   R    ++APE     
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218

Query: 345 TITAKVDVYSFGVLLLEIIS 364
             T + DV+S+G+LL EI S
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+K+++   Q  ++   NE++V+ +  H N+V  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQE---VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 137

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 350 VDVYSFGVLLLEII 363
           VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 21/200 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNLV 227
           G G++GIVY+       TS   VA+KK   V  D E++        E+ ++    H N+V
Sbjct: 16  GEGTYGIVYRA---RDTTSGEIVALKK---VRMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 228 RLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDC 284
            L          +  LV E+     LAS L     P S +    +  Q+ RGL YLHE+ 
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              IIH D+K  N+LL D    +I+DFGLA+   L         +  T  Y APE     
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGC 183

Query: 345 TI-TAKVDVYSFGVLLLEII 363
           T  T  +D+++ G +L E++
Sbjct: 184 TTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 24/221 (10%)

Query: 164 ATDNFKEEAGRGSFGIVYKGVI--ETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQ 220
           +T  F EE G   FG VYKG +        T AVA+K L D+      +EFK+E ++  +
Sbjct: 5   STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSR 64

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPSWNLRT----- 267
             H N+V LLG   + Q   +++ + ++  L  FL         G+      +++     
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 268 ---NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSK 323
              +I  QIA G+ +L    S  ++H D+  +N+L+ D  N +ISD GL + +   +  K
Sbjct: 125 DFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181

Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            +  ++   + +++PE       +   D++S+GV+L E+ S
Sbjct: 182 LMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 9/191 (4%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GS GIV    I   + S   VAVK +D   Q   +   NEVV++    H+N+V +   
Sbjct: 30  GEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
              G+   ++ EFL  G L   +    + +      +   + + L YLH   S  +IH D
Sbjct: 87  YLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRD 142

Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           IK  +ILL      ++SDFG    ++ +  K  + ++ GT  ++APE   ++    +VD+
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 353 YSFGVLLLEII 363
           +S G++++E++
Sbjct: 201 WSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 14/216 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQT-HHKNLVRLL 230
           G+GSFG V    ++ T     AV V K D + QD + E    E  V+     H  L +L 
Sbjct: 4   GKGSFGKVLLAELKGTD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             C + ++RL  V E++N G L   +  + +         A +I  GL +LHE     II
Sbjct: 63  S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGII 118

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+K  N+LLD   + +I+DFG+ K   L    T  +   GT  Y+APE          
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPYGPA 176

Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTD 382
           VD ++ GVLL E+++ +  F+ +  E+    +IL D
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGD-DEDELFQSILED 211

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 30/270 (11%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 16  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 75

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L + + +  G L  ++     N+   + L  N   QIA+G+ YL E    +
Sbjct: 76  GICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEE---RR 129

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL  ++ +      +    ++A E       T
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 348 AKVDVYSFGVLLLEIISC-RKSFD-IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            + DV+S+GV + E+++   K +D I   E  +IL                 +G+     
Sbjct: 190 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------------KGERLPQP 233

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            I C   + M+ + C   D   RP  R++ 
Sbjct: 234 PI-CTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 1e-15
 Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+K+++   Q  ++   NE++V+ +  + N+V  
Sbjct: 25  EKIGQGASGTVYTAIDIAT---GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLH---SNQVI 137

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 350 VDVYSFGVLLLEII 363
           VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.1 bits (189), Expect = 1e-15
 Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 26  EKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 350 VDVYSFGVLLLEII 363
           VD++S G++ +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 35/215 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNLVRLL 230
           G G+FG V K  I+       A A+K++ +   +D  ++F  E+ V+ +  HH N++ LL
Sbjct: 4   GEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF------------------- 271
           G C+      L  E+  +G L  FL    + S  L T+ AF                   
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 272 -QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KTAI 329
             +ARG+ YL +    Q IH D+  +NIL+ ++Y A+I+DFGL++   +   KT+ +  +
Sbjct: 119 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           R    ++A E    S  T   DV+S+GVLL EI+S
Sbjct: 176 R----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 34/271 (12%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K L +       KE  +E  V+       + RLL
Sbjct: 16  GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLL 75

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDCSSQI 288
           G C     +L V + +  G L  ++  N     S +L  N   QIA+G+ YL E    ++
Sbjct: 76  GICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-LNWCVQIAKGMSYLEE---VRL 130

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-- 346
           +H D+  +N+L+    + +I+DFGLA+LL +++     T      G V  +W    +I  
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDE-----TEYHADGGKVPIKWMALESILH 185

Query: 347 ---TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
              T + DV+S+GV + E++    +F  +            +D     ++ DL+E     
Sbjct: 186 RRFTHQSDVWSYGVTVWELM----TFGAK-----------PYDGIPAREIPDLLEKGERL 230

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                C   + M+ + C   D   RP  R++
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFREL 261

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 43/276 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLG 231
           G G+ G VYK VI   R +    A+K +    +D   ++   E+ ++   +H N+V+   
Sbjct: 83  GSGAGGTVYK-VIH--RPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC 291
             D      ++ EF++ G+L     G          ++A QI  G+ YLH      I+H 
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILSGIAYLH---RRHIVHR 192

Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-- 349
           DIKP N+L++   N +I+DFG++++  L Q+     +  GT  Y++PE  R +T      
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPE--RINTDLNHGA 248

Query: 350 -----VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----FDCYRNGKLDDLVEGD 400
                 D++S GV +LE    R  F   +G +     DWA      C      +      
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGR--FPFGVGRQ----GDWASLMCAICMSQPP-EAPATAS 301

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
            E  + I C          C+Q +P+ R +  ++ Q
Sbjct: 302 REFRHFISC----------CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 16/203 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG V    +   R +    A KKL++     + GE    NE  ++ + + + +V L
Sbjct: 9   GKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
             +  E ++ L LV   +N G L   ++   +  +     +  A +I  GL  LH++   
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--- 121

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +I++ D+KP+NILLDDH + RISD GLA  + + + +TIK  + GT GY+APE  +    
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNERY 178

Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
           T   D ++ G LL E+I+ +  F
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 16/216 (7%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFK-NEVVVIGQTHH 223
           NF    G+GSFG   K ++   + +    A+K  K D + QD + E    E  V+     
Sbjct: 3   NFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 224 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 280
              +  L  C +  +RL  V E++N G L   +   G  K         A +IA GL +L
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP--HAVFYAAEIAIGLFFL 117

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S  II+ D+K  N++LD   + +I+DFG+ K   +   KT +T   GT  Y+APE 
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFC-GTPDYIAPEI 172

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                    VD ++FGVLL E+++ +  FD E  +E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 81/297 (27%), Positives = 132/297 (44%), Gaps = 50/297 (16%)

Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-----DRVFQDGEKEFKNEVV-VIGQTH 222
           G G FG V +    G+ ++    T  VAVK L     D+   D   E   E++ +IG+  
Sbjct: 21  GEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--ELMKLIGK-- 76

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------------- 269
           HKN++ LLG C +     ++ E+   G L  FL     P  +   +I             
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           +  R    ++APE       T + DV+SFG+L+ EI +         G  Y  I  +  F
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG-------GSPYPGIPVEELF 246

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              R G         M+  ++  C  +L M+   C    P+ RPT +++ + L+ V+
Sbjct: 247 KLLREGH-------RMDKPSN--CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 61/185 (32%), Positives = 87/185 (47%), Gaps = 24/185 (12%)

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           LL +H   S  +IH DIK  NILL  +   ++ DFG +K+     S  +     GT  YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           APE +R+   + K D++S GVLL E+++ ++ FD E  EE    T         G+ D L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------LAGRYDPL 265

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM------LEGVVEVDVPPNP 450
                  M +I  V  LL         DP  RP+  K+  M      + G++E+ V   P
Sbjct: 266 PPSISPEMQEI--VTALL-------SSDPKRRPSSSKLLNMPICKLFISGLLEI-VQTQP 315

Query: 451 SPFSG 455
             FSG
Sbjct: 316 G-FSG 319

Length = 496

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 62/297 (20%)

Query: 165 TDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVI 218
             NFK E   G+G F +VYK            VA+KK+ ++F+  + + +     E+ ++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKA---ICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLL 56

Query: 219 GQTHHKNLVRLL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRT--NIAFQ 272
            Q  H N+++ L  F +   N L +V E  + G L+  +  F   K     RT      Q
Sbjct: 57  KQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-AIRG 331
           +   L ++H   S +I+H DIKP N+ +      ++ D GL +  +   SKT    ++ G
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG 168

Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF------------DIEMGEEYAI 379
           T  Y++PE   ++    K D++S G LL E+ + +  F             IE   +Y  
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-DYPP 227

Query: 380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
           L     D Y + +L DLV                      CI  DP  RP +  V Q
Sbjct: 228 LPA---DHY-SEELRDLVSR--------------------CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 51/194 (26%), Positives = 99/194 (51%), Gaps = 9/194 (4%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G V+         +   VA+K+++   Q  ++   NE++V+ +  + N+V  
Sbjct: 25  EKIGQGASGTVFTA---IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF 81

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   ++Q+I
Sbjct: 82  LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLH---ANQVI 137

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  N+LL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 350 VDVYSFGVLLLEII 363
           VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 36/228 (15%)

Query: 159 KALEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNE 214
           K + E  D +++  + G G++G V   +    RT    VA+KKL R FQ     K    E
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAK-VAIKKLYRPFQSELFAKRAYRE 64

Query: 215 VVVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 268
           + ++    H+N++ LL         D   +  LV  F+  GT    L  + K S +    
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF 122

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           + +Q+ +GL Y+H   ++ IIH D+KP N+ +++    +I DFGLA+     Q+ +  T 
Sbjct: 123 LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMT- 173

Query: 329 IRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
                GYV   WYR   +       T  VD++S G ++ E+++ +  F
Sbjct: 174 -----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 79/297 (26%), Positives = 124/297 (41%), Gaps = 50/297 (16%)

Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 27  GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 82

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-------------- 268
           HKN++ LLG C +     ++ E+ + G L  +L     P      N              
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 269 --IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 252

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 253 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 26/208 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V +G +     S   VAVK  K+    +   ++F +E V + +  H N++RL+
Sbjct: 8   GEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 231 GFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGLL 278
           G C +          +++  F+ +G L SFL     G+       +  + F   IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL----TLNQSKTIKTAIRGTKG 334
           YL    S   IH D+  +N +L+++ N  ++DFGL+K +       Q +  K  ++    
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---- 179

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEI 362
           ++A E       T K DV+SFGV + EI
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)

Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 24  GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 83

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---------------- 270
           + LLG C +     ++ E+ + G L  +L     P      +IA                
Sbjct: 84  INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 144 YQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 253

Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 254 EGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 15/220 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRLL 230
           G+GSFG V    ++ T       A+KK D V +D + E       V+     H  L  L 
Sbjct: 4   GKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
                 ++   V E+LN G L   +  + +         A +I  GL +LH      II+
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIY 119

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  N+LLD   + +I+DFG+ K     + K   +   GT  Y+APE  +       V
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYNESV 177

Query: 351 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 390
           D +SFGVLL E++  +  F  E  +E        FD   N
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 31/212 (14%)

Query: 173 GRGSFGIVY--KGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSFG +Y  K   ++       + + K+       EKE  K EV+++ +  H N+V  
Sbjct: 9   GEGSFGKIYLAKAKSDSEHCVIKEIDLTKM----PVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLY 279
                E     +V E+ + G L   +        N +  + F          QI+ GL +
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRI--------NRQRGVLFSEDQILSWFVQISLGLKH 116

Query: 280 LHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +H+    +I+H DIK QNI L  +   A++ DFG+A+   LN S  +     GT  Y++P
Sbjct: 117 IHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSP 171

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
           E  +      K D++S G +L E+ + +  F+
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 26/207 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLG 231
           G G++  V+KG    ++ +   VA+K++    ++G       EV ++    H N+V L  
Sbjct: 14  GEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 232 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +   LV+E+L++  L  +L   GNL    N++    FQ+ RGL Y H+    +I+
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK---RKIL 125

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI--- 346
           H D+KPQN+L+++    +++DFGLA+      +K++ T     +  V   WYR   +   
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDVLLG 177

Query: 347 ----TAKVDVYSFGVLLLEIISCRKSF 369
               +  +D++  G +L E+ + R  F
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 30/223 (13%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHK 224
           E G+G++GIV         +    VA+KK+  VF          +E K   ++     HK
Sbjct: 7   ELGQGAYGIVCS-ARNAETSEEETVAIKKITNVFSKKILAKRALRELK---LLRHFRGHK 62

Query: 225 NLVRL--LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           N+  L  +     G  N L +YE L    L   +      +     +  +QI  GL Y+H
Sbjct: 63  NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ ++H D+KP N+L++     +I DFGLA+  + N  +           YVA  WY
Sbjct: 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF----MTEYVATRWY 175

Query: 342 RKSTI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
           R   I       T  +DV+S G +L E++  +  F    G++Y
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF---KGKDY 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 37/214 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN--------EVVVIGQTHHK 224
           G G++ +VYK       T    VA+KK   +     KE K+        E+ ++ +  H 
Sbjct: 9   GEGTYAVVYKA--RDKETGRI-VAIKK---IKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 225 NLVRLLGFCDEGQNRLLVYEFL--------NNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
           N++ LL       N  LV+EF+         + ++      ++K S+ L         RG
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-VLTPADIK-SYML------MTLRG 114

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L YLH   S+ I+H D+KP N+L+      +++DFGLA+  +        T    T+ Y 
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYR 169

Query: 337 APE-WYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE  +        VD++S G +  E++  R  F
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 15/106 (14%)

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+ + + +I DFGLA++       T      
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL--- 166

Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
            T+ YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 167 -TE-YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 68/230 (29%), Positives = 105/230 (45%), Gaps = 40/230 (17%)

Query: 159 KALEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNE 214
           K + E  + ++     G G++G V       T+T    VAVKKL R FQ     K    E
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRE 66

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN-- 268
           + ++    H+N++ LL      ++     E  N+  L + L G    N+     L  +  
Sbjct: 67  LRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122

Query: 269 --IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
             + +QI RGL Y+H   S+ IIH D+KP N+ +++    +I DFGLA+           
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------H 169

Query: 327 TAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           T    T GYVA  WYR   I          VD++S G ++ E+++ R  F
Sbjct: 170 TDDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 16/203 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG V    +   R +    A KKL++     + GE    NE  ++ + + + +V L
Sbjct: 9   GKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
             +  E ++ L LV   +N G L   ++    P ++    +  A +I  GL  LH     
Sbjct: 66  -AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RE 121

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +I++ D+KP+NILLDD+ + RISD GLA  + + + +TI+  + GT GY+APE  +    
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNERY 178

Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
           T   D +  G L+ E+I  +  F
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G V+K      +     VA+K++ RV Q GE+        EV V+       H
Sbjct: 8   EIGEGAYGKVFKA--RDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RG
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH   S +++H D+KPQNIL+      +++DFGLA++ +    +   T++  T  Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +S+    VD++S G +  E+   +  F
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 36/240 (15%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIG---QTHH 223
           E G G++G VYK        S   VA+K + RV Q  E         EV ++       H
Sbjct: 7   EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-QTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL+  C     D      LV+E ++   L ++L     P     T  ++  Q  RG
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH +C   I+H D+KP+NIL+      +++DFGLA++ +   +    T +  T  Y 
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYR 174

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIIS-----CRKSFDIEMGEEYAIL-----TDWAFD 386
           APE   +ST    VD++S G +  E+       C  S   ++G+ + ++      DW  D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 32/217 (14%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKN 225
           E  G G++G+V   +     T +   VA+KK+   F      ++  + E+ ++    H N
Sbjct: 11  ENIGSGAYGVVCSAI----DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDN 65

Query: 226 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           ++ +         + ++  +V + L    L   +  +   +        +Q+ RGL Y+H
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS--KTIKTAIRGTKGYVAPE 339
              S+ +IH D+KP N+L+++    RI DFG+A+ L+ + +  K   T       YVA  
Sbjct: 125 ---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE------YVATR 175

Query: 340 WYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           WYR   +       T  +D++S G +  E++  R+ F
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 29/288 (10%)

Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
           L+  +   +   G G FG + +G ++        VA+  L     D ++  F  E + +G
Sbjct: 2   LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61

Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARG 276
           Q  H N+VRL G    G   ++V E+++NG L SFL    G L     +   +   +A G
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLASG 119

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL E      +H  +    +L++     +IS F     L  ++S+ I T + G     
Sbjct: 120 MKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVL 173

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           + APE  +    ++  DV+SFG+++ E++S  +    +M  +  I               
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI--------------- 218

Query: 395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
             VE          C   L  + + C Q++   RP   ++  +L  +V
Sbjct: 219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 56/210 (26%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 228
           E+ G G++  V+KG    ++ +   VA+K++    ++G       EV ++    H N+V 
Sbjct: 12  EKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L       ++  LV+E+L+   L  ++   GN+    N++  + +QI RGL Y H     
Sbjct: 69  LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHR---R 123

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---- 342
           +++H D+KPQN+L+++    +++DFGLA+      +K++ T     +  V   WYR    
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 175

Query: 343 ---KSTITAKVDVYSFGVLLLEIISCRKSF 369
               S  + ++D++  G +  E+ S R  F
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 43/211 (20%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE------KEFKNEVVVIGQTHHKNL 226
           G GS+G+V+K      R +   VA+KK    F + E      K    E+ ++ Q  H NL
Sbjct: 10  GEGSYGVVFKC---RNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDC 284
           V L+      +   LV+E+ ++ T+ + L  N +  P   ++  I +Q  + + + H   
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCH--- 117

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG----YVAPEW 340
               IH D+KP+NIL+      ++ DFG A++LT            G       YVA  W
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILT------------GPGDDYTDYVATRW 165

Query: 341 YRKSTIT-------AKVDVYSFGVLLLEIIS 364
           YR   +          VDV++ G +  E+++
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 26/217 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 228
           ++ G G++  VYKG    ++ +   VA+K++    ++G       EV ++    H N+V 
Sbjct: 12  DKLGEGTYATVYKG---RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L       ++  LV+E+L+   L  +L   GN     N++  + FQ+ RGL Y H     
Sbjct: 69  LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR---R 123

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +++H D+KPQN+L+++    +++DFGLA+      +K+I T     +  V   WYR   I
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNE--VVTLWYRPPDI 175

Query: 347 -------TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                  + ++D++  G +  E+ + R  F     EE
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 65/239 (27%), Positives = 96/239 (40%), Gaps = 42/239 (17%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK-LDRVFQDGEKEFK----NEVVVIGQT 221
               + G G+FG VYK        +   VA+KK L    +DG   F      E+ ++ + 
Sbjct: 11  EILGKLGEGTFGEVYKAR---QIKTGRVVALKKILMHNEKDG---FPITALREIKILKKL 64

Query: 222 HHKNLVRLLGFC-----DEGQNRLLVY--EFLNNGTLASFLFGNLKPSWNLR----TNIA 270
            H N+V L+           + R  VY      +  L+  L  N  PS  L         
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-EN--PSVKLTESQIKCYM 121

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
            Q+  G+ YLHE   + I+H DIK  NIL+D+    +I+DFGLA+               
Sbjct: 122 LQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 331 GTKGY---VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF----DIEMGE 375
           GT+ Y   V   WYR   +       T  VD++  G +  E+ + R       DI+   
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 25/203 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNL 226
           E+ G G++G V+K      R +   VA+K++ R+  D E    +   E+ ++ +  HKN+
Sbjct: 6   EKIGEGTYGTVFKAK---NRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VRL       +   LV+E+ +      F   N      +  +  FQ+ +GL + H   S 
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SH 118

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            ++H D+KPQN+L++ +   +++DFGLA+   +         +R     V   WYR   +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PVRCYSAEVVTLWYRPPDV 170

Query: 347 -------TAKVDVYSFGVLLLEI 362
                  +  +D++S G +  E+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 32/218 (14%)

Query: 167 NFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQTHH 223
           NFK  E+ G G++  VYKG     RT+   VA+K++    ++G       E+ ++ +  H
Sbjct: 1   NFKQLEKLGEGTYATVYKG---RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRTNIAFQIARGLL 278
           +N+VRL          +LV+E+++   L  ++      G L P  N   +  +Q+ +G+ 
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDP--NTVKSFTYQLLKGIA 114

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           + HE+   +++H D+KPQN+L++     +++DFGLA        +     +      V  
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA--------RAFGIPVNTFSNEVVT 163

Query: 339 EWYR-------KSTITAKVDVYSFGVLLLEIISCRKSF 369
            WYR         T +  +D++S G ++ E+I+ R  F
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 66/199 (33%), Positives = 92/199 (46%), Gaps = 8/199 (4%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRLL 230
           G+GSFG V+   ++ T       A+KK D V  D + E     + V+     H  L  L 
Sbjct: 4   GKGSFGKVFLAELKGTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
                 +N   V E+LN G L   +    K      T  A +I  GL +LH   S  I++
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVY 119

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  NILLD   + +I+DFG+ K   L  +KT      GT  Y+APE          V
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNTSV 177

Query: 351 DVYSFGVLLLEIISCRKSF 369
           D +SFGVLL E++  +  F
Sbjct: 178 DWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 18/217 (8%)

Query: 159 KALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 216
           ++L + TD ++  E  G+G++G VYK    T +   +  AVK LD +  D ++E + E  
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYK---VTNKKDGSLAAVKILDPI-SDVDEEIEAEYN 70

Query: 217 VIGQ-THHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNL-RTN 268
           ++    +H N+V+  G          GQ   LV E  N G++   + G L     L    
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT---LNQSKTI 325
           I++ +   LL L    +++IIH D+K  NILL      ++ DFG++  LT   L ++ ++
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189

Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEI 362
            T        +A E     +  A+ DV+S G+  +E+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 60/212 (28%), Positives = 91/212 (42%), Gaps = 29/212 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           +E G G FG V  G       S   V VK+L      D +  F  EV    + +H N+++
Sbjct: 1   DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHED 283
            LG C E    LLV EF   G L ++L  N          ++   +A ++A GLL+LH+ 
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA------IRGTKGYVA 337
             +  IH D+  +N  L    + +I D+GLA  L         T       +R    ++A
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR----WLA 170

Query: 338 PEWY-------RKSTITAKVDVYSFGVLLLEI 362
           PE              T K +++S GV + E+
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.9 bits (173), Expect = 9e-14
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 27/209 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 228
           E  G G++G VYKG        T  +A  K+  V  D E+E K E+ ++ + +HH+N+  
Sbjct: 12  ELVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 229 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAFQIARGLL 278
             G F  +    +     LV EF   G++   +    GN LK  W     I  +I RGL 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLS 125

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +LH+    ++IH DIK QN+LL ++   ++ DFG++    L+++   +    GT  ++AP
Sbjct: 126 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 180

Query: 339 EWYR-----KSTITAKVDVYSFGVLLLEI 362
           E         +T   K D++S G+  +E+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 27/204 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--------DRVFQDGEKEFKNEVVVIGQTHHK 224
           G+GSFG V+     T   +    A+K L        DRV        K E  ++ + +H 
Sbjct: 5   GQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV------RTKMERDILAEVNHP 58

Query: 225 NLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYL 280
            +V+L   F  EG+   L+ +FL  G L + L    K       ++ F   ++A  L +L
Sbjct: 59  FIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHL 114

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S  II+ D+KP+NILLD+  + +++DFGL+K    ++ K    +  GT  Y+APE 
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEV 169

Query: 341 YRKSTITAKVDVYSFGVLLLEIIS 364
             +   T   D +SFGVL+ E+++
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 26/204 (12%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLVR 228
           E G G+FG VYK      + +    A K +    +  E+  +F  E+ ++ +  H N+V 
Sbjct: 12  ELGDGAFGKVYKAQ---HKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVG 66

Query: 229 LL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDC 284
           L   +  E +  +L+ EF + G L S +    +        I +   Q+   L +LH   
Sbjct: 67  LYEAYFYENKLWILI-EFCDGGALDSIMLELERGL--TEPQIRYVCRQMLEALNFLH--- 120

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGL-AKLLTLNQSKTIKTAIRGTKGYVAP----- 338
           S ++IH D+K  NILL    + +++DFG+ AK  +  Q +   T I GT  ++AP     
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFI-GTPYWMAPEVVAC 177

Query: 339 EWYRKSTITAKVDVYSFGVLLLEI 362
           E ++ +    K D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 28/210 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G GSFG   K ++  ++       +K+++  ++     +E + EV V+    H N+V+  
Sbjct: 9   GEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLYL 280
              +E  N  +V ++   G L   +        N +  + F          QI   L ++
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H+    +I+H DIK QNI L      ++ DFG+A++L  +  +  +T I GT  Y++PE 
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCI-GTPYYLSPEI 172

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
                   K D+++ G +L E+ + + +F+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG V+       R S    A+K +   + +    E+   NE  V+ +  H  ++RL
Sbjct: 10  GTGTFGRVHL---VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                + +   ++ E++  G L S+L  + + S +     A +I   L YLH   S +I+
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIV 123

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+NILLD   + +++DFG AK L  +++ T+     GT  Y+APE  +       
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWTLC----GTPEYLAPEVIQSKGHNKA 178

Query: 350 VDVYSFGVLLLEIIS 364
           VD ++ G+L+ E++ 
Sbjct: 179 VDWWALGILIYEMLV 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 20/218 (9%)

Query: 167 NFKEEAGRGSFGIVY----KGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQT 221
           NF    G+GSFG V     KG  E       A+ + K D V QD + E    E  V+  +
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELY-----AIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 222 HHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLL 278
                +  L  C +  +RL  V E++N G L   +   G  K    +    A +IA GL 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLF 115

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +LH   S  II+ D+K  N++LD   + +I+DFG+ K    +   T KT   GT  Y+AP
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTFC-GTPDYIAP 170

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
           E          VD ++FGVLL E+++ +  F+ E  +E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 36/285 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G+G FG V +  +++   S   VAVK  K D       +EF  E   + +  H N+++L+
Sbjct: 8   GKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLI 67

Query: 231 GFC--DEGQNRL----LVYEFLNNGTLASFLF----GNLKPSWNLRTNIAF--QIARGLL 278
           G       + RL    ++  F+ +G L +FL     G    +  L+T + F   IA G+ 
Sbjct: 68  GVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGME 127

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YL    S   IH D+  +N +L+++    ++DFGL+K +          A +    ++A 
Sbjct: 128 YLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           E    +  T   DV++FGV + EI++  ++    +E  E Y                  L
Sbjct: 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY----------------L 228

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
           ++G+        C+E +  +   C   +P  RP+ + +   LE +
Sbjct: 229 IKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 65/315 (20%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTA-------------VAVKKL-DRVFQDGEKEFKN 213
           FKE+ G G FG V+   +   +   T              VAVK L     ++   +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 214 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------------- 258
           EV ++ +    N++RLLG C +     ++ E++ NG L  FL  +               
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 259 ----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA 314
                  S++   ++A QIA G+ YL    S   +H D+  +N L+ ++   +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEM 373
           + L       I+        ++A E       T   DV++FGV L EI+  C++      
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE------ 239

Query: 374 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKLLMVSIWCIQE 423
            + Y  LTD           + ++E   E   D            C + L  + + C   
Sbjct: 240 -QPYGELTD-----------EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSR 287

Query: 424 DPSLRPTMRKVSQML 438
           D   RP+   +   L
Sbjct: 288 DCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 27/209 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 228
           E  G G++G VYKG        T  +A  K+  V +D E+E K E+ ++ + +HH+N+  
Sbjct: 22  EVVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 229 LLG-FCDE---GQNR--LLVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAFQIARGLL 278
             G F  +   G +    LV EF   G++   +    GN LK  W     I  +I RGL 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLA 135

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +LH   + ++IH DIK QN+LL ++   ++ DFG++    L+++   +    GT  ++AP
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAP 190

Query: 339 EWYR-----KSTITAKVDVYSFGVLLLEI 362
           E         +T   + D++S G+  +E+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG+V+     T       VA+KK+  VFQ+    K    E+ ++    H N++  L
Sbjct: 9   GYGAFGVVWS---VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 231 GFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
                        + V   L    L   +      S +      +QI RGL YLH   S+
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SA 122

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST- 345
            I+H DIKP N+L++ +   +I DFGLA++   ++SK + T    T+ Y APE    S  
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM-TQEVVTQYYRAPEILMGSRH 181

Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
            T+ VD++S G +  E++  R  F
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILF 205

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 27/200 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG+V        + +   VA+KK+ + F      K    E+ ++    H+N++ L 
Sbjct: 19  GMGAFGLVCSA---RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75

Query: 231 G-FCDEGQNRLLVYEFLNNGT-LASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
             F    ++   V E L  GT L   L    L+  +       +QI RGL Y+H   S+ 
Sbjct: 76  DIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQF--IQYFLYQILRGLKYVH---SAG 128

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE----WYRK 343
           ++H D+KP NIL++++ + +I DFGLA++    Q   + T    T+ Y APE    W + 
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVSTRYYRAPEIMLTWQKY 183

Query: 344 STITAKVDVYSFGVLLLEII 363
                +VD++S G +  E++
Sbjct: 184 DV---EVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 10/214 (4%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQTHHKNLVRLLG 231
           G+GSFG V    ++ +     AV V K D + QD + E    E  ++    +   +  L 
Sbjct: 4   GKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 232 FCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
            C +  +RL  V EF+N G L   +  + +         A +I   L++LH+     II+
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIY 119

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  N+LLD   + +++DFG+ K    N   T  +   GT  Y+APE  ++      V
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEMLYGPSV 177

Query: 351 DVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 382
           D ++ GVLL E++     F+ E  ++   AIL D
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 16/203 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG V    +   R +    A KKL++     + GE    NE  ++ + + + +V L
Sbjct: 9   GKGGFGEVCACQV---RATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
             +  E ++ L LV   +N G L   ++    P ++ +  I  A ++  GL  L  +   
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--- 121

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +I++ D+KP+NILLDD  + RISD GLA  + + + +T++  + GT GY+APE       
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVINNEKY 178

Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
           T   D +  G L+ E+I  +  F
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG V    +   R +    A K+L++     + GE    NE  ++ + + + +V L
Sbjct: 9   GKGGFGEVCACQV---RATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
             +  E ++ L LV   +N G L   ++    P +     +  A +I  GL  LH +   
Sbjct: 66  -AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--- 121

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
             ++ D+KP+NILLDD+ + RISD GLA  + + + ++I+  + GT GY+APE       
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLNNQRY 178

Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
           T   D +  G L+ E+I  +  F
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 29/208 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHH-KNLV 227
           EE GRG++G+V K        + T +AVK++       E K    ++ +  ++      V
Sbjct: 7   EELGRGAYGVVDK---MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63

Query: 228 RLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
              G          C E  +  L  +F        +  G   P  ++   IA  I + L 
Sbjct: 64  TFYGALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPE-DILGKIAVSIVKALE 117

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YLH   S  +IH D+KP N+L++ +   ++ DFG++  L  + +KTI     G K Y+AP
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA---GCKPYMAP 172

Query: 339 EWYRKSTITA----KVDVYSFGVLLLEI 362
           E             K DV+S G+ ++E+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 38/214 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V        R     VAVKKL R FQ     +    E+ ++    H+N++ LL
Sbjct: 24  GSGAYGSVCSAYDTRLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                  +     E  N   L + L G    N+     L       + +Q+ RGL Y+H 
Sbjct: 81  DVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH- 135

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    RI DFGLA+     Q+    T      GYVA  WYR
Sbjct: 136 --SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMT------GYVATRWYR 182

Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E++  +  F
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 26/220 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAV--AVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V    ++    + T     VKK   V    ++   +E  ++ + +H  +V+L 
Sbjct: 2   GVGGFGRVEL--VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 231 -GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
             F D+ +   ++ E+   G L + L   G     +  R  IA  +     YLH   +  
Sbjct: 60  RTFKDK-KYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIA-CVVLAFEYLH---NRG 113

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           II+ D+KP+N+LLD +   ++ DFG AK L  +  KT  T   GT  YVAPE      I 
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKT-WTFC-GTPEYVAPE-----IIL 165

Query: 348 AK-----VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 382
            K     VD +S G+LL E+++ R  F  +  +   I  D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 91/336 (27%), Positives = 135/336 (40%), Gaps = 90/336 (26%)

Query: 173 GRGSFGIVYKGVI--ETTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLVR 228
           G G+FG V +        ++S   VAVK L       E K   +E+ ++I   +H N+V 
Sbjct: 16  GHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVN 75

Query: 229 LLGFCDEGQNRLLV-YEFLNNGTL------------------------------------ 251
           LLG C +    L+V  EF   G L                                    
Sbjct: 76  LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDR 135

Query: 252 ------ASFLFGNLKPSWNLRTN--------------------IAFQIARGLLYLHEDCS 285
                 AS LF   +PS +  TN                     +FQ+ARG+ +L    S
Sbjct: 136 RIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---AS 192

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            + IH D+  +NILL ++   +I DFGLA+ +  +     K + R    ++APE      
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 346 ITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-ME 402
            T + DV+SFGVLL EI S   S    +++ EE+         C R      L +G  M 
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------CQR------LKDGTRMR 297

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           A  +       +M++ W  Q DP  RPT   + ++L
Sbjct: 298 APENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 40/225 (17%)

Query: 156 FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKN 213
           F+ + L++       E GRG+FG V K +    + S T +AVK++ R   D   +K    
Sbjct: 1   FTAEDLKD-----LGEIGRGAFGTVNKML---HKPSGTIMAVKRI-RSTVDEKEQKRLLM 51

Query: 214 EV-VVIGQTHHKNLVRLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLK--- 260
           ++ VV+  +    +V+  G          C E     L+   L+      +++  LK   
Sbjct: 52  DLDVVMRSSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVI 104

Query: 261 PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
           P   +   IA    + L YL E+   +IIH D+KP NILLD + N ++ DFG++  L   
Sbjct: 105 PE-EILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--- 158

Query: 321 QSKTIKTAIRGTKGYVAPEWYRKSTITA---KVDVYSFGVLLLEI 362
                KT   G + Y+APE    S       + DV+S G+ L E+
Sbjct: 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V   + + T      VA+KKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 24  GSGAYGSVCSAIDKRTGEK---VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHEDC 284
              D   + +   EF +   +  ++  +L+       +      + +Q+  GL Y+H   
Sbjct: 81  ---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S+ IIH D+KP N+ +++    +I DFGLA           + A     GYV   WYR  
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYRAP 183

Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
            +          VD++S G ++ E+++ +  F    G++Y
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK---GKDY 220

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 30/212 (14%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 227
           E+ G GS+  VYKG+   +R +   VA+K +    ++G   F    E  ++    H N+V
Sbjct: 11  EKLGEGSYATVYKGI---SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV 66

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            L       +    V+E+++   LA ++    G L P +N+R    FQ+ RGL Y+H   
Sbjct: 67  LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRL-FMFQLLRGLAYIH--- 120

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              I+H D+KPQN+L+      +++DFGLA+      +K+I +    ++  V   WYR  
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE--VVTLWYRPP 172

Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSF 369
            +       ++ +D++  G + +E++  + +F
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 12/216 (5%)

Query: 165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHH 223
             NF    G+GSFG V     + T     A+ + K D V QD + E    E  V+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK 59

Query: 224 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 280
              +  L  C +  +RL  V E++N G L   +   G  K    +    A +I+ GL +L
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF--YAAEISVGLFFL 117

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H      II+ D+K  N++LD   + +I+DFG+ K   +    T +T   GT  Y+APE 
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFC-GTPDYIAPEI 172

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                    VD +++GVLL E+++ +  FD E  +E
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 64/198 (32%), Positives = 92/198 (46%), Gaps = 16/198 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAV-AVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLV 227
           G+GSFG V          +     AVK L +     +KE K+ +    V++    H  LV
Sbjct: 4   GKGSFGKVL----LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 228 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
            L  +  +  ++L  V +++N G L   L              A +IA  L YLH   S 
Sbjct: 60  GL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SL 115

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            II+ D+KP+NILLD   +  ++DFGL K   +  SKT  T   GT  Y+APE  RK   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC-GTPEYLAPEVLRKQPY 173

Query: 347 TAKVDVYSFGVLLLEIIS 364
              VD +  G +L E++ 
Sbjct: 174 DRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 17/177 (9%)

Query: 195 VAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFL 246
           VAVKKL R FQ+    K    E+V++   +HKN++ LL         +E Q+  LV E +
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA 306
           +   L   +   L       + + +Q+  G+ +LH   S+ IIH D+KP NI++      
Sbjct: 109 D-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 162

Query: 307 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
           +I DFGLA+    N    + T    T+ Y APE          VD++S G ++ E++
Sbjct: 163 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 75/323 (23%), Positives = 135/323 (41%), Gaps = 86/323 (26%)

Query: 168 FKEEAGRGSFGIVY----KGV---------IETTRTSTTAVAVKKL-DRVFQDGEKEFKN 213
           FKE+ G G FG V+    +G+         ++ +      VAVK L +   ++   +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 214 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------------ 255
           E+ ++ +    N++RLL  C       ++ E++ NG L  FL                  
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 256 FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
           +  L         +A QIA G+ YL    S   +H D+  +N L+  +Y  +I+DFG+++
Sbjct: 129 YSTLI-------FMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-----TAKVDVYSFGVLLLEIIS-CRKSF 369
            L       I+      +  +   W    +I     T   DV++FGV L EI++ C++  
Sbjct: 179 NLYSGDYYRIQ-----GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE-- 231

Query: 370 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK----------CVEKL--LMVS 417
                + Y+ L+D           + ++E   E   D            C + L  LM+S
Sbjct: 232 -----QPYSQLSD-----------EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS 275

Query: 418 IWCIQEDPSLRPTMRKV-SQMLE 439
            W  + +   RP+ +++ + +LE
Sbjct: 276 CW--RRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 12/154 (7%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           +E G G FG V  G + +   +   V VK+L      Q+ + +F  E        H NL+
Sbjct: 1   KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLL 58

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHE 282
           + LG C E    LLV EF   G L  +L        + P       +A +IA GLL+LH+
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
           +     IH D+  +N LL      +I D+GL+  
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 76/283 (26%), Positives = 132/283 (46%), Gaps = 52/283 (18%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHK 224
             +E G+G++G VYK +    R +   +A+K++ R+  D E +F     E+ ++ +    
Sbjct: 5   VLDELGKGNYGSVYKVL---HRPTGVTMAMKEI-RLELD-ESKFNQIIMELDILHKAVSP 59

Query: 225 NLVRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARG 276
            +V   G F  EG     VY   E+++ G+L     G +     P   LR  I + + +G
Sbjct: 60  YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKG 114

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKTAIRGTKGY 335
           L +L E+    IIH D+KP N+L++ +   ++ DFG++  L  + +KT I     G + Y
Sbjct: 115 LKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSY 167

Query: 336 VAPEWYR------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
           +APE  +        T T + DV+S G+ +LE+   R  +  E               Y 
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--------------YA 213

Query: 390 N--GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT 430
           N   +L  +V+GD   +      +    V+  C+ + P+ RPT
Sbjct: 214 NIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 170 EEAGRGSFGIVYKG----VIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           E  G+G+F  ++KG    V +      T V +K LD+  ++  + F     ++ Q  HK+
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHE 282
           LV   G C  G   ++V E++  G+L ++L  N   +  SW L   +A Q+A  L +L +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLED 118

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEW 340
                + H ++  +N+LL    + +  +    KL     S T+  K  +     +V PE 
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175

Query: 341 YRKS-TITAKVDVYSFGVLLLEIIS 364
                 ++   D +SFG  L EI S
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRL 229
           GRG++GIV          +   VA+KK+   F    D ++  + E+ ++    H+N++ +
Sbjct: 14  GRGAYGIVCSAK---NSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 230 LGFCDEGQNR-----LLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYL 280
                           +VYE ++       L   ++ S  L  +      +Q+ RGL Y+
Sbjct: 70  KDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S+ ++H D+KP N+LL+ + + +I DFGLA+  T ++     T       YV   W
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTE------YVVTRW 173

Query: 341 YRK-------STITAKVDVYSFGVLLLEII 363
           YR        S  T  +DV+S G +  E++
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL--DRVFQDGEKE---FKNEVVVIGQTHHKNL 226
           GRG+FG VY     +T R     +AVK++  D   Q+  KE    + E+ ++    H  +
Sbjct: 11  GRGAFGEVYLCYDADTGRE----LAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 227 VRLLGFC--DEGQNRLLVY-EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
           V+  G C  D  + +L ++ E++  G++   L      + N+      QI +G+ YLH  
Sbjct: 67  VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-- 123

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWYR 342
            S+ I+H DIK  NIL D   N ++ DFG +K + T+  S T   ++ GT  +++PE   
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 343 KSTITAKVDVYSFGVLLLEIIS 364
                 K DV+S    ++E+++
Sbjct: 183 GEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVRL 229
           G+G+FG VY      T     A  V+  D    +  KE    + E+ ++    H+ +V+ 
Sbjct: 11  GQGAFGRVYLCYDVDTGRELAAKQVQ-FDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 230 LG-FCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
            G   D  +  L ++ E++  G++   L  +G L  S  +      QI  G+ YLH   S
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES--VTRKYTRQILEGMSYLH---S 124

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           + I+H DIK  NIL D   N ++ DFG +K L T+  S T   ++ GT  +++PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 345 TITAKVDVYSFGVLLLEIIS 364
               K DV+S G  ++E+++
Sbjct: 185 GYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.5 bits (159), Expect = 8e-12
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 30/212 (14%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 227
           E+ G GS+  VYKG    ++ +   VA+K + R+ ++    F    E  ++    H N+V
Sbjct: 11  EKLGEGSYATVYKG---KSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            L       +   LV+E+++   L  ++    G L P  N++  + FQ+ RGL Y+H+  
Sbjct: 67  LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQ-- 121

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              I+H D+KPQN+L+ D    +++DFGLA+      +K++ +     +  V   WYR  
Sbjct: 122 -RYILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNE--VVTLWYRPP 172

Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSF 369
            +       +  +D++  G + +E+I    +F
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 66/265 (24%), Positives = 119/265 (44%), Gaps = 25/265 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           ++E  G G+ G VYK     TR    AV V  LD +  + +K+  +E+ ++ +     ++
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTR-RILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62

Query: 228 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
              G F  E  NR+ +  EF++ G+L  +     K   ++   IA  + +GL YL    S
Sbjct: 63  GFYGAFFVE--NRISICTEFMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYL---WS 113

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +I+H D+KP N+L++     ++ DFG++  L      +I     GT  Y+APE      
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQ 169

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
                DV+S G+  +E+   R  +      + +++      C        +V+ D   + 
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC--------IVDEDPPVLP 221

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPT 430
             +  EK +     C+++ P  RP 
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 19/171 (11%)

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           + Q+A+G+ +L    S   IH D+  +N+LL D   A+I DFGLA+ +  + +  +K   
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCY 388
           R    ++APE       T + DV+S+G+LL EI S  KS        Y  IL +  F  Y
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF--Y 325

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +  K      G   +  D    E +  +   C   +P+ RPT  ++SQ+++
Sbjct: 326 KMVK-----RGYQMSRPDFAPPE-IYSIMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 13/215 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+GSFG V +     T+       ++K   V +        E  V+ Q +   +V L  F
Sbjct: 2   GKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-KF 60

Query: 233 CDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIH 290
             +   +L LV  F+N G L    F +L+       + A F  A  L  L       +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-AIRGTKGYVAPEWYRKSTITAK 349
            D+KP+NILLD   +  + DFGL K   LN     KT    GT  Y+APE       T  
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 350 VDVYSFGVLLLEIISCRKSF-DIEMGEEY-AILTD 382
           VD ++ GVLL E+++    F D  + E Y  IL +
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVR 228
           G+G+FG VY     +T R    AV   + D    +  KE    + E+ ++    H+ +V+
Sbjct: 11  GQGAFGRVYLCYDADTGRE--LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 229 LLGFCDEGQNRLL--VYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
             G   +   R L    E +  G++   L  +G L  + N+      QI  G+ YLH   
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL--TENVTRKYTRQILEGVSYLH--- 123

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
           S+ I+H DIK  NIL D   N ++ DFG +K L T+  S T   ++ GT  +++PE    
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 344 STITAKVDVYSFGVLLLEIISCR 366
                K D++S G  ++E+++ +
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK   +   T   A A K +D   ++  +++  E+ ++    H N+V+LL
Sbjct: 12  ELGDGAFGKVYKA--QNKETGVLAAA-KVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF-QIARGLLYLHEDCSSQII 289
                  N  ++ EF   G + + +    +P    +  +   Q    L YLHE   ++II
Sbjct: 69  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWYRKST-- 345
           H D+K  NIL     + +++DFG++       ++TI  + +  GT  ++APE     T  
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 346 ---ITAKVDVYSFGVLLLEI 362
                 K DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHHKNL 226
           + G G+ G V K         T  V  KK+  V    +   + +++    ++ +     +
Sbjct: 12  DLGAGNGGSVSK----VKHIPTGTVMAKKV--VHIGAKSSVRKQILRELQIMHECRSPYI 65

Query: 227 VRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 283
           V   G F +E  N  +  EF++ G+L       G +     +   IA  +  GL YL+  
Sbjct: 66  VSFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGPIPV--EILGKIAVAVVEGLTYLYN- 121

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +I+H DIKP NIL++     ++ DFG++  L      +I     GT  Y++PE  + 
Sbjct: 122 -VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQG 176

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFD 370
              T K DV+S G+ ++E+   +  F 
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 72/267 (26%), Positives = 110/267 (41%), Gaps = 35/267 (13%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 227
           E G GSFG VY     T   +   VAVKK+    +   +++++   EV  + Q  H N +
Sbjct: 28  EIGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSS 286
              G   +     LV E+   G+ +  L  + KP   +    I     +GL YLH     
Sbjct: 85  EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WYRK 343
            +IH DIK  NILL +    +++DFG A   +   S        GT  ++APE      +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDE 194

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
                KVDV+S G      I+C     IE+ E    L    F+      L  + + D   
Sbjct: 195 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 239

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPT 430
           +   +  +       +C+Q+ P  RP 
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 32/207 (15%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK      + +    A K ++   ++  +++  E+ ++   +H  +V+LL
Sbjct: 19  ELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75

Query: 231 G-FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           G F  +G+  +++ EF   G + + +     G  +P   +   I  Q+   L YLH   S
Sbjct: 76  GAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLH---S 128

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-----GTKGYVAPEW 340
            +IIH D+K  N+LL    + +++DFG++       +K +KT  R     GT  ++APE 
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMAPEV 181

Query: 341 YRKSTITA-----KVDVYSFGVLLLEI 362
               T+       K D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 44/211 (20%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+ GIV          +   VA+KKL R FQ+    K    E+V++   +HKN++ LL
Sbjct: 25  GSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 231 G-FC-----DEGQNRLLVYEF------------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
             F      +E Q+  LV E             L++  ++  L               +Q
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL---------------YQ 126

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
           +  G+ +LH   S+ IIH D+KP NI++      +I DFGLA+  T   S  + T    T
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTS-FMMTPYVVT 180

Query: 333 KGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
           + Y APE          VD++S G ++ E+I
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 36/212 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK--NEVVVIGQTHHKNLVRLL 230
           G GS+  VYKG  + T      VA+K++ R+  +    F    E  ++    H N+V L 
Sbjct: 14  GEGSYATVYKGRSKLTGQ---LVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLH 69

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                 +   LV+E+L+   L  ++    G L    N+R    FQ+ RGL Y H     +
Sbjct: 70  DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL-FLFQLLRGLAYCH---QRR 123

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY---VAPEWYRK- 343
           ++H D+KPQN+L+ +    +++DFGLA+      +K++      +K Y   V   WYR  
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR------AKSVP-----SKTYSNEVVTLWYRPP 172

Query: 344 -----ST-ITAKVDVYSFGVLLLEIISCRKSF 369
                ST  +  +D++  G +  E+ + R  F
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 24/277 (8%)

Query: 167 NFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 224
           NF+ E   GRG F  VY+      R       V+  + +     ++   E+ ++ Q +H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGLLYL 280
           N+++ L    E     +V E  + G L+  +  F   K     RT   +  Q+   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S +++H DIKP N+ +      ++ D GL +  +     T   ++ GT  Y++PE 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 177

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
             ++    K D++S G LL E+ + +  F    G++  + +     C +      + + D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFS----LCQK------IEQCD 224

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
              +      EKL  +   CI  DP  RP +  V Q+
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 8/199 (4%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRLL 230
           G+GSFG V    ++         A+KK D V  D + E     + V+     +  L  L 
Sbjct: 4   GKGSFGKVLLAELKGKGEYFAVKALKK-DVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
                 ++   V EFLN G L   +    +      T  A +I  GL +LH   S  II+
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIY 119

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  N++LD   + +I+DFG+ K      ++   +   GT  Y+APE  +    T  V
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFSV 177

Query: 351 DVYSFGVLLLEIISCRKSF 369
           D +SFGVLL E++  +  F
Sbjct: 178 DWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 69/237 (29%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN--------EVVVIGQTHHK 224
           GRG++G VYK   +  +      A+KK       G+KE           E+ ++ +  H+
Sbjct: 9   GRGTYGRVYKAKRKNGKD-GKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62

Query: 225 NLVRLLGFCDEGQNRL--LVYEFLNNGTLASF-LFGNLK----------PSWNLRTNIAF 271
           N+V L+    E  ++   L++++      A   L+  +K          P   ++ ++ +
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVK-SLLW 115

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAK--------LLTL 319
           QI  G+ YLH   S+ ++H D+KP NIL+     +    +I D GLA+        L  L
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 320 NQSKTIKTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           +               V   WYR   +       T  +D+++ G +  E+++    F
Sbjct: 173 D-------------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVR-- 228
           G+GS+G V    +   RT      +KKL+     +   K  + E  ++ Q  H N+V   
Sbjct: 9   GKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 229 ------------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
                       ++GFC+ G     +Y  L          G L P  N       QIA  
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK------GKLLPE-NQVVEWFVQIAMA 114

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L YLHE     I+H D+K QN+ L      ++ D G+A++L  NQ     T I GT  Y+
Sbjct: 115 LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI-GTPYYM 169

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
           +PE +       K DV++ G  + E+ + + +F+
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHKN 225
           GRG FG VY       R + T    A+K LD+     + GE    NE +++    T    
Sbjct: 3   GRGGFGEVYG-----CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            +  + +     ++L  + + +N G L   L  +   S       A +I  GL ++H   
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH--- 114

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +  +++ D+KP NILLD+H + RISD GLA     + SK    A  GT GY+APE  +K 
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 170

Query: 345 TI-TAKVDVYSFGVLLLEIISCRKSF 369
           T   +  D +S G +L +++     F
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 50/232 (21%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVIGQTHHKNLV 227
           G G++G VYK   + T      VA+KK   V  D EKE F      E+ ++ Q +H+N+V
Sbjct: 16  GEGTYGQVYKARDKDT---GELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNIV 69

Query: 228 RL----------LGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPSWNLRTNIAF--Q 272
            L          L F  +     LV+E++++   G L S L       ++     +F  Q
Sbjct: 70  NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFMKQ 124

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
           +  GL Y H+      +H DIK  NILL++    +++DFGLA+L    +S       R  
Sbjct: 125 LLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-------RPY 174

Query: 333 KGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGE 375
              V   WYR   +          +DV+S G +L E+ + +  F  + E+ +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 66/200 (33%), Positives = 94/200 (47%), Gaps = 22/200 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLVR 228
           G+GSFG   K ++   +      AVK L +      KE K+ +    V++    H  LV 
Sbjct: 4   GKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PSWNLRTNIAFQIARGLLYLHED 283
           L       +    V +F+N G L    F +L+     P    R   A +IA  L YLH  
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAA-EIASALGYLH-- 113

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            S  I++ D+KP+NILLD   +  ++DFGL K   + QS T  T   GT  Y+APE  RK
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDT-TTTFCGTPEYLAPEVIRK 170

Query: 344 STITAKVDVYSFGVLLLEII 363
                 VD +  G +L E++
Sbjct: 171 QPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI-GQTHHKNLVR 228
           E  G+G++G V+K +    + + +  AVK LD +  D ++E + E  ++   + H N+V+
Sbjct: 24  ETIGKGTYGKVFKVL---NKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVK 79

Query: 229 LLGF-----CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-IAFQIARGLLYLHE 282
             G         G    LV E  N G++   + G LK    +    IA+ +   L+ L  
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPE 339
              ++ IH D+K  NILL      ++ DFG++  LT   L ++ ++ T        +A E
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199

Query: 340 WYRKSTITAKVDVYSFGVLLLEI 362
               ST  A+ DV+S G+  +E+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+ARG+ +L    S + IH D+  +NILL ++   +I DFGLA+ +  +     K   
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           R    ++APE       T + DV+SFGVLL EI S
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 20/199 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLVR 228
           G+GSFG   K ++   ++  +  AVK L +     +KE  + +    V++    H  LV 
Sbjct: 4   GKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDC 284
           L       +    V +++N G L    F +L+             A ++A  + YLH   
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLH--- 113

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  II+ D+KP+NILLD   +  ++DFGL K     +  T  +   GT  Y+APE  RK 
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKE 171

Query: 345 TITAKVDVYSFGVLLLEII 363
                VD +  G +L E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 46/214 (21%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--- 225
            E  G GSFG V    I   + +    A+K L           K E++ + Q  H     
Sbjct: 23  GETLGTGSFGRVR---IAKHKGTGEYYAIKCLK----------KREILKMKQVQHVAQEK 69

Query: 226 ----------LVRLL-GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQ 272
                     +V ++  F DE  NR+  + EF+  G L    F +L+ +     ++A F 
Sbjct: 70  SILMELSHPFIVNMMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFY 123

Query: 273 IARGLL---YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
            A  +L   YLH   S  II+ D+KP+N+LLD+  + +++DFG AK +     +T    +
Sbjct: 124 HAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTF--TL 175

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
            GT  Y+APE  +       VD ++ GVLL E I
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 64/199 (32%), Positives = 90/199 (45%), Gaps = 20/199 (10%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEK--EFKNEVVVIGQTHHKNLV 227
           E G GSFG VY       RT+   VA+KK+     Q  EK  +   EV  + Q  H N +
Sbjct: 22  EIGHGSFGAVYFA--RDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSS 286
              G         LV E+   G+ +  L  + KP   +    I     +GL YLH   S 
Sbjct: 79  EYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SH 134

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WYRK 343
           + IH DIK  NILL +    +++DFG A L++   S        GT  ++APE      +
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAMDE 188

Query: 344 STITAKVDVYSFGVLLLEI 362
                KVDV+S G+  +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)

Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 26  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 80  SLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 136

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 190

Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 21/178 (11%)

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL ++   +I DFGLA+ +  +     K   
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 292

Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
            R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ +
Sbjct: 293 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 32/281 (11%)

Query: 167 NFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQT 221
           NF+ E   GRG F  VY+    T       VA+KK+   D +      +   E+ ++ Q 
Sbjct: 3   NFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGL 277
           +H N+++      E     +V E  + G L+  +  F   K     +T   +  Q+   L
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-AIRGTKGYV 336
            ++H   S +++H DIKP N+ +      ++ D GL +  +   SKT    ++ GT  Y+
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPYYM 173

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           +PE   ++    K D++S G LL E+ + +  F  +    Y++       C +      +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKK------I 220

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
            + D   +      E+L  +   CI  DP  RP +  V  +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.6 bits (152), Expect = 8e-11
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 14/216 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVRL 229
           G+GSFG V    ++ T     A+ V K D + QD + +    +  ++ +   H    +  
Sbjct: 4   GKGSFGKVMLAELKGT-DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PFLTA 60

Query: 230 LGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L  C + ++RL  V E++N G L   +  + K         A ++   L++LH      +
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           I+ D+K  NILLD   + +++DFG+ K   LN   T  T   GT  Y+APE  ++     
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEYGP 175

Query: 349 KVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 382
            VD ++ GVL+ E+++ +  F+ +  ++   +IL D
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.8 bits (152), Expect = 8e-11
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 10/202 (4%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLLG 231
           GRGS+  V    ++ T     A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 4   GRGSYAKVLLVRLKKT-ERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 232 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 118

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+K  N+LLD   + +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPEILRGEDYGFS 176

Query: 350 VDVYSFGVLLLEIISCRKSFDI 371
           VD ++ GVL+ E+++ R  FDI
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 55/184 (29%), Positives = 87/184 (47%), Gaps = 28/184 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FK----NEVVVIGQTHHKNLV 227
           G+G+FG V+K      + +   VA+KK   V  + EKE F      E+ ++    H+N+V
Sbjct: 21  GQGTFGEVFKA---RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 228 RLLGFCD---EGQNR-----LLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLL 278
            L+  C       NR      LV+EF  +  LA  L   N+K + +    +   +  GL 
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           Y+H    ++I+H D+K  NIL+      +++DFGLA+  +L+         R T   V  
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLS---KNSKPNRYT-NRVVT 186

Query: 339 EWYR 342
            WYR
Sbjct: 187 LWYR 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 26/202 (12%)

Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86

Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+  T   S  +   +  T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPEVI 197

Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 26/205 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHH-K 224
            E G G+ G VYK      + +   +AVK++ R    G KE    ++    V+ ++H   
Sbjct: 21  GEIGSGTCGQVYKM---RFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCP 74

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLH 281
            +V+  G+     +  +  E +   T    L   ++   P  ++   +   I + L YL 
Sbjct: 75  YIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPE-DILGKMTVAIVKALHYLK 131

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           E     +IH D+KP NILLD   N ++ DFG++  L  +++KT ++A  G   Y+APE  
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT-RSA--GCAAYMAPERI 186

Query: 342 RKSTITAK----VDVYSFGVLLLEI 362
                  K     DV+S G+ L+E+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 17/172 (9%)

Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
           + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  +K 
Sbjct: 218 SFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 387
             R    ++APE       T + DV+S+G+LL EI S   S    M  +        +  
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKM 329

Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            + G      E     M DI       M S W    DP  RPT +++ Q++E
Sbjct: 330 IKEGYRMLSPECAPSEMYDI-------MKSCW--DADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQ-THHKNLVRL 229
           GRGS+  V    ++ TR       +KK   +  D E     + E  V    ++H  LV L
Sbjct: 4   GRGSYAKVLLVELKKTRRIYAMKVIKK--ELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQ 287
              C + ++RL  V EF++ G L   +    K P  + R   A +I+  L +LHE     
Sbjct: 62  HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE---RG 116

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           II+ D+K  N+LLD   + +++D+G+ K   +    T  T   GT  Y+APE  R     
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFC-GTPNYIAPEILRGEDYG 174

Query: 348 AKVDVYSFGVLLLEIISCRKSFDI 371
             VD ++ GVL+ E+++ R  FDI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 29/204 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ-THHKNLVRLL 230
           G G+F  V K     +R +    A+K + + F+  E+     E+  + + + H N++RL+
Sbjct: 8   GEGTFSEVLKA---QSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 231 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT-NIAFQIARGLLYLHEDCSSQ 287
               D    RL LV+E L +  L   + G  +P    R  +  +Q+ + L ++H    + 
Sbjct: 65  EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK---- 343
           I H DIKP+NIL+ D    +++DFG  + +      T          Y++  WYR     
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE---------YISTRWYRAPECL 170

Query: 344 ---STITAKVDVYSFGVLLLEIIS 364
                   K+D+++ G +  EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G GSFG   + ++     S    A+K  +L +     E   K E V++ +  H N+V   
Sbjct: 9   GEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAFK 64

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
              +   +  +V E+ + G L   +    G L P  +       Q+  G+ ++HE    +
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQMCLGVQHIHE---KR 120

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H DIK +NI L  +   ++ DFG A+LLT            GT  YV PE +      
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 348 AKVDVYSFGVLLLEIISCRKSF 369
            K D++S G +L E+ + +  F
Sbjct: 179 NKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 48/215 (22%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-- 229
           G GSFG+VY+ +   T   +  VA+KK   V QD   ++KN E++++   +H N++ L  
Sbjct: 75  GNGSFGVVYEAICIDT---SEKVAIKK---VLQD--PQYKNRELLIMKNLNHINIIFLKD 126

Query: 230 -------------------LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 270
                              + F  +  ++ + +   NN  L  FL              +
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLYS 176

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLNQSKTIKTAI 329
           +Q+ R L Y+H   S  I H D+KPQN+L+D + +  ++ DFG AK L   Q        
Sbjct: 177 YQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233

Query: 330 RGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEII 363
           R    Y APE    +T  T  +D++S G ++ E+I
Sbjct: 234 R---FYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 37/220 (16%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNL 226
           E  G+GS+G+V   +   T      VA+KK++ VF+   D  +  + E+ ++    H ++
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEK---VAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDI 61

Query: 227 VRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGL 277
           V +          E ++  +V+E +      S L   +K + +L         +Q+ R L
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            Y+H   ++ + H D+KP+NIL +     +I DFGLA++   +      TAI  T  YVA
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP----TAIFWTD-YVA 168

Query: 338 PEWYRK--------STITAKVDVYSFGVLLLEIISCRKSF 369
             WYR         S  T  +D++S G +  E+++ +  F
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 44/225 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAV-AVKKL---DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V+          T  V A+K L   D + ++     + E  ++       +V+
Sbjct: 10  GRGAFGEVWL----VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65

Query: 229 LL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           L   F DE ++  LV E++  G L + L                 F IA  +L L     
Sbjct: 66  LYYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVHK 119

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLL---------------------------T 318
              IH DIKP NIL+D   + +++DFGL K +                            
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
             Q +    +  GT  Y+APE  R +    + D +S GV+L E++
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 62/201 (30%), Positives = 93/201 (46%), Gaps = 8/201 (3%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLLG 231
           GRGS+  V   V         A+ V K + V  D + ++ + E  V  Q      +  L 
Sbjct: 4   GRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 232 FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
            C +  +RL LV E++N G L   +    K         A +I   L +LHE     II+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  N+LLD   + +++D+G+ K   L    T  T   GT  Y+APE  R       V
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFC-GTPNYIAPEILRGEEYGFSV 177

Query: 351 DVYSFGVLLLEIISCRKSFDI 371
           D ++ GVL+ E+++ R  FDI
Sbjct: 178 DWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 28/216 (12%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQ 220
           D ++  E+ G G++G VYK      + +   VA+KK  R+  D E        E+ ++  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKA---RDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQM 56

Query: 221 THHKN-LVRLLGF----CDEGQNRL-LVYEFLNNGTLASFLFGNLK-PSWNLRTNIA--- 270
                 +VRLL         G+  L LV+E+L++  L  F+  N + P   L        
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 271 -FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTA 328
            +Q+ +G+ + H      ++H D+KPQN+L+D      +I+D GL +  ++         
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 329 IRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEII 363
           +  T  Y APE    ST  +  VD++S G +  E+ 
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 50/208 (24%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 162 EEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV--- 216
           E   D+F+   E G G+ G+V K         +  +  +KL  +  + +   +N+++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTK----VQHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54

Query: 217 -VIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
            V+ + +   +V   G F  +G+  + + E ++ G+L   L    +    +   ++  + 
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 113

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           RGL YL E    QI+H D+KP NIL++     ++ DFG++  L      ++  +  GT+ 
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEI 362
           Y++PE  + +  + + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 17/173 (9%)

Query: 214 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQ 272
           E +++   +H +++R+      G    +V    ++  L ++L    +P   +    I  Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
           I  GL YLH   + +IIH D+K +NI ++D     I D G A      Q   +  A  G 
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA------QFPVVAPAFLGL 216

Query: 333 KGYV---APEWYRKSTITAKVDVYSFGVLLLEIISCRKS-FDIE--MGEEYAI 379
            G V   APE   +    +K D++S G++L E+++   + F+      EEY  
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269

Length = 357

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 20/199 (10%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 227
           E G GSFG VY       RT+   VA+KK+    +   +++++   EV  + +  H N +
Sbjct: 32  EIGHGSFGAVY--FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSS 286
              G         LV E+   G+ +  L  + KP   +    I     +GL YLH   S 
Sbjct: 89  EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WYRK 343
            +IH DIK  NILL +    +++DFG A + +   S        GT  ++APE      +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDE 198

Query: 344 STITAKVDVYSFGVLLLEI 362
                KVDV+S G+  +E+
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 8/95 (8%)

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           A +I  GL ++H   +  +++ D+KP NILLD+H + RISD GLA     + SK    A 
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155

Query: 330 RGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEII 363
            GT GY+APE  +K     +  D +S G +L +++
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + S    A+K L +   + +D       E  V+  T H  L  L
Sbjct: 4   GKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
             +  + ++RL  V E++N G L   L      S +       +I   L YLH   S +I
Sbjct: 61  -KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKI 116

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +  + T+KT   GT  Y+APE    +    
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFC-GTPEYLAPEVLEDNDYGR 174

Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 20/199 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTHHKNLVR 228
           G+GSFG   K ++   +      AVK L +     +KE K+ +    V++    H  LV 
Sbjct: 4   GKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 229 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDC 284
           L  F  +  ++L  V +++N G L   L      L+P        A +IA  L YLH   
Sbjct: 61  L-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLH--- 113

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  I++ D+KP+NILLD   +  ++DFGL K    +   T  +   GT  Y+APE   K 
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPEVLHKQ 171

Query: 345 TITAKVDVYSFGVLLLEII 363
                VD +  G +L E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 48/208 (23%), Positives = 106/208 (50%), Gaps = 20/208 (9%)

Query: 162 EEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV--- 216
           E   D+F++  E G G+ G+V+K     +   +  +  +KL  +  + +   +N+++   
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFK----VSHKPSGLIMARKL--IHLEIKPAIRNQIIREL 54

Query: 217 -VIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
            V+ + +   +V   G F  +G+  + + E ++ G+L   L    +    +   ++  + 
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+ 
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRS 167

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEI 362
           Y++PE  + +  + + D++S G+ L+E+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 40/229 (17%)

Query: 173 GRGSFGIVYKG--VIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNLV 227
           G+G  G VY     + + R     VA+KK+     +     K F  E  +     H  +V
Sbjct: 11  GKGGMGEVYLAYDPVCSRR-----VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPSWNLRTNI-AF-----QIARG 276
            +   C +G        ++   TL S L       +L      +T++ AF     +I   
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ--------------- 321
           + Y+H   S  ++H D+KP NILL       I D+G A    L +               
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 322 -SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
            S TI   I GT  Y+APE       +   D+Y+ GV+L ++++    +
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 47/225 (20%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G GS G+V+  V          VAVKK+  V  D +  K    E+ +I +  H N+V++ 
Sbjct: 14  GCGSNGLVFSAVDSDCDKR---VAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVY 68

Query: 231 GFCDEGQNRL--------------LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
                  + L              +V E++    LA+ L        + R    +Q+ RG
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLRG 126

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           L Y+H   S+ ++H D+KP N+ ++ +    +I DFGLA+++  + S          KGY
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---------KGY 174

Query: 336 ----VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               +  +WYR   +       T  +D+++ G +  E+++ +  F
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 30/94 (31%), Positives = 55/94 (58%), Gaps = 6/94 (6%)

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           I+  + RGL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +
Sbjct: 104 ISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 157

Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEI 362
             GT+ Y++PE  + +  T + D++S G+ L+E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 31/225 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNE---VVVIGQTHHKNLVRL 229
           GRG FG V     + T       A+KK D + +D  +    E           H  LV L
Sbjct: 8   GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI---------AFQIARGLLY 279
              C + ++ +  V E+   G L            ++ T++         A  +  GL Y
Sbjct: 68  FA-CFQTEDHVCFVMEYAAGGDLM----------MHIHTDVFSEPRAVFYAACVVLGLQY 116

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LHE+   +I++ D+K  N+LLD     +I+DFGL K       +T  +   GT  ++APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEFLAPE 171

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 382
              +++ T  VD +  GVL+ E++     F  +  EE   +I+ D
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 39/156 (25%), Positives = 64/156 (41%), Gaps = 10/156 (6%)

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            + N ++L       +  +L+ +++ +G L   L    K S      I  Q+   L  LH
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 282 EDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
                 IIH DIK +N+L D       + D+GL K           +   GT  Y +PE 
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPEK 177

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
            +        D ++ GVL  E+++ +  F  +  EE
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213

Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 13/211 (6%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAV-KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           + K   GRG FG V + V E       A+ V KK   + Q+    F+ E  ++  ++   
Sbjct: 4   DVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDC 284
           + +L     +  N  LV E+   G L S L            ++A F +A  +L +H   
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHSVH 119

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW---- 340
               +H DIKP+N+L+D   + +++DFG A  LT N+    K  + GT  Y+APE     
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTM 178

Query: 341 --YRKSTITAKVDVYSFGVLLLEIISCRKSF 369
               K T   + D +S GV+  E+I  R  F
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDR---VFQDGEKEFKNEVVVIGQTH 222
           NF    G GSFG V   ++ T +      VA+K+ ++   + Q       +E  ++   +
Sbjct: 33  NFIRTLGTGSFGRV---ILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H   V L G   +     LV EF+  G   +FL  N +   ++    A QI     YL  
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ- 148

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S  I++ D+KP+N+LLD     +++DFG AK++      T    + GT  Y+APE   
Sbjct: 149 --SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILL 201

Query: 343 KSTITAKVDVYSFGVLLLEII 363
                   D ++ G+ + EI+
Sbjct: 202 NVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 227
           E G GSFG VY         ++  VA+KK+    +   +++++   EV  + +  H N +
Sbjct: 22  EIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSS 286
           +  G         LV E+   G+ +  L  + KP   +    +     +GL YLH   S 
Sbjct: 79  QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WYRK 343
            +IH D+K  NILL +    ++ DFG A ++             GT  ++APE      +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDE 188

Query: 344 STITAKVDVYSFGVLLLEI 362
                KVDV+S G+  +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 29/273 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G G++G VYK        +T  +A  K+ ++ + GE     + E++++    H N+V
Sbjct: 15  QRIGSGTYGDVYKA----RNVNTGELAAIKVIKL-EPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
              G         +  EF   G+L          S +    ++ +  +GL YLH   S  
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKG 126

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY---RKS 344
            +H DIK  NILL D+ + +++DFG++  +T   +K  + +  GT  ++APE     RK 
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKG 184

Query: 345 TITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
                 D+++ G+  +E+   +   FD+       ++T   F   +  KL D     M+ 
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF---QPPKLKD----KMKW 237

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
            N      K+ +       ++P  RPT  K+ Q
Sbjct: 238 SNSFHHFVKMALT------KNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 35/106 (33%), Positives = 47/106 (44%), Gaps = 7/106 (6%)

Query: 268 NIAFQIARGLL----YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK 323
             A  I R LL    YLH      IIH D+K +NI LD+  NA + DFG A  L  +   
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
                  GT    +PE        AK D++S G++L E+     + 
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 16/174 (9%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVR 228
           +  G G++G VYK         T  +A  K+ ++   D     + E+ ++ +  H N+V 
Sbjct: 15  QRVGSGTYGDVYKA----RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
             G     +   +  E+   G+L   ++    P   L+  IA+   +  +GL YLH   S
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ--IAYVCRETLQGLAYLH---S 124

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
              +H DIK  NILL D+ + +++DFG+A  +T   +K  + +  GT  ++APE
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 35/207 (16%)

Query: 240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ-IARGLLY------LHEDCSSQIIHCD 292
           LL+ E+ + G L      N +    L+ ++ FQ    GLL+      L E  S +++H D
Sbjct: 141 LLIMEYGSGGDL------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194

Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           +K  NI L      ++ DFG +K  + + S  + ++  GT  Y+APE + +   + K D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254

Query: 353 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL---VEGDMEAMNDIKC 409
           +S GV+L E+++  + F      E  I+    +     GK D     V   M+A+     
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQRE--IMQQVLY-----GKYDPFPCPVSSGMKAL----- 302

Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
           ++ LL        ++P+LRPT +++  
Sbjct: 303 LDPLL-------SKNPALRPTTQQLLH 322

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 10/136 (7%)

Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           L+ +++N G L + L+   +   S  +R  IA +I   L +LH+     II+ DIK +NI
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENI 136

Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI--TAKVDVYSFG 356
           LLD   +  ++DFGL+K       +    +  GT  Y+APE  R  +      VD +S G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195

Query: 357 VLLLEIISCRKSFDIE 372
           VL  E+++    F ++
Sbjct: 196 VLTFELLTGASPFTVD 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGE-KEFKNEVVVIGQTHHKNL 226
            + G+G +G V+   +   + +   VA+K++ +  +F+  E +    E  ++  T  + L
Sbjct: 7   TQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLY---LHE 282
           V+LL    + +   L  E++  G   + L  NL     L  + A F +A        LHE
Sbjct: 64  VKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLG---VLSEDHARFYMAEMFEAVDALHE 119

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVAPEWY 341
                 IH D+KP+N L+D   + +++DFGL+K ++T   S      + G+  Y+APE  
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPEVL 170

Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           R       VD +S G +L E + 
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 32/211 (15%)

Query: 173 GRGSFGIVYKGVIE-------TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           G+G+F  +YKGV+               +V +K L    +D    F     ++ Q  HK+
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHKH 62

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHE 282
           LV+L G C   +N ++V E++  G L  FL     N+   W L  ++A Q+A  L YL +
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHYLED 119

Query: 283 DCSSQIIHCDIKPQNILLDDHYN-------ARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
               +++H ++  +NIL+  +          ++SD G+   + L++ + ++        +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-LSREERVERI-----PW 170

Query: 336 VAPEWYR--KSTITAKVDVYSFGVLLLEIIS 364
           +APE  R  ++++T   D +SFG  LLEI S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICS 201

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L  L
Sbjct: 4   GKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
             +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 61  -KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 116

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K    + + T+KT   GT  Y+APE    +    
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFC-GTPEYLAPEVLEDNDYGR 174

Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 19/199 (9%)

Query: 173 GRGSFGIVYK------GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           G+G+FG VY+        I   +  +    V K +     GE+     ++V         
Sbjct: 2   GKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERN----ILVRTLLDESPF 57

Query: 227 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDC 284
           +  L F  +  + L LV ++++ G L    F +L+       + A F IA  +L L    
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELVLALEHLH 113

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRK 343
              I++ D+KP+NILLD   +  + DFGL+K   L  +KT  T   GT  Y+APE    +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFC-GTTEYLAPEVLLDE 171

Query: 344 STITAKVDVYSFGVLLLEI 362
              T  VD +S GVL+ E+
Sbjct: 172 KGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 67/241 (27%)

Query: 173 GRGSFG---IVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE----FKNEVVVIGQTHHKN 225
           GRG+FG   +V K      + +    A+KKL +  +  EKE     + E  ++ +  +  
Sbjct: 10  GRGAFGEVRLVQK------KDTGHIYAMKKLRKS-EMLEKEQVAHVRAERDILAEADNPW 62

Query: 226 LVRLL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI------AFQIARGLL 278
           +V+L   F DE     L+ E+L  G + + L         ++ +        F IA  +L
Sbjct: 63  VVKLYYSFQDE-NYLYLIMEYLPGGDMMTLL---------MKKDTFTEEETRFYIAETIL 112

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL--------------------- 317
            +        IH DIKP N+LLD   + ++SDFGL   L                     
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 318 -----TLNQSKTIKTAIR----------GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEI 362
                 ++  +  +T  R          GT  Y+APE + ++    + D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 363 I 363
           +
Sbjct: 233 L 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 6/105 (5%)

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           +I   L +LH+     I++ DIK +NILLD   +  ++DFGL+K   L++ K    +  G
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168

Query: 332 TKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGE 375
           T  Y+APE  R      K VD +S G+L+ E+++    F +E GE
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE-GE 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 37/245 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     + T        ++K D + ++     + E  ++ +     +V++   
Sbjct: 10  GRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
             +  N  L+ EFL  G + + L   +K          F IA  +L +        IH D
Sbjct: 70  FQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126

Query: 293 IKPQNILLDDHYNARISDFGLAKLL-----------------------TLNQSKTIKTAI 329
           IKP N+LLD   + ++SDFGL   L                        +N  +  +T  
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186

Query: 330 R----------GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YA 378
           R          GT  Y+APE + ++      D +S GV++ E++     F  E  +E Y 
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246

Query: 379 ILTDW 383
            + +W
Sbjct: 247 KVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L  L
Sbjct: 4   GKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLL 278
             +  +  +RL  V E+ N G L           ++L     F          +I   L 
Sbjct: 61  -KYSFQTHDRLCFVMEYANGGELF----------FHLSRERVFSEDRARFYGAEIVSALG 109

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YLH   S  +++ D+K +N++LD   + +I+DFGL K   ++   T+KT   GT  Y+AP
Sbjct: 110 YLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAP 164

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           E    +     VD +  GV++ E++  R  F
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 29/181 (16%)

Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
           +  +Q+ARG+ +L    S   +H D+  +N+LL      +I DFGLA+ +  + +   K 
Sbjct: 241 SFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF- 385
           +      ++APE    +  T   DV+S+G+LL EI S         G  Y  ++ D  F 
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG-------GTPYPGMIVDSTFY 350

Query: 386 ----DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
                 YR  K D        A  ++  +    MV  W    +P  RP+   +S ++E +
Sbjct: 351 NKIKSGYRMAKPD-------HATQEVYDI----MVKCW--NSEPEKRPSFLHLSDIVESL 397

Query: 442 V 442
           +
Sbjct: 398 L 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 24/160 (15%)

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+  G+ Y+H+    +I+H D+K +NI L ++   +I DFG+++LL    S  + T   G
Sbjct: 114 QLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTG 167

Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
           T  Y++PE  +     +K D++S G +L E+     +F     E    L+          
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-----EGQNFLS---------- 212

Query: 392 KLDDLVEGDMEAMNDIKCVE-KLLMVSIWCIQEDPSLRPT 430
            +  +VEG   ++ +    +   +M S+  + +DPSLRP+
Sbjct: 213 VVLRIVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT----------- 221
           G G++G V K     T T    VA+KK+  +  +   +   +  ++G             
Sbjct: 18  GEGTYGKVEKA--YDTLTGKI-VAIKKVKII--EISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 222 -----HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
                 H+N++ L+    EG    LV + +    L   +   ++ + +    I  QI  G
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-------LLTLNQSKTIKTAI 329
           L  LH       +H D+ P NI ++     +I+DFGLA+         TL++ +T++   
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 330 RGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIIS 364
             T   V   WYR   +          VD++S G +  E+++
Sbjct: 189 EMTSK-VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   V +D       E  V+  + H  L  L
Sbjct: 4   GKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
             +  +  +RL  V E+ N G L   L      S +       +I   L YLH +    +
Sbjct: 61  -KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 117

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +    T+KT   GT  Y+APE    +    
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 175

Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 7/138 (5%)

Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           L+ +++N G L + L    +         + +I   L +LH+     II+ DIK +NILL
Sbjct: 82  LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILL 138

Query: 301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR--KSTITAKVDVYSFGVL 358
           D + +  ++DFGL+K    ++ +    +  GT  Y+AP+  R         VD +S GVL
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197

Query: 359 LLEIISCRKSFDIEMGEE 376
           + E+++    F ++ GE+
Sbjct: 198 MYELLTGASPFTVD-GEK 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 19/197 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKN----EVVVIGQTHHKNL 226
           G G++G+V K   + T+     VA+KK    F+D E  +E K     E+ ++     +N+
Sbjct: 10  GEGAYGVVLKCRHKETKE---IVAIKK----FKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           V L           LV+E++    L       N  P   +R+ I +Q+ + + + H++  
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN-- 119

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             I+H DIKP+N+L+  +   ++ DFG A+ L+   S    T    T+ Y +PE    + 
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAP 177

Query: 346 ITAKVDVYSFGVLLLEI 362
               VD++S G +L E+
Sbjct: 178 YGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 31/213 (14%)

Query: 170 EEAGRGSFGIVYKGVIE---------TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ 220
           E  GRG+   +Y G++           +      V +K LD   +D    F     ++ Q
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGL 277
             HK++V L G C      ++V EF+  G L  F+      L   W     +A Q+A  L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118

Query: 278 LYLHEDCSSQIIHCDIKPQNILL-----DDHYNA--RISDFGLAKLLTLNQSKTIKTAIR 330
            YL ED    ++H ++  +NILL     D       ++SD G+  +  L++ + ++    
Sbjct: 119 SYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI-- 172

Query: 331 GTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEI 362
               ++APE    S  ++   D +SFG  L EI
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 37/245 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     + T        ++K D + ++     + E  ++ +     +V++   
Sbjct: 10  GRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
             + +N  L+ EFL  G + + L   +K          F IA  +L +        IH D
Sbjct: 70  FQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126

Query: 293 IKPQNILLDDHYNARISDFGLA------------KLLTLN--------------QSKTIK 326
           IKP N+LLD   + ++SDFGL             + LT N              +++T K
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186

Query: 327 TAIR-------GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YA 378
              R       GT  Y+APE + ++      D +S GV++ E++     F  E  +E Y 
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR 246

Query: 379 ILTDW 383
            + +W
Sbjct: 247 KVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQTHHKNLVRLL 230
           GRG+FG V    ++ T        + K + + +     F+ E  V+V G       +  L
Sbjct: 10  GRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ---WITTL 66

Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            +  + +N L LV ++   G L + L  F +  P    R    F IA  +L +H      
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQLH 122

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWYRK--- 343
            +H DIKP N+LLD + + R++DFG    L +NQ  T+++++  GT  Y++PE  +    
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 344 --STITAKVDVYSFGVLLLEIISCRKSFDIE 372
                  + D +S GV + E++     F  E
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 36/220 (16%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH----HKN 225
           +E G G FG V    I T  T    V VK+L        KE +NE +  G  +    H N
Sbjct: 1   QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKA--NASSKE-QNEFLQQGDPYRILQHPN 56

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLY 279
           +++ LG C E    LLV+E+   G L S+L        N +    L   +A +IA G+ +
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL--LLQRMACEIAAGVTH 114

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           +H+      +H D+  +N  L      ++ D+G+    +  +   I+T        V   
Sbjct: 115 MHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETE---DDKCVPLR 166

Query: 340 WYRKSTITAKVD------------VYSFGVLLLEIISCRK 367
           W     +                 V++ GV L E+     
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 49/198 (24%), Positives = 95/198 (47%), Gaps = 15/198 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     ++++       + K + + +     F  E  ++   +   +V+L   
Sbjct: 52  GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIHC 291
             + +   +V E++  G L      NL  ++++    A F  A  +L L    S  +IH 
Sbjct: 112 FQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHR 166

Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWYRKST---- 345
           D+KP N+LLD H + +++DFG    + ++++  ++  TA+ GT  Y++PE  +       
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGY 223

Query: 346 ITAKVDVYSFGVLLLEII 363
              + D +S GV L E++
Sbjct: 224 YGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 46.7 bits (111), Expect = 6e-07
 Identities = 15/78 (19%), Positives = 33/78 (42%), Gaps = 3/78 (3%)

Query: 4  GYNKELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFEDDS--CCFKKL 61
          G +     F ++ ++  P +        +  +C+ +CLS+C C A  + + S  C     
Sbjct: 6  GGDGSTDGFLKLPDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG 64

Query: 62 PLSNGMTDSRITSKAFIK 79
           L+N  + S      +++
Sbjct: 65 LLNNLRSLSSGGGTLYLR 82

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 6/102 (5%)

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL-LTLNQSKTIKT 327
           I   + R + YLHE+   +IIH DIK +NI ++   +  + DFG A   + +N +K    
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           A  GT    APE   +      VD++S G++L E+ +C  S 
Sbjct: 244 A--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 11/205 (5%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVR 228
           G+G +G V++    T   +    A+K L +      Q      K E  ++    H  +V 
Sbjct: 5   GKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVD 64

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQ 287
           L+     G    L+ E+L+ G L    F +L+       + A F ++   L L       
Sbjct: 65  LIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           II+ D+KP+NILLD   + +++DFGL K      + T      GT  Y+APE   +S   
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT--HTFCGTIEYMAPEILMRSGHG 178

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE 372
             VD +S G L+ ++++    F  E
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAE 203

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           GRG+FG V    +   + +    A+K L++  + +  E   F+ E  V+    ++ +  L
Sbjct: 10  GRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                +  N  LV ++   G L + L  F +  P    R    F +A  ++ +       
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQLH 122

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWYR---- 342
            +H DIKP NIL+D + + R++DFG    L L +  T+++++  GT  Y++PE  +    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 343 -KSTITAKVDVYSFGVLLLEIISCRKSFDIE 372
            K     + D +S GV + E++     F  E
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 39/229 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLG 231
           G G FG V+  +++  RT           R  ++ EK +   EV V+ +  HKN+VR + 
Sbjct: 22  GNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 232 -FCDEGQNRL-LVYEFLNNGTLASF------LFGNLKPSWNLRTNIAFQIARGLLYLHE- 282
            F ++   +L ++ EF + G L+        +FG ++   +   +I  Q+   L Y H  
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE--HAIVDITRQLLHALAYCHNL 137

Query: 283 ---DCSSQIIHCDIKPQNILLD-------------DHYN----ARISDFGLAKLLTLNQS 322
                  +++H D+KPQNI L              ++ N    A+I DFGL+K + +   
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI--- 194

Query: 323 KTIKTAIRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           +++  +  GT  Y +PE   +   +   K D+++ G ++ E+ S +  F
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           ++Q+A G+ +L    S   +H D+  +N+L+ +    +I DFGLA+ +  + +   K + 
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
                ++APE    +  T   DV+SFG+LL EI +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 37/166 (22%), Positives = 75/166 (45%), Gaps = 13/166 (7%)

Query: 211 FKNEVVVIGQTHHKNLVRLLGF----CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR 266
            +NE+  + +    N++++ GF     D+     L+ E+   G L   L      S+  +
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTK 124

Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
            ++A    +GL  L++  +    + ++   + L+ ++Y  +I   GL K+L+    K + 
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182

Query: 327 TAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFD 370
             +     Y + +      S  T K D+YS GV+L EI + +  F+
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 15/140 (10%)

Query: 232 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           F DE  N  LV ++   G L + L  F +  P    R    F +A  +L +        +
Sbjct: 70  FQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQLGYV 124

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWYR-----K 343
           H DIKP N+LLD + + R++DFG    L L    T+++ +  GT  Y++PE  +     K
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 344 STITAKVDVYSFGVLLLEII 363
                + D +S GV + E++
Sbjct: 183 GRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 15/198 (7%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     ++TR       + K + + +     F  E  ++   +   +V+L   
Sbjct: 52  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 111

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIHC 291
             + +   +V E++  G L      NL  ++++    A F  A  +L L    S   IH 
Sbjct: 112 FQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWYRKST---- 345
           D+KP N+LLD   + +++DFG    + +N+   ++  TA+ GT  Y++PE  +       
Sbjct: 167 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 223

Query: 346 ITAKVDVYSFGVLLLEII 363
              + D +S GV L E++
Sbjct: 224 YGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 34/185 (18%)

Query: 195 VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 254
           V +K LD   +D    F     ++ Q  H +L  + G C  G   ++V EF+ +G L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 255 LF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF 311
           L    G +  +W +   +A Q+A  L YL ED    ++H ++  +NILL     AR+   
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYL-ED--KNLVHGNVCAKNILL-----ARL--- 153

Query: 312 GLAKLLTLNQSKTIKTAIRGTK-------------GYVAPEWYRK-STITAKVDVYSFGV 357
           GLA+      S  IK +  G                ++APE     ++++   D +SFG 
Sbjct: 154 GLAE----GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209

Query: 358 LLLEI 362
            LLEI
Sbjct: 210 TLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 51/199 (25%), Positives = 75/199 (37%), Gaps = 48/199 (24%)

Query: 198 KKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 257
            K+ RV    E+E      ++    H  L  L           LV ++   G L   L  
Sbjct: 43  NKVKRVLT--EQE------ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-- 92

Query: 258 NLKPSWNLRTNIA-FQIARGLL---YLHEDCSSQIIHCDIKPQNILLDDHYNARI--SDF 311
             +P   L   +A F  A  LL   YLH      I++ D+KP+NILL  H +  I  SDF
Sbjct: 93  QRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILL--HESGHIMLSDF 147

Query: 312 GLAKLLTLNQSKTIKTAIR---------------------------GTKGYVAPEWYRKS 344
            L+K   +      K   +                           GT+ Y+APE     
Sbjct: 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD 207

Query: 345 TITAKVDVYSFGVLLLEII 363
              + VD ++ G+LL E++
Sbjct: 208 GHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)

Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN---- 320
           L  NI   +   L Y+HE     I H DIKP+NI++D +    I D+G+A    ++    
Sbjct: 127 LIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183

Query: 321 -QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
             SK  K   RGT  Y   + +  + +T + D+ S G  +L+
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 54/236 (22%), Positives = 97/236 (41%), Gaps = 75/236 (31%)

Query: 166 DNFK-----EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FK----NEV 215
           D ++     EE   G++G+VY+   + T      VA+KKL     + EKE F      E+
Sbjct: 5   DEYEKLNRIEE---GTYGVVYRARDKKT---GEIVALKKLK---MEKEKEGFPITSLREI 55

Query: 216 VVIGQTHHKNLVRL----LGFCDEGQNRL-LVYEF--------LNNGTLASFLFGNLKPS 262
            ++ +  H N+V +    +G      +++ +V E+        +       FL   +K  
Sbjct: 56  NILLKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVK-- 109

Query: 263 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA-------K 315
                 +  Q+  G+ +LH++    I+H D+K  N+LL++    +I DFGLA       K
Sbjct: 110 -----CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161

Query: 316 LLTLNQSKTIKTAIRGTKGYVAPEWYR-------KSTITAKVDVYSFGVLLLEIIS 364
             T                 V   WYR           +  +D++S G +  E+++
Sbjct: 162 PYTQL---------------VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 3/95 (3%)

Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
           T +A Q+   + Y+H      IIH DIK +N+L++   +  + DFG A     + S    
Sbjct: 263 TAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319

Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
             I GT    APE       T  VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 27/100 (27%), Positives = 50/100 (50%), Gaps = 16/100 (16%)

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----------- 325
           L YLH   +  I+H D+KP N+L+    + +++DFGL+K+  ++ +  +           
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 326 --KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
                + GT  Y+APE   +      VD ++ G++L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 8/150 (5%)

Query: 174 RGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC 233
           RG+FG VY G  +          VKK D + ++   + + E   +  +    +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 234 DEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC 291
               N  LV E+L  G + S L  +G       ++  I+ ++A  L YLH      IIH 
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLHR---HGIIHR 128

Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQ 321
           D+KP N+L+ +  + +++DFGL+K +TLN+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 44.8 bits (106), Expect = 6e-05
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           GRG+FG V    +   ++S    A+K   K + + +     F  E  ++   + + +V+L
Sbjct: 52  GRGAFGEVQ---LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 230 -LGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSS 286
              F D+ +   +V E++  G L + L  N  +   W       F  A  +L L    S 
Sbjct: 109 HYAFQDD-KYLYMVMEYMPGGDLVN-LMSNYDIPEKW-----ARFYTAEVVLALDAIHSM 161

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
             IH D+KP N+LLD   + +++DFG    +  N      TA+ GT  Y++PE  +    
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 347 TA----KVDVYSFGVLLLEII 363
                 + D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 55/243 (22%), Positives = 92/243 (37%), Gaps = 50/243 (20%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G+FG V       T        ++K D + ++     K E  ++ +  ++ +V+L   
Sbjct: 10  GIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYS 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC 291
             +  N   V +++  G + S L    + P    R    F IA   L +        IH 
Sbjct: 70  FQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR----FYIAELTLAIESVHKMGFIHR 125

Query: 292 DIKPQNILLDDHYNARISDFGLA------------------------------------- 314
           DIKP NIL+D   + +++DFGL                                      
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185

Query: 315 --KLLTLNQ------SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
             +L TL Q       + +  ++ GT  Y+APE   +   T   D +S GV+L E++  +
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245

Query: 367 KSF 369
             F
Sbjct: 246 PPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 30/122 (24%), Positives = 48/122 (39%), Gaps = 41/122 (33%)

Query: 289 IHCDIKPQNILLDDHYNARISDFGL----------------------------------- 313
           IH DIKP NIL+D   + +++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 314 AKLLTL------NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRK 367
            +L  L         + +  ++ GT  Y+APE   ++  T   D +S GV+L E++  + 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 368 SF 369
            F
Sbjct: 243 PF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 41/189 (21%), Positives = 70/189 (37%), Gaps = 23/189 (12%)

Query: 190 TSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 247
            + T VAVKK++      E  K  + E++   Q  H N++  +          +V   + 
Sbjct: 23  PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82

Query: 248 NGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY 304
            G+    L     P       IAF    +   L Y+H   S   IH  +K  +ILL    
Sbjct: 83  YGS-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDG 138

Query: 305 NARISDFGLAKLLTLNQSKTIKTAIRGTKG------YVAPEWYRKSTI--TAKVDVYSFG 356
              +S    +  + +   K  +      K       +++PE  +++      K D+YS G
Sbjct: 139 KVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197

Query: 357 VLLLEIISC 365
                I +C
Sbjct: 198 -----ITAC 201

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 19/212 (8%)

Query: 171 EAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E GRG   +    +   T T T   V +  L+   ++  K  +NEVV+     H N++  
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDCSS 286
                 G    ++  F+  G+ A+ L     P   S  L  NI F   RGL YLH++   
Sbjct: 65  WTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN--- 120

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAI------RGTKGYVAPE 339
             IH +IK  +IL+    +  +S  GL+ L +L    +  K              +++PE
Sbjct: 121 GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178

Query: 340 WYRK--STITAKVDVYSFGVLLLEIISCRKSF 369
             R+       K D+YS G+   E+ + R  F
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.8 bits (98), Expect = 6e-04
 Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 12/91 (13%)

Query: 173 GRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQT-HHK 224
           G G+FG     V+E T        +   VAVK L       E+E   +E+ ++     HK
Sbjct: 47  GAGAFG----KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHK 102

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 255
           N+V LLG C  G   L++ E+   G L +FL
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 54/249 (21%), Positives = 94/249 (37%), Gaps = 62/249 (24%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G+FG V       T+       ++K D + ++     K E  ++ +  ++ +VRL   
Sbjct: 10  GIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYS 69

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE-DCSSQ---- 287
             +  N   V +++  G + S L         +R  I F       Y+ E  C+ +    
Sbjct: 70  FQDKDNLYFVMDYIPGGDMMSLL---------IRMGI-FPEDLARFYIAELTCAVESVHK 119

Query: 288 --IIHCDIKPQNILLDDHYNARISDFGLA------------------------------- 314
              IH DIKP NIL+D   + +++DFGL                                
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 315 --------KLLTL------NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLL 360
                   +L  L         + +  ++ GT  Y+APE   ++  T   D +S GV+L 
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 361 EIISCRKSF 369
           E++  +  F
Sbjct: 240 EMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 18/164 (10%)

Query: 210 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV---YEFLNNGTLASFLFG---NLKPS- 262
           + +NE++ +G+ +H+N++++        N  ++   Y+F     L SF++    + K   
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264

Query: 263 --WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
                R  I  Q+   + Y+H     ++IH DIK +NI L+      + DFG A      
Sbjct: 265 LLKQTRA-IMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-K 319

Query: 321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           + +       GT    +PE           D++S G++LL+++S
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 51/234 (21%), Positives = 100/234 (42%), Gaps = 39/234 (16%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           + GRG++G VYK   +  +      A+K+++            E+ ++ +  H N++ L 
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRD-YALKQIEGT--GISMSACREIALLRELKHPNVISLQ 64

Query: 231 G-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPSWNLR---TNIAFQIARGLLYL 280
             F      ++ L++++  +       F      N KP    R    ++ +QI  G+ YL
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 281 HEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   ++ ++H D+KP NIL+     +    +I+D G A+L       +    +      V
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLADLDPVV 176

Query: 337 APEWYRKSTI-------TAKVDVYSFGVLLLEIIS------CRKSFDIEMGEEY 377
              WYR   +       T  +D+++ G +  E+++      CR+  DI+    Y
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNPY 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 47/220 (21%), Positives = 95/220 (43%), Gaps = 32/220 (14%)

Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           + GRG++G VYK   +  +      A+K+++            E+ ++ +  H N++ L 
Sbjct: 8   KVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQ 64

Query: 231 G-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPSWNLRT---NIAFQIARGLLYL 280
             F      ++ L++++  +       F      N KP    R+   ++ +QI  G+ YL
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 281 HEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   ++ ++H D+KP NIL+     +    +I+D G A+L       +    +      V
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN-----SPLKPLADLDPVV 176

Query: 337 APEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              WYR   +       T  +D+++ G +  E+++    F
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 25/76 (32%), Positives = 38/76 (50%), Gaps = 7/76 (9%)

Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTN--IAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           L+ EFL  G L + L       ++  +     F +A  +L +        IH DIKP NI
Sbjct: 78  LIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132

Query: 299 LLDDHYNARISDFGLA 314
           L+D   + ++SDFGL+
Sbjct: 133 LIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 10/141 (7%)

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           N+V L  +     +  LV +    G L S +   L          A ++   L  LH   
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR-- 103

Query: 285 SSQIIHC-DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
             + I C D+ P NILLDD  + +++ F     +   +      A+     Y APE    
Sbjct: 104 --EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV---EDSCDGEAV--ENMYCAPEVGGI 156

Query: 344 STITAKVDVYSFGVLLLEIIS 364
           S  T   D +S G +L E+++
Sbjct: 157 SEETEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	455
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
smart00090	237	RIO RIO-like kinase.	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.3
KOG1243	690	consensus Protein kinase [General function predict	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.22
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.16
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.93
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.89
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.86
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
PRK09902	216	hypothetical protein; Provisional	98.72
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.64
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.6
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.46
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.36
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.16
PF01636	239	APH: Phosphotransferase enzyme family This family	98.12
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.07
PLN02876	822	acyl-CoA dehydrogenase	98.05
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.04
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.82
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.72
PRK10593	297	hypothetical protein; Provisional	97.72
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.71
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	97.68
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.58
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.54
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.44
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.26
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.99
PLN02236	344	choline kinase	96.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.76
PRK05231	319	homoserine kinase; Provisional	96.76
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.66
PLN02756	418	S-methyl-5-thioribose kinase	96.34
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.24
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.22
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.09
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.06
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.02
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.94
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.68
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.66
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.62
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.88
PRK06148	1013	hypothetical protein; Provisional	94.87
PTZ00384	383	choline kinase; Provisional	94.61
KOG2270	520	consensus Serine/threonine protein kinase involved	94.5

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-63  Score=480.07  Aligned_cols=287  Identities=46%  Similarity=0.768  Sum_probs=254.7

Q ss_pred             cccccCHHHHHHHHHhhh--hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceee
Q 037780          152 NLRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL  229 (455)
Q Consensus       152 ~~~~~~~~~l~~~t~~f~--~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  229 (455)
                      ..+.|+|.+|.+||++|+  +.||+|+||.||+|.+.    ++..||||++.....+..++|.+|+.++++++|||||+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L  136 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL  136 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence            567899999999999999  58999999999999997    447899999876543315669999999999999999999


Q ss_pred             eeeEecCC-eEEEEEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcE
Q 037780          230 LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA  306 (455)
Q Consensus       230 ~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  306 (455)
                      +|||.+.+ +.+||||||+||+|.++|+...  .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++
T Consensus       137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            99999999 5999999999999999999875  88999999999999999999999988999999999999999999999


Q ss_pred             EEeeccCcccccCCCCccccccc-cccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH
Q 037780          307 RISDFGLAKLLTLNQSKTIKTAI-RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  385 (455)
Q Consensus       307 kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  385 (455)
                      ||+|||+|+..+......  ... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+..|++
T Consensus       217 KlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             EccCccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            999999997655411111  112 79999999999999999999999999999999999999988766555556899999


Q ss_pred             HHhhcCccccccccccc-cCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          386 DCYRNGKLDDLVEGDME-AMNDI-KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~l~-~~~~~-~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ..+.++.+.+++|+.+. ..+.. +++..+.+++..|++.+|.+||+|.+|+++|+.+...
T Consensus       295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            99999999999999987 55554 6889999999999999999999999999999765543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=396.92  Aligned_cols=251  Identities=35%  Similarity=0.538  Sum_probs=209.6

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceE-EEEEecccccccc--HHHHHHHHHHHcccCCCCceeeeeeEecCC-eEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVY  243 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-~~~lv~  243 (455)
                      +.+.||+|+||+||+|.+.     +.. ||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. ...+||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~-----g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWR-----GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hhhhcccCCceeEEEEEeC-----CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            4456999999999999997     334 9999997644322  458999999999999999999999999988 799999


Q ss_pred             EeCCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCCEEEcCCC-cEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQ-IIHCDIKPQNILLDDHY-NARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  319 (455)
                      |||++|+|.++++.  ...+++..++.|+.|||+|+.|||++   + ||||||||+|||++.++ ++||+|||+++....
T Consensus       120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999999988  68999999999999999999999965   5 99999999999999998 999999999987664


Q ss_pred             CCCccccccccccCccccccccc--CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYR--KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ..  ...+...||+.|||||++.  ...++.|+|||||||+||||+||+.||.......      .+......+      
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v~~~~------  262 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAVVVGG------  262 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcC------
Confidence            32  2224467999999999999  5689999999999999999999999998665411      111111222      


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                         .....+..+...+..++..||+.||..||++.+++.+|+.+..
T Consensus       263 ---~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  263 ---LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ---CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence               2222223367888999999999999999999999999997544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=388.57  Aligned_cols=260  Identities=29%  Similarity=0.463  Sum_probs=220.3

Q ss_pred             HHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          160 ALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       160 ~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      ++......+.++||+|-||.||.|.+.    ....||+|.+... ....++|.+|+++|++++|+|||+++|+|..++.+
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~----~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWN----GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEc----CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            444555668899999999999999997    3446899988764 34567899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          240 LLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +||||||++|+|.+||+.  ...+...+.+.++.|||+|++||+   +.++|||||.++||||+++..+||+|||||+..
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence            999999999999999986  577899999999999999999999   559999999999999999999999999999965


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ..+.... .....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+       +.+         .
T Consensus       354 ~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~---------~  416 (468)
T KOG0197|consen  354 GDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLE---------L  416 (468)
T ss_pred             CCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHH---------H
Confidence            5444432 244456778999999999999999999999999999999 999987655422       222         2


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ++...+-..+..++..+.+++..||..+|++|||+..+...|+.+...
T Consensus       417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            333333345566899999999999999999999999999999886653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-49  Score=364.26  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=212.8

Q ss_pred             cCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEe
Q 037780          156 FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD  234 (455)
Q Consensus       156 ~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~  234 (455)
                      .+..+|+.     .+.||+|..|+|||+.++   .+++.+|+|.+... .....+++.+|++++.+.+||+||.++|.|.
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk---~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHK---PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEc---CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            44555543     467999999999999998   56789999999543 3345678999999999999999999999999


Q ss_pred             cCC-eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          235 EGQ-NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       235 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      .+. ...++||||++|||++++...+.+++...-+|+.+|++||.|||+.  .+||||||||+|||++..|++||+|||.
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence            988 5999999999999999999889999999999999999999999963  6999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ++.+...    ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+... ...+ .        +
T Consensus       226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~~-L--------l  291 (364)
T KOG0581|consen  226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIFE-L--------L  291 (364)
T ss_pred             cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHHH-H--------H
Confidence            9987654    22557899999999999999999999999999999999999999987522111 1111 1        1


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+++..........++.++..++..||+.||.+|||..++++
T Consensus       292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1222221111112247889999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-48  Score=360.68  Aligned_cols=202  Identities=32%  Similarity=0.501  Sum_probs=181.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.++||+|+||+||+|++..   .+..||||.+...  .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             ceehhhccCcceEEEEEeEecc---CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            3456779999999999999984   4589999999765  4445667899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC------CcEEEeeccCcccc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH------YNARISDFGLAKLL  317 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~a~~~  317 (455)
                      |||.+|+|.+|++..+.+++...+.++.|+|.||++||+   .+||||||||+||||+..      -.+||+|||+|+.+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999999999999999999999999995   499999999999999865      46899999999998


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE  376 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~  376 (455)
                      .+....   ...+|++-|||||++..++|+.|+|+||.|++||++++|+.||+.....+
T Consensus       166 ~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  166 QPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             CchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            754432   55789999999999999999999999999999999999999998766543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-48  Score=361.77  Aligned_cols=253  Identities=27%  Similarity=0.410  Sum_probs=207.9

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-------HHHHHHHHHHHcccCCCCceeeeeeEec
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCDE  235 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~g~~~~  235 (455)
                      ...+-.++.||+|+||.|-+|...   .+++.||||++++.....       .....+|+++|++++|||||++++++..
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~---~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEK---KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEc---ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            344455688999999999999987   467899999997543221       2335799999999999999999999999


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CcEEEeecc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH---YNARISDFG  312 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg  312 (455)
                      .+..|||+|||+||.|.+++-.++.+.+..-..++.|++.|+.|||+   .||+||||||+|||+..+   ..+||+|||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999999999999999999999999999999999995   599999999999999866   789999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccCCCC--C-CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI--T-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      +|+..+...   .+...+||+.|.|||++.+...  . .|+|+||+||+||-++||.+||........      +.+.+.
T Consensus       325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI~  395 (475)
T KOG0615|consen  325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQIL  395 (475)
T ss_pred             hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHHh
Confidence            999887332   3366889999999999976643  3 378999999999999999999986554321      222333


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .|.....      .....+..++..+++.++|..||++|||+.|+++
T Consensus       396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            3433211      1123356788999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-48  Score=392.68  Aligned_cols=263  Identities=29%  Similarity=0.490  Sum_probs=223.2

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      .....|.++||+|+||.||+|...+-.  +....||||.++..... ...+|++|+++++.++|||||+|+|.|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            334457789999999999999987644  56678999999876655 678899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          240 LLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                      ++|+|||..|+|.+||...              ..++..+.+.||.|||.|+.||-   +..+|||||..+|+|+.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence            9999999999999999632              22788899999999999999999   459999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  384 (455)
                      +||+||||++-.-..+.........-..+||+||.+..++||++||||||||+|||++| |+.|+.....++       +
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V  714 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V  714 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence            99999999997655444333223334679999999999999999999999999999999 999998655433       4


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      .+.+++|.+-         ..+.+++.++..|+..||+.+|++||++.||-..|+...+.
T Consensus       715 Ie~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  715 IECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            4555566542         34556899999999999999999999999999999985543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=383.38  Aligned_cols=272  Identities=24%  Similarity=0.429  Sum_probs=233.9

Q ss_pred             ccccCHHHHHHHHHhhhh-----------hcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcc
Q 037780          153 LRCFSYKALEEATDNFKE-----------EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQ  220 (455)
Q Consensus       153 ~~~~~~~~l~~~t~~f~~-----------~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~  220 (455)
                      ...++|++-..|-.+|.+           .||.|.||.||+|.++..++....||||.|+... +....+|+.|+.+|.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            467899988888888754           4899999999999999877788899999997654 4456789999999999


Q ss_pred             cCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEE
Q 037780          221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL  299 (455)
Q Consensus       221 l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  299 (455)
                      ++||||++|.|+.......++|.|||+||+|+.||+.+ +.+++.+...+..+||.|+.||.   ..++|||||.++|||
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL  763 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL  763 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence            99999999999999999999999999999999999865 67999999999999999999999   569999999999999


Q ss_pred             EcCCCcEEEeeccCcccccCCCCcccc-ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchh
Q 037780          300 LDDHYNARISDFGLAKLLTLNQSKTIK-TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  377 (455)
Q Consensus       300 l~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~  377 (455)
                      ++.+..+||+|||+++.+.++.....+ .+..-..+|.|||.+...++|.+||||||||+|||.++ |.+||=.....  
T Consensus       764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--  841 (996)
T KOG0196|consen  764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--  841 (996)
T ss_pred             eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--
Confidence            999999999999999987655522221 11223578999999999999999999999999999998 99998544332  


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                                    ++.+.++...+...+++++..+.+|+++|||.|..+||++.+|+.+|++++.
T Consensus       842 --------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  842 --------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             --------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                          1223444556667788999999999999999999999999999999998654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-47  Score=367.49  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=210.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ++...+.||+|||..+|+++..   ..+..+|+|.+.+.   .....+...+||++-++++|||||+++++|++.++.||
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~---~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi   95 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDL---DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI   95 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEc---CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence            3445578999999999999985   35788999999763   23445678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |.|+|++++|..+++..+.+++.+++.++.||+.||.|||+   .+|+|||||..|++|+++.++||+|||||..+..+.
T Consensus        96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999999999999999999999999999999999994   599999999999999999999999999999887554


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ...  ...+|||.|+|||++....++..+||||+||+||.|+.|++||+...-.+       ....+.....        
T Consensus       173 Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y--------  235 (592)
T KOG0575|consen  173 ERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY--------  235 (592)
T ss_pred             ccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc--------
Confidence            332  55789999999999999999999999999999999999999998664322       1112222111        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        ..+.....+..+++..+|+.||.+|||+.+|+.
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              112234567789999999999999999999995

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-47  Score=335.84  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=211.3

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeee-EecCCe-E
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGF-CDEGQN-R  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~-~~~~~~-~  239 (455)
                      +.+.+.++||+|.||+|||+...   .++..+|.|.+.-.  ......++..|+.+|++++|||||+++++ +.++.+ .
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~---~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCL---LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeec---cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            44667789999999999999987   56788999998622  23344568999999999999999999994 445555 7


Q ss_pred             EEEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          240 LLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSS-QIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      +|||||+..|+|...++.    .+.+++...++++.|+++||.++|..... -|+||||||.||+|+++|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            899999999999998853    46789999999999999999999964332 3889999999999999999999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      +.+....+..  ...+|||.||+||.+.+..|+.||||||+||++|||..-+.||.+.+-       ..+.+.+.++...
T Consensus       176 r~l~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  176 RFLSSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------LSLCKKIEQGDYP  246 (375)
T ss_pred             hHhcchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH-------HHHHHHHHcCCCC
Confidence            9987655433  667899999999999999999999999999999999999999986521       2234455566544


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .+.+        .-.+..+..++..|+..||..||+.-.+++.+..
T Consensus       247 ~~p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 PLPD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCcH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            3332        3467889999999999999999996666555543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-44  Score=353.67  Aligned_cols=262  Identities=27%  Similarity=0.397  Sum_probs=205.0

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCC-e
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ-N  238 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~-~  238 (455)
                      ..+.+.+.||+|+||.||+|....  ....+..||||++..... .....+.+|+.++.++ +||||++++++|...+ .
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            345667889999999999998642  223456799999865332 2345689999999999 8999999999887644 5


Q ss_pred             EEEEEEeCCCCCHHHHhcCC------------------------------------------------------------
Q 037780          239 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------  258 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  258 (455)
                      .++||||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            78999999999999998642                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCccc
Q 037780          259 --LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV  336 (455)
Q Consensus       259 --~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  336 (455)
                        ..+++.....++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence              236788899999999999999995   599999999999999999999999999998654332222222344678899


Q ss_pred             ccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHH
Q 037780          337 APEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLM  415 (455)
Q Consensus       337 aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  415 (455)
                      |||++.+..++.++||||||++||||++ |..||......+.      .......+.....         +...+..+.+
T Consensus       244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~l~~  308 (338)
T cd05102         244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRMRA---------PENATPEIYR  308 (338)
T ss_pred             CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCCCC---------CCCCCHHHHH
Confidence            9999999999999999999999999997 9999975433211      1112222221111         1123567889


Q ss_pred             HHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          416 VSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       416 l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ++..||+.+|.+|||+.+|+++|+.+..
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=337.67  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=202.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC--eEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv~  243 (455)
                      ....+.||+|+||+||++...+   ++...|||.+........+.+.+|+.+|.+++|||||+.+|......  ..++.|
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             hhhhccccCccceEEEEEEecC---CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            4456789999999999999873   36789999987653333567899999999999999999999865555  588999


Q ss_pred             EeCCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++|+|.+++.+.+ .+++.....+..||++||+|||   +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999998776 7999999999999999999999   559999999999999999 7999999999998776411


Q ss_pred             -CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          322 -SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 -~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                       .........||+.|||||++..+ ....++|||||||+++||+||+.||....     ....+.......+....+   
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~~~P~i---  244 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGREDSLPEI---  244 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccCCCCCC---
Confidence             11122457799999999999864 33459999999999999999999997531     111222222223322222   


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                            +...+....+++..|++.+|+.|||+.++++.-
T Consensus       245 ------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  245 ------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                  223567889999999999999999999999753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-44  Score=337.59  Aligned_cols=263  Identities=24%  Similarity=0.250  Sum_probs=206.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  241 (455)
                      ++-.++||+|.||.||||+..   .+++.||+|++....  .....-..+||.+|++++||||++|.+...+.  ..+||
T Consensus       119 feki~kIGeGTyg~VYkAr~~---~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDL---ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             HHHHHHhcCcchhheeEeeec---ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            444578999999999999987   467899999996543  33445567899999999999999999988776  68999


Q ss_pred             EEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+|||++ +|.-++.. .-.++..++..++.|++.||.|+|   +.+|+|||||.+|||||.+|.+||+|||||+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999988 77777766 468999999999999999999999   569999999999999999999999999999988777


Q ss_pred             CCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH-----HHhhcCccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRNGKLD  394 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~  394 (455)
                      ..... +..+-|.+|.|||.+.+. .|+.++|+||.||+|.||++|++.|....+-++...+.-+.     ..|...++.
T Consensus       272 ~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 GSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            66554 667789999999998765 79999999999999999999999998877644333221111     111111111


Q ss_pred             cccccccccCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMND-------IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~-------~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..........+.       ...+...++|+..+|..||.+|.|+.++++
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            000000000111       112446788889999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-45  Score=356.41  Aligned_cols=261  Identities=30%  Similarity=0.398  Sum_probs=212.0

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceE-EEEEeccc---cccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~-vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      ..-.+.++||+|+||.||+|.+...+..... ||||....   .......+|++|+++|++++|||||+++|++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            3344568999999999999999865432223 99999875   3355678899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          240 LLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++|||+|+||+|.++|...+ .++..++..++.+.|.||+|||+   .+++||||-++|+|++.++.+||+|||+++.-.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999999886 59999999999999999999995   599999999999999999999999999987644


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHh-hcCccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY-RNGKLDDL  396 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  396 (455)
                      ......  ....-...|+|||.+..+.++.++|||||||++||+.+ |..||......+       +...+ .++--.. 
T Consensus       314 ~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI~~~~~r~~-  383 (474)
T KOG0194|consen  314 QYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKIVKNGYRMP-  383 (474)
T ss_pred             ceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHHHhcCccCC-
Confidence            111111  12235679999999999999999999999999999999 898987655421       22222 2221111 


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                              .+...+..+..++.+||..+|++||||.++.+.|+.+....
T Consensus       384 --------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  384 --------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             --------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                    11234678888889999999999999999999998765543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=345.66  Aligned_cols=244  Identities=27%  Similarity=0.393  Sum_probs=209.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      ++||+|+.|.||.+...   ..+..||||++........+-+.+|+.+|+..+|+|||+++..|...++.++|||||++|
T Consensus       279 ~kigqgaSG~vy~A~~~---~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg  355 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKI---STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG  355 (550)
T ss_pred             hhhccccccceeeeeec---cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence            57999999999999877   456789999998877777777999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccc
Q 037780          250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI  329 (455)
Q Consensus       250 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  329 (455)
                      +|.+.+... .+++.++..|+.++++||+|||   ..+|+|||||.+|||++.++.+||+|||++..+.......  ...
T Consensus       356 sLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR--~Tm  429 (550)
T KOG0578|consen  356 SLTDVVTKT-RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR--STM  429 (550)
T ss_pred             chhhhhhcc-cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc--ccc
Confidence            999988554 4899999999999999999999   4599999999999999999999999999999887666533  567


Q ss_pred             cccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHH
Q 037780          330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC  409 (455)
Q Consensus       330 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  409 (455)
                      +||+.|||||++....|.+|.||||||++++||+-|.+||-.+.+-.      -.+....+|..        ........
T Consensus       430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~ng~P--------~lk~~~kl  495 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTP--------KLKNPEKL  495 (550)
T ss_pred             cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhhcCCC--------CcCCcccc
Confidence            89999999999999999999999999999999999999997644311      11111222221        12223345


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          410 VEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       410 ~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...+.+++.+||+.|+++||++.|+++
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            778999999999999999999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=347.92  Aligned_cols=255  Identities=29%  Similarity=0.458  Sum_probs=203.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...+.||+|+||+||+|.+.+      .||||.++..  ..+..+.|++|+..+++-+|.||+-+.|||..+.. .+|.-
T Consensus       395 ~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             hccceeccccccceeeccccc------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            345679999999999999973      3999998654  33456789999999999999999999999999887 99999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +|+|.+|+.+|+-. .+++..+.+.|+.|||+|+.|||   ..+|||||||+.||+|.+++++||+|||++..-..-...
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            99999999999865 57888999999999999999999   459999999999999999999999999999764432111


Q ss_pred             cccccccccCcccccccccCC---CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .-...-.|...|||||++..+   +|+..+||||||+|+|||+||..||.....+.....       +..|-+    .++
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-------VGrG~l----~pd  613 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-------VGRGYL----MPD  613 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-------eccccc----Ccc
Confidence            111222377889999999754   689999999999999999999999984433221110       111111    011


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      +. ....+++.++.+|+..||..++++||++.+|+.+|+.+..
T Consensus       614 ~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  614 LS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11 1223568899999999999999999999999998887654

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=376.85  Aligned_cols=261  Identities=29%  Similarity=0.469  Sum_probs=214.9

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCC--ceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTS--TTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ..-.+.+.||+|+||.||.|...+-..+  ...||||.+.+.. .+...+|.+|..+|+.++|||||+++|.|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            3334556799999999999999865433  4569999997653 455678999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          241 LVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      +++|||++|+|..||++.       ..++....+.|+.|||+|+.||++   .++|||||.++|+||++...+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999865       457889999999999999999995   5999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      |+.....+.........-...|||||.+..+.++.|+|||||||+||||+| |..||......+.      .......|.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~ggR  922 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGGR  922 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCCc
Confidence            995444333222111234568999999999999999999999999999999 9999976554221      111223332


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                                ...+..+++.+.+++.+||+.+|++||++..++++++.+..
T Consensus       923 ----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  923 ----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                      22355688999999999999999999999999999987654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=332.33  Aligned_cols=239  Identities=28%  Similarity=0.353  Sum_probs=200.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||.++..   ..++.+|+|.+++..   ....+...+|..+|.+++||.||+++-.|++.+..|||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~---dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKK---DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             eeeeeeeccCCceEEEEEEc---ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            45688999999999999987   467889999987642   234567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+.||.|..+|++.+.+++..+.-++..|+.||.|||+   .+||||||||+|||||++|+++|+|||+++........
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            999999999999999999999999999999999999995   59999999999999999999999999999965443332


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      +  ..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+...       ..+.+..++..         
T Consensus       182 t--~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~~---------  243 (357)
T KOG0598|consen  182 T--RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKLP---------  243 (357)
T ss_pred             c--ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcCC---------
Confidence            2  45789999999999999999999999999999999999999998665422       11112222211         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRP  429 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RP  429 (455)
                      ..+.-...+..+++...+..||.+|.
T Consensus       244 ~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCCccCCHHHHHHHHHHhccCHHHhc
Confidence            11111356778888999999999995

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-43  Score=337.03  Aligned_cols=261  Identities=18%  Similarity=0.287  Sum_probs=207.5

Q ss_pred             cccccCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc---HHHHHHHHHHHcccCCCCcee
Q 037780          152 NLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVR  228 (455)
Q Consensus       152 ~~~~~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~  228 (455)
                      +.+.+++++++..+   ...||+|++|.||+|.+     ++..||||.+.......   .+.|.+|+.++.+++||||++
T Consensus        11 ~~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~   82 (283)
T PHA02988         11 DIKCIESDDIDKYT---SVLIKENDQNSIYKGIF-----NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK   82 (283)
T ss_pred             cceecCHHHcCCCC---CeEEeeCCceEEEEEEE-----CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence            34555666663221   13699999999999997     36789999997643333   466889999999999999999


Q ss_pred             eeeeEec----CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          229 LLGFCDE----GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       229 l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      ++|++.+    ....++||||+++|+|.+++.....++|..+..++.+++.||.|||+.  .+++||||||+||++++++
T Consensus        83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~  160 (283)
T PHA02988         83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENY  160 (283)
T ss_pred             EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCC
Confidence            9999876    346789999999999999999888899999999999999999999952  3788999999999999999


Q ss_pred             cEEEeeccCcccccCCCCccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~  382 (455)
                      .+||+|||+++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+.     
T Consensus       161 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----  230 (283)
T PHA02988        161 KLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----  230 (283)
T ss_pred             cEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence            99999999998654322     22347899999999976  6789999999999999999999999985543211     


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                       .......+. .        ...+...+..+.+++..||+.||++|||+.++++.|+...
T Consensus       231 -~~~i~~~~~-~--------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        231 -YDLIINKNN-S--------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             -HHHHHhcCC-C--------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence             111111111 0        0112234678999999999999999999999999998643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=339.22  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=215.8

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-HHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +..--|.++||+|-||.|.++...    ....||||.++...... ..+|..|+++|.+++|||||+|+|+|..++.+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec----CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            334457789999999999999986    46889999998765443 4889999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          242 VYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      |+|||++|+|..|+..+.  .+.-..-.+|+.|||.|++||.   +.++|||||.++|+|+|.++++||+|||+++.+-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999998773  3344556779999999999999   67999999999999999999999999999997766


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh--CCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      .+........+-..+|||||.+..++++.+||||+||++|||+++  ...||.....+.   .++.....++.+..... 
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~-  765 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVV-  765 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCccee-
Confidence            666555555667889999999999999999999999999999865  778887554432   22233333333222211 


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                           ...+.-++..+.++++.||..+.++|||++++...|+..
T Consensus       766 -----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 -----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                 122345778899999999999999999999999988753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.8e-44  Score=317.62  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=204.6

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .-++|+|+||+|||++.+   ..++.||||++....+  .-.+-.++|+++|++++|+|+|.++.+|......+||+||+
T Consensus         7 LgkvGEGSYGvV~KCrnk---~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNK---DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             hhccccCcceEEEEeccC---CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            346999999999999987   4678999999865433  23455789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      +..-|.+.-......+.....+++.|+++|+.|+|   +.++|||||||+|||++.++.+||+|||+|+.+...  ....
T Consensus        84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~Y  158 (396)
T KOG0593|consen   84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNY  158 (396)
T ss_pred             chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cchh
Confidence            98777776555567788999999999999999999   559999999999999999999999999999987631  2223


Q ss_pred             ccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH--------HHHHHhhcCc-cccc
Q 037780          327 TAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCYRNGK-LDDL  396 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~  396 (455)
                      +..+.|.+|+|||.+.+ .+|...+||||.||++.||++|.+.|.+..+-+...+..        .-.+.+..+. ...+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            66789999999999877 689999999999999999999999998766533222111        1112222221 2222


Q ss_pred             cccccccCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDMEAMNDI-----KCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .-|..+...+.     ....-+++++..|++.||.+|++-++++.
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22222221111     23446789999999999999999999874

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-43  Score=333.27  Aligned_cols=259  Identities=22%  Similarity=0.353  Sum_probs=208.1

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .....+.+.||+|+||.||+|.+......+..+|+|.++.... .....|.+|+..+.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            3455677889999999999998865555678899999875432 334578999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+++|+|.+++... ..++|.+++.++.|++.||+|||+   .+++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999764 578999999999999999999995   49999999999999999999999999987654322


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+       ....+..+...     
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~-----  227 (266)
T cd05064         161 AIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRL-----  227 (266)
T ss_pred             chh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC-----
Confidence            111 1112335678999999999999999999999999999875 999997544321       11111222110     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                          ..+...+..+.+++..||+.+|.+|||+.+|.+.|+++
T Consensus       228 ----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                11223567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.7e-42  Score=378.37  Aligned_cols=269  Identities=26%  Similarity=0.504  Sum_probs=216.5

Q ss_pred             cCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec
Q 037780          156 FSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE  235 (455)
Q Consensus       156 ~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  235 (455)
                      ++++++..+. ...+.||+|+||.||+|...   .++..||||++......    ...|++.+++++|||||+++|+|.+
T Consensus       683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        683 ITINDILSSL-KEENVISRGKKGASYKGKSI---KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             hhHHHHHhhC-CcccEEccCCCeeEEEEEEC---CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            3444444322 23357999999999999985   35678999998654322    2346889999999999999999999


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      .+..++||||+++|+|.++++   .++|.++.+|+.|+++||+|||+.++++|+||||||+||+++.++.+++. ||...
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            999999999999999999995   38999999999999999999998878899999999999999999988876 66654


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      .....      ....+|.+|+|||++.+..++.++|||||||++|||+||+.||+.... ....+..|+...........
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  903 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDM  903 (968)
T ss_pred             ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhh
Confidence            33211      123578999999999999999999999999999999999999965433 23345667766665555556


Q ss_pred             cccccccc--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          396 LVEGDMEA--MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       396 ~~~~~l~~--~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+++.+..  ..+.++..++.+++.+||+.+|++||||.+|+++|+++..
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            66665533  2344667789999999999999999999999999998755

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3e-43  Score=347.76  Aligned_cols=260  Identities=27%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  239 (455)
                      ....+.+.||+|+||.||+|....  ....+..||||+++... ....+.+.+|+.++..+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            345677899999999999997542  12345689999986433 23345688999999999 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC-------------------------------------------------------------
Q 037780          240 LLVYEFLNNGTLASFLFGN-------------------------------------------------------------  258 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-------------------------------------------------------------  258 (455)
                      ++||||+++|+|.+++...                                                             
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            9999999999999998542                                                             


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          259 --------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       259 --------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                                    ..++|..++.|+.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                          146888999999999999999995   599999999999999999999999999998765433222


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..||.......  .    ....+..+....        
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~--------  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--K----FYKMIKEGYRML--------  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--H----HHHHHHhCccCC--------
Confidence            2223345678999999999999999999999999999998 888886543221  1    111222221100        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                       .+...+.++.+++.+||+.||++|||+.+|+++|++.
T Consensus       338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             0111246788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=341.43  Aligned_cols=236  Identities=27%  Similarity=0.434  Sum_probs=204.0

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  250 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs  250 (455)
                      =||+|+-|.||+|++.     +..||||+++...       ..+|+-|++++|+||+.+.|+|.....+++|||||+.|-
T Consensus       131 WlGSGaQGAVF~Grl~-----netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRLH-----NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhccCcccceeeeecc-----CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            4999999999999986     5789999986432       247889999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccccc
Q 037780          251 LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR  330 (455)
Q Consensus       251 L~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  330 (455)
                      |...|+...+++-.....+..+||.|+.|||.+   .|||||||+-||||..+..+||+|||-++......   .+..+.
T Consensus       199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFA  272 (904)
T ss_pred             HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhh
Confidence            999999999999999999999999999999965   99999999999999999999999999998765442   224578


Q ss_pred             ccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHH
Q 037780          331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV  410 (455)
Q Consensus       331 gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  410 (455)
                      ||..|||||++.+.+.++|+||||||||||||+||..||.......               .+-.+-...+....+..++
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEeccCCcccccCcccCc
Confidence            9999999999999999999999999999999999999997543211               0111112234444566789


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          411 EKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       411 ~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      +.+.-|+++||+..|.+||++.+|+..|+
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            99999999999999999999999999886

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=339.36  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=208.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..|.+.||.|+|++|++|+..   ..++++|||++++..   +...+-...|-.+|.+| .||.|++|+-.|.+...+|+
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~---~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREK---ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             cchhheeccccceeEEEeeec---CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            457899999999999999987   467899999997532   22334577888899999 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+||++||+|.++|.+.+.+++...+.++.+|+.||+|||   +.|||||||||+|||||.|+++||+|||.|+.+.+..
T Consensus       152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            9999999999999999999999999999999999999999   5699999999999999999999999999999886543


Q ss_pred             Cc---------cc--cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          322 SK---------TI--KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       322 ~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      ..         ..  ...++||..|++||++..+..++.+|+|+|||+||.|+.|++||...++  +..+          
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yliF----------  296 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLIF----------  296 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHHH----------
Confidence            22         11  1457899999999999999999999999999999999999999986553  1111          


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                         ..+++-  ....+...++.+.+|+...|..||.+|+|.++|.+.
T Consensus       297 ---qkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  297 ---QKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ---HHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence               111111  112222345778888999999999999999998864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.9e-44  Score=334.42  Aligned_cols=252  Identities=33%  Similarity=0.536  Sum_probs=199.4

Q ss_pred             hhhhcCcCCCccEEEEEEe-ccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIE-TTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.||.|.||.||+|.+. ........|+||.+.... ....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3567999999999999998 455567889999996533 23467899999999999999999999999988889999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.++|...  ..+++.++..|+.|+++||+|||+.   +++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999876  7889999999999999999999964   8999999999999999999999999999877333222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+.......       ....+.++....       
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~~-------  225 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRLP-------  225 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEETT-------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccce-------
Confidence            22233457789999999999889999999999999999999 788886543221       111122222211       


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                        .+..++..+.+++..||..+|++||||.++++.|
T Consensus       226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              1122466788999999999999999999999987

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=334.21  Aligned_cols=262  Identities=24%  Similarity=0.340  Sum_probs=206.1

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHH--HHHHHHHHcccC-CCCceeeeeeEecCC-eE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTH-HKNLVRLLGFCDEGQ-NR  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~g~~~~~~-~~  239 (455)
                      .+|...++||.|+||.||+|+..   ..+..||||++++.... .++  =++|+..|++++ |||||++.+.+.+.+ ..
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~---~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSK---ETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeec---CCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            45677799999999999999987   45677999999865443 333  368999999999 999999999999888 89


Q ss_pred             EEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          240 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++|||||+. +|++.+++. +.+++..++.|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+||...
T Consensus        86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999999955 899998765 6789999999999999999999955   99999999999999999999999999999776


Q ss_pred             CCCCccccccccccCccccccccc-CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH-----HHhhcC-
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYR-KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYRNG-  391 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~-  391 (455)
                      ....   .+..+.|.+|+|||++. .+.|+.+.|+||+||+++||.+-++.|.+..+-++..-.-.+.     +.+..| 
T Consensus       162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            4443   26678999999999875 5679999999999999999999999987665422211110000     001110 


Q ss_pred             --------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          392 --------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       392 --------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                              .+.......+....+ ....++.+++..|++.||.+|||+.+.++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                    111111111222122 267789999999999999999999999874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=325.29  Aligned_cols=266  Identities=28%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc--cCCCCceeeeeeEecCC----eEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDEGQ----NRL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~~~----~~~  240 (455)
                      ++.+.||+|+||.||||.+.     ++.||||++..   +....|++|-++.+.  ++|+||+++++.-....    +.+
T Consensus       213 ~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD-----NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             hhHHHhhcCccceeehhhcc-----CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            46788999999999999996     47899999864   345668888777776  58999999999987666    889


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------SSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      ||+||.++|||.+||.. ..++|....+|+..+++||+|||+..      +++|+|||||++||||.+|+++.|+|||+|
T Consensus       285 LVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999999965 46799999999999999999999753      567999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCC-CC-----CCCCeecHHHHHHHHHhCCCCCCccccchhhh---------
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKST-IT-----AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI---------  379 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~---------  379 (455)
                      ..+............+||.+|||||++.+.- +.     .+.||||+|.|||||++...-+......++..         
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            9988776665556688999999999996542 22     26899999999999999765543211111111         


Q ss_pred             -hHHHHHHHhh-cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          380 -LTDWAFDCYR-NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       380 -~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                       -.+..+..+. +..-..+.+.-...    ..+..+.+.+..||..||+.|.|+.=|-+++..+..+.
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence             1112222221 11112222221111    34678899999999999999999999999888755443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4e-43  Score=346.64  Aligned_cols=261  Identities=26%  Similarity=0.399  Sum_probs=205.2

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  239 (455)
                      ..+.+.+.||+|+||.||+|+....  ......||+|++.... ......+.+|+.+++.+ +|+||++++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            3456778999999999999987532  2344679999997543 22345688999999999 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC-------------------------------------------------------------
Q 037780          240 LLVYEFLNNGTLASFLFGN-------------------------------------------------------------  258 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-------------------------------------------------------------  258 (455)
                      ++||||+++|+|.+++...                                                             
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999999998532                                                             


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccc
Q 037780          259 ---------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI  329 (455)
Q Consensus       259 ---------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  329 (455)
                               ..+++.+.++|+.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     236788899999999999999995   59999999999999999999999999999865443322222233


Q ss_pred             cccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHH
Q 037780          330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK  408 (455)
Q Consensus       330 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  408 (455)
                      .++..|+|||++.+..++.++||||||+++|||++ |+.||........      .......+...         ..+..
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~---------~~~~~  339 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQM---------SRPDF  339 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCc---------cCCCC
Confidence            45678999999998899999999999999999997 9999975433211      11111111100         00111


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          409 CVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       409 ~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .+..+.+++..||+.+|++|||+.+|+++|+++.
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            2467889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=326.85  Aligned_cols=259  Identities=22%  Similarity=0.306  Sum_probs=206.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .|++.++||.|..++||+|+..   ..+..||||+++...-. ..+.+.+|+..|+.++||||++.+..|..+...|+||
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~---p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCI---PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeec---ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3566789999999999999987   44588999999654322 3578999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      .||.+||+.+.++..  ..+++..+..|.+++++||.|||++   |.||||||+.||||+.+|.+||+|||.+..+-...
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999764  4588999999999999999999965   99999999999999999999999999877554322


Q ss_pred             Ccc-cc-ccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          322 SKT-IK-TAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       322 ~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ... .. ..++||+.|||||++..  ..|+.|+||||||++..||.+|..||...-+-..      +...+ ++....+.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tL-qn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTL-QNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHh-cCCCCCcc
Confidence            211 11 45679999999999543  3699999999999999999999999985543211      11111 22222122


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      -..+...........+.+++..||+.||.+|||+.++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            222222233345668999999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-42  Score=334.18  Aligned_cols=264  Identities=25%  Similarity=0.402  Sum_probs=203.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC-------------CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeee
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR-------------TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL  230 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~-------------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  230 (455)
                      .+.+.++||+|+||.||++.+....             ..+..||+|.+.... .....+|.+|+.++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            3456688999999999999865321             234579999986542 23356799999999999999999999


Q ss_pred             eeEecCCeEEEEEEeCCCCCHHHHhcCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 037780          231 GFCDEGQNRLLVYEFLNNGTLASFLFGN-------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC  291 (455)
Q Consensus       231 g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  291 (455)
                      +++.+.+..++||||+++|+|.+++...                   ..++|...+.|+.|++.||+|||+   .+|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence            9999999999999999999999998542                   246888999999999999999995   499999


Q ss_pred             CCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh--CCCCC
Q 037780          292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS--CRKSF  369 (455)
Q Consensus       292 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~  369 (455)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++  +..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999986644333222233446789999999988899999999999999999987  55677


Q ss_pred             CccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          370 DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .......   ....+.............      ..+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       243 ~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         243 GELTDEQ---VIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CcCCHHH---HHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            6433221   112222222211110000      0112345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=338.09  Aligned_cols=245  Identities=26%  Similarity=0.372  Sum_probs=203.7

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc----cc-ccHHHHHHHHHHHcccC-CCCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV----FQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||+|+.|....   .+..||+|.++..    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            45567889999999999999874   4588999977653    11 23456778999999999 9999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEEEeeccCcccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLL  317 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~  317 (455)
                      .++||||+.+|+|.+++.+...+.+.....++.|++.|++|+|   +.+|+||||||+|||+|.+ +++||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            9999999999999999999889999999999999999999999   5599999999999999999 99999999999987


Q ss_pred             c-CCCCccccccccccCcccccccccCCC-CC-CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          318 T-LNQSKTIKTAIRGTKGYVAPEWYRKST-IT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       318 ~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      . ...   .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......       ....+..+...
T Consensus       172 ~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~~~  241 (370)
T KOG0583|consen  172 PGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGEFK  241 (370)
T ss_pred             CCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCCcc
Confidence            4 222   225578999999999999877 86 68999999999999999999998633211       11112222211


Q ss_pred             cccccccccCCCHHH-HHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          395 DLVEGDMEAMNDIKC-VEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~-~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                                .+... ..++..++..|++.||.+|+|+.+|+
T Consensus       242 ----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  242 ----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                      11112 67889999999999999999999999

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.7e-42  Score=327.17  Aligned_cols=257  Identities=30%  Similarity=0.480  Sum_probs=207.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ...+.+.||+|+||.||+|......  .....+++|.+..... .....|.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            3456789999999999999986432  2346799999864332 234568999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          242 VYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                      +|||+++++|.+++...                ..+++...+.++.|++.||+|||+   .+++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence            99999999999999653                457889999999999999999995   49999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  384 (455)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+       .
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~  235 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------V  235 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence            99999999986544332222233456889999999988899999999999999999998 999987544321       1


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ...+..+....         .+..++..+.+++..||+.+|.+||++.+|++.|++
T Consensus       236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            12222222211         123456889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.9e-42  Score=325.79  Aligned_cols=259  Identities=27%  Similarity=0.475  Sum_probs=209.3

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      ..++.+.+.||+|+||.||+|.....  ......+|+|.+...... ....+.+|++++.+++|+|++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            45677889999999999999987643  234578999998765443 456899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          240 LLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                      ++||||+++++|.+++...              ..+++.+...++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence            9999999999999999643              347899999999999999999995   49999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  384 (455)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.......       .
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------V  233 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence            99999999986543322222233346788999999999999999999999999999999 999986544322       1


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ......+.....         +...+..+.+++..||+.+|++|||+.||++.|++
T Consensus       234 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 IECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            111222222111         11345778999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=322.92  Aligned_cols=258  Identities=25%  Similarity=0.416  Sum_probs=208.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||+||+|.+...+.....+|+|.+.... .....+|.+|+.++.+++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            3456688999999999999987654456789999986543 233457899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++++|.+++... ..+++..++.++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++.......
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            999999999999764 478999999999999999999995   5999999999999999999999999999998753222


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||.......       .......+...       
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~-------  227 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL-------  227 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence            221122345678999999998899999999999999999998 999986433221       11111111110       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                        ..+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              01123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.9e-42  Score=300.21  Aligned_cols=263  Identities=22%  Similarity=0.275  Sum_probs=205.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +|.-.+.||+|.||.||+|++.   ..++.||||++....  +.-.....+|++.|+.++|+||+.+++++...+..-||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~---~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDT---ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEec---CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            3445578999999999999987   467889999997542  22245688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +|||+. +|...+++. ..++..+...++.++++||+|||.   ..|+||||||.|+|++++|.+||+|||+|+.++...
T Consensus        80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            999965 999999865 677899999999999999999995   599999999999999999999999999999987554


Q ss_pred             CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc---cccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL---DDLV  397 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  397 (455)
                      ...  +..+-|.+|.|||.+.+. .|+..+|+||.||++.||+-|.+-|.+..+-++....-.+...-....+   ..+.
T Consensus       156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            432  334689999999988765 6999999999999999999999888766553322211111111011111   1111


Q ss_pred             c---------cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          398 E---------GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       398 ~---------~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      |         +.+.... .......++++..++..||.+|+|+.|++++
T Consensus       234 dY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1         1111111 1245567999999999999999999999875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.3e-42  Score=339.26  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=205.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEecccccc-ccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~  240 (455)
                      ...+.+.||+|+||.||+|......  .....||||++..... ...+.+.+|+.++.++. ||||++++++|.+....+
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY  117 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence            4456689999999999999875322  2345799999965432 23456999999999996 999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC--------------------------------------------------------------
Q 037780          241 LVYEFLNNGTLASFLFGN--------------------------------------------------------------  258 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~--------------------------------------------------------------  258 (455)
                      +||||+++|+|.+++...                                                              
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (400)
T cd05105         118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA  197 (400)
T ss_pred             EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence            999999999999988542                                                              


Q ss_pred             ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          259 ----------------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       259 ----------------------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                                                        ..+++..+..++.|+++||+|||+   .+|+||||||+|||+++++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCC
Confidence                                              236788889999999999999995   5999999999999999999


Q ss_pred             cEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW  383 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  383 (455)
                      .+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........      
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~------  348 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST------  348 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH------
Confidence            999999999987644332222223346788999999998899999999999999999997 9999875432111      


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .......+...         ..+...+..+.+++.+||+.+|++|||+.+|.++|+.+.+
T Consensus       349 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 FYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111221110         1112345788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.9e-42  Score=333.88  Aligned_cols=260  Identities=21%  Similarity=0.297  Sum_probs=203.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +...+.||+|+||.||++...   ..+..+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEEC---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            445578999999999999986   356789999886532 2334679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  159 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  159 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccccc--
Confidence            999999999998888899999999999999999999953  3699999999999999999999999999986543221  


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc---c--------
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---L--------  393 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~--------  393 (455)
                        ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   .........+.   .        
T Consensus       160 --~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         160 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE---AIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHhcccccccccCCccccCcccc
Confidence              3346899999999999989999999999999999999999999754432111   00000000000   0        


Q ss_pred             -----------------------ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          394 -----------------------DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       394 -----------------------~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                                             ..+................+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                   00000000001111245678999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-42  Score=329.88  Aligned_cols=241  Identities=25%  Similarity=0.274  Sum_probs=195.5

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||+|+||.||++...   ..+..+|+|.+...   .......+..|+.++.+++||||+++++++...+..++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKR---DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence            799999999999986   34678999988643   223345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      |+|.+++.....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........  ...
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~  152 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNT  152 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--ccc
Confidence            9999999888889999999999999999999995   59999999999999999999999999999864332221  134


Q ss_pred             ccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHH
Q 037780          329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK  408 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  408 (455)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ...... .+..          ..+..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~-~~~~----------~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKIL-QEPL----------RFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHH-cCCC----------CCCCc
Confidence            569999999999999999999999999999999999999997543221      111111 1111          11122


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          409 CVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       409 ~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ....+.+++..||+.||.+||++..+.+.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence            35678899999999999999865444333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.6e-42  Score=326.18  Aligned_cols=259  Identities=24%  Similarity=0.447  Sum_probs=209.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.+.||+|+||.||+|.....  ......+++|.+........+.+.+|+.++++++|+||+++++++...+..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF   86 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence            34457899999999999986532  2345679999987665555678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEE
Q 037780          244 EFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR  307 (455)
Q Consensus       244 e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  307 (455)
                      ||+++++|.+++...                ..++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence            999999999998643                347899999999999999999995   4999999999999999999999


Q ss_pred             EeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHH
Q 037780          308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  386 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  386 (455)
                      |+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.||......+       ..+
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~  236 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIE  236 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence            999999986544332222233446789999999998899999999999999999999 999986544321       112


Q ss_pred             HhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       387 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ....+.....         ....+..+.+++.+||+.+|++|||+.+|+++|+++..
T Consensus       237 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            2222222211         11245678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=320.20  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=205.3

Q ss_pred             HHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          162 EEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       162 ~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ...+..+.+.||+|++|.||+|...    .+..+|+|.++... ...+++.+|+.++++++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            3445667789999999999999875    34679999986543 346779999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          242 VYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999999997653  78999999999999999999995   4999999999999999999999999999987653


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ...... .....+..|+|||++.+..++.++||||||++++||+| |+.||.......       ....+..+..     
T Consensus       156 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-----  222 (261)
T cd05068         156 DIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR-----  222 (261)
T ss_pred             Cccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence            322111 22223468999999998899999999999999999999 999987543211       1111111110     


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                          ...+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                01112345778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.7e-42  Score=331.35  Aligned_cols=242  Identities=23%  Similarity=0.271  Sum_probs=197.9

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||+|+||.||++...   .+++.+|+|.+....   ......+.+|+.++.+++||||+++.+++...+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREK---ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence            36899999999999886   356789999986432   223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|+|.+++.....+++.+...++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  152 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence            999999999888889999999999999999999995   5999999999999999999999999999875322211  11


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........       ......+..          ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~----------~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI----------RFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCC----------CCC
Confidence            345699999999999999999999999999999999999999975432211       111111111          011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      ......+.+++..||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12356788999999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-41  Score=332.19  Aligned_cols=262  Identities=27%  Similarity=0.385  Sum_probs=205.6

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecC-Ce
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-QN  238 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~-~~  238 (455)
                      ..+.+.+.||+|+||.||+|...++  ...++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            3566778999999999999986532  2345789999986432 22345688899999999 899999999988654 56


Q ss_pred             EEEEEEeCCCCCHHHHhcCC------------------------------------------------------------
Q 037780          239 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------  258 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  258 (455)
                      .++++||+++++|.+++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            78999999999999998532                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccc
Q 037780          259 -LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA  337 (455)
Q Consensus       259 -~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  337 (455)
                       ..++|..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence             257899999999999999999995   5999999999999999999999999999987644332222233456788999


Q ss_pred             cccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHH
Q 037780          338 PEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMV  416 (455)
Q Consensus       338 PE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  416 (455)
                      ||++.+..++.++|||||||+|+||++ |..||......+.      ....+..+....         .+......+.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR---------APEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC---------CCccCCHHHHHH
Confidence            999999999999999999999999998 9999875432211      111122221111         111235678999


Q ss_pred             HHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          417 SIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       417 ~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      +..||+.+|++||++.+|++.|+.+++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.8e-42  Score=330.03  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCC-CceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+...+.||+|+||.||+|.+..++. ....||+|.+.... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            344556789999999999999764332 23458999986443 33456799999999999999999999999765 5679


Q ss_pred             EEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+||+++|+|.+++... ..+++...+.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999764 468899999999999999999995   59999999999999999999999999999876544


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ..........++..|+|||++.+..++.++||||||+++|||++ |+.||+.....+.       ......+...     
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~-----  230 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERL-----  230 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCCC-----
Confidence            33221122334678999999999999999999999999999998 9999875432211       1111111110     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                          ..+..+...+.+++..||+.+|.+|||+.+++..|..+..
T Consensus       231 ----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                0111234568899999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.9e-42  Score=325.58  Aligned_cols=260  Identities=24%  Similarity=0.460  Sum_probs=208.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      ...+.+.||+|+||.||++.....  ......+|+|.+..........+.+|+.++.+++|||++++++++...+..++|
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            344567899999999999986432  234567999998766555567899999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEe
Q 037780          243 YEFLNNGTLASFLFGNL-------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS  309 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  309 (455)
                      +||+++++|.+++....             .+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEec
Confidence            99999999999986432             48999999999999999999995   499999999999999999999999


Q ss_pred             eccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHh
Q 037780          310 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY  388 (455)
Q Consensus       310 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  388 (455)
                      |||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||.......       .....
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i  235 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECI  235 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            9999986643332222223345778999999998899999999999999999999 999986544321       11122


Q ss_pred             hcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       389 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ..+.....         +...+..+.+++..||+.+|.+|||+.+|.+.|+++..
T Consensus       236 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         236 TQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            22222111         11234578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.3e-41  Score=322.26  Aligned_cols=247  Identities=25%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ..+.||+|+||.||++...   .+++.+|+|.+....   ......+.+|+.++.+++|+|++++.+++.+++..++|+|
T Consensus         4 ~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           4 HYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             EEEEEecCCCEEEEEEEEe---cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4568999999999999987   356789999886432   2233468899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            9999999988754  3468999999999999999999995   5999999999999999999999999999987543222


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....||..|+|||++.+..++.++|||||||++|||++|+.||.........   ...........          
T Consensus       158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------  221 (285)
T cd05631         158 V---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ----------  221 (285)
T ss_pred             e---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc----------
Confidence            1   3346899999999999999999999999999999999999999865432111   00111111110          


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                      ..........+.+++..||+.||.+||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            0112224567889999999999999997     788776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.2e-42  Score=328.91  Aligned_cols=245  Identities=28%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +...+.||+|+||.||||+-+   .+.+.||+|.+.+...  ...+.+.+|++++++++|||||.++++|+...+.++|.
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK---~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRK---YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             hhHHHHhcCCccceeeecccc---cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            455688999999999999877   4568899999976533  23456899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+.+ +|..+|.....+++++...|+.+++.||.|||   +.+|+|||+||+|||++.++++|++|||+|+.+....  
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--  154 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--  154 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence            99977 99999999999999999999999999999999   5599999999999999999999999999999876533  


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ...+.+.||+-|||||.+.+++|+..+|.||+||+|||+.+|++||....      +...+. .+.....          
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~-~I~~d~v----------  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVK-SILKDPV----------  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHH-HHhcCCC----------
Confidence            33467889999999999999999999999999999999999999996332      111111 1111111          


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+.+....+..++...++.||..|.|..+++.
T Consensus       218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            123356778899999999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=305.03  Aligned_cols=234  Identities=29%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ++.+.||.|+||.|.+.+.+   .++..+|+|.+++..-   ...+...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus        47 e~~~tlGtGSFGrV~LVr~k---~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREK---HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hheeeeccCccceEEEEEEc---cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45578999999999999987   4578899999976432   23456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||++||.|..+|++.+++++...+-++.+|+.||+|||   +.+|++|||||+|||||.+|.+||+|||+|+.+...   
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999999999999999999999999999999999999   569999999999999999999999999999987643   


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        +...+||+.|+|||.++...++.++|.|||||++|||+.|.+||....+.       ...+.+-++++.         
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v~---------  259 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKVK---------  259 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCccc---------
Confidence              25678999999999999999999999999999999999999999866651       122222233221         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLR  428 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~R  428 (455)
                       .+.-....+.+++...|+.|-.+|
T Consensus       260 -fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 -FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -CCcccCHHHHHHHHHHHhhhhHhh
Confidence             122234566677777788888877

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-41  Score=320.04  Aligned_cols=252  Identities=28%  Similarity=0.424  Sum_probs=204.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.+.||+|+||.||+|...   ..+..+++|.+... .....++.+|+.++.+++|+|++++++++...+..++||||
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~---~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             eEEeeecCCcccceEEEEEEe---cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            445678999999999999987   34678999998643 33456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++++|.+++...  ..+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999998653  468999999999999999999995   59999999999999999999999999999876543221


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      . .....++..|+|||++.+..++.++||||||+++|||++ |..||.....++.       ......+..         
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~---------  223 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGYR---------  223 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC---------
Confidence            1 112234678999999998899999999999999999998 9999875433211       111111110         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ...+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            011122457789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-41  Score=323.00  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=204.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc-CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT-RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      ...+.+.||+|+||.||+|..... ...+..+++|.+.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            445678899999999999986432 2356789999986432 23346789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          243 YEFLNNGTLASFLFGN-----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                      |||+++++|.+++...                 ..+++.+.+.++.|++.||+|||+   .+++|+||||+||++++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence            9999999999998522                 247889999999999999999995   49999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  384 (455)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......       +
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------~  235 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------V  235 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence            99999999987654332222233446778999999988889999999999999999998 999986543211       1


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .+....+....         .+...+..+.+++.+||+.+|.+||++.+|.+.|.+
T Consensus       236 ~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11112221111         111245678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.1e-41  Score=322.14  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=206.3

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ..+.+.++||+|+||.||+|....+  ......+|+|++...... ....+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4567788999999999999988643  234578999999754332 2356889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          241 LVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      +++||+++++|.+++...                ..+++..+..++.|++.||+|||+   .+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence            999999999999998421                347888999999999999999995   5999999999999999999


Q ss_pred             cEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW  383 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  383 (455)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||......+       
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999887644332222233346789999999988889999999999999999998 888886543321       


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ....+..+....         .+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       235 ~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            112222222111         122356778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=331.43  Aligned_cols=251  Identities=20%  Similarity=0.275  Sum_probs=202.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||+|....   .+..||+|++....   ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            455789999999999999873   46789999986432   223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....    
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            999999999999888889999999999999999999995   4999999999999999999999999999986543    


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...       .+....  .........
T Consensus       154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------~i~~~~--~~~~~~~~~  223 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-------NLKYWK--ETLQRPVYD  223 (333)
T ss_pred             -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-------HHHhcc--ccccCCCCC
Confidence             1134568999999999999899999999999999999999999997654322111       001000  000000000


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .........+.+++..||+.+|.+||++.++++.
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0012345678899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.5e-41  Score=321.04  Aligned_cols=257  Identities=25%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCC-CceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|.+..++. ....+++|.+..... ....++..|+..+++++||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            345789999999999999864322 123588888754322 234568888999999999999999999864 45788999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..++|..+..|+.|++.||+|||+   .+++||||||+||++++++.+||+|||+++........
T Consensus        89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            99999999999754 578999999999999999999995   48999999999999999999999999999876543322


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.||........       ...+..+....  .+   
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~--~~---  233 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERLA--QP---  233 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCC--CC---
Confidence            22234457789999999998899999999999999999998 9999975443221       11122222111  11   


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                          ..+...+.+++..||..+|.+|||+.++++.|..+..
T Consensus       234 ----~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         234 ----QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                1134567889999999999999999999999988664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-42  Score=334.90  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=210.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||.|+-|.|-.|++.   .+|+.+|||.+.+..   ......+.+|+.+|+.+.|||++++++++++..+.|+|.
T Consensus        15 kLgkTLG~Gstg~vrlakh~---~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHA---ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             eccccccCCCCceehhhhcc---cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            35678999999999999887   567899999997652   222345789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|-|++++-..+.+++.+..+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||||.+-.++.-.
T Consensus        92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            999999999999999999999999999999999999995   59999999999999999999999999999876544332


Q ss_pred             cccccccccCcccccccccCCCCC-CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                         ...+|++.|.|||++.+.+|+ .++||||.||+||.|+||+.||+..+-       ..+...+..|.+.        
T Consensus       169 ---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f~--------  230 (786)
T KOG0588|consen  169 ---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVFE--------  230 (786)
T ss_pred             ---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCccc--------
Confidence               456799999999999999985 689999999999999999999984332       1122233344332        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcCcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGVVE  443 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~~~  443 (455)
                        .+.+.+.++.+|+..|+..||+.|.|+++|.+.  |.+-..
T Consensus       231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             --CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence              123456788899999999999999999999973  555333

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.5e-41  Score=322.14  Aligned_cols=258  Identities=27%  Similarity=0.462  Sum_probs=202.9

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ..+.+.+.||+|+||.||+|.....  ......+|+|++.... .....+|.+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            3455668899999999999987532  1245679999986432 223456899999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEee
Q 037780          241 LVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD  310 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  310 (455)
                      +|+||+++++|.+++...          ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECC
Confidence            999999999999998642          235788999999999999999995   5999999999999999999999999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhh
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+.       ......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~~  235 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVM  235 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHH
Confidence            999986543332221122335778999999998899999999999999999999 788886543321       111111


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .+.....         +...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       236 ~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2211111         11235678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-41  Score=328.70  Aligned_cols=245  Identities=25%  Similarity=0.302  Sum_probs=199.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||++....+...+..+|+|.+....    ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999876555577899999986432    12334578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.....+.+..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  156 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--  156 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence            9999999999888888999999999999999999995   59999999999999999999999999998754322221  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......      .. ..+..+...          .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~-~~~~~~~~~----------~  219 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TI-DKILKGKLN----------L  219 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCCCC----------C
Confidence            133568999999999998889999999999999999999999997544321      11 111111110          1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      +......+.+++..||+.+|++||     ++.++++
T Consensus       220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            112346788999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-41  Score=316.23  Aligned_cols=249  Identities=26%  Similarity=0.432  Sum_probs=200.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.+.||+|+||.||++.+.    ....+|+|.+... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             cEEeeEecCCcCceEEEEEec----cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            445678999999999999875    3457899987643 33456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++|+|.+++... ..++|..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999753 568999999999999999999995   499999999999999999999999999998654332211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.      . ..+..+..  ...+    
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~-~~i~~~~~--~~~~----  223 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------V-EMISRGFR--LYRP----  223 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------H-HHHHCCCC--CCCC----
Confidence             122335678999999988889999999999999999999 8999975443211      1 11111111  0011    


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                         ......+.+++.+||+.+|++|||+.++++.|.
T Consensus       224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               112457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.7e-41  Score=315.89  Aligned_cols=249  Identities=30%  Similarity=0.434  Sum_probs=200.4

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +||+|+||.||+|.+... ..+..+|+|++....  ....+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK-KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecC-CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            699999999999987543 356789999986432  223567999999999999999999999985 4567899999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc-cc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KT  327 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  327 (455)
                      ++|.+++.....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.......... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999999887889999999999999999999995   5999999999999999999999999999987654432111 12


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||......+       ....+..+....         .+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~~---------~~  220 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERME---------CP  220 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC---------CC
Confidence            2234678999999988889999999999999999998 999997544321       111222222111         11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ...+..+.+++.+||+.+|++||++.+|.+.|++
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            1245678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.8e-41  Score=328.04  Aligned_cols=242  Identities=24%  Similarity=0.277  Sum_probs=197.7

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||+|+||.||++...   ..+..+|+|.+....   ......+.+|+.+++.++||||+++.+++...+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREK---ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence            36899999999999876   356789999986432   233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|+|.+++.....+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  .
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~  152 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--M  152 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--c
Confidence            999999999888889999999999999999999995   59999999999999999999999999998754322111  1


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........       ......+..          ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~----------~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEDI----------KFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccCCc----------cCC
Confidence            345699999999999988999999999999999999999999975433211       111111111          011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      ......+.+++..||+.||.+||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            12356788999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.6e-41  Score=320.41  Aligned_cols=264  Identities=20%  Similarity=0.231  Sum_probs=201.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||++...   .++..+|+|++....  ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHK---ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             ceEEEEecccCCEEEEEEEEC---CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            345678999999999999986   346789999986432  233456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||++++++..+......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            999998887776556678999999999999999999995   59999999999999999999999999999876433222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHH---------HHHHhhcCccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW---------AFDCYRNGKLD  394 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~  394 (455)
                      .. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..............         ...........
T Consensus       157 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         157 NY-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             cc-cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            21 334689999999999988899999999999999999999999976543221110000         00000111111


Q ss_pred             ccccccccc------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEA------MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~------~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+....      ......+..+.+++..||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            110010000      001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-41  Score=327.17  Aligned_cols=261  Identities=20%  Similarity=0.342  Sum_probs=202.3

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ...+.+.++||+|+||.||++...   ..+..+|+|.+.... ......+.+|++++++++|+||+++++++.+++..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK---PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            345566789999999999999886   346778999876532 2334678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++++|.+++.....+++.....++.+++.||.|||+.  .+++|+||||+|||++.++.+||+|||++.......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            999999999999998888889999999999999999999952  379999999999999999999999999997654322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc-------
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD-------  394 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------  394 (455)
                      .    ....||..|+|||++.+..++.++|||||||++|||++|+.||...........    ......+...       
T Consensus       159 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         159 A----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM----FGCPVEGDPAESETSPR  230 (333)
T ss_pred             c----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH----hcCcccCCccccccCcc
Confidence            1    234689999999999988899999999999999999999999975433211100    0000000000       


Q ss_pred             ----------------------cccc----cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 ----------------------DLVE----GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ----------------------~~~~----~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                            .+.+    .............++.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                  0000    00000000112456889999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.7e-41  Score=314.82  Aligned_cols=248  Identities=27%  Similarity=0.412  Sum_probs=197.9

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|+||.||+|.+.   .+++.+|+|...... ......+.+|++++++++||||+++++++......++|+||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLR---ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEe---cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46999999999999986   346789999875432 33456799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          249 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       249 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      ++|.+++... ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.............
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9999999754 468999999999999999999995   599999999999999999999999999987654321111111


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....+..|+|||.+.++.++.++||||||+++|||++ |..||.......       .......+..         ...+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVR---------LPCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCC---------CCCc
Confidence            1123457999999999899999999999999999998 888886543321       1111111110         0112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      ...+..+.+++.+||+.+|++|||+.+|.++|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            234568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.8e-41  Score=334.95  Aligned_cols=262  Identities=24%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccccc-cHHHHHHHHHHHcccC-CCCceeeeeeEecCCe
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN  238 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~  238 (455)
                      .....+.+.||+|+||.||+|++...  ......||+|++...... ....+.+|+.++.++. ||||++++++|.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            33445568999999999999997642  234568999999754322 2346889999999997 9999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC------------------------------------------------------------
Q 037780          239 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------  258 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  258 (455)
                      .++|+||+++|+|.++++..                                                            
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            99999999999999998643                                                            


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          259 --------------------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       259 --------------------------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                                                            ..++|...+.|+.|++.||+|||   +.+++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence                                                  13577888999999999999999   4599999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  379 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~  379 (455)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~---  349 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE---  349 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence            9999999999999986543322111123346789999999998889999999999999999998 888986433211   


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                         .....+..+..         ...+......+.+++..||+.+|.+||++.+|++.|++++
T Consensus       350 ---~~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 ---QFYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ---HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               11111112210         0111123568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-41  Score=318.69  Aligned_cols=257  Identities=25%  Similarity=0.459  Sum_probs=206.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||.||+|.+..+......+++|.+.... .....++.+|+.++++++|+|++++.+++...+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            44578999999999999987655556689999986542 23356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++..........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  164 (268)
T cd05063          88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT  164 (268)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence            9999999999754 678999999999999999999995   499999999999999999999999999998665332221


Q ss_pred             cc-ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          325 IK-TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       325 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .. .....+..|+|||++....++.++||||||+++|||++ |+.||......+       ....+..+.         .
T Consensus       165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~---------~  228 (268)
T cd05063         165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF---------R  228 (268)
T ss_pred             eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC---------C
Confidence            11 11223567999999988889999999999999999998 999996543321       111111111         0


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .......+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            0111134567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-41  Score=312.16  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=212.4

Q ss_pred             HHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---cHHHHHHHHHHHcccCCCCceeeeeeEecCCe
Q 037780          162 EEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       162 ~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  238 (455)
                      .+-+++|.+.||+|.||.|-++...   ..++.||||.+.+..-.   +.-.+.+|+++|+.++||||+.++.+|+..+.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~---~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEH---KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK  127 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhc---cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence            4457889999999999999999875   46789999999765433   33457899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      +.+||||..+|.|++|+...+.+++...++++.||..|+.|+|.   .+++|||||.+|||||+++++||+|||++.++.
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999999999999999999999999999999999995   499999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      .....   ..++|++-|.+||.+.+.+| .+.+|-||+||+||.|+.|..||++.+-.       ...+.+..|...+- 
T Consensus       205 ~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP-  273 (668)
T KOG0611|consen  205 DKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREP-  273 (668)
T ss_pred             cccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCC-
Confidence            54432   56789999999999999988 46899999999999999999999865431       12233344433321 


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                                +.+....-++.|||..||++|-|+.+|...
T Consensus       274 ----------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 ----------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ----------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                      234556778999999999999999999864

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-41  Score=329.27  Aligned_cols=242  Identities=24%  Similarity=0.273  Sum_probs=197.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||+|+||.||++...   .++..||+|.+....   ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence            36899999999999876   356789999986432   223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|+|..++.....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++........  .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~  152 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M  152 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence            999999999888889999999999999999999995   49999999999999999999999999998753222211  1


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........       ......+...          .+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~~~~~~~~----------~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEIR----------FP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCCC----------CC
Confidence            335689999999999999999999999999999999999999975443211       1111111110          11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      ......+.+++..||+.||.+||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            12356788999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-41  Score=314.64  Aligned_cols=253  Identities=30%  Similarity=0.459  Sum_probs=204.1

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ++||+|+||.||+|.+.........+|+|.+..... ...+++.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999999875544557899999875443 24567999999999999999999999876 4567999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc-cc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KT  327 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  327 (455)
                      ++|.+++.....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            9999999888889999999999999999999995   4899999999999999999999999999987654332211 11


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   +.    ..+..+...         ..+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~  220 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VI----AMLESGERL---------PRP  220 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HH----HHHHcCCcC---------CCC
Confidence            2224568999999998899999999999999999998 999997544321   11    111121111         111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            223567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-41  Score=317.44  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=202.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...+.++||+|+||.||+|...    ++..+|+|.+.... ...+.+.+|+.++++++|+|++++++.+...+..++++|
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEec----CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            3445688999999999999865    34579999886432 345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999653  567899999999999999999995   5999999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. .....++..|+|||++....++.++||||||+++|+|+| |+.||.......   ..    ..+..+...    +  
T Consensus       159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~----~--  224 (261)
T cd05072         159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM----SALQRGYRM----P--  224 (261)
T ss_pred             ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCC----C--
Confidence            11 123346778999999988889999999999999999998 999986543221   11    111111100    0  


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                         .....+..+.+++.+||+.+|++|||++++.+.|++
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 ---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               111235678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-42  Score=326.14  Aligned_cols=243  Identities=25%  Similarity=0.266  Sum_probs=199.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||++...   ..++.+|+|.+....   ......+.+|+.++++++||||+++++++.+....++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDR---ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEc---CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            45678999999999999986   346789999986432   123456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            999999999999888889999999999999999999995   599999999999999999999999999998654321  


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                         ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....+..+...         
T Consensus       156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~---------  216 (291)
T cd05612         156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-------IYEKILAGKLE---------  216 (291)
T ss_pred             ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCcC---------
Confidence               23458999999999998889999999999999999999999997644321       11111122111         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~~  437 (455)
                       .+......+.+++..||+.||.+||+     +.++++.
T Consensus       217 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 -FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             11122457889999999999999995     7777753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-41  Score=320.31  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=204.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.++||+|+||.||++....  ....+..+++|.+..........+.+|++++++++|+||+++++++...+..++++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF   86 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence            3456789999999999997643  22346689999987666566678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEE
Q 037780          244 EFLNNGTLASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI  308 (455)
Q Consensus       244 e~~~~gsL~~~l~~~---------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  308 (455)
                      ||+++++|.+++...               ..+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence            999999999998654               247899999999999999999995   59999999999999999999999


Q ss_pred             eeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHH
Q 037780          309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       309 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~  236 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------IEC  236 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------HHH
Confidence            99999976543322222122335788999999998899999999999999999998 9999864433211       111


Q ss_pred             hhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       388 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ...+...         ..+...+..+.+++.+||+.+|.+||++.+|.+.|++
T Consensus       237 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 ITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1111111         1111235678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-41  Score=329.99  Aligned_cols=243  Identities=23%  Similarity=0.281  Sum_probs=199.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .++..+|+|.+....   ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHK---GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            456688999999999999987   346789999986432   22345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence            9999999999999888889999999999999999999995   599999999999999999999999999998664322 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....+..+...        
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~--------  233 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRLK--------  233 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCcC--------
Confidence                23468999999999999999999999999999999999999997543211       11112222211        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                        .+......+.+++..||+.||.+||+     +.+++.
T Consensus       234 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 --FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              01112456789999999999999997     577663

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.8e-41  Score=321.92  Aligned_cols=258  Identities=28%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++......  .....+|+|.+.... .....++.+|+.++.++ +|+||+++++++..++..++
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   93 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV   93 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence            445578999999999999986443  345789999987532 23345688999999999 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          242 VYEFLNNGTLASFLFG----------------NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~----------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                      +|||+++|+|.+++..                ...+++..++.++.|++.||+|||+   .+|+||||||+||++++++.
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCe
Confidence            9999999999999853                2467899999999999999999995   49999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  384 (455)
                      +||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......       .
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~  243 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------L  243 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------H
Confidence            99999999987654332222122345678999999988899999999999999999998 999986543321       1


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ......+...         ..+......+.+++..||+.+|++|||+.++++.|++++
T Consensus       244 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1122222111         112234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=328.02  Aligned_cols=261  Identities=27%  Similarity=0.400  Sum_probs=217.7

Q ss_pred             HHHHHhhhhhcCcCCCccEEEEEEecc-CCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          162 EEATDNFKEEAGRGSFGIVYKGVIETT-RTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       162 ~~~t~~f~~~lG~G~fg~Vy~~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      .++.....+.||.|-||.||+|++.+. +...-.||||..+.. ..+..+.|+.|..+|++++|||||+++|.|.+. ..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            333344567899999999999999765 344567999998763 445567799999999999999999999999764 67


Q ss_pred             EEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          240 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++|||.++-|.|..||+.+ ..++......++.||..+|+|||   +..+|||||..+|||+...--+|++|||+++.+.
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999999865 56888888899999999999999   5699999999999999999999999999999988


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      .+..... +...-..-|||||.+.-.+++.+||||.|||++||+++ |..||......                ++-..+
T Consensus       543 d~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~i  605 (974)
T KOG4257|consen  543 DDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHI  605 (974)
T ss_pred             ccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEe
Confidence            7665443 23345678999999999999999999999999999998 99999754321                222233


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ....+...+.+++..+..++.+||..+|.+||++.++...|+.+.+
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            3334445566789999999999999999999999999988876554

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=323.85  Aligned_cols=243  Identities=26%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|.||.||||.+.   ..++.||+|.+.... ....+++++|+.+|.+++++||.+.+|.+..+...+++|||+.+
T Consensus        19 ~~IgrGsfG~Vyk~~d~---~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g   95 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDN---KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG   95 (467)
T ss_pred             hhccccccceeeeeeec---cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence            78999999999999987   456889999997543 33457799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      |++.+.|.....+++....-|+.++..||.|||.+   +.+|||||+.|||+..+|.+|++|||.+..+.......  ..
T Consensus        96 Gsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~t  170 (467)
T KOG0201|consen   96 GSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KT  170 (467)
T ss_pred             cchhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--cc
Confidence            99999998888878888888999999999999954   99999999999999999999999999998877655543  56


Q ss_pred             ccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHH
Q 037780          329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK  408 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  408 (455)
                      ++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+...                ..++-.......+..
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~PP~L~~~  234 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSAPPRLDGD  234 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCCCCccccc
Confidence            7899999999999988999999999999999999999999986555211                112211111122225


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          409 CVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       409 ~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+.+++..||..||+.|||+.++++
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            6778999999999999999999999885

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-41  Score=316.11  Aligned_cols=255  Identities=27%  Similarity=0.447  Sum_probs=202.4

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe------E
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------R  239 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~------~  239 (455)
                      +.+.||+|+||.||+|.+..+......+|+|++....  ......+.+|+..++.++|+|++++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            4578999999999999987654456789999986432  2334678999999999999999999999876554      7


Q ss_pred             EEEEEeCCCCCHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          240 LLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ++++||+++++|..++...      ..+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence            8999999999999998432      367999999999999999999995   4999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+   +    ......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRHGN  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCC
Confidence            987654332221122335678999999988889999999999999999999 888886433211   1    11112221


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ...         .+......+.+++..||+.||++|||+.+|++.|+++
T Consensus       233 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 RLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111         1123456889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.5e-41  Score=318.76  Aligned_cols=271  Identities=25%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             hhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv  242 (455)
                      .+.+.||+|+||+||++.... ...++..+|+|.+.... ......|.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            466789999999999876542 22456789999986543 23456789999999999999999999998654  357899


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++... .+++.++..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++.......
T Consensus        87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            9999999999999654 589999999999999999999954   999999999999999999999999999987654322


Q ss_pred             cc-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KT-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. ......++..|+|||.+.+..++.++||||||++++||+||+.|+......... .............+.+.++...
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhhhhhcCC
Confidence            11 112223567799999998888999999999999999999999998643321100 0000000000011111122211


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ....+...+..+.+++..||+.+|++|||+++|+++|+.+.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11122335678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.7e-41  Score=316.72  Aligned_cols=258  Identities=25%  Similarity=0.438  Sum_probs=206.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ...+.+.||+|+||.||+|.+..++.....+++|.+.... .....+|..|+.++++++|||++++++++..+...++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            3456788999999999999988665556689999987542 334567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++++|.+++... ..+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999999999753 568999999999999999999995   4999999999999999999999999999886644322


Q ss_pred             cccccc-c--cccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          323 KTIKTA-I--RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       323 ~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ...... .  ..+..|+|||++....++.++||||||+++||+++ |..||.......   ...++    ... .     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~-~-----  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQD-Y-----  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcC-C-----
Confidence            211111 1  12457999999998899999999999999999887 999986543321   11111    111 0     


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                         ....+.+.+..+.+++..||+.+|.+||++.+|+..|+++
T Consensus       229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ---RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0011123456788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.3e-41  Score=314.41  Aligned_cols=252  Identities=26%  Similarity=0.457  Sum_probs=207.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.++||.|+||.||+|...    .+..+++|.+.........++..|+.+++.++|+|++++++++...+..++|||
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~----~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWK----NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEec----CCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            4566789999999999999986    367799999876655456789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++.+++.++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999753  468999999999999999999995   4899999999999999999999999999987643322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..  ....++..|+|||.+....++.++||||||+++++|++ |+.||......+.   .    .....+..        
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~----~~~~~~~~--------  222 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---Y----DQITAGYR--------  222 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---H----HHHHhCCc--------
Confidence            11  23346778999999988899999999999999999998 8999975442211   1    11111110        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                       ...+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             111223456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-41  Score=343.48  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=201.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|....+  .+..|++|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            45668899999999999986533  2467888877554444455688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          246 LNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       246 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999988753    3467899999999999999999995   599999999999999999999999999998765443


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .........||++|+|||++.+..++.++|||||||++|||++|+.||......+      .... ...+....      
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~-~~~~~~~~------  290 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQ-VLYGKYDP------  290 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCCCC------
Confidence            3222344569999999999999999999999999999999999999997543211      1111 11111111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         .+......+.+++..||+.+|++||++.+++.
T Consensus       291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               11123467889999999999999999998864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9e-41  Score=324.58  Aligned_cols=244  Identities=25%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||++...   ..+..+|+|.+....   ......+..|+.++.++ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK---KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence            36999999999999987   346789999986532   22345578898888876 899999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|..++.....+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++........  
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--  152 (329)
T cd05618          78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--  152 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence            9999999999888889999999999999999999995   49999999999999999999999999999754322211  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccc--hhhhhHHHHHHHhhcCcccccccccccc
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......  .......+...........         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---------
Confidence            13456899999999999999999999999999999999999999642221  1111222333322222211         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                       .+......+.+++..||+.||++||+.
T Consensus       224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 -IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence             111234667899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.5e-41  Score=320.47  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=203.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccC--CCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||+|......  .....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++|+
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            34578999999999999875322  2335788988865432 23467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEE
Q 037780          244 EFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL  299 (455)
Q Consensus       244 e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  299 (455)
                      ||+++++|.+++...                        ..+++.+++.++.|++.||.|||+   .+++||||||+||+
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence            999999999997532                        347899999999999999999995   59999999999999


Q ss_pred             EcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhh
Q 037780          300 LDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYA  378 (455)
Q Consensus       300 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~  378 (455)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.....+.  
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--  237 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--  237 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence            99999999999999986543332211123346778999999988889999999999999999999 999986544321  


Q ss_pred             hhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                           +......+..         ...+......+.+++.+||+.+|++||++.++++.|+++..
T Consensus       238 -----~~~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 -----LFNLLKTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----HHHHHhCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 1112221110         11112345678899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=318.35  Aligned_cols=265  Identities=26%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccC-----------CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeee
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTR-----------TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL  230 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~-----------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  230 (455)
                      +..+.+.+.||+|+||.||++....+.           .....||+|.+.... ......|.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            345567789999999999999875321           123468999986542 23345799999999999999999999


Q ss_pred             eeEecCCeEEEEEEeCCCCCHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 037780          231 GFCDEGQNRLLVYEFLNNGTLASFLFGN------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI  298 (455)
Q Consensus       231 g~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  298 (455)
                      +++...+..++||||+++++|.+++...            ..++|..++.++.|++.||+|||+   .+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence            9999999999999999999999998543            246899999999999999999995   5999999999999


Q ss_pred             EEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh--CCCCCCccccch
Q 037780          299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEE  376 (455)
Q Consensus       299 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~  376 (455)
                      ++++++.+||+|||++................++..|+|||++.++.++.++||||||++++||++  |..||.....+.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999986543332222122345778999999988889999999999999999998  566776543321


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      .   .................      ..+...+..+.+++.+||+.+|++||||.+|++.|+
T Consensus       241 ~---~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 V---IENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H---HHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1   11111111111000000      011123568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-40  Score=324.22  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=198.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||++...   ..+..+|+|.++...   ....+.+..|..++.++ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELK---KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence            36899999999999987   356789999986532   22345588899999988 799999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++.....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......  .
T Consensus        78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~  152 (329)
T cd05588          78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T  152 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence            9999999999888889999999999999999999995   4999999999999999999999999999875322111  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch--hhhhHHHHHHHhhcCcccccccccccc
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||+......  ......+.......+...         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---------  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---------
Confidence            134568999999999999999999999999999999999999997432211  111222333333222211         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPT------MRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt------~~~v~~  436 (455)
                       .+......+.+++..||+.||.+|||      +.++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence             01123457889999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-41  Score=328.65  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=201.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||+|.+..+  ....+|+|++....   ....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            456678899999999999987633  34689999885432   2334568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++++||+|||+++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence            99999999999999888889999999999999999999995   599999999999999999999999999998654321


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                           ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....+..+...       
T Consensus       186 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~-------  246 (340)
T PTZ00426        186 -----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGIIY-------  246 (340)
T ss_pred             -----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCC-------
Confidence                 33568999999999998889999999999999999999999997544321       11111222111       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQM  437 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~~  437 (455)
                         .+......+.+++..|++.+|.+|+     |++++++.
T Consensus       247 ---~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 ---FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               0112245678999999999999995     88888763

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-40  Score=311.32  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=203.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|++|.||+|.+...+.....+|+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999876444455799999976555 456789999999999999999999999988 889999999999


Q ss_pred             CCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc-cc
Q 037780          249 GTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-TI  325 (455)
Q Consensus       249 gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~  325 (455)
                      ++|.+++....  .++|...+.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++........ ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997654  68999999999999999999995   59999999999999999999999999999877543221 11


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.      .......+..  .       .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~--~-------~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKEGER--L-------E  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCc--C-------C
Confidence            123447789999999998899999999999999999999 9999965433211      1111111100  0       0


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      .+...+..+.+++..||+.+|++|||+.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11124567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.1e-41  Score=319.59  Aligned_cols=264  Identities=25%  Similarity=0.415  Sum_probs=202.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv  242 (455)
                      ..+.+.||+|+||+||++.... ....+..+++|++........+.|.+|++++.+++|||++++.+++..  ....++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            3456789999999999998642 223567899999876655556789999999999999999999998754  3467899


Q ss_pred             EEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +||+++++|.+++... ..++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999999999764 568999999999999999999995   499999999999999999999999999998765432


Q ss_pred             Ccc-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh---------hhhHHHHHHHhhcC
Q 037780          322 SKT-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAFDCYRNG  391 (455)
Q Consensus       322 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~---------~~~~~~~~~~~~~~  391 (455)
                      ... ......++..|+|||++.+..++.++||||||++++||++|..++........         .............+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            211 11112244569999999888899999999999999999998876543221100         00000011111111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                               .........+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       243 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         243 ---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                     11111223456799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.2e-41  Score=313.77  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=200.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|...    +...+|+|.+.... ....+|.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~----~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             eEEeeEecCcccceEEEEEec----CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            456678999999999999875    33469999886432 3456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.++.........
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999764 468999999999999999999995   499999999999999999999999999988654332211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......       .......+....        
T Consensus       158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------  221 (256)
T cd05113         158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRLY--------  221 (256)
T ss_pred             -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCCC--------
Confidence             122335678999999988889999999999999999999 999987544321       111111111110        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                       ........+.+++.+||+.+|.+|||+.++++.|+
T Consensus       222 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 -RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             01123578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-41  Score=326.76  Aligned_cols=242  Identities=25%  Similarity=0.271  Sum_probs=197.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.||+|+||.||++....+...+..+|+|++.....  .....+..|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            569999999999998765545678999999865321  233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      +|+|.+++.....+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++........  ..
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~  156 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY  156 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence            99999999888889999999999999999999995   59999999999999999999999999999865433221  13


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCH
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI  407 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  407 (455)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||........      . ..+......          .+.
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~-~~i~~~~~~----------~p~  219 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------M-TMILKAKLG----------MPQ  219 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------H-HHHHcCCCC----------CCC
Confidence            45689999999999988899999999999999999999999975443211      1 111111110          111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHH
Q 037780          408 KCVEKLLMVSIWCIQEDPSLRPTMRK  433 (455)
Q Consensus       408 ~~~~~~~~l~~~cl~~~p~~RPt~~~  433 (455)
                      .....+.+++..||+.||++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            23467789999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-41  Score=316.94  Aligned_cols=257  Identities=29%  Similarity=0.466  Sum_probs=205.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||+|......  .....+|+|.+.... ......+.+|+.++..++|+|++++++++......++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            3445678999999999999987433  345789999986543 2334578999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          242 VYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                      ||||+++++|.+++...          ..++|..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence            99999999999998642          246899999999999999999995   59999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |+++...............++..|+|||.+.+..++.++||||||+++|||+| |+.||........       .+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~  236 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LKFVID  236 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HHHHhc
Confidence            99986654332211123346789999999988889999999999999999998 9999865443221       112222


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      +.....         +...+..+.+++..||+.+|++|||+.++++.|+.
T Consensus       237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 GGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            221111         11235788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.1e-40  Score=317.30  Aligned_cols=264  Identities=26%  Similarity=0.418  Sum_probs=206.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCC-------------CceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeee
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRT-------------STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL  230 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~-------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  230 (455)
                      .+.+.++||+|+||.||++.....+.             ....+|+|.+.... ....+++.+|++++.+++|||+++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            45567899999999999998864332             23568999987543 23456789999999999999999999


Q ss_pred             eeEecCCeEEEEEEeCCCCCHHHHhcCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEE
Q 037780          231 GFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL  299 (455)
Q Consensus       231 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  299 (455)
                      +++..++..++|+||+++++|.+++....           .+++..++.++.|++.||+|||+   .+++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhcee
Confidence            99999999999999999999999997654           68999999999999999999995   49999999999999


Q ss_pred             EcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh--CCCCCCccccchh
Q 037780          300 LDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEY  377 (455)
Q Consensus       300 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~~  377 (455)
                      ++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence            99999999999999986544332222233446789999999988889999999999999999998  677775433211 


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                        ........+..........      .+...+.++.+++.+||+.+|++|||+.+|++.|+.
T Consensus       242 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 --VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              1122222211111111111      111234689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.6e-41  Score=325.66  Aligned_cols=243  Identities=23%  Similarity=0.261  Sum_probs=197.1

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||+|+||.||++...   ..+..+|+|.+....   ......+..|+.++..++||||+++.+++...+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            36899999999999876   356789999986432   223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|+|..++.....+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++........  .
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~  153 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M  153 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence            9999999998888899999999999999999999941  48999999999999999999999999998754322211  1


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+...       .....+...          .+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-------~~i~~~~~~----------~p  216 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEIR----------FP  216 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-------HHHhcCCCC----------CC
Confidence            3346999999999999989999999999999999999999999754432111       111111110          11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      ......+.+++..||+.||++|+     ++.++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            12345788999999999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=320.13  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=205.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      ...+.+.||+|+||.||++.....  ......+|+|.++... ....+.+.+|+.+++++ +|+||+++++++...+..+
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            445668899999999999986422  2345679999886543 22345689999999999 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          241 LVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      +|+||+++|+|.+++....  .+++.++..++.+++.||+|||+   .+++|+||||+||+++.++.+|++|||+++...
T Consensus       116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            9999999999999997543  38999999999999999999995   499999999999999999999999999998665


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.||........      .......+...   
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~---  263 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGYRM---  263 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcCCcC---
Confidence            4332222223346788999999998899999999999999999998 9999875443211      11111111100   


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                            ..+......+.+++..||+.+|++|||+.++++.|+++
T Consensus       264 ------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 ------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  01112346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.2e-41  Score=321.46  Aligned_cols=267  Identities=25%  Similarity=0.397  Sum_probs=210.1

Q ss_pred             HHHHHHhhhhhcCcCCCccEEEEEEec----cCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEe
Q 037780          161 LEEATDNFKEEAGRGSFGIVYKGVIET----TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD  234 (455)
Q Consensus       161 l~~~t~~f~~~lG~G~fg~Vy~~~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  234 (455)
                      +....+.+.+.||+|+||.||++....    .......+|+|.+.... .....++.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            334455667889999999999998642    22345679999986432 23456789999999999 8999999999999


Q ss_pred             cCCeEEEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 037780          235 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI  298 (455)
Q Consensus       235 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  298 (455)
                      .....++||||+++++|.+++...                ..++|.++..++.|+++||.|||+   .+++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence            999999999999999999998653                246888999999999999999995   4999999999999


Q ss_pred             EEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchh
Q 037780          299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  377 (455)
Q Consensus       299 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~  377 (455)
                      ++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+ 
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-  247 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-  247 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence            999999999999999987654332222223346778999999988889999999999999999998 788886443221 


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCCC
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV  446 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~~  446 (455)
                            .......+...         ..+...+..+.+++..||+.+|++|||+.+|++.|+++..+..
T Consensus       248 ------~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         248 ------LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence                  11112222111         0112345778899999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-40  Score=314.23  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=198.4

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecC------CeE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QNR  239 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~  239 (455)
                      +.+.||+|+||.||+|.+..+. ....+|+|.++..  .....+.+..|+.+++.++|+||+++++++...      ...
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             cccccCcccCceEEEeEEccCC-CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4578999999999999986442 2346899987643  233456789999999999999999999987432      246


Q ss_pred             EEEEEeCCCCCHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          240 LLVYEFLNNGTLASFLFG------NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ++++||+++|+|.+++..      ...+++.....++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999998742      2457899999999999999999995   4999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.......       ....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCC
Confidence            987654332111122335778999999999899999999999999999999 888886533211       122222222


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ...         .....+..+.+++..||+.+|++|||+.++++.|+.+
T Consensus       232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111         1112456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-40  Score=323.01  Aligned_cols=242  Identities=23%  Similarity=0.348  Sum_probs=196.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||+|...   ..+..+|+|.+....   ......+..|..++..+ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELK---GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence            36999999999999986   346789999986532   23345577888888866 799999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|..++.....+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--  152 (321)
T cd05591          78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--  152 (321)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence            9999999999888889999999999999999999995   49999999999999999999999999998754322221  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||........       ...+..+..   .       .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~~---~-------~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDDV---L-------Y  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC---C-------C
Confidence            1345689999999999988999999999999999999999999976543221       111111111   0       1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRP-------TMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RP-------t~~~v~~  436 (455)
                      +......+.+++..||+.+|++||       ++.++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            111346788999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-40  Score=315.43  Aligned_cols=260  Identities=26%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCC-ceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTS-TTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.+.||+|+||+||+|.+..++.. ...||+|.+.... .....++.+|+.++..++|+|++++++++... ..++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence            44567899999999999987643322 2358999986432 33456789999999999999999999999754 577999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++... ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.......
T Consensus        88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            999999999999764 568999999999999999999995   5999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |..||+......   +.    ..+..+....      
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~------  231 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP----DLLEKGERLP------  231 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCcCC------
Confidence            211122235678999999998899999999999999999998 999986543221   11    1111211110      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                         .+...+..+.+++..||+.||++||++.++++.|+.+...+
T Consensus       232 ---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 ---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence               11124567889999999999999999999999998765533

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.4e-40  Score=311.41  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=194.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|+||.||+|...++ .....+++|++..... .....+.+|+.++++++|||++++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCC-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            3699999999999987643 3456799998865432 2345789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          249 GTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       249 gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+|.+++...     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++++||+|||+++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            9999998643     245788888999999999999995   59999999999999999999999999999765433322


Q ss_pred             cccccccccCcccccccccCC-------CCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-------TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      .......++..|+|||++...       .++.++||||||+++|||++ |+.||......+..       .....+....
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~  229 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-------TYTVREQQLK  229 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-------HHHhhcccCC
Confidence            222234578889999988642       35789999999999999997 99999654332110       0001111112


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      ...+.+..    ...+.+.+++..|+ .+|++|||+.+|+..|+
T Consensus       230 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22222211    12456778888998 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-40  Score=316.10  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=199.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||+|.+....  .....+++|...... ......|..|+.++++++|+||+++++++.+....++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            34578999999999999987411  145779999886443 233456999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeeccC
Q 037780          244 EFLNNGTLASFLFGNL-------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDFGL  313 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~  313 (455)
                      ||+++++|.+++....       .++|..++.++.||+.||+|||+   .+++|+||||+||+++.++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999986542       57999999999999999999995   4899999999999998654   599999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ++................+..|+|||++.+..++.++|||||||++|||++ |+.||.....+..       ...+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~  238 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------MEFVTGGG  238 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHcCC
Confidence            987643222111112223568999999998899999999999999999997 9999875443221       11111110


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                               ....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       239 ---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 ---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                     01112234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=311.61  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=199.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.+.||+|+||.||+|...    ....+|+|.+.... .....|.+|+.++++++|+|++++++++...+..++|+||
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             cchhhhhccCCCceEEEeEec----CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            457789999999999999875    34568999876432 2356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++..+..|+.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999753 568999999999999999999995   489999999999999999999999999998664322211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      . ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ......+..         .
T Consensus       158 ~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~---------~  220 (256)
T cd05059         158 S-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSAGYR---------L  220 (256)
T ss_pred             c-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHcCCc---------C
Confidence            1 12224568999999998899999999999999999999 8999875433211       111111110         0


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            111124668999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-41  Score=328.34  Aligned_cols=271  Identities=23%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC-----CeE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR  239 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  239 (455)
                      .+.+.||+|+||.||+|...   .++..||||++....  ......+.+|+.++++++||||+++++++...     ...
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDT---HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             EEEEEEeecCCeEEEEEEEC---CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            45678999999999999976   356789999986432  22345688999999999999999999988543     247


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++||||+. ++|.+++.....+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            99999995 6899999888889999999999999999999995   4999999999999999999999999999986543


Q ss_pred             CCCc-cccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH--------HHHHHh
Q 037780          320 NQSK-TIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCY  388 (455)
Q Consensus       320 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~  388 (455)
                      .... .......||+.|+|||++.+  ..++.++|||||||++|||+||+.||.............        .....+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2221 11134568999999999876  578999999999999999999999997544311100000        000000


Q ss_pred             hcCcccccccc---ccccC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcCcCC
Q 037780          389 RNGKLDDLVEG---DMEAM---NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGVVEV  444 (455)
Q Consensus       389 ~~~~~~~~~~~---~l~~~---~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~~~~  444 (455)
                      ...........   .....   ........+.+++..||+.+|++|||+.++++.  +.++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence            00000000000   00000   000123567899999999999999999999853  5444433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.4e-41  Score=318.55  Aligned_cols=262  Identities=21%  Similarity=0.285  Sum_probs=196.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||.|+||+||+|...   .++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSK---LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEEC---CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            445678999999999999876   346789999886432 2234568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++ +|.+++... ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++........
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            9975 898888654 457899999999999999999995   59999999999999999999999999999765432211


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH-----HHhh----cCcc
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----DCYR----NGKL  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~----~~~~  393 (455)
                        .....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||......+.........     ..+.    ....
T Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         160 --YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             --ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence              133458999999998865 568999999999999999999999997654422211110000     0000    0001


Q ss_pred             ccccccccccCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMN----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....+......    ......+..+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111111100000    0112456789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-40  Score=309.28  Aligned_cols=250  Identities=27%  Similarity=0.422  Sum_probs=198.6

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      +||+|+||.||+|.+.... .+..||+|.+..... ...+.+.+|+.++++++|+||+++++++. .+..++|+||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCC-CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            4899999999999876432 456799999865432 23456999999999999999999999885 45789999999999


Q ss_pred             CHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc-cc
Q 037780          250 TLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KT  327 (455)
Q Consensus       250 sL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  327 (455)
                      +|.+++.. ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.......... ..
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99999975 4578999999999999999999995   4999999999999999999999999999986543322111 12


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...++..|+|||++.+..++.++||||||+++||+++ |+.||.......       +...+..+...         ..+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CCC
Confidence            2224678999999988889999999999999999996 999997544321       11122222111         112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ..++..+.+++..||+.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            23467888999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-40  Score=329.83  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=195.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||+|...   ..+..+|+|++....   ......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKV---DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             eEEEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            34578999999999999876   356789999986432   223456899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC-
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  322 (455)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++.+..... 
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999995   5999999999999999999999999999864321100 


Q ss_pred             --------------------------------------------ccccccccccCcccccccccCCCCCCCCCeecHHHH
Q 037780          323 --------------------------------------------KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVL  358 (455)
Q Consensus       323 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~  358 (455)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999998889999999999999


Q ss_pred             HHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHh--cccCCCCCCCCHHHHHH
Q 037780          359 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW--CIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       359 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~--cl~~~p~~RPt~~~v~~  436 (455)
                      +|||++|+.||......+..      .........       +...........+.+++.+  |+..+|..||++.+++.
T Consensus       238 l~elltG~~Pf~~~~~~~~~------~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ------LKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH------HHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            99999999999765432211      011100000       0000011123455666655  66777888999999986


Q ss_pred             H
Q 037780          437 M  437 (455)
Q Consensus       437 ~  437 (455)
                      .
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=294.11  Aligned_cols=260  Identities=25%  Similarity=0.279  Sum_probs=210.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC-----eE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~  239 (455)
                      ++.+.++||+|||+-||.+..-   .++..+|+|++.....++.+..++|++.-++++|||++++++++..+.     +.
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~---s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGL---STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             eEEEeeeecCCCceeeeeeccc---CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            4556789999999999999854   456789999998777778888999999999999999999999875433     48


Q ss_pred             EEEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ||+++|...|||.+.+..    +..+++.+.++|+.+|++||.+||+. .++++||||||.|||+.+++.+++.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999864    35789999999999999999999976 4569999999999999999999999999988


Q ss_pred             cccCCCCc-------cccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH
Q 037780          316 LLTLNQSK-------TIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  385 (455)
Q Consensus       316 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  385 (455)
                      ...-....       .-......|..|.|||.+.   +...++++|||||||+||+|+-|..||+.....          
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------  247 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------  247 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence            65422111       0112234789999999885   446789999999999999999999999754331          


Q ss_pred             HHhhcCccc-cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          386 DCYRNGKLD-DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       386 ~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                          .+.+. .+..+.+........++.+.+++.+|++.||.+||++.+++..++++.
T Consensus       248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                12222 223333433344447889999999999999999999999999988753

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-40  Score=321.73  Aligned_cols=237  Identities=25%  Similarity=0.362  Sum_probs=193.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||++...   .++..+|+|.+....   ......+..|..++..+ +||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLK---ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEc---CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence            36999999999999976   356789999986431   23345677888888876 699999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++.....+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++........  
T Consensus        78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--  152 (320)
T cd05590          78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--  152 (320)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--
Confidence            9999999999888889999999999999999999995   59999999999999999999999999998754322211  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....+..+...          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~----------~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVV----------Y  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCCC----------C
Confidence            134568999999999998899999999999999999999999997554321       11111121111          1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                      +......+.+++..||+.||.+||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11234678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-40  Score=310.36  Aligned_cols=256  Identities=21%  Similarity=0.331  Sum_probs=205.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||++...   .++..++||.+....   .....++.+|+.+++.++|+||+++++++.+++..++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   79 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI   79 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeec---CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence            3456788999999999999976   356789999875422   2234578999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          242 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +|||+++++|.+++..    ...+++.+++.++.+++.||+|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            9999999999998863    3568999999999999999999995   59999999999999999999999999998876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ......  .....++..|+|||++.+..++.++||||||+++|+|++|..||.....+..    ... .......     
T Consensus       157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~-~~~~~~~-----  224 (267)
T cd08229         157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLC-KKIEQCD-----  224 (267)
T ss_pred             ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH----HHh-hhhhcCC-----
Confidence            533221  1334588999999999888899999999999999999999999864332111    111 1111111     


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      .+   ..........+.+++..||+.+|++||||.+|.++++++
T Consensus       225 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 YP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            01   111123566889999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-40  Score=315.94  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=206.9

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccC-CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNR  239 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~  239 (455)
                      ...+.+.+.||+|+||.||+|....+. .....|++|++.... ......+.+|+.++++++|+|++++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            344556788999999999999987432 136789999886442 2335668899999999999999999998876 5678


Q ss_pred             EEEEEeCCCCCHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          240 LLVYEFLNNGTLASFLFGN--------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                      ++++||+++++|.+++...        ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998643        457899999999999999999995   49999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||......+   +.    ..+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MA----AYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHc
Confidence            99987654433222223346778999999988889999999999999999999 999997543321   11    11111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      +..         .......+..+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus       235 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 GYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            110         00111235678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=312.32  Aligned_cols=250  Identities=29%  Similarity=0.452  Sum_probs=196.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.||+|+||.||+|.+.+++ ....+++|.+.... ......+.+|+.++.++ +|||++++++++...+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC-CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            36899999999999987442 22457888886432 33456789999999999 89999999999999999999999999


Q ss_pred             CCCHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          248 NGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       248 ~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                      +++|.+++....                .+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence            999999986532                47899999999999999999995   59999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |++.........   .....+..|+|||++....++.++||||||++++||++ |..||.......       .......
T Consensus       157 gl~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~  226 (270)
T cd05047         157 GLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQ  226 (270)
T ss_pred             CCccccchhhhc---cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhC
Confidence            998632211111   11224667999999988889999999999999999997 999996543211       1111111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      +...         .........+.+++..||+.+|.+|||+.+++..|+++.
T Consensus       227 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 GYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1100         011123457889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4e-40  Score=319.81  Aligned_cols=244  Identities=25%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||++...   ..++.+|+|.+....   ....+.+..|+.++.++ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK---KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence            36999999999999986   356789999987532   22345588899999888 699999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|..++.....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  152 (327)
T cd05617          78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T  152 (327)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence            9999999999888889999999999999999999995   4999999999999999999999999999875322211  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||+||||++|+.||.............+...........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------I  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------C
Confidence            134569999999999999999999999999999999999999997543322222222333332222111          1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                      +......+.+++..||+.||.+||++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            11234567899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-40  Score=319.90  Aligned_cols=241  Identities=27%  Similarity=0.335  Sum_probs=192.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcc-cCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||+|....   .+..||+|.+....   ....+.+..|..++.. .+||||+++++++..++..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            369999999999999863   46789999886432   2233445667777765 4899999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++.....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~  152 (316)
T cd05592          78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K  152 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence            9999999999888889999999999999999999995   5999999999999999999999999999986433221  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........       ...+....      +    ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~------~----~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILNDR------P----HF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCC------C----CC
Confidence            1345689999999999988999999999999999999999999975543211       11111110      0    01


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMR-KVS  435 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~-~v~  435 (455)
                      +......+.+++..||+.+|++||++. +++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            112345678899999999999999986 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.2e-40  Score=311.19  Aligned_cols=254  Identities=21%  Similarity=0.288  Sum_probs=202.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||+|...   .++..+|+|++..........+.+|+.++.+++|||++++++.+...+..++|+|
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~---~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNL---HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hcchhheeecCCCeEEEEEEEC---CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            4556789999999999999986   3567899999875544455678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++.++..++.|++.||.|||+   .+|+|+||+|+||+++.++.+||+|||+++........ 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-  162 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence            99999999999877888999999999999999999995   49999999999999999999999999999876432221 


Q ss_pred             ccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                       .....++..|+|||.+.   ...++.++||||||++++||++|+.||..........       .+.....   ..+..
T Consensus       163 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~~  231 (267)
T cd06646         163 -RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPKL  231 (267)
T ss_pred             -cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCCC
Confidence             12345889999999874   3457889999999999999999999986433211100       0000110   01111


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                      .  .....+..+.+++..||+.+|++|||++++++.|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  1112356889999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.1e-40  Score=322.65  Aligned_cols=253  Identities=21%  Similarity=0.233  Sum_probs=199.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.||+|+||.||+++...+...+..+|+|.+....    ....+.+..|+.++.++ +|+||+++++++...+..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            35678999999999999876555567899999986421    22345688899999999 59999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999999888889999999999999999999995   499999999999999999999999999998654332


Q ss_pred             CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ... .....||..|+|||++.+. .++.++|||||||++|||+||+.||.........   ......+...      ++.
T Consensus       160 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~------~~~  229 (332)
T cd05614         160 KER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC------DPP  229 (332)
T ss_pred             CCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC------CCC
Confidence            221 1345699999999999765 4788999999999999999999999754321111   1111111111      011


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                          .+......+.+++..||+.||++||     +++++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                1112346678999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=327.60  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=214.8

Q ss_pred             HHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          160 ALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       160 ~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      |+++......++||.|-||.||.|+++   .-...||||.++... ...++|+.|..+|+.++|||+|+|+|+|......
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWK---kyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeee---ccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            444444445678999999999999998   345679999997653 3467899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          240 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      |+|.|||.+|+|.+||.+.  ..++--..+.++.||+.|+.||.   ..++|||||.++|.|+.++..+||+|||+++++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999999999864  34566677889999999999999   559999999999999999999999999999998


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ..+..... ....-..-|.|||.+.-..++.|+|||+|||+||||.| |..||....-       ..++.++++|     
T Consensus       416 tgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkg-----  482 (1157)
T KOG4278|consen  416 TGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKG-----  482 (1157)
T ss_pred             cCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhcc-----
Confidence            75543221 33345678999999999999999999999999999999 8888864332       2344444443     


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                          .+-..+..|+..+.++++.||+.+|.+||++.|+-+.+|.+.
T Consensus       483 ----yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  483 ----YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ----ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                222335568899999999999999999999999999888754

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-40  Score=318.66  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=201.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-ccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||+|....++ ....+++|.+... .....+.+.+|+.++.++ +||||+++++++......++|+
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCC-CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            345678999999999999987543 2344788887643 233456789999999999 7999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEE
Q 037780          244 EFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR  307 (455)
Q Consensus       244 e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  307 (455)
                      ||+++++|.+++...                ..+++..++.|+.|++.||+|||+   .+++||||||+|||+++++.+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence            999999999999643                247899999999999999999995   5999999999999999999999


Q ss_pred             EeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHH
Q 037780          308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  386 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  386 (455)
                      |+|||++.........   .....+..|+|||++....++.++||||||+++|||++ |+.||.......       ...
T Consensus       160 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~  229 (297)
T cd05089         160 IADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE  229 (297)
T ss_pred             ECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence            9999998643211111   11223567999999988889999999999999999998 999997544321       111


Q ss_pred             HhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       387 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                      ....+...         ..+...+..+.+++..||+.+|.+|||+.++++.|+++.+..
T Consensus       230 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 KLPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111100         111124567889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.4e-40  Score=310.02  Aligned_cols=254  Identities=26%  Similarity=0.482  Sum_probs=197.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEe-cCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~  247 (455)
                      +.||+|+||.||+|.+.+.......+|+|++.... ....+.+.+|+.+++.++|||++++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999987655566789999985432 234567889999999999999999999876 4556789999999


Q ss_pred             CCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc--
Q 037780          248 NGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT--  324 (455)
Q Consensus       248 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--  324 (455)
                      +++|.+++... ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.........  
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999764 456888889999999999999995   499999999999999999999999999998654322111  


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhC-CCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ......++..|+|||.+.+..++.++||||||+++|||++| ..||.......   +.   . ....+...         
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~---~-~~~~~~~~---------  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT---V-YLLQGRRL---------  221 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---H-HHhcCCCC---------
Confidence            11233467789999999888999999999999999999995 55565332211   11   1 11111100         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ..+...+..+.+++..||+.+|++||++.+|++.|+++.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            001123467889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.2e-40  Score=309.16  Aligned_cols=251  Identities=28%  Similarity=0.435  Sum_probs=200.7

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.+.++||+|+||.||+|...    .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec----CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            34667789999999999999875    345699999875432 4567999999999999999999999885 45689999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++++|.+++...  ..+++.++..++.+++.||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999753  4589999999999999999999954   89999999999999999999999999998765432


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ... .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+   .    ...+..+..       
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~-------  221 (260)
T cd05070         157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---V----LEQVERGYR-------  221 (260)
T ss_pred             ccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCCC-------
Confidence            211 122335678999999988889999999999999999999 899986543221   1    111111110       


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                        ...+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 --MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              01122345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-40  Score=311.37  Aligned_cols=258  Identities=24%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||.||+|....++.....+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3456688999999999999986554456689999986532 233467999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++++|.+++... ..+++.+++.|+.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            999999999999764 567999999999999999999995   5999999999999999999999999999987654322


Q ss_pred             ccc-cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          323 KTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       323 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ... .....++..|+|||++.+..++.++||||||++++|+++ |+.||......+   .    ...+.++.  ..    
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~--~~----  228 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V----IKAIEEGY--RL----  228 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H----HHHHhCCC--cC----
Confidence            111 111223568999999998889999999999999999887 999987544321   1    11111110  00    


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                         ......+..+.+++..|++.+|.+||+|.++++.|+++
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 ---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence               11112356788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-41  Score=328.83  Aligned_cols=251  Identities=22%  Similarity=0.277  Sum_probs=202.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||+|...   .++..+|+|++....   ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEEC---CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            45678999999999999986   356789999986432   234567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC--
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ--  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~--  321 (455)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            999999999999888889999999999999999999995   599999999999999999999999999998765433  


Q ss_pred             -------------------------CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch
Q 037780          322 -------------------------SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE  376 (455)
Q Consensus       322 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~  376 (455)
                                               .........||+.|+|||.+.+..++.++|||||||+||||++|+.||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                     0011133468999999999999999999999999999999999999997654321


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT-MRKVSQM  437 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~~v~~~  437 (455)
                      .      ........  ..+..+     .....+..+.+++..|++ +|.+||+ +.++++.
T Consensus       238 ~------~~~i~~~~--~~~~~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         238 T------YNKIINWK--ESLRFP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H------HHHHhccC--CcccCC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1      11111100  000000     011145678889999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-40  Score=320.79  Aligned_cols=262  Identities=28%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccC----CCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecC
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG  236 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~  236 (455)
                      ...+.+.+.||+|+||.||++......    .....+|+|.+.... .....++..|+.++.++ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            345667789999999999999875322    234579999987532 23345688899999999 799999999999999


Q ss_pred             CeEEEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          237 QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      +..++|+||+++|+|.+++...                ..++|.+++.++.|++.||+|||+   .+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            9999999999999999999653                247899999999999999999995   499999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  379 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~  379 (455)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.....++   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            9999999999999986643222111122234578999999988889999999999999999998 888886433221   


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                          .......+....         .+......+.+++..||+.+|++||||.+|++.|+.+.+
T Consensus       251 ----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         251 ----LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ----HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                111122221111         111235688899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-40  Score=328.48  Aligned_cols=256  Identities=20%  Similarity=0.245  Sum_probs=195.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||++...   ..++.||+|...      ...+.+|+.++++++||||+++++++..+...++|+|+
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~---~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDN---KTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEEC---CCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            455688999999999999986   356789999753      23478899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +. ++|..++.....+++..++.|+.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......... 
T Consensus       165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~-  239 (391)
T PHA03212        165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-  239 (391)
T ss_pred             CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc-
Confidence            85 7899998887889999999999999999999995   499999999999999999999999999997543222111 


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch-----hhhhHHHHHHHhhc----------
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRN----------  390 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~----------  390 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.......     ...+. .+......          
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~-~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK-LIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH-HHHHHhcCChhhcCcchh
Confidence            134569999999999999899999999999999999999998875332110     00000 00000000          


Q ss_pred             Ccccccc---------ccccc--cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLV---------EGDME--AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~---------~~~l~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+....         .+...  .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000         00000  0001123567889999999999999999999985

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6e-40  Score=307.63  Aligned_cols=251  Identities=33%  Similarity=0.502  Sum_probs=206.1

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-HHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|+||.||+|........+..+++|.+....... .+.+.+|+..+.+++|+|++++++++......++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46999999999999987442347789999987654333 67899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          249 GTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       249 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|.+++...         ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875         778999999999999999999995   5999999999999999999999999999987765


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.||.......       .......+...    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC----
Confidence            432222234557889999999988889999999999999999999 699997653221       11111211111    


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                           ..+...+..+.+++..||+.+|++|||+.++++.|+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 111223578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=305.12  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc--cCCCCceeeeeeEecCC----eEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDEGQ----NRLL  241 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~~~----~~~l  241 (455)
                      +.+.||+|.||.||+|.++     |..||||++...   +++.+.+|.++...  ++|+||+.+++.-..+.    ..+|
T Consensus       215 L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             EEEEecCccccceeecccc-----CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            4567999999999999997     667999998643   45567777777665  59999999999875544    5789


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE-----DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      |.+|.++|||+|||.. .+++....++++..+|.||+|||.     +.++.|.|||||+.|||+..++...|+|+|||..
T Consensus       287 vTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             eeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            9999999999999977 678899999999999999999995     3477899999999999999999999999999987


Q ss_pred             ccCCCC--ccccccccccCcccccccccCCC----CC--CCCCeecHHHHHHHHHhC----------CCCCCccccchhh
Q 037780          317 LTLNQS--KTIKTAIRGTKGYVAPEWYRKST----IT--AKVDVYSFGVLLLEIISC----------RKSFDIEMGEEYA  378 (455)
Q Consensus       317 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dv~s~Gv~l~el~tg----------~~p~~~~~~~~~~  378 (455)
                      ......  .......+||.+|||||++...-    +.  ..+||||||.++||+...          +.||....+.+..
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            654422  11223467999999999986542    21  258999999999998742          3455433332111


Q ss_pred             hhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      .  +..++.+=..++...+.   ....+.+.+..+.++++.||..||..|.|+-.|.+.|.++.+.
T Consensus       446 ~--eeMrkVVCv~~~RP~ip---nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  446 F--EEMRKVVCVQKLRPNIP---NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             H--HHHhcceeecccCCCCC---cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            0  00011100011111111   1123446788999999999999999999999999999887654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.6e-40  Score=309.64  Aligned_cols=254  Identities=30%  Similarity=0.461  Sum_probs=203.9

Q ss_pred             HHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       161 l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      +...++++.++||+|+||.||+|...    ++..+|+|.+.... ....++.+|+.++++++|+|++++++++. .+..+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC----CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            34567778899999999999999865    45679999987543 34567999999999999999999999874 45689


Q ss_pred             EEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          241 LVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      +++||+++++|.+++...  ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999999999998653  467999999999999999999994   599999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ...... .....++..|+|||++....++.++||||||++++||++ |+.||........       ...+..+...   
T Consensus       154 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~---  222 (260)
T cd05067         154 DNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-------IQNLERGYRM---  222 (260)
T ss_pred             CCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-------HHHHHcCCCC---
Confidence            322211 123346778999999998889999999999999999999 9999975443211       1111111110   


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                            ......+..+.+++.+||+.+|++|||++++.+.|+.
T Consensus       223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  1111235679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-40  Score=319.58  Aligned_cols=256  Identities=29%  Similarity=0.462  Sum_probs=200.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.+.||+|+||.||+|.+..++ ....+++|++.... ......+.+|+.++.++ +|+||+++++++..++..++|
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCC-ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            4456788999999999999986432 23456888775432 33456789999999999 899999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcE
Q 037780          243 YEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA  306 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  306 (455)
                      +||+++++|.+++...                ..+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            9999999999999643                257899999999999999999995   599999999999999999999


Q ss_pred             EEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHH
Q 037780          307 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  385 (455)
Q Consensus       307 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  385 (455)
                      ||+|||+++........   ....++..|+|||++.+..++.++||||||++++||+| |..||......+.       .
T Consensus       164 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~  233 (303)
T cd05088         164 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y  233 (303)
T ss_pred             EeCccccCcccchhhhc---ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-------H
Confidence            99999998643211111   11224668999999988889999999999999999998 9999865433211       1


Q ss_pred             HHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .....+.         ....+...+..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         234 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111110         000111234578899999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.1e-40  Score=322.55  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=191.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ++.++||+|+||.||+|...   .+++.||||.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHR---PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             hhhhhccCCCCeEEEEEEEC---CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            35678999999999999876   3567899999864322 2346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+.    ...++.....|+.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++........  
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--  224 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--  224 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--
Confidence            999998654    345677888999999999999995   49999999999999999999999999999876433211  


Q ss_pred             cccccccCcccccccccCC-----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          326 KTAIRGTKGYVAPEWYRKS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .....||..|+|||.+...     ..+.++|||||||++|||++|+.||..........+.   . .......       
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~-~~~~~~~-------  293 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---C-AICMSQP-------  293 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---H-HHhccCC-------
Confidence            1334689999999987432     2356899999999999999999999743322211111   0 0000000       


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                        ..........+.+++..||+.||++|||+.|+++.
T Consensus       294 --~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 --PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              01112345678999999999999999999999974

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-40  Score=319.09  Aligned_cols=241  Identities=28%  Similarity=0.359  Sum_probs=193.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcc-cCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||+|...   ..+..+|+|.+....   ......+..|..++.. ++||||+++++++.+.+..++||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELK---GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence            36999999999999986   346789999986532   2234456778888876 4899999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++.....+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  152 (316)
T cd05619          78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--  152 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence            9999999999887889999999999999999999995   59999999999999999999999999998753322211  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||......+   +    ...+..+.      +.    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~----~~~i~~~~------~~----~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L----FQSIRMDN------PC----Y  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCC------CC----C
Confidence            134568999999999999899999999999999999999999997544321   1    11111111      00    1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMR-KVS  435 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~-~v~  435 (455)
                      +......+.+++..||+.+|++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            112345678999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-40  Score=311.98  Aligned_cols=248  Identities=25%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ...+.||+|+||+||++...   .++..||+|++....   ......+.+|+.++++++||||+++++.+..++..++||
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEc---CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            34578999999999999876   356789999986432   122345788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999888643  468999999999999999999995   499999999999999999999999999998754322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..   ....|+..|+|||++.+..++.++||||||+++|||++|+.||.........   ..+...+..+.         
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~---------  221 (285)
T cd05605         157 TI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ---------  221 (285)
T ss_pred             cc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc---------
Confidence            21   2346899999999999888999999999999999999999999754432110   11111111111         


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                       ...+...+..+.+++..||+.||.+||     ++.++++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             011223456788999999999999999     7888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-40  Score=315.08  Aligned_cols=265  Identities=25%  Similarity=0.428  Sum_probs=207.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc-CCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT-RTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~  240 (455)
                      ...+.+.||+|+||.||++.+... ...+..+|||.+...... ....|.+|+.++++++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            445668899999999999997633 345788999998755443 46789999999999999999999999877  55789


Q ss_pred             EEEEeCCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      +|+||+++++|.+++.... .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            9999999999999997654 68999999999999999999995   4999999999999999999999999999987763


Q ss_pred             CCCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhh--------hhHHHHHHHhhc
Q 037780          320 NQSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDCYRN  390 (455)
Q Consensus       320 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~~~  390 (455)
                      .... .......++..|+|||.+.+..++.++||||||++++||+||+.|+.........        .........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            3221 1111233566799999998889999999999999999999999998643321100        000111111111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      +         .....+...+..+.+++.+||+.+|++||||.+|+++|+++
T Consensus       242 ~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 G---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             C---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1         11111223457799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-40  Score=315.29  Aligned_cols=260  Identities=28%  Similarity=0.450  Sum_probs=203.5

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ..+.+.+.||+|+||.||+|...+  .......||+|.+..... .....+.+|+..+++++|+|++++++++...+..+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            345567899999999999998753  223456899998864332 23346889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEee
Q 037780          241 LVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD  310 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  310 (455)
                      +||||+++|+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence            999999999999999642          344678889999999999999995   5999999999999999999999999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhh
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..||.....++       ......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~  235 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVM  235 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH
Confidence            999986543332211122235678999999998899999999999999999999 788886543321       111111


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .+....         .+...+..+.+++.+||+.+|++|||+.++++.|.+..
T Consensus       236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            111111         01123568999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=335.80  Aligned_cols=255  Identities=21%  Similarity=0.282  Sum_probs=208.7

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeee-eEec------CCeE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLG-FCDE------GQNR  239 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g-~~~~------~~~~  239 (455)
                      +.+.|.+|||+.||.+.+..   .+..+|+|++-.......+.+.+|+.+|++|+ |+|||.+++ ....      .-+.
T Consensus        41 V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVK---GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEccCCcEEEEEEEecC---CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            44679999999999999873   33889999997777777888999999999996 999999999 3321      1367


Q ss_pred             EEEEEeCCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          240 LLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +|.||||++|+|-+++..  ...|++.++++|+.|+++|+++||.. +++|||||||-+||||+.+++.||||||.+.-.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            899999999999999974  35599999999999999999999976 889999999999999999999999999998743


Q ss_pred             cCCC-C-ccc---cc--cccccCcccccccc---cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH
Q 037780          318 TLNQ-S-KTI---KT--AIRGTKGYVAPEWY---RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       318 ~~~~-~-~~~---~~--~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      .... . ...   ..  ...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+....             
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------  263 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------  263 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------
Confidence            3222 1 110   00  11258999999976   567899999999999999999999999985422             


Q ss_pred             hhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       388 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                            ..+++..........+...+.+||..||+.||.+||++.+|++.+-.+...+
T Consensus       264 ------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                  1244444444444578999999999999999999999999999987766544

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-40  Score=323.07  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=202.4

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecC-Ce
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-QN  238 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~-~~  238 (455)
                      ..+.+.+.||+|+||.||+|....  ....++.||||++.... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            456678899999999999998643  22356789999986533 22345688999999999 689999999988654 46


Q ss_pred             EEEEEEeCCCCCHHHHhcCC------------------------------------------------------------
Q 037780          239 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------  258 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  258 (455)
                      .++|+||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            78999999999999998642                                                            


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccc
Q 037780          259 -------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG  331 (455)
Q Consensus       259 -------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  331 (455)
                             ..++|.++..++.|+++||+|||+   .+|+||||||+||++++++++||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   136788889999999999999995   5999999999999999999999999999987543322221122345


Q ss_pred             cCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHH
Q 037780          332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV  410 (455)
Q Consensus       332 t~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  410 (455)
                      +..|+|||++.+..++.++||||||+++|||++ |..||........      .......+.....         +....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA---------PDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCCC---------CCCCC
Confidence            678999999988899999999999999999997 9999865432111      1111222211111         00123


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          411 EKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       411 ~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ..+.+++..||+.+|++|||+.+|++.|+.+.+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            568899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2e-40  Score=321.49  Aligned_cols=238  Identities=27%  Similarity=0.305  Sum_probs=190.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHH-HHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||+|...   .+++.+|+|.+....   ......+..|.. +++.++||||+++++.+...+..++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence            36899999999999986   456789999986432   122334555554 56789999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|..++.....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T  152 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence            9999999999888889999999999999999999995   4999999999999999999999999999875432221  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+...      +    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~------~----  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-------MYDNILNKPLR------L----  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCCCC------C----
Confidence            234568999999999999999999999999999999999999997543221       11111111110      0    


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMR  432 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~  432 (455)
                      .......+.+++..||+.+|.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            112356788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=312.70  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--------------cHHHHHHHHHHHcccCCCCceeee
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--------------GEKEFKNEVVVIGQTHHKNLVRLL  230 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~l~  230 (455)
                      ++.+.++||+|.||.|-+|+..   .+++.+|||.+.+....              ..+...+||.+|++++|||||+|+
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~---~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDE---VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             heehhhhhcCCccceEEEEeec---CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3556688999999999999987   46789999999653211              125789999999999999999999


Q ss_pred             eeEecC--CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEE
Q 037780          231 GFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI  308 (455)
Q Consensus       231 g~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  308 (455)
                      .+..+.  +..|||+|||..|.+...=-....++..+++.++.++..||.|||.   .+||||||||+|+||+++|++||
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEe
Confidence            998764  5789999999999886544333448999999999999999999995   49999999999999999999999


Q ss_pred             eeccCcccccCCC---CccccccccccCcccccccccCCC----CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhH
Q 037780          309 SDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWYRKST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  381 (455)
Q Consensus       309 ~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~  381 (455)
                      +|||.+.......   .........||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||.....-+     
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-----  326 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-----  326 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-----
Confidence            9999988663221   111123467999999999887642    3568999999999999999999997554321     


Q ss_pred             HHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          382 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                                ....++...+......+..+.+.++++.+|+.||+.|.+..+|....
T Consensus       327 ----------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  327 ----------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ----------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                      11233333343333335678899999999999999999999987654

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.5e-40  Score=313.19  Aligned_cols=264  Identities=24%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc-------------CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeee
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT-------------RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL  230 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~-------------~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  230 (455)
                      .+.+.+.||+|+||.||++.....             ......+|+|.+.... .....+|.+|+.++++++|+|+++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            345678899999999999865421             1234579999987542 33456799999999999999999999


Q ss_pred             eeEecCCeEEEEEEeCCCCCHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEE
Q 037780          231 GFCDEGQNRLLVYEFLNNGTLASFLFGN-----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL  299 (455)
Q Consensus       231 g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  299 (455)
                      +++...+..++||||+++++|.+++...           ..+++.+...++.|++.||+|||+   .+++|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil  162 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence            9999999999999999999999998653           246788999999999999999995   49999999999999


Q ss_pred             EcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh--CCCCCCccccchh
Q 037780          300 LDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS--CRKSFDIEMGEEY  377 (455)
Q Consensus       300 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t--g~~p~~~~~~~~~  377 (455)
                      ++.++.++|+|||+++.+.............++..|+|||....+.++.++||||||+++|||++  |..||......+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999986644332222122334678999999888889999999999999999998  7788865433221


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .   ................      ..+..++..+.+++.+||+.+|.+|||+.+|.+.|+.
T Consensus       243 ~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 I---ENTGEFFRDQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHhhccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   1111111111100000      0111245788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-40  Score=319.77  Aligned_cols=242  Identities=25%  Similarity=0.328  Sum_probs=196.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||++...   .++..+|+|.+....   ......+..|..++..+ +||||+++++++...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELK---GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            36999999999999986   345789999986432   23345677888888887 799999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|..++.....+++.++..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++........  
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  152 (318)
T cd05570          78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--  152 (318)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence            9999999999888889999999999999999999995   59999999999999999999999999998753222211  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ....+.....          ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CC
Confidence            133468999999999999999999999999999999999999997544221       1111111111          01


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTM-----RKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~-----~~v~~  436 (455)
                      +......+.+++..||+.||.+|||+     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11235678899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-40  Score=321.46  Aligned_cols=266  Identities=28%  Similarity=0.417  Sum_probs=208.1

Q ss_pred             HHHHHHHhhhhhcCcCCCccEEEEEEeccC----CCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeE
Q 037780          160 ALEEATDNFKEEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFC  233 (455)
Q Consensus       160 ~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~  233 (455)
                      ++...++.+.+.||+|+||.||++......    .....+|+|.+.... ....+++.+|+.++.++ +||||++++++|
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            344456677889999999999999865322    123478999886432 23356799999999999 899999999999


Q ss_pred             ecCCeEEEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 037780          234 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQN  297 (455)
Q Consensus       234 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  297 (455)
                      ...+..++++||+++|+|.+++...                ..++|.++..++.|++.||+|||+   .+++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  164 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN  164 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence            9999999999999999999998642                247899999999999999999995   599999999999


Q ss_pred             EEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccch
Q 037780          298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  376 (455)
Q Consensus       298 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~  376 (455)
                      |++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....++
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986653322211122334578999999999899999999999999999998 888886543221


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                             ....+..+....         .+...+..+.+++..||+.+|.+|||+.++++.|+.+...
T Consensus       245 -------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         245 -------LFKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             -------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence                   111111111111         1112356788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.2e-40  Score=309.65  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=203.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|....   ++..+|||.+...   .......+.+|+.++++++|||++++++++...+..++|
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            3456789999999999999873   4678999987532   223345689999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          243 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      +||+++++|.+++..    ...+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999988852    3457889999999999999999995   499999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      .....  .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......    ..+. ..+.......   
T Consensus       158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~---  227 (267)
T cd08228         158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC-QKIEQCDYPP---  227 (267)
T ss_pred             chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH-HHHhcCCCCC---
Confidence            43221  123458889999999988889999999999999999999999986443211    1111 1111111111   


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                           .........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 -----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                 11123457789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.7e-40  Score=309.33  Aligned_cols=251  Identities=29%  Similarity=0.448  Sum_probs=200.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.++||+|+||.||+|.+.    +...+|+|++.... ...+.+.+|+.++++++|+|++++++++.+ ...++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~----~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEec----CCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            4567789999999999999875    23459999987532 345679999999999999999999998754 56799999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999753  457999999999999999999995   5999999999999999999999999999986654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. .....++..|+|||+..+..++.++||||||+++|||+| |+.||........       ......+..        
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~~--------  221 (262)
T cd05071         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR--------  221 (262)
T ss_pred             cc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcCCC--------
Confidence            11 123346778999999988899999999999999999999 8888865433211       111111110        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                       .....+.+..+.+++..|++.+|++|||+.+++++|+..
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             011223567789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.5e-40  Score=305.93  Aligned_cols=246  Identities=26%  Similarity=0.404  Sum_probs=197.7

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|+||.||+|...    ++..+|+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEec----CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence            36899999999999864    456899999865432 2345689999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          249 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       249 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      ++|.+++... ..+++..+..++.+++.+|.|||+   .+++|+||||+||++++++.+||+|||++.......... ..
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~  152 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SG  152 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CC
Confidence            9999998654 467899999999999999999995   599999999999999999999999999987544322111 11


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...++..|+|||++.+..++.++||||||+++|++++ |..||.......       .......+...         ..+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~  216 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRM---------SCP  216 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCC
Confidence            2234678999999998899999999999999999998 999986543221       11111111111         111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      ...+..+.+++.+|++.+|++|||+.++++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            124578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-40  Score=326.20  Aligned_cols=202  Identities=24%  Similarity=0.329  Sum_probs=173.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++...   ..++.+|+|.+....   ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKK---DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            34578999999999999876   346789999986432   223356888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++........
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999999999888889999999999999999999995   59999999999999999999999999999765321100


Q ss_pred             ---------------------------------cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCC
Q 037780          324 ---------------------------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       324 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             cccc
Q 037780          371 IEMG  374 (455)
Q Consensus       371 ~~~~  374 (455)
                      ....
T Consensus       238 ~~~~  241 (363)
T cd05628         238 SETP  241 (363)
T ss_pred             CCCH
Confidence            5543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.5e-40  Score=311.96  Aligned_cols=244  Identities=27%  Similarity=0.318  Sum_probs=194.4

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||+|+||+||++...   .+++.+|+|.+.....   ...+.+..|+.++++++|+|++++.+++......++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMR---ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEc---cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence            799999999999876   3567899999864321   2235678899999999999999999999999999999999999


Q ss_pred             CCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          249 GTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       249 gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+|.+++..    ...+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++......... 
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-  153 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-  153 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence            999988743    3568999999999999999999995   49999999999999999999999999999866543322 


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........   .........+.        .  .
T Consensus       154 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~--~  219 (280)
T cd05608         154 -TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS--------V--T  219 (280)
T ss_pred             -ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC--------C--C
Confidence             13456899999999999999999999999999999999999999754331110   00011100010        0  1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      .+...+..+.+++..||+.+|++||     |+.++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1223456788999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.8e-40  Score=310.31  Aligned_cols=242  Identities=24%  Similarity=0.357  Sum_probs=190.6

Q ss_pred             hcCcCCCccEEEEEEeccC---------------------CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceee
Q 037780          171 EAGRGSFGIVYKGVIETTR---------------------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL  229 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~---------------------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  229 (455)
                      .||+|+||.||+|.+..+.                     .....|++|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999874321                     1234689999876544445678999999999999999999


Q ss_pred             eeeEecCCeEEEEEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----
Q 037780          230 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----  304 (455)
Q Consensus       230 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----  304 (455)
                      +++|.+....++||||+++|+|..++.. ...+++..+..++.|+++||+|||+   .+|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999865 4678999999999999999999995   5999999999999997643    


Q ss_pred             ---cEEEeeccCcccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHH-hCCCCCCccccchhhh
Q 037780          305 ---NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAI  379 (455)
Q Consensus       305 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~-tg~~p~~~~~~~~~~~  379 (455)
                         .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+...
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               3899999988644321      12246788999998875 56899999999999999995 6999987544322110


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                             ......  .+         +......+.+++..||+.+|++|||+.+|++.|+
T Consensus       233 -------~~~~~~--~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 -------FYEKKH--RL---------PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -------HHHhcc--CC---------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                   111000  00         0011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4e-40  Score=318.29  Aligned_cols=241  Identities=27%  Similarity=0.335  Sum_probs=193.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||+|...   ..+..+|+|.++...   ......+..|..++... +||||+++++++.+.+..++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELK---GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence            46999999999999987   346789999986532   22344567788888754 899999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|..++.....+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05620          78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R  152 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence            9999999999888889999999999999999999995   5999999999999999999999999999874322111  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ..+.+..+.      +..    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~------~~~----  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDT------PHY----  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------CCC----
Confidence            234568999999999999999999999999999999999999997544321       111111111      001    


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMR-KVS  435 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~-~v~  435 (455)
                      +......+.+++..||+.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            111345678899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-40  Score=337.93  Aligned_cols=251  Identities=25%  Similarity=0.311  Sum_probs=200.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCC-----
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----  237 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----  237 (455)
                      .+.+.+.||+|+||+||++...   .+++.||||.+...  .......+.+|+..+..++|+|++++...+...+     
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRV---SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEc---CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            4556788999999999999876   35678999998643  2334456889999999999999999988765432     


Q ss_pred             ---eEEEEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEee
Q 037780          238 ---NRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD  310 (455)
Q Consensus       238 ---~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  310 (455)
                         ..++||||+++|+|.+++..    ...+++.....|+.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999864    2568899999999999999999995   5999999999999999999999999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      ||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||......+      .... ...
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~-~~~  259 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHK-TLA  259 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHH-Hhc
Confidence            999987654433333345679999999999999999999999999999999999999997543211      1111 111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      +....         .+...+..+.+++..||+.+|.+||++.++++.
T Consensus       260 ~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            21111         112345678999999999999999999998763

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.2e-40  Score=307.00  Aligned_cols=247  Identities=26%  Similarity=0.358  Sum_probs=202.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|++|.||++...   .++..+++|.+...  .......+.+|+.++++++|||++++++++.+.+..++|+|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRK---ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEc---CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            35578999999999999987   34678999987532  23445679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+   .+++|+||||+||++++++.++|+|||+++.......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999999764  578899999999999999999995   5999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....|+..|+|||++.+..++.++||||||++++||++|+.||.......       .......+....+      
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------  221 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVFPPV------  221 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCC------
Confidence            2  133458899999999999999999999999999999999999997554211       1111111211111      


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                         .......+.+++.+||+.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               11345678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4e-40  Score=319.54  Aligned_cols=240  Identities=26%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCC-CceeeeeeEecCCeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHK-NLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.||+|+||.||+|....   .++.+|+|.+....   ....+.+..|..++..++|+ +|+++.+++.+.+..++|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            456789999999999999763   45789999986432   23445688899999999765 588899999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999999888889999999999999999999995   4999999999999999999999999999875322211


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                        ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.       ...+.....         
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~---------  218 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNV---------  218 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence              11345689999999999999999999999999999999999999975443211       111111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                       ..+......+.+++..||+.+|.+||+.
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             0111234678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-40  Score=326.03  Aligned_cols=251  Identities=20%  Similarity=0.260  Sum_probs=197.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||++...   ..+..+|+|.+....   ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3455678999999999999986   356789999986421   2234457899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++... .++......++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999998654 57888888999999999999995   599999999999999999999999999998654332


Q ss_pred             CccccccccccCcccccccccCC----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ... .....||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.......       ....+..+.. .  
T Consensus       197 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~-~--  265 (370)
T cd05596         197 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-------TYSKIMDHKN-S--  265 (370)
T ss_pred             ccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-------HHHHHHcCCC-c--
Confidence            211 1345699999999998653    47889999999999999999999997544321       1111111110 0  


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSL--RPTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~~v~~  436 (455)
                         +........+..+.+++..||+.+|.+  |||+.++++
T Consensus       266 ---~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 ---LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ---CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence               001111124567889999999999987  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.7e-40  Score=310.44  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=192.9

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||+|+||.||++...   ..+..+|+|.+....   ......+..|++++.+++||||+++.+++..+...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVK---NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEc---cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence            799999999999987   356789999986422   12234567799999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          249 GTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       249 gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|.+++...  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---  151 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---  151 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---
Confidence            9999888643  457899999999999999999995   59999999999999999999999999998866533221   


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||........  ......... .....    .     ..
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~----~-----~~  219 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDEVK----F-----EH  219 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-ccccc----c-----cc
Confidence            234589999999999988899999999999999999999999975432111  011111111 11110    0     01


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ......+.+++..||+.||++||++.|+++
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            123567899999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-39  Score=306.33  Aligned_cols=243  Identities=25%  Similarity=0.376  Sum_probs=192.1

Q ss_pred             hhcCcCCCccEEEEEEeccC---------CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          170 EEAGRGSFGIVYKGVIETTR---------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      +.||+|+||.||+|....+.         .....|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999864321         123468899887655555567899999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc-------EEEeecc
Q 037780          241 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN-------ARISDFG  312 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~Dfg  312 (455)
                      +||||+++++|..++... ..+++..++.|+.|+++||+|||+   .+|+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998753 568999999999999999999994   59999999999999987664       8999999


Q ss_pred             CcccccCCCCccccccccccCccccccccc-CCCCCCCCCeecHHHHHHHHH-hCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      ++......      ....++..|+|||++. +..++.++||||||+++|||+ +|+.|+......+..       .. ..
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~-~~  223 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RF-YE  223 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HH-Hh
Confidence            98755322      2234788999999887 456899999999999999998 588887643322111       00 11


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      +... ..         ......+.+++..||+.+|.+||++.+|++.|+
T Consensus       224 ~~~~-~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQCM-LV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCcc-CC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1110 10         112457889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-40  Score=307.28  Aligned_cols=247  Identities=29%  Similarity=0.433  Sum_probs=203.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...+.+.||.|+||.||+|...     +..+++|.+..... ..+++.+|+.++++++|+|++++++++...+..++|+|
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            4456788999999999999864     56799999976543 46789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||.++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            999999999997654  78999999999999999999995   4999999999999999999999999999987632221


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                           ....+..|+|||++....++.++||||||++++|+++ |+.||.......       .......+....      
T Consensus       158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------  219 (256)
T cd05039         158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRME------  219 (256)
T ss_pred             -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC------
Confidence                 2235678999999988889999999999999999998 999986543221       111111111111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                         .+...+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 ---APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               1112357788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=326.76  Aligned_cols=250  Identities=20%  Similarity=0.253  Sum_probs=196.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++...   ..++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             eEEEEEEecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            34578999999999999987   346789999986432   223456888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            999999999999888889999999999999999999995   49999999999999999999999999998764322110


Q ss_pred             c------------------------------------ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCC
Q 037780          324 T------------------------------------IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRK  367 (455)
Q Consensus       324 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~  367 (455)
                      .                                    ......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence            0                                    0012458999999999999899999999999999999999999


Q ss_pred             CCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 037780          368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT---MRKVSQ  436 (455)
Q Consensus       368 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt---~~~v~~  436 (455)
                      ||......+.      .........  .+..     .........+.+++..|+. +|.+|++   +.++++
T Consensus       238 Pf~~~~~~~~------~~~i~~~~~--~~~~-----~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         238 PFCSDNPQET------YRKIINWKE--TLQF-----PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCHHHH------HHHHHcCCC--ccCC-----CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9975543211      111111000  0000     0111234567788888886 9999998   888766

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.3e-40  Score=315.95  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=203.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc----CCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT----RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  238 (455)
                      ...+.+.||+|+||.||++.....    ......+|+|.+.... .....++.+|+.++.++ +||||+++++++.....
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            445678899999999999986421    1245678999886432 23345688999999999 69999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 037780          239 RLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD  302 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  302 (455)
                      .++|+||+++|+|.+++...                ..++|.+...++.|++.||.|||+   .+++||||||+||++++
T Consensus        93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~  169 (314)
T cd05099          93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTE  169 (314)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcC
Confidence            99999999999999999643                347899999999999999999995   49999999999999999


Q ss_pred             CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhH
Q 037780          303 HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT  381 (455)
Q Consensus       303 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~  381 (455)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+     
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----  244 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-----  244 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999987653322211122234567999999998899999999999999999999 888886543221     


Q ss_pred             HHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          382 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                        .......+....         .+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       245 --~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 --LFKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             --HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence              111222221111         11223567889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-40  Score=311.89  Aligned_cols=266  Identities=26%  Similarity=0.377  Sum_probs=204.7

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNR  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  239 (455)
                      .++...+.||+|+||.||++.... ....+..+|+|.+.... ......+.+|+.++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            445566789999999999998642 23457789999986443 33346799999999999999999999998775  568


Q ss_pred             EEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          240 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++||||+++++|.+++... ..++|..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            8999999999999999664 468999999999999999999995   499999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch--------hhhhHHHHHHHhh
Q 037780          319 LNQSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--------YAILTDWAFDCYR  389 (455)
Q Consensus       319 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~  389 (455)
                      ..... .......++..|+|||++.+..++.++||||||+++|||+|++.|........        .............
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            43221 11123456778999999988889999999999999999999887653221100        0000011111111


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      .+...         ......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       241 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11110         11122467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.4e-40  Score=314.22  Aligned_cols=247  Identities=20%  Similarity=0.305  Sum_probs=201.6

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ...||+|+||.||+++-+   ..+..+|+|++.+..   ....+..+.|-.+|...++|.||+|+-.|.+.+.+||||||
T Consensus       146 Lk~IgkGAfGeVrLarKk---~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy  222 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKK---DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY  222 (550)
T ss_pred             heeeccccceeEEEEEEc---cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence            357999999999999987   457889999997653   23456688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC-----
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-----  320 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-----  320 (455)
                      ++||++..+|.....|++......+.+++-|+.-||+   .|+|||||||+|+|||..|++||+||||+.-+...     
T Consensus       223 lPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  223 LPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             cCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence            9999999999999999999999999999999999995   49999999999999999999999999998643210     


Q ss_pred             ------------------CCc----------------------cccccccccCcccccccccCCCCCCCCCeecHHHHHH
Q 037780          321 ------------------QSK----------------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLL  360 (455)
Q Consensus       321 ------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~  360 (455)
                                        ...                      ......+|||-|+|||++.+..|+..+|.||+||++|
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy  379 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY  379 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence                              000                      0012346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCccccc-hhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 037780          361 EIISCRKSFDIEMGE-EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT---MRKVSQ  436 (455)
Q Consensus       361 el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt---~~~v~~  436 (455)
                      ||+.|.+||....+. ....+..|-...              .........++..+++..|+. ||.+|.-   ++||.+
T Consensus       380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l--------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  380 EMLVGYPPFCSETPQETYRKIVNWRETL--------------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhhhc--------------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            999999999988773 333444332211              111122334788899999998 9999965   555554

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=329.01  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=213.7

Q ss_pred             hhhcCcCCCccEEEEEEeccC-CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .++||+|+||+||||.+.-.+ .-..+||+|.+.... .+...++.+|+-+|.+++||||++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            467999999999999986332 334679999986543 445678999999999999999999999998876 78999999


Q ss_pred             CCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          247 NNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       247 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +.|+|.+|++.+ ..+.-...+.|..|||+|+.|||++   .++||||.++|||+.+...+||.|||+++.+..+.....
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence            999999999765 5678888999999999999999955   999999999999999999999999999999887765544


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                      .....-.+-|||-|.+....++.++|||||||++||++| |..|++....++.                .+++....+..
T Consensus       857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~geRLs  920 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKGERLS  920 (1177)
T ss_pred             ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhccccCC
Confidence            344445678999999999999999999999999999999 9999986655432                22333333344


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+..+...+..++..||..|+..||+++++...+..+..
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            556688899999999999999999999999988776544

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-40  Score=313.52  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=202.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++.....  +..+..+|+|.+.... .....++.+|+.++++++|||++++++++..+...++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            44557899999999999987531  2356789999986543 23346799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          243 YEFLNNGTLASFLFGN----------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      +||+++++|.+++...                      ..+++..++.++.|++.||+|||+   .+++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEe
Confidence            9999999999998632                      246788999999999999999995   499999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  379 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~  379 (455)
                      ++++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.....++   
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~---  240 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---  240 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999886543322111122234678999999988899999999999999999998 888886443321   


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                          ....+..+....         .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 ----~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ----VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                111222222211         111235678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-39  Score=307.42  Aligned_cols=254  Identities=28%  Similarity=0.401  Sum_probs=192.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ++||+|+||.||+|..... .....+++|.+.... ......|.+|+..++.++|+||+++++.+......++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            3699999999999986543 345678999876432 22345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          249 GTLASFLFGNL-----KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       249 gsL~~~l~~~~-----~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+|.+++....     ..++.....++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999997542     34678889999999999999995   49999999999999999999999999998754333221


Q ss_pred             cccccccccCcccccccccC-------CCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      .......++..|+|||++..       ..++.++||||||+++|||++ |..||......+      ........+ ...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~  229 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIK  229 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-Ccc
Confidence            11122345778999998743       356889999999999999999 788886543221      011111111 111


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      +..+..    .......+.+++..|+ .+|++|||+.+|++.|.
T Consensus       230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222211    1224466677888888 49999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.2e-40  Score=320.34  Aligned_cols=241  Identities=26%  Similarity=0.280  Sum_probs=191.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHH-HHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||++...   .++..+|+|.+....   ......+..|.. +++.++||||+++++.+...+..++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK---LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence            46999999999999876   456789999986431   222344555554 56779999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|..++.....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......  .
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  152 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T  152 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence            9999999999888889999999999999999999995   5999999999999999999999999999875332211  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .. .....+...  .        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~-~~~~~~~~~--~--------  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MY-DNILHKPLV--L--------  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HH-HHHHcCCcc--C--------
Confidence            134568999999999999999999999999999999999999997543221      11 111111110  0        


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                      .......+.+++..|++.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            011345678899999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=303.54  Aligned_cols=258  Identities=25%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec-----CCeEEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQNRLL  241 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-----~~~~~l  241 (455)
                      .+.||+|++|.|+.+....   ++..||||++....  ....++..+|+++|++++|+||+.+++.+.-     -+..|+
T Consensus        27 ~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi  103 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL  103 (359)
T ss_pred             cccccCcceeeEEEEEEcC---CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence            4679999999999999884   45889999997443  3345678899999999999999999998754     457899


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+|+| ..+|...++.+..++.....-++.|+++||.|+|   +.+++||||||+|+|++.+..+||+|||+|+......
T Consensus       104 V~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  104 VFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             ehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999 6699999999888999999999999999999999   6699999999999999999999999999999886543


Q ss_pred             CccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH-----------------H
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD-----------------W  383 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~-----------------~  383 (455)
                      .....+..+.|.+|.|||.+.. ..|+.+.||||.||++.||++|++-|.+...-.+..+..                 .
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            3344467789999999998754 579999999999999999999999997655422211111                 1


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ++..+..-.  ...........+ ......++++.++|..||.+|+|++|.++
T Consensus       260 ar~yi~slp--~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  260 ARPYIKSLP--QIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhCC--CCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111111100  000000000011 22346788999999999999999999885

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-41  Score=289.85  Aligned_cols=243  Identities=26%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +..+.||+|-||.||.|+.+   .+.-.||+|++.+..   .+...++.+|+++-+.++||||+++++++.+....||++
T Consensus        25 eigr~LgkgkFG~vYlarek---ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREK---KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             cccccccCCccccEeEeeec---cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            45688999999999999987   456789999986542   234577999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||.++|+|...|+  ....+++.....++.|+|.||.|+|   .++++||||||+|+|++..+..||+|||.+...+...
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k  178 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK  178 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence            9999999999999  5577899999999999999999999   6699999999999999999999999999987654211


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                          ....+||.-|++||...+..++.++|+|++|++.+|++.|.+||+.....+       ..+.+.+-+   +     
T Consensus       179 ----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~~---~-----  239 (281)
T KOG0580|consen  179 ----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKVD---L-----  239 (281)
T ss_pred             ----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHcc---c-----
Confidence                245779999999999999999999999999999999999999998665321       111111111   1     


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        ..+........+++..|+..+|.+|.+..+|+.
T Consensus       240 --~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 --KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence              112345677889999999999999999999875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.6e-40  Score=318.36  Aligned_cols=240  Identities=25%  Similarity=0.321  Sum_probs=193.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.||+|+||.||+|...   ..+..+|+|.+....   ......+..|..++..+ +|++++++.+++...+..++|
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            45678999999999999986   346789999986532   22334567788888777 588999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++.++..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999999999888889999999999999999999995   4999999999999999999999999999975432221


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....||+.|+|||++.+..++.++|||||||++|||+||+.||.......   +    ...+.....         
T Consensus       157 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~----~~~i~~~~~---------  218 (323)
T cd05616         157 T--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHNV---------  218 (323)
T ss_pred             c--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCC---------
Confidence            1  134568999999999999999999999999999999999999997544321   1    111111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                       ..+......+.+++..||+.+|.+|++.
T Consensus       219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             1112235678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7e-40  Score=312.72  Aligned_cols=259  Identities=24%  Similarity=0.327  Sum_probs=191.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHccc---CCCCceeeeeeEe-----c
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT---HHKNLVRLLGFCD-----E  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~-----~  235 (455)
                      +.+.+.||+|+||.||+|....+  .+..+|+|++....  ......+.+|+.++.++   +||||++++++|.     .
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            45667899999999999987432  35789999886432  22234566777776665   6999999999985     3


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ....++|+||++ ++|.+++...  ..+++.++..|+.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            446899999996 6899988653  457999999999999999999995   4999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh---c
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---N  390 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~  390 (455)
                      ++......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..   ........   .
T Consensus       157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~  230 (290)
T cd07862         157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE  230 (290)
T ss_pred             eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCCh
Confidence            98654332   123456899999999998889999999999999999999999999865442211   11111100   0


Q ss_pred             Cccc-------ccccccccc---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLD-------DLVEGDMEA---MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~-------~~~~~~l~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....       .........   .........+.+++.+||+.+|++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000       000000000   000123456789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=326.61  Aligned_cols=251  Identities=22%  Similarity=0.245  Sum_probs=194.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++...   .++..+|+|.+....   ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKK---DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             eEeEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            34578999999999999876   356789999985432   223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999999999888889999999999999999999995   59999999999999999999999999999643211000


Q ss_pred             ---------------------------------------------cccccccccCcccccccccCCCCCCCCCeecHHHH
Q 037780          324 ---------------------------------------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVL  358 (455)
Q Consensus       324 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~  358 (455)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                         00012459999999999999899999999999999


Q ss_pred             HHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHH
Q 037780          359 LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLR---PTMRKVS  435 (455)
Q Consensus       359 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R---Pt~~~v~  435 (455)
                      +|||++|+.||......+.      ............+  +     ........+.+++..|++ +|.+|   +|+.+++
T Consensus       238 l~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         238 MFECLIGWPPFCSENSHET------YRKIINWRETLYF--P-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHH------HHHHHccCCccCC--C-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999975443211      1111110000001  0     111234567788888887 66665   5888887


Q ss_pred             HH
Q 037780          436 QM  437 (455)
Q Consensus       436 ~~  437 (455)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.7e-40  Score=319.05  Aligned_cols=243  Identities=25%  Similarity=0.302  Sum_probs=191.6

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHH---cccCCCCceeeeeeEecCCeEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVI---GQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.||+|+||.||+|...   ..++.||||.+....   ....+.+..|+.++   .+++||||+++++++...+..++
T Consensus         3 i~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             EEEEEeecCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            4578999999999999886   356789999986432   22234566666554   56789999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++++|..++.. ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999988854 568999999999999999999995   599999999999999999999999999987533222


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..  .....|++.|+|||.+.+..++.++|||||||++|||++|+.||........      . ..+..+...       
T Consensus       156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~-~~i~~~~~~-------  219 (324)
T cd05589         156 DR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------F-DSIVNDEVR-------  219 (324)
T ss_pred             Cc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhCCCC-------
Confidence            11  1345689999999999998999999999999999999999999975543211      1 111111110       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                         .+...+..+.+++..||+.||.+||+     +.++++
T Consensus       220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               11123567789999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-39  Score=308.37  Aligned_cols=259  Identities=23%  Similarity=0.299  Sum_probs=207.2

Q ss_pred             HHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          162 EEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       162 ~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ....+.+.+.||+|+||+||++...   ..+..+|+|.+.... ....+.+.+|++++..++||||+++++++......+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHI---PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEc---CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            3445677889999999999999876   346789999875432 334567999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||||+++++|.+++.....+++.....++.+++.+|.|||+  ..+++|+||+|+||++++++.++|+|||++......
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999999999999887889999999999999999999995  247999999999999999999999999998754322


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch-----hhhhHHHHHHHhhcCcccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  395 (455)
                      ..    ....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+     ...+..+........    
T Consensus       158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence            11    23468999999999988889999999999999999999999998654321     111112222111110    


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                           .........+..+.+++..||+.+|++|||+.||+++.
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                 00111112456788999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.5e-40  Score=308.23  Aligned_cols=252  Identities=27%  Similarity=0.457  Sum_probs=199.1

Q ss_pred             hhcCcCCCccEEEEEEeccC---CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTR---TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||+|...+..   .....+++|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999876422   234678999886543 23456799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-----cEEEeeccC
Q 037780          246 LNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-----NARISDFGL  313 (455)
Q Consensus       246 ~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~  313 (455)
                      +++++|.+++...       ..+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999642       347899999999999999999995   5899999999999999887     899999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ++...............++..|+|||++.++.++.++||||||+++|||+| |+.||.......   ..    .....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VL----QHVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HH----HHHhcCC
Confidence            986543322211122345788999999999999999999999999999998 999986443211   11    1111111


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ..         ..+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            00         1112345778999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.9e-40  Score=308.73  Aligned_cols=260  Identities=25%  Similarity=0.374  Sum_probs=206.0

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+..+.+.||+|+||.||+|...+.......+++|...... ....+.+.+|+.++++++|||++++++++.. +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            344556788999999999999986543345679999886544 3345679999999999999999999999875 45789


Q ss_pred             EEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+++++|.+++... ..+++.+++.++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999764 458999999999999999999995   59999999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ..... ....++..|+|||.+....++.++||||||++++|+++ |..||......+..       ..+..+....    
T Consensus       161 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~~~----  228 (270)
T cd05056         161 SYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-------GRIENGERLP----  228 (270)
T ss_pred             cceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHcCCcCC----
Confidence            22111 22234568999999988889999999999999999996 99999755432111       1111111110    


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                           .+...+..+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus       229 -----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         229 -----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 112245678999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-39  Score=311.80  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=201.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|...   ..+..+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEEC---CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            344577999999999999875   35678999998765555567799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.. ..+++.++..++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||++.......... 
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-  173 (296)
T cd06654          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-  173 (296)
T ss_pred             cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc-
Confidence            999999999864 457899999999999999999995   499999999999999999999999999988654332211 


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........      .......+ ...+       ..
T Consensus       174 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~~~-------~~  238 (296)
T cd06654         174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TPEL-------QN  238 (296)
T ss_pred             -CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC-CCCC-------CC
Confidence             234588999999999988899999999999999999999999975443211      11111111 0000       11


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      +......+.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            22345678899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.2e-40  Score=318.32  Aligned_cols=241  Identities=27%  Similarity=0.286  Sum_probs=190.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHH-HHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEV-VVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||++...   .++..+|+|.+....   ......+..|. .+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHK---AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEEC---CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence            36999999999999876   346789999986432   12223444444 456788999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.....+++.....++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~  152 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T  152 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence            9999999999888888899999999999999999995   5999999999999999999999999999975432221  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      . .........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~-~~i~~~~~~----------~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------Y-DNILNKPLQ----------L  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------H-HHHHhCCcC----------C
Confidence            2345699999999999999999999999999999999999999975443211      1 111111110          1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                      .......+.+++..||+.+|.+||++.+.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            112356788999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.1e-39  Score=305.54  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=199.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ++..+.||+|+||.||+|...   ..+..+++|.+..........+.+|+.+++.++|||++++++++...+..++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK---ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC---CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            445678999999999999886   34678899998765555567799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|..++.. ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++......... 
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-  159 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-  159 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence            999999998865 4678999999999999999999995   49999999999999999999999999998765432211 


Q ss_pred             ccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                       .....++..|+|||++.     +..++.++|||||||++|||++|+.||........      .... ..+....+.  
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~~~--  229 (282)
T cd06643         160 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKSEPPTLA--  229 (282)
T ss_pred             -cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHH-hhcCCCCCC--
Confidence             13345899999999984     34578899999999999999999999875432111      1111 111111111  


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                           .+...+..+.+++..||+.+|.+|||+.++++.
T Consensus       230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 112235678999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-40  Score=322.22  Aligned_cols=249  Identities=23%  Similarity=0.269  Sum_probs=198.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++...   ..+..+|+|.+....   ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             eEEEEEEeccCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            45678999999999999876   356789999986532   223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++... ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999776 678999999999999999999995   5999999999999999999999999999987654332


Q ss_pred             ccccccccccCccccccccc------CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYR------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      .. .....||+.|+|||++.      ...++.++|||||||++|||++|+.||........      .............
T Consensus       158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~  230 (330)
T cd05601         158 VN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLKF  230 (330)
T ss_pred             ee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccCC
Confidence            21 13346899999999986      45678999999999999999999999975443211      1111111111111


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             .........+.+++..|++ +|.+|||+.+++.
T Consensus       231 -------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 -------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                   1111235667888899998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-39  Score=305.78  Aligned_cols=250  Identities=29%  Similarity=0.440  Sum_probs=199.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.++||+|++|.||++.+..    ...+++|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            45566889999999999998752    3458999876432 34567899999999999999999999875 456789999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..++|..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999999754  357899999999999999999995   4899999999999999999999999999987643322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. .....++..|+|||++.+..++.++||||||+++|||+| |+.||......+   .    ......+...       
T Consensus       158 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~-------  222 (260)
T cd05069         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V----LEQVERGYRM-------  222 (260)
T ss_pred             cc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCC-------
Confidence            11 122346778999999988889999999999999999999 899987543321   1    1111111100       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                        ..+...+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              1112345778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-39  Score=314.11  Aligned_cols=259  Identities=21%  Similarity=0.322  Sum_probs=200.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||.||++....   .+..+|+|.+.... .....++.+|++++.+++||||+++++++..++..++|+||
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            455789999999999998763   45678888876432 22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.....+++..+..++.|+++||.|||+.  .+++|+||||+||+++.++.+||+|||++........   
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---  155 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---  155 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence            99999999998888899999999999999999999952  4899999999999999999999999999876543221   


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc-----------
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD-----------  394 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  394 (455)
                       ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..........   +...........           
T Consensus       156 -~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         156 -NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA---MFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH---hhcCccccccccCCcccccCCCC
Confidence             33468899999999988889999999999999999999999986443211110   000000000000           


Q ss_pred             ---------c----ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          395 ---------D----LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       395 ---------~----~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                               +    +................+.+++.+||+.+|++|||+.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0    000000000001134568899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.8e-39  Score=306.95  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=196.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||.||+|...   ..+..+|+|.+... ......++.+|+.++.+++|||++++++++...+..++|+||
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHL---LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             hheeeeccCCCeEEEEEEEc---CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            45678999999999999876   35678999988643 233346799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|..+    ..+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++........   
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~---  150 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---  150 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc---
Confidence            999999765    346788899999999999999995   4999999999999999999999999999986543221   


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....||..|+|||++.+..++.++||||||+++|+|++|+.||..........................        ..
T Consensus       151 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~  221 (279)
T cd06619         151 -KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--------LP  221 (279)
T ss_pred             -cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC--------CC
Confidence             334689999999999988999999999999999999999999975332111111001111111111110        01


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .......+.+++..||+.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11234578899999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-39  Score=307.28  Aligned_cols=253  Identities=25%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             HHHHHhhh--hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          162 EEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       162 ~~~t~~f~--~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      +.+++++.  ..||+|+||.||+|.+.   .++..+++|.+........+.+.+|+.++++++|+||+++++++..++..
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDL---STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEec---CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            34455554  46999999999999876   34678999998766555667899999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFLFGN-LKP--SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-~~~--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~  315 (455)
                      ++|+||+++++|.+++... ..+  ++..+..++.|++.||+|||+   .+|+||||||+||+++. ++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999999764 444  788899999999999999995   59999999999999986 6799999999987


Q ss_pred             cccCCCCccccccccccCcccccccccCCC--CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ........  .....++..|+|||++.+..  ++.++||||||+++|+|++|+.||.........   .+.....  +. 
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~--~~-  229 (268)
T cd06624         158 RLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMF--KI-  229 (268)
T ss_pred             ecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhh--cc-
Confidence            65432221  12345789999999986643  788999999999999999999998643321110   0000000  00 


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                              ....+....+.+.+++.+||+.+|.+|||+.++++
T Consensus       230 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 --------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                    00112234567889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.3e-40  Score=295.23  Aligned_cols=259  Identities=21%  Similarity=0.220  Sum_probs=197.6

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEe--cCCeEEEEEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLLVYE  244 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e  244 (455)
                      .+.|++|+||.||+|++.   .++..||+|+++-...  .-.-.-.+||.+|.+++|||||.+..+..  +-+..|+|||
T Consensus        81 lnrI~EGtyGiVYRakdk---~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe  157 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDK---KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME  157 (419)
T ss_pred             HhhcccCcceeEEEeccC---CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence            467999999999999987   4568999999964321  11223578999999999999999999875  4457999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+. +|...+..- .++...+..-++.|+++|++|||.   ..|+|||||++|+|++..|.+||+|||+|+.++.....
T Consensus       158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            9977 888888765 478899999999999999999995   49999999999999999999999999999988765332


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc----
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE----  398 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  398 (455)
                        .+..+-|.+|.|||.+.+. .|+++.|+||+||++.||+++++.|.+...-++.+........-.+..+..+..    
T Consensus       234 --~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  234 --YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             --CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence              2566789999999998765 699999999999999999999999987765333222111111111111111110    


Q ss_pred             ----------cccccCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 ----------GDMEAMNDIK-CVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ----------~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                ..++...... ..+.-.+++...+..||.+|.|+.+.++
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                      1111111111 3466788888899999999999999875

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8e-40  Score=324.64  Aligned_cols=202  Identities=24%  Similarity=0.342  Sum_probs=171.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||+|...   ..++.+|+|.+....   ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKV---DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEEC---CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            34578999999999999986   356789999986432   223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC-
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  322 (455)
                      ||+++|+|.+++.....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+..... 
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999999888888999999999999999999995   4999999999999999999999999999753321000 


Q ss_pred             --------------------------------------------ccccccccccCcccccccccCCCCCCCCCeecHHHH
Q 037780          323 --------------------------------------------KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVL  358 (455)
Q Consensus       323 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~  358 (455)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCcccc
Q 037780          359 LLEIISCRKSFDIEMG  374 (455)
Q Consensus       359 l~el~tg~~p~~~~~~  374 (455)
                      ||||++|+.||.....
T Consensus       238 l~elltG~~Pf~~~~~  253 (382)
T cd05625         238 LYEMLVGQPPFLAQTP  253 (382)
T ss_pred             HHHHHhCCCCCCCCCH
Confidence            9999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.7e-40  Score=323.06  Aligned_cols=252  Identities=19%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||++...   ..+..+|+|.+....   ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3445678999999999999987   346789999885421   2234568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++... .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            99999999999998654 57889999999999999999995   599999999999999999999999999998764322


Q ss_pred             CccccccccccCcccccccccCC----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ... .....||+.|+|||++.+.    .++.++|||||||+||||++|+.||........      ..........    
T Consensus       197 ~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~----  265 (370)
T cd05621         197 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKNS----  265 (370)
T ss_pred             cee-cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCcc----
Confidence            211 1345699999999998654    378899999999999999999999975443211      1111111110    


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSL--RPTMRKVSQM  437 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~~v~~~  437 (455)
                         +...........+.+++..|++.++.+  |||+.++++.
T Consensus       266 ---~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 ---LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               111111223566778888888755543  8899998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=323.59  Aligned_cols=239  Identities=26%  Similarity=0.319  Sum_probs=200.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv  242 (455)
                      .|.+.||+|+||+|+++.++.   ++..+|||.+++.   ..+..+..+.|-+++...+ ||.|++++.++...++.++|
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            456789999999999999984   4568888888764   3455677888998888885 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+.||++.. ++....+++..+.-++..|+.||.|||++   +||+||||.+|||||.+|++||+||||++.......
T Consensus       448 mey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            99999999443 34557889999999999999999999965   999999999999999999999999999996543332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                        .+..++||+.|||||++.+..|+.++|.|||||+||||+.|..||...++++...       .        ++..  +
T Consensus       524 --~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------s--------I~~d--~  584 (694)
T KOG0694|consen  524 --RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------S--------IVND--E  584 (694)
T ss_pred             --ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------H--------HhcC--C
Confidence              2367899999999999999999999999999999999999999999777654211       1        1111  1


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                      ..++...+.+.+.++...|..||++|.-+
T Consensus       585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            23455567889999999999999999877

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=307.96  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=205.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCC-CceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRT-STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      ...+.+.||+|+||.||+|....++. ....+|+|.+..... ....++.+|+.++++++|||++++++++.. ...++|
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            34566889999999999999865432 234689998865432 344678999999999999999999999987 788999


Q ss_pred             EEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +||+++|+|.+++... ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++......
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            9999999999999764 568999999999999999999995   599999999999999999999999999998765433


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .........++..|+|||.+....++.++||||||++++|+++ |+.||.....++       ....+..+...      
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~------  230 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL------  230 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC------
Confidence            2221122234678999999988889999999999999999999 999997544321       11111121110      


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                         ..+..+...+.+++..||..+|.+|||+.++++.|+.+..
T Consensus       231 ---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 ---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               0111133567899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-39  Score=312.85  Aligned_cols=260  Identities=21%  Similarity=0.264  Sum_probs=193.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|...   .++..+|+|.+..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSK---VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEEC---CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            455688999999999999986   3567899999864432 223467889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |++ ++|.+++... ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            996 5777776543 568899999999999999999995   59999999999999999999999999998754322211


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---cc------
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL------  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------  393 (455)
                        .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||........  ........+...   ..      
T Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         160 --YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhc
Confidence              133458999999998865 4578899999999999999999999975432110  011111110000   00      


Q ss_pred             ccccccccccCC---------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMN---------DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~---------~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ............         .......+.+++..||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000000000         0012346789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.7e-41  Score=307.09  Aligned_cols=253  Identities=26%  Similarity=0.328  Sum_probs=191.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCe-----EEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-----RLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----~~lv~e  244 (455)
                      +.+|.|+||.||+|.+..+   ...||||++-....    --..|+.+|+++.|||||+|+-+|....+     ..+|||
T Consensus        30 ~liG~GsFg~Vyq~~~~e~---~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRET---EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEeecccceEEEEEEcCC---CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            5799999999999999844   67899999854322    23568999999999999999998865332     248999


Q ss_pred             eCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEEEeeccCcccccC
Q 037780          245 FLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTL  319 (455)
Q Consensus       245 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~  319 (455)
                      |||. +|..+++.    +..++...+.-+..||.+||+|||+   .+|+||||||+|+|+|.+ |.+||+|||.|+.+..
T Consensus       103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9987 88888763    5667777777899999999999994   599999999999999966 9999999999998876


Q ss_pred             CCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH-----hh----
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC-----YR----  389 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~----  389 (455)
                      .+...   ...-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.....+....-.+...     +.    
T Consensus       179 ~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  179 GEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             CCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            65542   34468899999988765 7999999999999999999999999876653322111111100     00    


Q ss_pred             ---cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 ---NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ---~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         +....++...............+.++++.++++.+|.+|.+..|++.
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               00111111111111122234667899999999999999999999875

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-39  Score=297.64  Aligned_cols=261  Identities=25%  Similarity=0.317  Sum_probs=200.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCC-ceeeeeeEecCC----
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQ----  237 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~----  237 (455)
                      .+...++||+|+||+||+|+...   +++.||+|++.....  .......+|+.++++++|+| ||++.+++...+    
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            34455789999999999999984   558899999976543  23455789999999999999 999999998877    


Q ss_pred             --eEEEEEEeCCCCCHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          238 --NRLLVYEFLNNGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       238 --~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                        ..++|+||++. +|..++....    .++-..+..++.|+++||+|||+   .+|+||||||+|||++++|.+||+||
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeecc
Confidence              78899999954 9999987654    46667899999999999999995   59999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |+|+...-....  .+..++|.+|.|||++.+. .|++..||||+||++.||++++.-|....+.+..   ..+.+.+..
T Consensus       165 GlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lGt  239 (323)
T KOG0594|consen  165 GLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLGT  239 (323)
T ss_pred             chHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcCC
Confidence            999965522211  2556789999999999877 7999999999999999999999988776652221   112222211


Q ss_pred             ---Cccc---cccccccc---cCCCHH-------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          391 ---GKLD---DLVEGDME---AMNDIK-------CVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       391 ---~~~~---~~~~~~l~---~~~~~~-------~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                         ..+.   .+.+....   ...+..       ......+++.+|++.+|.+|.|+..+++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               1111   11111110   000111       11367899999999999999999999885

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6e-40  Score=307.85  Aligned_cols=243  Identities=24%  Similarity=0.391  Sum_probs=192.2

Q ss_pred             hhcCcCCCccEEEEEEeccCC----CceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRT----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||+||+|.......    ....+++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998764322    2445888888665445556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc--------EEEeeccCccc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN--------ARISDFGLAKL  316 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~a~~  316 (455)
                      +++|+|..++... ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999765 468999999999999999999995   49999999999999987765        59999998875


Q ss_pred             ccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCC-CCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      ....      ....++..|+|||++.+. .++.++||||||+++|||++|. .|+..........       .....  .
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~~--~  222 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYEDR--H  222 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHcc--c
Confidence            4322      224578899999999864 5799999999999999999985 5554332211100       01110  0


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      .         .+......+.+++..||+.+|++|||++++++.|+
T Consensus       223 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 Q---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0         01112356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-39  Score=322.23  Aligned_cols=260  Identities=25%  Similarity=0.302  Sum_probs=197.4

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC-----eEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NRL  240 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~~  240 (455)
                      ..+.||+|+||.||++...   .++..||+|++....  ....+.+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDP---RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             ccceeeeCCCEEEEEEEEC---CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4578999999999999875   356789999986532  223467889999999999999999999998776     789


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +|+||+. ++|.+++.....+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            9999996 5888888888889999999999999999999995   59999999999999999999999999999875443


Q ss_pred             CCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH----------------H
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD----------------W  383 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~----------------~  383 (455)
                      ..... ....+|..|+|||++.+. .++.++|||||||++|||++|+.||.............                .
T Consensus       157 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         157 ESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             ccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            32222 334578999999998764 57899999999999999999999997654321111000                0


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+.......-....+. .......+.+.+++..||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            0011100000000000000 001122567889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=301.69  Aligned_cols=248  Identities=27%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ++||+|+||.||++.+.    .++.+++|........ ....+.+|+.++++++|+||+++++++......++|+||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEe----CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            46999999999999976    3678999988654333 456799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          249 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       249 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      ++|.+++... ..+++.....++.+++.+|+|||+   .+++||||||+||+++.++.+||+|||++.............
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9999999653 567899999999999999999995   499999999999999999999999999998654322211111


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....+..|+|||.+.++.++.++||||||++++||+| |..||........       ...+..+.         ....+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~~~~~---------~~~~~  217 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERIESGY---------RMPAP  217 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHHhcCC---------CCCCC
Confidence            2234667999999988899999999999999999999 8888865443211       11111110         00112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ...+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            2345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.4e-39  Score=302.63  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=191.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ++||+|+||.||+|....+. ....+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            36999999999999865432 34567788775433 23456799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          249 GTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       249 gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+|.+++...    ...++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999999753    345677788999999999999995   499999999999999999999999999986432221111


Q ss_pred             ccccccccCcccccccccC-------CCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRK-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..||......+      .....+. +....+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~  229 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKL  229 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh-hccccc
Confidence            1123457889999998743       245789999999999999997 566775433211      1111111 222223


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      .++.....    ..+.+.+++..|| .+|++||++.+|++.|.
T Consensus       230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33333221    3456778888899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4e-39  Score=303.41  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .++..+++|.++..   .....+.+.+|++++++++|+|++++++++...+..++|
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICL---LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEc---CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456688999999999999987   35678999987532   122356789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          243 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      |||+++++|.+++..    ...+++.++..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            999999999998853    3557899999999999999999995   599999999999999999999999999988654


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ......  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......    ... .......+....   
T Consensus       158 ~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~~---  227 (267)
T cd08224         158 SKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDYPP---  227 (267)
T ss_pred             CCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCCCC---
Confidence            332211  2345888999999998888999999999999999999999998643321    111 111111221111   


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                           .........+.+++.+||..+|++|||+.+|+++|+++
T Consensus       228 -----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 -----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                 11113456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=305.85  Aligned_cols=252  Identities=30%  Similarity=0.484  Sum_probs=202.9

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.+.+.||+|+||.||+|...    +...+++|.+.... ...+++.+|+.++++++|+|++++++++......++||
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            34556788999999999999875    34669999987533 34577999999999999999999999999989999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++++|.+++...  ..+++.++..++.+++.||.|||+.   +++|+||||+||++++++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999999764  4689999999999999999999954   99999999999999999999999999998765322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ... .....++..|+|||.+.+..++.++||||||++++||++ |+.||.......   ..    .....+.        
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~--------  221 (261)
T cd05034         158 YTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL----EQVERGY--------  221 (261)
T ss_pred             hhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCC--------
Confidence            111 122235678999999998889999999999999999999 999996543221   11    1111110        


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                       ....+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             001111235678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=304.39  Aligned_cols=250  Identities=21%  Similarity=0.263  Sum_probs=199.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-----ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ...+.||+|++|.||++...   ..+..+++|.+.....     .....+.+|+.++.+++||||+++++++.+.+..++
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~---~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDV---DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             cccceecCCCceEEEEEEEc---CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            34578999999999999876   3467899998754321     123568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+||+++++|.+++.....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            99999999999999888888999999999999999999995   499999999999999999999999999997654322


Q ss_pred             Cccc-cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .... .....++..|+|||++.+..++.++||||||+++|||++|+.||........      ..........       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~-------  225 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPTN-------  225 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccCCC-------
Confidence            1111 0224578899999999998899999999999999999999999865432111      1111111110       


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                        ...+......+.+++..||+.+|.+|||+.++++.
T Consensus       226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              11122345678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.2e-39  Score=306.19  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+...+.||+|+||.||+|.+.   ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDN---RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEc---CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            4455678999999999999876   346789999886432 333457899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.. ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            99999999999864 568999999999999999999995   59999999999999999999999999999866533221


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        .....++..|+|||++.+..++.++||||||++++||++|+.|+........      . ..+..+..     +    
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~-~~~~~~~~-----~----  219 (277)
T cd06642         158 --RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------L-FLIPKNSP-----P----  219 (277)
T ss_pred             --hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------H-hhhhcCCC-----C----
Confidence              1234578899999999988899999999999999999999999864432211      0 01111111     1    


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ......+..+.+++..||+.+|.+||||.+|++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            1112345678899999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.2e-39  Score=303.55  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=201.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||+|...   ..+..+|+|.++.........+.+|+.++..++|||++++++.+...+..++|+|
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNV---NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEc---CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            4567789999999999999876   3467899998865544445668899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++.+.+.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++......... 
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-  162 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-
Confidence            99999999999888889999999999999999999995   49999999999999999999999999998765432221 


Q ss_pred             ccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                       .....|+..|+|||++.   ...++.++|||||||++|+|++|+.||....+....      ... ......   .+..
T Consensus       163 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~-~~~~~~---~~~~  231 (267)
T cd06645         163 -RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLM-TKSNFQ---PPKL  231 (267)
T ss_pred             -cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhh-hccCCC---CCcc
Confidence             13346899999999874   456889999999999999999999998644321110      000 011110   0001


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..  ....+..+.+++..||+.+|++|||+.+|++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00  1123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.2e-40  Score=317.48  Aligned_cols=241  Identities=26%  Similarity=0.321  Sum_probs=193.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~l  241 (455)
                      .++.+.||+|+||+||++...   .++..||+|.+....   ....+.+..|..++..+. |++|+++.+++...+..++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERK---GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            356688999999999999876   356789999986432   233456788999998886 5678889999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++.++..|+.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999999999888889999999999999999999995   499999999999999999999999999987543222


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +    ...+..+...       
T Consensus       156 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~----~~~i~~~~~~-------  219 (323)
T cd05615         156 VT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L----FQSIMEHNVS-------  219 (323)
T ss_pred             cc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCCCC-------
Confidence            11  133568999999999998899999999999999999999999997654321   1    1111111110       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                         .+......+.+++..||+.+|.+|++.
T Consensus       220 ---~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 ---YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               111234677899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-39  Score=315.95  Aligned_cols=238  Identities=24%  Similarity=0.270  Sum_probs=189.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHH-HHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||+|+||.||+|...   .++..+|+|.+....   ......+..|.. +++.++||||+++++++.+.+..++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK---SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence            36999999999999986   356789999986432   122334555554 67889999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|..++.....+++.....++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T  152 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence            9999999999887888999999999999999999995   5999999999999999999999999999875322221  1


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ....+..+..          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~----------~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKPL----------QL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCCC----------CC
Confidence            234568999999999998899999999999999999999999997543211       1111111111          01


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMR  432 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~  432 (455)
                      +......+.+++.+||+.+|.+||+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            112346788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.1e-39  Score=303.67  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=197.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEe-cCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||.||++...     +..+++|.....  ...+.+.+|+.++++++|+|++++++++. .++..++|+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            4456688999999999999764     566899988643  33567999999999999999999999764 556789999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            999999999999764  347899999999999999999995   499999999999999999999999999987654322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                           ....++..|+|||++.+..++.++||||||+++|||++ |+.||.......   +    ...+..+....     
T Consensus       157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~~-----  219 (256)
T cd05082         157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKGYKMD-----  219 (256)
T ss_pred             -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcCCCCC-----
Confidence                 12235678999999998889999999999999999998 999986433211   1    11111111111     


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                          .....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       220 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 ----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                1113456788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=315.36  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=208.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCe-EEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-RLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-~~l  241 (455)
                      .+...+++|+|+||.++..+.+   .+...+++|++...  .....+...+|+.++++++|||||.+.+.+.+++. .++
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk---~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHK---SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhc---cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            4567789999999999998877   45668999988543  23334568899999999999999999999998888 899


Q ss_pred             EEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          242 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||+|++||+|.+.+.+.  ..++++....++.|++.|+.|||+   ..|+|||||+.||+++.+..+||+|||+|+.+..
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999999765  467889999999999999999995   4999999999999999999999999999999887


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      .....  ..+.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+....      +.+... +    ... 
T Consensus       159 ~~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L------i~ki~~-~----~~~-  224 (426)
T KOG0589|consen  159 EDSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL------ILKINR-G----LYS-  224 (426)
T ss_pred             chhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH------HHHHhh-c----cCC-
Confidence            65332  567899999999999999999999999999999999999999986553221      111111 1    111 


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                          ..+..+..++..++..|++.+|..||++.+++.+
T Consensus       225 ----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 ----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                2233467889999999999999999999999865

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-39  Score=304.40  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=201.3

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .....+.++||+|+||.||++.+.    ....+++|.+... ....+.+.+|+.++++++|+|++++.+++.+ ...+++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec----CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            345567789999999999999865    3456999988643 2335678999999999999999999999887 778999


Q ss_pred             EEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          243 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |||+++++|.+++...  ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999753  467899999999999999999995   49999999999999999999999999999866433


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ... ......++..|+|||++....++.++|+||||+++++++| |+.||.......   +    ...+..+....    
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~~----  223 (260)
T cd05073         156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRMP----  223 (260)
T ss_pred             Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCCCCC----
Confidence            221 1122345678999999998889999999999999999999 999987543211   1    11111111110    


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                           .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       224 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 -----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 111235678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-39  Score=323.24  Aligned_cols=265  Identities=19%  Similarity=0.206  Sum_probs=201.1

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      ...+.+.+.||+|+||.||++...+. ..+..|++|.+...     ..+.+|+.++++++||||+++++++......++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            33566778899999999999976533 35678999987542     2456899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||++. ++|.+++.....+++..++.|+.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99985 6888998777889999999999999999999995   4999999999999999999999999999987654433


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc-------
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD-------  395 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  395 (455)
                      ........||+.|+|||++....++.++|||||||++|||++|+.||..............+.+.+.......       
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            3222345799999999999999999999999999999999999999965443211111111111111000000       


Q ss_pred             -------c---cccccc---cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          396 -------L---VEGDME---AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       396 -------~---~~~~l~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                             .   ..+...   ..........+.+++.+||+.+|++|||+.+++..
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   0   000000   00001123467789999999999999999999864

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.5e-40  Score=324.20  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=194.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||++...   ..++.+|+|.+....   ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKV---DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEEC---CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            45578999999999999976   346789999986432   223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC-
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-  322 (455)
                      ||+++|+|.+++.....+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            999999999999888888999999999999999999995   4999999999999999999999999999753321000 


Q ss_pred             ----------------------------------------ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHH
Q 037780          323 ----------------------------------------KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEI  362 (455)
Q Consensus       323 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el  362 (455)
                                                              ........||+.|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                    0001234699999999999999999999999999999999


Q ss_pred             HhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 037780          363 ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP---TMRKVSQM  437 (455)
Q Consensus       363 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP---t~~~v~~~  437 (455)
                      ++|+.||......+..      ........  ....+     ........+.+++..|+ .+|.+|+   |+.++++.
T Consensus       238 l~G~~Pf~~~~~~~~~------~~i~~~~~--~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         238 LVGQPPFLADTPAETQ------LKVINWET--TLHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhCCCCCCCCCHHHHH------HHHhccCc--cccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999765532211      11110000  00000     01122345566666655 4999999   88888753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-39  Score=311.20  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=198.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCC-ceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTS-TTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.||+|+||.||+|.+..++.. ...+|+|.+..... ....++.+|+.++++++||||++++++|... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            346799999999999998644322 23578898865432 2234688999999999999999999998754 46799999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++|+|.+++... ..+++..++.++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++.........
T Consensus        90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccccc
Confidence            9999999998765 468999999999999999999995   599999999999999999999999999998765433222


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......       .......+...  .      
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--~------  231 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERL--P------  231 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC--C------
Confidence            1123345778999999998899999999999999999998 899986543221       11111221111  0      


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                       .+......+.+++..||..+|++||++.++++.|+.+.
T Consensus       232 -~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         232 -QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             01113457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.1e-39  Score=339.73  Aligned_cols=257  Identities=24%  Similarity=0.359  Sum_probs=199.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.++||+|+||.||+|...   ..++.||+|++.....   ...+.|.+|+.++++++||||+++++++.+++..++||
T Consensus         5 eIi~~LGkGgfG~VYlA~d~---~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDP---VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             EEEEEEecCCCEEEEEEEEC---CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            45578999999999999876   3467899999865322   22457999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeecc
Q 037780          244 EFLNNGTLASFLFGN-----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFG  312 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  312 (455)
                      ||+++++|.+++...           ...++..++.|+.|+++||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531           235677889999999999999995   499999999999999999999999999


Q ss_pred             CcccccCCCC----------------ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch
Q 037780          313 LAKLLTLNQS----------------KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE  376 (455)
Q Consensus       313 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~  376 (455)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                001122469999999999999999999999999999999999999997533221


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcCcC
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP-TMRKVSQMLEGVVE  443 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~~v~~~L~~~~~  443 (455)
                      ..      .    ...+   .++. ......+.+..+.+++.+|++.||++|| +++++.+.|+...+
T Consensus       239 i~------~----~~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 IS------Y----RDVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh------h----hhhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            10      0    0000   0000 0001113456788999999999999995 67777777776543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.7e-39  Score=304.90  Aligned_cols=255  Identities=23%  Similarity=0.412  Sum_probs=200.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC------eE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------NR  239 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~  239 (455)
                      +.+.||+|+||.||+|.+......+..+|+|.+....  ....+++.+|+.++++++|||++++++++...+      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4578999999999999987655567899999886532  234567899999999999999999999886542      23


Q ss_pred             EEEEEeCCCCCHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          240 LLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ++++||+++|+|.+++...      ..+++.....++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence            7899999999999887432      247889999999999999999995   4999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ++...............++..|++||.+....++.++||||||+++|||++ |+.||......+   +    ......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIKGN  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHcCC
Confidence            987643332211122335678999999988889999999999999999999 888886443211   1    11111111


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ...         .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       233 ~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100         0112456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.2e-39  Score=301.88  Aligned_cols=241  Identities=27%  Similarity=0.428  Sum_probs=192.2

Q ss_pred             hhcCcCCCccEEEEEEeccC-------CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTR-------TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.||+|+||.||+|.+..+.       .....+++|.+...... ...|.+|+.++++++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999997543       11245778877544332 6789999999999999999999999988 778999


Q ss_pred             EEeCCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-------cEEEeeccCc
Q 037780          243 YEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-------NARISDFGLA  314 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg~a  314 (455)
                      +||+++|+|.+++.... .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999998765 78999999999999999999994   5999999999999999888       7999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCC--CCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKS--TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      ......      ....++..|+|||++...  .++.++||||||+++|||++ |..|+......+...       .+...
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~  222 (259)
T cd05037         156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQ  222 (259)
T ss_pred             cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcC
Confidence            865431      223467789999999876  78999999999999999999 577776543221110       00100


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      ..  ...         .....+.+++..||..+|.+|||+.+|++.|+
T Consensus       223 ~~--~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 HR--LPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC--CCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00  000         01267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-40  Score=288.70  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  239 (455)
                      .+.||+|..++|-++..+   ..+...|+|++.....        .-.+.-..|+.+|+++ .||+|+.+.++++.+.-.
T Consensus        22 keilgrgvss~vrRci~k---~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~   98 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHK---ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV   98 (411)
T ss_pred             HHHhcccchhhhhhhhhc---ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence            467999999999999887   4567788888753221        1124567899999998 699999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+|.|+.|.|.|+|.+..++++...++|+.|+.+|+.|||   ..+|+||||||+|||+|++.++||+|||++..+.+
T Consensus        99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            999999999999999999999999999999999999999999   45999999999999999999999999999998876


Q ss_pred             CCCccccccccccCcccccccccC------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRK------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ....   ...+||++|+|||.+..      ..|+..+|+||.||+||.|+.|.+||-....       -...+.+.+|+.
T Consensus       176 GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeGky  245 (411)
T KOG0599|consen  176 GEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEGKY  245 (411)
T ss_pred             chhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhccc
Confidence            5543   56789999999998753      3477789999999999999999999853221       112233444443


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .- -.     ..-.+......+++.+||+.||.+|.|.+|++.
T Consensus       246 qF-~s-----peWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 QF-RS-----PEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cc-CC-----cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            21 11     112345778899999999999999999999875

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.5e-39  Score=304.10  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=194.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecC------Ce
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG------QN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~------~~  238 (455)
                      +.+.+.||+|+||.||+|...   ..+..+|+|.+.... .....+..|+.++.++ +|+|++++++++...      ..
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEc---CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            455678999999999999886   346789999986543 3456788999999998 799999999998653      46


Q ss_pred             EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          239 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||++..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            78999999999999998763  468999999999999999999995   4999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      .......  .....|+..|+|||++.     ...++.++|||||||++|||++|+.||.........      .. ....
T Consensus       161 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~-~~~~  231 (272)
T cd06637         161 LDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPRN  231 (272)
T ss_pred             ccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HH-HhcC
Confidence            5432221  13356899999999986     335788999999999999999999999643321110      00 0111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ......        ....+..+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            111111        1123467889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-39  Score=312.45  Aligned_cols=266  Identities=20%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +...++||+|+||.||+|....   .+..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            4455789999999999998763   45689999986433 2234567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++ +|.+++... ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++........
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            9975 788877654 457899999999999999999995   49999999999999999999999999999765432221


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH--------HHHhhcC-cc
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNG-KL  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~-~~  393 (455)
                        .....+|..|+|||.+.+ ..++.++||||||+++|||+||+.||......+........        +..+... ..
T Consensus       161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             --cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence              123457899999998865 46889999999999999999999999765543221111000        0000000 00


Q ss_pred             cccccccccc----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          394 DDLVEGDMEA----MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       394 ~~~~~~~l~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                      ...-.+....    .........+.+++..||+.||.+|||+.|+++  .+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence            0000000000    000123456789999999999999999999987  4444

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.3e-39  Score=302.24  Aligned_cols=249  Identities=27%  Similarity=0.464  Sum_probs=200.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.+.||+|+||.||++.+.    .+..+++|.+.... ....+|.+|++++++++|||++++++++......++|+||
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             eEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            456688999999999999875    34579999886432 3356799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++..++.++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999764 467999999999999999999995   489999999999999999999999999988654332211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      . ....++.+|+|||++.+..++.++||||||+++|||++ |+.||.......   +   . .....+.  ....+.   
T Consensus       158 ~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~---~-~~~~~~~--~~~~~~---  224 (256)
T cd05112         158 S-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---V---V-ETINAGF--RLYKPR---  224 (256)
T ss_pred             c-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---H---H-HHHhCCC--CCCCCC---
Confidence            1 22235678999999998889999999999999999998 999987544321   1   1 1111110  111111   


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                          ..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                12467899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.3e-39  Score=305.57  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=202.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ..+.||+|+||.||+|......  .....+++|.+...... ..+.+.+|++++++++|+|++++++++.+.+..++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3467999999999999976432  24567999988654333 34679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          245 FLNNGTLASFLFGNL---------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~---------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      |+++++|.+++....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++++|||+++
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999997655         68999999999999999999995   499999999999999999999999999987


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      ......... .....++..|+|||.+.+..++.++||||||+++++|++ |..||.......       .......+...
T Consensus       166 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~~  237 (275)
T cd05046         166 DVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKLE  237 (275)
T ss_pred             ccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCCcC
Confidence            543222211 123346778999999988888999999999999999999 788886433211       11111112211


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .        ......+..+.+++.+||+.+|++|||+.+++..|.+
T Consensus       238 ~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         238 L--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             C--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1        1111245688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-39  Score=303.45  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=201.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||.|++|.||+|...   .++..+++|.+.... ......+.+|+.+++.++|+|++++.+++.++...++|+|
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDK---RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEEC---CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            456688999999999999986   356789999986543 3344678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++... .+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.........
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            99999999998765 78999999999999999999995   599999999999999999999999999998776432221


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                        ....++..|+|||++.+..++.++||||||+++|+|+||+.||........       ......+....+..      
T Consensus       156 --~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~------  220 (274)
T cd06609         156 --NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNPPSLEG------  220 (274)
T ss_pred             --ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCCCCCcc------
Confidence              334588899999999988899999999999999999999999975432110       11111111111111      


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        ...+..+.+++..||..+|++|||++++++
T Consensus       221 --~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 --NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              014567889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.9e-39  Score=308.56  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=201.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .+.+.||.|++|.||+|...   ..+..+++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        22 ~~~~~lg~g~~g~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          22 TRYEKIGQGASGTVFTAIDV---ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             EEEEEEecCCCeEEEEEEEc---CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            34567999999999999875   356789999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++++|..++.. ..+++.++..++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........  
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--  172 (296)
T cd06655          99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--  172 (296)
T ss_pred             CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC--
Confidence            99999999864 468999999999999999999995   599999999999999999999999999988655433221  


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........      ..... .....+       ..+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~-~~~~~~-------~~~  238 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT-NGTPEL-------QNP  238 (296)
T ss_pred             CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-cCCccc-------CCc
Confidence            2345889999999999888999999999999999999999999765432111      11111 111111       011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ......+.+++.+||+.+|.+|||+.++++
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            223457888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.3e-39  Score=299.34  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||+|....   ++..+++|.+.....  .+++.+|++++++++|+|++++++++......++++|
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            34567889999999999999873   457899999865432  6789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK  155 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence            9999999999975 4678999999999999999999995   49999999999999999999999999999876543321


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        .....++..|+|||++.+..++.++||||||+++|+|++|+.||..........       .......     ...  
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~-----~~~--  219 (256)
T cd06612         156 --RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKPP-----PTL--  219 (256)
T ss_pred             --cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCCC-----CCC--
Confidence              123447889999999998899999999999999999999999997543321100       0000000     000  


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+......+.+++..||+.+|++|||+.+|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112234567899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.2e-39  Score=307.34  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||++...   ..+..+|+|.+........+.+.+|+.+++.++|+|++++++++..++..++|||
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDI---ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEEC---CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            3445678999999999999875   3567899999876555556778999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.+ ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..........
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            9999999999854 457899999999999999999995   499999999999999999999999999998654433211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                        ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........      .....+        .....
T Consensus       173 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~--------~~~~~  236 (297)
T cd06656         173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPELQ  236 (297)
T ss_pred             --CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC--------CCCCC
Confidence              23458889999999998889999999999999999999999997544321100      000000        00001


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCc
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV  442 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~  442 (455)
                      .+......+.+++..||+.+|++||++.+|++  .++...
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            12233566789999999999999999999997  444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-39  Score=304.85  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=199.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHH--HHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||++...   .++..+|+|.+.........  ....|+.++.+++||||+++++++......++|||
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNK---KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEET---TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             EEeEEEEeCCCEEEEEEEEC---CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            35678999999999999987   45668999999765433222  34569999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..++.|+++||++||+.   +++|+||||+||++++++.++|+|||.+.......  .
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~  153 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--E  153 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--S
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--c
Confidence            999999999998778889999999999999999999965   99999999999999999999999999997642111  1


Q ss_pred             ccccccccCccccccccc-CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR-KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ......++..|+|||++. +..++.++||||+|+++++|++|+.||............   ..... ....   .. .. 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~-~~~~---~~-~~-  224 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILK-RPLP---SS-SQ-  224 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHH-THHH---HH-TT-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccc-cccc---cc-cc-
Confidence            224456899999999998 788999999999999999999999999865221111111   00000 0000   00 00 


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ........+.+++..||+.+|++|||+.++++
T Consensus       225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00011378999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=318.59  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=211.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ...|+||+|.||.|++|.+.....+...||||.+...... ...+|.+|+.+|.+++|+|+++|+|...+ ....||+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            3568999999999999999887777788999999765443 56789999999999999999999999987 778899999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ++.|||.+.|++.  ..+.....-.++.|||.|+.||.   +.++|||||..+|+||-..-.+||+|||+.+-++..+..
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            9999999999873  45667778889999999999999   559999999999999999999999999999988766544


Q ss_pred             ccccc-ccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          324 TIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       324 ~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..... ..-...|.|||.+....++.+||||+|||+||||+| |..||-+..+-                .+.+.+|...
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~e  332 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGE  332 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccccc
Confidence            33222 234668999999999999999999999999999999 88888654431                1222334334


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ....+..+++.+.++++.||..+|.+|||+..|.+.
T Consensus       333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            444566789999999999999999999999999743

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.2e-39  Score=321.65  Aligned_cols=256  Identities=21%  Similarity=0.216  Sum_probs=191.1

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      .+.||+|+||.||++....   .+..||||...      ...+.+|++++++++|+|||++++++..++..++|||++. 
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPD---YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             EEEEccCCCeEEEEEEECC---CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            3568999999999999873   45789999642      2346789999999999999999999999999999999995 


Q ss_pred             CCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          249 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       249 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      ++|.+++... ..++|.+++.|+.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++............
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            6888887654 578999999999999999999995   499999999999999999999999999998765433322223


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccc-cchhhhhHHHHHHHhhcCcc-----cccccccc
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEM-GEEYAILTDWAFDCYRNGKL-----DDLVEGDM  401 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l  401 (455)
                      ...||..|+|||++.+..++.++|||||||+||||++|..|+.... ..........+.+.+.....     .......+
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l  400 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL  400 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence            4569999999999999999999999999999999999887653221 11111111111111111110     00000000


Q ss_pred             ------------c-------cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          402 ------------E-------AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       402 ------------~-------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                                  .       ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                        0       00000122367889999999999999999999863

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.3e-38  Score=300.26  Aligned_cols=247  Identities=26%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +...+.||.|+||.||+|...   ..+..+|+|.+.... ......+.+|+.++++++|+|++++++++.++...++|||
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDN---RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEc---cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            445578999999999999886   346789999886432 3345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.. ..+++.+...++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence            9999999999865 467899999999999999999995   59999999999999999999999999999776543221 


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                       .....++..|+|||++.+..++.++||||||+++|||+||+.||.........       .....+.         ...
T Consensus       158 -~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~---------~~~  220 (277)
T cd06640         158 -RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNN---------PPT  220 (277)
T ss_pred             -cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcCC---------CCC
Confidence             12345788999999998888999999999999999999999998754432110       0111111         111


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .....+..+.+++..||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            223456788999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7e-39  Score=301.94  Aligned_cols=248  Identities=27%  Similarity=0.379  Sum_probs=199.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---------cHHHHHHHHHHHcccCCCCceeeeeeEecCC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  237 (455)
                      .+...||+|+||.||+|...   ..+..+|+|.+......         ..+.+.+|+.++++++||||+++++++.+.+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNA---SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD   79 (267)
T ss_pred             cccceeecCCCeEEEEEEec---CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence            35578999999999999876   34678999987543221         1246889999999999999999999999999


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++|+||+++++|.+++.....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999999888888999999999999999999995   49999999999999999999999999999876


Q ss_pred             cCCCCcc----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          318 TLNQSKT----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       318 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      .......    ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........      .... ...  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~--  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKI-GEN--  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHH-hcc--
Confidence            5322111    11224578899999999988899999999999999999999999975432110      0110 011  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ..+    ..+......+.+++.+||+.+|.+||++.+|++
T Consensus       228 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ---ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               011    111234577889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1e-38  Score=303.98  Aligned_cols=247  Identities=27%  Similarity=0.311  Sum_probs=196.3

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ..+.||+|+||+||++...   ..++.+|+|.+.....   .....+.+|+.++.+++|+|++++++.+...+..++|||
T Consensus         4 ~~~~ig~G~~g~v~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             eeEEeecCCCeEEEEEEEc---CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4467999999999999987   3567899999864321   223457889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++.++..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999998643  458899999999999999999994   5999999999999999999999999999876543322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....|+..|+|||++.+..++.++||||||+++|+|++|+.||..........   .........  .   .    
T Consensus       158 ~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~~~--~---~----  222 (285)
T cd05630         158 I---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEV--Q---E----  222 (285)
T ss_pred             c---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhhhh--h---h----
Confidence            1   23458999999999999999999999999999999999999997543211100   001110000  0   0    


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                       .........+.+++..||+.+|++|||     +.++++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 -EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             011123456889999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=315.69  Aligned_cols=241  Identities=23%  Similarity=0.274  Sum_probs=188.7

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHccc---CCCCceeeeeeEecCCeEEEEEEe
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT---HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ||+|+||+||+|...   ..+..+|+|++.....   .....+..|..++.+.   +||||+++.+.+.+.+..++||||
T Consensus         1 lG~G~~g~Vy~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFGQVYQVRKK---DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY   77 (330)
T ss_pred             CCCCCceEEEEEEEC---CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence            799999999999986   3567899999864321   1223455566666655   699999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++.....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++........  
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--  152 (330)
T cd05586          78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--  152 (330)
T ss_pred             CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence            9999999999888889999999999999999999995   49999999999999999999999999998754322211  


Q ss_pred             cccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          326 KTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.||......+       ....+..+... +.       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~-~~-------  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVR-FP-------  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCCC-CC-------
Confidence            1345699999999998765 47999999999999999999999997544321       11112222111 10       


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPT----MRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt----~~~v~~  436 (455)
                       .......+.+++..||+.+|.+||+    +.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             1113467788999999999999985    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.9e-38  Score=301.93  Aligned_cols=250  Identities=21%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.++||.|+||.||+|...   ..+..+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++|||
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNK---ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEEC---CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            4557788999999999999886   3467899999876655556779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|..++.. ...+++..+..++.|++.+|+|||+   .+++||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999988754 4568999999999999999999994   59999999999999999999999999998754322111


Q ss_pred             cccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                        .....++..|+|||++.     ...++.++|||||||++|||++|+.||.......      ..... ........  
T Consensus       167 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~~~~~--  235 (292)
T cd06644         167 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKI-AKSEPPTL--  235 (292)
T ss_pred             --cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHH-hcCCCccC--
Confidence              13345788999999984     3457889999999999999999999986543211      01111 11111111  


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           ..+......+.+++..||+.+|++||++.++++
T Consensus       236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 111233457889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.4e-39  Score=317.49  Aligned_cols=252  Identities=18%  Similarity=0.225  Sum_probs=194.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||++...   ..+..+|+|.+....   ......+.+|+.+++.++||||+++++.+.+++..++
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEEC---CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3445578999999999999987   356789999885421   2234457899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++... .++...+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            99999999999998654 57888899999999999999995   599999999999999999999999999998765332


Q ss_pred             CccccccccccCcccccccccCC----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ... .....||+.|+|||++...    .++.++|||||||++|||++|+.||.......      .............+.
T Consensus       197 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~~  269 (371)
T cd05622         197 MVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNSLTFP  269 (371)
T ss_pred             ccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCcccCC
Confidence            211 1345699999999998654    37889999999999999999999997544311      111111111111111


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSL--RPTMRKVSQM  437 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~~v~~~  437 (455)
                             ........+.+++..|++.++.+  ||++.++++.
T Consensus       270 -------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         270 -------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             -------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                   11124567788889999844433  7889888874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5e-39  Score=312.64  Aligned_cols=251  Identities=19%  Similarity=0.223  Sum_probs=192.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++...   ..+..+|+|.+....   ......+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMK---HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            45678999999999999876   356789999986421   223345888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999976 4678999999999999999999995   5999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccC-----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ... ....||+.|+|||++.+     +.++.++||||||++||||++|+.||......+      .............+ 
T Consensus       158 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~-  229 (331)
T cd05624         158 VQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQF-  229 (331)
T ss_pred             eee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCcccC-
Confidence            211 23469999999999875     467889999999999999999999997543311      11111111100000 


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSL--RPTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~~v~~  436 (455)
                      ...     ....++.+.+++..|+...+.+  |++++++++
T Consensus       230 p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         230 PSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             CCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            000     0123567778888888765543  467887765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=299.15  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=202.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||.|+||.||++....   .+..+++|.+........+.+.+|+.++++++|||++++++++......+++|||
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            3456789999999999999863   4567999998765555667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++.+...++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++......... 
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhc-
Confidence            9999999999776 788999999999999999999995   49999999999999999999999999999865432211 


Q ss_pred             ccccccccCcccccccccCC---CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                       .....++..|+|||.+.+.   .++.++||||||+++|||+||+.||..........      . .......   ...+
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~-~~~~~~~---~~~~  226 (262)
T cd06613         158 -RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------L-ISKSNFP---PPKL  226 (262)
T ss_pred             -cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhccCC---Cccc
Confidence             1334578899999999776   78999999999999999999999997544321110      0 0111110   0001


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        ......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112234677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-38  Score=308.00  Aligned_cols=197  Identities=22%  Similarity=0.394  Sum_probs=160.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~  247 (455)
                      ++||+|+||+||+|..... ..+..+|+|.+...  .....+.+|+.++++++||||+++++++..  +...++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             cccccCCCeEEEEEEEccC-CCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            5799999999999987543 35678999998643  224467889999999999999999998854  456789999986


Q ss_pred             CCCHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCcEEEeeccCc
Q 037780          248 NGTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLA  314 (455)
Q Consensus       248 ~gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a  314 (455)
                      + +|.+++...         ..+++.....|+.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 787776421         257899999999999999999995   499999999999999    46678999999999


Q ss_pred             ccccCCCCc-cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccc
Q 037780          315 KLLTLNQSK-TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEM  373 (455)
Q Consensus       315 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~  373 (455)
                      +........ .......||+.|+|||++.+. .++.++||||+||+++||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876533221 111345689999999998764 58999999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=325.35  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=187.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecC--------C
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--------Q  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------~  237 (455)
                      +.+.+.||+|+||.||+|...   ..+..||||++....    ....+|+.++++++||||+++++++...        .
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICI---DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEEC---CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            445678999999999999986   346789999885422    2345799999999999999999876432        2


Q ss_pred             eEEEEEEeCCCCCHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeecc
Q 037780          238 NRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFG  312 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg  312 (455)
                      ..++||||+++ +|.+++.    ....+++.....++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            35689999985 6666653    35678999999999999999999995   5999999999999999664 79999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc-
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-  390 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  390 (455)
                      +++.+......   ....||+.|+|||++.+. .++.++|||||||+||||++|++||......+...  . ....+.. 
T Consensus       217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~-i~~~~~~p  290 (440)
T PTZ00036        217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--R-IIQVLGTP  290 (440)
T ss_pred             cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHhCCC
Confidence            99876533221   234589999999988654 68999999999999999999999997654322110  0 0000000 


Q ss_pred             ---------C-----ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 ---------G-----KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ---------~-----~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                               .     .+..+....+....+...+.++.+++..||+.+|.+|||+.++++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                     0     000111111111111123467899999999999999999999884

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=308.76  Aligned_cols=251  Identities=28%  Similarity=0.354  Sum_probs=210.1

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---cHHHHHHHHHHHcccC-CCCceeeeeeEecCCe
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN  238 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~  238 (455)
                      ...+.+.++||+|.||.||++....   ++..+|+|.+.+....   ....+.+|+.+|.++. |||+|.+.+.++....
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            3456677899999999999999884   4778999998765433   3468999999999998 9999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC----CcEEEeeccCc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH----YNARISDFGLA  314 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a  314 (455)
                      .++|||++.||.|.+.+... .+++.....++.|++.++.|||   +.+++||||||+|+|+...    +.+|++|||++
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999999999776 4899999999999999999999   4699999999999999633    57999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      ......   ......+||+.|+|||++....|+..+||||.||++|.|++|..||..........       .+..+.. 
T Consensus       187 ~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-  255 (382)
T KOG0032|consen  187 KFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-  255 (382)
T ss_pred             eEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence            988762   22366789999999999999999999999999999999999999998776533211       2223332 


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           ......-....+.+.+++..++..||..|+|+.++++
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                 1111222345778899999999999999999999998

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-38  Score=297.67  Aligned_cols=251  Identities=31%  Similarity=0.509  Sum_probs=202.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccC-CCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.||.|+||.||++...... .....+|+|.+...... ..+.+..|+..+.+++|+|++++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            4578999999999999987432 23478999999755433 567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++++|.+++.....  +++.++..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999976544  8999999999999999999995   59999999999999999999999999999876544222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .. ....++..|+|||.+.+..++.++||||+|+++++|++ |+.||.......       .......+....       
T Consensus       160 ~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~-------  224 (258)
T smart00219      160 KK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRLP-------  224 (258)
T ss_pred             cc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCC-------
Confidence            21 12337789999999988889999999999999999998 888886533211       111111211111       


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                        .....+..+.+++.+|+..+|++|||+.++++.|
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 --KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              1112456789999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-38  Score=302.69  Aligned_cols=247  Identities=25%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ..+.||+|+||+||+|...   .+++.+|+|.+....   ......+.+|+.++.+++|+|++++.+.+..++..++|+|
T Consensus         4 ~~~~lg~G~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVR---ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             EEEEEecCCCeEEEEEEEC---CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3467999999999999987   356789999986432   1223457889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999999988643  468999999999999999999994   5999999999999999999999999999876543221


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....|+..|+|||++.+..++.++|+||||+++|||++|+.||.........   ............         
T Consensus       158 ~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~---------  222 (285)
T cd05632         158 I---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEE---------  222 (285)
T ss_pred             c---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcccc---------
Confidence            1   2346899999999999889999999999999999999999999754332111   011111111110         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                       .........+.+++..||+.+|++||+     +.+++.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             011123456789999999999999999     566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=300.29  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=201.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||.|+||.||++....   ++..+++|..........+.|..|+.++++++|+|++++++.+..+...++|||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            35667889999999999999863   467899999876555556779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++... ..+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            99999999998764 568999999999999999999995   49999999999999999999999999998765432221


Q ss_pred             cccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                        .....++..|+|||.+.     ...++.++||||||+++|||++|+.||........      . ..+..+....+. 
T Consensus       160 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~~~-  229 (280)
T cd06611         160 --RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------L-LKILKSEPPTLD-  229 (280)
T ss_pred             --cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------H-HHHhcCCCCCcC-
Confidence              13345899999999874     34577899999999999999999999975433110      1 111111111110 


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                            .+......+.+++..||+.+|.+||++.+|++.
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         230 ------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  111235678899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-39  Score=318.82  Aligned_cols=202  Identities=24%  Similarity=0.337  Sum_probs=173.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ++.+.||+|+||+||++...   ..+..+|+|.+....   ......+.+|+.++.+++|+|++++++.+.+.+..++||
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKK---DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            34578999999999999987   356789999986422   223456888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            999999999999888889999999999999999999995   59999999999999999999999999998754321100


Q ss_pred             ---------------------------------cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCC
Q 037780          324 ---------------------------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       324 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00123469999999999999999999999999999999999999997


Q ss_pred             cccc
Q 037780          371 IEMG  374 (455)
Q Consensus       371 ~~~~  374 (455)
                      ....
T Consensus       238 ~~~~  241 (360)
T cd05627         238 SETP  241 (360)
T ss_pred             CCCH
Confidence            6544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-38  Score=299.22  Aligned_cols=252  Identities=26%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc----------ccccHHHHHHHHHHHcc-cCCCCceeeeeeEec
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV----------FQDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDE  235 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~  235 (455)
                      .+.+.||+|+||.||+|.+..+  .+..+|+|.+...          ......++.+|+.++.+ ++|||++++++++.+
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4567899999999999998742  3578999987432          12233457788888875 799999999999999


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          236 GQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                      ++..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743    35688999999999999999999952  47999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      |++.......   ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......      .. .....+
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~-~~~~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LA-TKIVEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HH-HHHhhc
Confidence            9998765433   1234568999999999998889999999999999999999999986443211      01 111111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .....        ........+.+++.+||+.||++||++.||..+++.
T Consensus       229 ~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            11111        111234678899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.5e-38  Score=307.31  Aligned_cols=256  Identities=17%  Similarity=0.197  Sum_probs=193.8

Q ss_pred             hhhhcCcC--CCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          168 FKEEAGRG--SFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       168 f~~~lG~G--~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.++||+|  +||+||++...   .++..||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYK---PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeec---ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence            56789999  78899999887   457889999986532  223456788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++|+|.+++...  ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999998653  458999999999999999999995   499999999999999999999999998654432111


Q ss_pred             C-----ccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          322 S-----KTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       322 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      .     ........++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ....     ..+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~-----~~~~~~  228 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK-----LNGTVP  228 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHH-----hcCCcc
Confidence            0     001122346778999999876  4689999999999999999999999974332110  0000     001110


Q ss_pred             ccccc------------------------------------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEG------------------------------------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~------------------------------------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...+.                                    .............+.+++..||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00000                                    0000111233567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-38  Score=309.85  Aligned_cols=252  Identities=20%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++...   ..+..+|+|.+....   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEEC---CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            45678999999999999986   346789999985421   222345888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999976 4678999999999999999999995   5999999999999999999999999999976543322


Q ss_pred             ccccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      .. .....||+.|+|||++.     ...++.++|||||||++|||++|+.||......+      .............+.
T Consensus       158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~~p  230 (332)
T cd05623         158 VQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERFQFP  230 (332)
T ss_pred             ce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccccCC
Confidence            11 12346999999999986     3467899999999999999999999997543311      111111111000000


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQE--DPSLRPTMRKVSQM  437 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~--~p~~RPt~~~v~~~  437 (455)
                       .     ........+.+++..|+..  ++..|+++.++++.
T Consensus       231 -~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 -A-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -C-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             0     0112345667777777654  44447889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-38  Score=298.63  Aligned_cols=247  Identities=22%  Similarity=0.313  Sum_probs=199.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||.||++...   .++..+++|.+.... ....+.+.+|+.++++++|+|++++++.+..++..++|+||
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHV---NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEc---CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            35678999999999999876   346779999875432 33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++++|.+++..  ...+++...+.++.|++.||.|||+   .+++|+||||+||++++++.++++|||++.........
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999999998864  3457899999999999999999995   49999999999999999999999999999866432221


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.......      ... ....+....+       
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~~-------  220 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LIL-KVCQGSYKPL-------  220 (255)
T ss_pred             --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHH-HHhcCCCCCC-------
Confidence              133568899999999998889999999999999999999999997543211      111 1112222111       


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                        +......+.+++.+||+.+|++|||+.+++..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              11234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-38  Score=298.42  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=191.3

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-----cccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRL  240 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~  240 (455)
                      ..+.||+|+||.||+|....   .+..+++|++....     ......+.+|+.++++++||||+++++++.+  ....+
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             ccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            45789999999999998763   46789999875332     1223568899999999999999999998865  35678


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +++||+++++|.+++.....+++...+.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++.....
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            999999999999999887788999999999999999999994   59999999999999999999999999999865432


Q ss_pred             CCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ... .......++..|+|||++.+..++.++||||||+++|||++|+.||.......      ..........     .+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~-----~~  228 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT-----NP  228 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC-----CC
Confidence            111 11123458899999999998889999999999999999999999997543211      1111111111     11


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .    .+....+.+.+++ .||..+|++||++.+|++
T Consensus       229 ~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 Q----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1    1112234445555 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=307.54  Aligned_cols=253  Identities=20%  Similarity=0.228  Sum_probs=192.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||++...   ..++.+|+|.+...   .....+.+.+|+.++..++|+||+++++++.+++..++|
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMK---NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            345678999999999999987   34678999998642   122345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |||+++|+|.+++.. ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999976 4678999999999999999999995   599999999999999999999999999987654332


Q ss_pred             CccccccccccCcccccccccC-----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRK-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ... .....||+.|+|||++..     ..++.++|||||||++|||++|+.||......+      .............+
T Consensus       157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~  229 (331)
T cd05597         157 TVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQF  229 (331)
T ss_pred             Ccc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccC
Confidence            211 123458999999999863     457889999999999999999999997543211      11111111111111


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcc--cCCCCCCCCHHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCI--QEDPSLRPTMRKVSQM  437 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl--~~~p~~RPt~~~v~~~  437 (455)
                      ...      ....+..+.+++..|+  ..++..||++.++++.
T Consensus       230 ~~~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 PPD------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCc------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            110      0113455666776655  4444458899888865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-38  Score=298.54  Aligned_cols=251  Identities=26%  Similarity=0.372  Sum_probs=197.5

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc----------ccHHHHHHHHHHHcccCCCCceeeeeeEecCCe
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ----------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  238 (455)
                      .+.||.|+||.||+|...   .++..+|+|.++....          ...+.+..|+.++.+++|+|++++++++...+.
T Consensus         6 ~~~lg~g~~~~vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           6 GELIGKGTYGRVYLALNV---TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             cceecccCceEEEEEeec---CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            467999999999999876   3467899998753211          112467889999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++|+||+++++|.+++.....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||+++...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            99999999999999999888889999999999999999999995   499999999999999999999999999998654


Q ss_pred             CCCCccccccccccCcccccccccCCC--CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ............++..|+|||.+....  ++.++||||||+++|++++|+.||.......      .............+
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~  233 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKRSAPPI  233 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccccCCcC
Confidence            332222223445889999999987654  7899999999999999999999986432211      11111111111111


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ..    ......+..+.+++..||+.+|++|||+.+|++
T Consensus       234 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         234 -PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             11    111124578889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-38  Score=302.84  Aligned_cols=257  Identities=25%  Similarity=0.302  Sum_probs=189.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHccc---CCCCceeeeeeEec-----C
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCDE-----G  236 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----~  236 (455)
                      .+.+.||+|+||+||+|...   .+++.+|+|.+.....  .....+.+|+.+++++   +||||+++++++..     .
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             eEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            45578999999999999987   3567899998864321  2234566777777665   79999999998864     3


Q ss_pred             CeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          237 QNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      ...++|+||+++ +|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            457899999975 888888654  458999999999999999999995   49999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh---cC
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NG  391 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~  391 (455)
                      +........   ....||..|+|||++.+..++.++|||||||+++||++|++||........  +. .......   ..
T Consensus       156 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~-~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LG-KIFDLIGLPPED  229 (288)
T ss_pred             ccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HH-HHHHHhCCCChh
Confidence            876533221   334589999999999988999999999999999999999999975443211  10 0111000   00


Q ss_pred             cccc-------ccccccc---cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDD-------LVEGDME---AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~-------~~~~~l~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....       ...+...   ........+.+.+++..||+.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000       0000000   0000123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.2e-38  Score=296.64  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=202.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||.|+||.||.+...   .++..+++|.+...  ......++.+|+.++++++|+|++++++++.+.+..+++||
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRT---EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             eEeeEecccCCceEEEEEEc---CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            45678999999999999876   35678999987543  23445678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++.++..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999999764  568999999999999999999995   4899999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+      ..... ..+.....      
T Consensus       157 ~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~~~~------  221 (256)
T cd08221         157 M--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI-VQGNYTPV------  221 (256)
T ss_pred             c--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCCCCC------
Confidence            1  133458999999999988888999999999999999999999997543321      11111 12221111      


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                         .......+.+++.+||+.+|.+||++.++++.+
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               123456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-38  Score=300.38  Aligned_cols=249  Identities=21%  Similarity=0.359  Sum_probs=198.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +++.+.||+|+||.||++...   ..+..+|+|.+.... ......+.+|+.++.+++|+||+++++.+...+..++|+|
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHR---PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEc---CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            567789999999999999886   356789999886432 2334678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+++++|..++...   ..+++..+..++.+++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999998763   3789999999999999999999952  489999999999999999999999999997654322


Q ss_pred             CccccccccccCcccccccccCCC------CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKST------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      .    ....++..|+|||.+.+..      ++.++|||||||++|+|++|+.||........   .... .....+... 
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~-~~~~~~~~~-  228 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQL-SAIVDGDPP-  228 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHH-HHHhhcCCC-
Confidence            2    2234788999999985543      47899999999999999999999965332111   0000 011111111 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                              ..+......+.+++.+||+.+|++||++.+++.
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 --------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                    112235677889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.6e-38  Score=299.35  Aligned_cols=263  Identities=23%  Similarity=0.304  Sum_probs=200.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +++.+.||+|+||.||+|...   .++..+|+|++....  ....+.+.+|+.++++++|+|++++++++......++||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNR---ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             eeeeeeecccCCeEEEEEEEC---CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            345678999999999999986   346789999875432  223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|..++.....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            999999999988777789999999999999999999995   59999999999999999999999999999876543321


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh-HHHHH-------HHhhcCcc-
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-TDWAF-------DCYRNGKL-  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~-~~~~~-------~~~~~~~~-  393 (455)
                        .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... .....       ..+..... 
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence              123447889999999876 4578999999999999999999999975543221110 00000       00000000 


Q ss_pred             ccccccccccCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....+......+     ......+.+++..||+.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0011111110111     122567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-38  Score=303.26  Aligned_cols=245  Identities=25%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      ..||+|+||.||++...   ..+..+++|.+........+.+.+|+.++..++|||++++++++..++..++|+||++++
T Consensus        27 ~~ig~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          27 IKIGEGSTGIVCIAREK---HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhcCCCCceeEEEEEEc---CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            47999999999999876   356789999986554455667899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccc
Q 037780          250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI  329 (455)
Q Consensus       250 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  329 (455)
                      +|..++.. ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..........  ...
T Consensus       104 ~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~~~  177 (297)
T cd06659         104 ALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSL  177 (297)
T ss_pred             CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc--cce
Confidence            99998754 568999999999999999999995   499999999999999999999999999987654332211  334


Q ss_pred             cccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHH
Q 037780          330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC  409 (455)
Q Consensus       330 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  409 (455)
                      .|+..|+|||++.+..++.++||||||++++||++|+.||......+..       ..+........     .  .....
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~-----~--~~~~~  243 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSPPPKL-----K--NAHKI  243 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCCCCc-----c--ccCCC
Confidence            5899999999999888999999999999999999999999754332110       01111111000     0  01123


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          410 VEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       410 ~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ...+.+++..||+.+|++||++.++++.
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            4568899999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.2e-38  Score=309.72  Aligned_cols=259  Identities=25%  Similarity=0.287  Sum_probs=192.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCC------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  237 (455)
                      +...+.||+|+||.||++...   ..+..+|+|++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDT---VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEc---CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            445678999999999999876   35678999998643  2234567889999999999999999999986443      


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++||||+++ +|...+.  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            57999999975 5666553  347888999999999999999995   49999999999999999999999999999764


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh----------------hH
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI----------------LT  381 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~----------------~~  381 (455)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..........                +.
T Consensus       174 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         174 CTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             ccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence            43221   133468999999999999999999999999999999999999997553211000                00


Q ss_pred             HHHHHHhhcC-ccc-----cccccc-c--ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          382 DWAFDCYRNG-KLD-----DLVEGD-M--EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       382 ~~~~~~~~~~-~~~-----~~~~~~-l--~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+....... ...     +..... .  ...........+.+++..||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0001111100 000     000000 0  00001112456889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-38  Score=297.10  Aligned_cols=244  Identities=30%  Similarity=0.477  Sum_probs=196.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||++..     .+..+|+|.+...  .....+.+|+.++.+++|||++++++++..+ ..++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-----CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            355678899999999999874     3567999998643  2346789999999999999999999998664 4799999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++...... 
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            99999999999754  357899999999999999999995   599999999999999999999999999987643221 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                          .....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+       .......+....      
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------  217 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRME------  217 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCC------
Confidence                12234678999999998899999999999999999998 999987544321       111112221111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                         .....+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       218 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 ---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               111245778899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-38  Score=305.62  Aligned_cols=197  Identities=22%  Similarity=0.385  Sum_probs=160.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~  247 (455)
                      .+||+|+||+||+|...+. ..+..+|+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDG-KDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCC-CccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4799999999999997643 256789999986532  23467899999999999999999998853  557799999987


Q ss_pred             CCCHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCcEEEeeccCc
Q 037780          248 NGTLASFLFG---------NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLA  314 (455)
Q Consensus       248 ~gsL~~~l~~---------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a  314 (455)
                      + +|.+++..         ...+++..+..++.|++.||.|||+   .+|+||||||+|||+    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 77776632         1357899999999999999999995   599999999999999    56778999999999


Q ss_pred             ccccCCCCc-cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccc
Q 037780          315 KLLTLNQSK-TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEM  373 (455)
Q Consensus       315 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~  373 (455)
                      +........ .......+|+.|+|||++.+. .++.++||||||+++|||+||+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            876543221 111345689999999998764 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-39  Score=313.11  Aligned_cols=246  Identities=25%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecc--cc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCe--EE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN--RL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~--~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~--~~  240 (455)
                      .|.++||+|+|-+||||.+..   .+.+||--.++  ..  .......|..|+.+|+.|+|||||+++..+.+...  ..
T Consensus        43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            466789999999999999863   45666643332  11  12234679999999999999999999999877665  77


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  319 (455)
                      +|+|.|..|+|..|+.+.+..+.....+|+.||++||.|||.+ .++|||||||-+||+|+ ..|.+||+|+|||+....
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999999999999999999999999999999999998 88999999999999998 458999999999998875


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ...    ..+.|||.|||||... ..|++.+||||||++|+||+|+.-||..-..      ...+++.+..|.....+..
T Consensus       199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSK  267 (632)
T ss_pred             ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhc
Confidence            543    3367999999999986 7899999999999999999999999974433      2345555566654443332


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      -    .    -.++.+++..|+.. .++|||+.|++.
T Consensus       268 V----~----dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 V----K----DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             c----C----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1    1    24678899999998 999999999985

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=284.72  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=203.3

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccc--cccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+++.+.||+|.|+.||+....   ..++..|+|.++.  ....+.+++.+|+.+-..++||||++|.....+....||
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~---~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhc---cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            45667789999999999999876   4566677777643  234467789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCcEEEeeccCccccc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLT  318 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~  318 (455)
                      |+|+|+|++|..-+-.....++...-+.+.||+++|.|+|.   .+|||||+||+|++|-   ..--+||+|||+|..+.
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            99999999998776655666788888999999999999995   5999999999999995   34459999999999887


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      .   .....+..|||+|||||++...+|+-.+|||+.||+||-|+.|.+||......       .+++.+..|...-   
T Consensus       165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd~---  231 (355)
T KOG0033|consen  165 D---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYDY---  231 (355)
T ss_pred             C---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccCC---
Confidence            2   22336678999999999999999999999999999999999999999864432       2333344443321   


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ....-....++..+++..||..||.+|.|+.|.+.
T Consensus       232 ---~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 ---PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ---CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence               11111234567888999999999999999988763

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-38  Score=303.81  Aligned_cols=263  Identities=24%  Similarity=0.326  Sum_probs=199.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +++.+.||+|+||.||+|...   ..++.+|+|++.....  ...+.+.+|++++++++|||++++++++..++..++|+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEEC---CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            345678999999999999986   3467899998764322  23457889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|..+......++|.+++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            999999999988777779999999999999999999995   49999999999999999999999999999876443321


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchh-hhhHHHH-------HHHhhcCcc-
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWA-------FDCYRNGKL-  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-~~~~~~~-------~~~~~~~~~-  393 (455)
                        .....++..|+|||++.+ ..++.++||||||++++||++|+.||......+. ..+..+.       ........+ 
T Consensus       157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         157 --YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             --cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence              133457899999999875 4578899999999999999999999865432111 0111000       000000000 


Q ss_pred             ccccccccccCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMN-----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....+......     ....+..+.+++..||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000000     1123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-38  Score=297.12  Aligned_cols=245  Identities=28%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-----cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.||+|+||.||+|...   .++..+++|.+....     .+..+.+.+|+.++++++|+|++++.+++......++|
T Consensus         4 ~~~~ig~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNL---DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             ccceeeecCCceEEEEEEc---CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4567999999999999886   346789999875432     22456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +||+++++|.+++.....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            9999999999999888788999999999999999999995   499999999999999999999999999988764333 


Q ss_pred             ccccccccccCcccccccccCCC-CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                        ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.......      .............      
T Consensus       157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~------  222 (258)
T cd06632         157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKELPP------  222 (258)
T ss_pred             --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccCCC------
Confidence              113345889999999987776 8999999999999999999999997543211      1111111111111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         .+......+.+++.+||+.+|.+||++.++++
T Consensus       223 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 ---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               11123567788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3e-38  Score=295.79  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv  242 (455)
                      +.+.+.||+|++|.||++....   ++..+++|++....  ....+.+.+|+.++++++|+|++++++.+.. ....+++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            3456789999999999999863   45689999986432  2344568999999999999999999998764 4467899


Q ss_pred             EEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          243 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |||+++++|.+++...  ..+++.++..++.+++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999999753  458999999999999999999995   49999999999999999999999999999876433


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ...  .....+++.|+|||++.+..++.++||||||+++++|++|+.||......      ..... ...+....     
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~-~~~~~~~~-----  221 (257)
T cd08223         156 CDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR-IIEGKLPP-----  221 (257)
T ss_pred             CCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcCCCC-----
Confidence            221  13345889999999999999999999999999999999999998743321      11111 11222211     


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                          .+......+.+++.+||+.+|++|||+.++++.
T Consensus       222 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 ----MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                112345678999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-38  Score=309.90  Aligned_cols=188  Identities=23%  Similarity=0.330  Sum_probs=159.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|....   .+..||+|.....      ....|+.++++++|+||+++++++......++|+|+
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            4556789999999999999863   4567899975432      235699999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +. ++|.+++.. ...+++..++.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--  212 (357)
T PHA03209        139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--  212 (357)
T ss_pred             cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc--
Confidence            95 588888754 4678999999999999999999995   4999999999999999999999999999975432221  


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF  369 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~  369 (455)
                       .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       213 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 -FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             13356899999999999999999999999999999999965554

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.4e-38  Score=297.01  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=197.1

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc------ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+.||+|+||+||+|...    ++..+|+|.+.....      .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus         4 ~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             ccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4567999999999999763    567899998764321      123458899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+||+++++|.+++.+...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999999887788999999999999999999995   489999999999999999999999999988653211


Q ss_pred             C----ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          322 S----KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       322 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      .    ........++..|+|||++.+..++.++||||||+++++|++|+.||.........     .......+....  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~--  229 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRGLMPR--  229 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccCCCCC--
Confidence            1    11112345899999999999888999999999999999999999999753321110     000000011111  


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         .    +......+.+++.+||+.+|++||++.++++
T Consensus       230 ---~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 ---L----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---C----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               1    1124567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.1e-38  Score=301.73  Aligned_cols=263  Identities=23%  Similarity=0.266  Sum_probs=199.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-----cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.||+|+||.||+|....   .++.+++|++......     ....+..|+.++++++|+|++++++++.+.+..++
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             eeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence            445789999999999999863   4678999998654322     23457789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+ +++|.+++.... .+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||+++.....
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            99999 999999998765 78999999999999999999995   49999999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---------
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---------  390 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------  390 (455)
                      ....  ....++..|+|||.+.+ ..++.++||||||++++||++|..||......+..   .........         
T Consensus       156 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         156 NRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGV  230 (298)
T ss_pred             Cccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhc
Confidence            2211  22346788999998865 46789999999999999999998887654432110   001100000         


Q ss_pred             CccccccccccccC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcC
Q 037780          391 GKLDDLVEGDMEAM-----NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGV  441 (455)
Q Consensus       391 ~~~~~~~~~~l~~~-----~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~  441 (455)
                      ..............     ........+.+++..||+.+|++|||+.+|++.  +++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence            00000000000000     011235678999999999999999999999985  5553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=301.55  Aligned_cols=264  Identities=25%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +++.+.||+|+||.||+|....   ++..+++|+++...  ....+.+.+|++++++++|+|++++++++..++..++|+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            3456789999999999999863   46789999886432  233467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||++++.+..+......+++.++..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||++.........
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9999988887777667789999999999999999999954   9999999999999999999999999999876654331


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH--------HHh-hcCcc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------DCY-RNGKL  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~~  393 (455)
                      .. ....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.........        ..+ .....
T Consensus       157 ~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         157 PL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            22 334578899999999888 78999999999999999999999997543321111000000        000 00000


Q ss_pred             c--ccccc---c-cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 D--DLVEG---D-MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~--~~~~~---~-l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .  .....   . .....+...+..+.+++..||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0  00000   0 000111123678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-38  Score=309.68  Aligned_cols=261  Identities=24%  Similarity=0.272  Sum_probs=193.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC------
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------  236 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------  236 (455)
                      .+.+.+.||+|+||.||++...   ..+..+|||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEEC---CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3455678999999999999876   346779999986532  23345688999999999999999999987543      


Q ss_pred             CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          237 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ...++||||+++ +|.+++.  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            357999999975 6777664  347889999999999999999995   5999999999999999999999999999986


Q ss_pred             ccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hH--------------
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT--------------  381 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~--------------  381 (455)
                      ......   .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+... +.              
T Consensus       176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         176 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             cCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            543222   133468999999999999999999999999999999999999997544311100 00              


Q ss_pred             -HHHHHHhhcC-ccc-----ccccccc---ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          382 -DWAFDCYRNG-KLD-----DLVEGDM---EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       382 -~~~~~~~~~~-~~~-----~~~~~~l---~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                       ........+. ...     .+.....   ...........+.+++.+||+.||.+|||+.++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             0000000000 000     0000000   000011124578899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-38  Score=302.45  Aligned_cols=245  Identities=27%  Similarity=0.390  Sum_probs=197.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      ..||+|+||.||++...   ..+..+|||.+........+.+.+|+..+++++|+|++++++.+..++..++||||++++
T Consensus        28 ~~lg~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          28 IKIGEGSTGIVCIATEK---HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hcccCCCCeEEEEEEEC---CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            56999999999999876   346789999987655555667999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccc
Q 037780          250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI  329 (455)
Q Consensus       250 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  329 (455)
                      +|.+++.. ..+++.+...++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++..........  ...
T Consensus       105 ~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~--~~~  178 (292)
T cd06658         105 ALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSL  178 (292)
T ss_pred             cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC--cee
Confidence            99998854 468999999999999999999995   499999999999999999999999999987654332211  234


Q ss_pred             cccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHH
Q 037780          330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC  409 (455)
Q Consensus       330 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  409 (455)
                      .|+..|+|||.+.+..++.++||||||++++||++|+.||........  +     ..+... .    .+....  ....
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-----~~~~~~-~----~~~~~~--~~~~  244 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M-----RRIRDN-L----PPRVKD--SHKV  244 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----HHHHhc-C----CCcccc--cccc
Confidence            588999999999888899999999999999999999999975433111  0     011111 1    111111  1123


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          410 VEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       410 ~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ...+.+++..||+.+|.+|||+.++++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            4567888999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.1e-38  Score=296.69  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=200.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~lv  242 (455)
                      ++.+.||.|+||.||++....   ++..+++|.+...  .....+.+.+|+.++++++|+|++++++++..  ....+++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            455789999999999998763   4577999988542  23345568899999999999999999998754  4567899


Q ss_pred             EEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          243 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      +||+++++|.+++..    ...+++..++.++.+++.||+|||..+  +.+++|+||+|+||++++++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999865    367899999999999999999999443  55999999999999999999999999999987


Q ss_pred             ccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ........  ....++..|+|||.+.+..++.++||||||+++++|++|+.||.......       .......+.... 
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-  229 (265)
T cd08217         160 LGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGKFRR-  229 (265)
T ss_pred             ccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhcCCCCC-
Confidence            75443211  33468999999999998889999999999999999999999997654211       112222222211 


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                              .+......+.+++..|++.+|++|||+.+|++.
T Consensus       230 --------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         230 --------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    122345788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-38  Score=310.80  Aligned_cols=260  Identities=24%  Similarity=0.290  Sum_probs=192.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC------C
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  237 (455)
                      +...+.||+|+||.||++...   ..+..+|||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEec---CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            344578999999999999876   356789999986532  23345688899999999999999999988543      3


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++||||+++ +|.+++.  ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            57999999965 6666664  357889999999999999999995   59999999999999999999999999999865


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-h---------------H
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-L---------------T  381 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~---------------~  381 (455)
                      .....   .....||..|+|||++.+..++.++|||||||++|||++|+.||.......... .               .
T Consensus       170 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         170 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             CCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            43221   133468999999999998899999999999999999999999997543211100 0               0


Q ss_pred             HHHHHHhhcC-cccccc------cccc--ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          382 DWAFDCYRNG-KLDDLV------EGDM--EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       382 ~~~~~~~~~~-~~~~~~------~~~l--~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .......... ....+.      +...  ...........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0001111110 000000      0000  000111234578899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.4e-38  Score=296.82  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=201.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||.|+||.||++...   ..+..+++|.+.... .....++.+|++++++++||||+++++.+......++++|
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHR---PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEc---CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            346688999999999999986   356789999886543 2345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++... ..+++.....++.|++.||+|||+  ..+++|+||||+||++++++.++|+|||.+.........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99999999999776 778999999999999999999994  169999999999999999999999999998765432221


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                          ...++..|+|||++.+..++.++||||||+++++|++|+.||........ ......... ..+....        
T Consensus       158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~--------  223 (265)
T cd06605         158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYI-VNEPPPR--------  223 (265)
T ss_pred             ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHH-hcCCCCC--------
Confidence                24588899999999988999999999999999999999999975432111 111111111 1111100        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .........+.+++..||..+|++|||+.+++.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111114567899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2e-38  Score=304.43  Aligned_cols=259  Identities=21%  Similarity=0.299  Sum_probs=195.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||.|+||.||+|...   ..+..||+|.+.... ......+.+|+.++++++||||+++++++......++|+|
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSK---LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEc---CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            445578999999999999876   345789999886432 2234567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |++ ++|.+++... ..+++.....++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.........
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            997 5888888653 568899999999999999999994   59999999999999999999999999999764432211


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh---cCccccccc-
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR---NGKLDDLVE-  398 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-  398 (455)
                        .....++..|+|||.+.+. .++.++||||||+++|||+||+.||......+...   .....+.   ......+.. 
T Consensus       161 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         161 --YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             --ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhcc
Confidence              1233578899999988654 57889999999999999999999997654322111   1111100   000000000 


Q ss_pred             --------ccccc----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 --------GDMEA----MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 --------~~l~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                              +....    .........+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    00000    001123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=323.34  Aligned_cols=259  Identities=21%  Similarity=0.285  Sum_probs=189.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC------CCceeeeeeEecC-Ce
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH------KNLVRLLGFCDEG-QN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~g~~~~~-~~  238 (455)
                      +.+.+.||+|+||+||+|.+.   ..+..||||+++... ....++..|+.++..++|      .+++++++++... .+
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~---~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDR---KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEc---CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            445678999999999999986   346789999986432 223445667777766654      4588999988764 46


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC--------------
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY--------------  304 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--------------  304 (455)
                      .++|||++ +++|.+++.....+++..+..|+.||+.||.|||++  .+|+||||||+|||++.++              
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            88999987 778999998888899999999999999999999952  4899999999999998765              


Q ss_pred             --cEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH
Q 037780          305 --NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       305 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~  382 (455)
                        .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus       284 ~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        284 PCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence              4999999987643221     134569999999999999999999999999999999999999997654322111111


Q ss_pred             ---------HHHH--------Hhhc-Cccccccccc-c------ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          383 ---------WAFD--------CYRN-GKLDDLVEGD-M------EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       383 ---------~~~~--------~~~~-~~~~~~~~~~-l------~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                               |...        .+.. +.+....++. +      ...........+.+++..||+.||.+|||+.|+++
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                     1100        0000 0000000000 0      00000112346789999999999999999999986

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-38  Score=295.69  Aligned_cols=246  Identities=21%  Similarity=0.317  Sum_probs=199.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||++...   .+++.+++|.+...  .....+++.+|+.++++++|||++++++++...+..++|+|
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSK---EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             eEEEEeccCCceEEEEEEEc---CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            45678999999999999876   35678999988642  22334678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++.+.+.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999998754  357899999999999999999995   4999999999999999999999999999986643322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....|+..|+|||++.+..++.++||||||+++++|++|+.||......+      ..... ..+....       
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~~~-------  220 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKI-IRGSYPP-------  220 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHH-hcCCCCC-------
Confidence            1  123457889999999998889999999999999999999999987543221      11111 1111111       


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .+......+.+++.+||+.+|.+||+|.+|++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              12234567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-38  Score=302.27  Aligned_cols=254  Identities=19%  Similarity=0.248  Sum_probs=200.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||++...   ..+..|++|.+....   ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHK---ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             eEeeEeecCCCeeEEEEEEC---CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            34578999999999999886   346789999886543   223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            999999999999888889999999999999999999995   49999999999999999999999999998742111100


Q ss_pred             -------------cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          324 -------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       324 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                                   .......++..|+|||.+....++.++|+||||+++|||++|+.||......+      .. .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~-~~~~~  230 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LF-GQVIS  230 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHh
Confidence                         01112357889999999988889999999999999999999999997443211      11 11111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      +...   .+..    ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 ~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1111   1110    11245678999999999999999998877777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-38  Score=300.10  Aligned_cols=260  Identities=24%  Similarity=0.333  Sum_probs=193.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|++|.||+|...   ..+..+|+|++....  ....+.+.+|+.++.+++|||++++++++.++...++|+|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNK---KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             eEeeEecccCceEEEEEEEC---CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            34578999999999999986   346789999886432  2234678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |++ ++|.+++...   ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 6888887543   568999999999999999999995   599999999999999999999999999997654322


Q ss_pred             CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHHHH----HHHhhc-----
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA----FDCYRN-----  390 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~~----~~~~~~-----  390 (455)
                      ..  .....+++.|+|||++.+. .++.++||||||+++++|+||+.||.......... .....    ...+..     
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 RV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             cc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence            11  1233468899999988654 57889999999999999999999997544311100 00000    000000     


Q ss_pred             ---CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 ---GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ---~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ............ ........++.+++.+||+.||.+|||+.+|++
T Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence               000000000000 001113467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=295.33  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=197.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccC---CCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||+|...   .++..+++|.+.... .....++.+|+.++++++   |||++++++++..+...++
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHV---PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhheeccCCceEEEEEEc---CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            345678999999999999986   356789999886432 334567889999999986   9999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++++|.+++... .+++...+.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            99999999999998654 78999999999999999999995   499999999999999999999999999998765443


Q ss_pred             CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ...  ....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........      . ........     +.
T Consensus       156 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~~-----~~  221 (277)
T cd06917         156 SKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSKP-----PR  221 (277)
T ss_pred             ccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCCC-----CC
Confidence            221  334588999999998754 468999999999999999999999975432111      0 00111111     11


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +.   ....+..+.+++..||+.+|++||++.++++
T Consensus       222 ~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LE---DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11   1114567889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-37  Score=295.69  Aligned_cols=248  Identities=26%  Similarity=0.378  Sum_probs=199.7

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||.||+|...   .++..+|+|...... ......+.+|+..+.+++|||++++++++..+...++|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDN---RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEEC---CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            3455678999999999999875   346789999875432 233467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.. ..+++.....++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            99999999999864 468999999999999999999995   59999999999999999999999999998765432211


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......       .......+....        
T Consensus       158 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------  220 (277)
T cd06641         158 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNPPT--------  220 (277)
T ss_pred             --hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCCCC--------
Confidence              123457889999999988889999999999999999999999986433211       111111111110        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                       .....+..+.+++..||+.+|.+||++.++++.
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             112245678899999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-37  Score=300.14  Aligned_cols=244  Identities=25%  Similarity=0.306  Sum_probs=193.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   ..+..|++|.+....   .....++.+|+.+++.++|||++++.+++..++..++|
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDV---RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEc---CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            556678999999999999986   346789999875332   22335688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +||++ |+|.+++. ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99997 56666664 34678999999999999999999995   59999999999999999999999999998765432 


Q ss_pred             CccccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                           ....++..|+|||++.   ...++.++||||||+++|||+||+.||........      .... ..+...    
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~-~~~~~~----  232 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHI-AQNDSP----  232 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHH-hcCCCC----
Confidence                 2235788999999874   45688999999999999999999999865432111      1111 111110    


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                          ..........+.+++..||+.+|++||++.+|+..
T Consensus       233 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 ----TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ----CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                11122356678999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9e-38  Score=298.71  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=201.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ++.+.+.||+|+||.||++...   ..+..+++|.+........+.+.+|+.++++++|||++++++.+...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDV---ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEc---CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            4455678999999999999875   3456799999865544556678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.+ ..+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++..........
T Consensus        97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            9999999999865 357899999999999999999995   499999999999999999999999999987655433211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                        ....+++.|+|||.+....++.++||||||+++|++++|+.||..........      .....+.        ....
T Consensus       173 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~--------~~~~  236 (293)
T cd06647         173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PELQ  236 (293)
T ss_pred             --ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC--------CCCC
Confidence              33458889999999988889999999999999999999999997544321100      0000000        0011


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ........+.+++..||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122235678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=291.98  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=207.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .++.++||+|+||.|||+.++   ..|..+|||++..  ..+..++..|+.++.+.+.|++|+++|.|......++||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~---EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHR---ESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHh---ccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            345689999999999999987   5688999999865  34577899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |--||..+.++. ++++++.++..|+.+.++||+|||.   ..-+|||||+.||||+.+|.+||+|||.|..+...-...
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            999999999874 5789999999999999999999994   578999999999999999999999999998776433221


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc-ccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL-VEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~  403 (455)
                        ..+.||+.|||||++..-.|+.++||||+|+...||.-|++||..-.+-..               +.-+ ..+..-.
T Consensus       187 --NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IFMIPT~PPPTF  249 (502)
T KOG0574|consen  187 --NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IFMIPTKPPPTF  249 (502)
T ss_pred             --CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eEeccCCCCCCC
Confidence              446799999999999999999999999999999999999999975443110               1001 1111122


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+...+.++.+++++||-.+|++|-|+.++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            335567889999999999999999999988876

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-38  Score=302.79  Aligned_cols=249  Identities=22%  Similarity=0.253  Sum_probs=197.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||+||++....   .+..+|+|.+.....   ...+.+.+|++++.+++|+||+++++.+......++||
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            345789999999999998863   467899999865432   23456899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||.   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998754  568999999999999999999994   599999999999999999999999999987553221


Q ss_pred             Ccc---------------------------ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          322 SKT---------------------------IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       322 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      ...                           ......||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                           01123578899999999988899999999999999999999999975443


Q ss_pred             chhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 037780          375 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT----MRKVSQ  436 (455)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt----~~~v~~  436 (455)
                      ...      .....         ...............+.+++.+||+.+|++|||    +.+++.
T Consensus       238 ~~~------~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DET------FSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH------HHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211      01111         111111111124678999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.4e-38  Score=293.91  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...+.||+|+||.||+|...   .++..+++|.+......  ..+.+.+|+.++++++|+||+++++++...+..++|+|
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNL---DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             eeeeEeecCCCcEEEEEEEC---CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            34578999999999999876   34678999998654332  56779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..|+.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999999887778999999999999999999995   499999999999999999999999999998765433221


Q ss_pred             c--cccccccCcccccccccCCC---CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          325 I--KTAIRGTKGYVAPEWYRKST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       325 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      .  .....++..|+|||++.+..   .+.++||||||++++|+++|+.||........     ..... ..+....+.  
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~-~~~~~~~~~--  228 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHV-GAGHKPPIP--  228 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHH-hcCCCCCCC--
Confidence            1  12345788999999998766   88999999999999999999999964432110     01110 011111110  


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           ........+.+++..||+.+|.+|||+.+++.
T Consensus       229 -----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         229 -----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -----cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 11123566789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.2e-38  Score=294.46  Aligned_cols=247  Identities=21%  Similarity=0.275  Sum_probs=193.1

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-----cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL  240 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~  240 (455)
                      ..+.||+|+||.||+|...   .++..|++|.+....     ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         6 ~~~~l~~g~~g~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDA---DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             EeeEEecCCceEEEEEEEc---CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            3578999999999999986   346789999875321     12235688899999999999999999988664  4578


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +|+||+++++|.+++.....+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++.....
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            999999999999999877778999999999999999999995   48999999999999999999999999999865432


Q ss_pred             CCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........      ........        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~--------  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQP--------  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcCC--------
Confidence            111 111234588999999999888899999999999999999999999974322110      11111110        


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       .....+......+.+++..|+. +|++||++++|++
T Consensus       226 -~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 -TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             0111223345677788888885 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.6e-38  Score=297.64  Aligned_cols=244  Identities=25%  Similarity=0.365  Sum_probs=198.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      +.||+|++|.||++...   ..+..+++|++........+.+.+|+.++++++|+|++++++++...+..++|+||++++
T Consensus        25 ~~lg~g~~g~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~  101 (285)
T cd06648          25 VKIGEGSTGIVCIATDK---STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG  101 (285)
T ss_pred             eEeccCCCeEEEEEEEC---CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence            58999999999999876   346789999886554455667899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccc
Q 037780          250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI  329 (455)
Q Consensus       250 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  329 (455)
                      +|.+++.. ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++..........  ...
T Consensus       102 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~~  175 (285)
T cd06648         102 ALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KSL  175 (285)
T ss_pred             CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc--ccc
Confidence            99999877 678999999999999999999995   599999999999999999999999999887654322211  234


Q ss_pred             cccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHH
Q 037780          330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC  409 (455)
Q Consensus       330 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  409 (455)
                      .|+..|+|||.+.+..++.++||||||++++||++|+.||.......      ... ....+.....     .  .....
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~-~~~~~~~~~~-----~--~~~~~  241 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMK-RIRDNLPPKL-----K--NLHKV  241 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHH-HHHhcCCCCC-----c--ccccC
Confidence            58899999999988889999999999999999999999986533211      111 1111111111     0  11123


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          410 VEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       410 ~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...+.+++.+||+.+|++|||+.++++
T Consensus       242 ~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         242 SPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.6e-38  Score=331.03  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=194.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~  240 (455)
                      .+.+.+.||+|+||+||++...   ..+..+|+|.+...  .......|..|+.++.+++|||||++++++..  ....+
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk---~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHK---RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEEC---CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4556788999999999999987   35678899987643  22335678999999999999999999998754  45689


Q ss_pred             EEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEeCCCCCCEEEcC----------
Q 037780          241 LVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC----SSQIIHCDIKPQNILLDD----------  302 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~----~~~ivH~dlk~~Nill~~----------  302 (455)
                      |||||+++|+|.++|..    ...+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999999864    257899999999999999999999642    146999999999999964          


Q ss_pred             -------CCcEEEeeccCcccccCCCCccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccc
Q 037780          303 -------HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEM  373 (455)
Q Consensus       303 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~  373 (455)
                             ...+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||+||||+||+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   23489999999987643322   134568999999999854  458899999999999999999999997433


Q ss_pred             cchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          374 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...      .+...+..+.  .+     .   ....+..+.+++..||+.+|.+||++.+++.
T Consensus       248 ~~~------qli~~lk~~p--~l-----p---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFS------QLISELKRGP--DL-----P---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHH------HHHHHHhcCC--CC-----C---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            211      1111111111  00     0   0112467889999999999999999999983

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.1e-37  Score=296.88  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=192.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEe-----cCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCD-----EGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~-----~~~~~  239 (455)
                      +.+.+.||+|+||.||++...   ..+..+|+|.+... .....++.+|+.++.++ +|||++++++++.     .+...
T Consensus        20 ~~~~~~lg~g~~~~vy~~~~~---~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          20 WEIIETIGKGTYGKVFKVLNK---KNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             eeeeeeeccCCCcEEEEEEEC---CCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            344578999999999999986   34678999987643 22346788999999999 6999999999884     34568


Q ss_pred             EEEEEeCCCCCHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ++||||+++++|.+++.    ....+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            99999999999999875    23567899999999999999999995   599999999999999999999999999998


Q ss_pred             cccCCCCccccccccccCcccccccccC-----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRK-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      ........  .....|+..|+|||++..     ..++.++|||||||++|||++|+.||........  +    .. ...
T Consensus       173 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~----~~-~~~  243 (286)
T cd06638         173 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L----FK-IPR  243 (286)
T ss_pred             ecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H----hh-ccc
Confidence            76433221  133468999999998853     4578899999999999999999999875432110  0    00 011


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      +......+       +......+.+++..||+.+|++|||+.+|++.
T Consensus       244 ~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         244 NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11111111       11134578899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=307.99  Aligned_cols=239  Identities=26%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      ++||.|+||.||-+++.   .+...||||+++-...+   ...++..|+..|.+++|||.|.+.|+|......+||||||
T Consensus        32 rEIGHGSFGAVYfArd~---~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC  108 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC  108 (948)
T ss_pred             HHhcCCccceeEEeecc---CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence            57999999999999987   45678999999643333   3456899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          247 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       247 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                       -||..|.+.- .+++.+..+..|..+.+.||+|||   +.+.||||||+.||||++.|.+||+|||.|....+.     
T Consensus       109 -lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----  179 (948)
T KOG0577|consen  109 -LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----  179 (948)
T ss_pred             -hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence             4577777753 467788899999999999999999   559999999999999999999999999999876543     


Q ss_pred             cccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          326 KTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                       ..++|||.|||||++.   .+.|+-|+||||+|++-.||.-.++|+...+...       +.-.+..+.-.     .  
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNesP-----t--  244 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESP-----T--  244 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCCC-----C--
Confidence             3467999999999874   5789999999999999999999999987555321       11111122111     1  


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ....+..+.+.+++..||+.-|.+|||..+++.
T Consensus       245 -Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 -LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             123467899999999999999999999998875

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-37  Score=295.61  Aligned_cols=248  Identities=27%  Similarity=0.412  Sum_probs=201.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|++|.||+|.+..   .+..+++|.+..... ....+.+|++.+++++|+|++++++.+......++|+||
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            3455789999999999999863   467899999875433 466789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++.... .+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  172 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-  172 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh-
Confidence            99999999998776 89999999999999999999995   59999999999999999999999999998765432211 


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                       .....++..|+|||++.+..++.++||||||+++|+|++|+.||........      ... ..........       
T Consensus       173 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~-------  237 (286)
T cd06614         173 -RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-ITTKGIPPLK-------  237 (286)
T ss_pred             -hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCCCCc-------
Confidence             1233478899999999888899999999999999999999999875433211      000 1111111111       


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ........+.+++.+||+.+|.+|||+.+|++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11124567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=288.68  Aligned_cols=250  Identities=23%  Similarity=0.285  Sum_probs=206.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .++.+.||.|.-|+||++.+.++   ....|+|++++..-   ....+.+.|-++|+.++||.+..|++.++.++..++|
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t---~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGT---NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCC---CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            34567899999999999999844   48899999976543   2345678899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          243 YEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+||+|...++.+  +.+++..++-++..|+-||+|||   -.|||+|||||+||||.++|++-|+||.|+......
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999999865  67899999999999999999999   569999999999999999999999999987532110


Q ss_pred             --------------------------------C-C---------------------ccccccccccCcccccccccCCCC
Q 037780          321 --------------------------------Q-S---------------------KTIKTAIRGTKGYVAPEWYRKSTI  346 (455)
Q Consensus       321 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  346 (455)
                                                      . .                     ......++||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     001123568999999999999999


Q ss_pred             CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCC
Q 037780          347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPS  426 (455)
Q Consensus       347 ~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~  426 (455)
                      +.++|.|+|||+||||+.|+.||.+.+.++               .+..++...+........+..+.+|+...|..||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence            999999999999999999999998776543               23334444444333445677889999999999999


Q ss_pred             CCCC----HHHHHH
Q 037780          427 LRPT----MRKVSQ  436 (455)
Q Consensus       427 ~RPt----~~~v~~  436 (455)
                      +|.-    +.||.+
T Consensus       378 kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhccccchHHhhc
Confidence            9988    777765

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-37  Score=296.56  Aligned_cols=247  Identities=24%  Similarity=0.352  Sum_probs=192.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEec------CCe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE------GQN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~------~~~  238 (455)
                      +.+.+.||.|+||.||+|...   ..+..+|+|...... ....++..|+.++.++ +|+|++++++++..      ...
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEc---CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            344578999999999999986   346789999886532 3345688999999998 79999999999853      457


Q ss_pred             EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          239 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      .+++|||+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            89999999999999998653  457888899999999999999995   4999999999999999999999999999876


Q ss_pred             ccCCCCccccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      .......  .....|+..|+|||.+.     ...++.++||||||+++|||++|+.||..........      . ....
T Consensus       171 ~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~-~~~~  241 (282)
T cd06636         171 LDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRN  241 (282)
T ss_pred             hhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------h-HhhC
Confidence            5432211  13345899999999886     3467889999999999999999999996543211100      0 0000


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..     .   .......+..+.+++..||+.||.+|||+.++++
T Consensus       242 ~~-----~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 PP-----P---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CC-----C---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00     0   0111234568999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-37  Score=294.06  Aligned_cols=243  Identities=26%  Similarity=0.287  Sum_probs=188.9

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHH---cccCCCCceeeeeeEecCCeEEEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVI---GQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .||+|+||.||++...   .++..+|+|.+.....   .....+.+|..++   ...+|||++.+.+++...+..++|||
T Consensus         1 ~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD   77 (279)
T ss_pred             CcccCCCeEEEEEEEC---CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence            3899999999999876   3567899998864321   1223344454433   33479999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++.....|+.|++.||+|||+   .+++|+||||+||++++++.++|+|||++........  
T Consensus        78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            99999999999888889999999999999999999995   5999999999999999999999999999875543221  


Q ss_pred             ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        ....|+..|+|||.+.+ ..++.++||||||++++||++|+.||..........+    ......      ...    
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~------~~~----  216 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------VNV----  216 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhc------CCc----
Confidence              23458999999999864 5689999999999999999999999975443221111    111000      001    


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~~  437 (455)
                      ..+...+..+.+++..||+.||++||     |++++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11223456788999999999999999     69999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.7e-37  Score=298.75  Aligned_cols=248  Identities=24%  Similarity=0.290  Sum_probs=195.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +...+.||+|+||.||+++...   ++..+|+|++....   ......+.+|+.++++++|+|++++++++.++...++|
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            4456789999999999999763   46789999986432   22345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |||+++ +|.+.+.. ...++|.++..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++...... 
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            999975 77776643 5668999999999999999999995   49999999999999999999999999998754422 


Q ss_pred             CccccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                           ....++..|+|||++.   .+.++.++||||||+++|||++|+.||........      .......+ ..    
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~-~~----  242 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-SP----  242 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhcc-CC----
Confidence                 2235788999999973   45689999999999999999999999865432111      11111111 10    


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                          ..........+.+++.+||+.+|.+||++.+|++.+--.
T Consensus       243 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         243 ----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence                011112456788999999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-37  Score=292.41  Aligned_cols=251  Identities=26%  Similarity=0.357  Sum_probs=205.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ++.+.||+|++|.||++....   .+..+++|++..... .....+.+|+..+.+++|+|++++++++......++|+||
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            455789999999999999873   467899999876533 3467799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.....+++..++.++.|+++||+|||+  ..+++|+||+|+||+++.++.++|+|||++.......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-  157 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-  157 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence            9999999999887889999999999999999999994  0599999999999999999999999999998765433321 


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....++..|+|||.+.+..++.++||||||+++|+|+||+.||..........+..    .+.......         .
T Consensus       158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~---------~  223 (264)
T cd06623         158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AICDGPPPS---------L  223 (264)
T ss_pred             -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----HHhcCCCCC---------C
Confidence             23457889999999999899999999999999999999999997654211111111    111111111         1


Q ss_pred             CHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          406 DIK-CVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       406 ~~~-~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      +.. .+..+.+++..||+.+|++|||+.++++.
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            112 46789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-37  Score=293.06  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=198.8

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc------ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+.||+|++|.||++...   .++..+|+|.+.....      ...+.+..|+.++++++|+||+++++++.+.+..++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~---~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDV---KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             ccceecCcCceEEEEEEEc---CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            3467999999999999875   3567899998864321      134678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~  320 (455)
                      |+||+++++|.+++.....+++.....++.|++.||.|||+   .+++|+||+|+||+++.++ .+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            99999999999999887888999999999999999999995   4999999999999998775 5999999999876543


Q ss_pred             CCc--cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          321 QSK--TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       321 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ...  .......++..|+|||.+.+..++.++||||+|+++++|++|+.||.........   ...........      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~------  228 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATT------  228 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCC------
Confidence            211  1112345789999999998888999999999999999999999999643321111   11111111000      


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ....+......+.+++.+|++.+|++|||+.++++
T Consensus       229 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 ---APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               01122234577889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=310.41  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=202.2

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  250 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs  250 (455)
                      .||+|.||+||-|++..   +...+|||-+.........-+.+|+.+-++++|.|||+++|.|.+++..-+.||-+||||
T Consensus       582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeecccc---ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            49999999999999873   457899999976655556678999999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccCCCCcccc
Q 037780          251 LASFLFGN-LKP--SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       251 L~~~l~~~-~~~--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      |.+.|... +++  ++.+.--+.+||++||.|||++   .|||||||-.|||++ -.|.+||+|||-++.+..-  .+.+
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T  733 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT  733 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence            99999765 555  7888888999999999999965   999999999999997 5789999999999876532  2333


Q ss_pred             ccccccCcccccccccCC--CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          327 TAIRGTKGYVAPEWYRKS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                      ..+.||..|||||++..+  .|..++|||||||++.||.||++||-.........        +.-|-.      .....
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVGmy------KvHP~  799 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVGMY------KVHPP  799 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhcce------ecCCC
Confidence            567799999999999766  48889999999999999999999997544322111        111111      11223


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+.+...+...+++.|+.++|.+||++.++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            45567889999999999999999999999985

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-38  Score=307.19  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=190.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecC------C
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  237 (455)
                      +...+.||+|+||.||+|...   ..+..||||++.....  .....+.+|+.++++++||||+++++++...      .
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDT---RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhheecccCCCeEEEEEEEC---CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            445578999999999999876   3467899999865322  2345678899999999999999999987543      3


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++++|++ +++|.+++. ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++..
T Consensus        94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence            568999988 789988875 4568999999999999999999995   49999999999999999999999999999865


Q ss_pred             cCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHh--------
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY--------  388 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  388 (455)
                      ....     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........  +.. .....        
T Consensus       169 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~  240 (343)
T cd07878         169 DDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKR-IMEVVGTPSPEVL  240 (343)
T ss_pred             CCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCCCCHHHH
Confidence            4322     33468999999999876 5689999999999999999999999965432110  000 00000        


Q ss_pred             ---hcCc-------cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          389 ---RNGK-------LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       389 ---~~~~-------~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                         ....       +.......+... .......+.+++..||+.||.+|||+.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         241 KKISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HhcchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0000       000000000000 00112357899999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.2e-37  Score=291.48  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=201.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||.|+||+||+|....   ++..+++|++.... ......+.+|+..++.++|+|++++++.+...+..++|+|
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            3456789999999999998763   46789999986432 2345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ++++++|.+++...   ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999764   458999999999999999999995   599999999999999999999999999998765433


Q ss_pred             Ccc--ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          322 SKT--IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       322 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ...  ......|+..|+|||++... .++.++||||||++++||++|+.||........      ....... ..     
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~-~~-----  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQN-DP-----  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcC-CC-----
Confidence            221  22334588999999998877 789999999999999999999999975433210      1111111 00     


Q ss_pred             cccccC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAM-NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~-~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +..... .....+..+.+++..||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            001110 11234577899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-37  Score=296.65  Aligned_cols=258  Identities=26%  Similarity=0.384  Sum_probs=197.6

Q ss_pred             cCHHHHHHHHHhh--hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeee
Q 037780          156 FSYKALEEATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGF  232 (455)
Q Consensus       156 ~~~~~l~~~t~~f--~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~  232 (455)
                      ++..++.+++.+|  .+.||+|+||.||++...   .+++.+|+|.+.... .....+.+|+.++.++ +|||+++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~---~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNK---KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEEC---CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            3334444444444  468999999999999886   356789999886432 2345688899999998 89999999999


Q ss_pred             EecC-----CeEEEEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          233 CDEG-----QNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       233 ~~~~-----~~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      +...     ...++|+||+++++|.+++..    ...+++..++.++.|++.||.|||+   .+++|+||||+||+++++
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCC
Confidence            8654     358999999999999998753    4578999999999999999999995   499999999999999999


Q ss_pred             CcEEEeeccCcccccCCCCccccccccccCcccccccccCC-----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh
Q 037780          304 YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA  378 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~  378 (455)
                      +.+||+|||++..........  ....|+..|+|||.+...     .++.++|||||||++|||++|+.||........ 
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-  241 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-  241 (291)
T ss_pred             CCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence            999999999988654322211  234588999999998643     368899999999999999999999975432111 


Q ss_pred             hhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       +    .. +..+....+.+       ..+....+.+++.+||+.+|++||++.++++
T Consensus       242 -~----~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 -L----FK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -H----HH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1    11 11111111111       1123457899999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-37  Score=291.00  Aligned_cols=245  Identities=25%  Similarity=0.386  Sum_probs=197.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||++....   .+..+++|.+...  .......+.+|+.++++++|||++++++.+...+..++|+|
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             eEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            455789999999999998763   5678999988643  22345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+++++|.+++...  ..+++..+..++.+++.||+|||+   .+++|+||+|+||+++++ +.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999999763  457999999999999999999995   499999999999999855 468999999998765432


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......      ..... ..+....+     
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~-~~~~~~~~-----  221 (256)
T cd08220         157 KA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKI-MSGTFAPI-----  221 (256)
T ss_pred             cc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHH-HhcCCCCC-----
Confidence            21   23458889999999998889999999999999999999999997544321      11111 11111111     


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          .......+.+++..||+.+|++|||+.++++
T Consensus       222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1124567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.7e-38  Score=293.61  Aligned_cols=248  Identities=25%  Similarity=0.351  Sum_probs=199.9

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||+|+||.||++...   ..+..+++|.+.....   .....+.+|++++.+++|+|++++++.+..+...++|+||+++
T Consensus         1 lg~g~~~~vy~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKK---STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEEC---CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence            689999999999986   3467899999865432   3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc-----
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-----  323 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----  323 (455)
                      ++|.+++.+...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........     
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9999999887789999999999999999999995   49999999999999999999999999998765433210     


Q ss_pred             -cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 -TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                       .......++..|+|||.+.....+.++||||||+++++|++|+.||......+.      .. ....+...        
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~--------  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQ-NILNGKIE--------  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHhcCCcC--------
Confidence             111334578899999999888899999999999999999999999975543211      11 11111111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .......+..+.+++..||+.+|.+|||+.++.+.|+.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            00011125778999999999999999999777777753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.6e-38  Score=298.58  Aligned_cols=259  Identities=20%  Similarity=0.273  Sum_probs=193.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||+|...   ..+..+++|++....  ......+.+|+.++++++|+|++++++++.+....++|+|
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~---~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             eeEEEecccCCeEEEEEEEC---CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            45578999999999999986   346789999886432  2223567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |++ ++|.+++.. ...+++...+.++.||++||.|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            997 478777754 5678999999999999999999995   49999999999999999999999999999865432211


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC------ccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------KLDDL  396 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~  396 (455)
                        .....++..|+|||++.+. .++.++||||||+++|||+||+.|+........ . ...........      .+...
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         156 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-Q-LKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-H-HHHHHHHhCCCChHHhHHhhhc
Confidence              1234578899999998765 468999999999999999999998643322111 0 01111100000      00000


Q ss_pred             cccc----cc-----cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGD----ME-----AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~----l~-----~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+..    ..     ..........+.+++..||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000    00     0001123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.7e-37  Score=290.34  Aligned_cols=243  Identities=22%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||.|+||.||++....   .+..+++|.+....   ....+.+.+|+.++++++|||++++++.+.++...++|+||+++
T Consensus         1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence            7999999999999863   46789999986432   23446799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      ++|.+++.....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||+++.......   ...
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~  151 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT  151 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence            9999999888888999999999999999999995   5999999999999999999999999999987654321   123


Q ss_pred             ccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHH
Q 037780          329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK  408 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  408 (455)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|+.||.....+..    ....... .+        ......+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~-~~--------~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDIL-KG--------NGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHh-cc--------CCCCCCCcc
Confidence            4578899999999888899999999999999999999999976543111    1111111 00        001111222


Q ss_pred             HHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          409 CVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       409 ~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                      ....+.+++..||+.+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            2578899999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-37  Score=296.13  Aligned_cols=241  Identities=26%  Similarity=0.304  Sum_probs=198.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||++....   .++.+|+|.+....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            456789999999999999873   46789999885432   223466889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+++......  
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence            999999999999888889999999999999999999995   599999999999999999999999999998765431  


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                         ....+++.|+|||.+.+...+.++||||||+++++|++|+.||.......       .......+...         
T Consensus       156 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------  216 (290)
T cd05580         156 ---YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKVR---------  216 (290)
T ss_pred             ---CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCcc---------
Confidence               33458899999999988888999999999999999999999997544211       11111111110         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVS  435 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~  435 (455)
                       .+......+.+++..||+.+|.+||     ++++++
T Consensus       217 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 -FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             1112256788999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=323.41  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=209.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCC----ceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTS----TTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.||+|.||.|++|........    ...||||.+..... ...+.+..|+++|..+ +|+|++.++|+|......+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            4567899999999999998754332    67899999975543 3456799999999998 6999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          241 LVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      +|.||+..|+|.++|+..+                .++....+.++.|||.|++||+   +.+++||||.++|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence            9999999999999997655                4788899999999999999999   45899999999999999999


Q ss_pred             cEEEeeccCcccccCCCCccccccc-cccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAI-RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  382 (455)
                      .+||+|||+++.............. .-...|||||.+....++.|+|||||||+||||+| |..||......      .
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~------~  529 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT------E  529 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH------H
Confidence            9999999999965544433221111 12456999999999999999999999999999999 89998652211      1


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      .+.+.+++|...         ..+..+..++.++++.||+.+|++||++.++++.++..
T Consensus       530 ~l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 ELLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            123344444332         22334678899999999999999999999999999873

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=305.11  Aligned_cols=197  Identities=29%  Similarity=0.405  Sum_probs=170.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-C-----CCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-H-----KNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~g~~~~~~~  238 (455)
                      ++...+.||+|+||.|-||++.   .+++.||||+++.. .....+-..|+.+|.+++ |     -|+|++++++...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~---~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDH---KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEec---CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            5566789999999999999988   45688999999764 344567788999999997 4     379999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC--CcEEEeeccCc
Q 037780          239 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH--YNARISDFGLA  314 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a  314 (455)
                      .+||+|.+ ..+|+++|+.+  ..++....+.|+.||+.||.+||+   .+|||+||||+||||.+.  ..+||+|||.|
T Consensus       263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999988 55999999876  567899999999999999999995   499999999999999754  36999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      ......-.     ...-+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.+.+.
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            87654332     34468899999999999999999999999999999999888876554

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=295.15  Aligned_cols=258  Identities=24%  Similarity=0.281  Sum_probs=197.1

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLVY  243 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv~  243 (455)
                      +.++||.|+||.||+|...   ..+..+++|++....  ......+.+|+.++++++|+|++++++++...  +..++|+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNK---KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             eeEEeccCCCeEEEEEEEC---CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            4578999999999999986   346789999997653  33345788999999999999999999999888  8899999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++ +|.+++... ..+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            99975 888888665 678999999999999999999995   4999999999999999999999999999987654432


Q ss_pred             ccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---Cccc---c
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLD---D  395 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---~  395 (455)
                      ... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........   ........   ....   .
T Consensus       156 ~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         156 ADY-TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             ccc-cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhcccccc
Confidence            111 33446888999998764 457899999999999999999999997655322111   11111000   0000   0


Q ss_pred             c-----------cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 L-----------VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~-----------~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +           ....+.......++..+.+++..||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0           0000000001112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-37  Score=294.66  Aligned_cols=259  Identities=22%  Similarity=0.289  Sum_probs=198.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||+|...   .++..+++|++....  ......+.+|+.++++++|||++++++++..+...++|+|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDR---ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             eEEeecccCCCcEEEEEEEC---CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            45678999999999999986   346789999986543  3335679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+ +++|.+++.. ...+++.+++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99 9999999865 4668999999999999999999995   49999999999999999999999999999876543321


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC-----------
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----------  391 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  391 (455)
                      . .....++..|+|||.+.+. .++.++||||+|++++||++|++||........   .......+...           
T Consensus       156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         156 L-YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             c-cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence            1 1334589999999998654 468999999999999999999888865443111   11111111000           


Q ss_pred             -cccccccccccc----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 -KLDDLVEGDMEA----MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 -~~~~~~~~~l~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ....+..+....    ....+....+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             000000000000    000123478899999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.7e-37  Score=293.71  Aligned_cols=247  Identities=24%  Similarity=0.343  Sum_probs=189.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHH-HcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||++...   .++..||+|++.... .....++..|+.. ++..+|||++++++++..++..++|+|
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHV---PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             eEEEEecccCCeEEEEEEEc---CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            35578999999999999987   357889999986542 2234456666665 566789999999999999999999999


Q ss_pred             eCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          245 FLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       245 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |++ |+|.+++..    ...+++..++.++.|++.||+|||++  .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 688777643    35689999999999999999999952  38999999999999999999999999999865432


Q ss_pred             CCccccccccccCcccccccccC----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRK----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ...   ....++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.......     ....... .+....+
T Consensus       158 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~~~~~  228 (283)
T cd06617         158 VAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVV-EEPSPQL  228 (283)
T ss_pred             ccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHH-hcCCCCC
Confidence            211   22457889999998864    456889999999999999999999986432211     0011111 1111111


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .        ....+..+.+++..||+.+|++|||+.++++
T Consensus       229 ~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 P--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             C--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1        1124567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-37  Score=292.57  Aligned_cols=250  Identities=25%  Similarity=0.372  Sum_probs=193.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.||+|+||.||++...   ..+..+|+|++.... ......+.+|+.++.++. |+||+++++++..+...++++||
T Consensus         8 ~~~~lg~G~~g~vy~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHK---PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HHHHhCCCCceEEEEEEEC---CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4578999999999999986   356789999986433 234557889999999996 99999999999999999999999


Q ss_pred             CCCCCHHHH---hc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          246 LNNGTLASF---LF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       246 ~~~gsL~~~---l~--~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +.. +|.++   +.  ....+++.....++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55443   22  246789999999999999999999952  48999999999999999999999999999765433


Q ss_pred             CCccccccccccCcccccccccCC---CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ...   ....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||.....     ......+... +...   
T Consensus       162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~~~---  229 (288)
T cd06616         162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GDPP---  229 (288)
T ss_pred             Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CCCC---
Confidence            221   223578899999998776   689999999999999999999999964331     1111111111 1111   


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                        .+........+..+.+++..||+.+|++|||+.+|++.
T Consensus       230 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 --ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              11111112356688999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=291.62  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCC------
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~------  237 (455)
                      .+.+.+.||+|+||.||+|....   .+..+++|.+..... ..+++.+|+.+++++ +|+|++++++++....      
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            34556889999999999999863   456899998865432 356799999999999 7999999999997644      


Q ss_pred             eEEEEEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          238 NRLLVYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            48999999999999999864    3578999999999999999999994   5999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccC-----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHh
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  388 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  388 (455)
                      +.........  .....++..|+|||.+..     ..++.++||||||+++++|++|+.||.......  .    ... .
T Consensus       160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~-~  230 (275)
T cd06608         160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A----LFK-I  230 (275)
T ss_pred             ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H----HHH-h
Confidence            8765433221  133458899999998753     346789999999999999999999996433211  0    111 1


Q ss_pred             hcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       389 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+....+       .........+.+++.+||..||++|||+.++++
T Consensus       231 ~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111111       112235678899999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.3e-37  Score=292.81  Aligned_cols=263  Identities=18%  Similarity=0.225  Sum_probs=195.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~  240 (455)
                      .+.+.+.||.|+||.||+|...   ..++.+++|.+....  ......+.+|+.++.+++|||++++++++...  ...+
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDK---KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEEC---CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            3556688999999999999986   346789999986432  22234577899999999999999999998877  8899


Q ss_pred             EEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      +|+||+++ +|.+++... ..+++...+.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.....
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99999974 999888664 458999999999999999999995   4999999999999999999999999999987654


Q ss_pred             CCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh-hhHHH-------HHHHhhc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTDW-------AFDCYRN  390 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~-~~~~~-------~~~~~~~  390 (455)
                      .....  ....++..|+|||.+.+. .++.++|+||||++++||++|+.||......... .+...       .+..+..
T Consensus       159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            32111  233478899999998764 4689999999999999999999999755432111 00000       0000000


Q ss_pred             ------CccccccccccccCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 ------GKLDDLVEGDMEAMNDIK-CVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ------~~~~~~~~~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                            ..........+....... ....+.+++..||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000011111111111 3566889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3e-37  Score=295.19  Aligned_cols=260  Identities=18%  Similarity=0.175  Sum_probs=186.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccH-----------HHHHHHHHHHcccCCCCceeeeeeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-----------KEFKNEVVVIGQTHHKNLVRLLGFC  233 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~g~~  233 (455)
                      .+.+.+.||+|+||+||+|....+......+++|..........           .....+...+..++|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            45567889999999999999875433355667765432221110           1123344556677899999999976


Q ss_pred             ecCC----eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEe
Q 037780          234 DEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS  309 (455)
Q Consensus       234 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  309 (455)
                      ....    ..++++|+.. .++.+.+......++.....|+.|++.||+|||+   .+|+||||||+|||++.++.++|+
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEEE
Confidence            5543    3467777764 3666666555556888899999999999999995   499999999999999999999999


Q ss_pred             eccCcccccCCCC-----ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh--hHH
Q 037780          310 DFGLAKLLTLNQS-----KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTD  382 (455)
Q Consensus       310 Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~--~~~  382 (455)
                      |||+++.+.....     ........||+.|+|||++.+..++.++|||||||+|+||++|+.||..........  ...
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            9999987643221     111133469999999999999999999999999999999999999997653321110  000


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      .....+..+..        .   ....+..+.+++..|++.+|++||++.++.+.|+
T Consensus       249 ~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        249 DFIKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            00111111111        0   1123577889999999999999999999998874

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-37  Score=290.39  Aligned_cols=246  Identities=25%  Similarity=0.316  Sum_probs=200.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||.|+||.||++...   ..+..+++|.+....   ....+.+.+|++++++++||||+++++++.++...++|+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKR---DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             eEEEEeccCCCceEEEEEEc---cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            45678999999999999876   346789999986432   234567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++.....|+.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  155 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-  155 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence            999999999999877788999999999999999999995   4999999999999999999999999999887654321 


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........    .+........          ..
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~----------~~  219 (258)
T cd05578         156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETA----------DV  219 (258)
T ss_pred             --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccc----------cc
Confidence              1334588899999999888899999999999999999999999986553211    1111111110          01


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTM--RKVS  435 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~--~~v~  435 (455)
                      ..+...+..+.+++.+||+.+|.+||++  .+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1122345788899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.3e-37  Score=294.43  Aligned_cols=259  Identities=20%  Similarity=0.268  Sum_probs=191.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||.||+|....   ++..+++|.+..... .....+.+|+.+++.++|+||+++.+++..++..++|+||
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            345789999999999999863   456899999864432 2234678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +. ++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........ 
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  159 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-  159 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence            96 677666654 3567888899999999999999995   49999999999999999999999999999764332211 


Q ss_pred             ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---C------ccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---G------KLD  394 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~------~~~  394 (455)
                       .....++..|+|||++.+. .++.++||||||+++|||++|+.||......... +. ..+..+..   .      ...
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LE-KIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HH-HHHHHcCCCChhhhhhhhhcc
Confidence             1233478899999998764 5788999999999999999999999754432111 10 00100000   0      000


Q ss_pred             ----ccccc----cccc-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 ----DLVEG----DMEA-MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ----~~~~~----~l~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          .....    .+.. .........+.+++.+|++.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                00000    0000 000112456788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.1e-37  Score=285.37  Aligned_cols=246  Identities=25%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      ..+.||+|++|.||++...   .++..+++|++..........+.+|+..+++++|+|++++++++......++++||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHK---RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             eeeeeccCCceEEEEEEEC---CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3467999999999999986   3567899999976554456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          248 NGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       248 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      +++|.+++... ..+++..+..++.+++.+|+|||+   .+++|+||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999776 688999999999999999999995   5999999999999999999999999999987654432   1


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....++..|+|||.+....++.++||||||+++++|++|+.||..........      . ........+..       .
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~~~~-------~  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------K-IATNGPPGLRN-------P  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------H-HHhcCCCCcCc-------c
Confidence            33458899999999988889999999999999999999999987543211100      0 01111111111       1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ......+.+++..||+.+|++|||+.++++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            112567899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-36  Score=290.09  Aligned_cols=252  Identities=27%  Similarity=0.332  Sum_probs=196.6

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e  244 (455)
                      +.+.||.|++|.||++.+..   .+..+|+|.+..... .....+.+|++++++++||||+++++++.+.  ...++|||
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             EEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            45689999999999999863   467899998864322 3456799999999999999999999988653  46899999


Q ss_pred             eCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          245 FLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       245 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+++++|.+++..    ...+++.....|+.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999988653    3567899999999999999999995   59999999999999999999999999998765432


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccc--hhhhhHHHHHHHhhcCccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--EYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ..    ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....+  ....+..+.    .......+.+
T Consensus       159 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  230 (287)
T cd06621         159 LA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKD  230 (287)
T ss_pred             cc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhhcc
Confidence            21    2234788999999999889999999999999999999999999765321  111111111    1111111111


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      . .  .......+.+.+++.+||+.+|++|||+.||++
T Consensus       231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0 0  111224577899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=294.69  Aligned_cols=260  Identities=20%  Similarity=0.297  Sum_probs=192.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|++|.||+|...   .++..+|+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSK---LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEc---CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            345578999999999999976   3467899999864322 223457789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++ +|.+++... ..+++.....++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9985 899988654 467899999999999999999995   59999999999999999999999999998754322111


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---cc------
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL------  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~------  393 (455)
                        .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........  ........+...   ..      
T Consensus       160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhc
Confidence              122346889999998865 4578999999999999999999999965442110  000011111000   00      


Q ss_pred             ---ccc-----ccccccc-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 ---DDL-----VEGDMEA-MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ---~~~-----~~~~l~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ...     ....+.. .........+.+++..||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000     0000000 000111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=293.76  Aligned_cols=257  Identities=25%  Similarity=0.326  Sum_probs=194.8

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.||.|++|.||+|...   .++..+++|++....  ......+.+|+..+++++|||++++++++.+++..+++|||
T Consensus         3 ~~~~l~~g~~~~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDK---LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             hheEecCCCCeEEEEEEEc---CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            4578999999999999986   356789999886432  22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ++ ++|.+++....  .+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            95 69999987665  78999999999999999999995   49999999999999999999999999999765432211


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc------------
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------------  390 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------  390 (455)
                      .  ....++..|+|||++.+. .++.++||||||+++|+|++|+.||........  +..........            
T Consensus       156 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         156 Y--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhch
Confidence            1  223468899999988664 578899999999999999999999975443111  00000000000            


Q ss_pred             C---ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 G---KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~---~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +   ........... .........+.+++.+||+.+|.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0   00000000000 001123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-36  Score=290.95  Aligned_cols=245  Identities=25%  Similarity=0.361  Sum_probs=197.5

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ..+||+|+||.||++...   .++..+|+|++..........+.+|+.++++++|+|++++++++...+..++||||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVK---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEc---CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            367999999999999886   35678999998655455566799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      ++|.+++.. ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........  ...
T Consensus       102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~  175 (292)
T cd06657         102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS  175 (292)
T ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence            999998754 467999999999999999999995   49999999999999999999999999998765433211  123


Q ss_pred             ccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHH
Q 037780          329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK  408 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  408 (455)
                      ..++..|+|||++.+..++.++||||||+++++|++|+.||........   .    .....+. .    .....  ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~----~~~~~~~-~----~~~~~--~~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M----KMIRDNL-P----PKLKN--LHK  241 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHhhC-C----cccCC--ccc
Confidence            4588999999999888899999999999999999999999875432111   0    1111110 0    00100  112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          409 CVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       409 ~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            3456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-36  Score=284.31  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=202.9

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEEEEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLVYE  244 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e  244 (455)
                      .+.||+|++|.||+|...   .++..+++|.+.....  ...+.+.+|+..+++++|+|++++++.+...  ...++|+|
T Consensus         5 ~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           5 GELLGRGSFGSVYLALDK---DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             eeEeeecCceEEEEEEEC---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            467999999999999986   3567899999865432  3467799999999999999999999999988  88999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            99999999999887799999999999999999999995   599999999999999999999999999998776544311


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                      ......++..|+|||.+.+...+.++||||||+++++|++|+.||......     ..............         .
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~---------~  224 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGEPP---------E  224 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCCCc---------C
Confidence            113345889999999998888999999999999999999999999755411     11111111111111         1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+......+.+++.+|++.+|++||++.+++.
T Consensus       225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            12223678899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.2e-37  Score=298.85  Aligned_cols=266  Identities=23%  Similarity=0.337  Sum_probs=196.1

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHccc-CCCCceeeeeeEecC--Ce
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG--QN  238 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~--~~  238 (455)
                      ..+.+.+.||+|+||.||+|.+.   ..+..+++|++...  .......+..|+.++.++ +||||+++++++...  ..
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDR---RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEc---CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            34566789999999999999976   34678999988542  122345677899999999 999999999998654  36


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++|+||++ ++|..++... .++|..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||+++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            899999997 5999998766 78999999999999999999995   599999999999999999999999999998765


Q ss_pred             CCCCc---cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHHHH-------HH
Q 037780          319 LNQSK---TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA-------FD  386 (455)
Q Consensus       319 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~~-------~~  386 (455)
                      .....   .......|+..|+|||++.+ ..++.++||||||+++|+|+||+.||.......... .....       ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            43321   12233568999999998765 457889999999999999999999996544321100 00000       00


Q ss_pred             HhhcCccccccc----cccc--cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          387 CYRNGKLDDLVE----GDME--AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       387 ~~~~~~~~~~~~----~~l~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .+.......+++    ....  ..........+.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000000000    0000  00001135678999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-37  Score=292.19  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=192.5

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.||.|++|.||+|...   ..+..++||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             eeeeecCCCceEEEEEEEC---CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            3467999999999999986   346789999886432  22335789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +. ++|..++..  ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            95 689888865  3568999999999999999999995   49999999999999999999999999998865432211


Q ss_pred             cccccccccCcccccccccCCC-CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc------------
Q 037780          324 TIKTAIRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN------------  390 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------  390 (455)
                        .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......  .+.... .....            
T Consensus       157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         157 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             --cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhHH
Confidence              12234688999999887654 5889999999999999999999997544311  111000 00000            


Q ss_pred             ----CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 ----GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ----~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          .............. .......+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         232 PDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                00000000000000 0112356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.2e-37  Score=288.78  Aligned_cols=246  Identities=23%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||+|....   ++..+|+|.+....  ....+.+.+|+.++++++|+|++++++.+......++|+|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            355789999999999999873   45678999986431  2334578899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  321 (455)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++ .+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999998754  357999999999999999999995   4999999999999999885 46999999998765332


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ...  ....|+..|+|||++.+..++.++||||||++++||++|+.||......      .+..... .+.....     
T Consensus       157 ~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~-----  222 (257)
T cd08225         157 ELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYFAPI-----  222 (257)
T ss_pred             ccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccCCCC-----
Confidence            211  2345889999999998888999999999999999999999998644321      1111111 1111111     


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          .......+.+++.+||+.+|++|||+.++++
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                1123467889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-37  Score=313.71  Aligned_cols=265  Identities=19%  Similarity=0.272  Sum_probs=183.8

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEE------------------EEeccccccccHHHHHHHHHHHcccCCCC
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVA------------------VKKLDRVFQDGEKEFKNEVVVIGQTHHKN  225 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~va------------------vK~~~~~~~~~~~~~~~e~~~l~~l~h~n  225 (455)
                      ..+.+.++||+|+||+||++.+....  +...+                  .|++.. .......+.+|+.++.+++|+|
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRAST--EEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccc--hhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            34556688999999999998765321  11111                  122211 1223456889999999999999


Q ss_pred             ceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       226 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      |+++++++...+..++|+|++. ++|.+++...     ..........|+.|++.||.|||+   .+|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            9999999999999999999985 5777776432     223456677899999999999995   599999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCC-CCccccchhhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAI  379 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p-~~~~~~~~~~~  379 (455)
                      +.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||+||||++|..+ +..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999998765432221 1345699999999999999999999999999999999998754 43322211111


Q ss_pred             hHHHHH-----------------HHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          380 LTDWAF-----------------DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       380 ~~~~~~-----------------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +.....                 ..+....+...................+.+++.+||+.||.+|||+.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111110                 000000000000000000000012345677889999999999999999986

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=301.70  Aligned_cols=249  Identities=21%  Similarity=0.329  Sum_probs=203.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .++.-.||.|+||.|||+..+   ..+...|-|.+...+....++|+-||++|+...||+||+|++.|...+.++++.||
T Consensus        34 WeIiGELGDGAFGKVyKA~nk---et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNK---ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcc---cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            456678999999999999987   34556677888777777778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |.||-.+..+-. ...+++.++.-++++++.||.|||   +.+|||||||+.|||++-+|.++|+|||.+.......  .
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--Q  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH--h
Confidence            999999988765 477899999999999999999999   5599999999999999999999999999886543221  1


Q ss_pred             ccccccccCcccccccc-----cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          325 IKTAIRGTKGYVAPEWY-----RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ....+.||+.|||||+.     ...+|+.++||||||++|.||..+.+|....++..       +.-.+......-++  
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKiaKSePPTLl--  256 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTLL--  256 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHhhcCCCccc--
Confidence            22457799999999986     45689999999999999999999999976433311       11111222222222  


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           .+......+.+++..||..||..||++.++++
T Consensus       257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 23456788999999999999999999999875

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=286.55  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHH-HcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.||.|+||.||+|....   .++.+|+|.+.....   .....+..|..+ ....+|+|++++++++..++..++|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence            468999999999998863   467899999864321   122334455444 4455899999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+++.....     
T Consensus        79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence            9999999999887889999999999999999999995   59999999999999999999999999998764331     


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....++..|+|||.+.+..++.++||||||++++||++|..||.......       .......+....      ....
T Consensus       151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~------~~~~  216 (260)
T cd05611         151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRINW------PEEV  216 (260)
T ss_pred             -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccCC------CCcc
Confidence             23457889999999988888999999999999999999999997544321       111111111110      0001


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      ....+..+.+++..||+.+|++||++.++.+.|.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            1124577899999999999999998877776664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-36  Score=292.56  Aligned_cols=247  Identities=23%  Similarity=0.293  Sum_probs=194.2

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      .++...+.||+|+||.||+|+..   ..+..+++|.+...   ......++.+|+.+++.++|+|++++.+++......+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc---CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            34455678999999999999986   34678999987532   2233456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      +|+||+. |+|.+++. ....+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9999997 57777764 34568999999999999999999995   4999999999999999999999999999876543


Q ss_pred             CCCccccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      .      ....++..|+|||++.   ...++.++||||||+++|+|++|+.||........      ... +..+.... 
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~~~~-  233 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNESPA-  233 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHH-HhhcCCCC-
Confidence            2      2235788999999874   35678899999999999999999999865432111      111 11111111 


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                             .........+.+++.+||+.+|.+||++.++++.-
T Consensus       234 -------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                   11123456788999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-36  Score=289.63  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=194.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||.|++|.||+|...   .++..+|||.+..... .....+.+|+.++++++|+|++++++++...+..++||||
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNR---TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             eEeeeeccCCceEEEEEEEC---CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            34578999999999999986   3567899999865432 2345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +++ +|.+++...   ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            985 888887643   458999999999999999999995   4999999999999999999999999999976543221


Q ss_pred             ccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHHH-------HHHHhhcC--
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRNG--  391 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~-------~~~~~~~~--  391 (455)
                      .  .....++..|++||.+.+. .++.++||||||+++|+|++|+.||......+... ....       .++.+...  
T Consensus       156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            1  1234478899999988654 56889999999999999999999997654322111 0000       00000000  


Q ss_pred             ---ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 ---KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ---~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ......+.... .........+.+++..|++.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQ-QLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHH-HHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               00000000000 000123467889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-36  Score=287.94  Aligned_cols=255  Identities=21%  Similarity=0.261  Sum_probs=191.4

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccC-CCCceeeeeeEecC--CeEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEG--QNRLLVY  243 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~  243 (455)
                      +.++||+|+||.||+|...   .++..+|+|++..... ........|+..+.++. |+|++++++++.+.  +..++|+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSR---KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             eEeeccccccceEEEEEEc---CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            4578999999999999986   3567899999865422 22234557888999885 99999999999887  8899999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||++ ++|.+++.. ...++|.++..++.|++.||+|||+.   +++|+||+|+||+++. +.+||+|||+++.......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            9997 578887765 35789999999999999999999954   9999999999999999 9999999999987653322


Q ss_pred             ccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHH-----------Hhhc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----------CYRN  390 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~  390 (455)
                      .   ....++..|+|||++.. ..++.++|||||||++|||++|+.||......+.   ..+...           ....
T Consensus       155 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         155 Y---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             c---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence            2   22347889999997644 5678899999999999999999999976543211   111111           1111


Q ss_pred             Ccccccccccccc----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLVEGDMEA----MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~~~~l~~----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ........+....    ......+..+.+++..||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1111110000000    001124678999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=290.38  Aligned_cols=245  Identities=22%  Similarity=0.347  Sum_probs=207.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      |++.+.||+|.|..|-++++-   -.|..||||++++..-+  ....+.+|++-|+.++|||||+|+.+......+|||+
T Consensus        20 YDLekTlG~GHFAVVKLArHV---FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhh---cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            556788999999999988776   56789999999865433  3456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |.-.+|+|++|+-.. ..+.+....+++.||+.|+.|+|+   ..+|||||||+||.+- .-|-+||+|||++..+.+..
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999998654 678999999999999999999995   5999999999998775 56789999999998877665


Q ss_pred             CccccccccccCcccccccccCCCCC-CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ..   +..+|+..|-|||.+.+..|+ +++||||+||+||.|++|+.||+..+..+               .+..++|-.
T Consensus       174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCK  235 (864)
T KOG4717|consen  174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCK  235 (864)
T ss_pred             hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhccc
Confidence            44   456799999999999999886 58999999999999999999998655433               222333332


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .  ..+.-...++.+++..||+.||++|-|.++|+.
T Consensus       236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2  234456789999999999999999999999985

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-36  Score=289.62  Aligned_cols=257  Identities=21%  Similarity=0.243  Sum_probs=202.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.||+|++|.||++.......++..+|||.+....    ....+.+.+|+.++.++ +|||++++++.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            34578999999999999876555567889999886421    22345688999999999 59999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++++|.+++.....+++.....++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||+++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            99999999999999877788999999999999999999995   599999999999999999999999999988754432


Q ss_pred             CccccccccccCcccccccccCCC--CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ... .....|+..|+|||.+.+..  .+.++||||||++++||++|..||.......  .............       .
T Consensus       160 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~-------~  229 (288)
T cd05583         160 EER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK-------P  229 (288)
T ss_pred             ccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC-------C
Confidence            211 12345889999999987654  7889999999999999999999986432211  0111111111110       0


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                          ..+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       230 ----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         230 ----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                0111234567889999999999999999999888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.8e-37  Score=298.54  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecC-----CeE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR  239 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  239 (455)
                      ...+.||+|+||+||++...   ..+..||||.+...  .......+.+|+.+++.++|+||+++++++...     ...
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNS---ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             eEEEEeccCCCeEEEEEEec---CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            34568999999999999976   45678999998643  223345678899999999999999999988654     357


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||+. ++|.+++.....+++.....++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            99999996 6899999888889999999999999999999995   4999999999999999999999999999987643


Q ss_pred             CCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHHHH-------HHHhhc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDWA-------FDCYRN  390 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~~-------~~~~~~  390 (455)
                      ...  ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.......... .....       ......
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         161 KGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             Ccc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            321  1133457889999998865 468899999999999999999999997543211100 00000       000000


Q ss_pred             Cccccc-------cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcC
Q 037780          391 GKLDDL-------VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGV  441 (455)
Q Consensus       391 ~~~~~~-------~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~  441 (455)
                      ......       .+...... .......+.+++.+||+.+|++|||+.++++.  ++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            000000       00000000 11245678999999999999999999999875  5553

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=294.40  Aligned_cols=265  Identities=21%  Similarity=0.286  Sum_probs=194.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL  241 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  241 (455)
                      .+.++||+|+||.||+|..... ..+..+|+|.+....   ......+.+|+.++.+++|||++++++++.+.  ...++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            4567899999999999998742 156889999987632   33346688899999999999999999999888  78999


Q ss_pred             EEEeCCCCCHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC----CCcEEEeecc
Q 037780          242 VYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD----HYNARISDFG  312 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg  312 (455)
                      ||||+++ +|.+++...     ..+++...+.|+.|++.||.|||+   .+|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 666665321     367899999999999999999995   59999999999999999    9999999999


Q ss_pred             CcccccCCCCc-cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh------hhHHHH
Q 037780          313 LAKLLTLNQSK-TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA------ILTDWA  384 (455)
Q Consensus       313 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~------~~~~~~  384 (455)
                      +++........ .......++..|+|||.+.+. .++.++||||||+++++|++|+.||.........      .....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            99876543221 111234578999999987664 5789999999999999999999999765432200      000000


Q ss_pred             HHHhhc------------CccccccccccccCCC---------H--HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          385 FDCYRN------------GKLDDLVEGDMEAMND---------I--KCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       385 ~~~~~~------------~~~~~~~~~~l~~~~~---------~--~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...+..            .......+.......+         .  .....+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            010000            0000000000000000         0  23456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.5e-36  Score=286.29  Aligned_cols=243  Identities=28%  Similarity=0.341  Sum_probs=192.3

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||+|+||+||++...   .++..+++|.+....   ......+.+|+.++++++|||++++++.+...+..++|+||+++
T Consensus         1 lg~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVK---ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEc---CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence            699999999999876   356789999885432   22344578899999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          249 GTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       249 gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|.+++....  .+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||.+.........   
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---  151 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---  151 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---
Confidence            99999997654  78999999999999999999995   49999999999999999999999999998765432211   


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ....++..|+|||++.+..++.++||||||+++++|++|+.||..........   ..    .......      ....+
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~----~~~~~~~------~~~~~  218 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---EL----KRRTLEM------AVEYP  218 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HH----Hhccccc------cccCC
Confidence            23457889999999988889999999999999999999999997544311100   00    0100000      00111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                      ......+.+++..||+.+|.+||     +..+++.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            12356788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.9e-36  Score=290.65  Aligned_cols=260  Identities=24%  Similarity=0.294  Sum_probs=193.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC-----
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----  237 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----  237 (455)
                      .+.+.+.||+|+||.||+|....   ++..+|+|.++...  ......+.+|+.++++++|||++++++++.+..     
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            34556889999999999999873   46789999986432  223456788999999999999999999987654     


Q ss_pred             -----eEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          238 -----NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       238 -----~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                           ..++|+||+++ +|...+... ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcc
Confidence                 78999999986 666666543 578999999999999999999995   49999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |++........... ....++..|+|||.+.+ ..++.++||||||++++||++|+.||........  + ..+......
T Consensus       161 g~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~-~~~~~~~~~  236 (302)
T cd07864         161 GLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--L-ELISRLCGS  236 (302)
T ss_pred             cccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCC
Confidence            99987654332111 22346788999998865 3578999999999999999999999975433111  1 011111000


Q ss_pred             C---ccccc--------ccc------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 G---KLDDL--------VEG------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~---~~~~~--------~~~------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .   ....+        .+.      ..... ....+..+.+++..||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0   00000        000      00000 0013567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-36  Score=285.92  Aligned_cols=242  Identities=25%  Similarity=0.289  Sum_probs=188.7

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHH---HHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVV---VIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .||+|+||.||++...   ..++.||+|.+.....   .....+..|..   .+....|||++++.+++...+..++|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEe---cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence            3899999999999876   3467899998864321   12223444443   3444579999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..|+.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++........  
T Consensus        78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            99999999999888889999999999999999999995   5999999999999999999999999999876543221  


Q ss_pred             ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        ....|+..|+|||.+.++ .++.++||||+|++++||++|+.||..........    .......      ....+  
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~--  218 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVEL--  218 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCC--
Confidence              234589999999998754 68999999999999999999999997553221111    0000000      01111  


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                        +...+..+.+++..|++.+|.+||     ++.++++
T Consensus       219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              112356788999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=283.20  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=201.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|++|.||++...   ..+..+++|.+.....  .....+.+|++++.+++|+|++++++++.+....++|+|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNL---ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEc---CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            35678999999999999876   3457899999876543  345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            99999999999888889999999999999999999994   59999999999999999999999999999876543322 


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                       .....++..|+|||.+.+..++.++||||+|+++++|++|+.||.......  .    .... .......         
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~----~~~~-~~~~~~~---------  218 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--A----LFRI-VQDDHPP---------  218 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--H----HHHH-hccCCCC---------
Confidence             123457889999999988888999999999999999999999987443211  0    0111 1111111         


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+......+.+++.+||+.+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11123567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.9e-36  Score=295.99  Aligned_cols=260  Identities=23%  Similarity=0.274  Sum_probs=193.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecC------C
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  237 (455)
                      +...+.||+|+||.||++...   ..+..+|+|.+...  .......+.+|+.++++++|+|++++++++...      .
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDT---VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEEC---CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            344578999999999999886   35678999998643  223345678899999999999999999988543      3


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++|+||+. ++|.+.+...  +++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            5799999996 4888887654  8899999999999999999995   49999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh-hhhH-----------H---
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILT-----------D---  382 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-~~~~-----------~---  382 (455)
                      .....   .....++..|+|||.+.+..++.++||||||+++++|++|+.||........ ..+.           .   
T Consensus       169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         169 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             CCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            43322   1234578999999999999999999999999999999999999975432110 0000           0   


Q ss_pred             -HHHHHhhcCc------ccccccccc----ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          383 -WAFDCYRNGK------LDDLVEGDM----EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       383 -~~~~~~~~~~------~~~~~~~~l----~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                       ..........      +.++.....    ...........+.+++..||+.||++|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0000000000      001111000    001112346678899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-36  Score=292.60  Aligned_cols=264  Identities=20%  Similarity=0.267  Sum_probs=191.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  237 (455)
                      +.+.++||+|+||.||+|...   .++..+|||.+....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~---~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHK---KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEEC---CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            445678999999999999876   356789999885432  222345678999999999999999999986654      


Q ss_pred             --eEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          238 --NRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       238 --~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                        ..++|+||+.+ +|.+++... ..+++.+.+.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45999999975 787777654 4789999999999999999999954   9999999999999999999999999999


Q ss_pred             ccccCCCCc--cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          315 KLLTLNQSK--TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       315 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      .........  .......++..|+|||.+.+. .++.++||||||++++||++|+.||......................
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            866433221  111234578899999988664 47889999999999999999999997654422211111111000000


Q ss_pred             ccccc-----cc----cc-c----c-cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDL-----VE----GD-M----E-AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~-----~~----~~-l----~-~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....     .+    +. .    . ..........+.+++.+||+.||.+|||++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000     00    00 0    0 0000011345678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.6e-36  Score=292.33  Aligned_cols=259  Identities=24%  Similarity=0.297  Sum_probs=192.4

Q ss_pred             hhcCcC--CCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          170 EEAGRG--SFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G--~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ++||+|  +||+||++...   ..+..||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHT---PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEc---CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            567777  89999999876   457889999986432  22346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +.+++|.+++...  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+.........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999998764  458899999999999999999994   59999999999999999999999999865433221111


Q ss_pred             c-----ccccccccCcccccccccCC--CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH-----------
Q 037780          324 T-----IKTAIRGTKGYVAPEWYRKS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF-----------  385 (455)
Q Consensus       324 ~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----------  385 (455)
                      .     ......++..|+|||++.+.  .++.++||||||++++||++|+.||........  ......           
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence            0     00112346679999998764  478999999999999999999999975432111  000000           


Q ss_pred             -----HH-------h---------hcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          386 -----DC-------Y---------RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       386 -----~~-------~---------~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           ..       .         ..+....+.+..+...........+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                 00       0         000000111111222223345678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=284.32  Aligned_cols=248  Identities=21%  Similarity=0.263  Sum_probs=194.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-----ccccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNR  239 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~  239 (455)
                      .+.+.||+|+||.||+|...   .++..+++|.+...     .......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDA---DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEc---CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            45678999999999999876   34678999987421     122345789999999999999999999998664  457


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||+++++|.+++.....+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            8999999999999999877778999999999999999999995   4999999999999999999999999999986543


Q ss_pred             CCC-ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          320 NQS-KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       320 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ... ........++..|+|||++.+..++.++||||||+++++|++|+.||.......      .+.......       
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-------  225 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQP-------  225 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcCC-------
Confidence            211 111123458899999999998889999999999999999999999997432211      011111111       


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .....+....+.+.+++..|++ +|..|||..+++.
T Consensus       226 --~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 --TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              1111222345778999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-36  Score=284.41  Aligned_cols=244  Identities=26%  Similarity=0.356  Sum_probs=200.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||++...   .++..+++|.+....  .....++.+|+.++++++|+||+++.+++.+....++|+|
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRL---SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             eEeeeecCCCceeEEEEEEC---CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            34578999999999999876   356789999886432  2334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          245 FLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       245 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+++++|.+++..    ...+++..++.++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999999865    356899999999999999999999   459999999999999999999999999999877654


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ..    ....++..|+|||.+.+..++.++|+||||+++|||++|+.||.......       .......+....+    
T Consensus       157 ~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~----  221 (256)
T cd08530         157 MA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYPPI----  221 (256)
T ss_pred             Cc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCCCC----
Confidence            21    23457889999999999889999999999999999999999997554321       1111122222111    


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           .......+.+++..|++.+|.+|||+.++++
T Consensus       222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         222 -----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -----chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 1234677899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-36  Score=290.12  Aligned_cols=257  Identities=22%  Similarity=0.281  Sum_probs=189.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccC-CCCceeeeeeEecCCe-----
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQN-----  238 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~-----  238 (455)
                      ...+.||+|+||.||+|...   .++..||+|.......  .....+.+|+.++++++ |+|++++++++...+.     
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~---~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDK---NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             eEeeEecccCCeEEEEEEEC---CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            34578999999999999986   3567899998764322  23457888999999995 6999999999877665     


Q ss_pred             EEEEEEeCCCCCHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeecc
Q 037780          239 RLLVYEFLNNGTLASFLFGN-----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFG  312 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg  312 (455)
                      .++||||+++ +|.+++...     ..+++..++.++.||+.||.|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 788887542     357999999999999999999995   59999999999999998 8999999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      +++.........  ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||........  +.. ....+...
T Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTP  231 (295)
T ss_pred             cceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCC
Confidence            988654322111  22346889999998865 4578999999999999999999999975433111  000 00110000


Q ss_pred             cc---ccc---c---------ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KL---DDL---V---------EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~---~~~---~---------~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..   ...   .         ...+.. ........+.+++..||+.+|.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00   000   0         000000 00123567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=286.60  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=194.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|....   .+..++||++..... .......+|+..+.+++ |+|++++++++..++..++|||
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             eeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            356789999999999999863   457899999865432 22334567999999999 9999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+ +|+|.+++....  .+++.++..++.|++.+|.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            99 889999887654  78999999999999999999995   4999999999999999999999999999986643322


Q ss_pred             ccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hH---------HHHHHHhhcC
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LT---------DWAFDCYRNG  391 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~---------~~~~~~~~~~  391 (455)
                      .   ....++..|+|||++.. ..++.++|+||||++++||++|+.||......+... ..         .|........
T Consensus       155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            1   23457889999998754 457899999999999999999999996554321110 00         0000000000


Q ss_pred             ccccccc----cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVE----GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~----~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+...+.    ..+....+ .....+.+++..||+.+|++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1110000    00000001 11467899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=298.29  Aligned_cols=265  Identities=23%  Similarity=0.318  Sum_probs=194.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC-----CeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  239 (455)
                      +.+.+.||+|+||.||+|...   .++..||+|++.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEc---CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            345578999999999999886   356789999986432 23345688899999999999999999987544     357


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||+++ +|..++. ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            999999975 8887774 4568999999999999999999995   5999999999999999999999999999986543


Q ss_pred             CCCcc-ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc---cc
Q 037780          320 NQSKT-IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LD  394 (455)
Q Consensus       320 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  394 (455)
                      ..... ......||..|+|||.+.+ ..++.++||||||+++++|++|+.||........   .......+....   ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence            32211 1123458899999998754 4688999999999999999999999965432110   011111111000   00


Q ss_pred             cccccc-------c--ccCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcC
Q 037780          395 DLVEGD-------M--EAMN-----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGV  441 (455)
Q Consensus       395 ~~~~~~-------l--~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~  441 (455)
                      .+.+..       .  ....     .......+.+++..||+.+|++|||+.++++.  ++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            000000       0  0000     01124678899999999999999999999985  5553

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.6e-37  Score=297.47  Aligned_cols=264  Identities=22%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec----CCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~  239 (455)
                      +.+.+.||+|+||.||+|...   ..+..+++|++....  ......+.+|+.++.+++||||+++++++..    ....
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDT---RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEc---CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            344578999999999999887   346789999986532  2335668889999999999999999998753    3468


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||+. ++|.+++.....+++.....++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            99999995 6999999888889999999999999999999995   4999999999999999999999999999986543


Q ss_pred             CCCc--cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHH--------HHHHh
Q 037780          320 NQSK--TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDCY  388 (455)
Q Consensus       320 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~  388 (455)
                      ....  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............        .....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            3221  11123468899999999865 4688999999999999999999999975443111100000        00000


Q ss_pred             hcCccccccccc-cccCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          389 RNGKLDDLVEGD-MEAMN-----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       389 ~~~~~~~~~~~~-l~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+....+.. .....     ....+..+.+++..||+.+|.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000000000 00000     0123577899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.5e-36  Score=294.36  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=195.7

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc--------------HHHHHHHHHHHcccCCCCceeeeeeE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--------------EKEFKNEVVVIGQTHHKNLVRLLGFC  233 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~g~~  233 (455)
                      +.+.||.|+||+||+|...   ..++.+|||.+.......              ...+.+|+.++++++|+||+++++++
T Consensus        13 ~~~~ig~G~~g~vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDT---LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY   89 (335)
T ss_pred             hhhcccCCCceeEEEEEEC---CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence            3467999999999999976   356789999885432211              12578899999999999999999999


Q ss_pred             ecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          234 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       234 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ...+..++||||++ ++|.+++.....+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         90 VEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             ecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence            99999999999997 6999999887889999999999999999999995   5999999999999999999999999999


Q ss_pred             cccccCCCC------------ccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh
Q 037780          314 AKLLTLNQS------------KTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL  380 (455)
Q Consensus       314 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~  380 (455)
                      ++.......            ........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.   
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---  242 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ---  242 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence            986651110            0111223468899999998764 468899999999999999999999976554221   


Q ss_pred             HHHHHHHhhcCc---cccc------------cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          381 TDWAFDCYRNGK---LDDL------------VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       381 ~~~~~~~~~~~~---~~~~------------~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ...+........   +...            ........ .......+.+++..||+.+|++|||+.+++..
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            111111111100   0000            00000000 01235678899999999999999999999963

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.5e-36  Score=288.58  Aligned_cols=241  Identities=25%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .++||+|+||+||+|+..   ..+..+++|++.....   .....+.+|+.++.+++|||++++++++.+....++||||
T Consensus        26 ~~~lg~g~~g~v~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          26 LHEIGHGSFGAVYFATNS---HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             ceeeccCCCeEEEEEEEC---CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            357999999999999876   3567899999864322   2335688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +. ++|.+++.. ...+++.++..++.|++.+|.|||+   .+++|+||+|+||+++.++.+||+|||++......    
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            96 577777654 4678999999999999999999995   49999999999999999999999999998643221    


Q ss_pred             ccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                        ....|+..|+|||++.   ...++.++||||||+++|||++|+.||........      ...... .......    
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~-~~~~~~~----  241 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NDSPTLQ----  241 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh-cCCCCCC----
Confidence              2345888999999984   45688899999999999999999999865433111      111111 1111111    


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                          .......+.+++.+||+.+|.+||++.+++..
T Consensus       242 ----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                11234568899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-36  Score=288.75  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=191.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|++|+||+|...   .+++.+++|++....  ....+.+.+|+.++++++|+|++++++++......++|+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDR---VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEec---CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            345578999999999999986   346789999986432  223457889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcccccCC
Q 037780          244 EFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLN  320 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||++ ++|.+++....  ..++.....++.|++.||+|||+   .+++|+||+|+||+++. ++.+||+|||++......
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9996 57887775543  35788888999999999999995   49999999999999985 567999999999765432


Q ss_pred             CCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---cc---
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KL---  393 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---  393 (455)
                      ...  .....++..|+|||++.+. .++.++||||||+++|+|+||+.||......+...  . ........   ..   
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--K-IFRILGTPNEETWPGV  231 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCCCChhhcccc
Confidence            211  1233578899999988664 57899999999999999999999997644321110  0 00000000   00   


Q ss_pred             cccccc-----ccccC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEG-----DMEAM----NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~-----~l~~~----~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+.+.     .....    ........+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000     00000    01123456889999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.9e-36  Score=280.71  Aligned_cols=239  Identities=21%  Similarity=0.245  Sum_probs=185.3

Q ss_pred             hhhh--cCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc-cCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEE--AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~--lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.  ||+|+||.||++...   ..+..+++|.........   .  |+..... .+|||++++++.+...+..++|||
T Consensus        18 ~~~~~~lg~g~~g~v~~~~~~---~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         18 IVKKLKLIDGKFGKVSVLKHK---PTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             cccceeecCCCceEEEEEEEc---CCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            3444  599999999999876   346778998875432111   1  2222221 279999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++.....++|.++..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||+++......  
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--  164 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--  164 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence            99999999999887789999999999999999999995   4899999999999999998 99999999987654322  


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                          ...++..|+|||++.+..++.++||||||++++||++|+.||.....+. .....+....  ....          
T Consensus       165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~~----------  227 (267)
T PHA03390        165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--QKKL----------  227 (267)
T ss_pred             ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--cccC----------
Confidence                2357899999999998899999999999999999999999997443322 1111111111  0000          


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPT-MRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~~v~~  436 (455)
                      .........+.+++..||+.+|.+||+ ++++++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            011134567889999999999999996 688773

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.5e-36  Score=281.42  Aligned_cols=245  Identities=25%  Similarity=0.379  Sum_probs=201.1

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.||.|+||.||++....   ++..+++|++.....  .....+.+|++++++++|+|++++.+.+......++|+||
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            45679999999999999863   467899999875432  4556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          246 LNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       246 ~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +++++|.+++...    ..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999763    678999999999999999999995   499999999999999999999999999998765443


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .  ......|++.|+|||.+....++.++||||+|+++++|++|+.||.......       .......+....+     
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~-----  223 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKILKGQYPPI-----  223 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHhcCCCCCC-----
Confidence            1  1133458889999999988889999999999999999999999986543211       1111111111111     


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          +......+.+++.+||..+|++|||+.++++
T Consensus       224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1134567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-36  Score=291.64  Aligned_cols=249  Identities=23%  Similarity=0.360  Sum_probs=198.1

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~  240 (455)
                      ..++..++||+||.+.||++...    +...+|+|++...  ..+....|.+|+..|.+++ |.+||+|++|-..++.+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            34566789999999999999865    4567888887532  2344567999999999995 999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          241 LVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      |||||= .-+|..+|.....  +.| .++.+..|++.++.++|++   +|||.||||.|+|+-. |.+||+|||+|..+.
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            999986 5699999986532  345 6777999999999999976   9999999999999975 589999999999998


Q ss_pred             CCCCccccccccccCcccccccccCC-----------CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKS-----------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      .+.+.......+||+.||+||.+...           ..+++|||||+||+||+|+.|+.||....     +  .|.   
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~a---  580 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIA---  580 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHH---
Confidence            88877777788999999999988432           25679999999999999999999996321     1  111   


Q ss_pred             hhcCccccccccccccCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          388 YRNGKLDDLVEGDMEAMND-IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       388 ~~~~~~~~~~~~~l~~~~~-~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          ++..+.++.-+-.++ .....+++++++.||+.||.+|||+.++++
T Consensus       581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                233344443221111 112234899999999999999999999986

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-36  Score=294.26  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=193.0

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC------CeEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QNRL  240 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~  240 (455)
                      .+.||+|+||.||+|...   ..+..+|+|++....  ......+.+|+.++++++||||+++++++...      ...+
T Consensus        20 ~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   96 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDK---RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY   96 (342)
T ss_pred             EEEeeecCCeEEEEEEeC---CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence            367999999999999876   346789999986432  22345688999999999999999999998654      3468


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +|+||+.. +|..++.  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        97 lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          97 LVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             EEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            99999964 7777652  468899999999999999999995   49999999999999999999999999998765322


Q ss_pred             CCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHH--------HHHHhhcC
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDCYRNG  391 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~  391 (455)
                      .     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............        ..+.+...
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         171 M-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             C-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            1     23457889999999876 4688999999999999999999999975432111000000        00000000


Q ss_pred             cccccc-------ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCcCCCCCCCC
Q 037780          392 KLDDLV-------EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVDVPPNP  450 (455)
Q Consensus       392 ~~~~~~-------~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~~~~~p~~p  450 (455)
                      ......       ...+.... ......+.+++..||+.||++||++.+++.  .+++..+....+.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~  312 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQ  312 (342)
T ss_pred             chHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCC
Confidence            000000       00000000 012356789999999999999999999994  47765554333333

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.2e-36  Score=285.08  Aligned_cols=253  Identities=21%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.||.|+||.||++.......++..+|+|.+....    ....+.+.+|+.++.++ +|+||+++.+++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            34578999999999999876544467889999986432    12346688999999999 59999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+||+++++|.+++.....+++.....++.|++.||.|||+   .+++||||+|+|||+++++.+||+|||+++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999888888999999999999999999995   599999999999999999999999999998764332


Q ss_pred             CccccccccccCcccccccccCC--CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      .... ....|+..|+|||.+...  .++.++||||||+++|+|++|+.||.......  ..............       
T Consensus       160 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~-------  229 (290)
T cd05613         160 VERA-YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP-------  229 (290)
T ss_pred             cccc-ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCC-------
Confidence            2211 234588999999998753  46789999999999999999999996432211  11111111111110       


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                          ..+......+.+++..||+.+|++||     ++.+++.
T Consensus       230 ----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 ----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                01112346778999999999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.2e-36  Score=290.27  Aligned_cols=262  Identities=26%  Similarity=0.297  Sum_probs=192.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  241 (455)
                      +++.+.||+|+||.||+|...   ..+..||+|.+.....  .....+.+|+.++.+++|+|++++++++.+.  +..++
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDT---TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEEC---CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            345578999999999999986   3567899999864322  2233567899999999999999999998755  46899


Q ss_pred             EEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+||+.+ +|.+++.. ...+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999975 78888765 3678999999999999999999995   49999999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHHH-------HHHHhhcC
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTDW-------AFDCYRNG  391 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~-------~~~~~~~~  391 (455)
                      ....  ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +...       .+..+...
T Consensus       162 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            2111  22345788999999865 457899999999999999999999997654322111 0000       00000000


Q ss_pred             cc-ccc--cccccccC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KL-DDL--VEGDMEAM--NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~-~~~--~~~~l~~~--~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .. ...  ........  ........+.+++..||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00 000  00000000  00012556789999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=285.47  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ..+.||.|++|.||++...   .++..+++|++.....  .....+..|+.++++++|+|++++++++..++..++|+||
T Consensus         3 ~~~~i~~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDK---LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             cceeeecCCCceEEEEEcC---CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            4567999999999999976   3567899999865432  2456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++ +|.+++.. ...+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.+||+|||.+......... 
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~-  154 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-  154 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc-
Confidence            975 88887765 4678999999999999999999995   49999999999999999999999999999877654311 


Q ss_pred             ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---ccccc----
Q 037780          325 IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDL----  396 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~----  396 (455)
                       .....++..|+|||.+.+. .++.++||||||+++++|+||+.||......+...   .....+...   ....+    
T Consensus       155 -~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         155 -YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             -ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCchHhcccchhhh
Confidence             1234578899999998776 78999999999999999999999996544321100   000000000   00000    


Q ss_pred             -------cccccc--cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 -------VEGDME--AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 -------~~~~l~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ......  .....+....+.+++..||+.+|.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   000000  0011234678899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4e-36  Score=287.75  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=191.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||+|....   .+..+|||.+.... .....++..|+.++.+.. |+||+++++++......++||
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3566889999999999999863   36789999986532 223455677777776664 999999999999999999999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++ +|.+++.. ...+++..+..|+.|++.||+|||+.  .+|+||||+|+||++++++.+||+|||++........
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            99854 77776654 45789999999999999999999952  4899999999999999999999999999986643322


Q ss_pred             ccccccccccCcccccccccCCC----CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      .   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....+.     +........ ....+..
T Consensus       171 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-~~~~~~~  241 (296)
T cd06618         171 K---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQE-EPPSLPP  241 (296)
T ss_pred             c---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcC-CCCCCCC
Confidence            2   2234788999999987553    7889999999999999999999996432211     111111111 1111100


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                             .......+.+++.+||+.+|++||++.++++.
T Consensus       242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   11235678999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=282.95  Aligned_cols=257  Identities=26%  Similarity=0.305  Sum_probs=191.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHccc---CCCCceeeeeeEecCCe----
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCDEGQN----  238 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~~~~----  238 (455)
                      +.+.||+|+||.||+|....   ++..+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.    
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             EEEEecccCceEEEEEEECC---CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            45689999999999999863   467899999864322  2234566787777665   69999999999988776    


Q ss_pred             -EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          239 -RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       239 -~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                       .+++|||+++ +|.+++...  ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcce
Confidence             8999999974 898888654  358999999999999999999995   499999999999999999999999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc--
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL--  393 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  393 (455)
                      ........   ....++..|+|||++.+..++.++||||||++++||++|+.||......+.  +..........+..  
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  230 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW  230 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence            76543221   233478899999999988999999999999999999999999876543221  11111000000000  


Q ss_pred             -------ccccccccc---cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 -------DDLVEGDME---AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 -------~~~~~~~l~---~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             .........   .....+....+.+++.+||+.+|++||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                   000000000   0001133567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-36  Score=294.42  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=203.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC-----eE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-----NR  239 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-----~~  239 (455)
                      .+.+.||.|+||.||+|...   ..+..+++|++....  ....+.+.+|+.++++++|+||+++.+++....     ..
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDK---RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeC---CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            45678999999999999976   346789999987643  334567999999999999999999999988775     78


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||++ ++|.+++.....+++..+..++.+++.||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999998 5899999887889999999999999999999995   5999999999999999999999999999987654


Q ss_pred             CCCc-cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHh---------
Q 037780          320 NQSK-TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY---------  388 (455)
Q Consensus       320 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------  388 (455)
                      .... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+...   ......         
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  232 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHhh
Confidence            4310 111334578899999999887 78999999999999999999999997655322111   000000         


Q ss_pred             --hcCcccccccc-ccccC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcCc
Q 037780          389 --RNGKLDDLVEG-DMEAM-----NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGVV  442 (455)
Q Consensus       389 --~~~~~~~~~~~-~l~~~-----~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~~  442 (455)
                        ........+.. .....     ........+.+++..||+.+|.+|||+.+++..  +++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence              00000000000 00000     011135678899999999999999999999974  55533

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.7e-35  Score=284.33  Aligned_cols=258  Identities=17%  Similarity=0.186  Sum_probs=189.6

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .+.+|.|+++.||++..     ++..+|+|++...  .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         7 ~~~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hHhhcCCceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            34455555555555542     5778999998653  2344567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC--
Q 037780          247 NNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS--  322 (455)
Q Consensus       247 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--  322 (455)
                      ++++|.+++...  ..+++.....++.|++.||+|||+   .+|+|+||||+||+++.++.+||+|||.+........  
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999999753  467889999999999999999995   4999999999999999999999999998875532211  


Q ss_pred             ---ccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH----hhcC--
Q 037780          323 ---KTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC----YRNG--  391 (455)
Q Consensus       323 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~--  391 (455)
                         ........++..|+|||++..  ..++.++||||||+++|||++|+.||.......  ...+.....    +...  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence               111123447789999999866  358899999999999999999999997543211  111100000    0000  


Q ss_pred             -----cccc----ccccc----cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 -----KLDD----LVEGD----MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 -----~~~~----~~~~~----l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           ....    ..++.    ............+.+++..||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                 0000    00000    111112234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.9e-36  Score=281.48  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=192.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.++||+|+||.||++...........+++|.....  ......++..|+.++++++|||++++++++.+....++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            34567899999999999988754333334444443321  1223445778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+   .+++|+||+|+||++++ +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998853    3578999999999999999999995   59999999999999975 5699999999887643


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ....  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......      ..... ...+...     
T Consensus       158 ~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~-~~~~~~~-----  223 (260)
T cd08222         158 SCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLR-IVEGPTP-----  223 (260)
T ss_pred             Cccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHH-HHcCCCC-----
Confidence            3221  13345788999999998888899999999999999999999998643221      11111 1111111     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          ..+......+.+++.+||+.+|++||++.++++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                112244678899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-36  Score=293.47  Aligned_cols=245  Identities=23%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc--HHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|.|+.|..|+...   .+..||+|.+++.....  ...+.+|+++|..++|||||+++.+.......|+||
T Consensus        58 y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            3455789999999999999884   46789999998754332  244889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+.+|.+++++.............++.|+..+++|||+   ..|+|||||++||||+.+.++||+|||++..+......
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecccccc
Confidence            999999999999998888888999999999999999995   59999999999999999999999999999988744332


Q ss_pred             cccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                         ...+|++.|.|||++.+..+ .+.+|+||+|++||-|++|..||+...-.+...               ..+...++
T Consensus       212 ---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk~r  273 (596)
T KOG0586|consen  212 ---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGKYR  273 (596)
T ss_pred             ---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeeeec
Confidence               55789999999999998876 578999999999999999999998654322110               01111111


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      -  +.....++.++++..+-.+|.+|++++++.+
T Consensus       274 I--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  274 I--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             c--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1  1123456778889999999999999999875

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.6e-36  Score=284.46  Aligned_cols=247  Identities=25%  Similarity=0.300  Sum_probs=199.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.||+|+||.||++....   ++..+++|.+...   .....+.+..|+.++.+++ |+||+++++++..++..++|
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            455789999999999999873   5678999988642   2233467889999999998 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++.....+++..++.|+.|++.||.|||+   .+++|+||+|+||+++.++.++++|||++........
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            9999999999999888889999999999999999999995   4999999999999999999999999999986654322


Q ss_pred             c------------------cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH
Q 037780          323 K------------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       323 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  384 (455)
                      .                  .......++..|+|||++....++.++||||||++++++++|+.||........      .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~  231 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT------F  231 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH------H
Confidence            1                  111234578899999999888899999999999999999999999975542110      0


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTM----RKVSQ  436 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~----~~v~~  436 (455)
                      .... ..          ....+......+.+++..||+.+|++|||+    .++++
T Consensus       232 ~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 QKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1111 10          001112235678999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=286.45  Aligned_cols=240  Identities=28%  Similarity=0.329  Sum_probs=196.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||+||||.||-+...   .+|+++|.|++.+.   ..+++.-.++|-.+|.+++.+.||.+--.|+..+..+||+..|
T Consensus       191 RvlGkGGFGEV~acqvr---aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM  267 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVR---ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM  267 (591)
T ss_pred             EEEecccccceeEEEEe---cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence            57999999999999887   45789999998653   2345566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          247 NNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       247 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      .||+|.-+|.+.+  .+++....-++.+|+.||++||+   ..||.|||||+|||||+.|+++|+|+|+|..+...... 
T Consensus       268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~-  343 (591)
T KOG0986|consen  268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI-  343 (591)
T ss_pred             cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence            9999999998754  78899999999999999999995   49999999999999999999999999999987765543 


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                        +..+||.||||||++.+..|+...|.||+||+||||+-|+.||..........            .++..+... ...
T Consensus       344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e------------Evdrr~~~~-~~e  408 (591)
T KOG0986|consen  344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE------------EVDRRTLED-PEE  408 (591)
T ss_pred             --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH------------HHHHHHhcc-hhh
Confidence              44579999999999999999999999999999999999999997554322110            111111000 112


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                      ++...+++...+....|+.||++|.--
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhccC
Confidence            334456677777777899999998543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=281.44  Aligned_cols=259  Identities=25%  Similarity=0.338  Sum_probs=197.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.||+|++|.||+|....   .+..+++|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             eehcccccCcceEEEeeecC---CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            45679999999999999873   46789999987543  33346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      ++ ++|.+++... ..+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||+++.........
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            98 5899999776 5789999999999999999999954   99999999999999999999999999998765432211


Q ss_pred             ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh-hhHH-------HHHHHhh-----c
Q 037780          325 IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTD-------WAFDCYR-----N  390 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~-~~~~-------~~~~~~~-----~  390 (455)
                        ....++..|+|||.+.+. .++.++||||||++++||++|+.||......+.. .+..       ..+..+.     .
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         156 --THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             --CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence              223457789999998776 7899999999999999999999999765432110 0000       0000000     0


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .............. .......+.+++..||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000000000 0112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=269.49  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=209.3

Q ss_pred             ccCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeE
Q 037780          155 CFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFC  233 (455)
Q Consensus       155 ~~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~  233 (455)
                      .-++.++.+-|.   +.||+|+++.|-.++..   .++.++|||++++...+......+|++++.+.+ |+||+.|+.||
T Consensus        72 ~g~F~d~YkLt~---e~LGeGAyasVqtcv~i---~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   72 SGKFEDMYKLTS---ELLGEGAYASVQTCVSI---QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             cchHHHHHHhHH---HHhcCccceeeeeeeee---ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            345677776664   57999999999988876   467889999999887778888999999999985 99999999999


Q ss_pred             ecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc---EEEee
Q 037780          234 DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISD  310 (455)
Q Consensus       234 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  310 (455)
                      +++...|||||-|.||+|..+++....+++.++.++..+|+.||.+||   ..+|.||||||+|||-.....   +||+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeec
Confidence            999999999999999999999999999999999999999999999999   559999999999999976554   89999


Q ss_pred             ccCcccccCC--CC---ccccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhh--
Q 037780          311 FGLAKLLTLN--QS---KTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--  378 (455)
Q Consensus       311 fg~a~~~~~~--~~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--  378 (455)
                      |.+..-....  -+   .+-...-+|+..|||||+..     ...|+.+.|.|||||+||-|++|.+||.+..+++-.  
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            9887543221  11   11112346888999999763     235788999999999999999999999876653211  


Q ss_pred             ------hhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          379 ------ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       379 ------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                            .=...+.+.+.+|..+ +.|.+.     ...+.+..+++...+..++.+|.++..++.
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkYe-FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKYE-FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCCc-CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                  1112223333444332 333221     123556677777788899999999998886

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.8e-36  Score=286.80  Aligned_cols=264  Identities=23%  Similarity=0.249  Sum_probs=189.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCC------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  237 (455)
                      +.+.+.||+|+||.||+|...   .++..+++|++.....  .....+.+|++++++++|+||+++++++.+..      
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQI---KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEEC---CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            345578999999999999976   3467799998854322  22346788999999999999999999875433      


Q ss_pred             --eEEEEEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          238 --NRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       238 --~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                        ..++|+||+.+ +|...+.. ...+++.++..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46999999975 66666654 4578999999999999999999995   59999999999999999999999999999


Q ss_pred             ccccCCCCcc---------ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH
Q 037780          315 KLLTLNQSKT---------IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       315 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  384 (455)
                      +.........         ..+...++..|+|||.+.+. .++.++||||||++++||++|+.||...............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            8654332111         11234578889999987654 5789999999999999999999999765442211110000


Q ss_pred             HHHhhc------Ccccccc----ccccccC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          385 FDCYRN------GKLDDLV----EGDMEAM---NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       385 ~~~~~~------~~~~~~~----~~~l~~~---~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ......      ..+....    .......   ........+.+++.+||+.+|.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000      0000000    0000000   00112357889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=274.85  Aligned_cols=237  Identities=28%  Similarity=0.290  Sum_probs=194.0

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      ||+|+||.||++....   .+..+++|.+.....   .....+..|+.++++++|+|++++++.+..+...++||||+++
T Consensus         1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence            7999999999999863   467899998865432   2345789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      ++|.+++.....+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT  152 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence            9999999888889999999999999999999995   5999999999999999999999999999987654321  1134


Q ss_pred             ccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHH
Q 037780          329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK  408 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  408 (455)
                      ..++..|+|||.+.+...+.++|+||||+++|+|++|+.||.......   +   .... ..+..          ..+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~---~~~~-~~~~~----------~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---I---YEKI-LKDPL----------RFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHH-hcCCC----------CCCCC
Confidence            458889999999988888999999999999999999999996543211   1   1111 11110          11112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHH
Q 037780          409 CVEKLLMVSIWCIQEDPSLRPTMRK  433 (455)
Q Consensus       409 ~~~~~~~l~~~cl~~~p~~RPt~~~  433 (455)
                      .+..+.+++..||..+|++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2567889999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8e-36  Score=291.53  Aligned_cols=263  Identities=22%  Similarity=0.237  Sum_probs=190.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecC---------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG---------  236 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~---------  236 (455)
                      +.+.+.||.|+||.||+|...   ..+..|++|++........+.+.+|+.++++++||||+++++++...         
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~---~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDS---DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEEC---CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            445678999999999999876   35678999998765555667799999999999999999999876543         


Q ss_pred             -----CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEee
Q 037780          237 -----QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISD  310 (455)
Q Consensus       237 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D  310 (455)
                           ...++|+||++ ++|.+++.. ..+++.....++.|++.||.|||+   .+++||||||+||+++ +++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence                 35789999997 589888854 468899999999999999999995   4999999999999998 556789999


Q ss_pred             ccCcccccCCCCcc-ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH----
Q 037780          311 FGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA----  384 (455)
Q Consensus       311 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~----  384 (455)
                      ||+++.+....... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...............    
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998654322111 1122347889999998654 46788999999999999999999999755431111000000    


Q ss_pred             ----HHHhhcCccccccccccccCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          385 ----FDCYRNGKLDDLVEGDMEAMN-----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       385 ----~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          .....................     .......+.+++.+||+.+|.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                000000000000000000000     0113456889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-35  Score=288.46  Aligned_cols=264  Identities=23%  Similarity=0.292  Sum_probs=191.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHccc-CCCCceeeeeeEecC----CeE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG----QNR  239 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~----~~~  239 (455)
                      .+.+.||+|+||.||++....+. .+..+|+|++....  ....+.+.+|+.++.++ +||||+++++.+...    ...
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCC-cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            35578999999999999986431 26789999986432  22345688899999999 599999999975432    456


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++++||+. ++|.+++.....+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            88888885 6899999888889999999999999999999995   4999999999999999999999999999986543


Q ss_pred             CCCc--cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh---------HHHHHHH
Q 037780          320 NQSK--TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL---------TDWAFDC  387 (455)
Q Consensus       320 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~---------~~~~~~~  387 (455)
                      ....  .......||..|+|||++.+ ..++.++||||||+++++|++|+.||...........         ..+....
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            2221  11123468999999998765 4689999999999999999999999975442110000         0000000


Q ss_pred             hhcC------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          388 YRNG------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       388 ~~~~------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....      .........+... .......+.+++.+||+.+|++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000      0000000000000 0012457889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=264.52  Aligned_cols=247  Identities=22%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +...||.|+.|.|++....   ..+..+|||.+.... ....+.++..+.++..-+ .|.||+.+|||..+...++-||.
T Consensus        96 ~l~dlGsGtcG~V~k~~~r---s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFR---STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hHHhhcCCCccceEEEEEc---ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            4567999999999999998   456899999997643 333456777777776665 89999999999999999999998


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |. ..++..+.. ..++++...-++...++.||.||.+  +.+|+|||+||+|||+|+.|++|++|||++..+.....+ 
T Consensus       173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence            84 345555543 3567888888899999999999987  469999999999999999999999999999877654433 


Q ss_pred             ccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                        +...|-+.|||||.+.-   ..|+..+||||||+.|+||.||+.||.....+-.. +    -..+. .. .    +.+
T Consensus       249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-l----tkvln-~e-P----P~L  315 (391)
T KOG0983|consen  249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-L----TKVLN-EE-P----PLL  315 (391)
T ss_pred             --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-H----HHHHh-cC-C----CCC
Confidence              33458889999999853   46888999999999999999999999875543211 1    11111 11 1    112


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..  ....+..+.+++..||+.|+.+||...++++
T Consensus       316 ~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11  1225678999999999999999999998875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=292.18  Aligned_cols=199  Identities=30%  Similarity=0.459  Sum_probs=171.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCC------eEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------NRL  240 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~~  240 (455)
                      -.+.||+|+||.||+|+.+   ..|..||||....... ...+....|+++|++++|+|||++++.-++..      ...
T Consensus        17 ~~e~LG~Ga~g~V~rgrnk---etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNK---ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ehhhhcCCccceeeeeccc---ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3567999999999999977   5678999999876432 33456788999999999999999999876544      568


Q ss_pred             EEEEeCCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCC--cEEEeeccC
Q 037780          241 LVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD--DHY--NARISDFGL  313 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~  313 (455)
                      +|||||.+|||...|.+.   ..+++.+.+.+..+++.||.|||++   +|+||||||.||++-  ++|  ..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999999764   5789999999999999999999976   999999999999984  333  489999999


Q ss_pred             cccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGE  375 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~  375 (455)
                      |+-+..+.   ......||..|++||.+.. +.|+..+|.|||||++|+.+||..||......
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99887655   2266789999999999985 78899999999999999999999999876553

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=318.00  Aligned_cols=246  Identities=28%  Similarity=0.366  Sum_probs=199.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      ..||.|.||.||-|...+   +|...|+|-+....  ....+...+|+.++..++|||+|+.+|+-.+.+..+|.||||+
T Consensus      1241 ~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred             cccCCcceeeeEEeecCC---ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence            459999999999999874   45677888764322  3344568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC--ccc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS--KTI  325 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~~~  325 (455)
                      +|+|.+.+...+-.++.....+..|++.|++|||+.   +||||||||.||+|+.+|.+|++|||.|..+.....  ...
T Consensus      1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            999999998888888888888999999999999965   999999999999999999999999999998765421  111


Q ss_pred             cccccccCcccccccccCCC---CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHH-HhhcCcccccccccc
Q 037780          326 KTAIRGTKGYVAPEWYRKST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-CYRNGKLDDLVEGDM  401 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  401 (455)
                      .....||+-|||||++.+..   ...++||||+|||++||+||++||.....+       |+.. .+..|...++.    
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~Pq~P---- 1463 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHKPQIP---- 1463 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCCCCCc----
Confidence            13456999999999997643   456899999999999999999999755432       2221 22334433332    


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                           .....+-.+++..||+.||++|.++.++++.
T Consensus      1464 -----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 -----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                 2356677899999999999999888877654

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-35  Score=288.66  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=193.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC------e
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------N  238 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~  238 (455)
                      ...+.||+|+||.||++...   .++..||||++....  ......+.+|+.++++++||||+++++++....      .
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          18 RDLKQVGSGAYGTVCSALDR---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             EEEEEeeecCCeEEEEEEEC---CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            34568999999999999876   356789999985432  223456889999999999999999999886543      4


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+   .+|+||||||+||++++++.+||+|||++....
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            58999998 7799888754 568999999999999999999995   599999999999999999999999999998654


Q ss_pred             CCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchh-hhhHH-------HHHHHhh
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTD-------WAFDCYR  389 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-~~~~~-------~~~~~~~  389 (455)
                      ...     ....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||........ .....       .....+.
T Consensus       170 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         170 SEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             cCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            321     23457889999999876 4588999999999999999999999975432110 00000       0000000


Q ss_pred             cCccccccc-------cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH--HHHhcCcCC
Q 037780          390 NGKLDDLVE-------GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS--QMLEGVVEV  444 (455)
Q Consensus       390 ~~~~~~~~~-------~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~--~~L~~~~~~  444 (455)
                      .........       ..+.. ........+.+++..|++.+|++|||+.+++  ..++...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             chhHHHHHHhccccCcchHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            000000000       00000 0012345688999999999999999999999  445554433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-35  Score=288.14  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=192.2

Q ss_pred             HHHHHHHHhh--hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEe
Q 037780          159 KALEEATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD  234 (455)
Q Consensus       159 ~~l~~~t~~f--~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~  234 (455)
                      .++...+.+|  .+.||+|+||.||+|...   .++..||+|++....  ....+.+.+|+.++.+++|+||+++.+++.
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEc---CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            4444444444  367999999999999876   356789999986532  223456888999999999999999999885


Q ss_pred             cC------CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEE
Q 037780          235 EG------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI  308 (455)
Q Consensus       235 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  308 (455)
                      ..      ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence            43      3467888876 7899888754 468999999999999999999995   49999999999999999999999


Q ss_pred             eeccCcccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHH----
Q 037780          309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD----  382 (455)
Q Consensus       309 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~----  382 (455)
                      +|||+++......     ....++..|+|||.+.+ ..++.++||||||++++||++|+.||.......... ...    
T Consensus       162 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             ecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999987653221     23457889999998866 468899999999999999999999996543211100 000    


Q ss_pred             ---HHHHHhhcCcc-------ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          383 ---WAFDCYRNGKL-------DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       383 ---~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                         .....+.....       .......... ........+.+++..|++.+|.+|||+.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence               00000000000       0000000000 000124568899999999999999999998853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5e-35  Score=270.94  Aligned_cols=222  Identities=21%  Similarity=0.170  Sum_probs=178.9

Q ss_pred             CCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHH
Q 037780          175 GSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF  254 (455)
Q Consensus       175 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~  254 (455)
                      |.+|.||++...   .+++.+|+|++....     .+..|...+....|||++++++++.+.+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~---~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDT---RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEc---cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999987   456789999986532     234555666666799999999999999999999999999999999


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCc
Q 037780          255 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG  334 (455)
Q Consensus       255 l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  334 (455)
                      +.....+++.....++.|++.||.|||+   .+++||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence            9877789999999999999999999995   599999999999999999999999999886654321     22345778


Q ss_pred             ccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHH
Q 037780          335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL  414 (455)
Q Consensus       335 y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  414 (455)
                      |+|||.+....++.++||||+|++++||++|+.|+........              ....+       ..+......+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~~~~~-------~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------THTTL-------NIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------ccccc-------CCcccCCHHHH
Confidence            9999999888899999999999999999999988653211000              00000       01112346788


Q ss_pred             HHHHhcccCCCCCCCCHHH
Q 037780          415 MVSIWCIQEDPSLRPTMRK  433 (455)
Q Consensus       415 ~l~~~cl~~~p~~RPt~~~  433 (455)
                      +++.+|++.||++||++.+
T Consensus       207 ~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHHccCCHHHhcCCCc
Confidence            9999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-34  Score=281.71  Aligned_cols=258  Identities=22%  Similarity=0.280  Sum_probs=190.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~  243 (455)
                      .+.+.||.|+||.||++...   .++..+|+|++...  .....+.+..|+.++.+++|||++++.+++.. ....++|+
T Consensus        13 ~~~~~ig~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          13 VDLQPVGMGAFGLVCSARDQ---LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             EEEEeecccCCeEEEEEEEC---CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            34578999999999999876   35678999987542  22334678899999999999999999998865 56789999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+ +++|..++.. ..+++.....++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++.......  
T Consensus        90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--  162 (328)
T cd07856          90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--  162 (328)
T ss_pred             ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence            998 5689888754 457888888999999999999995   599999999999999999999999999987543221  


Q ss_pred             cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhh-hhHH--------HHHHHhhcCcc
Q 037780          324 TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-ILTD--------WAFDCYRNGKL  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~-~~~~--------~~~~~~~~~~~  393 (455)
                         ....++..|+|||.+.+ ..++.++||||||+++++|+||+.||......... .+..        +.......+..
T Consensus       163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence               23357889999998766 56899999999999999999999999754431110 0000        00000000000


Q ss_pred             ccccccccccCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          394 DDLVEGDMEAMNDI-----KCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       394 ~~~~~~~l~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ..+.........+.     .....+.+++..||+.+|++|||+.+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000010     134678999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.4e-35  Score=302.73  Aligned_cols=252  Identities=28%  Similarity=0.390  Sum_probs=188.8

Q ss_pred             HHHhhhh--hcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEec-----
Q 037780          164 ATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----  235 (455)
Q Consensus       164 ~t~~f~~--~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-----  235 (455)
                      --.+|.+  .||+||||.|||++.+   -+++.+|||++.... ......+.+|+..+++++|||+|+++..+.+     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNK---lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNK---LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeec---ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            3445654  6999999999999987   678999999997543 2334568889999999999999999721100     


Q ss_pred             --------------------------------------------------------------------------------
Q 037780          236 --------------------------------------------------------------------------------  235 (455)
Q Consensus       236 --------------------------------------------------------------------------------  235 (455)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------C--------CeEEEEEEeCCCCCHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHH
Q 037780          236 --------------------------G--------QNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYL  280 (455)
Q Consensus       236 --------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~~ia~~l~~L  280 (455)
                                                .        ...|+=||||+..+|.+++..+... .-...++++.+|++||+|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                      0        1236778999888888888766544 4667789999999999999


Q ss_pred             HhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc----------------CCCCccccccccccCcccccccccCC
Q 037780          281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT----------------LNQSKTIKTAIRGTKGYVAPEWYRKS  344 (455)
Q Consensus       281 H~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~  344 (455)
                      |+   .+||||||||.||+||++..+||+|||+|+...                ........+..+||.-|+|||.+.+.
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            95   489999999999999999999999999998721                00111123567799999999999765


Q ss_pred             C---CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcc
Q 037780          345 T---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCI  421 (455)
Q Consensus       345 ~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl  421 (455)
                      .   |+.|+|+||+||+|+||+.   ||....+..      .+...++++.+..-  +.    ...+....-.+++.|++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------~iL~~LR~g~iP~~--~~----f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------SILTNLRKGSIPEP--AD----FFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHH------HHHHhcccCCCCCC--cc----cccccchHHHHHHHHHh
Confidence            4   9999999999999999987   565444321      12233445544432  11    12233445578899999


Q ss_pred             cCCCCCCCCHHHHHH
Q 037780          422 QEDPSLRPTMRKVSQ  436 (455)
Q Consensus       422 ~~~p~~RPt~~~v~~  436 (455)
                      +.||.+|||+.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=267.04  Aligned_cols=239  Identities=25%  Similarity=0.257  Sum_probs=196.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+|.+.||+|.||.|.+++-+   ..++.+|+|++++..-   +....-..|-++|...+||.+..|.-.+...++.++|
T Consensus       170 FdfLKvLGkGTFGKVIL~rEK---at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREK---ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             hhHHHHhcCCccceEEEEeec---ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            457799999999999999876   4678899999976432   2234467789999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||..||.|.-+|.+.+.+++...+-....|+.||.|||   +.+||.||||.+|.|||.+|++||+|||+++.--... 
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-  322 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence            999999999999999999999988889999999999999   5599999999999999999999999999998532211 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                       ..+..++||+.|+|||++....|..++|.|.+||++|||++|+.||.....+...       +++..+        .+ 
T Consensus       323 -~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-------eLIl~e--------d~-  385 (516)
T KOG0690|consen  323 -DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-------ELILME--------DL-  385 (516)
T ss_pred             -ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH-------HHHHhh--------hc-
Confidence             2225688999999999999999999999999999999999999999765543221       111111        11 


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP  429 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP  429 (455)
                       ..+.....+...++...|..||.+|.
T Consensus       386 -kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 -KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -cCCccCCHHHHHHHHHHhhcChHhhc
Confidence             12223455667777788999999994

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=270.76  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=207.9

Q ss_pred             hhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC-CeEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-QNRLLVY  243 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv~  243 (455)
                      .+..+-+|.||.||+|.+.+.  -.+.+.|-||.++... +-....+..|...+..+.|||+..+.+.+.+. ...+++|
T Consensus       288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y  367 (563)
T KOG1024|consen  288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY  367 (563)
T ss_pred             chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence            345689999999999987643  2345667788775433 23345688999999999999999999999765 4578999


Q ss_pred             EeCCCCCHHHHhc-----C---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          244 EFLNNGTLASFLF-----G---NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       244 e~~~~gsL~~~l~-----~---~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      .++.-|+|..||.     +   .+.++-.+...++.|++.|++|||   +.++||.||.++|.++|+...+||+|=.+++
T Consensus       368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR  444 (563)
T KOG1024|consen  368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSR  444 (563)
T ss_pred             eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhcc
Confidence            9999999999997     2   245677788899999999999999   5599999999999999999999999999999


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      -+-+.+.+........+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.+.       ..++.+|   
T Consensus       445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~ylkdG---  514 (563)
T KOG1024|consen  445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHYLKDG---  514 (563)
T ss_pred             ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHHHhcc---
Confidence            8777666665555556789999999999999999999999999999999 9999976665331       1122222   


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                            .+...+.++++++..++..||...|++||++++++.-|.+
T Consensus       515 ------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  515 ------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                  2334466799999999999999999999999999988864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=265.13  Aligned_cols=261  Identities=25%  Similarity=0.331  Sum_probs=200.5

Q ss_pred             ccccCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeee
Q 037780          153 LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLL  230 (455)
Q Consensus       153 ~~~~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~  230 (455)
                      ...|+-.+|+.     ..+||.|+||+|+|-.++   ..++..|||+++.... ...++++.|.+...+- +.||||+++
T Consensus        58 ~~~F~~~~Lqd-----lg~iG~G~fG~V~KM~hk---~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   58 LHTFTSDNLQD-----LGEIGNGAFGTVNKMLHK---PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             ccccccchHHH-----HHHhcCCcchhhhhhhcC---ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            34455555544     347999999999999887   6788999999976544 4456688888766655 789999999


Q ss_pred             eeEecCCeEEEEEEeCCCCCHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          231 GFCDEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       231 g~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                      |.+..++..++-||.|. .||+.+-.     ....+++...-+|..-.++||.||.+  ...|||||+||+|||||..|.
T Consensus       130 Ga~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~  206 (361)
T KOG1006|consen  130 GALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD  206 (361)
T ss_pred             hhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence            99999999999999994 46655432     34678888888999999999999987  468999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCC--CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW  383 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~  383 (455)
                      +||+|||++..+......   +.-.|-..|||||.+...  .|+.+|||||||++|+|+.||+.|+.....     +.+.
T Consensus       207 vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeq  278 (361)
T KOG1006|consen  207 VKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQ  278 (361)
T ss_pred             EeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHH
Confidence            999999999876543322   334578899999998643  489999999999999999999999975443     2222


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      +... ..|....+...    .........+.+++..|+..|.++||...++.++
T Consensus       279 l~~V-v~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  279 LCQV-VIGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHH-HcCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2222 22333322221    1223456788999999999999999999987753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-35  Score=286.47  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=191.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe------
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN------  238 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~------  238 (455)
                      .+.+.||+|++|.||+|....   .+..+|+|++....  ......+.+|+.++++++|+|++++++++...+.      
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             EEEEEeccCCceEEEEEEECC---CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            345689999999999999873   46789999986432  2234567889999999999999999998766554      


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||++....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            89999998 6699998865 468999999999999999999995   599999999999999999999999999998654


Q ss_pred             CCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchh-hhhHHH-------HHHHhh
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDW-------AFDCYR  389 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~-~~~~~~-------~~~~~~  389 (455)
                      ...     ....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ..+...       ....+.
T Consensus       170 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         170 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            321     33457889999998865 3678999999999999999999999975433111 000000       000000


Q ss_pred             cCcccccccc-------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEG-------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~-------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......+..       ..... .......+.+++..||+.+|++|||+.+|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000000000       00000 0012567899999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.6e-35  Score=260.95  Aligned_cols=203  Identities=25%  Similarity=0.370  Sum_probs=166.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCC-CceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRT-STTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~l  241 (455)
                      ++...+||+|.+|.||||.-.+++. -.+.+|+|+++....  .-.....+|+.+++.++|||++.|..++.. +...+|
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            4455679999999999997665542 135799999975422  223456789999999999999999999877 778899


Q ss_pred             EEEeCCCCCHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC----CcEEEeecc
Q 037780          242 VYEFLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH----YNARISDFG  312 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~-----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg  312 (455)
                      ++||.+. +|...++-     .+.++-....+|+.||+.|+.|||++   -|+||||||.|||+..+    |.+||+|||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999987 77777752     25678889999999999999999954   89999999999999877    899999999


Q ss_pred             CcccccCCCCcc-ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCcc
Q 037780          313 LAKLLTLNQSKT-IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIE  372 (455)
Q Consensus       313 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~  372 (455)
                      +++.+...-..- ....++-|.+|.|||.+.+. .||.+.||||.||+..||+|-.+.|...
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            999876543221 22456789999999998775 6899999999999999999999888654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.2e-34  Score=301.90  Aligned_cols=143  Identities=27%  Similarity=0.381  Sum_probs=127.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.++||+|+||.||+|.+.   ..+..||+|++....   ......+..|+.++..++|+||+++++++......++||
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKK---NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             EEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            45678999999999999986   356789999986432   222366889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ||+++++|.+++.....+++...+.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999877888999999999999999999995   499999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=283.55  Aligned_cols=238  Identities=26%  Similarity=0.321  Sum_probs=194.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.|...+|.|+|+.|-++...   ...+..+||++.+.    ..+-.+|+.++.+. +|||++++.+.+.++.+.++||
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~---~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESS---PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             hhccccccCCCCccceeeeecc---ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3456677999999999999887   45567899998654    22345677666665 7999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE-cCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL-DDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |.+.++-|.+.+...+... ..+..|+.+++.++.|||+   .+++||||||+|||+ ++.++++|+|||.++.....- 
T Consensus       396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-  470 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-  470 (612)
T ss_pred             hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchhh-
Confidence            9999999988887776666 7888899999999999995   499999999999999 699999999999999876541 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ..-+-|..|.|||++....+++++|+||||++||+|++|+.||......      ..+...+..+...        
T Consensus       471 ----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s--------  532 (612)
T KOG0603|consen  471 ----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS--------  532 (612)
T ss_pred             ----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------
Confidence                2234688999999999999999999999999999999999999754433      1122222222221        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          ...++...+++.+||+.||.+||+|.++..
T Consensus       533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                345678889999999999999999999864

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=268.93  Aligned_cols=258  Identities=25%  Similarity=0.325  Sum_probs=198.2

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecc--cccccc-----HHHHHHHHHHHcccCCCCceeeeeeEec
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDG-----EKEFKNEVVVIGQTHHKNLVRLLGFCDE  235 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~--~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~g~~~~  235 (455)
                      ..++-+.+.||+|||+.|||+.+-   ...+.||||+-.  +...+.     .+...+|.++-+.+.||.||++++++.-
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl---~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDL---TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhccc---chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            344556678999999999999976   345678888743  222221     2446789999999999999999999864


Q ss_pred             -CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCcEEEeec
Q 037780          236 -GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDF  311 (455)
Q Consensus       236 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Df  311 (455)
                       .+..+-|+||++|.+|+-||+.++..++..++.|+.||+.||.||.+. +++|||-||||.||||.   .-|.+||+||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence             556789999999999999999999999999999999999999999987 89999999999999995   4578999999


Q ss_pred             cCcccccCCCCc-----cccccccccCcccccccccCC----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH
Q 037780          312 GLAKLLTLNQSK-----TIKTAIRGTKGYVAPEWYRKS----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       312 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~  382 (455)
                      |+++.+..+...     ..+....||.+|++||.+.-+    .++.|+||||.||++|..+.|+.||........     
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-----  692 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-----  692 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-----
Confidence            999998765443     223445699999999987543    478899999999999999999999986554221     


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                          .+..+.+.....-..  ..-.....+...++..||+...++|....++.
T Consensus       693 ----ILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  693 ----ILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----HHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                111222211111111  11112345677889999999999998777765

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.7e-34  Score=262.60  Aligned_cols=239  Identities=29%  Similarity=0.356  Sum_probs=195.1

Q ss_pred             CCccEEEEEEeccCCCceEEEEEecccccccc-HHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHH
Q 037780          176 SFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF  254 (455)
Q Consensus       176 ~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~  254 (455)
                      +||.||+|....   ++..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.++
T Consensus         1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999873   46789999987654444 67899999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCc
Q 037780          255 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG  334 (455)
Q Consensus       255 l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  334 (455)
                      +.....+++..++.++.++++++.|||+.   +++|+||+|+||++++++.++|+|||.+........   .....++..
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~  151 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGTPE  151 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCCcC
Confidence            98776689999999999999999999954   999999999999999999999999999987664421   133457889


Q ss_pred             ccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHH
Q 037780          335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL  414 (455)
Q Consensus       335 y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  414 (455)
                      |++||.+....++.++||||||+++++|++|..||.......  .    ..+....+.......       .......+.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~~~~~-------~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E----LFKKIGKPKPPFPPP-------EWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCCCCccc-------cccCCHHHH
Confidence            999999988889999999999999999999999987532211  1    111111111111000       000456889


Q ss_pred             HHHHhcccCCCCCCCCHHHHHH
Q 037780          415 MVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       415 ~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=266.00  Aligned_cols=269  Identities=23%  Similarity=0.307  Sum_probs=206.6

Q ss_pred             ccCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC--CC----cee
Q 037780          155 CFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KN----LVR  228 (455)
Q Consensus       155 ~~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~  228 (455)
                      .|...+.....+.....+|+|.||.|-++.+..+   +..||||+++... ...+..+-|+++|.++.+  |+    +|.
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~---~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRET---KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCC---CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            4555666667777888999999999999998743   6889999997653 345567789999999942  33    788


Q ss_pred             eeeeEecCCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC----
Q 037780          229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD----  302 (455)
Q Consensus       229 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----  302 (455)
                      +.+|+.-.++.++|+|.+ |-|+.++|..+  .+++..+++.|+.|+++++++||   +.+++|.||||+|||+.+    
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceE
Confidence            889999999999999988 67999999886  56788999999999999999999   459999999999999831    


Q ss_pred             ----------------CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCC
Q 037780          303 ----------------HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR  366 (455)
Q Consensus       303 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~  366 (455)
                                      +..+||+|||.|+.-....     ...+.|..|.|||++.+-.++.++||||+||+|.|+.||.
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence                            3458999999998765544     4456899999999999999999999999999999999999


Q ss_pred             CCCCccccchhhhhHHH--------------HHHHhhcCccc-----------cccccc--c--ccCCCHHHHHHHHHHH
Q 037780          367 KSFDIEMGEEYAILTDW--------------AFDCYRNGKLD-----------DLVEGD--M--EAMNDIKCVEKLLMVS  417 (455)
Q Consensus       367 ~p~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-----------~~~~~~--l--~~~~~~~~~~~~~~l~  417 (455)
                      ..|......+..-+.+.              ..+....+.+.           ...++.  +  .-.....+..++.+++
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            99976654221111111              11111222111           000000  0  0011234566899999


Q ss_pred             HhcccCCCCCCCCHHHHHH
Q 037780          418 IWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       418 ~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+|..||.+|+|+.|+++
T Consensus       387 ~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHccCccccccHHHHhc
Confidence            9999999999999999875

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=296.78  Aligned_cols=251  Identities=20%  Similarity=0.238  Sum_probs=199.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||.|...+.+   ..++.+|.|+++++.   .....-|..|-.+|..-+.+=|+.++-.|.++.+.|+
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k---~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHK---STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEee---ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            3456689999999999999988   456789999998742   3344568999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |||||+||+|-..+.+...+++..++-++..|+-||.-||   +.|+|||||||+|||||..|++||+|||.+-.+..+.
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999999988888999999999999999999999   6699999999999999999999999999998877554


Q ss_pred             CccccccccccCccccccccc----C-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYR----K-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      .-.. ...+|||-|++||++.    + +.|.+..|.||+||++|||+.|..||....-      ++.-.+.+.......+
T Consensus       230 ~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  230 TVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETYGKIMNHKESLSF  302 (1317)
T ss_pred             cEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHHHHHhchhhhcCC
Confidence            3322 4567999999999985    2 5688999999999999999999999974432      1111111111111111


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT---MRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt---~~~v~~  436 (455)
                      .       ...+.++...+++...+. +|+.|..   +.++..
T Consensus       303 P-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  303 P-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             C-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            1       122355667777776554 7888877   777654

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-34  Score=252.82  Aligned_cols=244  Identities=23%  Similarity=0.269  Sum_probs=189.6

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEec----CCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE----GQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e  244 (455)
                      ++||-|-.|.|-.+..+.   .+...|+|.+...     ....+|+++--.. .|||||.++++|..    ....++|||
T Consensus        68 qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE  139 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKR---TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME  139 (400)
T ss_pred             hhhccccCCceEEEEecc---chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence            679999999999998874   4567899988542     2345677665444 69999999998854    346789999


Q ss_pred             eCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccC
Q 037780          245 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTL  319 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  319 (455)
                      +|+||.|...+++.+  .+++.++..|+.||+.|+.|||   +.+|.||||||+|+|...   |-.+||+|||+|+....
T Consensus       140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            999999999998765  4899999999999999999999   669999999999999974   55699999999987553


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ...  . ..-+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......   +.--....++.|... +.++
T Consensus       217 ~~~--L-~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy~-FP~p  289 (400)
T KOG0604|consen  217 PGD--L-MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQYE-FPEP  289 (400)
T ss_pred             Ccc--c-cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCcc-CCCh
Confidence            222  1 33457999999999999999999999999999999999999997655421   111112222333221 1111


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           .-...++...++++..|..+|.+|.|+.+++.
T Consensus       290 -----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  290 -----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                 11234667788999999999999999999886

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=234.45  Aligned_cols=259  Identities=21%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      -++||+|.+|+||||+..   .....||+|++....  +.......+|+-+++.++|+|||++++....+...-+|+||+
T Consensus         7 mekigegtygtvfkarn~---~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             HHhhcCCcceeeEecccC---CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            468999999999999877   456789999986432  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          247 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       247 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      . .+|..|..+ ++.++.+..++++.|+++||.++|   +.++.|||+||+|.|++.+|+.|++|||+++-++-.-..  
T Consensus        84 d-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc--  157 (292)
T KOG0662|consen   84 D-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--  157 (292)
T ss_pred             h-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--
Confidence            5 478777654 577889999999999999999999   559999999999999999999999999999977643211  


Q ss_pred             cccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCc---cccccccc
Q 037780          326 KTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGK---LDDLVEGD  400 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  400 (455)
                      ....+-|.+|.+|.++.+. -|++..|+||-||++.|+.. |++.|......++..-..|......+..   +..+.|-.
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            1233468999999998775 58999999999999999998 6666655444333322222222222222   22333333


Q ss_pred             cccCCCH---------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          401 MEAMNDI---------KCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~---------~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....++.         .....-.+++...+.-+|..|.++++.++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2222221         11112245555556669999999988765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=271.77  Aligned_cols=242  Identities=26%  Similarity=0.391  Sum_probs=190.1

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.||+|-||+||-|+.+   ..|+.||||.+++..  ...+.++.+|+.+|.++.||.||.+.-.|+..+..++|||-+.
T Consensus       570 evLGSGQFG~VYgg~hR---ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHR---KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             hhccCCcceeeecceec---ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            56999999999999987   567889999997642  3456789999999999999999999999999999999999995


Q ss_pred             CCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CcEEEeeccCcccccCCCCc
Q 037780          248 NGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       248 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |.-|.-.|.. .+.+++..-.-++.||+.||.|||.   .+|+|+||||+||||...   -.+||+|||+|+..+.....
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            5445444443 4778888888899999999999995   499999999999999643   46999999999998865543


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                         ..++||+.|+|||++.+..|+..-|+||.||++|--++|..||+...+     +.+.++    +-.   ++-+.   
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQ----NAa---FMyPp---  785 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQ----NAA---FMYPP---  785 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhh----ccc---cccCC---
Confidence               567899999999999999999999999999999999999999974332     111111    111   11110   


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                      ..-.+.....++++...||..-.+|.|...-+
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            01113345566777777777777887776543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-34  Score=252.18  Aligned_cols=264  Identities=20%  Similarity=0.266  Sum_probs=195.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecc--ccccccHHHHHHHHHHHcccCCCCceeeeeeEecC-------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-------  236 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-------  236 (455)
                      +.-..+||+|.||.||+|...+   .++.||+|++-  .....-.....+|+++|..++|+|++.++..|...       
T Consensus        19 yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            3344679999999999998874   45668888763  22222334568899999999999999999988532       


Q ss_pred             -CeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          237 -QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       237 -~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                       ...|+||++++. +|...|... ..++..++.+++.++..||.|+|   +..|+|||+||.|+|++.++.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence             347999999977 788888665 67899999999999999999999   459999999999999999999999999999


Q ss_pred             ccccCCC--CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          315 KLLTLNQ--SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       315 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      +.+....  ..+..+..+-|.+|++||.+.+. .++++.|||.-||++.||+||.+.+..........+...+...+...
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            8664332  22223455679999999988764 68999999999999999999999988776644444433332222222


Q ss_pred             ccccccccc---------cc-cCC--CHHH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVEGD---------ME-AMN--DIKC------VEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~~~---------l~-~~~--~~~~------~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+.....-.         +. ...  -.+.      -++.++++..++..||.+|+++.+++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            221111100         00 000  0011      125678888899999999999998874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=262.31  Aligned_cols=243  Identities=27%  Similarity=0.334  Sum_probs=197.3

Q ss_pred             HHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCC
Q 037780          162 EEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       162 ~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  237 (455)
                      ..+..+|...||+|+||.|.++.-++   ....+|||++++..   .++.+--+.|-++|+.. +-|.++.++.++..-+
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             eecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            33445888999999999999997663   45678999987642   23334456788888877 4678999999999999


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      .+|+||||+.+|+|-.+++.-+.+.+..+.-+|..||-||-+||   +.+||.||||..||+||.+|++||+|||+++.-
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999999999998889999999999999999999999   569999999999999999999999999999843


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      --+  ...+..++||+.|+|||.+.-++|..++|.|||||+||||+.|++||+...+++.       .+.+.        
T Consensus       501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~--------  563 (683)
T KOG0696|consen  501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIM--------  563 (683)
T ss_pred             ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHH--------
Confidence            221  2223568899999999999999999999999999999999999999998776432       11111        


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP  429 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP  429 (455)
                      +..  ..++...+.+...+....+..+|.+|.
T Consensus       564 ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            111  123444567777788888888999883

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-32  Score=273.86  Aligned_cols=257  Identities=22%  Similarity=0.254  Sum_probs=176.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc-------------CCCceEEEEEeccccccccHHH--------------HHHHHHHH
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT-------------RTSTTAVAVKKLDRVFQDGEKE--------------FKNEVVVI  218 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~-------------~~~~~~vavK~~~~~~~~~~~~--------------~~~e~~~l  218 (455)
                      +.+.++||+|+||+||+|.+...             ...++.||||++........++              +..|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            33457899999999999976321             1245679999986543332233              34467777


Q ss_pred             cccCCCCc-----eeeeeeEec--------CCeEEEEEEeCCCCCHHHHhcCC------------------------CCC
Q 037780          219 GQTHHKNL-----VRLLGFCDE--------GQNRLLVYEFLNNGTLASFLFGN------------------------LKP  261 (455)
Q Consensus       219 ~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------~~~  261 (455)
                      .+++|.++     ++++++|..        ....+|||||+++++|.++++..                        ..+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            77776654     677888753        35689999999999999998642                        124


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccc
Q 037780          262 SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY  341 (455)
Q Consensus       262 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  341 (455)
                      +|..++.|+.|++.+|.|||+   .+|+||||||+|||++.++.+||+|||+++.......... ....+|+.|+|||.+
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSPPEEL  382 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeChhhh
Confidence            678889999999999999995   4899999999999999999999999999976543222111 122357899999987


Q ss_pred             cCCCC----------------------CCCCCeecHHHHHHHHHhCCC-CCCcccc--ch----hhhhHHHHHHHhhcCc
Q 037780          342 RKSTI----------------------TAKVDVYSFGVLLLEIISCRK-SFDIEMG--EE----YAILTDWAFDCYRNGK  392 (455)
Q Consensus       342 ~~~~~----------------------~~~~Dv~s~Gv~l~el~tg~~-p~~~~~~--~~----~~~~~~~~~~~~~~~~  392 (455)
                      .....                      ..+.||||+||++++|++|.. |+.....  .+    ...+..|  +......
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~  460 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQK  460 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccC
Confidence            54321                      134799999999999999875 6643211  00    0111111  1111111


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDP---SLRPTMRKVSQ  436 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p---~~RPt~~~v~~  436 (455)
                      ..        ........+...+++..+|..+|   .+|+|+.|+++
T Consensus       461 ~~--------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 YD--------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CC--------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11        01111235677888888888765   68999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-32  Score=281.58  Aligned_cols=258  Identities=20%  Similarity=0.192  Sum_probs=164.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc-CCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeee------EecCCe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT-RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF------CDEGQN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~------~~~~~~  238 (455)
                      +.+.+.||+|+||.||+|.+..+ ...+..+|+|++.....  .+.+..+  .+.+..+.++..+...      +.....
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            34457899999999999998733 11267899998764321  1112211  1222222233222221      245668


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 037780          239 RLLVYEFLNNGTLASFLFGNLK--------------------PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI  298 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  298 (455)
                      .++|+||+++++|.+++.....                    .....+..|+.|++.||+|||+   .+|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence            8999999999999999865321                    1123456799999999999995   5999999999999


Q ss_pred             EEcC-CCcEEEeeccCcccccCCCCccccccccccCcccccccccCC----------------------CCCCCCCeecH
Q 037780          299 LLDD-HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS----------------------TITAKVDVYSF  355 (455)
Q Consensus       299 ll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~s~  355 (455)
                      |+++ ++.+||+|||+++.+....... .....+|+.|+|||.+...                      .++.++|||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            9996 5799999999998664333222 1345689999999965322                      23446799999


Q ss_pred             HHHHHHHHhCCCCCCccccchh-------hhhHHHHHHHhhcCccccccccccccCC--CHHHHHHHHHHHHhcccCCCC
Q 037780          356 GVLLLEIISCRKSFDIEMGEEY-------AILTDWAFDCYRNGKLDDLVEGDMEAMN--DIKCVEKLLMVSIWCIQEDPS  426 (455)
Q Consensus       356 Gv~l~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~l~~~cl~~~p~  426 (455)
                      ||+||||+++..+++.......       ..+..|.... ...     ..+.+....  .........+++..||+.||+
T Consensus       366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPR-----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccc-----cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999998776542211000       0011111100 000     000000000  000123456899999999999


Q ss_pred             CCCCHHHHHHH
Q 037780          427 LRPTMRKVSQM  437 (455)
Q Consensus       427 ~RPt~~~v~~~  437 (455)
                      +|||+.++++.
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999873

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-32  Score=274.24  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=203.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEec-----CCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE-----GQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~-----~~~  238 (455)
                      +..|.+.||.|.+|.||+++..   .+++..|+|+++-. .+..++...|.++++.. +|||++.++|++..     ++.
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~---~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHV---KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeee---ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            4567789999999999999987   45677888887654 34466788899999988 69999999999853     568


Q ss_pred             EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          239 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ++||||||.+||..|.++..  ..+.|..+.-|+..++.||.|||.   ..++|||||-.||||++++.+|+.|||.+..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            99999999999999998764  678899999999999999999995   4999999999999999999999999999987


Q ss_pred             ccCCCCccccccccccCcccccccccCC-----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYRKS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      +.......  ....||+.|||||++...     .|+..+|+||+|++..||--|.+|+....+....             
T Consensus       173 ldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------------  237 (953)
T KOG0587|consen  173 LDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------------  237 (953)
T ss_pred             eecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------------
Confidence            76543332  446799999999998543     4677899999999999999999999765542110             


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       +.-.-.|......+.....++.+++..||..|-.+||++.++++
T Consensus       238 -F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 -FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence             01112233344456678999999999999999999999998875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-33  Score=267.85  Aligned_cols=242  Identities=21%  Similarity=0.251  Sum_probs=197.0

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccc---cccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      .||-||||.|=+.......   ...|+|.+++   ......+....|-.+|...+.|.||+++-.|.+....|+.||-|-
T Consensus       427 TLGvGgFGRVELV~~~~~~---~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl  503 (732)
T KOG0614|consen  427 TLGVGGFGRVELVKVNSQK---ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL  503 (732)
T ss_pred             hcccCccceEEEEEecccc---hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence            3899999999998876432   2355555543   344456678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      ||.|+..|.+.+.++..+..-++..+.+|++|||   +.+||+|||||+|.+||.+|-+||.|||+|+.++....   +.
T Consensus       504 GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---Tw  577 (732)
T KOG0614|consen  504 GGELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TW  577 (732)
T ss_pred             CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---ee
Confidence            9999999999999999999999999999999999   55999999999999999999999999999998875543   25


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCH
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI  407 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  407 (455)
                      .++||+.|+|||.+.+...+.++|.||+|++++||++|++||...++...-+       .+-+|. +       ....+.
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-------~ILkGi-d-------~i~~Pr  642 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-------LILKGI-D-------KIEFPR  642 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-------HHHhhh-h-------hhhccc
Confidence            6889999999999999999999999999999999999999999777632111       111111 0       011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          408 KCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       408 ~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                      .......++++.....+|.+|.-     +.+|.+
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            34556677888878889999976     455544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=246.41  Aligned_cols=243  Identities=25%  Similarity=0.287  Sum_probs=196.5

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...||+|++..|-.+.+..+   .+.+|+|.+++.   ..++.+..+.|-.+..+. +||.+|.+..++......++|.|
T Consensus       255 l~vigrgsyakvl~~~~~~t---~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKT---DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             eeeecCcchhhhhheehccc---ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            36799999999999999854   466777777542   344556678888888776 79999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++|+|--+++.+++++++.++-+...|.-||.|||+   .+||.||||..|+|+|..|++|++|+|+++.--...  .
T Consensus       332 yv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g--d  406 (593)
T KOG0695|consen  332 YVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG--D  406 (593)
T ss_pred             EecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC--c
Confidence            99999999999999999999999999999999999995   599999999999999999999999999998533222  2


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc-chhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .+..++||+.|+|||.+.+..|...+|.|++||+++||+.|+.||+.... ....+..+++.+.+-+..+.-        
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri--------  478 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI--------  478 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc--------
Confidence            23668899999999999999999999999999999999999999986443 233344455555544433220        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRP  429 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RP  429 (455)
                        +...+.+...+++.-|..||.+|.
T Consensus       479 --prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 --PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --cceeehhhHHHHHHhhcCCcHHhc
Confidence              112234455677778899999884

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=229.22  Aligned_cols=197  Identities=27%  Similarity=0.384  Sum_probs=165.7

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .+.||+|++|.|-+-++.   .++...|+|++.... .+..+....|+.+..+. ..|.+|.++|........++.||.|
T Consensus        51 i~elGrGayG~vekmrh~---~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHI---QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhcCCccchhhheeec---cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            367999999999888877   678999999996432 34456678888887775 7999999999999999999999999


Q ss_pred             CCCCHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          247 NNGTLASFL----FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       247 ~~gsL~~~l----~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      . .||+.+-    ......++...-+|+..+.+||.|||+  ...++|||+||+|||+|.+|++|++|||.+..+.+.-.
T Consensus       128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence            4 4777664    456788999999999999999999998  47899999999999999999999999999988765433


Q ss_pred             ccccccccccCcccccccccC----CCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK----STITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      .   +...|-..|||||.+..    ..|+.||||||||+.+.||.+++.||+....
T Consensus       205 k---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  205 K---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             H---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            2   22347778999998743    3689999999999999999999999986554

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=271.19  Aligned_cols=239  Identities=31%  Similarity=0.420  Sum_probs=185.3

Q ss_pred             hhcCcCCCcc-EEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGI-VYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~-Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.+|.|+.|+ ||+|...     ++.||||++-.   +..+-..+|+..|..- +|||||++++.-.+.+..|+..|.| 
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-----~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-----GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-----CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            5689998885 7999984     67999999853   2344568899999887 6999999999999999999999999 


Q ss_pred             CCCHHHHhcCC-CCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---C--CcEEEeeccCccccc
Q 037780          248 NGTLASFLFGN-LKP---SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---H--YNARISDFGLAKLLT  318 (455)
Q Consensus       248 ~gsL~~~l~~~-~~~---~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~  318 (455)
                      ..+|.+++... ...   .-...+.+..|++.||+|||   +.+||||||||+||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            55999999764 111   11234678899999999999   679999999999999975   2  579999999999887


Q ss_pred             CCCCcc-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhC-CCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          319 LNQSKT-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       319 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      .+.+.- ......||.||+|||.+....-+.++||||+||++|+.++| ..||......+...+         .+...-.
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---------~~~~~L~  733 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---------TGNYTLV  733 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------cCcccee
Confidence            655432 22456699999999999998888999999999999999995 999986554322211         1111100


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         .+.  ...++  +..+++..|+..+|..||++.+|+.
T Consensus       734 ---~L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 ---HLE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---eec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               011  11112  7789999999999999999999973

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=249.06  Aligned_cols=269  Identities=23%  Similarity=0.315  Sum_probs=196.2

Q ss_pred             cCHHHHHH-HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-----C---CCc
Q 037780          156 FSYKALEE-ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----H---KNL  226 (455)
Q Consensus       156 ~~~~~l~~-~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~ni  226 (455)
                      ....++.. ++|...++||.|.|++||++++.   +..+.||+|+.+.. ++..+..+.||++|++++     |   ..|
T Consensus        69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDt---q~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~V  144 (590)
T KOG1290|consen   69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDT---QNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCV  144 (590)
T ss_pred             eeccccccCceEEEEEeccccccceeEEEeec---cCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence            33444444 66677789999999999999987   56788999998653 445567889999999983     3   359


Q ss_pred             eeeeeeEec----CCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          227 VRLLGFCDE----GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       227 v~l~g~~~~----~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      |+|+++|..    +.+.+||+|+. |.+|..+|...  +.++.....+|+.||+.||.|||++|  +|||.||||+|||+
T Consensus       145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            999999864    56899999998 66888887643  77899999999999999999999975  99999999999997


Q ss_pred             cCC-----------------------------------------------------------------------------
Q 037780          301 DDH-----------------------------------------------------------------------------  303 (455)
Q Consensus       301 ~~~-----------------------------------------------------------------------------  303 (455)
                      ..+                                                                             
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            100                                                                             


Q ss_pred             --------------------------------------------------------------------------------
Q 037780          304 --------------------------------------------------------------------------------  303 (455)
Q Consensus       304 --------------------------------------------------------------------------------  303 (455)
                                                                                                      
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                                                                                            


Q ss_pred             ---------CcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          304 ---------YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       304 ---------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                               .++||+|||-|.-.....+..     ..|..|+|||++.+..|++.+|||||+|++|||+||...|+...+
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~~khFT~D-----IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG  456 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWVHKHFTED-----IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSG  456 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhhhhhhchh-----hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCC
Confidence                     002333333333222222111     247789999999999999999999999999999999999987665


Q ss_pred             chhhh-------h----HHHHHHHhhcCccc-cccccc-----------------c--ccCCCHHHHHHHHHHHHhcccC
Q 037780          375 EEYAI-------L----TDWAFDCYRNGKLD-DLVEGD-----------------M--EAMNDIKCVEKLLMVSIWCIQE  423 (455)
Q Consensus       375 ~~~~~-------~----~~~~~~~~~~~~~~-~~~~~~-----------------l--~~~~~~~~~~~~~~l~~~cl~~  423 (455)
                      +.+..       +    ....+.....|+.. ++++..                 |  ......+++.++.+++.-||+.
T Consensus       457 ~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef  536 (590)
T KOG1290|consen  457 ENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEF  536 (590)
T ss_pred             CCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhc
Confidence            43221       1    11122222333221 122111                 0  1123456788999999999999


Q ss_pred             CCCCCCCHHHHHH
Q 037780          424 DPSLRPTMRKVSQ  436 (455)
Q Consensus       424 ~p~~RPt~~~v~~  436 (455)
                      +|++|||+.+.++
T Consensus       537 ~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  537 DPEKRPTAAQCLK  549 (590)
T ss_pred             CccccccHHHHhc
Confidence            9999999999884

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=8.8e-30  Score=229.73  Aligned_cols=210  Identities=35%  Similarity=0.542  Sum_probs=183.0

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT  250 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs  250 (455)
                      ||+|.+|.||++....   .+..+++|........ ....+.+|+..+..++|++++++++++......++++|++++++
T Consensus         1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecC---CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            6899999999999863   4678999998754332 34679999999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcccccCCCCcccccc
Q 037780          251 LASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       251 L~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      |.+++... ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            99999765 5789999999999999999999954   9999999999999999 89999999999987654321  1133


Q ss_pred             ccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCH
Q 037780          329 IRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI  407 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  407 (455)
                      ..+...|++||.+... ..+.++|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4578899999999877 788999999999999998                                             


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       408 ~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                         ..+.+++..|++.+|++||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               567889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.5e-30  Score=252.54  Aligned_cols=200  Identities=25%  Similarity=0.356  Sum_probs=171.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||-|+||.|.++.-.++   ...+|.|.|.+..   .......++|-.+|+.-..+=+|+|+-.|.+.+.+|+||||+
T Consensus       635 k~iGvGAFGeV~Lv~KvDT---~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI  711 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDT---RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI  711 (1034)
T ss_pred             eeecccccceeEEEeecch---hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence            3599999999999987644   4678888886532   233455788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC----
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS----  322 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----  322 (455)
                      +||++-.+|...+.+.+..++-++..+..|+++.|   +.|+|||||||+|||||.+|++||+||||+.-+.-...    
T Consensus       712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            99999999999999999999999999999999999   67999999999999999999999999999864421100    


Q ss_pred             ----c--------------------------------cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCC
Q 037780          323 ----K--------------------------------TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR  366 (455)
Q Consensus       323 ----~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~  366 (455)
                          +                                ......+||+.|+|||++....++...|.||.||+|+||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence                0                                0012346999999999999999999999999999999999999


Q ss_pred             CCCCccccc
Q 037780          367 KSFDIEMGE  375 (455)
Q Consensus       367 ~p~~~~~~~  375 (455)
                      .||....+.
T Consensus       869 ~pf~~~tp~  877 (1034)
T KOG0608|consen  869 PPFLADTPG  877 (1034)
T ss_pred             CCccCCCCC
Confidence            999877663

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=239.19  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--cHHHHHHHHHHHcccCCCCceeeeeeEecC-----CeEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNRLLV  242 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~~lv  242 (455)
                      +-||-|+||.||...+.   .+++.||.|++......  ..+.+.+|+++|..++|.|++..++...-.     +++|++
T Consensus        59 RPIGYGAFGVVWsVTDP---RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDP---RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CcccccceeEEEeccCC---CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            56999999999998876   56789999998765432  346788999999999999999998876433     356888


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      .|.|. .+|...+-+...++-+...-+..||++||.|||   +.+|.||||||.|.|++.|..+||+|||+++....++.
T Consensus       136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            89884 488888888888888899999999999999999   56999999999999999999999999999998877666


Q ss_pred             ccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHH--------HHHHhhcCcc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW--------AFDCYRNGKL  393 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  393 (455)
                      ..+ +..+-|..|.|||.+.+. .|+.+.||||.||++.||+..+..|....+-+...+...        ..+..-+|.-
T Consensus       212 ~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  212 LNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            554 444568899999999875 689999999999999999999999876665332221111        1111111110


Q ss_pred             ccccc-----cc---ccc-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          394 DDLVE-----GD---MEA-MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       394 ~~~~~-----~~---l~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                      .-++.     +.   +.. ..+..--.+.+.+...++..+|..|.+..+.+..+
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            00111     11   100 11112223456677778999999999988877644

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-30  Score=249.13  Aligned_cols=191  Identities=23%  Similarity=0.334  Sum_probs=165.6

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------ccHHHHHHHHHHHcccC---CCCceeeeeeEecCCe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQN  238 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~  238 (455)
                      +.+|+|+||.|+.+.++   .+..+|+||.+.+..-        ...-....|+.+|+.++   |+||++++++|++++.
T Consensus       567 q~lG~GAyGkV~lai~K---~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~  643 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHK---ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY  643 (772)
T ss_pred             eeccccccceEEEeeec---ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence            57999999999999998   4568899998864311        01123567999999997   9999999999999999


Q ss_pred             EEEEEEeC-CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          239 RLLVYEFL-NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       239 ~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      .||++|-. ++-+|.+++.-.+.+++....-|+.||+.|+++||+   .+|||||||-+||.++.+|-+||+|||.+.+.
T Consensus       644 yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  644 YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhhh
Confidence            99999965 467999999999999999999999999999999994   59999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCC-CCCeecHHHHHHHHHhCCCCCC
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITA-KVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                      .....    ..++||.+|.|||++.+.+|-- .-|||++|++||.++....||.
T Consensus       721 ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  721 KSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            65443    4578999999999999988754 5899999999999999888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=5.3e-29  Score=227.79  Aligned_cols=197  Identities=30%  Similarity=0.460  Sum_probs=171.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.+.||.|++|+||++....   .+..+++|........ ..+.+.+|++.+.+++|+|++++++++......++++||+
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            45789999999999999873   3578999998765444 5678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          247 NNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       247 ~~gsL~~~l~~~~~-~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      ++++|.+++..... +++.....++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+......... .
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~  155 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L  155 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence            99999999987766 89999999999999999999954   9999999999999999999999999999877654311 1


Q ss_pred             cccccccCcccccccc-cCCCCCCCCCeecHHHHHHHHHhCCCCCCc
Q 037780          326 KTAIRGTKGYVAPEWY-RKSTITAKVDVYSFGVLLLEIISCRKSFDI  371 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~  371 (455)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            1334578899999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-29  Score=225.35  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=186.9

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec------CCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~~~~lv  242 (455)
                      -+|.|.- .|.-+.+.   -.++.||+|++....  ....+...+|...+..++|+|+++++.++.-      -.+.|+|
T Consensus        24 p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v   99 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV   99 (369)
T ss_pred             ccCCCCc-eEEecchh---hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence            3666665 55555544   356789999985432  3345678899999999999999999999843      3467999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+| ..+|...+.  -.++-.+...|..|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+.-...  
T Consensus       100 ~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--  171 (369)
T KOG0665|consen  100 MELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--  171 (369)
T ss_pred             HHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc--
Confidence            9999 458888776  55677788899999999999999   569999999999999999999999999999865544  


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch----------------hhhhHHHHHH
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE----------------YAILTDWAFD  386 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~----------------~~~~~~~~~~  386 (455)
                       -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+...-+                ...+..-++.
T Consensus       172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence             23366778999999999998889999999999999999999999887543211                0111111222


Q ss_pred             HhhcCc------ccc-cccccccc--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          387 CYRNGK------LDD-LVEGDMEA--MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       387 ~~~~~~------~~~-~~~~~l~~--~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ..+...      ..+ +.|.....  ..+........+++..||-.+|++|.+++++++-
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            221110      111 11111111  1111235567889999999999999999999863

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-29  Score=245.13  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=201.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +....+|+|.+|.|||+++.   ..+...|+|.++....+...-.++|+-+++..+|||||.++|-+...+..++.|||+
T Consensus        18 ellqrvgsgTygdvyKaRd~---~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   18 ELLQRVGSGTYGDVYKARDK---RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             hheeeecCCcccchhhhccc---ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            34567999999999999987   456778888887766677778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      .+|+|.+.-+-...+++.++...++...+||+|||   +.+-+|||||-.|||+++.+.+|++|||.+..+...-.+  .
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K--r  169 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK--R  169 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhhh--h
Confidence            99999999999999999999999999999999999   568899999999999999999999999998765432221  1


Q ss_pred             ccccccCcccccccc---cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          327 TAIRGTKGYVAPEWY---RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ..+.||+.|||||+.   ..+.|..++|||+.|+...|+---++|.....+.       .+..++.+....   .+.+  
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTkS~~q---pp~l--  237 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTKSGFQ---PPTL--  237 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhccCCC---CCcc--
Confidence            346699999999976   4567899999999999999998777775433321       111122222111   1111  


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......+.+.++++.|+-.+|++|||.+.+++
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            123345778899999999999999999987653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=4.7e-28  Score=208.74  Aligned_cols=253  Identities=19%  Similarity=0.308  Sum_probs=189.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCC--eEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQ--NRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~--~~~l  241 (455)
                      .+++.+++|+|-++.||.|....   +...++||.++..   ..+.+.+|+.+|..+. ||||+++++...+..  ...|
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccC---CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45677899999999999998663   4567889988754   3567899999999997 999999999987655  4579


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+||+.|.+....-   ++++...+...+.++++||.|+|   +.||+|||+||.|+++|. .-.++|+|+|+|.+.++.
T Consensus       113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            99999998776553   45666778889999999999999   669999999999999995 456999999999998876


Q ss_pred             CCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh-----------hhHHHHHHHh
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA-----------ILTDWAFDCY  388 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~-----------~~~~~~~~~~  388 (455)
                      .....   .+.+..|--||.+-.- .|+.+-|+|||||+|..|+..+.||-........           .+..++.+.-
T Consensus       187 ~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  187 KEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             ceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            65432   3467788899988654 5788999999999999999999999654432111           1111111110


Q ss_pred             h--cCc------------cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          389 R--NGK------------LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       389 ~--~~~------------~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      -  ...            +..++.+.-..    -...+.++++...|..|-++|||+.|.+.
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h----l~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQH----LVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccc----cCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0  011            11111111111    12357788888899999999999999764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=9.9e-29  Score=235.16  Aligned_cols=272  Identities=21%  Similarity=0.232  Sum_probs=206.2

Q ss_pred             ccccCHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC------CCCc
Q 037780          153 LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH------HKNL  226 (455)
Q Consensus       153 ~~~~~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~ni  226 (455)
                      .-.+.+.|+....|...-..|+|-|++|.+|.+..   .+..||||++..... -.+.=+.|+++|++|+      --|.
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence            44566778888888877789999999999999873   455899999976532 2344567999999996      3479


Q ss_pred             eeeeeeEecCCeEEEEEEeCCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       227 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      ++++-.|...++++||||-+ .-+|.+.|...   ..|.......++.|+.-||.+|.   ..+|+|.||||.|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccC
Confidence            99999999999999999977 55899998753   45778889999999999999999   5599999999999999975


Q ss_pred             -CcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH
Q 037780          304 -YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       304 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~  382 (455)
                       ..+||||||.|.....++.    +.+.-+..|.|||++.+.+|+...|+||.||+||||.||+..|.+........+..
T Consensus       573 k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence             5689999999987665443    33335668999999999999999999999999999999999997655432211111


Q ss_pred             -----HHHHHhhcCccc-ccccccc--------------------------------cc-----CCCHHHHHHHHHHHHh
Q 037780          383 -----WAFDCYRNGKLD-DLVEGDM--------------------------------EA-----MNDIKCVEKLLMVSIW  419 (455)
Q Consensus       383 -----~~~~~~~~~~~~-~~~~~~l--------------------------------~~-----~~~~~~~~~~~~l~~~  419 (455)
                           +...+++.|.+. +.+|..+                                ..     .........+.+|+..
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence                 112222222211 1111111                                00     0112345678889999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 037780          420 CIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       420 cl~~~p~~RPt~~~v~~  436 (455)
                      |+..||++|.|..+.+.
T Consensus       729 ml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALK  745 (752)
T ss_pred             HhccChhhcCCHHHHhc
Confidence            99999999999998764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2e-28  Score=264.05  Aligned_cols=195  Identities=18%  Similarity=0.231  Sum_probs=138.5

Q ss_pred             ccCC-CCceeeeeeE-------ecCCeEEEEEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 037780          220 QTHH-KNLVRLLGFC-------DEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH  290 (455)
Q Consensus       220 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH  290 (455)
                      .++| .||++++++|       .+....++++||+ +++|.++|.. ...+++.+++.|+.||++||+|||+   .+|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence            3555 5888888877       2334567888987 6699999975 3568999999999999999999995   59999


Q ss_pred             eCCCCCCEEEcC-------------------CCcEEEeeccCcccccCCCC--------------ccccccccccCcccc
Q 037780          291 CDIKPQNILLDD-------------------HYNARISDFGLAKLLTLNQS--------------KTIKTAIRGTKGYVA  337 (455)
Q Consensus       291 ~dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~a  337 (455)
                      |||||+||||+.                   ++.+|++|||+++.......              ........||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965                   44556666666653211000              000012357889999


Q ss_pred             cccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHH
Q 037780          338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVS  417 (455)
Q Consensus       338 PE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  417 (455)
                      ||++.+..++.++|||||||+||||++|..|+.....    .+..     +....    ..+..     .........++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~-----~~~~~----~~~~~-----~~~~~~~~~~~  245 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS-----LRHRV----LPPQI-----LLNWPKEASFC  245 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH-----HHHhh----cChhh-----hhcCHHHHHHH
Confidence            9999999999999999999999999999888652211    0000     00000    01100     11123456788


Q ss_pred             HhcccCCCCCCCCHHHHHH
Q 037780          418 IWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       418 ~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+||+.+|.+||||.+|++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            8999999999999999975

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=2.5e-27  Score=221.50  Aligned_cols=197  Identities=26%  Similarity=0.368  Sum_probs=162.2

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      .++||+|.|++||++.+.........||+|.+...+  ......+|++.|..+ .+.|++++.+++..++...+|+||++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            467999999999999987533356789999986543  455689999999999 59999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccCCC-----
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQ-----  321 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~-----  321 (455)
                      .....++..   .++...+...+..+..||+++|.   .|||||||||+|+|.+ ..+.-.|.|||+|.......     
T Consensus       119 H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  119 HDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             ccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999988875   35688899999999999999995   5999999999999998 45678999999987211000     


Q ss_pred             --------Cc-----------------------------cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHH
Q 037780          322 --------SK-----------------------------TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEII  363 (455)
Q Consensus       322 --------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~  363 (455)
                              ..                             .......||+||.|||++.. +..++++||||-||+++.++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                    00                             00112358999999999865 45789999999999999999


Q ss_pred             hCCCCCCccc
Q 037780          364 SCRKSFDIEM  373 (455)
Q Consensus       364 tg~~p~~~~~  373 (455)
                      +++.||-...
T Consensus       273 s~~~PFf~a~  282 (418)
T KOG1167|consen  273 SRRYPFFKAK  282 (418)
T ss_pred             ccccccccCc
Confidence            9999996544

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-27  Score=207.56  Aligned_cols=251  Identities=19%  Similarity=0.289  Sum_probs=187.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeee-EecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGF-CDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~-~~~~~~~~lv  242 (455)
                      .+++.+.||+|.||.+-++.++   +..+.+++|-+... ....++|.+|..---.+ .|.||+.-++. ++..+..+++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr---~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHR---QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhHHHHhcccceeeEEeeecc---CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4667789999999999999887   45678999988754 33467899998776666 58999988765 5666778899


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCCcEEEeeccCcccccCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD--DHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||+|.|+|..-+.. ..+.+.....++.|++.|+.|+|   +.++||||||.+|||+-  +..++||+|||+++..+..
T Consensus       101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            999999999988755 44577778889999999999999   55999999999999994  4457999999998865532


Q ss_pred             CCccccccccccCcccccccccCC-----CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS-----TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      -     ....-+..|.+||.....     ...+.+|||.||++++.++||+.||......+   ...|-+..|..+....
T Consensus       177 V-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  177 V-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKNPA  248 (378)
T ss_pred             e-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccCcc
Confidence            2     222346679999976432     35788999999999999999999998443322   2345555666665554


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      +.+.--      ...+.+.++-+.-+..+|++|-...++.++
T Consensus       249 ~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  249 LPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             Cchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            333211      124455666667788899888666555554

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=9.5e-27  Score=205.19  Aligned_cols=166  Identities=22%  Similarity=0.161  Sum_probs=125.9

Q ss_pred             CCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccc
Q 037780          249 GTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT  327 (455)
Q Consensus       249 gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  327 (455)
                      |+|.+++.. ...++|.+++.|+.|++.||.|||+.   +      ||+|||++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            789999986 45699999999999999999999965   3      999999999999999  99998764322      


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCH
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI  407 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  407 (455)
                       ..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+...... ....    ...   ......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~-~~~~----~~~---~~~~~~  133 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNG-MPAD----DPR---DRSNLE  133 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHH-hccC----Ccc---ccccHH
Confidence             258899999999999999999999999999999999999996543211 111111111 0000    000   001111


Q ss_pred             HHHH--HHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          408 KCVE--KLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       408 ~~~~--~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ....  .+.+++..||+.+|.+|||+.++++.+..+
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            2233  689999999999999999999999987643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-28  Score=212.13  Aligned_cols=252  Identities=19%  Similarity=0.328  Sum_probs=193.7

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecc--ccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      -..-+|..+|.+...|..|+|++++.     .+++|++.  .....-.++|..|.-.|+-+.||||++++|.|....+..
T Consensus       189 ~~~lnl~tkl~e~hsgelwrgrwqgn-----divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  189 VSSLNLITKLAESHSGELWRGRWQGN-----DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhhhccCCCcccccccccCc-----chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            33446777899999999999999743     35556653  233344567999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          241 LVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++..||+.|||+..|++..  ..+-.+..+++.++|+|++|||+- .+-|..--|.+..+++|++.+++|+= +-+++.-
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf  341 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF  341 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee
Confidence            9999999999999999864  357788999999999999999975 33455557899999999999998851 1111100


Q ss_pred             CCCCccccccccccCcccccccccCCCCC---CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTIT---AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ..      .+..-.+.||+||.++..+-+   .++|+|||.++||||.|...||....+.+...               +
T Consensus       342 qe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------k  400 (448)
T KOG0195|consen  342 QE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------K  400 (448)
T ss_pred             ec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------h
Confidence            00      112246789999999877644   47999999999999999999998655533211               1


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      +.-..++...+...+..+.+++.-|+..||.+||.+.+|+-.||++.
T Consensus       401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            22223333344456778899999999999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.1e-24  Score=210.34  Aligned_cols=165  Identities=21%  Similarity=0.109  Sum_probs=125.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-----ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      .+.+.+.||+|+||+||+|.+..+  ++..+|||++...     .......|.+|+++|.+++|+|+++.+..+   +..
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~   93 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD   93 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence            355668899999999999987632  3566899986532     112345699999999999999998533322   457


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCEEEcCCCcEEEeeccCccccc
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDI-KPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++||||+++++|... ....      ...++.+++++|.|||+   .+|+|||| ||+|||++.++.+||+|||+++.+.
T Consensus        94 ~LVmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         94 GLVRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             EEEEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            999999999999732 1111      24678899999999995   59999999 9999999999999999999999775


Q ss_pred             CCCCccc------cccccccCcccccccccCC
Q 037780          319 LNQSKTI------KTAIRGTKGYVAPEWYRKS  344 (455)
Q Consensus       319 ~~~~~~~------~~~~~gt~~y~aPE~~~~~  344 (455)
                      .......      .+...+++.|+|||.+...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            4431111      1345688899999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-23  Score=201.00  Aligned_cols=260  Identities=21%  Similarity=0.227  Sum_probs=191.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC----CCceeeeeeE-ecCCeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH----KNLVRLLGFC-DEGQNR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~g~~-~~~~~~  239 (455)
                      .+.+.++||+|+||.||++....+.  ...+|+|............+..|..++..+..    +++..+++.. ..+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            3445688999999999999986442  45678887655433333368889999988873    5788888888 477788


Q ss_pred             EEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-----CcEEEeecc
Q 037780          240 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-----YNARISDFG  312 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg  312 (455)
                      ++||+.. |.+|.++....  +.++..+.+.|+.|++.+|.+||   +.+++||||||+|+++...     ..+.|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999977 88999987543  68899999999999999999999   4599999999999999855     469999999


Q ss_pred             Ccc--cccCCCC------ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccc-hhhhhHHH
Q 037780          313 LAK--LLTLNQS------KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE-EYAILTDW  383 (455)
Q Consensus       313 ~a~--~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~  383 (455)
                      +++  .......      .......+||..|.++..+.+...+.+.|+||++.++.|+..|..||...... ....+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  3322221      11123467999999999999999999999999999999999999999654432 11111100


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .    .    ......     .....+..+.++...+-..+..++|....+...|.....
T Consensus       253 ~----~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  253 P----R----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             h----h----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            0    0    001100     111124556666666666899999999999999876543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=3.6e-22  Score=192.52  Aligned_cols=257  Identities=28%  Similarity=0.361  Sum_probs=195.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---cHHHHHHHHHHHcccCCC-CceeeeeeEecCCeEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHK-NLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.||.|+||.||++...      ..+++|.+......   ....+.+|+.++..+.|+ +++++.+++......++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             eEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            4467999999999999875      56888888654433   366799999999999988 7999999997777789999


Q ss_pred             EeCCCCCHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  319 (455)
                      +++.++++.+++....   .+.......++.+++.++.|+|+.   +++|||+||+||+++... .++++|||+++....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            9999999997776664   788999999999999999999954   899999999999999988 799999999986654


Q ss_pred             CCCcc----ccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          320 NQSKT----IKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       320 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      .....    ......||..|+|||.+.+   ...+...|+||+|++++++++|..|+......   .........+....
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~  231 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP  231 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcC
Confidence            43321    2245679999999999987   57889999999999999999999997654421   00111111111111


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .. .................+.+++..|+..+|..|.++.+....
T Consensus       232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11 000000000001224577888889999999999999887764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=9.9e-24  Score=216.71  Aligned_cols=255  Identities=22%  Similarity=0.273  Sum_probs=187.1

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCc--eEEEEEecccc-c-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTST--TAVAVKKLDRV-F-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~--~~vavK~~~~~-~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+|.|++|.|+...........  ....+| .... . ......+..|+-+-..+.|+|++..+..+.+....+-+||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            456899999977766654222111  111222 1011 0 1111225567777788899999999888887777777799


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc-
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  323 (455)
                      |+++ +|..++.....+.-..+-.++.|+..|+.|+|   ..+|.|||+|++|++++.++.+||+|||.+..+...... 
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            9999 99999988878888999999999999999999   559999999999999999999999999999887655443 


Q ss_pred             -cccccccccCcccccccccCCCCCC-CCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          324 -TIKTAIRGTKGYVAPEWYRKSTITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       324 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                       ......+|+..|+|||.+....|++ ..||||.|+++..|++|+.||......+...     ... ....-.....+  
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~-~~~~~~~~~~~--  549 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTN-NYSDQRNIFEG--  549 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhh-ccccccccccC--
Confidence             3446678999999999999999876 5899999999999999999997655433221     000 00000000000  


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ........+.+...++..+|+.+|.+|.||++|++
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00112245667788999999999999999999985

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-22  Score=196.22  Aligned_cols=217  Identities=26%  Similarity=0.448  Sum_probs=165.0

Q ss_pred             HcccCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 037780          218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQ  296 (455)
Q Consensus       218 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~  296 (455)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ...++|.-...++.+++.||+|||..  +-..|+.++++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence            4678999999999999999999999999999999999987 57889999999999999999999953  23399999999


Q ss_pred             CEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCC-------CCCCCCCeecHHHHHHHHHhCCCCC
Q 037780          297 NILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-------TITAKVDVYSFGVLLLEIISCRKSF  369 (455)
Q Consensus       297 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gv~l~el~tg~~p~  369 (455)
                      |.++|..+.+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998876431111111222245579999998763       1467899999999999999999999


Q ss_pred             Cccccchh-hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          370 DIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       370 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ........ ..+..++    .+ .-....-+.+....  +..+.+..++..||..+|.+||++..|-..++.+..
T Consensus       159 ~~~~~~~~~~eii~~~----~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRV----KK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCChHHHHHHH----Hh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            86443222 1222222    22 11111222222111  344578999999999999999999999999887654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=6.5e-23  Score=211.02  Aligned_cols=250  Identities=23%  Similarity=0.263  Sum_probs=181.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHH--HcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVV--IGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      ..+.+.||+++|=.|.+|++.    .|. |+||.+-+.. .-..+.|.++++-  ...++|||.+++.-+-..+..-|||
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~----eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDR----EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             eeeecccCchhhhhhhhccCC----Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence            345678999999999999876    333 8888875433 2233444444333  4556899999998887777778899


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc--ccCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL--LTLN  320 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~--~~~~  320 (455)
                      -+|..+ +|+|.|...+-+...+.+.|+.|++.||.-+|   ..+|+|+|||.+|||++..+-+.|+||...+.  ++.+
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            999866 99999988888888899999999999999999   55999999999999999999999999987763  2322


Q ss_pred             CCccc---cccccccCcccccccccCC----------C-CCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHH
Q 037780          321 QSKTI---KTAIRGTKGYVAPEWYRKS----------T-ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  385 (455)
Q Consensus       321 ~~~~~---~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  385 (455)
                      .....   ....+.-.+|+|||.+-..          . .+++.||||+||++.||++ |++||+...-          .
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----------~  245 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----------L  245 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----------H
Confidence            22221   1122234579999976431          2 6789999999999999999 7888863221          1


Q ss_pred             HHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      .+ +.+. .......++...+    ..+..+++.|++.||++|.++++.++.-.+
T Consensus       246 aY-r~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  246 AY-RSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             hH-hccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            11 1111 1111111111111    257789999999999999999999987544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1e-21  Score=174.45  Aligned_cols=140  Identities=15%  Similarity=0.118  Sum_probs=108.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--c-------H-----------------HHHHHHHHHHcccCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--G-------E-----------------KEFKNEVVVIGQTHH  223 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h  223 (455)
                      ..||+|+||.||+|...    +++.||||.++.....  .       .                 .....|+..+.++.+
T Consensus         3 ~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05147           3 GCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT   78 (190)
T ss_pred             CccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence            57999999999999875    5788999998653211  1       1                 122349999999988


Q ss_pred             CCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       224 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      +++.....+..  ...++||||++++++.........+++.....++.|++.+|.|+|+  +.+|+||||||+|||++ +
T Consensus        79 ~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          79 AGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-C
Confidence            87644333322  2238999999998876654445678899999999999999999942  34999999999999998 4


Q ss_pred             CcEEEeeccCccccc
Q 037780          304 YNARISDFGLAKLLT  318 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~  318 (455)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-21  Score=168.77  Aligned_cols=202  Identities=22%  Similarity=0.248  Sum_probs=166.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC-CCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+...++||.|+||.+|.|...   ..+..||||.-+....  .-++.-|..+...+++ ..|..+..|..+...-.+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i---~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISI---TSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeec---cCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3456688999999999999987   5678999998765432  3457788999999976 67778888888999999999


Q ss_pred             EeCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  319 (455)
                      |.. |.||.+... ..+.++..+.+-++-|++.-++|+|.   .+++||||||+|+|+.-   -..+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            988 889988764 56788999999999999999999995   49999999999999963   34689999999997754


Q ss_pred             CCCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccc
Q 037780          320 NQSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE  375 (455)
Q Consensus       320 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~  375 (455)
                      ..+..     ......||.+|.+--.+.+...+...|+-|+|.+|.++.-|..||......
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            43221     123456999999988888878889999999999999999999999876553

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.6e-21  Score=175.31  Aligned_cols=169  Identities=14%  Similarity=0.099  Sum_probs=127.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHH---------HHHHHHHHcccCCCCceeeeeeEec
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---------FKNEVVVIGQTHHKNLVRLLGFCDE  235 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~g~~~~  235 (455)
                      .+...+.||.|+||.||....     ++..+|||.+..........         +.+|+..+.+++|++|..+..++..
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            344457899999999998543     24469999997543333222         6899999999999999999988653


Q ss_pred             C--------CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEE
Q 037780          236 G--------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR  307 (455)
Q Consensus       236 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  307 (455)
                      .        ...+|||||++|.+|.++..    ++.    ....+++.+|..+|+   .+++|||+||+||++++++ ++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EE
Confidence            3        35789999999999988742    222    345699999999995   4999999999999999988 99


Q ss_pred             EeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh
Q 037780          308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS  364 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t  364 (455)
                      |+|||..+....+....              .++....+..++|+||||+.+.-+..
T Consensus       175 liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence            99999887553222111              13344556789999999999886643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1e-20  Score=168.72  Aligned_cols=141  Identities=16%  Similarity=0.075  Sum_probs=110.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc--------------------------HHHHHHHHHHHcccCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--------------------------EKEFKNEVVVIGQTHH  223 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h  223 (455)
                      ..||+|+||.||+|...    ++..||||.++......                          ...+..|...+.++.|
T Consensus         3 ~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05145           3 GCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE   78 (190)
T ss_pred             ceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence            56999999999999875    57889999987542110                          1224678999999999


Q ss_pred             CCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       224 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      +++.....+...  ..+|||||++++++.........++......++.+++.++.+||+  ..+|+||||||+||+++ +
T Consensus        79 ~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          79 AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            987554444333  248999999988654443344567788899999999999999996  14999999999999999 8


Q ss_pred             CcEEEeeccCcccccC
Q 037780          304 YNARISDFGLAKLLTL  319 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~~  319 (455)
                      +.++|+|||+++....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3e-20  Score=168.99  Aligned_cols=199  Identities=22%  Similarity=0.301  Sum_probs=166.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ...++||+|.||..+.|..-   -++..||||.-...+  ..-++..|.+..+.+. .++|...+-|-.++.+-.||+|.
T Consensus        31 rVGkKIGeGsFG~lf~G~Nl---~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   31 RVGKKIGEGSFGVLFLGKNL---YNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             eeccccccCcceeeeccccc---ccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            45689999999999999876   457899999865432  3446788888888885 68898888888888899999998


Q ss_pred             CCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-----CcEEEeeccCcccccC
Q 037780          246 LNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-----YNARISDFGLAKLLTL  319 (455)
Q Consensus       246 ~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~  319 (455)
                      . |.||.|... ..++++..+...||.|++.-++|+|+.   .+|.|||||+|+||...     ..+.|+|||+|+....
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 788888764 568899999999999999999999954   99999999999999643     4589999999998766


Q ss_pred             CCCccc-----cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          320 NQSKTI-----KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       320 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      ..+..-     .....||.+||+-.-+.+...+...|+-|+|-++++.+-|..||..-..
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            544321     1234599999999999999999999999999999999999999986544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.4e-21  Score=189.41  Aligned_cols=189  Identities=26%  Similarity=0.275  Sum_probs=159.4

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccccc--cHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +|.|.||.|+...-......+..+|.|.+......  .......|..++...+ ||.+|++.-.+..+...+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            78999999998765555556677777776543211  1114566788888887 99999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA  328 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  328 (455)
                      |.|...+.....++..........++-+++++|   +.+|+|||+|++||+++.+|++++.|||+++..-.....     
T Consensus        82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----  153 (612)
T KOG0603|consen   82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----  153 (612)
T ss_pred             chhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence            999999988888888888888889999999999   559999999999999999999999999999875433221     


Q ss_pred             ccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCc
Q 037780          329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDI  371 (455)
Q Consensus       329 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~  371 (455)
                       +||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence             7899999999998  567899999999999999999999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.8e-19  Score=158.65  Aligned_cols=183  Identities=16%  Similarity=0.050  Sum_probs=134.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc----HHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG----EKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ..|++|+||+||.+..     .+..++.+.++....-.    ...|.+|+++|.+++ |+++.+++++    +..+++||
T Consensus         8 ~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             eeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            5699999999995542     45567766665432211    124889999999995 5889999886    45699999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDI-KPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+.|.+|...+..       ....++.+++++|.++|+.   +|+|||| ||+|||++.++.++|+|||++.........
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            9999999765421       1245788999999999954   9999999 799999999999999999999865543310


Q ss_pred             -------c----ccccccccCcccccccccCC-CCC-CCCCeecHHHHHHHHHhCCCCCCc
Q 037780          324 -------T----IKTAIRGTKGYVAPEWYRKS-TIT-AKVDVYSFGVLLLEIISCRKSFDI  371 (455)
Q Consensus       324 -------~----~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~Gv~l~el~tg~~p~~~  371 (455)
                             .    .+.....++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                   0    01122367788888754322 223 456888999999999999987643

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=2.4e-19  Score=160.83  Aligned_cols=134  Identities=19%  Similarity=0.233  Sum_probs=104.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-----CCCCceeeeeeEecCC---eEE-
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-----HHKNLVRLLGFCDEGQ---NRL-  240 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~g~~~~~~---~~~-  240 (455)
                      +.||+|+||.||.  +.   .+ ...+||+.........+.+.+|+.++.++     +||||++++|++.++.   ..+ 
T Consensus         8 ~~LG~G~~~~Vy~--hp---~~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          8 SPLGTGRHRKCYA--HP---ED-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             ceecCCCceEEEE--CC---CC-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            5799999999995  33   12 33468887654444567899999999999     5799999999998874   333 


Q ss_pred             EEEEe--CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeCCCCCCEEEcC----CCcEEEeeccC
Q 037780          241 LVYEF--LNNGTLASFLFGNLKPSWNLRTNIAFQIARGL-LYLHEDCSSQIIHCDIKPQNILLDD----HYNARISDFGL  313 (455)
Q Consensus       241 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~  313 (455)
                      +|+||  +++++|.+++.+. .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+||+.
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            78999  6689999999664 45555  35677888777 999954   9999999999999973    34799999554


Q ss_pred             cc
Q 037780          314 AK  315 (455)
Q Consensus       314 a~  315 (455)
                      ++
T Consensus       156 ~~  157 (210)
T PRK10345        156 ES  157 (210)
T ss_pred             Cc
Confidence            43

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=2.3e-19  Score=166.22  Aligned_cols=227  Identities=21%  Similarity=0.258  Sum_probs=146.2

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCC----------CCceeeeee---
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHH----------KNLVRLLGF---  232 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~g~---  232 (455)
                      .+.||.|+++.||.+.+.   ..++..|+|......   ....+++++|.-....+.+          -.++-.++.   
T Consensus        17 ~~~i~~g~~~~v~~v~d~---~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDV---ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEETTEEEEEEEET---TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             ccccccCCceEEEEEEEc---cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            356999999999999987   456789998874322   3345677777766666432          122222222   


Q ss_pred             ------EecCC--------eEEEEEEeCCCCCHHHHhc---CC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 037780          233 ------CDEGQ--------NRLLVYEFLNNGTLASFLF---GN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC  291 (455)
Q Consensus       233 ------~~~~~--------~~~lv~e~~~~gsL~~~l~---~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  291 (455)
                            .....        ..+++|+-+ .++|.+++.   ..    ..+....++.+..|+++.+++||..   +++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                  11111        235677776 558877753   21    1234566778889999999999954   99999


Q ss_pred             CCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccC--------CCCCCCCCeecHHHHHHHHH
Q 037780          292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK--------STITAKVDVYSFGVLLLEII  363 (455)
Q Consensus       292 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gv~l~el~  363 (455)
                      ||+|+|++++++|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999877654432211     234578999997643        24788999999999999999


Q ss_pred             hCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCC
Q 037780          364 SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLR  428 (455)
Q Consensus       364 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R  428 (455)
                      +|+.||+...++.....                   ... .+. +.++.+..++...|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~-------------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW-------------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG-------------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc-------------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986654321110                   111 223 578899999999999999988

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=2.7e-18  Score=157.75  Aligned_cols=141  Identities=17%  Similarity=0.180  Sum_probs=108.5

Q ss_pred             hhhhhcCcCCCccEEEEE-EeccCCCceEEEEEeccccccc------------------------cHHHHHHHHHHHccc
Q 037780          167 NFKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQD------------------------GEKEFKNEVVVIGQT  221 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~-~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  221 (455)
                      .+.+.||+|+||.||+|. ..   .++..||+|.+......                        ....+..|+..+.++
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~---~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFD---GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             HhCCeeccCcceeEEEEEecC---CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999998 32   25788999998643210                        012356899999999


Q ss_pred             CCCC--ceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCCE
Q 037780          222 HHKN--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ-IIHCDIKPQNI  298 (455)
Q Consensus       222 ~h~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Ni  298 (455)
                      .+..  +.+++++    ...++||||+++++|..+......+...+...++.|++.+|.+||+.   + ++||||||+||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI  180 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI  180 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence            7633  3344433    23589999999999877654445556666788999999999999954   8 99999999999


Q ss_pred             EEcCCCcEEEeeccCccccc
Q 037780          299 LLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       299 ll~~~~~~kl~Dfg~a~~~~  318 (455)
                      +++ +++++|+|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999987544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=4.5e-18  Score=154.43  Aligned_cols=134  Identities=19%  Similarity=0.250  Sum_probs=111.6

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--------cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.||+|++|.||+|...     +..+++|+.......        ....+.+|+.++..++|+++.....++...+..++
T Consensus         2 ~~l~~G~~~~vy~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-----GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII   76 (211)
T ss_pred             cccccCceEEEEEEeeC-----CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence            46899999999999863     445788875432211        12457889999999999999888888877888899


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ||||+++++|.+++....   + .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||.++.
T Consensus        77 v~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999986533   2 788999999999999995   4999999999999999 78999999999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=9e-20  Score=176.11  Aligned_cols=171  Identities=25%  Similarity=0.354  Sum_probs=129.0

Q ss_pred             eEEEEEEeCCCCCHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          238 NRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      ..++.|+++...+|.+||.+.   ...+|...+.++.|++.|+.|      .+.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999754   456899999999999999999      28999999999999999999999999999


Q ss_pred             ccccCCC----CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhh
Q 037780          315 KLLTLNQ----SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       315 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      .......    .....+...||..||+||.+.+..|+.|+||||||++|+||++ -...++..          -...-++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence            8766544    1222355679999999999999999999999999999999988 22222211          1112233


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK  433 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~  433 (455)
                      +|.+....        -.+.+ .-..++.+++...|.+||+..+
T Consensus       474 ~g~ip~~~--------~~d~p-~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  474 DGIIPPEF--------LQDYP-EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             cCCCChHH--------hhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence            44433111        00111 2245777889999999994444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=8e-18  Score=173.61  Aligned_cols=132  Identities=16%  Similarity=0.265  Sum_probs=107.4

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEec-ccccc-------ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQ-------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.||+|+||+||+|.+...     .+++|+. .....       ...+.+.+|++++.+++|++++....++......+
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-----~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-----DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-----cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            56899999999999987532     2333322 11111       12356889999999999999998888888877889


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +||||+++++|.+++.        .+..++.+++++|.|||+   .+++||||||+|||+ +++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999999874        467899999999999995   499999999999999 6779999999999764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=6.1e-18  Score=177.66  Aligned_cols=193  Identities=24%  Similarity=0.220  Sum_probs=155.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC---CCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~l  241 (455)
                      ...+.++||+|+||+||+|...    +++.||+|.-+...   .-+|.--.+++.||+   -+.|+.+...+.-.+..+|
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             eEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            3445678999999999999986    47899999865432   223333445555555   3456666666677888899


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-------CCCcEEEeeccCc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-------DHYNARISDFGLA  314 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-------~~~~~kl~Dfg~a  314 (455)
                      |+||.+.|+|.+++...+..+|.....|+.|+++.+.+||.   .+|||+||||+|.||.       ++..++|+|||-+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            99999999999999988999999999999999999999994   5999999999999994       3445999999988


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCC
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRK  367 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~  367 (455)
                      --+..-.........++|-++--+|...+.+++..+|.|.++.+++-|+-|+.
T Consensus       849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            65432222222355678999999999999999999999999999999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=8.5e-18  Score=151.14  Aligned_cols=130  Identities=19%  Similarity=0.291  Sum_probs=105.6

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEecccccc-c-------cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-D-------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .||+|+||.||+|.+.     +..+++|....... .       ....+.+|++++..++|+++.....++...+..++|
T Consensus         1 ~ig~G~~~~vy~~~~~-----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEeecC-----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence            3899999999999853     45688887543211 1       125578899999999998876666666667778999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      |||+++++|.+++.....       .++.+++.+|.+||+   .+++|+|++|+||+++ ++.++++|||+++.
T Consensus        76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999998754321       789999999999995   5999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.4e-17  Score=148.02  Aligned_cols=137  Identities=17%  Similarity=0.156  Sum_probs=106.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc----------------------ccHHHHHHHHHHHcccCC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ----------------------DGEKEFKNEVVVIGQTHH  223 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h  223 (455)
                      +.+.+.||+|+||.||++...    ++..+|||+......                      .....+..|...+..+.|
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   92 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE   92 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence            455678999999999999874    577899998653210                      011236778999999988


Q ss_pred             CC--ceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          224 KN--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       224 ~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      ++  +...++.    ...++||||+++++|......      .....++.+++.++.++|+   .+++|+||||+||+++
T Consensus        93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~  159 (198)
T cd05144          93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD  159 (198)
T ss_pred             cCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence            74  4444432    345899999999999876431      2356788999999999995   5999999999999999


Q ss_pred             CCCcEEEeeccCcccccC
Q 037780          302 DHYNARISDFGLAKLLTL  319 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~~~~  319 (455)
                      +++.++|+|||++.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999976554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=2.8e-17  Score=153.04  Aligned_cols=195  Identities=23%  Similarity=0.296  Sum_probs=133.5

Q ss_pred             CCCCceeeeeeEec---------------------------CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHH
Q 037780          222 HHKNLVRLLGFCDE---------------------------GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA  274 (455)
Q Consensus       222 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia  274 (455)
                      +|||||+++++|.+                           +...|+||...+. +|..++..+..-.| .+.-|+.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r-~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYR-TGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchH-HHHHHHHHHH
Confidence            59999999987632                           3356888887744 89999866554444 4555888999


Q ss_pred             HHHHHHHhCCCCCeEEeCCCCCCEEEc--CCC--cEEEeeccCcccccCC------CCccccccccccCcccccccccCC
Q 037780          275 RGLLYLHEDCSSQIIHCDIKPQNILLD--DHY--NARISDFGLAKLLTLN------QSKTIKTAIRGTKGYVAPEWYRKS  344 (455)
Q Consensus       275 ~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~  344 (455)
                      +|+.|||++   ++.|||+|++|||+.  +|.  .+.|+|||.+---...      .+..  -...|.-.-||||+....
T Consensus       352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~--Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDE--VDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccccccc--ccCCCcceecchhhhhcC
Confidence            999999955   999999999999994  443  4789999987422110      1111  122377789999988643


Q ss_pred             C------CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHH
Q 037780          345 T------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSI  418 (455)
Q Consensus       345 ~------~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  418 (455)
                      +      --.|+|.|+.|.+.||+++...||......   .+..   +.+.+..+..+.         ..++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~---r~Yqe~qLPalp---------~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDT---RTYQESQLPALP---------SRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eech---hhhhhhhCCCCc---------ccCChHHHHHHH
Confidence            2      124899999999999999999999753221   1100   001222222221         234566788888


Q ss_pred             hcccCCCCCCCCHHHHHHHH
Q 037780          419 WCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       419 ~cl~~~p~~RPt~~~v~~~L  438 (455)
                      ..|+.||++||+..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            89999999999876554443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=6.8e-16  Score=131.74  Aligned_cols=134  Identities=22%  Similarity=0.175  Sum_probs=114.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC--CCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.||+|.++.||++...     +..+++|.......  ...+..|+..+..++|  .++.+++++....+..++++||++
T Consensus         4 ~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           4 KLLKGGLTNRVYLLGTK-----DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             eecccccccceEEEEec-----CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            56999999999999975     25689998765432  5678999999999977  589999998888888999999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ++++..+       +......++.+++++|++||.....+++|+|++|+||++++++.++++|||.++..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9887654       66777889999999999999654457999999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=7.8e-17  Score=166.55  Aligned_cols=205  Identities=22%  Similarity=0.281  Sum_probs=137.9

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      .+.|-.|++|.||..+++.+   .+..|.| +++...    -.++   ++.....|.+|                     
T Consensus        88 IklisngAygavylvrh~~t---rqrfa~k-iNkq~l----ilRn---ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKET---RQRFAMK-INKQNL----ILRN---ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             eEeeccCCCCceeeeecccc---ccchhhc-ccccch----hhhc---cccccCCccee---------------------
Confidence            36789999999999988744   3456663 322110    0111   22222233322                     


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC-------
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ-------  321 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-------  321 (455)
                      |+=...+...+.++...        +.+++|||   +.+|+|||+||+|.+++.-|++|++|||+++......       
T Consensus       136 gDc~tllk~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             chhhhhcccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence            44445555545554333        78899999   6699999999999999999999999999987532211       


Q ss_pred             -----Cccc-cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          322 -----SKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       322 -----~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                           .+.. ...++||+.|+|||++....|...+|.|++|+++||.+-|+.||....+++....  .+...      ..
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~--visd~------i~  276 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--VISDD------IE  276 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh--hhhhh------cc
Confidence                 1111 1235799999999999999999999999999999999999999998877553211  11100      00


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT  430 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt  430 (455)
                      ..      +.+.....+..+++.+.|+.+|..|--
T Consensus       277 wp------E~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  277 WP------EEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cc------ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            11      112223556777888889999999943

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.2e-15  Score=135.78  Aligned_cols=139  Identities=19%  Similarity=0.166  Sum_probs=95.4

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc--HHH----------------------HHHHHHHHcccCCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKE----------------------FKNEVVVIGQTHHK  224 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~  224 (455)
                      .+.||+|+||+||+|...    ++..||||.........  ...                      ...|...+.++.+.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   77 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA   77 (187)
T ss_pred             CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence            467999999999999865    46789999876432111  111                      13455555555443


Q ss_pred             C--ceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 037780          225 N--LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD  302 (455)
Q Consensus       225 n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  302 (455)
                      .  +.+.+++    ...++||||++++.+........... .....++.+++.++.++|.  ..+|+|+||||+||+++ 
T Consensus        78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence            2  3333332    24589999999954321111111111 5677899999999999995  15999999999999999 


Q ss_pred             CCcEEEeeccCcccccC
Q 037780          303 HYNARISDFGLAKLLTL  319 (455)
Q Consensus       303 ~~~~kl~Dfg~a~~~~~  319 (455)
                      ++.++|+|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.9e-17  Score=169.15  Aligned_cols=253  Identities=22%  Similarity=0.283  Sum_probs=187.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+|+.|-......  .....+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~--~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSR--DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccchhhhhhhcC--CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4455669999999998776543  244567777776543  222334455777777776 99999999999999999999


Q ss_pred             EEeCCCCCHHHHh-cCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccC
Q 037780          243 YEFLNNGTLASFL-FGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTL  319 (455)
Q Consensus       243 ~e~~~~gsL~~~l-~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~  319 (455)
                      .+|..++++.+.+ .... ..+....-..+.|+..++.|+|.  ..++.|+||||+|.+++..+ ..+++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999988 4443 55566677789999999999993  23899999999999999999 999999999998876


Q ss_pred             -CCCccccccccc-cCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          320 -NQSKTIKTAIRG-TKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       320 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                       ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........              ....
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~~~~  243 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------YSSW  243 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------ceee
Confidence             433333344567 9999999999874 4567899999999999999999999765543211              1111


Q ss_pred             ccccc--ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDM--EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l--~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....  .............++...++..+|..|.+..++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            11100  00111123455667777788899999999888653

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=5.7e-15  Score=136.00  Aligned_cols=135  Identities=17%  Similarity=0.124  Sum_probs=103.8

Q ss_pred             hhcC-cCCCccEEEEEEeccCCCceEEEEEeccccc-------------cccHHHHHHHHHHHcccCCCCc--eeeeeeE
Q 037780          170 EEAG-RGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-------------QDGEKEFKNEVVVIGQTHHKNL--VRLLGFC  233 (455)
Q Consensus       170 ~~lG-~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~g~~  233 (455)
                      ..|| .||.|+||+....     +..++||+.....             ......+.+|+.++.+++|+++  ++.+++.
T Consensus        37 ~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~  111 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR  111 (239)
T ss_pred             ceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence            4688 8999999999864     4568888774311             1123467889999999998875  6777765


Q ss_pred             ecCCe----EEEEEEeCCC-CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEE
Q 037780          234 DEGQN----RLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI  308 (455)
Q Consensus       234 ~~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  308 (455)
                      .....    .++|+|++++ .+|.+++... .++..    .+.+++.+|.+||+   .+|+|+||||.|||++.++.++|
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence            43322    2599999997 6999888653 34433    35789999999995   49999999999999999999999


Q ss_pred             eeccCcccc
Q 037780          309 SDFGLAKLL  317 (455)
Q Consensus       309 ~Dfg~a~~~  317 (455)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=2.5e-14  Score=130.66  Aligned_cols=200  Identities=21%  Similarity=0.269  Sum_probs=137.4

Q ss_pred             HHHHHcccCCCCceeeeeeEecC-----CeEEEEEEeCCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037780          214 EVVVIGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDC  284 (455)
Q Consensus       214 e~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~  284 (455)
                      -...|-++-|.|||+++.|+.+.     .+..++.|||..|+|..+|++.    ..+....-.+++.||..||.|||.. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            34455667799999999998554     3568999999999999999754    4566777778999999999999975 


Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc---cccccccccCcccccccccCCCCCCCCCeecHHHHHHH
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK---TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE  361 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~e  361 (455)
                      .++|+|+++..+.|++..++-+||.--- ..........   .-+....+-++|.|||+=.....+.++|||+||+..+|
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            8999999999999999988888875211 1111110000   00112346789999998887788889999999999999


Q ss_pred             HHhCCCCC-Ccccc-chhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          362 IISCRKSF-DIEMG-EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       362 l~tg~~p~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      |.-+..-. +.... ......         .+.+..+-++ +           -..++..|++..|..||+|.+++.
T Consensus       275 mailEiq~tnseS~~~~ee~i---------a~~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENI---------ANVIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHheeccCCCcceeehhhhh---------hhheeeccCc-c-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            98776532 11111 000000         0011111111 1           123456699999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=6.5e-14  Score=140.05  Aligned_cols=139  Identities=21%  Similarity=0.219  Sum_probs=99.1

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEecccccccc----------------------------------------HHH
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG----------------------------------------EKE  210 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~  210 (455)
                      -||+|++|.||+|++.    +|+.||||+.+......                                        +-+
T Consensus       124 plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld  199 (437)
T TIGR01982       124 PLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD  199 (437)
T ss_pred             ceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence            4999999999999986    57889999985432110                                        013


Q ss_pred             HHHHHHHHcccC----CCCceeeeeeE-ecCCeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 037780          211 FKNEVVVIGQTH----HKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIAR-GLLYLHED  283 (455)
Q Consensus       211 ~~~e~~~l~~l~----h~niv~l~g~~-~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~-~l~~LH~~  283 (455)
                      |.+|...+.++.    |.+-+.+-..+ ......+|||||++|++|.++.... ...   .+..++..+++ .+..+|+ 
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh-
Confidence            555666666652    33333433333 3345679999999999998876432 112   24557777666 4677884 


Q ss_pred             CCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       284 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                        .+++|+|+||.||+++++++++++|||++..+..
T Consensus       276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              4999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.51  E-value=1.4e-14  Score=104.41  Aligned_cols=58  Identities=22%  Similarity=0.433  Sum_probs=50.2

Q ss_pred             cceeEEEeeCCCCCCCccc-cccccCHHhHHHhhccCCceeeeeecC----CcceeeccCCCC
Q 037780            8 ELFDFHEVKNIDWPQSDYE-RFKPYNEVQCKNSCLSDCFCAAVIFED----DSCCFKKLPLSN   65 (455)
Q Consensus         8 ~~~~f~~~~~~~~p~~~~~-~~~~~~~~~C~~~Cl~~C~C~a~~~~~----~~c~~~~~~L~~   65 (455)
                      .+.+|+++++|++|+++.. +..+++.++|+..||+||+|+||+|.+    ++|.+|..+|.|
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d   65 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD   65 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence            4679999999999998654 346799999999999999999999963    679999988765

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=3.1e-12  Score=111.71  Aligned_cols=130  Identities=19%  Similarity=0.127  Sum_probs=95.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.|+.|.++.||++...     +..+++|....... ....+..|+..+..+.+.+++ +++.+.  ....++||||+++
T Consensus         4 ~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eecCCcccCceEEEEEC-----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            45889999999998863     56799998754321 233567899999998766654 344433  2345899999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      .++....        .....++.+++++|+.||+..  ...++|+|++|+||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Ccccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            8876430        112346789999999999652  22369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=9.5e-13  Score=130.13  Aligned_cols=255  Identities=24%  Similarity=0.280  Sum_probs=179.9

Q ss_pred             HHHHHHHHhhhhhcCc--CCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHccc-CCCCceeeeeeE
Q 037780          159 KALEEATDNFKEEAGR--GSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFC  233 (455)
Q Consensus       159 ~~l~~~t~~f~~~lG~--G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~g~~  233 (455)
                      .+....+.++.+.+|.  |.+|.||.+.... ..+...+|+|+-+....  .....=.+|+..-+++ .|+|.++....+
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            3444455667788999  9999999998733 24667789988543322  2223334566666666 499999988889


Q ss_pred             ecCCeEEEEEEeCCCCCHHHHhcCCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEE
Q 037780          234 DEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIAR----GLLYLHEDCSSQIIHCDIKPQNILLDDH-YNAR  307 (455)
Q Consensus       234 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~k  307 (455)
                      ...+..++-.|++. .+|..+.+.... ++....+.+..+...    ||.++|   +.+++|-|+||.||++..+ ...+
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceee
Confidence            99999999999884 788888776543 566677777777777    999999   6699999999999999999 8899


Q ss_pred             EeeccCcccccCCCCcccc---ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH
Q 037780          308 ISDFGLAKLLTLNQSKTIK---TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  384 (455)
                      ++|||+...++........   ....|...|++||... +.++.++|+|++|.+.++..++..........      .  
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~--  334 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------S--  334 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------C--
Confidence            9999999887755422111   1224788899999885 45788999999999999999987665432110      0  


Q ss_pred             HHHhhcCccc-cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          385 FDCYRNGKLD-DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       385 ~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      |..++.+.+. +.++.         -..++...+.++++.+|-.|++.+.+..
T Consensus       335 W~~~r~~~ip~e~~~~---------~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  335 WSQLRQGYIPLEFCEG---------GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccccCchhhhcC---------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111111111 11111         1233444788899999999998877654

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.35  E-value=1.1e-12  Score=100.35  Aligned_cols=72  Identities=18%  Similarity=0.382  Sum_probs=60.1

Q ss_pred             ceeEEEeeCCCCCCCccccccccCHHhHHHhhccCCceeeeeec--CCcceeeccCCCCCccccccccceeeecc
Q 037780            9 LFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFE--DDSCCFKKLPLSNGMTDSRITSKAFIKYK   81 (455)
Q Consensus         9 ~~~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~~C~C~a~~~~--~~~c~~~~~~L~~g~~~~~~~~~~~~k~~   81 (455)
                      .+.|++++++++|+..+.. .+.++++|++.||+||+|+||+|.  +++|++|..++.+.+.........|+|++
T Consensus        11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence            5899999999999887655 778999999999999999999996  47899999988877654444567888863

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=1.8e-12  Score=131.26  Aligned_cols=141  Identities=15%  Similarity=0.135  Sum_probs=91.1

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccc----------------------------------------cHHH
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD----------------------------------------GEKE  210 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~  210 (455)
                      -||+|++|.||+|++.+   +++.||||..+.....                                        .+-+
T Consensus       126 PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD  202 (537)
T PRK04750        126 PLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELD  202 (537)
T ss_pred             hhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhC
Confidence            59999999999999973   3788999998643210                                        0012


Q ss_pred             HHHHHHHHcccC----CCCceeeeeeEec-CCeEEEEEEeCCCCCHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 037780          211 FKNEVVVIGQTH----HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED  283 (455)
Q Consensus       211 ~~~e~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~i~~~ia~~l~~LH~~  283 (455)
                      |.+|+..+.++.    +.+.+.+-..+.+ ....+|||||++|+.+.++-  ...+ .+   +..++...++.  |+++-
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~~--~~~Qi  276 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVEV--FFTQV  276 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHHH--HHHHH
Confidence            455555555552    3444444444433 45678999999999998752  2221 11   11222222221  22221


Q ss_pred             CCCCeEEeCCCCCCEEEcCCC----cEEEeeccCcccccCC
Q 037780          284 CSSQIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLN  320 (455)
Q Consensus       284 ~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~~  320 (455)
                      ...+++|+|+||.||+++.++    .+++.|||+...+...
T Consensus       277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            234999999999999999888    9999999999877543

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.30  E-value=2.9e-12  Score=95.29  Aligned_cols=67  Identities=12%  Similarity=0.138  Sum_probs=55.1

Q ss_pred             cceeEEEeeCCCCCCCccccccccCHHhHHHhhcc---CCceeeeeec--CCcceeeccCC-CCCccccccccceeee
Q 037780            8 ELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLS---DCFCAAVIFE--DDSCCFKKLPL-SNGMTDSRITSKAFIK   79 (455)
Q Consensus         8 ~~~~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~---~C~C~a~~~~--~~~c~~~~~~L-~~g~~~~~~~~~~~~k   79 (455)
                      ..=+|+++.++|+|++..     .+.+||++.|++   ||+|+||+|.  +++|.+|..++ .+.+.....+..+|+|
T Consensus         7 ~~g~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129           7 SAGTTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             cCCeEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence            345799999999998754     689999999999   9999999995  45899999999 7776665555667765

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.24  E-value=1.3e-10  Score=116.43  Aligned_cols=165  Identities=18%  Similarity=0.196  Sum_probs=121.4

Q ss_pred             CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHH
Q 037780          190 TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI  269 (455)
Q Consensus       190 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i  269 (455)
                      .++..|.|...+...........+-++.|+.++||||++++.........|||+|-+.  .|..++....   -......
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~G  109 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCLG  109 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHHH
Confidence            4566777777765544334557888999999999999999999999999999999763  4555554332   3344457


Q ss_pred             HHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCC
Q 037780          270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK  349 (455)
Q Consensus       270 ~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  349 (455)
                      +.||+.||.|||+.  .+++|++|.-..|++++.|+.||++|.++........  ......---.|..|+.+....  -.
T Consensus       110 l~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  110 LFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cc
Confidence            88999999999975  4899999999999999999999999988754332111  001111223466666543322  35


Q ss_pred             CCeecHHHHHHHHHhC
Q 037780          350 VDVYSFGVLLLEIISC  365 (455)
Q Consensus       350 ~Dv~s~Gv~l~el~tg  365 (455)
                      .|.|-||++++|++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.22  E-value=1.3e-10  Score=106.13  Aligned_cols=142  Identities=18%  Similarity=0.217  Sum_probs=109.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCC--CCceeeeeeEecCC---eEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ---NRLLVY  243 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~  243 (455)
                      +.|+.|..+.||++...    ++..+++|....... .....+..|+.++..+.+  .++.+++.+.....   ..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEec----CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            45899999999999874    246789998754322 134578999999999976  34567777776643   568999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC---------------------------------------  284 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------  284 (455)
                      ||+++.++.+.+.. ..++..++..++.++++.|+.||+..                                       
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999988776532 45677888889999999999998521                                       


Q ss_pred             --------------CCCeEEeCCCCCCEEEcC--CCcEEEeeccCccc
Q 037780          285 --------------SSQIIHCDIKPQNILLDD--HYNARISDFGLAKL  316 (455)
Q Consensus       285 --------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~  316 (455)
                                    ...++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.21  E-value=2.6e-10  Score=110.84  Aligned_cols=168  Identities=20%  Similarity=0.266  Sum_probs=132.4

Q ss_pred             CCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEe----cCCeEEEEEEeCCC-CC
Q 037780          176 SFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD----EGQNRLLVYEFLNN-GT  250 (455)
Q Consensus       176 ~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gs  250 (455)
                      .-.+.||+...   .+|..++.|+++....+.......-++.++++.|.|+|++..++.    .+..+++||+|.|+ ++
T Consensus       288 ~~~Ttyk~~s~---~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSN---VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeec---cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            45688999877   567889999996655444444556788999999999999999875    35578999999997 68


Q ss_pred             HHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          251 LASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       251 L~~~l~~~---------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      |.+.-+.+               ...++...|.++.|++.||.++|+   .|+.-+-|.+.+||++.+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEeccccee
Confidence            87765432               345788999999999999999994   599999999999999999999999988877


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCC
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS  368 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p  368 (455)
                      .+..+.....                .   --.+-|.=.||.+++.|.||...
T Consensus       442 vl~~d~~~~l----------------e---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  442 VLQEDPTEPL----------------E---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             eecCCCCcch----------------h---HHhhhhHHHHHHHHHHHhhcccc
Confidence            6654442211                0   12356888899999999999754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=4.1e-10  Score=96.12  Aligned_cols=130  Identities=20%  Similarity=0.318  Sum_probs=100.2

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEec-cccccc-------cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQD-------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+++|+-+.+|.+.+.     +..+++|.- .+....       ..+...+|..++.+++--.+-...=+..+.....++
T Consensus         3 ~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~   77 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIV   77 (204)
T ss_pred             hhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEE
Confidence            4788999999998664     223444432 221111       124578899999999876766666677788888999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      |||+++..|.+.+...       +..++..+-.-+.-||.   .+|+|+||.++||++..+. +.++||||+..
T Consensus        78 me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          78 MEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999998655       46678888888999995   5999999999999998775 99999999874

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.16  E-value=5.6e-10  Score=98.53  Aligned_cols=141  Identities=15%  Similarity=0.184  Sum_probs=97.5

Q ss_pred             hhcCcCCCccEEEEEEecc---CCCceEEEEEecccccc----------------------ccHHHH----HHHHHHHcc
Q 037780          170 EEAGRGSFGIVYKGVIETT---RTSTTAVAVKKLDRVFQ----------------------DGEKEF----KNEVVVIGQ  220 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~----------------------~~~~~~----~~e~~~l~~  220 (455)
                      -.||.|--+.||.|...+.   ...+..+|||.......                      ...+.+    .+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            3588999999999975421   01346889998642110                      001223    389999999


Q ss_pred             cCC--CCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCCCCC
Q 037780          221 THH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL-HEDCSSQIIHCDIKPQN  297 (455)
Q Consensus       221 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~N  297 (455)
                      +..  -++..++++    ...+|||||+.+..+..-.-....++..+...+..+++.+|..| |   ..+++|+||++.|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence            854  455566654    45689999997754422211222344556677889999999999 6   3499999999999


Q ss_pred             EEEcCCCcEEEeeccCccccc
Q 037780          298 ILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       298 ill~~~~~~kl~Dfg~a~~~~  318 (455)
                      |++++ +.+.|+|||.+....
T Consensus       156 IL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEEC-CcEEEEECCCceeCC
Confidence            99974 689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.13  E-value=1.9e-11  Score=127.37  Aligned_cols=194  Identities=24%  Similarity=0.240  Sum_probs=138.9

Q ss_pred             CCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       222 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      +||-+++..--+.-....+||++|..+++|..-|+.....+..-.+.....+...++|||   +..+.|+|++|.|++..
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~  938 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIA  938 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhc
Confidence            345555544444556678999999999999999988776666666677778889999999   44689999999999999


Q ss_pred             CCCcEEEeeccCcccccCC---------------------CC-----c---cccccccccCcccccccccCCCCCCCCCe
Q 037780          302 DHYNARISDFGLAKLLTLN---------------------QS-----K---TIKTAIRGTKGYVAPEWYRKSTITAKVDV  352 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~~~~~---------------------~~-----~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  352 (455)
                      .+++.+++|||.....+..                     ..     .   .......||+.|.+||.+.+......+|.
T Consensus       939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen  939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred             ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence            9999999999833221100                     00     0   01223458999999999999999999999


Q ss_pred             ecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 037780          353 YSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR  432 (455)
Q Consensus       353 ~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~  432 (455)
                      |++|++++|.++|..||+...++..       .+.+..+.+.-.       ..+.....+..+++..-+..+|.+|-.|.
T Consensus      1019 ~~~g~~l~e~l~g~pp~na~tpq~~-------f~ni~~~~~~~p-------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQI-------FENILNRDIPWP-------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhhhhhhcCCCCCCCcchhhh-------hhccccCCCCCC-------CCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999999999999987665321       122222222111       11122344555666667788899887766

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=8.7e-11  Score=116.41  Aligned_cols=241  Identities=20%  Similarity=0.208  Sum_probs=168.9

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHH--HHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ...||.|.|+.|++...+ . .++..+++|.+.+.......+  -..|+.+...+ .|.+.++....+......++=-||
T Consensus       270 v~~i~~~~~~~~~~~~~r-~-~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKR-P-EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             eEEccCCccccceeeeec-C-CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            357999999999987733 1 356789999886554333222  23455555555 588888888877778888899999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +.++++...+.-...++...++++..+++.++.++|   ++.++|+|+||+||++..+ +.-++.|||.+..+.-...  
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--  422 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--  422 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc--
Confidence            999999888755566788889999999999999999   6699999999999999886 8889999999875332211  


Q ss_pred             ccccccccCccc--ccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          325 IKTAIRGTKGYV--APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       325 ~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                         ....+-++.  +++......+-.+.|+||||.-+.|.+++..-......          +..+..+......     
T Consensus       423 ---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p~~~-----  484 (524)
T KOG0601|consen  423 ---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTPNLP-----  484 (524)
T ss_pred             ---cccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccccCCC-----
Confidence               111233444  55555566788899999999999999998754321110          0011112111111     


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                           ...+.+..++..++..++..||.+.+.....+
T Consensus       485 -----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  485 -----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -----chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                 11255666667788899999999888765543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=2.1e-09  Score=91.42  Aligned_cols=140  Identities=21%  Similarity=0.295  Sum_probs=102.6

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEec-ccccc-------ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQ-------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+-+|+-+.|+++.+.     ++...||.- .+...       -......+|++.|.++.--.|.-..-++.+...-.|
T Consensus        13 ~likQGAEArv~~~~~~-----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             eeeeccceeeEeeeccC-----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence            45789999999999875     455555542 22111       123567899999999876666655556666667789


Q ss_pred             EEEeCCC-CCHHHHhcCCC-CCCHHHH-HHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeeccCcc
Q 037780          242 VYEFLNN-GTLASFLFGNL-KPSWNLR-TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDFGLAK  315 (455)
Q Consensus       242 v~e~~~~-gsL~~~l~~~~-~~~~~~~-~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~  315 (455)
                      +|||.++ .++.+++.... ....... ..++..|-+.+.-||.   .+|+|+||..+||+|..++   .+.++|||++.
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            9999987 57888887542 2223333 6789999999999994   5999999999999997654   35899999986


Q ss_pred             cc
Q 037780          316 LL  317 (455)
Q Consensus       316 ~~  317 (455)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            43

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.93  E-value=1.6e-08  Score=94.34  Aligned_cols=130  Identities=15%  Similarity=0.082  Sum_probs=94.8

Q ss_pred             cEEEEEEeccCCCceEEEEEecccccc-----------ccHHHHHHHHHHHcccCCCC--ceeeeeeEec-----CCeEE
Q 037780          179 IVYKGVIETTRTSTTAVAVKKLDRVFQ-----------DGEKEFKNEVVVIGQTHHKN--LVRLLGFCDE-----GQNRL  240 (455)
Q Consensus       179 ~Vy~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~-----~~~~~  240 (455)
                      .|.+..+     +++.+.||+......           .....+.+|...+.++...+  ...++++...     ....+
T Consensus        37 rvvr~~~-----~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         37 RTLRFEL-----AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             eEEEEEE-----CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            3556654     356789997643221           01124788999998885444  3445556543     23578


Q ss_pred             EEEEeCCCC-CHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-------CCcEEEee
Q 037780          241 LVYEFLNNG-TLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-------HYNARISD  310 (455)
Q Consensus       241 lv~e~~~~g-sL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~D  310 (455)
                      ||+|++++. +|.+++..  ....+...+..++.+++..++-||+.   +|+|+|++++|||++.       +..+.++|
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            999999986 89998853  24456677789999999999999954   9999999999999985       56899999


Q ss_pred             ccCccc
Q 037780          311 FGLAKL  316 (455)
Q Consensus       311 fg~a~~  316 (455)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998853

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=5.9e-10  Score=112.11  Aligned_cols=151  Identities=19%  Similarity=0.266  Sum_probs=104.2

Q ss_pred             HHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc-------ccccccccCcccccccccC
Q 037780          271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-------IKTAIRGTKGYVAPEWYRK  343 (455)
Q Consensus       271 ~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~  343 (455)
                      .+++.|+.|+|+  +.++||++|.|++|.++.++..||+.|+.+..........       ...-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345699999997  6799999999999999999999999999876544311111       0011224568999999999


Q ss_pred             CCCCCCCCeecHHHHHHHHH-hCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhccc
Q 037780          344 STITAKVDVYSFGVLLLEII-SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQ  422 (455)
Q Consensus       344 ~~~~~~~Dv~s~Gv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~  422 (455)
                      ...+.++|+||+|++++.+. .|+.-+...........             ....+..-...+..+.+.++.+=+...+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHhc
Confidence            88899999999999999999 46655544332111110             00011111111123456777777788899


Q ss_pred             CCCCCCCCHHHHHH
Q 037780          423 EDPSLRPTMRKVSQ  436 (455)
Q Consensus       423 ~~p~~RPt~~~v~~  436 (455)
                      .++..||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=1.8e-08  Score=88.62  Aligned_cols=126  Identities=21%  Similarity=0.210  Sum_probs=80.0

Q ss_pred             EEEEEEeccCCCceEEEEEeccccccc--------------------------cHHHHHHHHHHHcccCCC--Cceeeee
Q 037780          180 VYKGVIETTRTSTTAVAVKKLDRVFQD--------------------------GEKEFKNEVVVIGQTHHK--NLVRLLG  231 (455)
Q Consensus       180 Vy~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~--niv~l~g  231 (455)
                      ||.|...    ++..+|||.-......                          ......+|.+.|.++..-  ++.++++
T Consensus         2 Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~   77 (188)
T PF01163_consen    2 VYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD   77 (188)
T ss_dssp             EEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred             EEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence            8888874    5678999986421100                          123578899999999866  4555654


Q ss_pred             eEecCCeEEEEEEeCC--CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEe
Q 037780          232 FCDEGQNRLLVYEFLN--NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS  309 (455)
Q Consensus       232 ~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  309 (455)
                      +.    ...|||||++  +..+..+....  ++......++.+++..+..+++  ..+|+|+||.+.||+++++ .+.|+
T Consensus        78 ~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   78 YN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             EE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             Ee----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEE
Confidence            42    3479999998  54554332211  1133456677788886666432  5699999999999999988 99999


Q ss_pred             eccCccccc
Q 037780          310 DFGLAKLLT  318 (455)
Q Consensus       310 Dfg~a~~~~  318 (455)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999887544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.81  E-value=2.5e-08  Score=100.70  Aligned_cols=157  Identities=20%  Similarity=0.290  Sum_probs=102.8

Q ss_pred             cccccCHHHHHHHH------------Hhhh-hhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-----------
Q 037780          152 NLRCFSYKALEEAT------------DNFK-EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-----------  207 (455)
Q Consensus       152 ~~~~~~~~~l~~~t------------~~f~-~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----------  207 (455)
                      ..+.|+++++.+.-            .+|. +-|+.++-|.||+|++.    +|+.||||+.+..-...           
T Consensus       100 ~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~  175 (517)
T COG0661         100 RVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRL  175 (517)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHH
Confidence            44566666544322            2444 34899999999999997    58899999976432210           


Q ss_pred             -----------------------------HHHHHHHHHHHcccC-----CCCceeeeeeE-ecCCeEEEEEEeCCCCCHH
Q 037780          208 -----------------------------EKEFKNEVVVIGQTH-----HKNLVRLLGFC-DEGQNRLLVYEFLNNGTLA  252 (455)
Q Consensus       208 -----------------------------~~~~~~e~~~l~~l~-----h~niv~l~g~~-~~~~~~~lv~e~~~~gsL~  252 (455)
                                                   +-++..|...+.++.     .+++ ++=..+ +-.....|+|||++|-.+.
T Consensus       176 a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~  254 (517)
T COG0661         176 ARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKIS  254 (517)
T ss_pred             HHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecc
Confidence                                         112455555555552     2333 333333 3456789999999999998


Q ss_pred             HHh--cCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          253 SFL--FGNLKPSWNLRTNIAFQIARGL-LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       253 ~~l--~~~~~~~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +..  .. ...+   +..|+..++++. ..+-   ..+++|+|.+|.||+++.++++.+.|||+...+.+.
T Consensus       255 d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         255 DIAALKS-AGID---RKELAELLVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cHHHHHh-cCCC---HHHHHHHHHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            884  33 3334   333444444331 1111   239999999999999999999999999998876644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=8.4e-08  Score=86.45  Aligned_cols=137  Identities=18%  Similarity=0.149  Sum_probs=99.6

Q ss_pred             ccEEEEEEeccCCCceEEEEEeccccc-c------ccHHHHHHHHHHHcccCC--CCceeeeeeEecCC----eEEEEEE
Q 037780          178 GIVYKGVIETTRTSTTAVAVKKLDRVF-Q------DGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQ----NRLLVYE  244 (455)
Q Consensus       178 g~Vy~~~~~~~~~~~~~vavK~~~~~~-~------~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~----~~~lv~e  244 (455)
                      |.++.+.........+.+-+|...... .      -......+|...+.++..  -...+.+++.....    ..++|+|
T Consensus        18 ~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite   97 (206)
T PF06293_consen   18 RGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITE   97 (206)
T ss_pred             ceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEE
Confidence            345555554333345566666542211 1      123457888888888854  34556667665532    4589999


Q ss_pred             eCCC-CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeeccCcccc
Q 037780          245 FLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDFGLAKLL  317 (455)
Q Consensus       245 ~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~  317 (455)
                      ++++ .+|.+++.....++...+..++.++++.++-||+.   +|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus        98 ~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen   98 ALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             eCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9998 48999998755577778889999999999999965   999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.72  E-value=3.2e-07  Score=81.27  Aligned_cols=136  Identities=17%  Similarity=0.134  Sum_probs=103.2

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccc------cccHHHHHHHHHHHcccCCCC--ceeeeeeEe-c----CCe
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF------QDGEKEFKNEVVVIGQTHHKN--LVRLLGFCD-E----GQN  238 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~-~----~~~  238 (455)
                      -|+||-+.|++-.+.     +..+-+|+-....      .-+...|.+|...|.++...+  +.++. ++. .    .-.
T Consensus        26 ~~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r   99 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR   99 (216)
T ss_pred             cCCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence            467999999997764     3368888875221      235678999999999996433  44444 332 1    123


Q ss_pred             EEEEEEeCCC-CCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc--EEEeeccC
Q 037780          239 RLLVYEFLNN-GTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN--ARISDFGL  313 (455)
Q Consensus       239 ~~lv~e~~~~-gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~  313 (455)
                      -+||+|-+++ .+|.+++.+.  ...+...+..+..++++.++-||+   .++.|+|+-+.||+++.++.  ++++||.-
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            5799998875 6999998663  455778889999999999999995   59999999999999986666  99999987


Q ss_pred             ccc
Q 037780          314 AKL  316 (455)
Q Consensus       314 a~~  316 (455)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.64  E-value=2.4e-07  Score=84.08  Aligned_cols=136  Identities=16%  Similarity=0.152  Sum_probs=94.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc----------------------ccHHHHHHHHHHHcccCC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ----------------------DGEKEFKNEVVVIGQTHH  223 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h  223 (455)
                      +.+.++||.|--+.||.|...    .+..+|||.=.....                      -.....++|.+.|.++.-
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~  168 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP  168 (304)
T ss_pred             HhhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence            356688999999999999986    567788886321100                      012346788899988865


Q ss_pred             C--CceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          224 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       224 ~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      .  .+.+.+++    +...+||||+++-.|...--     +....-.|+..|++-+.-+-   ..|+||+|+.+-||+++
T Consensus       169 ~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~  236 (304)
T COG0478         169 EGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVT  236 (304)
T ss_pred             cCCCCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEe
Confidence            4  56666664    45579999999877654421     22233334444444444444   24899999999999999


Q ss_pred             CCCcEEEeeccCcccc
Q 037780          302 DHYNARISDFGLAKLL  317 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~~  317 (455)
                      ++|.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999876543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=1e-06  Score=84.28  Aligned_cols=254  Identities=13%  Similarity=0.121  Sum_probs=149.6

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeE------ecCC-eEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFC------DEGQ-NRL  240 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~------~~~~-~~~  240 (455)
                      +..||+|+-+.+|-.--      ..--+-|+.+........+   .+..|... .||-+-.-+.|=      -+.+ ..-
T Consensus        16 gr~LgqGgea~ly~l~e------~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGE------VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecch------hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            46799999999995422      1122345554433322222   23333333 465443312221      1122 245


Q ss_pred             EEEEeCCCC-CHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          241 LVYEFLNNG-TLASFLF------GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       241 lv~e~~~~g-sL~~~l~------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      +.|..+++. ....++.      +....+|.-.++.+..+|.+.+-||+.   |.+-+|+.++|+|+.+++.+.|.|=..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence            777777664 2333332      224568999999999999999999965   899999999999999999999998543


Q ss_pred             cccccCCCCccccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhC-CCCCCccccc--hhhhhHHHHH
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGE--EYAILTDWAF  385 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg-~~p~~~~~~~--~~~~~~~~~~  385 (455)
                      -..-.   .......-+|...|.+||.-.     +-.-+...|-|.+||++++++.| +.||......  ......    
T Consensus       164 fqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----  236 (637)
T COG4248         164 FQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----  236 (637)
T ss_pred             eeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----
Confidence            33221   111113345889999999654     33456789999999999999985 9999754321  000000    


Q ss_pred             HHhhcCcccccccccc------ccCCCHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHhcC
Q 037780          386 DCYRNGKLDDLVEGDM------EAMNDIKCVEKLLMVSIWCIQE--DPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~l------~~~~~~~~~~~~~~l~~~cl~~--~p~~RPt~~~v~~~L~~~  441 (455)
                      .-+..|......+...      ....-.-.+..+..+-.+|+..  ++.-|||.+-++..|..+
T Consensus       237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            0011111111111110      0011112234555566677754  356899999998887654

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.60  E-value=1.1e-07  Score=71.14  Aligned_cols=60  Identities=17%  Similarity=0.340  Sum_probs=48.2

Q ss_pred             cceeEEEeeCCCCCCCccccccccCHHhHHHhhcc-CCceeeeeec--CCcceeec-cCCCCCc
Q 037780            8 ELFDFHEVKNIDWPQSDYERFKPYNEVQCKNSCLS-DCFCAAVIFE--DDSCCFKK-LPLSNGM   67 (455)
Q Consensus         8 ~~~~f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~-~C~C~a~~~~--~~~c~~~~-~~L~~g~   67 (455)
                      ....|++++++++|+.........+.++|++.|++ +|+|.||.|.  +++|.+|. .++.+..
T Consensus         2 ~~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~   65 (78)
T smart00473        2 SDDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR   65 (78)
T ss_pred             CCceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence            35679999999999765544456799999999999 9999999996  57899887 5555444

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.46  E-value=7.1e-07  Score=78.83  Aligned_cols=102  Identities=25%  Similarity=0.417  Sum_probs=83.6

Q ss_pred             HHHHHHHcccCC-CCceeeeeeEecCCeEEEEEEeCCCCCHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 037780          212 KNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASF---LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ  287 (455)
Q Consensus       212 ~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~  287 (455)
                      .+|..++..+++ +++.+++|+|    ..++|.||...+++...   +..-...+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            457888888876 6999999999    34789999988766431   222245689999999999999999999865556


Q ss_pred             eEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          288 IIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       288 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +.-+|++++|+-+++++++|++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=1.6e-06  Score=87.40  Aligned_cols=160  Identities=19%  Similarity=0.239  Sum_probs=102.6

Q ss_pred             cccccCHHHHHHHH------------Hhhh-hhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-----------
Q 037780          152 NLRCFSYKALEEAT------------DNFK-EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-----------  207 (455)
Q Consensus       152 ~~~~~~~~~l~~~t------------~~f~-~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----------  207 (455)
                      ..+.++++|+.+--            ..|. +-||.-+.|.||+|+++    +++.||||+-+..-...           
T Consensus       136 ~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~  211 (538)
T KOG1235|consen  136 QAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLL  211 (538)
T ss_pred             cCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHH
Confidence            45667777765433            2344 35999999999999998    58889999976432221           


Q ss_pred             --------------------------HHHHHHHHHHHccc----CCCCc---eeeeeeE-ecCCeEEEEEEeCCCCCHHH
Q 037780          208 --------------------------EKEFKNEVVVIGQT----HHKNL---VRLLGFC-DEGQNRLLVYEFLNNGTLAS  253 (455)
Q Consensus       208 --------------------------~~~~~~e~~~l~~l----~h~ni---v~l~g~~-~~~~~~~lv~e~~~~gsL~~  253 (455)
                                                +-+|.+|.+...++    .|-++   |.+=.++ .-...+.|+||||+|..+.|
T Consensus       212 ~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~D  291 (538)
T KOG1235|consen  212 AKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKIND  291 (538)
T ss_pred             HHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCC
Confidence                                      12356666655554    35552   2233333 33457899999999987766


Q ss_pred             Hhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC----CCcEEEeeccCcccccCC
Q 037780          254 FLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD----HYNARISDFGLAKLLTLN  320 (455)
Q Consensus       254 ~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~~~~~~  320 (455)
                      .-. +...++-.   .|+..+.++  |+++-...|++|+|-+|.||+++.    ++.+.+.|||+.......
T Consensus       292 l~~i~~~gi~~~---~i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  292 LDAIDKRGISPH---DILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHHHcCCCHH---HHHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            532 11223333   344333333  333333448999999999999984    678999999998866543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.36  E-value=9.9e-06  Score=74.00  Aligned_cols=137  Identities=15%  Similarity=0.208  Sum_probs=84.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      ..||+|..+.||+..       +...++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~~-------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEec-------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            468999999999831       2246677765422  3455788999999986544  4677788777777889999999


Q ss_pred             CCC-HHHHh---------------------cCC--CCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEE
Q 037780          248 NGT-LASFL---------------------FGN--LKPSWNLRTN-IAF----------QIAR-GLLYLHED-CSSQIIH  290 (455)
Q Consensus       248 ~gs-L~~~l---------------------~~~--~~~~~~~~~~-i~~----------~ia~-~l~~LH~~-~~~~ivH  290 (455)
                      |.. +...+                     +.-  ...+...+.. +..          .+.+ ...+|... ....++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 22111                     110  0111111100 000          0111 12222211 1345789


Q ss_pred             eCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          291 CDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       291 ~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      +|+.|.||++++++ +.|+||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=1.5e-07  Score=94.21  Aligned_cols=184  Identities=17%  Similarity=0.151  Sum_probs=131.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC-ceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN-LVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~  245 (455)
                      .|-+.+++|+.+.+||.+..    ..+...++.+...     ....-++++|.+++||| .++.++-+..+...++++++
T Consensus       245 ~~fh~fvK~altknpKkRpt----aeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPT----AEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCC----hhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            34467899999999998754    2233445544322     44566899999999999 77777777778888999999


Q ss_pred             CCCC-C-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNG-T-LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~g-s-L~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +..+ + ..........+...+...+...-++++++||+.   .-+|+|    ||+..+ +..|..||+....+.+... 
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~-  386 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK-  386 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccc-
Confidence            9876 2 211111112223334445566677899999942   458888    777766 5789999999887765542 


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCC
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                        .....+|+.|+|||+.....+..+.|+|+.|+--.++--|-+|-.
T Consensus       387 --~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 --PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              244568999999999999999999999999987667766766654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.16  E-value=3e-05  Score=71.83  Aligned_cols=137  Identities=13%  Similarity=0.046  Sum_probs=82.5

Q ss_pred             cCcCCC-ccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          172 AGRGSF-GIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       172 lG~G~f-g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      |-.|.. ..||+....     +..+.+|+.....   ..++..|++++..+. +--+.+++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~~-----~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK-----NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC-----CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            333444 788988642     2457778765432   345678888888884 344557777777666789999999998


Q ss_pred             CHHHHh-------------------cCCC----CCC--HHHHHHHHH--------------------HHHHHHHHHHhC-
Q 037780          250 TLASFL-------------------FGNL----KPS--WNLRTNIAF--------------------QIARGLLYLHED-  283 (455)
Q Consensus       250 sL~~~l-------------------~~~~----~~~--~~~~~~i~~--------------------~ia~~l~~LH~~-  283 (455)
                      +|....                   +...    ...  +..+.....                    .+...+..|-.. 
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            876432                   1110    000  001110000                    011112222111 


Q ss_pred             ---CCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          284 ---CSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       284 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                         ..+.++|+|+.|.|||++++....|+||+.+..
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence               134589999999999999987788999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.12  E-value=1.5e-05  Score=72.91  Aligned_cols=140  Identities=21%  Similarity=0.207  Sum_probs=82.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeeeEec---CCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDE---GQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~---~~~~~lv~e  244 (455)
                      +.|+.|..+.||+....    + ..+++|.....  .....+..|..++..+....  +.+++.++..   ....+++|+
T Consensus         3 ~~l~~G~~n~~~~v~~~----~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTD----D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEESSSSEEEEEEET----T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEEC----C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            35788999999999874    2 47889986543  34567888999988885443  4566664432   334689999


Q ss_pred             eCCCCCHHH----------------Hh---cCC----CCCCHHHH---------HHH------------HHHHHH-HHHH
Q 037780          245 FLNNGTLAS----------------FL---FGN----LKPSWNLR---------TNI------------AFQIAR-GLLY  279 (455)
Q Consensus       245 ~~~~gsL~~----------------~l---~~~----~~~~~~~~---------~~i------------~~~ia~-~l~~  279 (455)
                      ++++..+..                .+   +..    ....+...         ...            ...+.+ .+..
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999988877                11   111    11111110         000            111222 3333


Q ss_pred             HHh----CCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCccc
Q 037780          280 LHE----DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKL  316 (455)
Q Consensus       280 LH~----~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~  316 (455)
                      +++    .....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            332    1256799999999999999 666668999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.07  E-value=3.8e-05  Score=69.29  Aligned_cols=136  Identities=18%  Similarity=0.138  Sum_probs=89.1

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccH------------------------HHHHHHHHHHcccC--CC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE------------------------KEFKNEVVVIGQTH--HK  224 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~e~~~l~~l~--h~  224 (455)
                      .|..|--..||+|...    ++..+|||+.........                        .....|...|.++.  +-
T Consensus        55 ~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          55 CISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            3677888889998753    577899999754322110                        12355666776663  33


Q ss_pred             CceeeeeeEecCCeEEEEEEeCCCC-CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          225 NLVRLLGFCDEGQNRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       225 niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      .+.+.+++.    +-.|||||+... .-.-.|..-. +.......+..++++.+.-|-.  ..++||+||+.-|||+. +
T Consensus       131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~-~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP-LELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             CCCCceeec----CCeEEEEeccCCCCCCCCcccCC-cCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence            344444443    236999998653 2122222221 2222566677778888777774  35999999999999999 8


Q ss_pred             CcEEEeeccCccccc
Q 037780          304 YNARISDFGLAKLLT  318 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~  318 (455)
                      +.+.|+|||-|....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            899999999887654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=7.3e-05  Score=81.45  Aligned_cols=147  Identities=15%  Similarity=0.237  Sum_probs=90.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccC-CCCc--eeeeeeEecC---CeEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTH-HKNL--VRLLGFCDEG---QNRLLV  242 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv  242 (455)
                      +.++.|.+..+|+.....++ ....+++|+..... ......+.+|.++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56899999999997764321 12356677654321 223456889999999995 6664  7788888764   357899


Q ss_pred             EEeCCCCCHHH--------------------H---hcCC--C---------CCCHH--HHHHHH---------------H
Q 037780          243 YEFLNNGTLAS--------------------F---LFGN--L---------KPSWN--LRTNIA---------------F  271 (455)
Q Consensus       243 ~e~~~~gsL~~--------------------~---l~~~--~---------~~~~~--~~~~i~---------------~  271 (455)
                      |||+++..+.+                    .   |+.-  .         ...+.  +...+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998865321                    0   1110  0         00110  111110               1


Q ss_pred             HHHHHHHHHHhCCC--------CCeEEeCCCCCCEEEcCC-Cc-EEEeeccCcccc
Q 037780          272 QIARGLLYLHEDCS--------SQIIHCDIKPQNILLDDH-YN-ARISDFGLAKLL  317 (455)
Q Consensus       272 ~ia~~l~~LH~~~~--------~~ivH~dlk~~Nill~~~-~~-~kl~Dfg~a~~~  317 (455)
                      .+.+.+.+|..+..        ..++|+|+++.||+++.+ .. .-|.||.++..-
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            23344567754321        359999999999999853 33 579999988754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.04  E-value=3.4e-05  Score=68.80  Aligned_cols=68  Identities=22%  Similarity=0.315  Sum_probs=53.2

Q ss_pred             CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          237 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ...+|+|||++|..|.+...    ++.    .++..+++++.-||+.   |+.|+|.+|+|++++++ .++++||+..+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence            45579999999988876532    121    3556777889999954   99999999999999965 499999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.97  E-value=7.2e-05  Score=63.89  Aligned_cols=130  Identities=19%  Similarity=0.301  Sum_probs=88.7

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      ..+.|++|++|.||+|.+.     +..+|+|.-...  .....+..|+++|..++-.++-+=+-++.+.   ++.|||..
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~   95 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-----GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYID   95 (201)
T ss_pred             hhhhhhcccccEEEEeecc-----CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhc
Confidence            3567999999999999985     457888886543  3456799999999999877765444333222   34599999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC-CCCEEEcCCCcEEEeeccCcccc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIK-PQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      |-+|.++-...   +   +. -...+++.-.-|-   ..+|-|+.|. |..++|.++..+.|+||..|+.-
T Consensus        96 G~~L~~~~~~~---~---rk-~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG---D---RK-HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc---c---HH-HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            98887764322   1   22 2234444433344   4588898886 55555555559999999998743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.82  E-value=0.00013  Score=67.21  Aligned_cols=32  Identities=28%  Similarity=0.481  Sum_probs=26.8

Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ...++|+|+.+.||+++++...-|+||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            34589999999999999776567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.76  E-value=6.5e-05  Score=80.68  Aligned_cols=196  Identities=20%  Similarity=0.164  Sum_probs=137.9

Q ss_pred             HHHHHHHHcccCCCCceeeeeeEecCCeE----EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 037780          211 FKNEVVVIGQTHHKNLVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS  286 (455)
Q Consensus       211 ~~~e~~~l~~l~h~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~  286 (455)
                      ...|...+.++.|+|++.++.|-.+....    .+..+++..-++...++.-...+..+.+.+..++.+||+|+|..   
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~---  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL---  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence            44577788888999999999987655433    24557888889999998888889999999999999999999964   


Q ss_pred             CeEEeCCCCC---CEEEcCCCcEEEe--eccCcccccCCCCccccccccccCcccccccccCCCCCC--CCCeecHHHHH
Q 037780          287 QIIHCDIKPQ---NILLDDHYNARIS--DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA--KVDVYSFGVLL  359 (455)
Q Consensus       287 ~ivH~dlk~~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~s~Gv~l  359 (455)
                      ...|.-+..+   +-..+.++...++  ||+.++.+......   ....-+..+.+||.........  ..|+|.+|..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            4444444444   4445666677777  99888776544322   1223456788888877665544  47999999999


Q ss_pred             HHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 037780          360 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML  438 (455)
Q Consensus       360 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L  438 (455)
                      ..+..|..+-.....                  ...+.+.    .    ......+....|+..++++|++..+++...
T Consensus       383 ~~~~~~~~i~~~~~~------------------~~~~l~~----~----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAV------------------PVSLLDV----L----STSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccc------------------hhhhhcc----c----cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            999988765321110                  1111111    0    111456677789999999999999998764

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.72  E-value=0.0003  Score=65.69  Aligned_cols=135  Identities=13%  Similarity=0.096  Sum_probs=76.2

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeCCCCC
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNGT  250 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gs  250 (455)
                      +..|-...+|+...     ++..+++|........-.-+..+|..+++.+....++ ++++...    -.+|+||++|..
T Consensus         4 ~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe-----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            55677889998763     3456778775432221112357788888888654443 3333332    368999999876


Q ss_pred             HHHH-----------------hcCCC----CCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEEeCCC
Q 037780          251 LASF-----------------LFGNL----KPSWNLR-TNIAFQ---------IARGLLYLHED-----CSSQIIHCDIK  294 (455)
Q Consensus       251 L~~~-----------------l~~~~----~~~~~~~-~~i~~~---------ia~~l~~LH~~-----~~~~ivH~dlk  294 (455)
                      +...                 |+...    .++...+ .....+         +...+..+-..     ....++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            5421                 11111    1121111 111111         11112222111     13358999999


Q ss_pred             CCCEEEcCCCcEEEeeccCccc
Q 037780          295 PQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       295 ~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      |.||++++++ +.|+||..+..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.72  E-value=0.00059  Score=65.09  Aligned_cols=75  Identities=8%  Similarity=0.003  Sum_probs=53.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC---CCceeeeeeEec---CCeEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDE---GQNRLLVY  243 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~g~~~~---~~~~~lv~  243 (455)
                      +.||.|..+.||+....    ++ .+.+|..+.  ......|..|...|+.+..   ..+.+++++|..   .+..++||
T Consensus        20 ~~i~~G~~~~vy~~~~~----~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         20 ECISEQPYAALWALYDS----QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             eecCCccceeEEEEEcC----CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            35999999999997643    22 345555322  1123578999999998853   367788888754   35689999


Q ss_pred             EeCCCCCH
Q 037780          244 EFLNNGTL  251 (455)
Q Consensus       244 e~~~~gsL  251 (455)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.71  E-value=0.00077  Score=59.91  Aligned_cols=131  Identities=18%  Similarity=0.212  Sum_probs=89.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----------------cccHHHHHHHHHHHcccC------CCCce
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----------------QDGEKEFKNEVVVIGQTH------HKNLV  227 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv  227 (455)
                      ..||+|+.-.||.--      ......||+.....                ....+++.+|+.-..++.      +.+|.
T Consensus         7 ~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             cccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            458999999998632      33456777775443                123466777776666665      78899


Q ss_pred             eeeeeEecCCeEEEEEEeCCC------CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          228 RLLGFCDEGQNRLLVYEFLNN------GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       228 ~l~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      +++|+.+.+...-+|+|.+.+      -+|.+++... .++. ...+.+.   +-..||-+   ..|+.+|++|.||++.
T Consensus        81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEE
Confidence            999999999999999998643      3688888544 3444 3333333   33445553   3799999999999996


Q ss_pred             CC---C-cEEEee-ccCc
Q 037780          302 DH---Y-NARISD-FGLA  314 (455)
Q Consensus       302 ~~---~-~~kl~D-fg~a  314 (455)
                      ..   . .+.|+| ||..
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            32   2 577887 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=97.68  E-value=4.4e-05  Score=56.21  Aligned_cols=50  Identities=24%  Similarity=0.508  Sum_probs=40.0

Q ss_pred             EEEeeCCCCCCCccccccccCHHhHHHhhccCCceeeeeec--CCcceeecc
Q 037780           12 FHEVKNIDWPQSDYERFKPYNEVQCKNSCLSDCFCAAVIFE--DDSCCFKKL   61 (455)
Q Consensus        12 f~~~~~~~~p~~~~~~~~~~~~~~C~~~Cl~~C~C~a~~~~--~~~c~~~~~   61 (455)
                      |..++|+.+++.+.......+.++|++.|+.+|.|.||.|.  .+.|+++..
T Consensus         6 ~~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~   57 (73)
T cd01100           6 FRQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS   57 (73)
T ss_pred             ccccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence            44557899998877655567999999999999999999995  356886644

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.58  E-value=0.00068  Score=62.28  Aligned_cols=140  Identities=19%  Similarity=0.211  Sum_probs=78.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.|..|-...+|+....++  +...+++|........ .-+...|+.++..+...+++ ++++...    ..++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence            3467788889998864310  1356778866432221 12234688888888544443 4444332    2489999998


Q ss_pred             CCHHHH-----------------hcCC-C----------CC-CHHHHHHHHH----------------------HHHHHH
Q 037780          249 GTLASF-----------------LFGN-L----------KP-SWNLRTNIAF----------------------QIARGL  277 (455)
Q Consensus       249 gsL~~~-----------------l~~~-~----------~~-~~~~~~~i~~----------------------~ia~~l  277 (455)
                      .++...                 ++.. .          .. .|.....+..                      .+..-+
T Consensus        77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  156 (235)
T cd05157          77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI  156 (235)
T ss_pred             CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence            765321                 1111 0          11 1222212211                      111111


Q ss_pred             HHH----HhC-CCCCeEEeCCCCCCEEEcC-CCcEEEeeccCccc
Q 037780          278 LYL----HED-CSSQIIHCDIKPQNILLDD-HYNARISDFGLAKL  316 (455)
Q Consensus       278 ~~L----H~~-~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~  316 (455)
                      ..|    ... ....++|+|+.+.|||+++ +..+.++||..|..
T Consensus       157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            122    111 2346899999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.54  E-value=0.0008  Score=59.42  Aligned_cols=133  Identities=26%  Similarity=0.341  Sum_probs=91.5

Q ss_pred             ccccCHHHHHHHHHhhhhhcCcCCC-ccEEEEEEeccCCCceEEEEEecccc-----------cc----------ccHHH
Q 037780          153 LRCFSYKALEEATDNFKEEAGRGSF-GIVYKGVIETTRTSTTAVAVKKLDRV-----------FQ----------DGEKE  210 (455)
Q Consensus       153 ~~~~~~~~l~~~t~~f~~~lG~G~f-g~Vy~~~~~~~~~~~~~vavK~~~~~-----------~~----------~~~~~  210 (455)
                      +..|+..   .+..+|.+.||.|.- |.|||....     +..+|+|.....           ..          .....
T Consensus        29 L~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~-----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P  100 (207)
T PF13095_consen   29 LEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEID-----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP  100 (207)
T ss_pred             cCCcCCC---CCcEeeeeecCCCCceeEEEEEEEC-----CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence            4455552   145667889999999 999999974     678999993210           00          11235


Q ss_pred             HHHHHHHHcccC---CCCc--eeeeeeEecC------------------CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHH
Q 037780          211 FKNEVVVIGQTH---HKNL--VRLLGFCDEG------------------QNRLLVYEFLNNGTLASFLFGNLKPSWNLRT  267 (455)
Q Consensus       211 ~~~e~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  267 (455)
                      |..|.+..++++   +.++  |+.+||..-.                  ..+.+|.||++...         .+.    .
T Consensus       101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~  167 (207)
T PF13095_consen  101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----I  167 (207)
T ss_pred             HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----h
Confidence            889999999985   4456  8999987322                  12357888876644         112    2


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       268 ~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      +=+.++.+-+.-+|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       168 ~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 RDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            23445666777888   569999999999975     4589999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.47  E-value=0.00062  Score=64.97  Aligned_cols=139  Identities=17%  Similarity=0.181  Sum_probs=83.9

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeee------EecCCeEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGF------CDEGQNRLL  241 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~------~~~~~~~~l  241 (455)
                      +.|..|....+|+....     +..+++|....   ........|+.++..+.+.+  +.+++..      ....+..++
T Consensus        20 ~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          20 EGISAGIENTNYFVTTD-----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             ecccCccccceEEEEeC-----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            34777877899987643     23577887653   23455777888888875433  3444432      123445689


Q ss_pred             EEEeCCCCCHHH----H----------hcC---C--------CCCCHHHHHH----------HHHHHHHHHHHHHh----
Q 037780          242 VYEFLNNGTLAS----F----------LFG---N--------LKPSWNLRTN----------IAFQIARGLLYLHE----  282 (455)
Q Consensus       242 v~e~~~~gsL~~----~----------l~~---~--------~~~~~~~~~~----------i~~~ia~~l~~LH~----  282 (455)
                      |++|++|..+..    .          ++.   .        ....|.....          ....+...+.++.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999999876532    0          010   0        0112322210          11123344455543    


Q ss_pred             CCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       283 ~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ....+++|+|+.|.||+++++....|.||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            1245799999999999999987788999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.44  E-value=0.0033  Score=62.07  Aligned_cols=75  Identities=15%  Similarity=0.167  Sum_probs=51.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCc-eEEEEEecccc-------ccccHHHHHHHHHHHcccC---CCCceeeeeeEecCCe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRV-------FQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQN  238 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~  238 (455)
                      +.||.|.+..||+....    ++ +.+.||.-...       ..-..+.+..|.+.|..+.   -.++.+++.+  +.+.
T Consensus        32 ~elggGn~N~VyrV~~~----~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~  105 (401)
T PRK09550         32 REIGDGNLNLVFRVSDT----EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL  105 (401)
T ss_pred             eEcCCCceEEEEEEEeC----CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC
Confidence            46999999999999875    33 47999985321       1123456777888888763   2345666666  3355


Q ss_pred             EEEEEEeCCCCC
Q 037780          239 RLLVYEFLNNGT  250 (455)
Q Consensus       239 ~~lv~e~~~~gs  250 (455)
                      .++||||+++..
T Consensus       106 ~~lVME~L~~~~  117 (401)
T PRK09550        106 AVTVMEDLSDHK  117 (401)
T ss_pred             CEEEEecCCCcc
Confidence            789999998743

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.26  E-value=0.0016  Score=62.28  Aligned_cols=141  Identities=23%  Similarity=0.265  Sum_probs=80.7

Q ss_pred             hcCcCCCccEEEEEEecc---CCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeC
Q 037780          171 EAGRGSFGIVYKGVIETT---RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~  246 (455)
                      .|..|-...+|+.....+   ...+..+++|...... ....+..+|..++..+....+. ++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            355666678898875421   1124567788865432 2234567788888887544333 44555432    3589999


Q ss_pred             CCCCHHHH-----------------hcCC--C--C-----C--CHHHHHHH--------------------------HHH
Q 037780          247 NNGTLASF-----------------LFGN--L--K-----P--SWNLRTNI--------------------------AFQ  272 (455)
Q Consensus       247 ~~gsL~~~-----------------l~~~--~--~-----~--~~~~~~~i--------------------------~~~  272 (455)
                      +|..+...                 ++..  .  .     .  -|.....+                          ...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 1111  1  0     0  01111110                          111


Q ss_pred             HHHHHHHHHh------CCCCCeEEeCCCCCCEEEcCC----CcEEEeeccCccc
Q 037780          273 IARGLLYLHE------DCSSQIIHCDIKPQNILLDDH----YNARISDFGLAKL  316 (455)
Q Consensus       273 ia~~l~~LH~------~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~  316 (455)
                      +..-+.+|-.      .....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2222334432      135678999999999999985    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.99  E-value=0.0065  Score=57.28  Aligned_cols=32  Identities=28%  Similarity=0.527  Sum_probs=26.3

Q ss_pred             CCeEEeCCCCCCEEEcCCCc-EEEeeccCcccc
Q 037780          286 SQIIHCDIKPQNILLDDHYN-ARISDFGLAKLL  317 (455)
Q Consensus       286 ~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~  317 (455)
                      ..++|+|++|.||+++++++ .-|.||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            35899999999999997555 469999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=96.89  E-value=0.01  Score=57.85  Aligned_cols=140  Identities=19%  Similarity=0.175  Sum_probs=80.3

Q ss_pred             cCcCCCccEEEEEEeccC-CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeCCCC
Q 037780          172 AGRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      |-.|-.-.+|+....... ..+..+++|.......... +-.+|..++..+...++. ++++++..+    .|++|+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            445667788887654221 1235678887654432222 236788888888655543 455655332    589999876


Q ss_pred             CHHHH-----------------hcCCC------CCCHHHHHHHHHH-----------------HHHHHHHHHh-----CC
Q 037780          250 TLASF-----------------LFGNL------KPSWNLRTNIAFQ-----------------IARGLLYLHE-----DC  284 (455)
Q Consensus       250 sL~~~-----------------l~~~~------~~~~~~~~~i~~~-----------------ia~~l~~LH~-----~~  284 (455)
                      +|...                 +|...      ...|.+...+..+                 +...+..|..     ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            66421                 11111      1123333232211                 1122222221     12


Q ss_pred             CCCeEEeCCCCCCEEEcC-CCcEEEeeccCccc
Q 037780          285 SSQIIHCDIKPQNILLDD-HYNARISDFGLAKL  316 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~  316 (455)
                      ...++|+|+++.||++++ +..+.++||..+..
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            346899999999999986 46899999998864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.76  E-value=0.035  Score=53.23  Aligned_cols=139  Identities=15%  Similarity=0.218  Sum_probs=79.7

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeeeE------ecCCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFC------DEGQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv  242 (455)
                      .++.|....+|+....    ++ .+++|+.+...  ...+...|+.++..+....  +.+++...      ...+..+++
T Consensus        29 ~~~~G~~n~~y~v~t~----~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        29 GIAEGVENSNYLLTTD----VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccCCccccceEEEEeC----CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            4677777899987542    22 46677654321  2344566777777764322  33443321      224567899


Q ss_pred             EEeCCCCCHHH-----------H---hcCC-C-----------CCCHHHHHH------------HHHHHHHHHHHHHh--
Q 037780          243 YEFLNNGTLAS-----------F---LFGN-L-----------KPSWNLRTN------------IAFQIARGLLYLHE--  282 (455)
Q Consensus       243 ~e~~~~gsL~~-----------~---l~~~-~-----------~~~~~~~~~------------i~~~ia~~l~~LH~--  282 (455)
                      +||++|..+..           .   ++.. .           ...|.....            ....+.+.++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            99998855321           0   1110 0           012221110            11123344555542  


Q ss_pred             --CCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          283 --DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       283 --~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                        ....+++|+|+.+.||++++++...|+||+.+..
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence              2356899999999999999987778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=96.76  E-value=0.033  Score=53.74  Aligned_cols=138  Identities=12%  Similarity=0.128  Sum_probs=75.1

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeee------eEecCCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLG------FCDEGQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g------~~~~~~~~~lv  242 (455)
                      .|+.|....+|+....    ++ .+++|+.+.   ...+....|+.++..+...+  +.+.+.      +....+..+++
T Consensus        29 ~l~~G~~n~~y~v~t~----~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l  100 (319)
T PRK05231         29 GIAEGIENSNFFLTTT----QG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI  100 (319)
T ss_pred             hhccccccceEEEEeC----CC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence            4667777889987653    22 477887652   12334445556665553222  223332      12234567899


Q ss_pred             EEeCCCCCHHH-----H------h---cCC-----------CCCCH-HHHHH-H-----------H-HHHHHHHHHHHh-
Q 037780          243 YEFLNNGTLAS-----F------L---FGN-----------LKPSW-NLRTN-I-----------A-FQIARGLLYLHE-  282 (455)
Q Consensus       243 ~e~~~~gsL~~-----~------l---~~~-----------~~~~~-~~~~~-i-----------~-~~ia~~l~~LH~-  282 (455)
                      +||++|..+..     +      |   +..           ..+.| ..... +           . ..+...+..+.+ 
T Consensus       101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (319)
T PRK05231        101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA  180 (319)
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence            99999875311     1      1   110           01112 21111 1           1 111112233321 


Q ss_pred             ---CCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          283 ---DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       283 ---~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                         ....+++|+|+.|.||+++++...-|+||+.+..
T Consensus       181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               1355899999999999999775568999998753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.66  E-value=0.021  Score=54.04  Aligned_cols=72  Identities=19%  Similarity=0.296  Sum_probs=45.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC---CCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.++.|....+|+..     .++..+-||.-.   ......|..|..-|+.+.   --.+.+++++....+..+||+||+
T Consensus        23 ~~v~GG~i~~a~~~~-----~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-----TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEE--SSSSEEEEEE-----TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             EecCCCChhheEEEE-----CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            358889999999876     246678888765   233456888888888883   345778888887777789999999


Q ss_pred             CCC
Q 037780          247 NNG  249 (455)
Q Consensus       247 ~~g  249 (455)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.34  E-value=0.057  Score=53.35  Aligned_cols=79  Identities=16%  Similarity=0.185  Sum_probs=50.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-------ccHHHHHHHHHHHcccC---CCCceeeeeeEecCCeE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-------DGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~  239 (455)
                      +.||.|....||+....     +..++||+-.....       .....-..|...|..+.   ..++.+++.++.  +..
T Consensus        38 ~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~  110 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA  110 (418)
T ss_pred             EEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence            56899999999997652     24588888652111       12333344566666553   246778888887  446


Q ss_pred             EEEEEeCCC--CCHHHHh
Q 037780          240 LLVYEFLNN--GTLASFL  255 (455)
Q Consensus       240 ~lv~e~~~~--gsL~~~l  255 (455)
                      +++||++++  ..+.+-+
T Consensus       111 vlvME~L~~~~~ilr~~L  128 (418)
T PLN02756        111 LIGMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEEEeecCCcceehhhhh
Confidence            788999976  3454444

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.24  E-value=0.027  Score=54.61  Aligned_cols=142  Identities=18%  Similarity=0.257  Sum_probs=79.4

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      .|-.|-.-.+|+....+.......+++|........ .-+-.+|..++..+...++- ++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            355566677888865432222346778876543322 22346788888888665553 556555322    589999776


Q ss_pred             CHHH-------H----------hcCCC-----CC-CHHHHHHHHHHH----------------------HHHHHHHHh--
Q 037780          250 TLAS-------F----------LFGNL-----KP-SWNLRTNIAFQI----------------------ARGLLYLHE--  282 (455)
Q Consensus       250 sL~~-------~----------l~~~~-----~~-~~~~~~~i~~~i----------------------a~~l~~LH~--  282 (455)
                      .|..       .          +|...     .+ .|....++..++                      ..-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            5522       0          11111     11 233332222221                      111222221  


Q ss_pred             ---CCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcccc
Q 037780          283 ---DCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLL  317 (455)
Q Consensus       283 ---~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~  317 (455)
                         ....-.+|+|+.+.||++++ ++.++++||..|..-
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence               11234789999999999975 578999999988643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.22  E-value=0.0051  Score=57.90  Aligned_cols=134  Identities=13%  Similarity=0.095  Sum_probs=84.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----------------------cccHHHHHHHHHHHcccCC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----------------------QDGEKEFKNEVVVIGQTHH  223 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h  223 (455)
                      ..+.++||-|--+.+|.+...    .+.+.++|.=....                      .-+.-....|...|+.+..
T Consensus        94 ~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e  169 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE  169 (465)
T ss_pred             hhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence            456789999999999999875    45666666421100                      0011234567777777743


Q ss_pred             -C-CceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          224 -K-NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       224 -~-niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                       - -+.+.+++    +..++|||++.+-.|...-+-.   +..+   +...+..-+.-|.   ..|+||+|..-=||+++
T Consensus       170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~---ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPT---LYDDLMGLIVRLA---NHGLIHGDFNEFNIMVK  236 (465)
T ss_pred             cCCCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHH---HHHHHHHHHHHHH---HcCceecccchheeEEe
Confidence             2 23334433    3567999999887776543211   2222   2223333333444   33999999999999999


Q ss_pred             CCCcEEEeeccCccc
Q 037780          302 DHYNARISDFGLAKL  316 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~  316 (455)
                      ++..++++||--...
T Consensus       237 dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVS  251 (465)
T ss_pred             cCCCEEEeechHhhc
Confidence            999999999975543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.09  E-value=0.087  Score=50.33  Aligned_cols=34  Identities=26%  Similarity=0.453  Sum_probs=29.9

Q ss_pred             CCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       286 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ..++|+|+.+.|++++++.-.-|.||+++.+-.+
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            4689999999999999988899999999986543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.06  E-value=0.089  Score=51.04  Aligned_cols=82  Identities=17%  Similarity=0.102  Sum_probs=49.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccc-------ccccHHHHHHHHHHHcccC--CCCceeeeeeEecCCeEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-------FQDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~  240 (455)
                      ++||.|....||++...   ..++.|+||.-...       ..-..+...-|...|....  -|..++-+-+ .+.+...
T Consensus         1 ~EigdGnlN~VfrV~~~---~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~   76 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQ---EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAV   76 (370)
T ss_pred             CcCCCCceEEEEEEEcC---CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-Eccccce
Confidence            36899999999999864   12357999985321       1222344556777776653  3444433322 3444556


Q ss_pred             EEEEeCCC-CCHHHHh
Q 037780          241 LVYEFLNN-GTLASFL  255 (455)
Q Consensus       241 lv~e~~~~-gsL~~~l  255 (455)
                      +|||+++. ..|...|
T Consensus        77 ~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        77 TVMEDLSHHKIARKGL   92 (370)
T ss_pred             ehHhhCccchHHHHHH
Confidence            99999865 3344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.02  E-value=0.025  Score=54.95  Aligned_cols=60  Identities=20%  Similarity=0.252  Sum_probs=43.1

Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      ..|+-+|+++-++..++..... ++..+..++.--+.|+.-+-.  -.+.+|.|++|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~~-pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKSQ-PEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcccC-hHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            3577788999999998865433 445666676666666554432  23899999999999995

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.94  E-value=0.083  Score=50.74  Aligned_cols=32  Identities=16%  Similarity=0.331  Sum_probs=28.8

Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            55799999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.68  E-value=0.012  Score=58.67  Aligned_cols=50  Identities=18%  Similarity=0.262  Sum_probs=38.5

Q ss_pred             HHHHHHHHHHHcccCCCCceeeeeeEecCCe-EEEEEEeCCCCCHHHHhcCC
Q 037780          208 EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGN  258 (455)
Q Consensus       208 ~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~  258 (455)
                      ..++......++.++|+|+...+.+-..... ..+|+|++ +.||.+.+..+
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            3456667788888999999999998765544 56788887 67999987544

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.66  E-value=0.055  Score=48.33  Aligned_cols=140  Identities=17%  Similarity=0.204  Sum_probs=86.7

Q ss_pred             eEEEEEeccccccc-cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHH
Q 037780          193 TAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF  271 (455)
Q Consensus       193 ~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~  271 (455)
                      ....+|++....-. ...-|.++.+++++++  .|+++..=  ..-..-++.|+|-.....             -..++.
T Consensus        86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-------------~~N~i~  148 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-------------FSNFIT  148 (308)
T ss_pred             chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc-------------hhHHHH
Confidence            34667777544333 4456788899998875  45666621  233455888887432110             011222


Q ss_pred             HHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCC
Q 037780          272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVD  351 (455)
Q Consensus       272 ~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  351 (455)
                      -=...|.-.|+. +.+.+|+|-.|+||+-|..|.+||.|=+.--              ..+.-|.--|+.   ..|+++.
T Consensus       149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------------~~~V~~vN~~Y~---~lT~~aE  210 (308)
T PF07387_consen  149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------------ENQVNMVNIEYE---SLTQEAE  210 (308)
T ss_pred             HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--------------hheeeEEeeecc---ccChHHH
Confidence            224667788866 6789999999999999999999999965321              012223332222   3466777


Q ss_pred             eecHHHHHHHHHhCCC
Q 037780          352 VYSFGVLLLEIISCRK  367 (455)
Q Consensus       352 v~s~Gv~l~el~tg~~  367 (455)
                      +=+|=.-+++++...+
T Consensus       211 ~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  211 VKVFVKSCLKLVEKQR  226 (308)
T ss_pred             HHHHHHHHHHHHHHHh
Confidence            7777777777776443

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.66  E-value=0.016  Score=52.27  Aligned_cols=31  Identities=29%  Similarity=0.496  Sum_probs=21.8

Q ss_pred             CCeEEeCCCCCCEEE-cCCCcEEEeeccCccc
Q 037780          286 SQIIHCDIKPQNILL-DDHYNARISDFGLAKL  316 (455)
Q Consensus       286 ~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~  316 (455)
                      ..++|+|+.+.||++ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            357899999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.62  E-value=0.001  Score=73.62  Aligned_cols=156  Identities=12%  Similarity=-0.021  Sum_probs=106.9

Q ss_pred             HHHHHHHcccCCCCceeeeeeE--ecCCeEEEEEEeCCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC--
Q 037780          212 KNEVVVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHED--  283 (455)
Q Consensus       212 ~~e~~~l~~l~h~niv~l~g~~--~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~--  283 (455)
                      ..|...++...|+++.....-.  .+..+.+.+++|+..|.+.+.+-++    ..++..-......+......-.|..  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3444455556788876655433  2344568899999999999988654    2222222222222324444444432  


Q ss_pred             CCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHH
Q 037780          284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII  363 (455)
Q Consensus       284 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~  363 (455)
                      .+.--+|+++|+-|.+|+.+.++|+.++|+.+...+...  ......+++-|++|+....-.++.++|+|..|.-+++.-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            233468999999999999999999999999984332221  113455788999999998888898999999999999988


Q ss_pred             hCCCCC
Q 037780          364 SCRKSF  369 (455)
Q Consensus       364 tg~~p~  369 (455)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            777765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.88  E-value=0.089  Score=50.56  Aligned_cols=71  Identities=18%  Similarity=0.184  Sum_probs=54.6

Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ..|++|++. ++++.-.    ..-.|++...|+.+.+.-++-+..  ..+.=|||+.-.||||+ +|++-|+||-+++.
T Consensus       300 y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         300 YLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             EEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence            345666653 3343211    234689999999998888877775  46789999999999999 99999999999984

>PRK06148 hypothetical protein; Provisional

Probab=94.87  E-value=0.42  Score=53.59  Aligned_cols=32  Identities=38%  Similarity=0.488  Sum_probs=26.9

Q ss_pred             CCCeEEeCCCCCCEEEcCCC--cEE-EeeccCccc
Q 037780          285 SSQIIHCDIKPQNILLDDHY--NAR-ISDFGLAKL  316 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~--~~k-l~Dfg~a~~  316 (455)
                      ..++||+|+.+.|||++.+.  ++. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            56899999999999999875  555 999998753

>PTZ00384 choline kinase; Provisional

Probab=94.61  E-value=0.3  Score=48.29  Aligned_cols=77  Identities=13%  Similarity=0.193  Sum_probs=44.3

Q ss_pred             hcCcCCCccEEEEEEeccCCC---ceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEEeC
Q 037780          171 EAGRGSFGIVYKGVIETTRTS---TTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~  246 (455)
                      .|..|-...+|++........   .+.|.++...... .-.-+-..|+.+++.+...++- ++++.+..    .+++||+
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            355577788998876432111   1224444322211 1112235688899999766654 44555532    5999999


Q ss_pred             CCCCHH
Q 037780          247 NNGTLA  252 (455)
Q Consensus       247 ~~gsL~  252 (455)
                      +|..|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.50  E-value=0.35  Score=46.77  Aligned_cols=139  Identities=19%  Similarity=0.191  Sum_probs=88.1

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc---ccc-----------------------HHHHHHHHHHHcccCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDG-----------------------EKEFKNEVVVIGQTHHK  224 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~-----------------------~~~~~~e~~~l~~l~h~  224 (455)
                      .|..|--.-||-+.-.    +|..+|||+.+...   .+.                       .-....|++-|.+++..
T Consensus       151 CiSTGKEANVYHat~~----dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  151 CISTGKEANVYHATEE----DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ccccCccceeEeeecC----CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4677778889987654    67779999875321   000                       11245677777777644


Q ss_pred             CceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       225 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      .|.-.--...  ....|||+|+-......-.-....++...+..+-.+++.-+.-|.+.|  ++||.||.--|+|+-+ |
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence            4221111111  134699999853222111112334566667777788888888888764  8999999999999865 5


Q ss_pred             cEEEeeccCccccc
Q 037780          305 NARISDFGLAKLLT  318 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~  318 (455)
                      .+.|+|.+-+.-..
T Consensus       302 ~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  302 KLYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEEccccccCC
Confidence            89999988765443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	455
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-53
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-41
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-23
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-21
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-21
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-21
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-21
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-21
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-21
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-21
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-21
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-20
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-20
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-20
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		9e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-19
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-19
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-19
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-19
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-18
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-18
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-17
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-17
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-15
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-15
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-15
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		8e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-11
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-10
3soa_A	444	Full-Length Human Camkii Length = 444		1e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		7e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  210 bits (535), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 121/298 (40%), Positives = 176/298 (59%), Gaps = 14/298 (4%)
Query: 152 NLRCFSYKALEEATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGE 208
            L+ FS + L+ A+DNF  K   GRG FG VYKG +       T VAVK+L +   Q GE
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL----ADGTLVAVKRLKEERXQGGE 79
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WN 264
            +F+ EV +I    H+NL+RL GFC     RLLVY ++ NG++AS L    +      W 
Sbjct: 80  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 139
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
            R  IA   ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGLAKL+   +   
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDXH 198
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIE--MGEEYAILTD 382
           +  A+RGT G++APE+      + K DV+ +GV+LLE+I+ +++FD+     ++  +L D
Sbjct: 199 VXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 258
Query: 383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG 440
           W     +  KL+ LV+ D++     + VE+L+ V++ C Q  P  RP M +V +MLEG
Sbjct: 259 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  206 bits (523), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 119/298 (39%), Positives = 174/298 (58%), Gaps = 14/298 (4%)
Query: 152 NLRCFSYKALEEATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGE 208
            L+ FS + L+ A+DNF  K   GRG FG VYKG +         VAVK+L +   Q GE
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL----ADGXLVAVKRLKEERTQGGE 71
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WN 264
            +F+ EV +I    H+NL+RL GFC     RLLVY ++ NG++AS L    +      W 
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
            R  IA   ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGLAKL+   +   
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDXH 190
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIE--MGEEYAILTD 382
           +  A+RG  G++APE+      + K DV+ +GV+LLE+I+ +++FD+     ++  +L D
Sbjct: 191 VXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG 440
           W     +  KL+ LV+ D++     + VE+L+ V++ C Q  P  RP M +V +MLEG
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 113/305 (37%), Positives = 164/305 (53%), Gaps = 26/305 (8%)
Query: 150 ETNLRCFSYKALEEATDNFKE--------EAGRGSFGIVYKGVIETTRTSTTAVAVKKL- 200
           +T    FS+  L+  T+NF E        + G G FG+VYKG +     + T VAVKKL 
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA 63
Query: 201 ---DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA---SF 254
              D   ++ +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L    S 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 255 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA 314
           L G    SW++R  IA   A G+ +LHE+     IH DIK  NILLD+ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +         + + I GT  Y+APE  R   IT K D+YSFGV+LLEII+   + D E  
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHR 238
Query: 375 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           E   +L            ++D ++  M    D   VE +  V+  C+ E  + RP ++KV
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 435 SQMLE 439
            Q+L+
Sbjct: 298 QQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 113/305 (37%), Positives = 163/305 (53%), Gaps = 26/305 (8%)
Query: 150 ETNLRCFSYKALEEATDNFKE--------EAGRGSFGIVYKGVIETTRTSTTAVAVKKL- 200
           +T    FS+  L+  T+NF E        + G G FG+VYKG +     + T VAVKKL 
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA 63
Query: 201 ---DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA---SF 254
              D   ++ +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L    S 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 255 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA 314
           L G    SW++R  IA   A G+ +LHE+     IH DIK  NILLD+ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +         +   I GT  Y+APE  R   IT K D+YSFGV+LLEII+   + D E  
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHR 238
Query: 375 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           E   +L            ++D ++  M    D   VE +  V+  C+ E  + RP ++KV
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 435 SQMLE 439
            Q+L+
Sbjct: 298 QQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 113/305 (37%), Positives = 163/305 (53%), Gaps = 26/305 (8%)
Query: 150 ETNLRCFSYKALEEATDNFKE--------EAGRGSFGIVYKGVIETTRTSTTAVAVKKL- 200
           +T    FS+  L+  T+NF E        + G G FG+VYKG +     + T VAVKKL 
Sbjct: 3   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA 57
Query: 201 ---DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA---SF 254
              D   ++ +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L    S 
Sbjct: 58  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 117
Query: 255 LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA 314
           L G    SW++R  IA   A G+ +LHE+     IH DIK  NILLD+ + A+ISDFGLA
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 174
Query: 315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +         +   I GT  Y+APE  R   IT K D+YSFGV+LLEII+   + D E  
Sbjct: 175 RASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHR 232
Query: 375 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           E   +L            ++D ++  M    D   VE +  V+  C+ E  + RP ++KV
Sbjct: 233 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 291
Query: 435 SQMLE 439
            Q+L+
Sbjct: 292 QQLLQ 296

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 165/309 (53%), Gaps = 18/309 (5%)
Query: 142 NSPGDGTVETNLRCF-SYKA----LEEATDNFKEE--AGRGSFGIVYKGVIETTRTSTTA 194
           NS  D    + L  F SY+     LEEAT+NF  +   G G FG VYKGV+         
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----DGAK 65
Query: 195 VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 254
           VA+K+       G +EF+ E+  +    H +LV L+GFCDE    +L+Y+++ NG L   
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 255 LFGNLKP----SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD 310
           L+G+  P    SW  R  I    ARGL YLH   +  IIH D+K  NILLD+++  +I+D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182
Query: 311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
           FG++K  T      +   ++GT GY+ PE++ K  +T K DVYSFGV+L E++  R +  
Sbjct: 183 FGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 371 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT 430
             +  E   L +WA + + NG+L+ +V+ ++      + + K    ++ C+      RP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 431 MRKVSQMLE 439
           M  V   LE
Sbjct: 303 MGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 165/309 (53%), Gaps = 18/309 (5%)
Query: 142 NSPGDGTVETNLRCF-SYKA----LEEATDNFKEE--AGRGSFGIVYKGVIETTRTSTTA 194
           NS  D    + L  F SY+     LEEAT+NF  +   G G FG VYKGV+         
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----DGAK 65
Query: 195 VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 254
           VA+K+       G +EF+ E+  +    H +LV L+GFCDE    +L+Y+++ NG L   
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 255 LFGNLKP----SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD 310
           L+G+  P    SW  R  I    ARGL YLH   +  IIH D+K  NILLD+++  +I+D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD 182
Query: 311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
           FG++K  T      +   ++GT GY+ PE++ K  +T K DVYSFGV+L E++  R +  
Sbjct: 183 FGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 371 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT 430
             +  E   L +WA + + NG+L+ +V+ ++      + + K    ++ C+      RP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 431 MRKVSQMLE 439
           M  V   LE
Sbjct: 303 MGDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 112/304 (36%), Positives = 156/304 (51%), Gaps = 26/304 (8%)
Query: 151 TNLRCFSYKALEEATDNFKE--------EAGRGSFGIVYKGVIETTRTSTTAVAVKKL-- 200
           T    FS+  L+  T+NF E        + G G FG+VYKG +     + T VAVKKL  
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-----NNTTVAVKKLAA 55
Query: 201 --DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA---SFL 255
             D   ++ +++F  E+ V  +  H+NLV LLGF  +G +  LVY +  NG+L    S L
Sbjct: 56  MVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 256 FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
            G    SW+ R  IA   A G+ +LHE+     IH DIK  NILLD+ + A+ISDFGLA+
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 172
Query: 316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 375
                      + I GT  Y APE  R   IT K D+YSFGV+LLEII+   + D E  E
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 230
Query: 376 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
              +L            ++D ++       D   VE    V+  C+ E  + RP ++KV 
Sbjct: 231 PQLLLDIKEEIEDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKVQ 289
Query: 436 QMLE 439
           Q+L+
Sbjct: 290 QLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 135/293 (46%), Gaps = 40/293 (13%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           N KE+ G GSFG V++        S  AV +        +   EF  EV ++ +  H N+
Sbjct: 40  NIKEKIGAGSFGTVHRA---EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHED 283
           V  +G   +  N  +V E+L+ G+L   L       +     R ++A+ +A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            +  I+H D+K  N+L+D  Y  ++ DFGL++L       +   A  GT  ++APE  R 
Sbjct: 156 RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEWMAPEVLRD 213
Query: 344 STITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYR-------NGKLDD 395
                K DVYSFGV+L E+ + ++ + ++   +  A +    F C R       N ++  
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKRLEIPRNLNPQVAA 270
Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
           ++EG                    C   +P  RP+   +  +L  +++  VPP
Sbjct: 271 IIEG--------------------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 37/291 (12%)
Query: 152 NLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF 211
           +L    YK +E      +E  GRG+FG+V K      +     VA+K+++   +   K F
Sbjct: 2   SLHMIDYKEIE-----VEEVVGRGAFGVVCKA-----KWRAKDVAIKQIES--ESERKAF 49
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIA 270
             E+  + + +H N+V+L G C       LV E+   G+L + L G    P +     ++
Sbjct: 50  IVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 271 F--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKT 327
           +  Q ++G+ YLH      +IH D+KP N+LL       +I DFG     T    +T  T
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMT 162
Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 387
             +G+  ++APE +  S  + K DV+S+G++L E+I+ RK FD   G  + I+  WA   
Sbjct: 163 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV-- 218
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
             NG    L++      N  K +E L+     C  +DPS RP+M ++ +++
Sbjct: 219 -HNGTRPPLIK------NLPKPIESLMTR---CWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 37/291 (12%)
Query: 152 NLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF 211
           +L    YK +E      +E  GRG+FG+V K      +     VA+K+++   +   K F
Sbjct: 1   SLHMIDYKEIE-----VEEVVGRGAFGVVCKA-----KWRAKDVAIKQIES--ESERKAF 48
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIA 270
             E+  + + +H N+V+L G C       LV E+   G+L + L G    P +     ++
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 271 F--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKT 327
           +  Q ++G+ YLH      +IH D+KP N+LL       +I DFG     T    +T  T
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG-----TACDIQTHMT 161
Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 387
             +G+  ++APE +  S  + K DV+S+G++L E+I+ RK FD   G  + I+  WA   
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAV-- 217
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
             NG    L++      N  K +E L+     C  +DPS RP+M ++ +++
Sbjct: 218 -HNGTRPPLIK------NLPKPIESLMTR---CWSKDPSQRPSMEEIVKIM 258

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 137/295 (46%), Gaps = 44/295 (14%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           N KE+ G GSFG V++        S  AV +        +   EF  EV ++ +  H N+
Sbjct: 40  NIKEKIGAGSFGTVHRA---EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHED 283
           V  +G   +  N  +V E+L+ G+L   L       +     R ++A+ +A+G+ YLH +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKL--LTLNQSKTIKTAIRGTKGYVAPEWY 341
            +  I+H ++K  N+L+D  Y  ++ DFGL++L   T   SK+      GT  ++APE  
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA----GTPEWMAPEVL 211
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYR-------NGKL 393
           R      K DVYSFGV+L E+ + ++ + ++   +  A +    F C R       N ++
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GFKCKRLEIPRNLNPQV 268
Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
             ++EG                    C   +P  RP+   +  +L  +++  VPP
Sbjct: 269 AAIIEG--------------------CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G FG VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 9   ERTDITMKHKLGGGQFGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 64
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 125 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 180
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +   S                +      ++ +L+E 
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDPSQVYELLEK 225
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 226 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 167
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 146
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 147
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 168
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ YL   
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--- 141
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 117/235 (49%), Gaps = 18/235 (7%)
Query: 145 GDGTVETNLRCFSYKALEEATD----------NFKEEAGRGSFGIVYKGVIETTRTSTTA 194
           G GTV  +L   + + ++              +F E  GRG FG VY G +         
Sbjct: 1   GPGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 60
Query: 195 VAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVYEFLNNGTLA 252
            AVK L+R+   GE  +F  E +++    H N++ LLG C   + + L+V  ++ +G L 
Sbjct: 61  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 253 SFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF 311
           +F+      P+         Q+A+G+ +L    S + +H D+  +N +LD+ +  +++DF
Sbjct: 121 NFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADF 177
Query: 312 GLAKLLTLNQSKTI--KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           GLA+ +   +  ++  KT  +    ++A E  +    T K DV+SFGVLL E+++
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 9   ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 64
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 65  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 125 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 180
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +   S                +      ++ +L+E 
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDPSQVYELLEK 225
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 226 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 21  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 75
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 76  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 131
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 187
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 188 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 232
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 233 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 19  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 185
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 27  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 81
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 82  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 193
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 194 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 238
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 239 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 273

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 28  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 82
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 83  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 138
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 194
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 195 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 239
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 240 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 274

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 25  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 79
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 80  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 135
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 191
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 236
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 237 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 19  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 185
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 67
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 68  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 128 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 183
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 228
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 229 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 20  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 74
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 75  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 130
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX----TAREGAKFPIKWTAPEAINYG 186
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 187 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 231
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 232 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 266

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             +E  G G FG VY+        +  A      + + Q  E   + E  +     H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIEN-VRQEAKLFAMLKHPNI 68
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L G C +  N  LV EF   G L   L G   P  ++  N A QIARG+ YLH++   
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP-DILVNWAVQIARGMNYLHDEAIV 127
Query: 287 QIIHCDIKPQNILL------DDHYNA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
            IIH D+K  NIL+       D  N   +I+DFGLA+       +T K +  G   ++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAP 183
Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           E  R S  +   DV+S+GVLL E+++    F
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 71
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 132 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 187
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 232
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 29  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 83
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 84  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 139
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 195
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 196 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 240
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 241 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 71
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 132 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 232
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 19  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 185
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 70
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 130
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 186
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 231
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 24  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 78
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 79  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 134
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 190
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 191 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 235
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 236 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 270

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 71
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 72  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 132 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 232
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ +L   
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 25  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 79
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 80  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 135
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 191
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 192 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 236
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 237 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 271

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 14  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 68
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 69  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH D++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 180
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 181 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 225
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 226 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 71
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 131
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 132 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 232
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 30/282 (10%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 66
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 126
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 127 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
               +  + K DV++FGVLL EI +   S    I++ + Y                 +L+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----------------ELL 225
Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           E D        C EK+  +   C Q +PS RP+  ++ Q  E
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 66
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 126
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 127 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 227
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G+G FG   + +  T R +   + +K+L R  ++ ++ F  EV V+    H N+++ 
Sbjct: 16  EVLGKGCFG---QAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           +G   + +    + E++  GTL   +   + +  W+ R + A  IA G+ YLH   S  I
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-----KTIKTAIR-------GTKGYV 336
           IH D+   N L+ ++ N  ++DFGLA+L+   ++     +++K   R       G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDCYRNGKLDD 395
           APE     +   KVDV+SFG++L EII       +    +Y   T D+  +         
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIG-----RVNADPDYLPRTMDFGLN--------- 235
Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            V G ++      C      +++ C   DP  RP+  K+   LE
Sbjct: 236 -VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 24  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 79
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 80  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 139
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 140 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 195
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 240
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 241 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 66
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 127 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 227
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 16  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 71
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 132 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 232
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 233 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 12  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 67
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 68  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 128 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPE 183
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 228
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 229 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ +L   
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ +L   
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 147
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 68
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 129 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPE 184
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 229
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 230 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 68
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 129 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 184
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 229
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 230 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 13  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 68
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L    +   N  +   +A QI+  + Y
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 129 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 184
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 229
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 230 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 66
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 127 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 227
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 133/287 (46%), Gaps = 37/287 (12%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
            +E  G G FG V +G ++      + VA+K L   + + ++ EF +E  ++GQ  H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYL 280
           +RL G        +++ EF+ NG L SFL      F  ++    LR      IA G+ YL
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG-----IASGMRYL 134
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVA 337
            E      +H D+  +NIL++ +   ++SDFGL++ L  N S   +T+  G K    + A
Sbjct: 135 AE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA 191
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISC--RKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
           PE       T+  D +S+G+++ E++S   R  +D+                  N  + +
Sbjct: 192 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS-----------------NQDVIN 234
Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            +E D        C   L  + + C Q+D + RP   +V   L+ ++
Sbjct: 235 AIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 281

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 66
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 127 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 227
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ +L   
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 133/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 66
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 127 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +            Y +      D     ++ +L+E 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT------------YGMSPYPGIDL---SQVYELLEK 227
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ +L   
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 154
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 8/203 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 226 LVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHED 283
           ++ LLG C   + + L+V  ++ +G L +F+      P+         Q+A+G+ +L   
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY 341
            S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++A E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 342 RKSTITAKVDVYSFGVLLLEIIS 364
           +    T K DV+SFGVLL E+++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 141/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 136 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR---KGGKGLL 187
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 232
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + LL +   C Q +P +RP+  ++
Sbjct: 233 QVLRFVMEGGLLDKPD-NCPDMLLELMRMCWQYNPKMRPSFLEI 275

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 26/284 (9%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY+GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 9   ERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 64
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + Y
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 125 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPE 180
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
               +  + K DV++FGVLL EI +   S                +      ++ +L+E 
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDPSQVYELLEK 225
Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D        C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 226 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 37/287 (12%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
            +E  G G FG V +G ++      + VA+K L   + + ++ EF +E  ++GQ  H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYL 280
           +RL G        +++ EF+ NG L SFL      F  ++    LR      IA G+ YL
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG-----IASGMRYL 132
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVA 337
            E      +H D+  +NIL++ +   ++SDFGL++ L  N S    T+  G K    + A
Sbjct: 133 AE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA 189
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISC--RKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
           PE       T+  D +S+G+++ E++S   R  +D+                  N  + +
Sbjct: 190 PEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS-----------------NQDVIN 232
Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            +E D        C   L  + + C Q+D + RP   +V   L+ ++
Sbjct: 233 AIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMI 279

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 17/217 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 383
           A+ VDV+S G++L  +++    +D +  +     +DW
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD-QPSDSXQEYSDW 220

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 33/275 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 15  ERLGAGQFGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 69
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 70  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKS 344
            IH +++  NIL+ D  + +I+DFGLA+L+  N+     TA  G K    + APE     
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAINYG 181
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           T T K DV+SFG+LL EI++  +                 +    N ++   +E     +
Sbjct: 182 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 226
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  +   C +E P  RPT   +  +LE
Sbjct: 227 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 145 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR---KGGKGLL 196
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 241
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 242 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 284

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 138/283 (48%), Gaps = 43/283 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGN----LKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L++ E +  G L S+L        N      PS +    +A +IA G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 203
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             +++PE  +    T   DV+SFGV+L EI               A L +  +    N +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNEQ 248
Query: 393 -LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 249 VLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 290

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 141 RNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL 200
           RN P    V  N   +    +E      K + G G +G VY+GV    +  +  VAVK L
Sbjct: 239 RNKPTVYGVSPN---YDKWEMERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL 292
Query: 201 DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK 260
                + E EF  E  V+ +  H NLV+LLG C       ++ EF+  G L  +L    +
Sbjct: 293 KEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 351
Query: 261 PSWN--LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              N  +   +A QI+  + YL +      IH ++  +N L+ +++  +++DFGL++L+T
Sbjct: 352 QEVNAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 408
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
              + T     +    + APE    +  + K DV++FGVLL EI +            Y 
Sbjct: 409 -GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------------YG 455
Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           +      D     ++ +L+E D        C EK+  +   C Q +PS RP+  ++ Q  
Sbjct: 456 MSPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 512
Query: 439 E 439
           E
Sbjct: 513 E 513

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 136/301 (45%), Gaps = 28/301 (9%)
Query: 141 RNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL 200
           RN P    V  N   +    +E      K + G G +G VY+GV    +  +  VAVK L
Sbjct: 200 RNKPTIYGVSPN---YDKWEMERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL 253
Query: 201 DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GN 258
                + E EF  E  V+ +  H NLV+LLG C       ++ EF+  G L  +L     
Sbjct: 254 KEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 312
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
            + S  +   +A QI+  + YL +      IH ++  +N L+ +++  +++DFGL++L+T
Sbjct: 313 QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
              + T     +    + APE    +  + K DV++FGVLL EI +            Y 
Sbjct: 370 -GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------------YG 416
Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           +      D     ++ +L+E D        C EK+  +   C Q +PS RP+  ++ Q  
Sbjct: 417 MSPYPGIDL---SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473
Query: 439 E 439
           E
Sbjct: 474 E 474

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 138/283 (48%), Gaps = 43/283 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGN----LKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L++ E +  G L S+L        N      PS +    +A +IA G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 142 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 193
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             +++PE  +    T   DV+SFGV+L EI               A L +  +    N +
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNEQ 238
Query: 393 -LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 239 VLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 280

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 14  GEGAYGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 71  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 123
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 142 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 193
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 194 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 238
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 239 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 144 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 195
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 240
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 241 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 283

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 202
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 247
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 248 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 290

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 145 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 196
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 241
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 242 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 284

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 138 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 189
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 234
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 235 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 277

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N  + + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 138 MAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 189
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 234
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + LL +   C Q +P +RP+  ++
Sbjct: 235 QVLRFVMEGGLLDKPD-NCPDMLLELMRMCWQYNPKMRPSFLEI 277

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 144 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 195
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 240
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 241 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 283

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 140/284 (49%), Gaps = 45/284 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  ++V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----------PSWNLRTNIAFQIARG 276
           RLLG   +GQ  L++ E +  G L S+L  +L+           PS +    +A +IA G
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG-- 334
           + YL+   +++ +H D+  +N ++ + +  +I DFG+ +   + ++   +   +G KG  
Sbjct: 173 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLL 224
Query: 335 ---YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
              +++PE  +    T   DV+SFGV+L EI               A L +  +    N 
Sbjct: 225 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGLSNE 269
Query: 392 K-LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           + L  ++EG +    D  C + L  +   C Q +P +RP+  ++
Sbjct: 270 QVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 312

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 117/233 (50%), Gaps = 15/233 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGE-KEFKNEVVVIGQTHHKNLVRL 229
           G+GSF  VY+   E+  T    VA+K +D+  +++ G  +  +NEV +  Q  H +++ L
Sbjct: 20  GKGSFAGVYRA--ESIHTGL-EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSSQI 288
             + ++     LV E  +NG +  +L   +KP S N   +   QI  G+LYLH   S  I
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGI 133
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           +H D+   N+LL  + N +I+DFGLA  L +   K     + GT  Y++PE   +S    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGL 191
Query: 349 KVDVYSFGVLLLEIISCRKSFDIEMGEEY---AILTDWAFDCYRNGKLDDLVE 398
           + DV+S G +   ++  R  FD +  +      +L D+    + + +  DL+ 
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G  G V+ G         T VAVK L +     +  F  E  ++ Q  H+ LVRL
Sbjct: 19  ERLGAGQAGEVWMGYY----NGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +   ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E     
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
            IH D++  NIL+ D  + +I+DFGLA+L+  +   T +   +    + APE     T T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL EI++  +                 +    N ++   +E     +   
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVRPD 233
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            C E+L  +   C +E P  RPT   +  +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G+ G V   V    R +  AVAVK +D +   D  +  K E+ +    +H+N+V+  G
Sbjct: 15  GEGAAGEVQLAV---NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A     Q+  G++YLH      
Sbjct: 72  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 124
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  ++    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 348 AK-VDVYSFGVLLLEIISCRKSFD 370
           A+ VDV+S G++L  +++    +D
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H D+  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR---KGGKGLLP 195
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P++RPT  ++  +L+  +    P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H D+  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR---KGGKGLLP 195
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P +RPT  ++  +L+  +    P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H D+  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR---KGGKGLLP 192
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 237
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P +RPT  ++  +L+  +    P
Sbjct: 238 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 16  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 70
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 71  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 126
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 182
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 183 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 227
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 228 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 18  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 72
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 73  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 128
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 184
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 185 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 229
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 230 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 45/297 (15%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI--RGTKG- 334
            YL+   + + +H D+  +N ++   +  +I DFG+ +          +TA   +G KG 
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETAYYRKGGKGL 193
Query: 335 ----YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 390
               ++APE  +    T   D++SFGV+L EI S               L +  +    N
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSN 238
Query: 391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
            ++   V           C E++  +   C Q +P +RPT  ++  +L+  +    P
Sbjct: 239 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 137/303 (45%), Gaps = 34/303 (11%)
Query: 156 FSYKALEEATDNFKEEA-----------GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF 204
           F+++   EA   F +E            G G FG V  G ++        VA+K L   +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 205 QDGEK-EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSW 263
            + ++ +F +E  ++GQ  H N++ L G   +    +++ EF+ NG+L SFL  N     
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 264 NLR-TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
            ++   +   IA G+ YL        +H D+  +NIL++ +   ++SDFGL++ L  + S
Sbjct: 134 VIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 190
Query: 323 KTIKTAIRGTK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 379
               T+  G K    + APE  +    T+  DV+S+G+++ E++S            Y  
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------------YGE 238
Query: 380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
              W      N  + + +E D      + C   L  + + C Q+D + RP   ++   L+
Sbjct: 239 RPYWDM---TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 295
Query: 440 GVV 442
            ++
Sbjct: 296 KMI 298

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H D+  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 194
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 239
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P +RPT  ++  +L+  +    P
Sbjct: 240 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 294

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 134/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H D+  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 195
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P +RPT  ++  +L+  +    P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 135/290 (46%), Gaps = 50/290 (17%)
Query: 173 GRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLL 230
           G G FG VYKG+++T+       VA+K L   + + ++ +F  E  ++GQ  H N++RL 
Sbjct: 53  GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           G   + +  +++ E++ NG L  FL      F  L+    LR      IA G+ YL    
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG-----IAAGMKYL---A 164
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWY 341
           +   +H D+  +NIL++ +   ++SDFGL+++L  +   T  T+  G K    + APE  
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEAI 222
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 401
                T+  DV+SFG+++ E+++            Y     W    +            M
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT------------YGERPYWELSNHEV----------M 260
Query: 402 EAMND-------IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
           +A+ND       + C   +  + + C Q++ + RP    +  +L+ ++  
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 27  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D+   NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 194 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 239 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 32/271 (11%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVR 228
           G G FG V+KGV I    +    V +K ++   + G + F+   + ++ IG   H ++VR
Sbjct: 40  GSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           LLG C  G +  LV ++L  G+L   +    G L P   L  N   QIA+G+ YL E   
Sbjct: 98  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG- 153
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             ++H ++  +N+LL      +++DFG+A LL  +  + + +  +    ++A E      
Sbjct: 154 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEAM 404
            T + DV+S+GV + E+++          E YA L        R  ++ DL+E G+  A 
Sbjct: 212 YTHQSDVWSYGVTVWELMTFG-------AEPYAGL--------RLAEVPDLLEKGERLAQ 256
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
             I C   + MV + C   D ++RPT ++++
Sbjct: 257 PQI-CTIDVYMVMVKCWMIDENIRPTFKELA 286

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 134/271 (49%), Gaps = 32/271 (11%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVR 228
           G G FG V+KGV I    +    V +K ++   + G + F+   + ++ IG   H ++VR
Sbjct: 22  GSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           LLG C  G +  LV ++L  G+L   +    G L P   L  N   QIA+G+ YL E   
Sbjct: 80  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG- 135
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             ++H ++  +N+LL      +++DFG+A LL  +  + + +  +    ++A E      
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE-GDMEAM 404
            T + DV+S+GV + E+++          E YA L        R  ++ DL+E G+  A 
Sbjct: 194 YTHQSDVWSYGVTVWELMTFG-------AEPYAGL--------RLAEVPDLLEKGERLAQ 238
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
             I C   + MV + C   D ++RPT ++++
Sbjct: 239 PQI-CTIDVYMVMVKCWMIDENIRPTFKELA 268

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 135/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H ++  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 145 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 196
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 241
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P++RPT  ++  +L+  +    P
Sbjct: 242 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 296

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 135/295 (45%), Gaps = 41/295 (13%)
Query: 171 EAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLV 227
           E G+GSFG+VY+G         + T VAVK ++      E+ EF NE  V+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPSWNLRTNIAFQIARGL 277
           RLLG   +GQ  L+V E + +G L S+L           G   P+      +A +IA G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--- 334
            YL+   + + +H ++  +N ++   +  +I DFG+ +   + ++   +   +G KG   
Sbjct: 144 AYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 195
Query: 335 --YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++APE  +    T   D++SFGV+L EI S               L +  +    N +
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQ 240
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           +   V           C E++  +   C Q +P++RPT  ++  +L+  +    P
Sbjct: 241 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 24  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 78
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E++N G+L  FL G       L    +++ QIA G+ Y+        +H
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVH 134
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 191 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 235
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 236 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 194 GQGCFGEVWMG----TWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAV 248
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G +     L    ++A QIA G+ Y+        +H
Sbjct: 249 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 304
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGL +L+  N+     TA +G K    + APE       T
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 360
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 361 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 405
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C ++DP  RPT   +   LE
Sbjct: 406 ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGLA++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 17  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 71
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+        +H
Sbjct: 72  VSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYGRFT 183
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 184 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 228
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 229 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 24  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 78
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E++N G+L  FL G       L    +++ QIA G+ Y+        +H
Sbjct: 79  VSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVH 134
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEW----TARQGAKFPIKWTAPEAALYGRFT 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 191 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 235
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 236 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 22/266 (8%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ +    T    VA+K L+         EF +E +++    H +LVRLL
Sbjct: 24  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           G C     +L V + + +G L  ++  +       L  N   QIA+G++YL E    +++
Sbjct: 84  GVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLV 139
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+    + +I+DFGLA+LL  ++ +      +    ++A E       T +
Sbjct: 140 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 199
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
            DV+S+GV + E+++         G+ Y        D     ++ DL+E          C
Sbjct: 200 SDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEKGERLPQPPIC 244
Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKVS 435
              + MV + C   D   RP  ++++
Sbjct: 245 TIDVYMVMVKCWMIDADSRPKFKELA 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 20  GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 74
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+        +H
Sbjct: 75  VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 130
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 186
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 187 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 231
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 232 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G       +   VA+K + R     E++F  E  V+ +  H  L
Sbjct: 13  TFVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 67
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+L G C E     LV+EF+ +G L+ +L     L  +  L   +   +  G+ YL E C
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC 126
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              +IH D+  +N L+ ++   ++SDFG+ + + L+   T  T  +    + +PE +  S
Sbjct: 127 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E+ S
Sbjct: 183 RYSSKSDVWSFGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G       +   VA+K + R     E++F  E  V+ +  H  L
Sbjct: 10  TFVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 64
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+L G C E     LV+EF+ +G L+ +L     L  +  L   +   +  G+ YL E C
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC 123
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              +IH D+  +N L+ ++   ++SDFG+ + + L+   T  T  +    + +PE +  S
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E+ S
Sbjct: 180 RYSSKSDVWSFGVLMWEVFS 199

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 276 GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 330
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+        +H
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 442
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 443 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 487
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G       +   VA+K + R     E++F  E  V+ +  H  L
Sbjct: 8   TFVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+L G C E     LV+EF+ +G L+ +L     L  +  L   +   +  G+ YL E C
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC 121
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              +IH D+  +N L+ ++   ++SDFG+ + + L+   T  T  +    + +PE +  S
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E+ S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFS 197

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 22/266 (8%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ +    T    VA+K L+         EF +E +++    H +LVRLL
Sbjct: 47  GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLL 106
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           G C     +L V + + +G L  ++  +       L  N   QIA+G++YL E    +++
Sbjct: 107 GVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLV 162
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+    + +I+DFGLA+LL  ++ +      +    ++A E       T +
Sbjct: 163 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 222
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
            DV+S+GV + E+++         G+ Y        D     ++ DL+E          C
Sbjct: 223 SDVWSYGVTIWELMTFG-------GKPY--------DGIPTREIPDLLEKGERLPQPPIC 267
Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKVS 435
              + MV + C   D   RP  ++++
Sbjct: 268 TIDVYMVMVKCWMIDADSRPKFKELA 293

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 134/302 (44%), Gaps = 41/302 (13%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           N  +  GRG+FG V +    G+ +T    T AV + K      +         ++I   H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 223 HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNI------ 269
           H N+V LLG C + G   +++ EF   G L+++L      F   K   +L  +       
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWA 384
              R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+       
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------- 260
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
             C R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ 
Sbjct: 261 --CRR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
Query: 445 DV 446
           + 
Sbjct: 312 NA 313

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 45/303 (14%)
Query: 167 NFKEEAGRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
            F +  G G+FG     V+E T        +   VAVK L       EKE   +E+ ++ 
Sbjct: 49  QFGKTLGAGAFG----KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 220 QT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTN------ 268
               H+N+V LLG C  G   L++ E+   G L +FL     P    S+N   N      
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 269 ------IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
                  + Q+A+G+ +L    S   IH D+  +N+LL + + A+I DFGLA+ +  + +
Sbjct: 165 SRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 382
             +K   R    ++APE       T + DV+S+G+LL EI      F + +     IL  
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV- 274
Query: 383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                  N K   LV+   +        + +  +   C   +P+ RPT +++   L+   
Sbjct: 275 -------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 327
Query: 443 EVD 445
           + D
Sbjct: 328 QED 330

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 39/299 (13%)
Query: 168 FKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L    +   ++F+ E  ++    H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 269
           +VR  G C EG+  L+V+E++ +G L  FL  +  P   L                   +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           A Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
                ++ PE       T + DV+SFGV+L EI +  K         Y +    A DC  
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCIT 274
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
            G+         E      C  ++  +   C Q +P  R +++ V   L+ + +   PP
Sbjct: 275 QGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ--APP 322

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 39/299 (13%)
Query: 168 FKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L    +   ++F+ E  ++    H++
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 269
           +VR  G C EG+  L+V+E++ +G L  FL  +  P   L                   +
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           A Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
                ++ PE       T + DV+SFGV+L EI +  K         Y +    A DC  
Sbjct: 198 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCIT 251
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
            G+         E      C  ++  +   C Q +P  R +++ V   L+ + +   PP
Sbjct: 252 QGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ--APP 299

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 193 GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+        +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 359
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 360 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 404
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 39/299 (13%)
Query: 168 FKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L    +   ++F+ E  ++    H++
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 269
           +VR  G C EG+  L+V+E++ +G L  FL  +  P   L                   +
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           A Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +    
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
                ++ PE       T + DV+SFGV+L EI +  K         Y +    A DC  
Sbjct: 192 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ------PWYQLSNTEAIDCIT 245
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
            G+         E      C  ++  +   C Q +P  R +++ V   L+ + +   PP
Sbjct: 246 QGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ--APP 293

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 193 GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+        +H
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 359
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 360 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 404
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 136/295 (46%), Gaps = 35/295 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 143
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 144 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 197
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 198 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 248
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++ 
Sbjct: 249 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 131/295 (44%), Gaps = 40/295 (13%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 38  GRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 97
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFL------FGNLKP--------SWNLRTNIAFQI 273
           LLG C + G   +++ EF   G L+++L      F   KP        +       +FQ+
Sbjct: 98  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQV 157
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
           A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R   
Sbjct: 158 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNG 391
            ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R  
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR-- 263
Query: 392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
               L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 264 ----LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           N  +  GRG+FG V +    G+ +T    T AV + K      +         ++I   H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 223 HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNI--------- 269
           H N+V LLG C + G   +++ EF   G L+++L        P  +L  +          
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 257
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
            R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 258 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 43/301 (14%)
Query: 167 NFKEEAGRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
            F +  G G+FG     V+E T        +   VAVK L       EKE   +E+ ++ 
Sbjct: 49  QFGKTLGAGAFG----KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 220 QT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA---- 274
               H+N+V LLG C  G   L++ E+   G L +FL    + S  L T+ AF IA    
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTA 161
Query: 275 --RGLLYLHED--------CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
             R LL+             S   IH D+  +N+LL + + A+I DFGLA+ +  + +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+LL EI      F + +     IL    
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV--- 272
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
                N K   LV+   +        + +  +   C   +P+ RPT +++   L+   + 
Sbjct: 273 -----NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327
Query: 445 D 445
           D
Sbjct: 328 D 328

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 153
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 154 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 207
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 208 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 258
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 259 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 126
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 127 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 180
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 231
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 232 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 131/301 (43%), Gaps = 43/301 (14%)
Query: 167 NFKEEAGRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
            F +  G G+FG     V+E T        +   VAVK L       EKE   +E+ ++ 
Sbjct: 49  QFGKTLGAGAFG----KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 220 QT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA---- 274
               H+N+V LLG C  G   L++ E+   G L +FL    + S  L T+ AF IA    
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTL 161
Query: 275 --RGLLYLHED--------CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
             R LL+             S   IH D+  +N+LL + + A+I DFGLA+ +  + +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+LL EI      F + +     IL    
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV--- 272
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
                N K   LV+   +        + +  +   C   +P+ RPT +++   L+   + 
Sbjct: 273 -----NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327
Query: 445 D 445
           D
Sbjct: 328 D 328

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V+ G    T   TT VA+K L       E  F  E  V+ +  H+ LV+L   
Sbjct: 193 GQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+        +H
Sbjct: 248 VSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ ++   +++DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFT 359
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+ +  +                 +    N ++ D VE         
Sbjct: 360 IKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPCPP 404
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +C E L  +   C +++P  RPT   +   LE
Sbjct: 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E++ NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL ++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 158 YKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 217
           Y  L+     F++  G G+FG V K  I+       A   +  +   +D  ++F  E+ V
Sbjct: 19  YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 218 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 274
           + +  HH N++ LLG C+      L  E+  +G L  FL    + S  L T+ AF IA  
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 134
Query: 275 ------------------RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
                             RG+ YL +    Q IH D+  +NIL+ ++Y A+I+DFGL++ 
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 191
Query: 317 LTLNQSKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
             +   KT+ +  +R    ++A E    S  T   DV+S+GVLL EI+S
Sbjct: 192 QEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 167 NFKEEAGRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
            F +  G G+FG     V+E T        +   VAVK L       EKE   +E+ ++ 
Sbjct: 41  QFGKTLGAGAFG----KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 220 QT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--------LRTNIA 270
               H+N+V LLG C  G   L++ E+   G L +FL    +   +        LR  + 
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 271 F--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           F  Q+A+G+ +L    S   IH D+  +N+LL + + A+I DFGLA+ +  + +  +K  
Sbjct: 157 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            R    ++APE       T + DV+S+G+LL EI      F + +     IL        
Sbjct: 214 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
            N K   LV+   +        + +  +   C   +P+ RPT +++   L+   + D
Sbjct: 261 -NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 316

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 158 YKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 217
           Y  L+     F++  G G+FG V K  I+       A   +  +   +D  ++F  E+ V
Sbjct: 9   YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 68
Query: 218 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA-- 274
           + +  HH N++ LLG C+      L  E+  +G L  FL    + S  L T+ AF IA  
Sbjct: 69  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 124
Query: 275 ------------------RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
                             RG+ YL +    Q IH D+  +NIL+ ++Y A+I+DFGL++ 
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 181
Query: 317 LTLNQSKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
             +   KT+ +  +R    ++A E    S  T   DV+S+GVLL EI+S
Sbjct: 182 QEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRL 229
           E G G+FG V +GV    R     VA+K L +  +  + +E   E  ++ Q  +  +VRL
Sbjct: 17  ELGCGNFGSVRQGVYRM-RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL E     
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEE---KN 130
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKSTI 346
            +H D+  +N+LL + + A+ISDFGL+K L  + S  T ++A +    + APE       
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 347 TAKVDVYSFGVLLLEIIS 364
           +++ DV+S+GV + E +S
Sbjct: 191 SSRSDVWSYGVTMWEALS 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 30/282 (10%)
Query: 163 EATD-NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT 221
           E TD   K + G G +G VY GV    +  +  VAVK L     + E EF  E  V+ + 
Sbjct: 30  ERTDITMKHKLGGGQYGEVYVGVW---KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEI 85
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLY 279
            H NLV+LLG C       +V E++  G L  +L      + +  +   +A QI+  + Y
Sbjct: 86  KHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEY 145
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L +      IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE
Sbjct: 146 LEK---KNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 201
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
               +T + K DV++FGVLL EI +   S    I++ + Y                 DL+
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----------------DLL 244
Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           E          C  K+  +   C +  P+ RP+  +  Q  E
Sbjct: 245 EKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFE 286

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 167 NFKEEAGRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
            F +  G G+FG     V+E T        +   VAVK L       EKE   +E+ ++ 
Sbjct: 49  QFGKTLGAGAFG----KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 220 QT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWN--------LRTNIA 270
               H+N+V LLG C  G   L++ E+   G L +FL    +   +        LR  + 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 271 F--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           F  Q+A+G+ +L    S   IH D+  +N+LL + + A+I DFGLA+ +  + +  +K  
Sbjct: 165 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            R    ++APE       T + DV+S+G+LL EI      F + +     IL        
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV------- 268
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
            N K   LV+   +        + +  +   C   +P+ RPT +++   L+   + D
Sbjct: 269 -NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 324

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G       +   VA+K + R     E++F  E  V+ +  H  L
Sbjct: 11  TFVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+L G C E     LV EF+ +G L+ +L     L  +  L   +   +  G+ YL E C
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC 124
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              +IH D+  +N L+ ++   ++SDFG+ + + L+   T  T  +    + +PE +  S
Sbjct: 125 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 128/276 (46%), Gaps = 23/276 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLG 231
           G G FG V  G ++        VA+K L   + + ++ +F +E  ++GQ  H N++ L G
Sbjct: 16  GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEG 75
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSSQIIH 290
              +    +++ EF+ NG+L SFL  N      ++   +   IA G+ YL +      +H
Sbjct: 76  VVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVH 132
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
             +  +NIL++ +   ++SDFGL++ L  + S    T+  G K    + APE  +    T
Sbjct: 133 RALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 192
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+S+G+++ E++S            Y     W      N  + + +E D      +
Sbjct: 193 SASDVWSYGIVMWEVMS------------YGERPYWDMT---NQDVINAIEQDYRLPPPM 237
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  + + C Q+D + RP   ++   L+ ++ 
Sbjct: 238 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 156 FSYKALEEATDN---FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---- 208
           F    L    DN   ++++ G+G FG+V+KG +   ++    VA+K L     +GE    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKS---VVAIKSLILGDSEGETEMI 64
Query: 209 ---KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWN 264
              +EF+ EV ++   +H N+V+L G         +V EF+  G L   L     P  W+
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYN--ARISDFGLAKLLTL 319
           ++  +   IA G+ Y+ ++ +  I+H D++  NI    LD++    A+++DFGL++    
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 320 NQSKTIKTAIRGTKGYVAPEWY--RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
            QS    + + G   ++APE     + + T K D YSF ++L  I++    FD     EY
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EY 231
Query: 378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP 429
           +       +  R   L   +  D        C  +L  V   C   DP  RP
Sbjct: 232 SYGKIKFINMIREEGLRPTIPED--------CPPRLRNVIELCWSGDPKKRP 275

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 136/294 (46%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E + NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +  +   +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G       +   VA+K + +     E +F  E  V+ +  H  L
Sbjct: 30  TFVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKL 84
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+L G C E     LV+EF+ +G L+ +L     L  +  L   +   +  G+ YL E C
Sbjct: 85  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEEAC 143
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              +IH D+  +N L+ ++   ++SDFG+ + + L+   T  T  +    + +PE +  S
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E+ S
Sbjct: 200 RYSSKSDVWSFGVLMWEVFS 219

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 95/188 (50%), Gaps = 7/188 (3%)
Query: 195 VAVKKL---DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL 251
           VA+K +    R  ++  K F+ EV    Q  H+N+V ++   +E     LV E++   TL
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 252 ASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF 311
           + ++  +   S +   N   QI  G+ + H+    +I+H DIKPQNIL+D +   +I DF
Sbjct: 99  SEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDF 155
Query: 312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDI 371
           G+AK L+   S T    + GT  Y +PE  +        D+YS G++L E++     F+ 
Sbjct: 156 GIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
Query: 372 EMGEEYAI 379
           E     AI
Sbjct: 215 ETAVSIAI 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 125/291 (42%), Gaps = 33/291 (11%)
Query: 168 FKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L     +  K+F  E  ++    H++
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPSWNLRT--------NIAFQ 272
           +V+  G C EG   ++V+E++ +G L  FL  +     L    N  T        +IA Q
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
           IA G++YL    S   +H D+  +N L+ ++   +I DFG+++ +       +       
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 333 KGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
             ++ PE       T + DV+S GV+L EI +  K         Y +  +   +C   G+
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGR 247
Query: 393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           +               C +++  + + C Q +P +R  ++ +  +L+ + +
Sbjct: 248 V---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E + NG+L SFL      F  ++    LR     
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 156 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 209
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 260
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 261 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVR 228
           E+ GRG+FG V+ G +   R   T VAVK        D + +F  E  ++ Q  H N+VR
Sbjct: 120 EQIGRGNFGEVFSGRL---RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI----ARGLLYLHEDC 284
           L+G C + Q   +V E +  G   +FL         LR     Q+    A G+ YL   C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEW 340
               IH D+  +N L+ +    +ISDFG+++     ++  +  A  G +     + APE 
Sbjct: 234 C---IHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEA 286
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
                 +++ DV+SFG+LL E  S   S                +    N +  + VE  
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGAS---------------PYPNLSNQQTREFVEKG 331
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
                   C + +  +   C   +P  RP+   + Q L+ +
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 135/294 (45%), Gaps = 35/294 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+    +  +  G G FG V  G ++       +VA+K L   + + ++ +F  E  +
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N++RL G   + +  ++V E + NG+L SFL      F  ++    LR     
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRG---- 126
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG
Sbjct: 127 -IASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RG 180
Query: 332 TK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            K    + +PE       T+  DV+S+G++L E++S  +    EM  +  I         
Sbjct: 181 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------- 231
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                   V+        + C   L  + + C Q+D + RP   ++  +L+ ++
Sbjct: 232 ------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G       +   VA+K + R     E++F  E  V+ +  H  L
Sbjct: 10  TFVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 64
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+L G C E     LV+EF+ +G L+ +L     L  +  L   +   +  G+ YL E  
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE-- 121
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
            + +IH D+  +N L+ ++   ++SDFG+ + + L+   T  T  +    + +PE +  S
Sbjct: 122 -ASVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E+ S
Sbjct: 180 RYSSKSDVWSFGVLMWEVFS 199

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 130/302 (43%), Gaps = 44/302 (14%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           N  +  GRG+FG V +    G+ +T    T AV + K      +         ++I   H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 223 HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNI--------- 269
           H N+V LLG C + G   +++ EF   G L+++L        P  +L  +          
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
           R    ++APE       T + DV+SFGVLL EI S   S                   Y 
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------------------PYP 248
Query: 390 NGKLDD-----LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
             K+D+     L EG      D    E +    + C   +PS RPT  ++ + L  +++ 
Sbjct: 249 GVKIDEEFXRRLKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 307
Query: 445 DV 446
           + 
Sbjct: 308 NA 309

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 130 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVR 228
           E+ GRG+FG V+ G +   R   T VAVK        D + +F  E  ++ Q  H N+VR
Sbjct: 120 EQIGRGNFGEVFSGRL---RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI----ARGLLYLHEDC 284
           L+G C + Q   +V E +  G   +FL         LR     Q+    A G+ YL   C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK----GYVAPEW 340
               IH D+  +N L+ +    +ISDFG+++     ++  +  A  G +     + APE 
Sbjct: 234 C---IHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEA 286
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
                 +++ DV+SFG+LL E  S   S                +    N +  + VE  
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGAS---------------PYPNLSNQQTREFVEKG 331
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
                   C + +  +   C   +P  RP+   + Q L+ +
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 144/326 (44%), Gaps = 54/326 (16%)
Query: 152 NLRCFSYKALEEATDNFKEE-------AGRGSFGIVYKGVI--ETTRTSTTAVAVKKLDR 202
           +L   ++K LE+    F  +        G G FG V K        R   T VAVK L  
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 203 VFQDGE-KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK- 260
                E ++  +E  V+ Q +H ++++L G C +    LL+ E+   G+L  FL  + K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 261 ------------------PSWNLRT-----NIAFQIARGLLYLHEDCSSQIIHCDIKPQN 297
                             P     T     + A+QI++G+ YL E    +++H D+  +N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180
Query: 298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           IL+ +    +ISDFGL++ +    S   ++  R    ++A E       T + DV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 358 LLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMV 416
           LL EI++         G  Y  I  +  F+  + G         ME  ++  C E++  +
Sbjct: 241 LLWEIVTLG-------GNPYPGIPPERLFNLLKTGH-------RMERPDN--CSEEMYRL 284
Query: 417 SIWCIQEDPSLRPTMRKVSQMLEGVV 442
            + C +++P  RP    +S+ LE ++
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 42/247 (17%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           ++N+P D T+        Y  L+     F++  G G+FG V K  I+       A   + 
Sbjct: 7   VKNNP-DPTI--------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 57
Query: 200 LDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN 258
            +   +D  ++F  E+ V+ +  HH N++ LLG C+      L  E+  +G L  FL   
Sbjct: 58  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--- 114
Query: 259 LKPSWNLRTNIAFQIA--------------------RGLLYLHEDCSSQIIHCDIKPQNI 298
            + S  L T+ AF IA                    RG+ YL +    Q IH ++  +NI
Sbjct: 115 -RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNI 170
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           L+ ++Y A+I+DFGL++   +   KT+ +  +R    ++A E    S  T   DV+S+GV
Sbjct: 171 LVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGV 226
Query: 358 LLLEIIS 364
           LL EI+S
Sbjct: 227 LLWEIVS 233

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 143/326 (43%), Gaps = 54/326 (16%)
Query: 152 NLRCFSYKALEEATDNFKEE-------AGRGSFGIVYKGVI--ETTRTSTTAVAVKKLDR 202
           +L   ++K LE+    F  +        G G FG V K        R   T VAVK L  
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 203 VFQDGE-KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK- 260
                E ++  +E  V+ Q +H ++++L G C +    LL+ E+   G+L  FL  + K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 261 ------------------PSWNLRT-----NIAFQIARGLLYLHEDCSSQIIHCDIKPQN 297
                             P     T     + A+QI++G+ YL E     ++H D+  +N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAARN 180
Query: 298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           IL+ +    +ISDFGL++ +    S   ++  R    ++A E       T + DV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 358 LLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMV 416
           LL EI++         G  Y  I  +  F+  + G         ME  ++  C E++  +
Sbjct: 241 LLWEIVTLG-------GNPYPGIPPERLFNLLKTGH-------RMERPDN--CSEEMYRL 284
Query: 417 SIWCIQEDPSLRPTMRKVSQMLEGVV 442
            + C +++P  RP    +S+ LE ++
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F  + G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ EFL  G+L  +L  + +   +++      QI +G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 130 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 144/326 (44%), Gaps = 54/326 (16%)
Query: 152 NLRCFSYKALEEATDNFKEE-------AGRGSFGIVYKGVI--ETTRTSTTAVAVKKLDR 202
           +L   ++K LE+    F  +        G G FG V K        R   T VAVK L  
Sbjct: 4   SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 203 VFQDGE-KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK- 260
                E ++  +E  V+ Q +H ++++L G C +    LL+ E+   G+L  FL  + K 
Sbjct: 64  NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 261 ------------------PSWNLRT-----NIAFQIARGLLYLHEDCSSQIIHCDIKPQN 297
                             P     T     + A+QI++G+ YL E    +++H D+  +N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARN 180
Query: 298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           IL+ +    +ISDFGL++ +    S   ++  R    ++A E       T + DV+SFGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 358 LLLEIISCRKSFDIEMGEEY-AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMV 416
           LL EI++         G  Y  I  +  F+  + G         ME  ++  C E++  +
Sbjct: 241 LLWEIVTLG-------GNPYPGIPPERLFNLLKTGH-------RMERPDN--CSEEMYRL 284
Query: 417 SIWCIQEDPSLRPTMRKVSQMLEGVV 442
            + C +++P  RP    +S+ LE ++
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V+ +  E +F  E ++I + +H+N+VR 
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRC 113
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 114 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 228
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 42/292 (14%)
Query: 156 FSYKALEEATDN---FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---- 208
           F    L    DN   ++++ G+G FG+V+KG +   ++    VA+K L     +GE    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKS---VVAIKSLILGDSEGETEMI 64
Query: 209 ---KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWN 264
              +EF+ EV ++   +H N+V+L G         +V EF+  G L   L     P  W+
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYN--ARISDFGLAKLLTL 319
           ++  +   IA G+ Y+ ++ +  I+H D++  NI    LD++    A+++DFG     T 
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-----TS 176
Query: 320 NQSKTIKTAIRGTKGYVAPEWY--RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
            QS    + + G   ++APE     + + T K D YSF ++L  I++    FD     EY
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EY 231
Query: 378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP 429
           +       +  R   L   +  D        C  +L  V   C   DP  RP
Sbjct: 232 SYGKIKFINMIREEGLRPTIPED--------CPPRLRNVIELCWSGDPKKRP 275

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRL 229
           E G G+FG V +GV    R     VA+K L +  +  + +E   E  ++ Q  +  +VRL
Sbjct: 343 ELGCGNFGSVRQGVYRM-RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL E     
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEE---KN 456
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKSTI 346
            +H ++  +N+LL + + A+ISDFGL+K L  + S  T ++A +    + APE       
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 347 TAKVDVYSFGVLLLEIIS 364
           +++ DV+S+GV + E +S
Sbjct: 517 SSRSDVWSYGVTMWEALS 534

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 120/272 (44%), Gaps = 33/272 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G FG V+ G    T    T VA+K L       E  F  E  ++ +  H  LV+L   
Sbjct: 18  GNGQFGEVWMG----TWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQLYAV 72
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHEDCSSQIIH 290
             E +   +V E++N G+L  FL      +  L    ++A Q+A G+ Y+        IH
Sbjct: 73  VSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIH 128
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  NIL+ +    +I+DFGLA+L+  N+     TA +G K    + APE       T
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEX----TARQGAKFPIKWTAPEAALYGRFT 184
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            K DV+SFG+LL E+++  +                 +    N ++ + VE         
Sbjct: 185 IKSDVWSFGILLTELVTKGRV---------------PYPGMNNREVLEQVERGYRMPCPQ 229
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            C   L  + I C ++DP  RPT   +   LE
Sbjct: 230 DCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 131 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 187
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 188 YAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 130 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 126 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 182
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 183 YAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 133 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 189
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 190 YAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 132 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 188
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 189 YAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 158 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 214
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 134 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 190
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 191 YAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 125 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 133/310 (42%), Gaps = 52/310 (16%)
Query: 167 NFKEEAGRGSFGIVYKGVIETT------RTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIG 219
            F +  G G+FG     V+E T        +   VAVK L       EKE   +E+ ++ 
Sbjct: 34  QFGKTLGAGAFG----KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 220 QT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSW----------- 263
               H+N+V LLG C  G   L++ E+   G L +FL       L PS            
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 264 ------NLRTNIAF--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
                  LR  + F  Q+A+G+ +L    S   IH D+  +N+LL + + A+I DFGLA+
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 206
Query: 316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE 375
            +  + +  +K   R    ++APE       T + DV+S+G+LL EI      F + +  
Sbjct: 207 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNP 260
Query: 376 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
              IL         N K   LV+   +        + +  +   C   +P+ RPT +++ 
Sbjct: 261 YPGILV--------NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 312
Query: 436 QMLEGVVEVD 445
             L+   + D
Sbjct: 313 SFLQEQAQED 322

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 132/292 (45%), Gaps = 42/292 (14%)
Query: 156 FSYKALEEATDN---FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---- 208
           F    L    DN   ++++ G+G FG+V+KG +   ++    VA+K L     +GE    
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKS---VVAIKSLILGDSEGETEMI 64
Query: 209 ---KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWN 264
              +EF+ EV ++   +H N+V+L G         +V EF+  G L   L     P  W+
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYN--ARISDFGLAKLLTL 319
           ++  +   IA G+ Y+ ++ +  I+H D++  NI    LD++    A+++DF L++    
Sbjct: 123 VKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---- 177
Query: 320 NQSKTIKTAIRGTKGYVAPEWY--RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
            QS    + + G   ++APE     + + T K D YSF ++L  I++    FD     EY
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-----EY 231
Query: 378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP 429
           +       +  R   L   +  D        C  +L  V   C   DP  RP
Sbjct: 232 SYGKIKFINMIREEGLRPTIPED--------CPPRLRNVIELCWSGDPKKRP 275

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 33/280 (11%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G+G FG+VY G       +    A+K L R+ +  + E F  E +++   +H N++ L+G
Sbjct: 30  GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 232 FC--DEGQNRLLVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQI 288
                EG   +L+  ++ +G L  F+    + P+     +   Q+ARG+ YL E    + 
Sbjct: 90  IMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKF 145
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAK------LLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           +H D+  +N +LD+ +  +++DFGLA+        ++ Q +  +  ++ T    A E  +
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALESLQ 201
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 402
               T K DV+SFGVLL E+++            Y  +  +    +       L +G   
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT-------RGAPPYRHIDPFDLTHF-------LAQGRRL 247
Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              +  C + L  V   C + DP++RPT R +   +E +V
Sbjct: 248 PQPEY-CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  + +   +K        +
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 134/289 (46%), Gaps = 25/289 (8%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K +E +    +   G G FG V  G ++        VA+K L   + + ++ +F  E  +
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
           +GQ  H N++ L G   + +  ++V E++ NG+L +FL  N      ++   +   I+ G
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK--- 333
           + YL +      +H D+  +NIL++ +   ++SDFGL+++L  +      T  RG K   
Sbjct: 137 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGKIPI 191
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 393
            + APE       T+  DV+S+G+++ E++S  +    EM  +  I              
Sbjct: 192 RWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI-------------- 237
Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              VE      + + C   L  + + C Q++ + RP   ++  ML+ ++
Sbjct: 238 -KAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 263
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 264 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 147 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 254
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 255 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 87  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 147 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 254
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 255 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 43/264 (16%)
Query: 163 EATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVI 218
           E  +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIA 274
            + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ 
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLL 120
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           +GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R    
Sbjct: 121 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTH 169
Query: 335 YVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAF 385
            V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLF 221
Query: 386 DCYRN-GKLDDLVEGDMEAMNDIK 408
             +R  G  D++V   + +M D K
Sbjct: 222 RIFRTLGTPDEVVWPGVTSMPDYK 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 263
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 264 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E  G+GSFG V+KG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + +
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTK 85
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
             G   +G    ++ E+L  G+    L       + + T +  +I +GL YLH   S + 
Sbjct: 86  YYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH---SEKK 141
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           IH DIK  N+LL +  + +++DFG+A  LT  Q K  +    GT  ++APE  ++S   +
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDS 199
Query: 349 KVDVYSFGVLLLEI 362
           K D++S G+  +E+
Sbjct: 200 KADIWSLGITAIEL 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 155 CFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDGEKEFKN 213
           C      EE    +  + G+G+FG V     +    +T A VAVK+L     D +++F+ 
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 214 EVVVIGQTHHKNLVRLLG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           E+ ++   H   +V+  G  +    Q+  LV E+L +G L  FL          R     
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---------QRHRARL 111
Query: 272 QIARGLLYLHEDC-------SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-K 323
             +R LLY  + C       S + +H D+  +NIL++   + +I+DFGLAKLL L++   
Sbjct: 112 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 171
Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKS 368
            ++   +    + APE    +  + + DV+SFGV+L E+ + C KS
Sbjct: 172 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 217

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 21/220 (9%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    +  + G+G+FG V     +    +T A VAVK+L     D +++F+ E+ ++ 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 220 QTHHKNLVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 277
             H   +V+  G     G+  L LV E+L +G L  FL          R       +R L
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL---------QRHRARLDASRLL 114
Query: 278 LYLHEDC-------SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ-SKTIKTAI 329
           LY  + C       S + +H D+  +NIL++   + +I+DFGLAKLL L++    ++   
Sbjct: 115 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG 174
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKS 368
           +    + APE    +  + + DV+SFGV+L E+ + C KS
Sbjct: 175 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 43/264 (16%)
Query: 163 EATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVI 218
           E  +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIA 274
            + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ 
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLL 120
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           +GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R    
Sbjct: 121 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTH 169
Query: 335 YVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAF 385
            V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLF 221
Query: 386 DCYRN-GKLDDLVEGDMEAMNDIK 408
             +R  G  D++V   + +M D K
Sbjct: 222 RIFRTLGTPDEVVWPGVTSMPDYK 245

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 21/220 (9%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    +  + G+G+FG V     +    +T A VAVK+L     D +++F+ E+ ++ 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 220 QTHHKNLVRLLG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 277
             H   +V+  G  +    Q+  LV E+L +G L  FL          R       +R L
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---------QRHRARLDASRLL 118
Query: 278 LYLHEDC-------SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAI 329
           LY  + C       S + +H D+  +NIL++   + +I+DFGLAKLL L++    ++   
Sbjct: 119 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 178
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKS 368
           +    + APE    +  + + DV+SFGV+L E+ + C KS
Sbjct: 179 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 218

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 31/280 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           +E G G FG+V  G           VAVK + +     E EF  E   + +  H  LV+ 
Sbjct: 14  KELGSGQFGVVKLG----KWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSS 286
            G C +     +V E+++NG L ++L  +   L+PS  L   + + +  G+ +L    S 
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGMAFLE---SH 123
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           Q IH D+  +N L+D     ++SDFG+ + + L+         +    + APE +     
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 347 TAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
           ++K DV++FG+L+ E+ S  K  +D+    E  +        YR     D +   M +  
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS-- 240
Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
                         C  E P  RPT +++   +E + E D
Sbjct: 241 --------------CWHELPEKRPTFQQLLSSIEPLREKD 266

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 155 CFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTA-VAVKKLDRVFQDGEKEFKN 213
           C      EE    +  + G+G+FG V     +    +T A VAVK+L     D +++F+ 
Sbjct: 14  CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 73
Query: 214 EVVVIGQTHHKNLVRLLG--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           E+ ++   H   +V+  G  +    Q+  LV E+L +G L  FL          R     
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---------QRHRARL 124
Query: 272 QIARGLLYLHEDC-------SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-K 323
             +R LLY  + C       S + +H D+  +NIL++   + +I+DFGLAKLL L++   
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184
Query: 324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKS 368
            ++   +    + APE    +  + + DV+SFGV+L E+ + C KS
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRC 113
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 114 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 228
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 133/293 (45%), Gaps = 33/293 (11%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K L+ +    +   G G FG V  G ++       AVA+K L   + + ++ +F  E  +
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAF 271
           +GQ  H N+V L G    G+  ++V EF+ NG L +FL      F  ++    LR     
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRG---- 153
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            IA G+ YL        +H D+  +NIL++ +   ++SDFGL++++  +  + + T   G
Sbjct: 154 -IAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYTTTGG 208
Query: 332 --TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
                + APE  +    T+  DV+S+G+++ E++S            Y     W      
Sbjct: 209 KIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS--- 253
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
           N  +   +E        + C   L  + + C Q++ + RP   ++  +L+ ++
Sbjct: 254 NQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 141/310 (45%), Gaps = 36/310 (11%)
Query: 149 VETNLRCFSYKALEEATDNFKEEA-----------GRGSFGIVYKGVIETTRTSTTAVAV 197
           V T +  F+++   +A   F +E            G G FG V  G ++        VA+
Sbjct: 3   VRTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAI 62
Query: 198 KKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF 256
           K L   + D ++ +F +E  ++GQ  H N++ L G   + +  +++ E++ NG+L +FL 
Sbjct: 63  KTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR 122
Query: 257 GNLKPSWNLR-TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
            N      ++   +   I  G+ YL  D S+  +H D+  +NIL++ +   ++SDFG+++
Sbjct: 123 KNDGRFTVIQLVGMLRGIGSGMKYL-SDMSA--VHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 316 LLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIE 372
           +L  +      T  RG K    + APE       T+  DV+S+G+++ E++S        
Sbjct: 180 VLEDDPEAAYTT--RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-------- 229
Query: 373 MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
               Y     W      N  +   +E        + C   L  + + C Q++ S RP   
Sbjct: 230 ----YGERPYWDMS---NQDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFG 282
Query: 433 KVSQMLEGVV 442
           ++  ML+ ++
Sbjct: 283 QIVNMLDKLI 292

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 38  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 97
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 98  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSF 157
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 158 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 215 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 265
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 266 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 315

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 335
           + YL    + + IH D+  +NIL+++    +I DFGL K+L  ++    +K        +
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVI--ETTRTSTTAVAVKKL-DRVFQDGEKEFKNEV 215
           K +  +   F EE G   FG VYKG +        T AVA+K L D+      +EF++E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRT--- 267
           ++  +  H N+V LLG   + Q   +++ + ++G L  FL       ++  + + RT   
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 268 --------NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLT 318
                   ++  QIA G+ YL    S  ++H D+  +N+L+ D  N +ISD GL + +  
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
            +  K +  ++   + ++APE       +   D++S+GV+L E+ S            Y 
Sbjct: 181 ADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YG 227
Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           +     +  Y N  + +++           C   +  + I C  E PS RP  + +   L
Sbjct: 228 LQP---YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 439 EG 440
Sbjct: 285 RA 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 218
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 218
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 217
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 118
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 119 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 167
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 219
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 220 IFRTLGTPDEVVWPGVTSMPDYK 242

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 114
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 163
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 215
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 99  IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 213
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 218
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 114
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 163
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 215
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 217
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 114
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 163
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 215
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 263
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 264 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG FG V+   ++ T        + K     + G +    E  ++ + H + +V L   
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAF--QIARGLLYLHEDCSSQI 288
            +   +  LV   +N G +   ++      P +     I +  QI  GL +LH+     I
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNI 310
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           I+ D+KP+N+LLDD  N RISD GLA  L   Q+KT   A  GT G++APE         
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYDF 368
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD ++ GV L E+I+ R  F
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 99  IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 213
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRC 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 100 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 214
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHE 164
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 216
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 39/302 (12%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVI--ETTRTSTTAVAVKKL-DRVFQDGEKEFKNEV 215
           K +  +   F EE G   FG VYKG +        T AVA+K L D+      +EF++E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPSWNLRT--- 267
           ++  +  H N+V LLG   + Q   +++ + ++G L  FL       ++  + + RT   
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 268 --------NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLT 318
                   ++  QIA G+ YL    S  ++H D+  +N+L+ D  N +ISD GL + +  
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
            +  K +  ++   + ++APE       +   D++S+GV+L E+ S            Y 
Sbjct: 198 ADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YG 244
Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
           +     +  Y N  + +++           C   +  + I C  E PS RP  + +   L
Sbjct: 245 LQP---YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301
Query: 439 EG 440
Sbjct: 302 RA 303

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 216
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 54  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 113
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 114 IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 228
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 31  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 90
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 91  IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 205
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 116
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 165
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 217
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 218 RTLGTPDEVVWPGVTSMPDYK 238

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 115
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 164
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 216
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYK 237

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 115
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEVV 164
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 216
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYK 237

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 115
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEVV 164
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 216
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYK 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 114
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 163
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 215
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 73  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 192
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 193 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 250 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 300
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 301 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG FG V+   ++ T        + K     + G +    E  ++ + H + +V L   
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAF--QIARGLLYLHEDCSSQI 288
            +   +  LV   +N G +   ++      P +     I +  QI  GL +LH+     I
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNI 310
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           I+ D+KP+N+LLDD  N RISD GLA  L   Q+KT   A  GT G++APE         
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYDF 368
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD ++ GV L E+I+ R  F
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 117
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHEVV 166
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 218
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 219 RTLGTPDEVVWPGVTSMPDYK 239

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 147 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 254
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 255 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG FG V+   ++ T        + K     + G +    E  ++ + H + +V L   
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAF--QIARGLLYLHEDCSSQI 288
            +   +  LV   +N G +   ++      P +     I +  QI  GL +LH+     I
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNI 310
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           I+ D+KP+N+LLDD  N RISD GLA  L   Q+KT   A  GT G++APE         
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYDF 368
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD ++ GV L E+I+ R  F
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           GRG+FG V +    G+ +T    T AV + K      +         ++I   HH N+V 
Sbjct: 27  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 86
Query: 229 LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--------------LKPSWNLRTNI--AF 271
           LLG C + G   +++ EF   G L+++L                  K    L   I  +F
Sbjct: 87  LLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 146
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   R 
Sbjct: 147 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYR 389
              ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C R
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------CRR 254
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
                 L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 255 ------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 304

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 116
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 165
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 217
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 218 RTLGTPDEVVWPGVTSMPDYK 238

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/191 (31%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GS GIV    I T + +   VAVKK+D   Q   +   NEVV++   HH N+V +   
Sbjct: 54  GEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
              G    +V EFL  G L   +         + T +   + R L YLH   +  +IH D
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYLH---NQGVIHRD 166
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           IK  +ILL      ++SDFG    ++    K  +  + GT  ++APE   +     +VD+
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDI 224
Query: 353 YSFGVLLLEII 363
           +S G++++E+I
Sbjct: 225 WSLGIMVIEMI 235

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 115
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 164
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 216
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYK 237

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 56  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 115
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 116 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 230
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG FG V+   ++ T        + K     + G +    E  ++ + H + +V L   
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYA 253
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAF--QIARGLLYLHEDCSSQI 288
            +   +  LV   +N G +   ++      P +     I +  QI  GL +LH+     I
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNI 310
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           I+ D+KP+N+LLDD  N RISD GLA  L   Q+KT   A  GT G++APE         
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA--GTPGFMAPELLLGEEYDF 368
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD ++ GV L E+I+ R  F
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 120
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 169
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 221
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 222 RTLGTPDEVVWPGVTSMPDYK 242

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 116
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 165
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 166 TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 217
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 218 RTLGTPDEVVWPGVTSMPDYK 238

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 100 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 214
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E   RG FG V+K  +     +     ++  D+  Q  + E+  EV  +    H+N+++ 
Sbjct: 30  EVKARGRFGCVWKAQLLNEYVAVKIFPIQ--DK--QSWQNEY--EVYSLPGMKHENILQF 83
Query: 230 LGFCDEGQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +G    G     +  L+  F   G+L+ FL  N+  SWN   +IA  +ARGL YLHED  
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIP 142
Query: 286 S-------QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
                    I H DIK +N+LL ++  A I+DFGLA      +S        GT+ Y+AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 339 EWYR-----KSTITAKVDVYSFGVLLLEIIS 364
           E        +     ++D+Y+ G++L E+ S
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 46  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 105
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 106 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 220
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +      +    A+   K ++ 
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WMP 254
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 57  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 116
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 117 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +      +    A+   K ++ 
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK-WMP 231
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGL 116
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 117 SFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 165
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 217
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 218 RTLGTPDEVVWPGVTSMPDYK 238

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLN----NGTLASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+    +   AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 218
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLN----NGTLASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+    +   AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 217
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 40  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 100 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK-WMP 214
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E+ G+GSFG V+KG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + +
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQK---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 89
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
             G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH   S
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 142
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            + IH DIK  N+LL +H   +++DFG+A  LT  Q K  +    GT  ++APE  ++S 
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSA 200
Query: 346 ITAKVDVYSFGVLLLEI 362
             +K D++S G+  +E+
Sbjct: 201 YDSKADIWSLGITAIEL 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTA----VAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
            K E G G+FG V+  + E    S T     VAVK L        K+F+ E  ++    H
Sbjct: 19  LKRELGEGAFGKVF--LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 76
Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------------------GNLKPSWNL 265
           +++V+  G C +G   ++V+E++ +G L  FL                   G L  S  L
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 266 RTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
             +IA QIA G++YL    S   +H D+  +N L+  +   +I DFG+++ +       +
Sbjct: 137 --HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 385
                    ++ PE       T + DV+SFGV+L EI +  K    ++     I      
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------ 245
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
           +C   G++ +             C +++  V + C Q +P  R  ++++ ++L  +
Sbjct: 246 ECITQGRVLE---------RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 173 GRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG VY+G +       S   VAVK L  V  +  E +F  E ++I + +H+N+VR 
Sbjct: 66  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 125
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--------QIARGLLYLH 281
           +G   +   R ++ E +  G L SFL    +P  +  +++A          IA G  YL 
Sbjct: 126 IGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 282 EDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAK-LLTLNQSKTIKTAIRGTKGYVA 337
           E+     IH DI  +N LL        A+I DFG+A+ +   +  +    A+   K ++ 
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-WMP 240
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE + +   T+K D +SFGVLL EI S
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 133/290 (45%), Gaps = 25/290 (8%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K ++ +    ++  G G FG V  G ++        VA+K L   + D ++ +F +E  +
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
           +GQ  H N++ L G   + +  +++ E++ NG+L +FL  N      ++   +   I  G
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK--- 333
           + YL +      +H D+  +NIL++ +   ++SDFG++++L  +      T  RG K   
Sbjct: 123 MKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT--RGGKIPI 177
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 393
            + APE       T+  DV+S+G+++ E++S            Y     W      N  +
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS---NQDV 222
Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              +E        + C   L  + + C Q++ S RP   ++  ML+ ++ 
Sbjct: 223 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 272

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 8/209 (3%)
Query: 161 LEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIG 219
            EE    F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++ 
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 220 QTHHKNLVRLLGFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
              H N+V+  G C     +N  L+ E+L  G+L  +L  + +   +++      QI +G
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGY 335
           + YL    + + IH ++  +NIL+++    +I DFGL K+L  ++    +K        +
Sbjct: 128 MEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 184
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            APE   +S  +   DV+SFGV+L E+ +
Sbjct: 185 YAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 136/299 (45%), Gaps = 36/299 (12%)
Query: 154 RCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFK 212
           R F+ + +E +  + ++  G G  G V  G +         VA+K L   + + ++ +F 
Sbjct: 40  RSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 213 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLR 266
           +E  ++GQ  H N++RL G    G+  ++V E++ NG+L +FL      F  ++    LR
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
                 +  G+ YL +      +H D+  +N+L+D +   ++SDFGL+++L  +      
Sbjct: 159 G-----VGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210
Query: 327 TAIRGTK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 383
           T   G K    + APE     T ++  DV+SFGV++ E+++            Y     W
Sbjct: 211 TT--GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------------YGERPYW 256
Query: 384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                 N  +   VE        + C   L  + + C  +D + RP   ++  +L+ ++
Sbjct: 257 NMT---NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 133/289 (46%), Gaps = 25/289 (8%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVV 217
           K ++ +    ++  G G FG V  G ++        VA+K L   + D ++ +F +E  +
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARG 276
           +GQ  H N++ L G   + +  +++ E++ NG+L +FL  N      ++   +   I  G
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK--- 333
           + YL +      +H D+  +NIL++ +   ++SDFG++++L  +      T  RG K   
Sbjct: 129 MKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT--RGGKIPI 183
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 393
            + APE       T+  DV+S+G+++ E++S            Y     W      N  +
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMS---NQDV 228
Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              +E        + C   L  + + C Q++ S RP   ++  ML+ ++
Sbjct: 229 IKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E+ G+GSFG V+KG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + +
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQK---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
             G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH   S
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 137
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            + IH DIK  N+LL +H   +++DFG+A  LT  Q K  +    GT  ++APE  ++S 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSA 195
Query: 346 ITAKVDVYSFGVLLLEI 362
             +K D++S G+  +E+
Sbjct: 196 YDSKADIWSLGITAIEL 212

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E+ G+GSFG V+KG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQK---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
             G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH   S
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 122
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            + IH DIK  N+LL +H   +++DFG+A  LT  Q K  +    GT  ++APE  ++S 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSA 180
Query: 346 ITAKVDVYSFGVLLLEI 362
             +K D++S G+  +E+
Sbjct: 181 YDSKADIWSLGITAIEL 197

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 136/299 (45%), Gaps = 36/299 (12%)
Query: 154 RCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFK 212
           R F+ + +E +  + ++  G G  G V  G +         VA+K L   + + ++ +F 
Sbjct: 40  RSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL 98
Query: 213 NEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLR 266
           +E  ++GQ  H N++RL G    G+  ++V E++ NG+L +FL      F  ++    LR
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
                 +  G+ YL +      +H D+  +N+L+D +   ++SDFGL+++L  +      
Sbjct: 159 G-----VGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210
Query: 327 TAIRGTK---GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 383
           T   G K    + APE     T ++  DV+SFGV++ E+++            Y     W
Sbjct: 211 TT--GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------------YGERPYW 256
Query: 384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
                 N  +   VE        + C   L  + + C  +D + RP   ++  +L+ ++
Sbjct: 257 NMT---NRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 116
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 117 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 165
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 217
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYK 240

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E+ G+GSFG V+KG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQK---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 69
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
             G   +     ++ E+L  G+    L    +P     T IA    +I +GL YLH   S
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 122
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            + IH DIK  N+LL +H   +++DFG+A  LT  Q K  +    GT  ++APE  ++S 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSA 180
Query: 346 ITAKVDVYSFGVLLLEI 362
             +K D++S G+  +E+
Sbjct: 181 YDSKADIWSLGITAIEL 197

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 216
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLP---LIKSYLFQLLQ 114
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 115 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 163
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 215
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYK 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 18  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             +G+  + Q   +V ++    +L   L  +  K       +IA Q ARG+ YLH   + 
Sbjct: 72  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AK 127
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---K 343
            IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  R    
Sbjct: 128 SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 187
Query: 344 STITAKVDVYSFGVLLLEIIS 364
           +  + + DVY+FG++L E+++
Sbjct: 188 NPYSFQSDVYAFGIVLYELMT 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 39/259 (15%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           +NF+  E+ G G++G+VYK   + T     A+   +LD   +        E+ ++ + +H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY 279
            N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL +
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAF 118
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
            H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V   
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVTL 167
Query: 340 WYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRN 390
           WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +R 
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIFRT 219
Query: 391 -GKLDDLVEGDMEAMNDIK 408
            G  D++V   + +M D K
Sbjct: 220 LGTPDEVVWPGVTSMPDYK 238

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 39/259 (15%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           +NF+  E+ G G++G+VYK   + T     A+   +LD   +        E+ ++ + +H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGLLY 279
            N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +GL +
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAF 117
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
            H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V   
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVVTL 166
Query: 340 WYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRN 390
           WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +R 
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIFRT 218
Query: 391 -GKLDDLVEGDMEAMNDIK 408
            G  D++V   + +M D K
Sbjct: 219 LGTPDEVVWPGVTSMPDYK 237

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 86/160 (53%), Gaps = 9/160 (5%)
Query: 210 EFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT 267
           + K E+ ++   +H+N+V+  G C E  G    L+ EFL +G+L  +L  N K   NL+ 
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQ 127
Query: 268 NI--AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLNQSKT 324
            +  A QI +G+ YL    S Q +H D+  +N+L++  +  +I DFGL K + T  +  T
Sbjct: 128 QLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           +K        + APE   +S      DV+SFGV L E+++
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 92
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 262
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 263 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 16/194 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G+GSFG VYKG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + R  G
Sbjct: 28  GKGSFGEVYKGIDNHTKE---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSSQI 288
              +     ++ E+L  G+    L    KP     T IA    +I +GL YLH   S + 
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH---SERK 137
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           IH DIK  N+LL +  + +++DFG+A  LT  Q K  +    GT  ++APE  ++S    
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAYDF 195
Query: 349 KVDVYSFGVLLLEI 362
           K D++S G+  +E+
Sbjct: 196 KADIWSLGITAIEL 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V     +    +T   VAVK L          + K E+ ++   +H+N+V+  
Sbjct: 18  GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 77
Query: 231 GFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
           G C E  G    L+ EFL +G+L  +L  N K   NL+  +  A QI +G+ YL    S 
Sbjct: 78  GICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL---GSR 133
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWYRKST 345
           Q +H D+  +N+L++  +  +I DFGL K + T  +  T+K        + APE   +S 
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 346 ITAKVDVYSFGVLLLEIIS 364
                DV+SFGV L E+++
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   RI+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 116/225 (51%), Gaps = 33/225 (14%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNL 226
           ++ G+G++GIV+K +    R +   VAVKK+   FQ   D ++ F+  +++   + H+N+
Sbjct: 15  KKLGKGAYGIVWKSI---DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI 71
Query: 227 VRLLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           V LL     D  ++  LV++++     A      L+P    +  + +Q+ + + YLH   
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH--KQYVVYQLIKVIKYLH--- 126
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAK------------LLTLNQS-------KTI 325
           S  ++H D+KP NILL+   + +++DFGL++             L++N++       + I
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 326 KTAIRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSF 369
            T    T+ Y APE    ST  T  +D++S G +L EI+  +  F
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 218
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+EFL+        AS L G   P   L  +  FQ+ +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQ 115
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KP+N+L++     +++DFGLA        +     +R     
Sbjct: 116 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 164
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 216
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYK 239

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   ++   +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 50/299 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 133
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 303
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V +
Sbjct: 304 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 92
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 262
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 263 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 29  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 84
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 254
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 255 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 30  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 85
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 255
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 256 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 26  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 81
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 251
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 252 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 92
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----SWNLRTNI--------- 269
           HKN++ LLG C +     ++ E+ + G L  +L     P    S+N   N          
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 262
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 263 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V +G ++    ++  VAVK  KLD   Q   +EF +E   +    H N++RLL
Sbjct: 43  GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 231 GFCDEGQNR-----LLVYEFLNNGTLASF-LFGNLKPSWN---LRTNIAFQ--IARGLLY 279
           G C E  ++     +++  F+  G L ++ L+  L+       L+T + F   IA G+ Y
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL----TLNQSKTIKTAIRGTKGY 335
           L    +   +H D+  +N +L D     ++DFGL+K +       Q +  K  ++    +
Sbjct: 163 L---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----W 215
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
           +A E       T+K DV++FGV + EI +  +      G +   + D+    +R  + +D
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYDYLLHGHRLKQPED 273
Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                        C+++L  +   C + DP  RPT   +   LE ++E
Sbjct: 274 -------------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 17/224 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           EE G G+FG+V++ V    + +      K ++  +   +   KNE+ ++ Q HH  L+ L
Sbjct: 57  EELGSGAFGVVHRCV---EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
               ++    +L+ EFL+ G L   +   + K S     N   Q   GL ++HE     I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 289 IHCDIKPQNILLDDH--YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +H DIKP+NI+ +     + +I DFGLA  L  ++   + TA   T  + APE   +  +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEFAAPEIVDREPV 227
Query: 347 TAKVDVYSFGVLLLEIISCRKSF----DIEMGEEYAILTDWAFD 386
               D+++ GVL   ++S    F    D+E  +      DW FD
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-RCDWEFD 270

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 30  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             +G+  + Q   +V ++    +L   L  +  K       +IA Q ARG+ YLH   + 
Sbjct: 84  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AK 139
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---K 343
            IIH D+K  NI L +    +I DFGLA   +          + G+  ++APE  R    
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 344 STITAKVDVYSFGVLLLEIIS 364
           +  + + DVY+FG++L E+++
Sbjct: 200 NPYSFQSDVYAFGIVLYELMT 220

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 IHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 113/241 (46%), Gaps = 18/241 (7%)
Query: 146 DGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ 205
           +G  E++L  + Y+  E      +   G+G++GIVY G      ++   +A+K++     
Sbjct: 7   EGDCESDLLEYDYEYDENGD---RVVLGKGTYGIVYAG---RDLSNQVRIAIKEIPERDS 60
Query: 206 DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNL 265
              +    E+ +     HKN+V+ LG   E     +  E +  G+L++ L     P  + 
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 266 RTNIAF---QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQ 321
              I F   QI  GL YLH++   QI+H DIK  N+L++ +    +ISDFG +K L    
Sbjct: 121 EQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 322 SKTIKTAIRGTKGYVAPEWYRKST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 379
             T      GT  Y+APE   K         D++S G  ++E+ + +  F  E+GE  A 
Sbjct: 178 PCT--ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGEPQAA 234
Query: 380 L 380
           +
Sbjct: 235 M 235

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G++GIVY G      ++   +A+K++        +    E+ +     HKN+V+ LG 
Sbjct: 17  GKGTYGIVYAG---RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSSQII 289
             E     +  E +  G+L++ L     P  +    I F   QI  GL YLH++   QI+
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 130
Query: 290 HCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST--I 346
           H DIK  N+L++ +    +ISDFG +K L      T      GT  Y+APE   K     
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGY 188
Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
               D++S G  ++E+ + +  F  E+GE  A +
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 142 NSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--K 199
            S G+G +++ L C     + E      E+ G GSFG+V +G  +     T +VAVK  K
Sbjct: 1   GSAGEGPLQS-LTCL----IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK 55
Query: 200 LDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL------- 251
            D + Q +   +F  EV  +    H+NL+RL G       ++ V E    G+L       
Sbjct: 56  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH 114
Query: 252 -ASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD 310
              FL G L       +  A Q+A G+ YL    S + IH D+  +N+LL      +I D
Sbjct: 115 QGHFLLGTL-------SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 311 FGLAKLLTLNQSKTIKTAIRGTK-GYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           FGL + L  N    +    R     + APE  +  T +   D + FGV L E+ +
Sbjct: 165 FGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 30  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             +G+    Q   +V ++    +L   L  +  K       +IA Q ARG+ YLH   + 
Sbjct: 84  LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AK 139
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---K 343
            IIH D+K  NI L +    +I DFGLA   +          + G+  ++APE  R    
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 344 STITAKVDVYSFGVLLLEIIS 364
           +  + + DVY+FG++L E+++
Sbjct: 200 NPYSFQSDVYAFGIVLYELMT 220

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 125/295 (42%), Gaps = 46/295 (15%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+   +N     K    
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYKNTTN 218
Query: 331 G--TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDC 387
           G     ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F  
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKL 271
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            + G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 272 LKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 104 ITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T R+S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 23  DNFIK-IGEGSTGIV---CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +  + + +      +   + + L  LH   +
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH---A 134
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE   +  
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLP 192
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
              +VD++S G++++E++     +
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 165 TDNF--KEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLD-RVFQDGEKEFKNEVVVIG 219
           +DN+  KEE G+G+F +V + V +TT     A  +  KKL  R FQ  E+E +    +  
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICR 59
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
           +  H N+VRL     E     LV++ +  G L   +      S    ++   QI   + Y
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
            H   S+ I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY+
Sbjct: 120 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYL 173
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFD 386
           +PE  +K   +  VD+++ GV+L  ++     F D +    YA +   A+D
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 224

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 43/263 (16%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIG 219
           + +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIAR 275
           + +H N+V+LL          LV+E ++        AS L G   P   L  +  FQ+ +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLP---LIKSYLFQLLQ 117
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYXHE 166
Query: 336 VAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFD 386
           V   WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F 
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFR 218
Query: 387 CYRN-GKLDDLVEGDMEAMNDIK 408
            +R  G  D++V   + +M D K
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYK 241

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T R+S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 34  DNFIK-IGEGSTGIV---CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +         +   +   + + L  LH   +
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLH---A 145
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE   +  
Sbjct: 146 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLP 203
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
              +VD++S G++++E++     +
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD++S G++ +E+I     +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 117/240 (48%), Gaps = 19/240 (7%)
Query: 156 FSYKALEEATDNF--KEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLD-RVFQDGEKE 210
           F   A  + +DN+  KEE G+G+F +V + V +TT     A  +  KKL  R FQ  E+E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 211 FKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 270
            +    +  +  H N+VRL     E     LV++ +  G L   +      S    ++  
Sbjct: 79  AR----ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI 134
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKT 327
            QI   + Y H   S+ I+H ++KP+N+LL         +++DFGLA  + +N S+    
Sbjct: 135 QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH- 188
Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFD 386
              GT GY++PE  +K   +  VD+++ GV+L  ++     F D +    YA +   A+D
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T R+S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 27  DNFIK-IGEGSTGIV---CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +  + + +      +   + + L  LH   +
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLH---A 138
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE   +  
Sbjct: 139 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLP 196
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
              +VD++S G++++E++     +
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 50/299 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 37  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 92
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------LKPSWNLRTNI----- 269
           HKN++ LLG C +     ++ E+ + G L  +L             PS N    +     
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 262
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V +
Sbjct: 263 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 165 TDNF--KEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLD-RVFQDGEKEFKNEVVVIG 219
           +DN+  KEE G+G+F +V + V +TT     A  +  KKL  R FQ  E+E +    +  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICR 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
           +  H N+VRL     E     LV++ +  G L   +      S    ++   QI   + Y
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
            H   S+ I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYL 174
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFD 386
           +PE  +K   +  VD+++ GV+L  ++     F D +    YA +   A+D
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 121/261 (46%), Gaps = 43/261 (16%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK      + +   VA+KK  LD   +        E+ ++ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTL----ASFLFGNLKPSWNLRTNIAFQIARGL 277
           +H N+V+LL          LV+E ++        AS L G   P   L  +  FQ+ +GL
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGL 115
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            + H   S +++H D+KPQN+L++     +++DFGLA        +     +R     V 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA--------RAFGVPVRTYTHEVV 164
Query: 338 PEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCY 388
             WYR   I       +  VD++S G +  E+++ R  F  D E+        D  F  +
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIF 216
Query: 389 RN-GKLDDLVEGDMEAMNDIK 408
           R  G  D++V   + +M D K
Sbjct: 217 RTLGTPDEVVWPGVTSMPDYK 237

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 19  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 73  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 126
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 114/231 (49%), Gaps = 19/231 (8%)
Query: 165 TDNF--KEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLD-RVFQDGEKEFKNEVVVIG 219
           +DN+  KEE G+G+F +V + V +TT     A  +  KKL  R FQ  E+E +    +  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR----ICR 60
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
           +  H N+VRL     E     LV++ +  G L   +      S    ++   QI   + Y
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
            H   S+ I+H ++KP+N+LL         +++DFGLA  + +N S+       GT GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH-GFAGTPGYL 174
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFD 386
           +PE  +K   +  VD+++ GV+L  ++     F D +    YA +   A+D
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T R+S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 32  DNFIK-IGEGSTGIV---CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +         +   +   + + L  LH   +
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLH---A 143
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE   +  
Sbjct: 144 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLP 201
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
              +VD++S G++++E++     +
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 14  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 68  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 121
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 43  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 156
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 157 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 262
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 263 -ISRLL-------KHNPSQRPMLREV 280

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 142 NSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--K 199
            S G+G +++ L C     + E      E+ G GSFG+V +G  +     T +VAVK  K
Sbjct: 1   GSAGEGPLQS-LTCL----IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK 55
Query: 200 LDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL------- 251
            D + Q +   +F  EV  +    H+NL+RL G       ++ V E    G+L       
Sbjct: 56  PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH 114
Query: 252 -ASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD 310
              FL G L       +  A Q+A G+ YL    S + IH D+  +N+LL      +I D
Sbjct: 115 QGHFLLGTL-------SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 311 FGLAKLLTLNQSKTIKTAIRGTK-GYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           FGL + L  N    +    R     + APE  +  T +   D + FGV L E+ +
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + + A+ GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 189
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 239
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 240 -ISRLL-------KHNPSQRPMLREV 257

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 158 YKALEEATD--NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNE 214
           +K  E+  D  +F++  G G+F  V   ++   + +   VA+K + +   +G E   +NE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           + V+ +  H N+V L    + G +  L+ + ++ G L   +      +    + + FQ+ 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
             + YLH+     I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACG 180
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVL 358
           T GYVAPE   +   +  VD +S GV+
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 19  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 73  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 126
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 127/297 (42%), Gaps = 50/297 (16%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------VIGQTH 222
           G G+FG V      G+ +      T VAVK L       EK+  + +       +IG+  
Sbjct: 22  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK-- 77
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------LKPSWNLRTNI----- 269
           HKN++ LLG C +     ++ E+ + G L  +L             PS N    +     
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 270 ---AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +         
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAF 385
           T  R    ++APE       T + DV+SFGVLL EI +         G  Y  +  +  F
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-------GSPYPGVPVEELF 247
Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V
Sbjct: 248 KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 83
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 139
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD++S G++ +E+I     +
Sbjct: 198 VDIWSLGIMAIEMIEGEPPY 217

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD++S G++ +E+I     +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY 216

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 16  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 70  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 123
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 124 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELMT 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD++S G++ +E+I     +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T R+S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 77  DNFIK-IGEGSTGIV---CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +         +   +   + + L  LH   +
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLH---A 188
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE   +  
Sbjct: 189 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLP 246
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
              +VD++S G++++E++     +
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 34  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 91  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 147
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 148 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 204 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 253
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 254 -ISRLL-------KHNPSQRPMLREV 271

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 41  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 95  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 148
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 149 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 22  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 241
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 242 -ISRLL-------KHNPSQRPMLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 239
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 240 -ISRLL-------KHNPSQRPMLREV 257

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 22  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEK 191
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 241
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 242 -ISRLL-------KHNPSQRPXLREV 259

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 42  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 96  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 149
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 26/219 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 228
           E   RG FG V+K      +     VAVK      QD +  + + E+       H+NL++
Sbjct: 21  EIKARGRFGCVWKA-----QLMNDFVAVKIFP--LQDKQSWQSEREIFSTPGMKHENLLQ 73
Query: 229 LLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED- 283
            +     G N      L+  F + G+L  +L GN+  +WN   ++A  ++RGL YLHED 
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNII-TWNELCHVAETMSRGLSYLHEDV 132
Query: 284 --CSSQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
             C  +     I H D K +N+LL     A ++DFGLA      +         GT+ Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 337 APEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFD 370
           APE        +     ++D+Y+ G++L E++S  K+ D
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 158 YKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEV 215
           Y  +E +        G GSFG VYKG           VAVK L  V    E+   F+NEV
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHGD------VAVKILKVVDPTPEQFQAFRNEV 83
Query: 216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIA 274
            V+ +T H N++  +G+  +  N  +V ++    +L   L     K       +IA Q A
Sbjct: 84  AVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTA 142
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           +G+ YLH   +  IIH D+K  NI L +    +I DFGLA + +            G+  
Sbjct: 143 QGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 335 YVAPEWYR---KSTITAKVDVYSFGVLLLEIIS 364
           ++APE  R    +  + + DVYS+G++L E+++
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT 232

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 18  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 131
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     + +   + +T + GT  Y+ PE         K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEK 187
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 237
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 238 -ISRLL-------KHNPSQRPMLREV 255

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 17/222 (7%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK-NEVVVIGQ 220
           ++  FK  E+ G G++  VYKG+    +T+   VA+K++    ++G       E+ ++ +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGL---NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGT---LASFLFGNLKP--SWNLRTNIAFQIAR 275
             H+N+VRL           LV+EF++N     + S   GN       NL     +Q+ +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL + HE+   +I+H D+KPQN+L++     ++ DFGLA+   +  +      +  T  Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWY 174
Query: 336 VAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
            AP+    S T +  +D++S G +L E+I+ +  F     EE
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 33  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 92
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 93  INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 152
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 153 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 210 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 262
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 263 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 14  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+    Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 68  LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 121
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 36  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 95
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 96  INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 155
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 156 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 213 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 265
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 266 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 10/217 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRLL 230
           G+GSFG V+    + T       A+KK D V  D + E     + V+     H  L  + 
Sbjct: 27  GKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
                 +N   V E+LN G L   +    K   +  T  A +I  GL +LH   S  I++
Sbjct: 86  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVY 142
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  NILLD   + +I+DFG+ K   L  +KT      GT  Y+APE          V
Sbjct: 143 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NEFCGTPDYIAPEILLGQKYNHSV 200
Query: 351 DVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAF 385
           D +SFGVLL E++  +  F  +  EE  ++I  D  F
Sbjct: 201 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 237

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 21  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 134
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 135 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 240
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 241 -ISRLL-------KHNPSQRPMLREV 258

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQ-DGEKEFKNEVVVIGQTHHKNL 226
           E+ G GSFG+V +G  +     T +VAVK  K D + Q +   +F  EV  +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 337
           YL    S + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE  +  T +   D + FGV L E+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 31  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 90
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 91  INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 150
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 151 YQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 208 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 260
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 261 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           DNF +  G GS GIV    I T R+S   VAVKK+D   Q   +   NEVV++    H+N
Sbjct: 154 DNFIK-IGEGSTGIV---CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V +      G    +V EFL  G L   +         +   +   + + L  LH   +
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-AAVCLAVLQALSVLH---A 265
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++    +  +  + GT  ++APE   +  
Sbjct: 266 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLP 323
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
              +VD++S G++++E++     +
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 89
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 145
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 89
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 145
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 158 YKALEEATD--NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNE 214
           +K  E+  D  +F++  G G+F  V   ++   + +   VA+K + +   +G E   +NE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           + V+ +  H N+V L    + G +  L+ + ++ G L   +      +    + + FQ+ 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
             + YLH+     I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACG 180
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVL 358
           T GYVAPE   +   +  VD +S GV+
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 100/217 (46%), Gaps = 10/217 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVRLL 230
           G+GSFG V+    + T       A+KK D V  D + E     + V+     H  L  + 
Sbjct: 26  GKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
                 +N   V E+LN G L   +    K   +  T  A +I  GL +LH   S  I++
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVY 141
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+K  NILLD   + +I+DFG+ K   L  +KT      GT  Y+APE          V
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NXFCGTPDYIAPEILLGQKYNHSV 199
Query: 351 DVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAF 385
           D +SFGVLL E++  +  F  +  EE  ++I  D  F
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 236

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 73
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 129
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 158 YKALEEATD--NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNE 214
           +K  E+  D  +F++  G G+F  V   ++   + +   VA+K + +   +G E   +NE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           + V+ +  H N+V L    + G +  L+ + ++ G L   +      +    + + FQ+ 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
             + YLH+     I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACG 180
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVL 358
           T GYVAPE   +   +  VD +S GV+
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 16  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 73  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 129
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 130 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 235
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 236 -ISRLL-------KHNPSQRPMLREV 253

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 33/278 (11%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             +++ G G FG V+      T    T VAVK +       E  F  E  V+    H  L
Sbjct: 18  KLEKKLGAGQFGEVWMA----TYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKL 72
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ ++ +  
Sbjct: 73  VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-- 129
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWY 341
               IH D++  NIL+      +I+DFGLA+++  N+     TA  G K    + APE  
Sbjct: 130 -RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAI 184
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 401
              + T K DV+SFG+LL+EI++  +                 +    N ++   +E   
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRALERGY 229
Query: 402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  C E+L  + + C +  P  RPT   +  +L+
Sbjct: 230 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 158 YKALEEATD--NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNE 214
           +K  E+  D  +F++  G G+F  V   ++   + +   VA+K + +   +G E   +NE
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           + V+ +  H N+V L    + G +  L+ + ++ G L   +      +    + + FQ+ 
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 126
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNIL---LDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
             + YLH+     I+H D+KP+N+L   LD+     ISDFGL+K+       ++ +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACG 180
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVL 358
           T GYVAPE   +   +  VD +S GV+
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + + A+ GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F        D + EG  + ++ + 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-----PDFVTEGARDLISRL- 243
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
                       ++ +PS RP +R+V
Sbjct: 244 ------------LKHNPSQRPMLREV 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 22  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 79  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 191
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 241
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 242 -ISRLL-------KHNPSQRPMLREV 259

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 22  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   G +   L    K           ++A  L Y H   S ++I
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH---SKRVI 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 241
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 242 -ISRLL-------KHNPSQRPMLREV 259

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLG 231
           G+G FG VY    E  R    A+ V    ++ + G E + + EV +     H N++RL G
Sbjct: 14  GKGKFGNVYLAR-EKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC 291
           +  +     L+ E+   GT+   L    K           ++A  L Y H   S ++IH 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHR 129
Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVD 351
           DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         KVD
Sbjct: 130 DIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 185
Query: 352 VYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 410
           ++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+  +
Sbjct: 186 LWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL--I 234
Query: 411 EKLLMVSIWCIQEDPSLRPTMRKV 434
            +LL       + +PS RP +R+V
Sbjct: 235 SRLL-------KHNPSQRPMLREV 251

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G V+K      +     VA+K++ RV Q GE+        EV V+       H
Sbjct: 18  EIGEGAYGKVFKA--RDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RG
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH   S +++H D+KPQNIL+      +++DFGLA++ +   +    T++  T  Y 
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYR 186
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +S+    VD++S G +  E+   +  F
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 87
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 143
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 30/265 (11%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKKVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + + A+ GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
           VD++S GVL  E +  +  F+    +          D Y+     +    D         
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQ----------DTYKRISRVEFTFPDFVTEGARDL 236
Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKV 434
           + +LL       + +PS RP +R+V
Sbjct: 237 ISRLL-------KHNPSQRPMLREV 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 18  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 131
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 237
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 238 -ISRLL-------KHNPSQRPMLREV 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G V+K      +     VA+K++ RV Q GE+        EV V+       H
Sbjct: 18  EIGEGAYGKVFKA--RDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RG
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH   S +++H D+KPQNIL+      +++DFGLA++ +   +    T++  T  Y 
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYR 186
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +S+    VD++S G +  E+   +  F
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQ-DGEKEFKNEVVVIGQTHHKNL 226
           E+ G GSFG+V +G  +     T +VAVK  K D + Q +   +F  EV  +    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 337
           YL    S + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE  +  T +   D + FGV L E+ +
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G V+K      +     VA+K++ RV Q GE+        EV V+       H
Sbjct: 18  EIGEGAYGKVFKA--RDLKNGGRFVALKRV-RV-QTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL   C     D      LV+E ++   L ++L    +P     T  ++ FQ+ RG
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH   S +++H D+KPQNIL+      +++DFGLA++ +   +    T++  T  Y 
Sbjct: 133 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYR 186
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +S+    VD++S G +  E+   +  F
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQ-DGEKEFKNEVVVIGQTHHKNL 226
           E+ G GSFG+V +G  +     T +VAVK  K D + Q +   +F  EV  +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 337
           YL    S + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE  +  T +   D + FGV L E+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQ-DGEKEFKNEVVVIGQTHHKNL 226
           E+ G GSFG+V +G  +     T +VAVK  K D + Q +   +F  EV  +    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 129
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 337
           YL    S + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE  +  T +   D + FGV L E+ +
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 33/278 (11%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             +++ G G FG V+      T    T VAVK +       E  F  E  V+    H  L
Sbjct: 191 KLEKKLGAGQFGEVWMA----TYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKL 245
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ ++ +  
Sbjct: 246 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-- 302
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWY 341
               IH D++  NIL+      +I+DFGLA+++  N+     TA  G K    + APE  
Sbjct: 303 -RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAI 357
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 401
              + T K DV+SFG+LL+EI++  +                 +    N ++   +E   
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRALERGY 402
Query: 402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  C E+L  + + C +  P  RPT   +  +L+
Sbjct: 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQ-DGEKEFKNEVVVIGQTHHKNL 226
           E+ G GSFG+V +G  +     T +VAVK  K D + Q +   +F  EV  +    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL--------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
           +RL G       ++ V E    G+L          FL G L       +  A Q+A G+ 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTL-------SRYAVQVAEGMG 125
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK-GYVA 337
           YL    S + IH D+  +N+LL      +I DFGL + L  N    +    R     + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS 364
           PE  +  T +   D + FGV L E+ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 73
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 129
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 67
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 123
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 69
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 39/295 (13%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           +F +  G G+FG V +    G+I++    T AV + K      + E       V+    +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLA--------SFLFGNLKPS----------WN 264
           H N+V LLG C  G   L++ E+   G L         SF+     P+            
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
              + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+ L E+ S   S    M  +        
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------- 277
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  K   +++     ++      ++  +   C   DP  RPT +++ Q++E
Sbjct: 278 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 79
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 135
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G FG V+ G       ++T VAVK L +      + F  E  ++    H  LVRL   
Sbjct: 22  GAGQFGEVWMGYY----NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQIIH 290
               +   ++ E++  G+L  FL  +      L   I F  QIA G+ Y+        IH
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 133
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  N+L+ +    +I+DFGLA+++  N+     TA  G K    + APE       T
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGCFT 189
Query: 348 AKVDVYSFGVLLLEIISCRK 367
            K DV+SFG+LL EI++  K
Sbjct: 190 IKSDVWSFGILLYEIVTYGK 209

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 39/295 (13%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           +F +  G G+FG V +    G+I++    T AV + K      + E       V+    +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLA--------SFLFGNLKPS----------WN 264
           H N+V LLG C  G   L++ E+   G L         SF+     P+            
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
              + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+ L E+ S   S    M  +        
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------- 254
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  K   +++     ++      ++  +   C   DP  RPT +++ Q++E
Sbjct: 255 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 19  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 78
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 79  VITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 191 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 235
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 236 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++  + + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 22  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   G +   L    K           ++A  L Y H   S ++I
Sbjct: 79  YGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCH---SKRVI 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 136 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEK 191
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 241
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 242 -ISRLL-------KHNPSQRPMLREV 259

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++ E+ + G L  +L     P      +I                 
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 210 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 319
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 320 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 14  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 68  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 121
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA   +          + G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMT 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G FG V+ G       ++T VAVK L +      + F  E  ++    H  LVRL   
Sbjct: 21  GAGQFGEVWMGYY----NNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQIIH 290
             + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ Y+        IH
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 132
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWYRKSTIT 347
            D++  N+L+ +    +I+DFGLA+++  N+     TA  G K    + APE       T
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGCFT 188
Query: 348 AKVDVYSFGVLLLEIISCRK 367
            K +V+SFG+LL EI++  K
Sbjct: 189 IKSNVWSFGILLYEIVTYGK 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 34  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 88  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 141
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA   +          + G+  ++APE  
Sbjct: 142 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 19  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 78
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 79  VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 191 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 235
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 236 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 83
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +         +   +  +  + L +LH   S+Q+I
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 139
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H +IK  NILL    + +++DFG    +T  QSK  ++ + GT  ++APE   +     K
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD++S G++ +E+I     +
Sbjct: 198 VDIWSLGIMAIEMIEGEPPY 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 39/295 (13%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           +F +  G G+FG V +    G+I++    T AV + K      + E       V+    +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLA--------SFLFGNLKPS----------WN 264
           H N+V LLG C  G   L++ E+   G L         SF+     P+            
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
              + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+ L E+ S   S    M  +        
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------- 277
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  K   +++     ++      ++  +   C   DP  RPT +++ Q++E
Sbjct: 278 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 22  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 81
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 82  VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 194 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 239 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 274

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIGQTHHKNLV 227
            G GS+G+V K      + +   VA+KK   +  D +K  K     E+ ++ Q  H+NLV
Sbjct: 33  VGEGSYGMVMKC---RNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASF-LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
            LL  C + +   LV+EF+++  L    LF N    + +     FQI  G+ + H   S 
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SH 143
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            IIH DIKP+NIL+      ++ DFG A+  TL     +      T+ Y APE       
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 347 TAK-VDVYSFGVLLLEIISCRKSF--DIEMGEEYAIL 380
             K VDV++ G L+ E+      F  D ++ + Y I+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK--EFKNEVVVIGQTHHKNLV 227
           +  G GSFG VYKG           VAVK L+      ++   FKNEV V+ +T H N++
Sbjct: 42  QRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPSWNLRTNIAFQIARGLLYLH 281
             +G+  + Q   +V ++    +L   L      F  +K       +IA Q A+G+ YLH
Sbjct: 96  LFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLH 149
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              +  IIH D+K  NI L +    +I DFGLA   +          + G+  ++APE  
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206
Query: 342 R---KSTITAKVDVYSFGVLLLEIIS 364
           R   K+  + + DVY+FG++L E+++
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V    +  T        ++K     + GE    NE  ++ + + + +V L  +
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AY 251
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------S 285
             E ++ L +   L NG       G+LK          F  AR + Y  E C        
Sbjct: 252 AYETKDALCLVLTLMNG-------GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +I++ D+KP+NILLDDH + RISD GLA  + + + +TIK  + GT GY+APE  +   
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNER 361
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
            T   D ++ G LL E+I+ +  F
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 47  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 106
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 107 VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 219 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 263
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 264 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 299

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEFKN-EVVVIGQTHHKNLVRL 229
           G GSFG V+   +  +R +    A+K L +  V +  + E  N E +++    H  ++R+
Sbjct: 15  GTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G   + Q   ++ +++  G L S L  + +    +    A ++   L YLH   S  II
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDII 128
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+NILLD + + +I+DFG AK +       +   + GT  Y+APE          
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPEVVSTKPYNKS 183
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           +D +SFG+L+ E+++    F
Sbjct: 184 IDWWSFGILIYEMLAGYTPF 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 39/295 (13%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           +F +  G G+FG V +    G+I++    T AV + K      + E       V+    +
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLA--------SFLFGNLKPS----------WN 264
           H N+V LLG C  G   L++ E+   G L         SF+     P+            
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
              + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  
Sbjct: 164 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+ L E+ S   S    M  +        
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------- 272
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  K   +++     ++      ++  +   C   DP  RPT +++ Q++E
Sbjct: 273 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 24  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 84  VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG--TKGYVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 196 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 240
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V    +  T        ++K     + GE    NE  ++ + + + +V L  +
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AY 251
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------S 285
             E ++ L +   L NG       G+LK          F  AR + Y  E C        
Sbjct: 252 AYETKDALCLVLTLMNG-------GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +I++ D+KP+NILLDDH + RISD GLA  + + + +TIK  + GT GY+APE  +   
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNER 361
Query: 346 ITAKVDVYSFGVLLLEIISCRKSF 369
            T   D ++ G LL E+I+ +  F
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 132
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 133 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 188
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 238
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 239 -ISRLL-------KHNPSQRPMLREV 256

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 19  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 76  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 132
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I++FG     +++   + +T + GT  Y+ PE         K
Sbjct: 133 HRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 188
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 238
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 239 -ISRLL-------KHNPSQRPMLREV 256

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 19  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 78
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 79  VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 191 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 235
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 236 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 21  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 80
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 81  VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 193 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 237
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 238 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 273

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 16  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 75
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 76  VITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 188 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 173 GRGSFGIVYK----GVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQT-HHKNL 226
           G G+FG V      G+ +        VAVK L D   +    +  +E+ ++     HKN+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI----------------A 270
           + LLG C +     ++  + + G L  +L     P      +I                 
Sbjct: 104 INLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +         T  R
Sbjct: 164 YQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY-AILTDWAFDCYR 389
               ++APE       T + DV+SFGVL+ EI +         G  Y  I  +  F   +
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG-------GSPYPGIPVEELFKLLK 273
Query: 390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
            G   D             C  +L M+   C    PS RPT +++ + L+ ++
Sbjct: 274 EGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 39/295 (13%)
Query: 167 NFKEEAGRGSFGIVYK----GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           +F +  G G+FG V +    G+I++    T AV + K      + E       V+    +
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLA--------SFLFGNLKPS----------WN 264
           H N+V LLG C  G   L++ E+   G L         SF+     P+            
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
              + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  
Sbjct: 162 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA 384
           +K   R    ++APE       T + DV+S+G+ L E+ S   S    M  +        
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------- 270
Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  K   +++     ++      ++  +   C   DP  RPT +++ Q++E
Sbjct: 271 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 431
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 432 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 487
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 548 KFSSKSDVWSFGVLMWEAFS 567

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I++FG     +++   + +T + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F        D + EG  + ++ + 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF-----PDFVTEGARDLISRL- 243
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
                       ++ +PS RP +R+V
Sbjct: 244 ------------LKHNPSQRPMLREV 257

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 18  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 131
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 187
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 237
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 238 -ISRLL-------KHNPSQRPMLREV 255

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAV----KKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           +E G G+FG V KG  +  +   T        +  D   +D   E   E  V+ Q  +  
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEANVMQQLDNPY 432
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +VR++G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   
Sbjct: 433 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE--- 488
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKS 344
           S  +H D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE     
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 345 TITAKVDVYSFGVLLLEIIS 364
             ++K DV+SFGVL+ E  S
Sbjct: 549 KFSSKSDVWSFGVLMWEAFS 568

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 17  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 74  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 131 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 236
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 237 -ISRLL-------KHNPSQRPMLREV 254

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 459 VITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWYRKSTIT 347
           H DI  +N+L+  +   ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 571 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 615
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   R S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 21  GKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    +           ++A  L Y H   S ++I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH---SKRVI 134
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL  +   +I+DFG     +++   + +T + GT  Y+ PE         K
Sbjct: 135 HRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE 376
           VD++S GVL  E +     F+    +E
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 43  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 100 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 156
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 157 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEK 212
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 262
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 263 -ISRLL-------KHNPSQRPMLREV 280

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 239
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 240 -ISRLL-------KHNPSQRPMLREV 257

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 18/195 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V  G     R +  AV   K D   Q     F  E  V+ Q  H NLV+LLG 
Sbjct: 21  GKGEFGDVMLG---DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 73
Query: 233 CDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             E +  L +V E++  G+L  +L   G      +     +  +   + YL     +  +
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 130
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++    + APE  R++  + K
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVK----WTAPEALREAAFSTK 185
Query: 350 VDVYSFGVLLLEIIS 364
            DV+SFG+LL EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 19  GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 78
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 79  VITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG--YVAPEWYRKSTIT 347
           H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 191 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 235
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 236 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 271

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 118/266 (44%), Gaps = 32/266 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 20  GKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    K           ++A  L Y H   S ++I
Sbjct: 77  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVI 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 134 HRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEK 189
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           VD++S GVL  E +  +  F+    +E Y  ++   F         D V    E   D+ 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------FPDFV---TEGARDL- 239
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + +LL       + +PS RP +R+V
Sbjct: 240 -ISRLL-------KHNPSQRPMLREV 257

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 27/268 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 27  TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 81
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S Q +H D+  +N L++D    ++SDFGL++ + L+  +T     +    +  PE    S
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +   
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 241
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                 EK+  +   C  E    RPT +
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFK 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GS GIV    +   + S   VAVK +D   Q   +   NEVV++    H N+V +   
Sbjct: 54  GEGSTGIV---CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
              G+   ++ EFL  G L   +   ++ +      +   + + L YLH   +  +IH D
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRD 166
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           IK  +ILL      ++SDFG    ++ +  K  +  + GT  ++APE   +S    +VD+
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDI 224
Query: 353 YSFGVLLLEII 363
           +S G++++E++
Sbjct: 225 WSLGIMVIEMV 235

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 120/271 (44%), Gaps = 33/271 (12%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 12  TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 66
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 67  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---GYVAPEWY 341
           S Q +H D+  +N L++D    ++SDFGL++ +  ++     T+ RG+K    +  PE  
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----TSSRGSKFPVRWSPPEVL 178
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 401
             S  ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGL 223
Query: 402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                    EK+  +   C  E    RPT +
Sbjct: 224 RLYRPHLASEKVYTIMYSCWHEKADERPTFK 254

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V  G     R +  AV   K D   Q     F  E  V+ Q  H NLV+LLG 
Sbjct: 30  GKGEFGDVMLG---DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 82
Query: 233 CDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             E +  L +V E++  G+L  +L   G      +     +  +   + YL     +  +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++    + APE  R+   + K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVK----WTAPEALREKKFSTK 194
Query: 350 VDVYSFGVLLLEIIS 364
            DV+SFG+LL EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V  G     R +  AV   K D   Q     F  E  V+ Q  H NLV+LLG 
Sbjct: 202 GKGEFGDVMLG---DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 254
Query: 233 CDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             E +  L +V E++  G+L  +L   G      +     +  +   + YL     +  +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R+   + K
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFSTK 366
Query: 350 VDVYSFGVLLLEIIS 364
            DV+SFG+LL EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 28/276 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++V+L+G
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSSQII 289
              E     ++ E    G L SFL    K S +L + I  A+Q++  L YL    S + +
Sbjct: 459 VITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK--GYVAPEWYRKSTIT 347
           H DI  +N+L+      ++ DFGL++ +   +  T   A +G     ++APE       T
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           +  DV+ FGV + EI+               +     F   +N  +   +E         
Sbjct: 571 SASDVWMFGVCMWEIL---------------MHGVKPFQGVKNNDVIGRIENGERLPMPP 615
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
            C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 24/266 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K L +       KE  +E  V+       + RLL
Sbjct: 26  GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDCSSQI 288
           G C     +L V + +  G L   +  N     S +L  N   QIA+G+ YL +    ++
Sbjct: 86  GICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDL-LNWCMQIAKGMSYLED---VRL 140
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           +H D+  +N+L+    + +I+DFGLA+LL +++++      +    ++A E   +   T 
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTH 200
Query: 349 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
           + DV+S+GV + E+++                    +D     ++ DL+E          
Sbjct: 201 QSDVWSYGVTVWELMTFGAK---------------PYDGIPAREIPDLLEKGERLPQPPI 245
Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKV 434
           C   + M+ + C   D   RP  R++
Sbjct: 246 CTIDVYMIMVKCWMIDSECRPRFREL 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G FG V  G     R +  AV   K D   Q     F  E  V+ Q  H NLV+LLG 
Sbjct: 15  GKGEFGDVMLG---DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 67
Query: 233 CDEGQNRL-LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             E +  L +V E++  G+L  +L   G      +     +  +   + YL     +  +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 124
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+ +   A++SDFGL K  +  Q  T K  ++ T    APE  R+   + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKFSTK 179
Query: 350 VDVYSFGVLLLEIIS 364
            DV+SFG+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 8/201 (3%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GSFG V      TT        + K      D +   + E+  +    H ++++L   
Sbjct: 17  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 76
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
                  ++V E+  N  L  ++    K S         QI   + Y H     +I+H D
Sbjct: 77  IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRD 132
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTITAKVD 351
           +KP+N+LLD+H N +I+DFGL+ ++T      +KT+  G+  Y APE    K     +VD
Sbjct: 133 LKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVISGKLYAGPEVD 189
Query: 352 VYSFGVLLLEIISCRKSFDIE 372
           V+S GV+L  ++  R  FD E
Sbjct: 190 VWSCGVILYVMLCRRLPFDDE 210

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 8/201 (3%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GSFG V      TT        + K      D +   + E+  +    H ++++L   
Sbjct: 23  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 82
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
                  ++V E+  N  L  ++    K S         QI   + Y H     +I+H D
Sbjct: 83  IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRD 138
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTITAKVD 351
           +KP+N+LLD+H N +I+DFGL+ ++T      +KT+  G+  Y APE    K     +VD
Sbjct: 139 LKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVISGKLYAGPEVD 195
Query: 352 VYSFGVLLLEIISCRKSFDIE 372
           V+S GV+L  ++  R  FD E
Sbjct: 196 VWSCGVILYVMLCRRLPFDDE 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 8/201 (3%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GSFG V      TT        + K      D +   + E+  +    H ++++L   
Sbjct: 13  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 72
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
                  ++V E+  N  L  ++    K S         QI   + Y H     +I+H D
Sbjct: 73  IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRD 128
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTITAKVD 351
           +KP+N+LLD+H N +I+DFGL+ ++T      +KT+  G+  Y APE    K     +VD
Sbjct: 129 LKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVISGKLYAGPEVD 185
Query: 352 VYSFGVLLLEIISCRKSFDIE 372
           V+S GV+L  ++  R  FD E
Sbjct: 186 VWSCGVILYVMLCRRLPFDDE 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 8/201 (3%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GSFG V      TT        + K      D +   + E+  +    H ++++L   
Sbjct: 22  GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV 81
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
                  ++V E+  N  L  ++    K S         QI   + Y H     +I+H D
Sbjct: 82  IKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRD 137
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTITAKVD 351
           +KP+N+LLD+H N +I+DFGL+ ++T      +KT+  G+  Y APE    K     +VD
Sbjct: 138 LKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVISGKLYAGPEVD 194
Query: 352 VYSFGVLLLEIISCRKSFDIE 372
           V+S GV+L  ++  R  FD E
Sbjct: 195 VWSCGVILYVMLCRRLPFDDE 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 27/268 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 27  TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 81
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S Q +H D+  +N L++D    ++SDFGL++ + L+   T     +    +  PE    S
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +   
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 241
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                 EK+  +   C  E    RPT +
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFK 269

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 111/224 (49%), Gaps = 20/224 (8%)
Query: 165 TDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIG 219
           +D +K +   G+GSFG V   ++   + +    AVK + +  V Q  +KE    EV ++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
           Q  H N+++L  F ++     LV E    G L   +    + S      I  Q+  G+ Y
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 147
Query: 280 LHEDCSSQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           +H++   +I+H D+KP+N+LL+      N RI DFGL+       SK +K  I GT  Y+
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYI 201
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
           APE     T   K DV+S GV+L  ++S    F+     EY IL
Sbjct: 202 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFN--GANEYDIL 242

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAV-KKLDR-VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G GS+G   K      R S   + V K+LD     + EK+   +EV ++ +  H N+VR 
Sbjct: 15  GTGSYGRCQK----IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 230 LGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                +  N  L  V E+   G LAS +    K    L      ++   L    ++C  +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 288 ------IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
                 ++H D+KP N+ LD   N ++ DFGLA++  LN   +   A  GT  Y++PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQM 188
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
            + +   K D++S G LL E+ +    F
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 27/268 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 18  TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 72
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 73  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S Q +H D+  +N L++D    ++SDFGL++ + L+   T     +    +  PE    S
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 187
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +   
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 232
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                 EK+  +   C  E    RPT +
Sbjct: 233 RPHLASEKVYTIMYSCWHEKADERPTFK 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 27/268 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 11  TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 65
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 66  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 121
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S Q +H D+  +N L++D    ++SDFGL++ + L+   T     +    +  PE    S
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +   
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 225
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                 EK+  +   C  E    RPT +
Sbjct: 226 RPHLASEKVYTIMYSCWHEKADERPTFK 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 27/268 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 12  TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 66
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 67  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 122
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S Q +H D+  +N L++D    ++SDFGL++ + L+   T     +    +  PE    S
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 181
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +   
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 226
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                 EK+  +   C  E    RPT +
Sbjct: 227 RPHLASEKVYTIMYSCWHEKADERPTFK 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 116/268 (43%), Gaps = 27/268 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ L
Sbjct: 7   TFLKELGTGQFGVVKYG----KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L G C + +   ++ E++ NG L ++L   ++  +  +  +     +   + YL    
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S Q +H D+  +N L++D    ++SDFGL++ + L+   T     +    +  PE    S
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +   
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 221
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
                 EK+  +   C  E    RPT +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFK 249

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   R S   +A+K L +   +    E + + EV +     H N++RL
Sbjct: 21  GKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            G+  +     L+ E+   GT+   L    +           ++A  L Y H   S ++I
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCH---SKRVI 134
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL  +   +I+DFG     +++   + +  + GT  Y+ PE         K
Sbjct: 135 HRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE 376
           VD++S GVL  E +     F+    +E
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 138/310 (44%), Gaps = 27/310 (8%)
Query: 142 NSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKL 200
             PGD TV      F  + L++  D      G G FG V     + T   T   VAVK L
Sbjct: 20  QGPGDPTV------FHKRYLKKIRD-----LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL 68
Query: 201 DRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFG 257
                   +  +K E+ ++   +H+++++  G C D G   L LV E++  G+L  +L  
Sbjct: 69  KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-- 126
Query: 258 NLKPSWNLRTNIAF--QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
             + S  L   + F  QI  G+ YLH   +   IH D+  +N+LLD+    +I DFGLAK
Sbjct: 127 -PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
Query: 316 LLTL-NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEM 373
            +   ++   ++        + APE  ++       DV+SFGV L E+++ C  S     
Sbjct: 183 AVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
Query: 374 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
             ++  L   A       +L +L+E         KC  ++  +   C + + S RPT   
Sbjct: 243 --KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300
Query: 434 VSQMLEGVVE 443
           +  +L+ V E
Sbjct: 301 LIPILKTVHE 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 224
           E+ G G++G+VYK      R     VA+K   R+  D E E        E+ ++ + HH 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRI----VALK---RIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI-AFQIARGLLYLHED 283
           N+V L+      +   LV+EF+    L   L  N     + +  I  +Q+ RG+ + H+ 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ- 137
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +I+H D+KPQN+L++     +++DFGLA+   +         +R     V   WYR 
Sbjct: 138 --HRILHRDLKPQNLLINSDGALKLADFGLARAFGI--------PVRSYTHEVVTLWYRA 187
Query: 344 STI-------TAKVDVYSFGVLLLEIISCRKSF 369
             +       +  VD++S G +  E+I+ +  F
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 268
           +E  NE+ ++    H N+++L    ++ +   LV EF   G L   +    K       N
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTI 325
           I  QI  G+ YLH+     I+H DIKP+NILL++     N +I DFGL+       SK  
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF----SKDY 203
Query: 326 KTAIR-GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF----------DIEMG 374
           K   R GT  Y+APE  +K     K DV+S GV++  ++     F           +E G
Sbjct: 204 KLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 375 EEYAILTDW 383
           + Y    DW
Sbjct: 263 KYYFDFNDW 271

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 21/227 (9%)
Query: 162 EEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-----EFKNE 214
           E+  D+++  EE G G F IV K   + T     A  +KK  R      +     E + E
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKK--RRLSSSRRGVSREEIERE 65
Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           V ++ +  H N++ L    +   + +L+ E ++ G L  FL      + +  T    QI 
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 125
Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHY--NARIS--DFGLA-KLLTLNQSKTIKTAI 329
            G+ YLH   S +I H D+KP+NI+L D    N RI   DFG+A K+   N+ K I    
Sbjct: 126 DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI---- 178
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
            GT  +VAPE      +  + D++S GV+   ++S    F  E  +E
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHK 224
           E+ G G++G+VYK      R     VA+K   R+  D E E        E+ ++ + HH 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRI----VALK---RIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI-AFQIARGLLYLHED 283
           N+V L+      +   LV+EF+    L   L  N     + +  I  +Q+ RG+ + H+ 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ- 137
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +I+H D+KPQN+L++     +++DFGLA+   +         +R     V   WYR 
Sbjct: 138 --HRILHRDLKPQNLLINSDGALKLADFGLARAFGI--------PVRSYTHEVVTLWYRA 187
Query: 344 STI-------TAKVDVYSFGVLLLEIISCRKSF 369
             +       +  VD++S G +  E+I+ +  F
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G+GSFG V   ++   + +    AVK + +  V Q  +KE    EV ++ Q  H N+++L
Sbjct: 35  GKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F ++     LV E    G L   +    + S      I  Q+  G+ Y+H++   +I+
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIV 148
Query: 290 HCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           H D+KP+N+LL+      N RI DFGL+       SK +K  I GT  Y+APE     T 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLH-GTY 204
Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
             K DV+S GV+L  ++S    F+     EY IL
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFN--GANEYDIL 236

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 28  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 88  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 141
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 202 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 246
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 247 ICTIDVYMIMVKCWMIDADSRPKFREL 273

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 38  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 95  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+           TA   T GYVA  WYR
Sbjct: 150 --SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEMT-GYVATRWYR 196
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 38  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 95  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+           TA   T GYVA  WYR
Sbjct: 150 --SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEMT-GYVATRWYR 196
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 87  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 140
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 201 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 245
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 246 ICTIDVYMIMVKCWMIDADSRPKFREL 272

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 86  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 139
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 200 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 244
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 245 ICTIDVYMIMVKCWMIDADSRPKFREL 271

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 25  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 84
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 85  GICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 138
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 199 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 243
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 244 ICTIDVYMIMVKCWMIDADSRPKFREL 270

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 225
            F  E GRGSF  VYKG+   T T+      +  DR     E++ FK E   +    H N
Sbjct: 29  KFDIEIGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPN 86
Query: 226 LVRLLGFCDEGQNR-------LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
           +VR   F D  ++        +LV E   +GTL ++L         +  +   QI +GL 
Sbjct: 87  IVR---FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQ 143
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
           +LH   +  IIH D+K  NI +     + +I D GLA L    +  +   A+ GT  + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXA 198
Query: 338 PEWYRKSTITAKVDVYSFGVLLLE 361
           PE Y +      VDVY+FG   LE
Sbjct: 199 PEXYEEK-YDESVDVYAFGXCXLE 221

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 38  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 95  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+           TA   T GYVA  WYR
Sbjct: 150 --SADIIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEMT-GYVATRWYR 196
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 25  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 84
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 85  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 138
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 199 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 243
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 244 ICTIDVYMIMVKCWMIDADSRPKFREL 270

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G+GSFG V   ++   + +    AVK + +  V Q  +KE    EV ++ Q  H N+++L
Sbjct: 58  GKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F ++     LV E    G L   +    + S      I  Q+  G+ Y+H++   +I+
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIV 171
Query: 290 HCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           H D+KP+N+LL+      N RI DFGL+       SK +K  I GT  Y+APE     T 
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLH-GTY 227
Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
             K DV+S GV+L  ++S    F+     EY IL
Sbjct: 228 DEKCDVWSTGVILYILLSGCPPFN--GANEYDIL 259

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G+GSFG V   ++   + +    AVK + +  V Q  +KE    EV ++ Q  H N+++L
Sbjct: 59  GKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F ++     LV E    G L   +    + S      I  Q+  G+ Y+H++   +I+
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIV 172
Query: 290 HCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           H D+KP+N+LL+      N RI DFGL+       SK +K  I GT  Y+APE     T 
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKI-GTAYYIAPEVLH-GTY 228
Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
             K DV+S GV+L  ++S    F+     EY IL
Sbjct: 229 DEKCDVWSTGVILYILLSGCPPFN--GANEYDIL 260

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 84  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 198 HQSDVWSYGVTVWELMT 214

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 226
           E+ G G++G V+K      R +   VA+K++ R+  D E        E+ ++ +  HKN+
Sbjct: 8   EKIGEGTYGTVFKA---KNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASF--LFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           VRL       +   LV+EF +      F    G+L P   +  +  FQ+ +GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCH--- 118
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  ++H D+KPQN+L++ +   +++DFGLA+   +         +R     V   WYR  
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--------PVRCYSAEVVTLWYRPP 170
Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSF 369
            +       +  +D++S G +  E+ +  +  
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 49  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 108
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 109 GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 162
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 223 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 267
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 268 ICTIDVYMIMVKCWMIDADSRPKFREL 294

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 84  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G +        +D     ++  ++E         
Sbjct: 198 HQSDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPP 242
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFREL 269

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 87  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 140
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 201 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 245
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 246 ICTIDVYMIMVKCWMIDADSRPKFREL 272

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 84  GICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 198 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 242
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFREL 269

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 86  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 139
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 200 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 244
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 245 ICTIDVYMIMVKCWMIDADSRPKFREL 271

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 87  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 140
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 201 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 245
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 246 ICTIDVYMIMVKCWMIDADSRPKFREL 272

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 18  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 77
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 78  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 131
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G +        +D     ++  ++E         
Sbjct: 192 HQSDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPP 236
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFREL 263

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG V  G  E T      VAVK L+R      D   + + E+  +    H ++++L
Sbjct: 25  GVGTFGKVKVGKHELT---GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                   +  +V E+++ G L  ++  N +        +  QI  G+ Y H      ++
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVV 138
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA- 348
           H D+KP+N+LLD H NA+I+DFGL+ +++    + ++ +  G+  Y APE          
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSC-GSPNYAAPEVISGRLYAGP 195
Query: 349 KVDVYSFGVLLLEIISCRKSFD 370
           +VD++S GV+L  ++     FD
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 34  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 94  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 147
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 208 HQSDVWSYGVTVWELMT 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 27  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 86
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 87  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 140
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 201 HQSDVWSYGVTVWELMT 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 226
           FKE  G G+F  V   V+   + +    AVK +  +  +  E   +NE+ V+ +  H+N+
Sbjct: 26  FKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENI 82
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           V L    +   +  LV + ++ G L   +      +    + +  Q+   + YLH     
Sbjct: 83  VALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR---M 139
Query: 287 QIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            I+H D+KP+N+L    D+     ISDFGL+K+    +   + TA  GT GYVAPE   +
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKME--GKGDVMSTAC-GTPGYVAPEVLAQ 196
Query: 344 STITAKVDVYSFGVL 358
              +  VD +S GV+
Sbjct: 197 KPYSKAVDCWSIGVI 211

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 30  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 89
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 90  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 143
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G +        +D     ++  ++E         
Sbjct: 204 HQSDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPP 248
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 249 ICTIDVYMIMVKCWMIDADSRPKFREL 275

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 31  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 91  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 144
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 205 HQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKGERLPQPP 249
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 250 ICTIDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 84  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 198 HQSDVWSYGVTVWELMT 214

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           +E GRG F +V + + ++T     A  +KK  R  QD   E  +E+ V+     K+  R+
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELA--KSCPRV 91
Query: 230 LGFCDEGQNR---LLVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDC 284
           +   +  +N    +L+ E+   G + S     L    S N    +  QI  G+ YLH++ 
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 285 SSQIIHCDIKPQNILLDDHY---NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              I+H D+KPQNILL   Y   + +I DFG+++   +  +  ++  I GT  Y+APE  
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGTPEYLAPEIL 205
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
               IT   D+++ G++   +++    F  E  +E
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G FG VY+GV    +     VAVK   +    D +++F +E V++    H ++V+L+G
Sbjct: 21  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQII 289
             +E +   ++ E    G L  +L  N K S  + T + +  QI + + YL    S   +
Sbjct: 81  IIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCV 135
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DI  +NIL+      ++ DFGL++ +  ++     +  R    +++PE       T  
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTTA 194
Query: 350 VDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            DV+ F V + EI+S  K   F +E  +   +L           K D L + D+      
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE----------KGDRLPKPDL------ 238
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
            C   L  +   C   DPS RP   ++   L  V +++
Sbjct: 239 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPAFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 17/228 (7%)
Query: 158 YKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD----GEKEFKN 213
           ++++ E      EE G G F IV K   + T     A  +KK  R+         +E + 
Sbjct: 20  FQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKK-RRLXSSRRGVSREEIER 78
Query: 214 EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
           EV ++ +  H N++ L    +   + +L+ E ++ G L  FL      + +  T    QI
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHY--NARIS--DFGLA-KLLTLNQSKTIKTA 328
             G+ YLH   S +I H D+KP+NI+L D    N RI   DFG+A K+   N+ K I   
Sbjct: 139 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--- 192
Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
             GT  +VAPE      +  + D++S GV+   ++S    F  E  +E
Sbjct: 193 -FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 239

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHK 224
            +E  G GSFG   K  + T   +   VA+K + R      D     + E+  +    H 
Sbjct: 13  IRETLGEGSFG---KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           ++++L        + ++V E+   G L  ++    + + +       QI   + Y H   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-- 126
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-K 343
             +I+H D+KP+N+LLDD+ N +I+DFGL+ ++T      +KT+  G+  Y APE    K
Sbjct: 127 -HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVINGK 182
Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIE 372
                +VDV+S G++L  ++  R  FD E
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G FG VY+GV    +     VAVK   +    D +++F +E V++    H ++V+L+G
Sbjct: 33  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 92
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQII 289
             +E +   ++ E    G L  +L  N K S  + T + +  QI + + YL    S   +
Sbjct: 93  IIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCV 147
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DI  +NIL+      ++ DFGL++ +  ++     +  R    +++PE       T  
Sbjct: 148 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTTA 206
Query: 350 VDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            DV+ F V + EI+S  K   F +E  +   +L           K D L + D+      
Sbjct: 207 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE----------KGDRLPKPDL------ 250
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
            C   L  +   C   DPS RP   ++   L  V +++
Sbjct: 251 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 287

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNLVR 228
           ++ G G++  VYKG    ++ +   VA+K++    ++G       EV ++    H N+V 
Sbjct: 8   DKLGEGTYATVYKG---KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L       ++  LV+E+L+   L  +L   GN+    N++  + FQ+ RGL Y H     
Sbjct: 65  LHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHR---Q 119
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +++H D+KPQN+L+++    +++DFGLA+      +K+I T     +  V   WYR   I
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNE--VVTLWYRPPDI 171
Query: 347 -------TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                  + ++D++  G +  E+ + R  F     EE
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G FG VY+GV    +     VAVK   +    D +++F +E V++    H ++V+L+G
Sbjct: 17  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 76
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSSQII 289
             +E +   ++ E    G L  +L  N K S  + T + +  QI + + YL    S   +
Sbjct: 77  IIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE---SINCV 131
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DI  +NIL+      ++ DFGL++ +  ++     +  R    +++PE       T  
Sbjct: 132 HRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFTTA 190
Query: 350 VDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            DV+ F V + EI+S  K   F +E  +   +L           K D L + D+      
Sbjct: 191 SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE----------KGDRLPKPDL------ 234
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
            C   L  +   C   DPS RP   ++   L  V +++
Sbjct: 235 -CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 271

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           +  EE G G+FG+V++    T R +    A K +    +  ++  + E+  +    H  L
Sbjct: 160 DIHEELGTGAFGVVHR---VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           V L    ++    +++YEF++ G L   +   + K S +       Q+ +GL ++HE+  
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-- 274
Query: 286 SQIIHCDIKPQNILLDDHYNARIS--DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +H D+KP+NI+     +  +   DFGL   L   QS  + T   GT  + APE    
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEG 330
Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
             +    D++S GVL   ++S    F  E  +E
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 12/225 (5%)
Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQ 220
             DNF+     G+GSFG V    ++ T     AV V K D + QD + E    E  ++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKET-GDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 221 THHKNLVRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
             +   +  L  C +  +RL  V EF+N G L   +  + +         A +I   L++
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH+     II+ D+K  N+LLD   + +++DFG+ K    N   T      GT  Y+APE
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPE 194
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTD 382
             ++      VD ++ GVLL E++     F+ E  ++   AIL D
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAV-KKLDR-VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G GS+G   K      R S   + V K+LD     + EK+   +EV ++ +  H N+VR 
Sbjct: 15  GTGSYGRCQK----IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 230 LGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                +  N  L  V E+   G LAS +    K    L      ++   L    ++C  +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 288 ------IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
                 ++H D+KP N+ LD   N ++ DFGLA++  LN   +      GT  Y++PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQM 188
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
            + +   K D++S G LL E+ +    F
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G FG V+K   E T T     A     R  +D E E KNE+ V+ Q  H NL++L   
Sbjct: 98  GGGRFGQVHK--CEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDA 154
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAF--QIARGLLYLHEDCSSQI 288
            +   + +LV E+++ G L   +   +  S+NL     I F  QI  G+ ++H+     I
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICEGIRHMHQ---MYI 208
Query: 289 IHCDIKPQNILL--DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +H D+KP+NIL    D    +I DFGLA+     +   +     GT  ++APE      +
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFV 265
Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
           +   D++S GV+   ++S    F
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNEVVVIGQTHHKNL 226
           FK + G G+FG V+   +   R+S     +K +++   Q   ++ + E+ V+    H N+
Sbjct: 26  FKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLHE 282
           +++    ++  N  +V E    G L   +         L       +  Q+   L Y H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH- 141
Query: 283 DCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
             S  ++H D+KP+NIL  D   H   +I DFGLA+L    +S    T   GT  Y+APE
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYMAPE 196
Query: 340 WYRKSTITAKVDVYSFGVLL 359
            +++  +T K D++S GV++
Sbjct: 197 VFKRD-VTFKCDIWSAGVVM 215

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-----EFKNEVVVIGQTHHK 224
           EE G G F IV K   + T     A  +KK  R      +     E + EV ++ +  H 
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKK--RRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           N++ L    +   + +L+ E ++ G L  FL      + +  T    QI  G+ YLH   
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 285 SSQIIHCDIKPQNILLDDHY--NARIS--DFGLA-KLLTLNQSKTIKTAIRGTKGYVAPE 339
           S +I H D+KP+NI+L D    N RI   DFG+A K+   N+ K I     GT  +VAPE
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTPEFVAPE 181
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                 +  + D++S GV+   ++S    F  E  +E
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 21  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA G+ YL +    +
Sbjct: 81  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAEGMNYLED---RR 134
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 195 HQSDVWSYGVTVWELMT 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAV-KKLDR-VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G GS+G   K      R S   + V K+LD     + EK+   +EV ++ +  H N+VR 
Sbjct: 15  GTGSYGRCQK----IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 230 LGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                +  N  L  V E+   G LAS +    K    L      ++   L    ++C  +
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 288 ------IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
                 ++H D+KP N+ LD   N ++ DFGLA++  LN  +       GT  Y++PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDEDFAKEFVGTPYYMSPEQM 188
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
            + +   K D++S G LL E+ +    F
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 42  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 99  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 153
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 154 --SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWYR 200
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 14/224 (6%)
Query: 153 LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDG--EK 209
           +  F  + +E+  D   EE G G F IV K   ++T     A  +KK   R  + G   +
Sbjct: 2   METFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 210 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 269
           E + EV ++ Q  H N++ L    +   + +L+ E ++ G L  FL      S    T+ 
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTI 325
             QI  G+ YLH   + +I H D+KP+NI+L D      + ++ DFGLA    +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF 175
Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           K  I GT  +VAPE      +  + D++S GV+   ++S    F
Sbjct: 176 KN-IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 36  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 93  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 148 --SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWYR 194
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 14/224 (6%)
Query: 153 LRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDG--EK 209
           +  F  + +E+  D   EE G G F IV K   ++T     A  +KK   R  + G   +
Sbjct: 2   MEPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 210 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 269
           E + EV ++ Q  H N++ L    +   + +L+ E ++ G L  FL      S    T+ 
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF 120
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTI 325
             QI  G+ YLH   + +I H D+KP+NI+L D      + ++ DFGLA    +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEF 175
Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           K  I GT  +VAPE      +  + D++S GV+   ++S    F
Sbjct: 176 KN-IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 36  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 93  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 148 --SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWYR 194
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           +  EE G G+FG+V++    T R +    A K +    +  ++  + E+  +    H  L
Sbjct: 54  DIHEELGTGAFGVVHR---VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           V L    ++    +++YEF++ G L   +   + K S +       Q+ +GL ++HE+  
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN-- 168
Query: 286 SQIIHCDIKPQNILLDDHYNARIS--DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +H D+KP+NI+     +  +   DFGL   L   QS  + T   GT  + APE    
Sbjct: 169 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEG 224
Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
             +    D++S GVL   ++S    F  E  +E
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 257

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 188
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F IV K   ++T     A  +KK   R  + G   +E + EV ++ Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E ++ G L  FL      S    T+   QI  G+ YLH   + 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           +I H D+KP+NI+L D      + ++ DFGLA    +      K  I GT  +VAPE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVN 191
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSF 369
              +  + D++S GV+   ++S    F
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 132
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 188
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 37  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 94  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 149 --SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----------GYVATRWYR 195
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+  S  L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGL +      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F IV K   ++T     A  +KK   R  + G   +E + EV ++ Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E ++ G L  FL      S    T+   QI  G+ YLH   + 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           +I H D+KP+NI+L D      + ++ DFGLA    +      K  I GT  +VAPE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVN 191
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSF 369
              +  + D++S GV+   ++S    F
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 33  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 90  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 145 --SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT-----------GYVATRWYR 191
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 16/279 (5%)
Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 230
           G G FG V     + T   T   VAVK L        +  +K E+ ++   +H+++++  
Sbjct: 23  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYK 82
Query: 231 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSS 286
           G C D+G+  L LV E++  G+L  +L    + S  L   + F  QI  G+ YLH   S 
Sbjct: 83  GCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYRKST 345
             IH ++  +N+LLD+    +I DFGLAK +   ++   ++        + APE  ++  
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 346 ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
                DV+SFGV L E+++ C  S       ++  L   A       +L +L+E      
Sbjct: 197 FYYASDVWSFGVTLYELLTHCDSSQSPPT--KFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              KC  ++  +   C + + S RPT   +  +L+ V E
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F IV K   ++T     A  +KK   R  + G   +E + EV ++ Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E ++ G L  FL      S    T+   QI  G+ YLH   + 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           +I H D+KP+NI+L D      + ++ DFGLA    +      K  I GT  +VAPE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVN 191
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSF 369
              +  + D++S GV+   ++S    F
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F IV K   ++T     A  +KK   R  + G   +E + EV ++ Q  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E ++ G L  FL      S    T+   QI  G+ YLH   + 
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TK 134
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           +I H D+KP+NI+L D      + ++ DFGLA    +      K  I GT  +VAPE   
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKN-IFGTPEFVAPEIVN 191
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSF 369
              +  + D++S GV+   ++S    F
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLVRL 229
           G+GSFG   K  I     +    A+K +++       E +N   E+ ++    H  LV L
Sbjct: 24  GKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                + ++  +V + L  G L   L  N+            ++   L YL    + +II
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRII 137
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY---RKSTI 346
           H D+KP NILLD+H +  I+DF +A +L     +T  T + GTK Y+APE +   + +  
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 347 TAKVDVYSFGVLLLEIISCRKSFDI 371
           +  VD +S GV   E++  R+ + I
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHI 219

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 37/275 (13%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             +++ G G FG V+      T    T VAVK +       E  F  E  V+    H  L
Sbjct: 185 KLEKKLGAGQFGEVWMA----TYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKL 239
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDC 284
           V+L     + +   ++ EF+  G+L  FL  +      L   I F  QIA G+ ++ +  
Sbjct: 240 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-- 296
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
               IH D++  NIL+      +I+DFGLA++         K  I+ T    APE     
Sbjct: 297 -RNYIHRDLRAANILVSASLVCKIADFGLARV-------GAKFPIKWT----APEAINFG 344
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
           + T K DV+SFG+LL+EI++  +                 +    N ++   +E      
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRALERGYRMP 389
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
               C E+L  + + C +  P  RPT   +  +L+
Sbjct: 390 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G VYK        S   VA+K + RV  +GE+        EV ++ +     H
Sbjct: 11  EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-PNGEEGLPISTVREVALLRRLEAFEH 65
Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL+  C     D      LV+E ++   L ++L     P     T  ++  Q  RG
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH +C   I+H D+KP+NIL+      +++DFGLA++ +   +      +  T  Y 
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LAPVVVTLWYR 178
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +ST    VD++S G +  E+   +  F
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 175 GSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLLG 
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 233 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +++
Sbjct: 93  CLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RRLV 146
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 350 VDVYSFGVLLLEIIS 364
            DV+S+GV + E+++
Sbjct: 207 SDVWSYGVTVWELMT 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 33  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 90  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 145 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 191
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 40/230 (17%)
Query: 159 KALEEATDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNE 214
           K + E  + ++  A  G G++G V       T+T    VAVKKL R FQ     K    E
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRE 81
Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN-- 268
           + ++    H+N++ LL      ++     E  N+  L + L G    N+     L  +  
Sbjct: 82  LRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 137
Query: 269 --IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
             + +QI RGL Y+H   S+ IIH D+KP N+ +++    +I DFGLA+      +    
Sbjct: 138 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---- 190
Query: 327 TAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
                  GYVA  WYR   I          VD++S G ++ E+++ R  F
Sbjct: 191 -------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+GSFG V K     T+       + K     +D     + EV ++ +  H N+++L   
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEI 89
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++  +  +V E    G L   +    + S +    I  Q+  G+ Y+H+     I+H D
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRD 146
Query: 293 IKPQNILLDDHY---NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           +KP+NILL+      + +I DFGL+      Q+  +K  I GT  Y+APE  R  T   K
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAPEVLR-GTYDEK 202
Query: 350 VDVYSFGVLLLEIISCRKSF 369
            DV+S GV+L  ++S    F
Sbjct: 203 CDVWSAGVILYILLSGTPPF 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVR 228
           E  G G++G VYKG        T  +A  K+  V  D E+E K E+ ++ + +HH+N+  
Sbjct: 30  ELVGNGTYGQVYKG----RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 229 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLF---GN-LKPSWNLRTNIAF---QIAR 275
             G F  +    +     LV EF   G++   +    GN LK  W     IA+   +I R
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILR 140
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL +LH+    ++IH DIK QN+LL ++   ++ DFG++    L+++   +    GT  +
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYW 195
Query: 336 VAPEWYR-----KSTITAKVDVYSFGVLLLEI 362
           +APE         +T   K D++S G+  +E+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 42  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 99  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 153
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 154 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 200
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 43  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 100 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 155 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 201
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 43  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 100 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 155 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 201
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 110/245 (44%), Gaps = 42/245 (17%)
Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNE--VVVIGQ 220
           DN K  E  GRG +G VYKG ++        VAVK    VF    ++ F NE  +  +  
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDER-----PVAVK----VFSFANRQNFINEKNIYRVPL 63
Query: 221 THHKNLVRLLG-----FCDEGQNRLLVYEFLNNGTLASFLFGNLKPS-WNLRTNIAFQIA 274
             H N+ R +        D     LLV E+  NG+L  +L  +L  S W     +A  + 
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVT 121
Query: 275 RGLLYLHEDC------SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ----SKT 324
           RGL YLH +          I H D+  +N+L+ +     ISDFGL+  LT N+     + 
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 325 IKTAIR--GTKGYVAPEWYRKS-------TITAKVDVYSFGVLLLEI-ISCRKSFDIEMG 374
              AI   GT  Y+APE    +       +   +VD+Y+ G++  EI + C   F  E  
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 375 EEYAI 379
            EY +
Sbjct: 242 PEYQM 246

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 54  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 111 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 165
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 166 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 212
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 38  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 95  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 150 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 196
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 33  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 90  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 145 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 191
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 37  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 94  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 149 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 195
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 120/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 86  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 139
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFG AKLL   + +      +    ++A E       T
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G +        +D     ++  ++E         
Sbjct: 200 HQSDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPP 244
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 245 ICTIDVYMIMVKCWMIDADSRPKFREL 271

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 36  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 93  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 148 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 194
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 30  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 87  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 141
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 142 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 188
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 50  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 107 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 161
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 162 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 208
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 51  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 108 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 163 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 209
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+GSFG V K     T+       + K     +D     + EV ++ +  H N+++L   
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEI 89
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++  +  +V E    G L   +    + S +    I  Q+  G+ Y+H+     I+H D
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRD 146
Query: 293 IKPQNILLDDHY---NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           +KP+NILL+      + +I DFGL+      Q+  +K  I GT  Y+APE  R  T   K
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAPEVLR-GTYDEK 202
Query: 350 VDVYSFGVLLLEIISCRKSF 369
            DV+S GV+L  ++S    F
Sbjct: 203 CDVWSAGVILYILLSGTPPF 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 165 TDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           TD+++  EE G+G+F +V +  ++ T T   A  +    ++     ++ + E  +     
Sbjct: 30  TDDYQLFEELGKGAFSVVRR-CVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H N+VRL     E     LV++ +  G L   +      S    ++   QI   + ++H+
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 283 DCSSQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
                I+H D+KP+N+LL         +++DFGLA  +   Q      A  GT GY++PE
Sbjct: 149 ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPGYLSPE 203
Query: 340 WYRKSTITAKVDVYSFGVLL 359
             RK      VD+++ GV+L
Sbjct: 204 VLRKDPYGKPVDIWACGVIL 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 26/242 (10%)
Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           + E GRG+  IVY+      + +    A+K L +     +K  + E+ V+ +  H N+++
Sbjct: 58  ESELGRGATSIVYRC---KQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIK 112
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L    +      LV E +  G L   +      S     +   QI   + YLHE+    I
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GI 169
Query: 289 IHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
           +H D+KP+N+L          +I+DFGL+K++   + + +   + GT GY APE  R   
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGE----------EYAILTDWAFDCYRNGKLDD 395
              +VD++S G++   ++   + F  E G+          EY  ++ W  +   N K  D
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK--D 284
Query: 396 LV 397
           LV
Sbjct: 285 LV 286

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+GSFG V K     T+       + K     +D     + EV ++ +  H N+++L   
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEI 89
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++  +  +V E    G L   +    + S +    I  Q+  G+ Y+H+     I+H D
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRD 146
Query: 293 IKPQNILLDDHY---NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           +KP+NILL+      + +I DFGL+      Q+  +K  I GT  Y+APE  R  T   K
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRI-GTAYYIAPEVLR-GTYDEK 202
Query: 350 VDVYSFGVLLLEIISCRKSF 369
            DV+S GV+L  ++S    F
Sbjct: 203 CDVWSAGVILYILLSGTPPF 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 26/265 (9%)
Query: 175 GSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLLG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 233 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +++
Sbjct: 86  CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RRLV 139
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
            DV+S+GV + E+++         G +        +D     ++  ++E          C
Sbjct: 200 SDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPPIC 244
Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKV 434
              + M+ + C   D   RP  R++
Sbjct: 245 TIDVYMIMVKCWMIDADSRPKFREL 269

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 50  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 107 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 161
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 162 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 208
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 36  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 93  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 148 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 194
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDG--EKEFKNEVVVIGQTHHKNL 226
           EE G G F +V K   ++T     A  +KK   +  + G   ++ + EV ++ +  H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           + L    +   + +L+ E +  G L  FL      +    T    QI  G+ YLH   S 
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SL 133
Query: 287 QIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWY 341
           QI H D+KP+NI+L D        +I DFGLA  +   N+ K     I GT  +VAPE  
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IFGTPEFVAPEIV 189
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +  + D++S GV+   ++S    F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 51  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 108 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 163 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 209
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 28  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 85  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 140 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 186
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 86  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 139
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFG AKLL   + +      +    ++A E       T
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 200 HQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 120/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 28  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L++ + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 88  GICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 141
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFG AKLL   + +      +    ++A E       T
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G +        +D     ++  ++E         
Sbjct: 202 HQSDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPP 246
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 247 ICTIDVYMIMVKCWMIDADSRPKFREL 273

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 54  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 111 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 165
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA           +       GYVA  WYR
Sbjct: 166 --SADIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTDDEMXGYVATRWYR 212
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 33  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 90  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 145 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 191
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 28  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 85  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 140 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 186
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G VYK        S   VA+K + RV  +GE+        EV ++ +     H
Sbjct: 11  EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-PNGEEGLPISTVREVALLRRLEAFEH 65
Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL+  C     D      LV+E ++   L ++L     P     T  ++  Q  RG
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH +C   I+H D+KP+NIL+      +++DFGLA++ +   +      +  T  Y 
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LDPVVVTLWYR 178
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +ST    VD++S G +  E+   +  F
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 29  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 86  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 140
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 141 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 187
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 27  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 84  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 185
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 27  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 84  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 185
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 84  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFG AKLL   + +      +    ++A E       T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++         G +        +D     ++  ++E         
Sbjct: 198 HQSDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPP 242
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 37  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 94  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 149 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 195
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V        R     VAVKKL R FQ     +    E+ ++    H+N++ LL
Sbjct: 37  GSGAYGSVCSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSS 286
                  +     E     TL      N+  S  L       + +Q+ RGL Y+H   S+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            IIH D+KP N+ +++    RI DFGLA           + A     GYVA  WYR   I
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLA-----------RQADEEMTGYVATRWYRAPEI 199
Query: 347 -------TAKVDVYSFGVLLLEIISCRKSF 369
                     VD++S G ++ E++  +  F
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 119/265 (44%), Gaps = 26/265 (9%)
Query: 175 GSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLLG 
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 233 CDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +++
Sbjct: 93  CLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RRLV 146
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T +
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
            DV+S+GV + E+++         G +        +D     ++  ++E          C
Sbjct: 207 SDVWSYGVTVWELMT--------FGSK-------PYDGIPASEISSILEKGERLPQPPIC 251
Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKV 434
              + M+ + C   D   RP  R++
Sbjct: 252 TIDVYMIMVKCWMIDADSRPKFREL 276

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 226
           E+ G G++G V+K      R +   VA+K++ R+  D E        E+ ++ +  HKN+
Sbjct: 8   EKIGEGTYGTVFKA---KNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASF--LFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           VRL       +   LV+EF +      F    G+L P   +  +  FQ+ +GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCH--- 118
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  ++H D+KPQN+L++ +   ++++FGLA+   +         +R     V   WYR  
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--------PVRCYSAEVVTLWYRPP 170
Query: 345 TI-------TAKVDVYSFGVLLLEI 362
            +       +  +D++S G +  E+
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 37  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 94  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 149 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 195
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 27  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 84  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH- 138
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 185
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 16/279 (5%)
Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 230
           G G FG V     + T   T   VAVK L        +  +K E+ ++   +H+++++  
Sbjct: 23  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYK 82
Query: 231 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSS 286
           G C D+G+  L LV E++  G+L  +L    + S  L   + F  QI  G+ YLH   + 
Sbjct: 83  GCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYRKST 345
             IH ++  +N+LLD+    +I DFGLAK +   ++   ++        + APE  ++  
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 346 ITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
                DV+SFGV L E+++ C  S       ++  L   A       +L +L+E      
Sbjct: 197 FYYASDVWSFGVTLYELLTHCDSSQSPPT--KFLELIGIAQGQMTVLRLTELLERGERLP 254
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              KC  ++  +   C + + S RPT   +  +L+ V E
Sbjct: 255 RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           F E  G G+F  V+   +   R +    A+K  K    F+D   E  NE+ V+ +  H+N
Sbjct: 13  FMEVLGSGAFSEVF---LVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHEN 67
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V L    +   +  LV + ++ G L   +      +    + +  Q+   + YLHE+  
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 286 SQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             I+H D+KP+N+L    +++    I+DFGL+K+    Q+  + TA  GT GYVAPE   
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC-GTPGYVAPEVLA 180
Query: 343 KSTITAKVDVYSFGVL 358
           +   +  VD +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVI 196

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 26  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 86  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 139
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFG AKLL   + +      +    ++A E       T
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 200 HQSDVWSYGVTVWELMT 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK----NEVVVIGQTH---H 223
           E G G++G VYK        S   VA+K + RV  +GE+        EV ++ +     H
Sbjct: 11  EIGVGAYGTVYKA---RDPHSGHFVALKSV-RV-PNGEEGLPISTVREVALLRRLEAFEH 65
Query: 224 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
            N+VRL+  C     D      LV+E ++   L ++L     P     T  ++  Q  RG
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L +LH +C   I+H D+KP+NIL+      +++DFGLA++ +  Q       +  T  Y 
Sbjct: 125 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALFPVVV--TLWYR 178
Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           APE   +ST    VD++S G +  E+   +  F
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 36/283 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G+G FG VY G          A+ +  ++R  +D  K FK EV+   QT H+N+V  
Sbjct: 39  ELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           +G C    +  ++       TL S +    +    N    IA +I +G+ YLH   +  I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY---VAPEWYR--- 342
           +H D+K +N+  D+     I+DFGL  +  + Q+   +  +R   G+   +APE  R   
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 343 ------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
                 K   +   DV++ G +  E+ +    F  +  E  AI+  W         L  +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--AII--WQMGTGMKPNLSQI 266
Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             G  + ++DI       ++  W  +++   RPT  K+  MLE
Sbjct: 267 GMG--KEISDI-------LLFCWAFEQEE--RPTFTKLMDMLE 298

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + ++ RLL
Sbjct: 31  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 91  GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 144
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFG AKLL   + +      +    ++A E       T
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
            + DV+S+GV + E+++                    +D     ++  ++E         
Sbjct: 205 HQSDVWSYGVTVWELMT---------------FGSKPYDGIPASEISSILEKGERLPQPP 249
Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            C   + M+ + C   D   RP  R++
Sbjct: 250 ICTIDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G+GSFG V   ++   + +    AVK + +  V Q  +KE    EV ++ Q  H N+ +L
Sbjct: 35  GKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F ++     LV E    G L   +    + S      I  Q+  G+ Y H++   +I+
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN---KIV 148
Query: 290 HCDIKPQNILLDDH---YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           H D+KP+N+LL+      N RI DFGL+       SK  K  I GT  Y+APE     T 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKI-GTAYYIAPEVLH-GTY 204
Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
             K DV+S GV+L  ++S    F+     EY IL
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFN--GANEYDIL 236

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+ +L +       KE  +E  V+    + ++ RLL
Sbjct: 58  GSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLL 117
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           G C     +L+  + +  G L  ++     N+   + L  N   QIA+G+ YL +    +
Sbjct: 118 GICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLED---RR 171
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T
Sbjct: 172 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 348 AKVDVYSFGVLLLEIIS 364
            + DV+S+GV + E+++
Sbjct: 232 HQSDVWSYGVTVWELMT 248

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 8/212 (3%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKN 225
           NF    G+GSFG V     + T     A+ + K D V QD + E    E  V+       
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTE-ELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            +  L  C +  +RL  V E++N G L   +    K         A +I+ GL +LH+  
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHK-- 138
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+K  N++LD   + +I+DFG+ K   ++   T +    GT  Y+APE     
Sbjct: 139 -RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC--GTPDYIAPEIIAYQ 195
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                VD +++GVLL E+++ +  FD E  +E
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I D+GLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 165 TDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           TD +  KE+ G GS+ +  + + + T       AVK +D+  +D  +E +   +++    
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNME---FAVKIIDKSKRDPTEEIE---ILLRYGQ 74
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H N++ L    D+G+   +V E +  G L   +      S    + + F I + + YLH 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH- 133
Query: 283 DCSSQIIHCDIKPQNILLDDHY----NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
             +  ++H D+KP NIL  D      + RI DFG AK L       +      T  +VAP
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY--TANFVAP 189
Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           E   +    A  D++S GVLL  +++    F
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL + FQ     K    E+ ++    H+N++ LL
Sbjct: 43  GSGAYGSVCAAF--DTKTGLR-VAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 100 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 155 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 201
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V          S   +AVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 60  GSGAYGSVCSSY---DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 116
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                  +     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 117 DVFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 171
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           GYVA  WYR
Sbjct: 172 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYR 218
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLF 252

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           G+VA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----------GFVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 31/205 (15%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLL 230
           G GS+G+V+K      R +   VA+KK      D   +K    E+ ++ Q  H NLV LL
Sbjct: 12  GEGSYGVVFKC---RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
                 +   LV+E+ ++  L            +L  +I +Q  + + + H+      IH
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIH 125
Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY----VAPEWYRKSTI 346
            D+KP+NIL+  H   ++ DFG A+LLT            G   Y    VA  WYR   +
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLT------------GPSDYYDDEVATRWYRSPEL 173
Query: 347 T-------AKVDVYSFGVLLLEIIS 364
                     VDV++ G +  E++S
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G++G V     + T     A+ + +   V      +   EV V+    H N+++L  F
Sbjct: 46  GSGAYGEVLLCRDKVTHVER-AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++ +N  LV E    G L   +   +K +      I  Q+  G+ YLH+     I+H D
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRD 161
Query: 293 IKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           +KP+N+LL+        +I DFGL+ +   NQ K  +    GT  Y+APE  RK     K
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL--GTAYYIAPEVLRKK-YDEK 217
Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEE 376
            DV+S GV+L  +++    F  +  +E
Sbjct: 218 CDVWSIGVILFILLAGYPPFGGQTDQE 244

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           G+VA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----------GFVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 109/234 (46%), Gaps = 39/234 (16%)
Query: 160 ALEEATDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 217
           +L  A+D F+E A  G+G+FG V K         +   A+KK+ R  ++      +EV++
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKA---RNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 218 IGQTHHKNLVRLLGFCDEGQN-------------RLLVYEFLNNGTLASFLFG-NLKPSW 263
           +   +H+ +VR      E +N               +  E+  NGTL   +   NL    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 264 NLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-------L 316
           +    +  QI   L Y+H   S  IIH D+KP NI +D+  N +I DFGLAK       +
Sbjct: 116 DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 317 LTLN------QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEII 363
           L L+       S  + +AI GT  YVA E    +     K+D+YS G++  E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 171 EAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKN 225
           E G G++G VYK     +    +  +V V                EV ++ +     H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 226 LVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLL 278
           +VRL+  C     D      LV+E ++   L ++L     P     T  ++  Q  RGL 
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +LH +C   I+H D+KP+NIL+      +++DFGLA++ +   +    T +  T  Y AP
Sbjct: 135 FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAP 188
Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           E   +ST    VD++S G +  E+   +  F
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 170 EEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           E  G+G+F +V + +   T  + +   V V K         ++ K E  +     H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTL---------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
            LL          +V+EF++   L         A F++     S  +R     QI   L 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QILEALR 144
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           Y H++    IIH D+KP+N+LL    N+   ++ DFG+A  + L +S  +     GT  +
Sbjct: 145 YCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHF 199
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           +APE  ++      VDV+  GV+L  ++S
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDG-EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + S   VA+K L   ++ ++G E + + E+ +    HH N++RL
Sbjct: 32  GKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             +  + +   L+ E+   G L   L  +          I  ++A  L+Y H     ++I
Sbjct: 89  YNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH---GKKVI 145
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+LL      +I+DFG     +++     +  + GT  Y+ PE         K
Sbjct: 146 HRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEK 201
Query: 350 VDVYSFGVLLLEIISCRKSFD 370
           VD++  GVL  E++     F+
Sbjct: 202 VDLWCIGVLCYELLVGNPPFE 222

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG V  G  + T      VAVK L+R      D   + K E+  +    H ++++L
Sbjct: 20  GVGTFGKVKIGEHQLT---GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                   +  +V E+++ G L  ++  + +        +  QI   + Y H      ++
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HMVV 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA- 348
           H D+KP+N+LLD H NA+I+DFGL+ +++    + ++T+  G+  Y APE          
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRLYAGP 190
Query: 349 KVDVYSFGVLLLEIISCRKSFDIE 372
           +VD++S GV+L  ++     FD E
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 27  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 84  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           G+VA  WYR
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-----------GFVATRWYR 185
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 34/226 (15%)
Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 224
           +  + G G+FG V++            T VAVK L +    D + +F+ E  ++ +  + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-----------SWNLRTN----- 268
           N+V+LLG C  G+   L++E++  G L  FL  ++ P           S   R +     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 269 ---------IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-LLT 318
                    IA Q+A G+ YL E    + +H D+  +N L+ ++   +I+DFGL++ + +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            +  K         + ++ PE    +  T + DV+++GV+L EI S
Sbjct: 227 ADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDG-EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + +   +A+K L   ++ ++G E + + E+ +     H N++R+
Sbjct: 24  GKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             +  + +   L+ EF   G L   L  + +           ++A  L Y HE    ++I
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVI 137
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+L+      +I+DFG     +++     +  + GT  Y+ PE     T   K
Sbjct: 138 HRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEK 193
Query: 350 VDVYSFGVLLLEIISCRKSFD 370
           VD++  GVL  E +     FD
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFD 214

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 35/212 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V   +    + S   VA+KKL R FQ     K    E++++    H+N++ LL
Sbjct: 33  GSGAYGSVCSAI---DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHEDC 284
                  +    Y+F     +  F+  +L+    L+ +      + +Q+ +GL Y+H   
Sbjct: 90  DVFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH--- 143
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S+ ++H D+KP N+ +++    +I DFGLA           + A     GYV   WYR  
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYRAP 192
Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSF 369
            +          VD++S G ++ E+++ +  F
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L+  +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLVGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S GV++ E+I
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMI 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDG-EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY   +   + +   +A+K L   ++ ++G E + + E+ +     H N++R+
Sbjct: 23  GKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             +  + +   L+ EF   G L   L  + +           ++A  L Y HE    ++I
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVI 136
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIKP+N+L+      +I+DFG     +++     +  + GT  Y+ PE     T   K
Sbjct: 137 HRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEK 192
Query: 350 VDVYSFGVLLLEIISCRKSFD 370
           VD++  GVL  E +     FD
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFD 213

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVVAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L+  +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLVGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S GV++ E+I
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMI 219

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V        R     VAVKKL R FQ     +    E+ ++    H+N++ LL
Sbjct: 37  GSGAYGSVCSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSS 286
                  +     E     TL      N+     L       + +Q+ RGL Y+H   S+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            IIH D+KP N+ +++    RI DFGLA           + A     GYVA  WYR   I
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLA-----------RQADEEMTGYVATRWYRAPEI 199
Query: 347 -------TAKVDVYSFGVLLLEIISCRKSF 369
                     VD++S G ++ E++  +  F
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 226
            KE  G G FG V + + + T      VA+K+  +      +E +  E+ ++ + +H N+
Sbjct: 18  MKERLGTGGFGYVLRWIHQDT---GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 227 VRLLGFCDEGQN------RLLVYEFLNNGTLASFL--FGN---LKPSWNLRTNIAFQIAR 275
           V      D  Q        LL  E+   G L  +L  F N   LK    +RT ++  I+ 
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIRTLLS-DISS 132
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
            L YLHE+   +IIH D+KP+NI+L         +I D G AK   L+Q + + T   GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGE-LCTEFVGT 186
Query: 333 KGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
             Y+APE   +   T  VD +SFG L  E I+  + F
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V        R     VAVKKL R FQ     +    E+ ++    H+N++ LL
Sbjct: 29  GSGAYGSVCSAYDARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSS 286
                  +     E     TL      N+     L       + +Q+ RGL Y+H   S+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 142
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            IIH D+KP N+ +++    RI DFGLA           + A     GYVA  WYR   I
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLA-----------RQADEEMTGYVATRWYRAPEI 191
Query: 347 -------TAKVDVYSFGVLLLEIISCRKSF 369
                     VD++S G ++ E++  +  F
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 226
            KE  G G FG V + + + T      VA+K+  +      +E +  E+ ++ + +H N+
Sbjct: 19  MKERLGTGGFGYVLRWIHQDT---GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 75
Query: 227 VRLLGFCDEGQN------RLLVYEFLNNGTLASFL--FGN---LKPSWNLRTNIAFQIAR 275
           V      D  Q        LL  E+   G L  +L  F N   LK    +RT ++  I+ 
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIRTLLS-DISS 133
Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
            L YLHE+   +IIH D+KP+NI+L         +I D G AK   L+Q + + T   GT
Sbjct: 134 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGE-LCTEFVGT 187
Query: 333 KGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
             Y+APE   +   T  VD +SFG L  E I+  + F
Sbjct: 188 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLLG 231
           GRGS+  V    ++ T     A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 61  GRGSYAKVLLVRLKKT-DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 232 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 175
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+K  N+LLD   + +++D+G+ K   L    T  T   GT  Y+APE  R       
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFC-GTPNYIAPEILRGEDYGFS 233
Query: 350 VDVYSFGVLLLEIISCRKSFDI 371
           VD ++ GVL+ E+++ R  FDI
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDI 255

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I D GLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 17/243 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 17  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 73
Query: 203 --VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV-YEFLNNGTLASFL--FG 257
             + ++       E  V+ +  H   V+L  FC +   +L     +  NG L  ++   G
Sbjct: 74  HIIKENKVPYVTRERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIG 132
Query: 258 NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL 317
           +   +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L
Sbjct: 133 SFDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 187
Query: 318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
           +    +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY
Sbjct: 188 SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEY 245
Query: 378 AIL 380
            I 
Sbjct: 246 LIF 248

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   L       + + +Q+  G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMEL--DHERMSYLLYQMLXGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I  FGLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLV 227
           +  G G++G V   V    RT    VA+KKL R FQ     K    E+ ++    H+N++
Sbjct: 31  QPVGSGAYGAVCSAV--DGRTGAK-VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         D+  +  LV  F+  GT    L  + K   +    + +Q+ +GL Y+H
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-- 339
              ++ IIH D+KP N+ +++    +I DFGLA+     Q+ +       T+ Y APE  
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVI 197
Query: 340 --WYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
             W R    T  VD++S G ++ E+I+ +  F
Sbjct: 198 LNWMR---YTQTVDIWSVGCIMAEMITGKTLF 226

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAVK +D+   +    +K F+ EV ++   +H N+V
Sbjct: 23  GKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTI 346
           I+H D+K +N+LLD   N +I+DFG +   T         A  G   Y APE ++ K   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYD 190
Query: 347 TAKVDVYSFGVLLLEIISCRKSFD 370
             +VDV+S GV+L  ++S    FD
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 173 GRGSFGIVY--KGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL- 229
           G+GSFG V+  K +  +      A+ V K   +        K E  ++ + +H  +V+L 
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH 92
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F  EG+   L+ +FL  G L + L    K       ++ F +A   L L    S  II
Sbjct: 93  YAFQTEGK-LYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+NILLD+  + +++DFGL+K    ++ K    +  GT  Y+APE   +   T  
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEVVNRRGHTQS 206
Query: 350 VDVYSFGVLLLEIISCRKSF 369
            D +SFGVL+ E+++    F
Sbjct: 207 ADWWSFGVLMFEMLTGTLPF 226

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I D GLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA+      +           G VA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GXVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 22/280 (7%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 12  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 68
Query: 203 --VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
             + ++       E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS 128
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 129 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +    +  GT  YV+PE   + + +   D+++ G ++ ++++    F    G EY 
Sbjct: 184 PESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 241
Query: 379 ILT-----DWAFDCYRNGKLDDLVEG--DMEAMNDIKCVE 411
           I       ++ F      K  DLVE    ++A   + C E
Sbjct: 242 IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEE 281

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTT---AVAVKKLDRVFQDGEKEFKN-EVVVIGQTH 222
           NF    G+GSFG     V+ + R  T    AV + K D V QD + E    E  V+    
Sbjct: 23  NFLMVLGKGSFG----KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 223 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 279
               +  L  C +  +RL  V E++N G L   +   G  K    +    A +IA GL +
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--YAAEIAIGLFF 136
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L    S  II+ D+K  N++LD   + +I+DFG+ K    +   T      GT  Y+APE
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KXFCGTPDYIAPE 191
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                     VD ++FGVLL E+++ +  F+ E  +E
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DF LA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 109/242 (45%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 66
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 127 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +    A  GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 182 PESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 239
Query: 379 IL 380
           I 
Sbjct: 240 IF 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VA+K +D+   +    +K F+ EV ++   +H N+V
Sbjct: 24  GKGNFAKV-----KLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   L+ E+ + G +  +L  + +       +   QI   + Y H+    +
Sbjct: 78  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KR 134
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTI 346
           I+H D+K +N+LLD   N +I+DFG +   T+        A  G   Y APE ++ K   
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYD 191
Query: 347 TAKVDVYSFGVLLLEIISCRKSFD 370
             +VDV+S GV+L  ++S    FD
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 51  GSGAYGSVCAAF--DTKTGHR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 108 DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I DFGLA           +       G VA  WYR
Sbjct: 163 --SADIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTDDEMXGXVATRWYR 209
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRLLG 231
           G GSFG+V++  +      +  VA+KK   V QD  K FKN E+ ++    H N+V L  
Sbjct: 49  GNGSFGVVFQAKL----VESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKA 99
Query: 232 FCDEGQNRL------LVYEFLNNGTL-ASFLFGNLKPSWN--LRTNIAFQIARGLLYLHE 282
           F     ++       LV E++      AS  +  LK +    L     +Q+ R L Y+H 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158
Query: 283 DCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 340
             S  I H DIKPQN+LLD      ++ DFG AK+L   +          ++ Y APE  
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC---SRYYRAPELI 213
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +  +  T  +D++S G ++ E++  +  F  E G
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 195 VAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFL 246
           VAVKKL R FQ+    K    E+V++   +HKN++ LL         +E Q+  LV E +
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA 306
           +   L   +   L       + + +Q+  G+ +LH   S+ IIH D+KP NI++      
Sbjct: 112 D-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 307 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
           +I DFGLA+    N    + T    T+ Y APE        A VD++S G ++ E++
Sbjct: 166 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 173 GRGSFGIVY--KGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL- 229
           G+GSFG V+  K +  +      A+ V K   +        K E  ++ + +H  +V+L 
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH 92
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F  EG+   L+ +FL  G L + L    K       ++ F +A   L L    S  II
Sbjct: 93  YAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+NILLD+  + +++DFGL+K    ++ K    +  GT  Y+APE   +   T  
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEVVNRRGHTQS 206
Query: 350 VDVYSFGVLLLEIISCRKSF 369
            D +SFGVL+ E+++    F
Sbjct: 207 ADWWSFGVLMFEMLTGTLPF 226

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T+T    VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 31  GSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPSWNLRTN----IAFQIARGLLYLHE 282
                 ++     E  N+  L + L G    N+     L  +    + +QI RGL Y+H 
Sbjct: 88  DVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S+ IIH D+KP N+ +++    +I D GLA+      +           GYVA  WYR
Sbjct: 143 --SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT-----------GYVATRWYR 189
Query: 343 KSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              I          VD++S G ++ E+++ R  F
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG------------------- 207
             K+E G+GS+G+V     E   T      + K   + Q G                   
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 208 ----EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLVYEFLNNGTLASFLFGNLKP 261
                ++   E+ ++ +  H N+V+L+   D+    +  +V+E +N G +       LKP
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKP 133
Query: 262 SWNLRTNIAFQ-IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
               +    FQ + +G+ YLH     +IIH DIKP N+L+ +  + +I+DFG++      
Sbjct: 134 LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN--EFK 188
Query: 321 QSKTIKTAIRGTKGYVAPEWY---RKSTITAKVDVYSFGVLL 359
            S  + +   GT  ++APE     RK      +DV++ GV L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V   +    + S   VA+KKL R FQ     K    E++++    H+N++ LL
Sbjct: 51  GSGAYGSVCSAI---DKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGLLYLHEDC 284
                  +    Y+F     +  F+  +L+    +  +      + +Q+ +GL Y+H   
Sbjct: 108 DVFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH--- 161
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S+ ++H D+KP N+ +++    +I DFGLA           + A     GYV   WYR  
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----------RHADAEMTGYVVTRWYRAP 210
Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSF 369
            +          VD++S G ++ E+++ +  F
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 173 GRGSFGIVY--KGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL- 229
           G+GSFG V+  K +  +      A+ V K   +        K E  ++ + +H  +V+L 
Sbjct: 34  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH 93
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             F  EG+   L+ +FL  G L + L    K       ++ F +A   L L    S  II
Sbjct: 94  YAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLGII 149
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+NILLD+  + +++DFGL+K    ++ K    +  GT  Y+APE   +   T  
Sbjct: 150 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEVVNRRGHTQS 207
Query: 350 VDVYSFGVLLLEIISCRKSF 369
            D +SFGVL+ E+++    F
Sbjct: 208 ADWWSFGVLMFEMLTGTLPF 227

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTT---AVAVKKLDRVFQDGEKEFKN-EVVVIGQTH 222
           NF    G+GSFG     V+ + R  T    AV + K D V QD + E    E  V+    
Sbjct: 344 NFLMVLGKGSFG----KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 223 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLY 279
               +  L  C +  +RL  V E++N G L   +   G  K    +    A +IA GL +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV--FYAAEIAIGLFF 457
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           L    S  II+ D+K  N++LD   + +I+DFG+ K    +   T      GT  Y+APE
Sbjct: 458 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KXFCGTPDYIAPE 512
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                     VD ++FGVLL E+++ +  F+ E  +E
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 20/265 (7%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 15  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 71
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 72  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 131
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 132 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 186
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 187 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 244
Query: 379 ILT-----DWAFDCYRNGKLDDLVE 398
           I       ++ F      K  DLVE
Sbjct: 245 IFQKIIKLEYDFPAAFFPKARDLVE 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAVK +D+   +    +K F+ EV ++   +H N+V
Sbjct: 24  GKGNFAKV-----KLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KY 134
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYR-KST 345
           I+H D+K +N+LLD   N +I+DFG +   T+ N+  T      G+  Y APE ++ K  
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC----GSPPYAAPELFQGKKY 190
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFD 370
              +VDV+S GV+L  ++S    FD
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 34/226 (15%)
Query: 168 FKEEAGRGSFGIVYKGV---IETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQT-H 222
           F +  G G+FG V       I  T  S   VAVK L       E+E   +E+ ++ Q   
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQ-VAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-------------FGNLK-----PSWN 264
           H+N+V LLG C       L++E+   G L ++L             + N K        N
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 265 LRTN-----IAFQIARGLLYLH-EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
           + T       A+Q+A+G+ +L  + C    +H D+  +N+L+      +I DFGLA+ + 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            + +  ++   R    ++APE   +   T K DV+S+G+LL EI S
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG V  G  + T      VAVK L+R      D   + K E+  +    H ++++L
Sbjct: 20  GVGTFGKVKIGEHQLT---GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                   +  +V E+++ G L  ++  + +        +  QI   + Y H      ++
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HMVV 133
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA- 348
           H D+KP+N+LLD H NA+I+DFGL+ +++    + ++ +  G+  Y APE          
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRDSC-GSPNYAAPEVISGRLYAGP 190
Query: 349 KVDVYSFGVLLLEIISCRKSFDIE 372
           +VD++S GV+L  ++     FD E
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 12/212 (5%)
Query: 159 KALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           K  EE  D   E+ G GS+G VYK +    + +   VA+K++    +   +E   E+ ++
Sbjct: 25  KQPEEVFDVL-EKLGEGSYGSVYKAI---HKETGQIVAIKQVP--VESDLQEIIKEISIM 78
Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGL 277
            Q    ++V+  G   +  +  +V E+   G+++  +   N   + +    I     +GL
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            YLH     + IH DIK  NILL+   +A+++DFG+A  LT   +K  +  + GT  ++A
Sbjct: 139 EYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK--RNXVIGTPFWMA 193
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           PE  ++       D++S G+  +E+   +  +
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 165 TDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           TD ++  E+ G+G+F +V + V   T     A  +       +D +K  + E  +     
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H N+VRL     E     LV++ +  G L   +      S    ++   QI   +L+ H+
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 283 DCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
                ++H D+KP+N+LL         +++DFGLA  +  +Q      A  GT GY++PE
Sbjct: 122 ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 340 WYRKSTITAKVDVYSFGVLL 359
             RK      VD+++ GV+L
Sbjct: 177 VLRKEAYGKPVDIWACGVIL 196

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL---------DRVFQDGEKEFKNEVVVIGQTHH 223
           G+GSFG V+  V + TR  +  +   K+         DRV    E++      ++   +H
Sbjct: 37  GQGSFGKVFL-VRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD------ILADVNH 89
Query: 224 KNLVRL-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
             +V+L   F  EG+   L+ +FL  G L + L   +  +         ++A GL +LH 
Sbjct: 90  PFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH- 147
Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             S  II+ D+KP+NILLD+  + +++DFGL+K    ++ K    +  GT  Y+APE   
Sbjct: 148 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY--SFCGTVEYMAPEVVN 203
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSF 369
           +   +   D +S+GVL+ E+++    F
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAVK +D+   +    +K F+ EV ++   +H N+V
Sbjct: 23  GKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYR-KST 345
           I+H D+K +N+LLD   N +I+DFG +   T  N+  T      G+  Y APE ++ K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKY 189
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFD 370
              +VDV+S GV+L  ++S    FD
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 13/195 (6%)
Query: 170 EEAGRGSFGIVYK--GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           EE G+G+F +V +   V+     +   +  KKL    +D +K  + E  +     H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA--RDHQK-LEREARICRLLKHPNIV 84
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           RL     E  +  L+++ +  G L   +      S    ++   QI   +L+ H+     
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 288 IIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           ++H D+KP+N+LL         +++DFGLA  +   Q      A  GT GY++PE  RK 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKD 199
Query: 345 TITAKVDVYSFGVLL 359
                VD+++ GV+L
Sbjct: 200 PYGKPVDLWACGVIL 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 32/294 (10%)
Query: 168 FKEEAGRGSFGIVYKGVIETT----RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           F E  G+G+F  ++KGV        +   T V +K LD+  ++  + F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYL 280
           K+LV   G C  G   +LV EF+  G+L ++L  N   +   W L   +A Q+A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAAAMHFL 129
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAP 338
            E+    +IH ++  +NILL    + +  +    KL     S T+  K  ++    +V P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 339 EWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           E       +    D +SFG  L EI S         G +  +    A D  R  +  +  
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICS---------GGDKPLS---ALDSQRKLQFYE-- 232
Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 451
             D   +   K  E   +++  C+  +P  RP+ R + + L  +   D+ P  S
Sbjct: 233 --DRHQLPAPKAAELANLINN-CMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAVK +D+   +    +K F+ EV ++   +H N+V
Sbjct: 23  GKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYR-KST 345
           I+H D+K +N+LLD   N +I+DFG +   T  N+  T      G+  Y APE ++ K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKY 189
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFD 370
              +VDV+S GV+L  ++S    FD
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 129/286 (45%), Gaps = 53/286 (18%)
Query: 169 KEEAGRGSFG-IVYKGVIETTRTSTTAVAVKK-LDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           K+  G G+ G IVY+G+ +        VAVK+ L   F   ++E +   ++     H N+
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNR-----DVAVKRILPECFSFADREVQ---LLRESDEHPNV 80
Query: 227 VRLLGFCDEGQNRLLVYEF-LNNGTLASFL----FGNL--KPSWNLRTNIAFQIARGLLY 279
           +R   FC E   +       L   TL  ++    F +L  +P   L+     Q   GL +
Sbjct: 81  IRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ-----QTTSGLAH 133
Query: 280 LHEDCSSQIIHCDIKPQNILLD-----DHYNARISDFGLAKLLTL-NQSKTIKTAIRGTK 333
           LH   S  I+H D+KP NIL+          A ISDFGL K L +   S + ++ + GT+
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 334 GYVAPEWYR---KSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW-AFDCY 388
           G++APE      K   T  VD++S G +   +IS     F   +  +  IL    + DC 
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250
Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
              K +D++  ++        +EK++ +       DP  RP+ + V
Sbjct: 251 HPEKHEDVIAREL--------IEKMIAM-------DPQKRPSAKHV 281

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 32/294 (10%)
Query: 168 FKEEAGRGSFGIVYKGVIETT----RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           F E  G+G+F  ++KGV        +   T V +K LD+  ++  + F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYL 280
           K+LV   G C  G   +LV EF+  G+L ++L  N   +   W L   +A Q+A  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE--VAKQLAWAMHFL 129
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAP 338
            E+    +IH ++  +NILL    + +  +    KL     S T+  K  ++    +V P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 339 EWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           E       +    D +SFG  L EI S         G +  +    A D  R  +  +  
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICS---------GGDKPLS---ALDSQRKLQFYE-- 232
Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 451
             D   +   K  E   +++  C+  +P  RP+ R + + L  +   D+ P  S
Sbjct: 233 --DRHQLPAPKAAELANLINN-CMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 109/242 (45%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 13  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 69
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 70  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 129
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 130 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 184
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +    +  GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 185 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 242
Query: 379 IL 380
           I 
Sbjct: 243 IF 244

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAVK +D+   +    +K F+ EV +    +H N+V
Sbjct: 23  GKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 77  KLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTI 346
           I+H D+K +N+LLD   N +I+DFG +   T         A  G   Y APE ++ K   
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYD 190
Query: 347 TAKVDVYSFGVLLLEIISCRKSFD 370
             +VDV+S GV+L  ++S    FD
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   L       + + +Q+  G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMEL--DHERMSYLLYQMLXGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ + +VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 26  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   L       + + +Q+  G+ +LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMEL--DHERMSYLLYQMLXGIKHLH 136
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 190
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 10/190 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G++G V     + T        +KK             +EV V+ Q  H N+++L  F
Sbjct: 30  GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEF 89
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++ +N  LV E    G L   +    K S      I  Q+  G  YLH+     I+H D
Sbjct: 90  FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRD 146
Query: 293 IKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           +KP+N+LL+        +I DFGL+    +      +    GT  Y+APE  RK     K
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAPEVLRKK-YDEK 202
Query: 350 VDVYSFGVLL 359
            DV+S GV+L
Sbjct: 203 CDVWSCGVIL 212

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLLG 231
           GRGS+  V    ++ T     A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 18  GRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 232 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 132
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+K  N+LLD   + +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT-SXFCGTPNYIAPEILRGEDYGFS 190
Query: 350 VDVYSFGVLLLEIISCRKSFDI 371
           VD ++ GVL+ E+++ R  FDI
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDI 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 165 TDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           TD +  KE+ G GS+ +  + + + T       AVK +D+  +D  +E +   +++    
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXE---FAVKIIDKSKRDPTEEIE---ILLRYGQ 74
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H N++ L    D+G+   +V E    G L   +      S    + + F I + + YLH 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH- 133
Query: 283 DCSSQIIHCDIKPQNIL-LDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
             +  ++H D+KP NIL +D+  N    RI DFG AK L              T  +VAP
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY--TANFVAP 189
Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
           E   +    A  D++S GVLL   ++    F
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLLG 231
           GRGS+  V    ++ T     A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 29  GRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 232 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 143
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+K  N+LLD   + +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT-SXFCGTPNYIAPEILRGEDYGFS 201
Query: 350 VDVYSFGVLLLEIISCRKSFDI 371
           VD ++ GVL+ E+++ R  FDI
Sbjct: 202 VDWWALGVLMFEMMAGRSPFDI 223

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 24/283 (8%)
Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG V     + T   T   VAVK L +         ++ E+ ++   +H+++V+  
Sbjct: 18  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYK 77
Query: 231 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           G C D+G+  + LV E++  G+L  +L  +      L    A QI  G+ YLH   +   
Sbjct: 78  GCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLH---AQHY 133
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IH  +  +N+LLD+    +I DFGLAK +   ++   ++        + APE  ++    
Sbjct: 134 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 193
Query: 348 AKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
              DV+SFGV L E++       S    F   +G     +T          +L +L+E  
Sbjct: 194 YASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL--------RLTELLERG 245
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                  +C  ++  +   C + + S RPT + +  +L+   E
Sbjct: 246 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           KE  G GS+    + V + T       AVK +D+  +D  +E +   +++    H N++ 
Sbjct: 32  KETIGVGSYSECKRCVHKATNME---YAVKVIDKSKRDPSEEIE---ILLRYGQHPNIIT 85
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L    D+G++  LV E +  G L   +      S    + +   I + + YLH   S  +
Sbjct: 86  LKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH---SQGV 142
Query: 289 IHCDIKPQNIL-LDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +H D+KP NIL +D+  N    RI DFG AK L       +      T  +VAPE  ++ 
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQ 200
Query: 345 TITAKVDVYSFGVLLLEIISCRKSF 369
                 D++S G+LL  +++    F
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKNLV 227
           ++ G GSFG   K ++  +        +K+++  R+     +E + EV V+    H N+V
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQ----------IARGL 277
           +     +E  +  +V ++   G L   +        N +  + FQ          I   L
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRI--------NAQKGVLFQEDQILDWFVQICLAL 138
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            ++H+    +I+H DIK QNI L      ++ DFG+A++  LN +  +  A  GT  Y++
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLS 193
Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
           PE         K D+++ G +L E+ + + +F+
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L+  +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLVGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 39/234 (16%)
Query: 160 ALEEATDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 217
           +L  A+D F+E A  G+G+FG V K         +   A+KK+ R  ++      +EV++
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKA---RNALDSRYYAIKKI-RHTEEKLSTILSEVML 55
Query: 218 IGQTHHKNLVRLLGFCDEGQN-------------RLLVYEFLNNGTLASFLFG-NLKPSW 263
           +   +H+ +VR      E +N               +  E+  N TL   +   NL    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR 115
Query: 264 NLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-------L 316
           +    +  QI   L Y+H   S  IIH D+KP NI +D+  N +I DFGLAK       +
Sbjct: 116 DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 317 LTLN------QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEII 363
           L L+       S  + +AI GT  YVA E    +     K+D+YS G++  E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 24/283 (8%)
Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 230
           G G FG V     + T   T   VAVK L        +  ++ E+ ++   +H+++V+  
Sbjct: 17  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYK 76
Query: 231 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           G C D+G+  + LV E++  G+L  +L  +      L    A QI  G+ YLH   +   
Sbjct: 77  GCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL-FAQQICEGMAYLH---AQHY 132
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IH  +  +N+LLD+    +I DFGLAK +   ++   ++        + APE  ++    
Sbjct: 133 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 192
Query: 348 AKVDVYSFGVLLLEII-------SCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
              DV+SFGV L E++       S    F   +G     +T          +L +L+E  
Sbjct: 193 YASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL--------RLTELLERG 244
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                  +C  ++  +   C + + S RPT + +  +L+   E
Sbjct: 245 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLLG 231
           GRGS+  V    ++ T     A+ V K + V  D + ++ + E  V  Q  +   +  L 
Sbjct: 14  GRGSYAKVLLVRLKKT-DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 232 FCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            C + ++RL  V E++N G L   +    K P  + R   A +I+  L YLHE     II
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGII 128
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+K  N+LLD   + +++D+G+ K   L    T  +   GT  Y+APE  R       
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTT-SXFCGTPNYIAPEILRGEDYGFS 186
Query: 350 VDVYSFGVLLLEIISCRKSFDI 371
           VD ++ GVL+ E+++ R  FDI
Sbjct: 187 VDWWALGVLMFEMMAGRSPFDI 208

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 10/190 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G++G V     + T        +KK             +EV V+ Q  H N+++L  F
Sbjct: 13  GSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEF 72
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++ +N  LV E    G L   +    K S      I  Q+  G  YLH+     I+H D
Sbjct: 73  FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRD 129
Query: 293 IKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           +KP+N+LL+        +I DFGL+    +      +    GT  Y+APE  RK     K
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAPEVLRKK-YDEK 185
Query: 350 VDVYSFGVLL 359
            DV+S GV+L
Sbjct: 186 CDVWSCGVIL 195

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VA+K +D+   +    +K F+ EV ++   +H N+V
Sbjct: 21  GKGNFAKV-----KLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 74
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   L+ E+ + G +  +L  + +       +   QI   + Y H+    +
Sbjct: 75  KLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KR 131
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTI 346
           I+H D+K +N+LLD   N +I+DFG +   T+           G+  Y APE ++ K   
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFCGSPPYAAPELFQGKKYD 188
Query: 347 TAKVDVYSFGVLLLEIISCRKSFD 370
             +VDV+S GV+L  ++S    FD
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 20/265 (7%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 12  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 68
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 128
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 129 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 184 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 241
Query: 379 ILT-----DWAFDCYRNGKLDDLVE 398
           I       ++ F      K  DLVE
Sbjct: 242 IFQKIIKLEYDFPEKFFPKARDLVE 266

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 24/274 (8%)
Query: 167 NFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 224
           NF+ E   GRG F  VY+              V+  D +      +   E+ ++ Q +H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAF--QIARGLLYL 280
           N+++      E     +V E  + G L+  +  F   K     RT   +  Q+   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S +++H DIKP N+ +      ++ D GL +  +     T   ++ GT  Y++PE 
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 207
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
             ++    K D++S G LL E+ + +  F  +    Y++       C +      + + D
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKK------IEQCD 254
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
              +      E+L  +   CI  DP  RP +  V
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAV+ +D+   +    +K F+ EV ++   +H N+V
Sbjct: 23  GKGNFAKV-----KLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYR-KST 345
           I+H D+K +N+LLD   N +I+DFG +   T  N+  T      G+  Y APE ++ K  
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKKY 189
Query: 346 ITAKVDVYSFGVLLLEIISCRKSFD 370
              +VDV+S GV+L  ++S    FD
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 12  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 68
Query: 203 --VFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
             + ++       E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 128
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 129 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 184 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 241
Query: 379 IL 380
           I 
Sbjct: 242 IF 243

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 20/265 (7%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 13  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 69
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 70  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 129
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 130 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 184
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 185 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 242
Query: 379 ILT-----DWAFDCYRNGKLDDLVE 398
           I       ++ F      K  DLVE
Sbjct: 243 IFQKIIKLEYDFPEKFFPKARDLVE 267

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 12  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 68
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 128
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 129 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 184 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 241
Query: 379 IL 380
           I 
Sbjct: 242 IF 243

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 66
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 127 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 182 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 239
Query: 379 IL 380
           I 
Sbjct: 240 IF 241

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 195 VAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFL 246
           VAVKKL R FQ+    K    E+V++   +HKN++ LL         +E Q+  LV E +
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA 306
           +   L   +   L       + + +Q+  G+ +LH   S+ IIH D+KP NI++      
Sbjct: 110 D-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 163
Query: 307 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEII 363
           +I DFGLA+  + N    + T    T+ Y APE          VD++S G ++ E++
Sbjct: 164 KILDFGLARTASTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 108/242 (44%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 66
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 127 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 182 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 239
Query: 379 IL 380
           I 
Sbjct: 240 IF 241

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L+  +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           KE  G GS+    + V + T       AVK +D+  +D  +E +   +++    H N++ 
Sbjct: 32  KETIGVGSYSECKRCVHKATNME---YAVKVIDKSKRDPSEEIE---ILLRYGQHPNIIT 85
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L    D+G++  LV E +  G L   +      S    + +   I + + YLH   S  +
Sbjct: 86  LKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH---SQGV 142
Query: 289 IHCDIKPQNIL-LDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +H D+KP NIL +D+  N    RI DFG AK L       +      T  +VAPE  ++ 
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQ 200
Query: 345 TITAKVDVYSFGVLLLEIISCRKSF 369
                 D++S G+LL  +++    F
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 38  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 149
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +    +  GT  YV+PE   + +  
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
              D+++ G ++ ++++    F    G EY I 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 240

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAV+ +D+   +    +K F+ EV ++   +H N+V
Sbjct: 23  GKGNFAKV-----KLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 76
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           +L    +  +   LV E+ + G +  +L  + +           QI   + Y H+     
Sbjct: 77  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF--- 133
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTI 346
           I+H D+K +N+LLD   N +I+DFG +   T            G+  Y APE ++ K   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYD 190
Query: 347 TAKVDVYSFGVLLLEIISCRKSFD 370
             +VDV+S GV+L  ++S    FD
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 71  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 181
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 235
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 63  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 173
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 228
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G+V        +T    VA+KK+     Q   +    E+ ++ +  H+N++ +  
Sbjct: 52  GEGAYGMVSSAYDHVRKTR---VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSSQI 288
                    +   ++    + + L+  LK       +I +   QI RGL Y+H   S+ +
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH---SANV 165
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKTAIRGTKGYVAPEWYRKST-I 346
           +H D+KP N+L++   + +I DFGLA++       T   T    T+ Y APE    S   
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
           T  +D++S G +L E++S R  F
Sbjct: 226 TKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 18  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 129
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +       GT  YV+PE   + +  
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-----DWAFDCYRNGKLDDLVEG--D 400
              D+++ G ++ ++++    F    G EY I       ++ F      K  DLVE    
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 247
Query: 401 MEAMNDIKCVE 411
           ++A   + C E
Sbjct: 248 LDATKRLGCEE 258

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 19  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 130
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +       GT  YV+PE   + +  
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-----DWAFDCYRNGKLDDLVEG--D 400
              D+++ G ++ ++++    F    G EY I       ++ F      K  DLVE    
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 248
Query: 401 MEAMNDIKCVE 411
           ++A   + C E
Sbjct: 249 LDATKRLGCEE 259

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 48  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 99
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 158
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 159 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 213
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 247

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L+  +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 161 LEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           +E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQIIRE 54
Query: 219 GQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
            Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++  +
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTR 167
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
            Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 161 LEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           +E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQIIRE 54
Query: 219 GQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
            Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++  +
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTR 167
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
            Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 17  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 128
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +       GT  YV+PE   + +  
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-----DWAFDCYRNGKLDDLVEG--D 400
              D+++ G ++ ++++    F    G EY I       ++ F      K  DLVE    
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246
Query: 401 MEAMNDIKCVE 411
           ++A   + C E
Sbjct: 247 LDATKRLGCEE 257

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK      + ++   A K +D   ++  +++  E+ ++    H N+V+LL
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQII 289
                  N  ++ EF   G + + +    +P    +  +   Q    L YLH++   +II
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYVAPEWY-----R 342
           H D+K  NIL     + +++DFG++       ++TI  + +  GT  ++APE       +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 343 KSTITAKVDVYSFGVLLLEI 362
                 K DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 113/251 (45%), Gaps = 22/251 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 16  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 127
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +       GT  YV+PE   + +  
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-----DWAFDCYRNGKLDDLVEG--D 400
              D+++ G ++ ++++    F    G EY I       ++ F      K  DLVE    
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 245
Query: 401 MEAMNDIKCVE 411
           ++A   + C E
Sbjct: 246 LDATKRLGCEE 256

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 37  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 88
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 147
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 148 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 202
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 33  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 84
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 143
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 144 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 198
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 232

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 161 LEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           +E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQIIRE 54
Query: 219 GQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
            Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++  +
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTR 167
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
            Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 41  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 151
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 152 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 206
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 240

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 41  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 92
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 151
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 152 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 206
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 240

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 71  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 181
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 235
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHKILF 263

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 161 LEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           +E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQIIRE 54
Query: 219 GQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
            Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++  +
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTR 167
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
            Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 30  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 81
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 140
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 141 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 195
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 229

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDG---EKEFKNEVVVIGQTHHKNLV 227
           G+G+F  V     +  R   T   VAVK +D+   +    +K F+ EV ++   +H N+V
Sbjct: 16  GKGNFAKV-----KLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIV 69
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSW--NLRTNIAF-QIARGLLYLHEDC 284
           +L    +  +   LV E+ + G +  +L  +    W         F QI   + Y H+  
Sbjct: 70  KLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPEWYR- 342
              I+H D+K +N+LLD   N +I+DFG +   T  N+  T      G+  Y APE ++ 
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQG 179
Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFD 370
           K     +VDV+S GV+L  ++S    FD
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 57  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 108
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 167
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 168 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 222
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 223 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 256

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHT-----G 182
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 38  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 149
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +       GT  YV+PE   + +  
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
              D+++ G ++ ++++    F    G EY I 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 240

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 63  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 173
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 340
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 228
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +  +  T+ +DV+S G +L E++  +  F  + G
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V   V+     ++   A+K L++  + ++ +  +   E  V+ +  H   V+L
Sbjct: 23  GEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                + +       +  NG L  ++   G+   +   R   A +I   L YLH      
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-EIVSALEYLH---GKG 134
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           IIH D+KP+NILL++  + +I+DFG AK+L+    +       GT  YV+PE   + +  
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
              D+++ G ++ ++++    F    G EY I 
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPF--RAGNEYLIF 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV--VVIGQTH---- 222
           K+  GRG   +V + V    R +    AVK ++   +    E   EV      +TH    
Sbjct: 99  KDVIGRGVSSVVRRCV---HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 223 ---HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
              H +++ L+   +      LV++ +  G L  +L   +  S     +I   +   + +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH   ++ I+H D+KP+NILLDD+   R+SDFG +    L   + ++  + GT GY+APE
Sbjct: 216 LH---ANNIVHRDLKPENILLDDNMQIRLSDFGFS--CHLEPGEKLRE-LCGTPGYLAPE 269
Query: 340 WYRKST------ITAKVDVYSFGVLLLEIISCRKSF 369
             + S          +VD+++ GV+L  +++    F
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G+V        +     VA+KK+     Q   +    E+ ++ +  H+N++ +  
Sbjct: 36  GEGAYGMVCSAYDNLNKVR---VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI---AFQIARGLLYLHEDCSSQI 288
                    +   ++    + + L+  LK       +I    +QI RGL Y+H   S+ +
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 149
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-- 346
           +H D+KP N+LL+   + +I DFGLA++   +   T          YVA  WYR   I  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT-----GFLTEYVATRWYRAPEIML 204
Query: 347 -----TAKVDVYSFGVLLLEIISCRKSF 369
                T  +D++S G +L E++S R  F
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 161 LEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI 218
           +E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQIIRE 54
Query: 219 GQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
            Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++  +
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  GT+
Sbjct: 114 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTR 167
Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
            Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 65  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 116
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 175
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 340
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 176 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELI 230
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +  +  T+ +DV+S G +L E++  +  F  + G
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 264

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G G++G+VYK   +     T A+   +L++  +        E+ ++ +  H N+V+L
Sbjct: 8   EKIGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 230 LGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                  +  +LV+E L+     L     G L+       +   Q+  G+ Y H+    +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHD---RR 120
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI- 346
           ++H D+KPQN+L++     +I+DFGLA+   +         +R     V   WYR   + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--------PVRKYTHEVVTLWYRAPDVL 172
Query: 347 ------TAKVDVYSFGVLLLEIISCRKSF 369
                 +  +D++S G +  E+++    F
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G G++G+VYK   +     T A+   +L++  +        E+ ++ +  H N+V+L
Sbjct: 8   EKIGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 230 LGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                  +  +LV+E L+     L     G L+       +   Q+  G+ Y H+    +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHD---RR 120
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI- 346
           ++H D+KPQN+L++     +I+DFGLA+   +         +R     V   WYR   + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--------PVRKYTHEVVTLWYRAPDVL 172
Query: 347 ------TAKVDVYSFGVLLLEIISCRKSF 369
                 +  +D++S G +  E+++    F
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 159 KALEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 216
           K  E   D+F+   E G G+ G+V K         +  +  +KL  +  + +   +N+++
Sbjct: 9   KVGELKDDDFERISELGAGNGGVVTK----VQHRPSGLIMARKL--IHLEIKPAIRNQII 62
Query: 217 VIGQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
              Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++ 
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSI 121
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            + RGL YL E    QI+H D+KP NIL++     ++ DFG++  L      ++  +  G
Sbjct: 122 AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVG 175
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
           T+ Y+APE  + +  + + D++S G+ L+E+   R
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 67  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 118
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 177
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 340
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 178 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELI 232
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +  +  T+ +DV+S G +L E++  +  F  + G
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 266

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G+V        +     VA+KK+     Q   +    E+ ++ +  H+N++ +  
Sbjct: 52  GEGAYGMVCSAYDNVNKVR---VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF---QIARGLLYLHEDCSSQI 288
                    +   +L    + + L+  LK       +I +   QI RGL Y+H   S+ +
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 165
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-- 346
           +H D+KP N+LL+   + +I DFGLA++   +   T          YVA  WYR   I  
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT-----GFLTEYVATRWYRAPEIML 220
Query: 347 -----TAKVDVYSFGVLLLEIISCRKSF 369
                T  +D++S G +L E++S R  F
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L+  +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLSQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 42  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 93
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 152
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 153 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 207
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 208 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 241

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 34  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 88  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 144
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 198
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 9/193 (4%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           EE G+G+F +V + V         A+ +       +D +K  + E  +     H N+VRL
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHPNIVRL 75
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                E  +  L+++ +  G L   +      S    ++   QI   +L+ H+     ++
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVV 132
Query: 290 HCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           H ++KP+N+LL         +++DFGLA  +   Q      A  GT GY++PE  RK   
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPY 190
Query: 347 TAKVDVYSFGVLL 359
              VD+++ GV+L
Sbjct: 191 GKPVDLWACGVIL 203

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 27  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 81  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 137
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 191
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 34  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 88  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 144
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 198
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHKILF 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 26  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 136
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 190
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILF 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 27  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 81  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 137
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 191
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHKILF 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   L       + + +Q+  G+ +LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILF 225

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  V++        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 32  GSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 85
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++   L   +   L       + + +Q+  G+ +LH
Sbjct: 86  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMEL--DHERMSYLLYQMLCGIKHLH 142
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 143 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 196
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSF 369
                   VD++S G ++ E++  +  F
Sbjct: 197 LGMGYKENVDIWSVGCIMGEMVRHKILF 224

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 108 GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 159
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 218
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 340
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 219 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELI 273
Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +  +  T+ +DV+S G +L E++  +  F  + G
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 307

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+  T   S  ++  +  T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV-VTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRK 367
                   VD++S G ++ E++ C K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMV-CHK 222

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 34  GNGSFGVVYQAKLCD---SGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 85
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 144
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 145 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 199
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           L+      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R  ++ A+ DVYS G 
Sbjct: 148 LISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 358 LLLEIISCRKSF 369
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 153 LRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGE 208
           L+  S+    +  D ++  E  G G++G+V        R +   VA+KK+   F      
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSA---RRRLTGQQVAIKKIPNAFDVVTNA 98
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCD------EGQNRLLVYEFLNNGTLASFLFGNLKPS 262
           K    E+ ++    H N++ +           E ++  +V + + +  L   +  +   +
Sbjct: 99  KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLT 157
Query: 263 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
                   +Q+ RGL Y+H   S+Q+IH D+KP N+L++++   +I DFG+A+ L  + +
Sbjct: 158 LEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 214
Query: 323 KTIKTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           +           YVA  WYR   +       T  +D++S G +  E+++ R+ F
Sbjct: 215 EHQYFMTE----YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT-----G 186
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT-----G 182
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT-----G 182
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G G++G+VYK   +     T A+   +L++  +        E+ ++ +  H N+V+L
Sbjct: 8   EKIGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 230 LGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                  +  +LV+E L+     L     G L+       +   Q+  G+ Y H+    +
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHD---RR 120
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI- 346
           ++H D+KPQN+L++     +I+DFGLA+   +         +R     +   WYR   + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--------PVRKYTHEIVTLWYRAPDVL 172
Query: 347 ------TAKVDVYSFGVLLLEIISCRKSF 369
                 +  +D++S G +  E+++    F
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 15/242 (6%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF      V+     ++   A+K L++ 
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTT---VLARELATSREYAIKILEKR 66
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 67  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 127 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA 378
               +       GT  YV+PE   + +     D+++ G ++ ++++    F    G EY 
Sbjct: 182 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYL 239
Query: 379 IL 380
           I 
Sbjct: 240 IF 241

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R  ++ A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 358 LLLEIISCRKSF 369
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHT-----G 184
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 115/240 (47%), Gaps = 24/240 (10%)
Query: 159 KALEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 216
           K  E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++
Sbjct: 61  KVGELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQII 114
Query: 217 VIGQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
              Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++ 
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSI 173
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            + +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  G
Sbjct: 174 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVG 227
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
           T+ Y++PE  + +  + + D++S G+ L+E+   R        +E  ++    F C   G
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM----FGCQVEG 283

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 122/284 (42%), Gaps = 32/284 (11%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G+G FG V +  ++    S   VAVK  K D +     +EF  E   + +  H ++ +L+
Sbjct: 32  GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 231 GFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQ--IARGLL 278
           G     + +      +++  F+ +G L +FL     G    +  L+T + F   IA G+ 
Sbjct: 92  GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YL    S   IH D+  +N +L +     ++DFGL++ +          A +    ++A 
Sbjct: 152 YL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208
Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 398
           E    +  T   DV++FGV + EI++  ++                +    N ++ + + 
Sbjct: 209 ESLADNLYTVHSDVWAFGVTMWEIMTRGQT---------------PYAGIENAEIYNYLI 253
Query: 399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
           G        +C+E++  +   C   DP  RP+   +   LE ++
Sbjct: 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 34  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 144
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 198
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMI 220

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK      + ++   A K +D   ++  +++  E+ ++    H N+V+LL
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQII 289
                  N  ++ EF   G + + +    +P    +  +   Q    L YLH++   +II
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY-----RKS 344
           H D+K  NIL     + +++DFG++   T    +  + +  GT  ++APE       +  
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDR 215
Query: 345 TITAKVDVYSFGVLLLEI 362
               K DV+S G+ L+E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+    +   T +     T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV---TRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R  ++ A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 358 LLLEIISCRKSF 369
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 159 KALEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 216
           K  E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++
Sbjct: 26  KVGELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQII 79
Query: 217 VIGQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
              Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++ 
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSI 138
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            + +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  G
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVG 192
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
           T+ Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R  ++ A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 358 LLLEIISCRKSF 369
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 27  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 81  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 137
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 191
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRK 367
                   VD++S G ++ E++ C K
Sbjct: 192 LGMGYKENVDLWSVGCIMGEMV-CHK 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R  ++ A+ DVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 358 LLLEIISCRKSF 369
           +L E+++    F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 33  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 143
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+  T   S  ++  +  T+ Y APE  
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEV-VTRYYRAPEVI 197
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRK 367
                   VD++S G ++ E++ C K
Sbjct: 198 LGMGYKENVDLWSVGCIMGEMV-CHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 38  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 91
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 92  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 148
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 149 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVI 202
Query: 342 RKSTITAKVDVYSFGVLLLEIISCRK 367
                   VD++S G ++ E++ C K
Sbjct: 203 LGMGYKENVDLWSVGCIMGEMV-CHK 227

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 241 LVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI 298
           +V E+++  TL   +   G + P   +   +     + L + H++    IIH D+KP NI
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAI--EVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 299 LLDDHYNARISDFGLAKLLTLNQSKTIKTA-IRGTKGYVAPEWYRKSTITAKVDVYSFGV 357
           ++      ++ DFG+A+ +  + +   +TA + GT  Y++PE  R  ++ A+ DVYS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 358 LLLEIISCRKSF 369
           +L E+++    F
Sbjct: 225 VLYEVLTGEPPF 236

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 244 EFLNNGTLASFLFGNLKPSWN--LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD 301
           EF + GTL  ++        +  L   +  QI +G+ Y+H   S ++IH D+KP NI L 
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLV 170
Query: 302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLE 361
           D    +I DFGL   L  N  K  +T  +GT  Y++PE         +VD+Y+ G++L E
Sbjct: 171 DTKQVKIGDFGLVTSLK-NDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
Query: 362 IIS-CRKSFD 370
           ++  C  +F+
Sbjct: 228 LLHVCDTAFE 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 13/231 (5%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 12  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 68
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 128
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 129 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +       GT  YV+PE   + +     D+++ G ++ ++++    F
Sbjct: 184 PESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 153 LRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGE 208
           L+  S+    +  D ++  E  G G++G+V        R +   VA+KK+   F      
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSA---RRRLTGQQVAIKKIPNAFDVVTNA 97
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCD------EGQNRLLVYEFLNNGTLASFLFGNLKPS 262
           K    E+ ++    H N++ +           E ++  +V + + +  L   +  +   +
Sbjct: 98  KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD-LHQIIHSSQPLT 156
Query: 263 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
                   +Q+ RGL Y+H   S+Q+IH D+KP N+L++++   +I DFG+A+ L  + +
Sbjct: 157 LEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213
Query: 323 KTIKTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           +           YVA  WYR   +       T  +D++S G +  E+++ R+ F
Sbjct: 214 EHQYFMTE----YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 186
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 182
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 139 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 190
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 191 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 182
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 184
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 184
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 180
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 181 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 202
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 203 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 180
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 181 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 187
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 188 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 137 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 188
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 189 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 128 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 179
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 180 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 186
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT-----G 186
Query: 331 GTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
               YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 304
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
            R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 305 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 356

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK      + ++   A K +D   ++  +++  E+ ++    H N+V+LL
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQII 289
                  N  ++ EF   G + + +    +P    +  +   Q    L YLH++   +II
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY-----RKS 344
           H D+K  NIL     + +++DFG++   T    +  +    GT  ++APE       +  
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDR 215
Query: 345 TITAKVDVYSFGVLLLEI 362
               K DV+S G+ L+E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 13/231 (5%)
Query: 144 PGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR- 202
           PG G+++        +        F +  G GSF  V   V+     ++   A+K L++ 
Sbjct: 12  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTV---VLARELATSREYAIKILEKR 68
Query: 203 -VFQDGEKEF-KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGN 258
            + ++ +  +   E  V+ +  H   V+L     + +       +  NG L  ++   G+
Sbjct: 69  HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 128
Query: 259 LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 318
              +   R   A +I   L YLH      IIH D+KP+NILL++  + +I+DFG AK+L+
Sbjct: 129 FDETCT-RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183
Query: 319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
               +       GT  YV+PE   + +     D+++ G ++ ++++    F
Sbjct: 184 PESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 306
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
            R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 307 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 358

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 112/230 (48%), Gaps = 30/230 (13%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           E+ GRG FGIV++ V  +++ +  A  V VK  D+V        K E+ ++    H+N++
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNIARHRNIL 64
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS---WNLRTNIAF--QIARGLLYLHE 282
            L    +  +  ++++EF++       +F  +  S    N R  +++  Q+   L +LH 
Sbjct: 65  HLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 283 DCSSQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPE 339
             S  I H DI+P+NI+     ++  +I +FG A+ L    + + + TA      Y APE
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA----PEYYAPE 173
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE---EYAILTDWAFD 386
            ++   ++   D++S G L+  ++S    F  E  +   E  +  ++ FD
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 311
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
            R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 312 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 363

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 159 KALEEATDNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV 216
           K  E   D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++
Sbjct: 18  KVGELKDDDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQII 71
Query: 217 VIGQTHHK-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
              Q  H+ N   ++GF      +G+  + + E ++ G+L   L    +    +   ++ 
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSI 130
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            + +GL YL E    +I+H D+KP NIL++     ++ DFG++  L      ++  +  G
Sbjct: 131 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVG 184
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR 366
           T+ Y++PE  + +  + + D++S G+ L+E+   R
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 21/179 (11%)
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K   
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       T + DV+SFGVLL EI S   S    +++ EE+         C
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 313
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
            R      L EG      D    E +    + C   +PS RPT  ++ + L  +++ + 
Sbjct: 314 RR------LKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 365

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +FQ+ARG+ +L    S + IH D+  +NILL ++   +I DFGLA+ +  N     K   
Sbjct: 205 SFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAFDC 387
           R    ++APE       + K DV+S+GVLL EI S   S    ++M E++         C
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF---------C 312
Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQML 438
            R      L EG M          ++  + + C   DP  RP   ++ + L
Sbjct: 313 SR------LREG-MRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 165 TDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           TD ++  EE G+G+F +V + +   T     A  +       +D +K  + E  +     
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H N+VRL     E     LV++ +  G L   +      S    ++   QI   + + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH- 120
Query: 283 DCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
              + I+H D+KP+N+LL         +++DFGLA  +  +Q      A  GT GY++PE
Sbjct: 121 --LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 340 WYRKSTITAKVDVYSFGVLL 359
             RK      VD+++ GV+L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 173 GRGSFGIV---YKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           G G+ GIV   Y  ++E        VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 35  GSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 88
Query: 228 RLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  +V E ++   L   +   ++      + + +Q+  G+ +LH
Sbjct: 89  GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKHLH 145
Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
              S+ IIH D+KP NI++      +I DFGLA+      +  +      T+ Y APE  
Sbjct: 146 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTRYYRAPEVI 199
Query: 342 RKSTITAKVDVYSFGVLLLEII 363
                   VD++S G ++ E+I
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMI 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 165 TDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
           TD ++  EE G+G+F +V + +   T     A  +       +D +K  + E  +     
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H N+VRL     E     LV++ +  G L   +      S    ++   QI   + + H 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 283 DCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           +    I+H D+KP+N+LL         +++DFGLA  +  +Q      A  GT GY++PE
Sbjct: 122 NG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 340 WYRKSTITAKVDVYSFGVLL 359
             RK      VD+++ GV+L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 25/193 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVIGQTHHKNLV 227
           G G F  VYK      + +   VA+KK+    +   K+  N     E+ ++ +  H N++
Sbjct: 19  GEGQFATVYKA---RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDC 284
            LL       N  LV++F+    L   +  N   L PS +++  +   + +GL YLH+  
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS-HIKAYMLMTL-QGLEYLHQHW 132
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              I+H D+KP N+LLD++   +++DFGLA        K+  +  R     V   WYR  
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLA--------KSFGSPNRAYXHQVVTRWYRAP 181
Query: 345 TITAKVDVYSFGV 357
            +     +Y  GV
Sbjct: 182 ELLFGARMYGVGV 194

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V Q   K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQG--KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    + + ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +          ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC---SRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEV----VVIGQTH 222
           +F +  G+GSFG   K ++   +      AVK L +     +KE K+ +    V++    
Sbjct: 41  HFLKVIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLY 279
           H  LV L            V +++N G L   L      L+P        A +IA  L Y
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGY 154
Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH   S  I++ D+KP+NILLD   +  ++DFGL K    + S T  +   GT  Y+APE
Sbjct: 155 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPE 209
Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSF 369
              K      VD +  G +L E++     F
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 170 EEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           E  G+G F +V + +   T  + +   V V K         ++ K E  +     H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTL---------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
            LL          +V+EF++   L         A F++     S  +R     QI   L 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QILEALR 144
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           Y H++    IIH D+KP  +LL    N+   ++  FG+A  + L +S  +     GT  +
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHF 199
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           +APE  ++      VDV+  GV+L  ++S
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G GSF I  K V    + S  A AVK +  R+  + +KE     +  G   H N+V+L  
Sbjct: 20  GEGSFSICRKCV---HKKSNQAFAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHE 73
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL----YLHEDCSSQ 287
              +  +  LV E LN G L    F  +K   +     A  I R L+    ++H+     
Sbjct: 74  VFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VG 126
Query: 288 IIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           ++H D+KP+N+L    +D+   +I DFG A+L   + ++ +KT    T  Y APE   ++
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCF-TLHYAAPELLNQN 184
Query: 345 TITAKVDVYSFGVLLLEIISCRKSF 369
                 D++S GV+L  ++S +  F
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G G FG V+K      R       +K   RV  + EK  + EV  + +  H N+V  
Sbjct: 17  ELIGSGGFGQVFKA---KHRIDGKTYVIK---RVKYNNEKA-EREVKALAKLDHVNIVHY 69
Query: 230 LGFCD----------EGQNR------LLVYEFLNNGTLASFLFGNLKPSWN--LRTNIAF 271
            G  D          +  +R       +  EF + GTL  ++        +  L   +  
Sbjct: 70  NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           QI +G+ Y+H   S ++I+ D+KP NI L D    +I DFGL   L  N  K  ++  +G
Sbjct: 130 QITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRXRS--KG 183
Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFD 370
           T  Y++PE         +VD+Y+ G++L E++  C  +F+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 170 EEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           E  G+G F +V + +   T  + +   V V K         ++ K E  +     H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTL---------ASFLFGNLKPSWNLRTNIAFQIARGLL 278
            LL          +V+EF++   L         A F++     S  +R     QI   L 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QILEALR 146
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           Y H++    IIH D+KP  +LL    N+   ++  FG+A  + L +S  +     GT  +
Sbjct: 147 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHF 201
Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           +APE  ++      VDV+  GV+L  ++S
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILFILLS 230

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 147 GTVETNLR---CFSYKALEEAT--DNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           GT+E   +     S  A   AT  D ++   + G G++G VYK  I+T    T A+   +
Sbjct: 10  GTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKA-IDTVTNETVAIKRIR 68
Query: 200 LDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL 259
           L+   +        EV ++ +  H+N++ L           L++E+  N  L  ++  N 
Sbjct: 69  LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNP 127
Query: 260 KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL-----DDHYNARISDFGLA 314
             S  +  +  +Q+  G+ + H   S + +H D+KPQN+LL      +    +I DFGLA
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEII 363
           +   +         IR     +   WYR   I       +  VD++S   +  E++
Sbjct: 185 RAFGI--------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 152 NLRCFSYKALEE---ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE 208
            L+   Y+  EE   AT   +   GRGSFG V++  +E  +T       K    VF+   
Sbjct: 80  KLKPVDYEYREEVHWATHQLR--LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR--- 132
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 268
                E++         +V L G   EG    +  E L  G+L   +    K    L  +
Sbjct: 133 ---AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPED 185
Query: 269 IAF----QIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLT---LN 320
            A     Q   GL YLH   S +I+H D+K  N+LL  D  +A + DFG A  L    L 
Sbjct: 186 RALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 242
Query: 321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           +S      I GT+ ++APE     +  AKVDV+S   ++L +++
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 286

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 166 DNFKE--EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           D+F++  E G G+ G+V+K     +   +  V  +KL  +  + +   +N+++   Q  H
Sbjct: 9   DDFEKISELGAGNGGVVFK----VSHKPSGLVMARKL--IHLEIKPAIRNQIIRELQVLH 62
Query: 224 K-NLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
           + N   ++GF      +G+  + + E ++ G+L   L    +    +   ++  + +GL 
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 121
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YL E    +I+H D+KP NIL++     ++ DFG++  L       +     GT+ Y++P
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DEMANEFVGTRSYMSP 175
Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCR 366
           E  + +  + + D++S G+ L+E+   R
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHKN 225
           GRG FG VY       R + T    A+K LD+     + GE    NE +++    T    
Sbjct: 198 GRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            +  + +     ++L  + + +N G L   L  +   S       A +I  GL ++H   
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--- 309
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +  +++ D+KP NILLD+H + RISD GLA     + SK    A  GT GY+APE  +K 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 345 TI-TAKVDVYSFGVLLLEIISCRKSF 369
               +  D +S G +L +++     F
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHKN 225
           GRG FG VY       R + T    A+K LD+     + GE    NE +++    T    
Sbjct: 197 GRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 251
Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            +  + +     ++L  + + +N G L   L  +   S       A +I  GL ++H   
Sbjct: 252 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--- 308
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +  +++ D+KP NILLD+H + RISD GLA     + SK    A  GT GY+APE  +K 
Sbjct: 309 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 364
Query: 345 TI-TAKVDVYSFGVLLLEIISCRKSF 369
               +  D +S G +L +++     F
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 50/244 (20%)
Query: 163 EATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVI 218
           +  DN+  K   GRGS+G VY   +   + +   VA+KK++R+F+D    K    E+ ++
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVY---LAYDKNANKNVAIKKVNRMFEDLIDCKRILREITIL 81
Query: 219 GQTHHKNLVRLLGFC--------DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 270
            +     ++RL            DE     +V E  ++     F         +++T I 
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDE---LYIVLEIADSDLKKLFKTPIFLTEQHVKT-IL 137
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----- 325
           + +  G  ++HE   S IIH D+KP N LL+   + +I DFGLA+  T+N  K I     
Sbjct: 138 YNLLLGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLAR--TINSDKDIHIVND 192
Query: 326 --------------KTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIIS 364
                         K   +    +V   WYR   +       T  +D++S G +  E+++
Sbjct: 193 LEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252
Query: 365 CRKS 368
             KS
Sbjct: 253 MMKS 256

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHKN 225
           GRG FG VY       R + T    A+K LD+     + GE    NE +++    T    
Sbjct: 198 GRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            +  + +     ++L  + + +N G L   L  +   S       A +I  GL ++H   
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--- 309
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +  +++ D+KP NILLD+H + RISD GLA     + SK    A  GT GY+APE  +K 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 345 TI-TAKVDVYSFGVLLLEIISCRKSF 369
               +  D +S G +L +++     F
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKLDRV---FQDGEKEFKNEVVVIG--QTHHKN 225
           GRG FG VY       R + T    A+K LD+     + GE    NE +++    T    
Sbjct: 198 GRGGFGEVY-----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
            +  + +     ++L  + + +N G L   L  +   S       A +I  GL ++H   
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH--- 309
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           +  +++ D+KP NILLD+H + RISD GLA     + SK    A  GT GY+APE  +K 
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 345 TI-TAKVDVYSFGVLLLEIISCRKSF 369
               +  D +S G +L +++     F
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKTAI 329
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 330 RGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSF 369
             T+ Y APE    S   T  +D++S G +L E++S R  F
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 5/101 (4%)
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKTAI 329
           +QI RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T      
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 330 RGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSF 369
             T+ Y APE    S   T  +D++S G +L E++S R  F
Sbjct: 193 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 39/234 (16%)
Query: 160 ALEEATDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV 217
           +L  A+D F+E A  G+G+FG V K         +   A+KK+ R  ++      +EV +
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKA---RNALDSRYYAIKKI-RHTEEKLSTILSEVXL 55
Query: 218 IGQTHHKNLVRLLGFCDEGQN-------------RLLVYEFLNNGTLASFLFG-NLKPSW 263
           +   +H+ +VR      E +N               +  E+  N TL   +   NL    
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR 115
Query: 264 NLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK-------L 316
           +    +  QI   L Y+H   S  IIH ++KP NI +D+  N +I DFGLAK       +
Sbjct: 116 DEYWRLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 317 LTLN------QSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEII 363
           L L+       S  + +AI GT  YVA E    +     K+D YS G++  E I
Sbjct: 173 LKLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V Q   K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQG--KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRL-L 230
           G GSFG+VY+  +     S   VA+KK   V Q   K FKN E+ ++ +  H N+VRL  
Sbjct: 29  GNGSFGVVYQAKLCD---SGELVAIKK---VLQG--KAFKNRELQIMRKLDHCNIVRLRY 80
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA--------FQIARGLLYLHE 282
            F   G+ +  VY  L    +   ++   +     +  +         +Q+ R L Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I H DIKPQN+LLD D    ++ DFG AK L   +      +   ++ Y APE  
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELI 194
Query: 342 RKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
             +T  T+ +DV+S G +L E++  +  F  + G
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 93/330 (28%), Positives = 140/330 (42%), Gaps = 56/330 (16%)
Query: 136 KKKWIRNSPGDGTVETNLRCFSYKALEEATDNF---KEEAGRGSFG-IVYKGVIETTRTS 191
           KKK  R S G G      R  +    E++  N    ++  G GS G +V++G  +     
Sbjct: 3   KKKRKRGSRG-GKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGR--- 58
Query: 192 TTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF-LNNG 249
              VAVK++   F D    E K   ++     H N++R   +C E  +R L     L N 
Sbjct: 59  --PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY--YCSETTDRFLYIALELCNL 111
Query: 250 TLASFLFGNLKPSWNLRTNIAF-------QIARGLLYLHEDCSSQIIHCDIKPQNILL-- 300
            L   +        NL+    +       QIA G+ +LH   S +IIH D+KPQNIL+  
Sbjct: 112 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVST 168
Query: 301 ------DDHYNAR-----ISDFGLAKLLTLNQS--KTIKTAIRGTKGYVAPEWYRKST-- 345
                 D    A      ISDFGL K L   Q   +       GT G+ APE   +ST  
Sbjct: 169 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 346 -ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
            +T  +D++S G +   I+S  K      G++Y+  ++     +    LD     +M+ +
Sbjct: 229 RLTRSIDIFSMGCVFYYILSKGKH---PFGDKYSRESNIIRGIF---SLD-----EMKCL 277
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           +D   + +   +    I  DP  RPT  KV
Sbjct: 278 HDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 93/330 (28%), Positives = 140/330 (42%), Gaps = 56/330 (16%)
Query: 136 KKKWIRNSPGDGTVETNLRCFSYKALEEATDNF---KEEAGRGSFG-IVYKGVIETTRTS 191
           KKK  R S G G      R  +    E++  N    ++  G GS G +V++G  +     
Sbjct: 3   KKKRKRGSRG-GKKGRKSRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGR--- 58
Query: 192 TTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF-LNNG 249
              VAVK++   F D    E K   ++     H N++R   +C E  +R L     L N 
Sbjct: 59  --PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY--YCSETTDRFLYIALELCNL 111
Query: 250 TLASFLFGNLKPSWNLRTNIAF-------QIARGLLYLHEDCSSQIIHCDIKPQNILL-- 300
            L   +        NL+    +       QIA G+ +LH   S +IIH D+KPQNIL+  
Sbjct: 112 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVST 168
Query: 301 ------DDHYNAR-----ISDFGLAKLLTLNQS--KTIKTAIRGTKGYVAPEWYRKST-- 345
                 D    A      ISDFGL K L   Q   +       GT G+ APE   +ST  
Sbjct: 169 SSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKR 228
Query: 346 -ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
            +T  +D++S G +   I+S  K      G++Y+  ++     +    LD     +M+ +
Sbjct: 229 RLTRSIDIFSMGCVFYYILSKGKH---PFGDKYSRESNIIRGIF---SLD-----EMKCL 277
Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           +D   + +   +    I  DP  RPT  KV
Sbjct: 278 HDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK      + +    A K ++   ++  +++  E+ ++    H  +V+LL
Sbjct: 18  ELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 74
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           G         ++ EF   G + + +     G  +P   +   +  Q+   L +LH   S 
Sbjct: 75  GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLH---SK 128
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLA--KLLTLNQSKTIKTAIRGTKGYVAP-----E 339
           +IIH D+K  N+L+    + R++DFG++   L TL +    + +  GT  ++AP     E
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK----RDSFIGTPYWMAPEVVMCE 184
Query: 340 WYRKSTITAKVDVYSFGVLLLEI 362
             + +    K D++S G+ L+E+
Sbjct: 185 TMKDTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           E G G+FG VYK      + +    A K ++   ++  +++  E+ ++    H  +V+LL
Sbjct: 26  ELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           G         ++ EF   G + + +     G  +P   +   +  Q+   L +LH   S 
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLH---SK 136
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLA--KLLTLNQSKTIKTAIRGTKGYVAP-----E 339
           +IIH D+K  N+L+    + R++DFG++   L TL +    + +  GT  ++AP     E
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK----RDSFIGTPYWMAPEVVMCE 192
Query: 340 WYRKSTITAKVDVYSFGVLLLEI 362
             + +    K D++S G+ L+E+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 126/294 (42%), Gaps = 56/294 (19%)
Query: 173 GRGSFG-IVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLL 230
           G GS G +V++G  +        VAVK++   F D    E K   ++     H N++R  
Sbjct: 24  GYGSSGTVVFQGSFQGR-----PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY- 74
Query: 231 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPSWNLRTNIAF-------QIARGLLYLHE 282
            +C E  +R L     L N  L   +        NL+    +       QIA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 283 DCSSQIIHCDIKPQNILL--------DDHYNAR-----ISDFGLAKLLTLNQS--KTIKT 327
             S +IIH D+KPQNIL+        D    A      ISDFGL K L   QS  +T   
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 328 AIRGTKGYVAPEWYRKST-------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
              GT G+ APE   +S        +T  +D++S G +   I+S  K      G++Y+  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH---PFGDKYSRE 247
Query: 381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           ++     +    LD     +M+ ++D   + +   +    I  DP  RPT  KV
Sbjct: 248 SNIIRGIF---SLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 152 NLRCFSYKALEE---ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE 208
            L+   Y+  EE   AT   +   GRGSFG V++  +E  +T       K    VF+   
Sbjct: 61  KLKPVDYEYREEVHWATHQLR--LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR--- 113
Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN 268
                E++         +V L G   EG    +  E L  G+L   +    K    L  +
Sbjct: 114 ---AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPED 166
Query: 269 IAF----QIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLT---LN 320
            A     Q   GL YLH   S +I+H D+K  N+LL  D  +A + DFG A  L    L 
Sbjct: 167 RALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLG 223
Query: 321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
           +       I GT+ ++APE     +  AKVDV+S   ++L +++
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLN 267

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVR 228
           G+G +G V++    T   +    A+K L +             K E  ++ +  H  +V 
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD 85
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDC 284
           L+     G    L+ E+L+ G L    F  L+       + A     +I+  L +LH+  
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQ-- 139
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+KP+NI+L+   + +++DFGL K        T+     GT  Y+APE   +S
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI--HDGTVTHTFCGTIEYMAPEILMRS 196
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 390
                VD +S G L+ ++++    F    GE      D    C  N
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCKLN 239

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVR 228
           G+G +G V++    T   +    A+K L +             K E  ++ +  H  +V 
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD 85
Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDC 284
           L+     G    L+ E+L+ G L    F  L+       + A     +I+  L +LH+  
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLHQ-- 139
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+KP+NI+L+   + +++DFGL K        T+     GT  Y+APE   +S
Sbjct: 140 -KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI--HDGTVTHXFCGTIEYMAPEILMRS 196
Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN 390
                VD +S G L+ ++++    F    GE      D    C  N
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCKLN 239

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 15/191 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRGS+G V   V + TR      A KK+ + F +    FK E+ ++    H N++RL   
Sbjct: 18  GRGSWGEVKIAVQKGTRIRR---AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS-QIIHC 291
            ++  +  LV E    G     LF  +      R + A +I + +L     C    + H 
Sbjct: 75  FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 292 DIKPQNIL-LDDHYNA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           D+KP+N L L D  ++  ++ DFGLA        K ++T + GT  YV+P+   +     
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQ-VLEGLYGP 186
Query: 349 KVDVYSFGVLL 359
           + D +S GV++
Sbjct: 187 ECDEWSAGVMM 197

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 101/236 (42%), Gaps = 37/236 (15%)
Query: 163 EATDNF--KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVI 218
              DN+  K   GRGS+G VY    + T  +   VA+KK++R+F+D    K    E+ ++
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKN---VAIKKVNRMFEDLIDCKRILREITIL 79
Query: 219 GQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
            +     ++RL                +V E  ++     F         +++T I + +
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT-ILYNL 138
Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-------- 325
             G  ++HE   S IIH D+KP N LL+   + ++ DFGLA+ +   +   I        
Sbjct: 139 LLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 326 ------KTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKS 368
                 K   +    +V   WYR   +       T  +D++S G +  E+++  +S
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 90/191 (47%), Gaps = 15/191 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRGS+G V   V + TR      A KK+ + F +    FK E+ ++    H N++RL   
Sbjct: 35  GRGSWGEVKIAVQKGTRIRR---AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS-QIIHC 291
            ++  +  LV E    G     LF  +      R + A +I + +L     C    + H 
Sbjct: 92  FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 292 DIKPQNIL-LDDHYNA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           D+KP+N L L D  ++  ++ DFGLA        K ++T + GT  YV+P+   +     
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQ-VLEGLYGP 203
Query: 349 KVDVYSFGVLL 359
           + D +S GV++
Sbjct: 204 ECDEWSAGVMM 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLLG 231
           GRG FG+V++      +      A+K++    ++  +E    EV  + +  H  +VR   
Sbjct: 14  GRGGFGVVFEA---KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPSWNLR-----------TNIAFQ 272
              E        E L   +   +L+         NLK   N R            +I  Q
Sbjct: 71  AWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK----------LLTLNQS 322
           IA  + +LH   S  ++H D+KP NI        ++ DFGL            +LT   +
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 382
               T   GTK Y++PE    ++ + KVD++S G++L E++     F  +M E    LTD
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRTLTD 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   Y+     T+       V K   +    +++   E+ +     + ++V   GF
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 110
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++     +V E     +L          +         Q  +G+ YLH   ++++IH D
Sbjct: 111 FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRD 167
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           +K  N+ L+D  + +I DFGLA  +  +  +  K  + GT  Y+APE   K   + +VD+
Sbjct: 168 LKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 353 YSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE 411
           +S G +L  ++  +  F+   + E Y  +    +   R+                I  V 
Sbjct: 226 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----------------INPVA 269
Query: 412 KLLMVSIWCIQEDPSLRPTM 431
             L+  +  +  DP+LRP++
Sbjct: 270 SALIRRM--LHADPTLRPSV 287

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK +   + +T   A  GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWXLA--GTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 19/193 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNLVRL 229
           G G+FG+     +   + +   VAVK ++R    GEK     K E++      H N+VR 
Sbjct: 28  GAGNFGVAR---LMRDKQANELVAVKYIER----GEKIDENVKREIINHRSLRHPNIVRF 80
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                   +  +V E+ + G L   +    + S +       Q+  G+ Y H   + Q+ 
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH---AMQVA 137
Query: 290 HCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           H D+K +N LLD     R  I+DFG +K   L+     K+A+ GT  Y+APE   K    
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP--KSAV-GTPAYIAPEVLLKKEYD 194
Query: 348 AKV-DVYSFGVLL 359
            KV DV+S GV L
Sbjct: 195 GKVADVWSCGVTL 207

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   Y+     T+       V K   +    +++   E+ +     + ++V   GF
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 110
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++     +V E     +L          +         Q  +G+ YLH   ++++IH D
Sbjct: 111 FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRD 167
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           +K  N+ L+D  + +I DFGLA  +  +  +  K  + GT  Y+APE   K   + +VD+
Sbjct: 168 LKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 353 YSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE 411
           +S G +L  ++  +  F+   + E Y  +    +   R+                I  V 
Sbjct: 226 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----------------INPVA 269
Query: 412 KLLMVSIWCIQEDPSLRPTM 431
             L+  +  +  DP+LRP++
Sbjct: 270 SALIRRM--LHADPTLRPSV 287

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 71  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAPEIILSKGYNKA 239
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 240 VDWWALGVLIYEMAAGYPPF 259

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   Y+     T+       V K   +    +++   E+ +     + ++V   GF
Sbjct: 35  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 94
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++     +V E     +L          +         Q  +G+ YLH   ++++IH D
Sbjct: 95  FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRD 151
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           +K  N+ L+D  + +I DFGLA  +  +  +  K  + GT  Y+APE   K   + +VD+
Sbjct: 152 LKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDI 209
Query: 353 YSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE 411
           +S G +L  ++  +  F+   + E Y  +    +   R+                I  V 
Sbjct: 210 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----------------INPVA 253
Query: 412 KLLMVSIWCIQEDPSLRPTM 431
             L+  +  +  DP+LRP++
Sbjct: 254 SALIRRM--LHADPTLRPSV 271

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 37  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 150
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D+    +++DFG AK     + K     + GT  Y+APE          
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 205
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 206 VDWWALGVLIYEMAAGYPPF 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           GRGSFG V++      + +    AVKK+   VF+        E+V         +V L G
Sbjct: 81  GRGSFGEVHR---MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYG 131
Query: 232 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
              EG    +  E L  G+L   +   G L     L      Q   GL YLH   + +I+
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQALEGLEYLH---TRRIL 186
Query: 290 HCDIKPQNILLD-DHYNARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPEWYRKST 345
           H D+K  N+LL  D   A + DFG A  L    L +S      I GT+ ++APE      
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 346 ITAKVDVYSFGVLLLEIIS 364
             AKVD++S   ++L +++
Sbjct: 247 CDAKVDIWSSCCMMLHMLN 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 225
             +   GRGSFG V++      + +    AVKK+   VF+        E+V         
Sbjct: 61  THQPRVGRGSFGEVHR---MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPR 111
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +V L G   EG    +  E L  G+L   +   G L     L      Q   GL YLH  
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQALEGLEYLH-- 167
Query: 284 CSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPE 339
            + +I+H D+K  N+LL  D   A + DFG A  L    L +S      I GT+ ++APE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 340 WYRKSTITAKVDVYSFGVLLLEIIS 364
                   AKVD++S   ++L +++
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLN 251

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 225
             +E  G G+  +V        +     VA+K+++    Q    E   E+  + Q HH N
Sbjct: 18  ELQEVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAF---QIARGL 277
           +V             LV + L+ G++   +      G  K      + IA    ++  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT----LNQSKTIKTAIRGTK 333
            YLH++     IH D+K  NILL +  + +I+DFG++  L     + ++K  KT + GT 
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTP 190
Query: 334 GYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
            ++APE   +      K D++SFG+  +E+ +    +      +Y  +         +  
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-----HKYPPMKVLMLTLQNDPP 245
Query: 393 LDDLVEGDMEAMNDI-KCVEKLLMVSIWCIQEDPSLRPT 430
             +    D E +    K   K  M+S+ C+Q+DP  RPT
Sbjct: 246 SLETGVQDKEMLKKYGKSFRK--MISL-CLQKDPEKRPT 281

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 16/160 (10%)
Query: 210 EFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 269
           +FKNE+ +I    ++  +   G         ++YE++ N ++  F         N    I
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 270 AFQIARGLL--------YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ 321
             Q+ + ++        Y+H +    I H D+KP NIL+D +   ++SDFG ++ +    
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--- 203
Query: 322 SKTIKTAIRGTKGYVAPEWY--RKSTITAKVDVYSFGVLL 359
            K IK + RGT  ++ PE++    S   AKVD++S G+ L
Sbjct: 204 DKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 225
             +E  G G+  +V        +     VA+K+++    Q    E   E+  + Q HH N
Sbjct: 13  ELQEVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAF---QIARGL 277
           +V             LV + L+ G++   +      G  K      + IA    ++  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT----LNQSKTIKTAIRGTK 333
            YLH++     IH D+K  NILL +  + +I+DFG++  L     + ++K  KT + GT 
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTP 185
Query: 334 GYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
            ++APE   +      K D++SFG+  +E+ +    +      +Y  +         +  
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY-----HKYPPMKVLMLTLQNDPP 240
Query: 393 LDDLVEGDMEAMNDI-KCVEKLLMVSIWCIQEDPSLRPT 430
             +    D E +    K   K  M+S+ C+Q+DP  RPT
Sbjct: 241 SLETGVQDKEMLKKYGKSFRK--MISL-CLQKDPEKRPT 276

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 24/260 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   Y+     T+       V K   +    +++   E+ +     + ++V   GF
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF 110
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCD 292
            ++     +V E     +L          +         Q  +G+ YLH   ++++IH D
Sbjct: 111 FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRD 167
Query: 293 IKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDV 352
           +K  N+ L+D  + +I DFGLA  +  +  +  K  + GT  Y+APE   K   + +VD+
Sbjct: 168 LKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGHSFEVDI 225
Query: 353 YSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVE 411
           +S G +L  ++  +  F+   + E Y  +    +   R+                I  V 
Sbjct: 226 WSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----------------INPVA 269
Query: 412 KLLMVSIWCIQEDPSLRPTM 431
             L+  +  +  DP+LRP++
Sbjct: 270 SALIRRM--LHADPTLRPSV 287

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 110/267 (41%), Gaps = 35/267 (13%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 227
           E G GSFG VY       R S   VA+KK+    +   +++++   EV  + +  H N +
Sbjct: 61  EIGHGSFGAVY--FARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSS 286
           +  G         LV E+   G+ +  L  + KP   +    +     +GL YLH   S 
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 173
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WYRK 343
            +IH D+K  NILL +    ++ DFG A ++             GT  ++APE      +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDE 227
Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
                KVDV+S G      I+C     IE+ E    L    F+      L  + + +  A
Sbjct: 228 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNESPA 272
Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPT 430
           +      E        C+Q+ P  RPT
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPT 299

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 171 EAGRGSFGIVYK------GVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK 224
           E GRG++G+V K      G I   +     V  ++  R+  D +   +        T + 
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 225 NLVR------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
            L R       +   D   ++          T+   + G           IA  I + L 
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK----------IAVSIVKALE 167
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +LH   S  +IH D+KP N+L++     ++ DFG++  L  + +KTI     G K Y+AP
Sbjct: 168 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA---GCKPYMAP 222
Query: 339 EW----YRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
           E       +   + K D++S G+ ++E+   R  +D
Sbjct: 223 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 225
             +   GRGSFG V++      + +    AVKK+   VF+        E+V         
Sbjct: 77  THQPRVGRGSFGEVHR---MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPR 127
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +V L G   EG    +  E L  G+L   +   G L     L      Q   GL YLH  
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLGQALEGLEYLH-- 183
Query: 284 CSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPE 339
            + +I+H D+K  N+LL  D   A + DFG A  L    L +S      I GT+ ++APE
Sbjct: 184 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 242
Query: 340 WYRKSTITAKVDVYSFGVLLLEIIS 364
                   AKVD++S   ++L +++
Sbjct: 243 VVMGKPCDAKVDIWSSCCMMLHMLN 267

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 103/231 (44%), Gaps = 46/231 (19%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLL 230
           G GS+G V +      +     VA+KK+ RVF+D    K    E+ ++ + +H ++V++L
Sbjct: 62  GTGSYGHVCEAY---DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 231 GFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
                   ++     +V E  ++     F         +++T + + +  G+ Y+H   S
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---S 174
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAK----------------------LLTLNQSK 323
           + I+H D+KP N L++   + ++ DFGLA+                      L+T   +K
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 324 TIKTAIRGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRK 367
            +K   R   G+V   WYR   +       T  +DV+S G +  E+++  K
Sbjct: 235 NLK---RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 110/267 (41%), Gaps = 35/267 (13%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLV 227
           E G GSFG VY       R S   VA+KK+    +   +++++   EV  + +  H N +
Sbjct: 22  EIGHGSFGAVY--FARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAFQIARGLLYLHEDCSS 286
           +  G         LV E+   G+ +  L  + KP   +    +     +GL YLH   S 
Sbjct: 79  QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---WYRK 343
            +IH D+K  NILL +    ++ DFG A ++             GT  ++APE      +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDE 188
Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
                KVDV+S G      I+C     IE+ E    L    F+      L  + + +  A
Sbjct: 189 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNESPA 233
Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPT 430
           +      E        C+Q+ P  RPT
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPT 260

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 113/260 (43%), Gaps = 36/260 (13%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN--EVVVIGQTHHK 224
             K   G G++G+V      T + +   VA+KK++  F       +   E+ ++    H+
Sbjct: 14  QLKSLLGEGAYGVVCSA---THKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHE 69
Query: 225 NLVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
           N++ +         E  N + + + L    L   +   +    +++  I +Q  R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLRAVKVL 128
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR--GTKGYVAP 338
           H    S +IH D+KP N+L++ + + ++ DFGLA+++  + +   +   +  G   YVA 
Sbjct: 129 H---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 339 EWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
            WYR   +       +  +DV+S G +L E+   R  F    G +Y       F      
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP---GRDYRHQLLLIFG----- 237
Query: 392 KLDDLVEGDMEAMNDIKCVE 411
                + G   + ND++C+E
Sbjct: 238 -----IIGTPHSDNDLRCIE 252

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 166 DNFKEE--AGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQT 221
           D F+ E  AG+G+FG V  G     +++  +VA+KK+  D  F++ E +   ++ V+   
Sbjct: 23  DRFQVERMAGQGTFGTVQLG---KEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL--- 76
Query: 222 HHKNLVRL------LGFCDEGQNRL-LVYEFLNNGTLA----SFLFGNLKPSWNLRTNIA 270
           HH N+V+L      LG  D     L +V E++ + TL     ++    + P   L     
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAI 329
           FQ+ R +  LH   S  + H DIKP N+L+++     ++ DFG AK L+ ++      A 
Sbjct: 136 FQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAY 191
Query: 330 RGTKGYVAPEW-YRKSTITAKVDVYSFGVLLLEII 363
             ++ Y APE  +     T  VD++S G +  E++
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 99/242 (40%), Gaps = 53/242 (21%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHH 223
           + K   G+GS+G+V +  IE    +  A+ +   +++ Q   K+    K EV ++ + HH
Sbjct: 29  HLKGAIGQGSYGVV-RVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---------------------------- 255
            N+ RL    ++ Q   LV E  + G L   L                            
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 256 ------FGNLKPSWN------LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL--D 301
                     + S +      L +NI  QI   L YLH   +  I H DIKP+N L   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTN 204
Query: 302 DHYNARISDFGLAK-LLTLNQSKTI-KTAIRGTKGYVAPEWYRKS--TITAKVDVYSFGV 357
             +  ++ DFGL+K    LN  +    T   GT  +VAPE    +  +   K D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 358 LL 359
           LL
Sbjct: 265 LL 266

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 176 LCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 176 LCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 128 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 181
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 182 LCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 121 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 174
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 175 LCGTPTYLAPEVL-VSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 175
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 176 LCGTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 14  GKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+KT   GT  Y+APE    +    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 247 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 300
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 301 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV----VIGQTHH-KN 225
           E G G+ G V+K      R +   +AVK++ R    G KE    ++    V+ ++H    
Sbjct: 32  EMGSGTCGQVWKMRF---RKTGHVIAVKQMRR---SGNKEENKRILMDLDVVLKSHDCPY 85
Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           +V+  G      +  +  E +  GT A  L   ++     R    +   I + L YL E 
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE- 142
Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
               +IH D+KP NILLD+    ++ DFG++  L  +++K  ++A  G   Y+APE    
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSA--GCAAYMAPERIDP 198
Query: 344 STITA-----KVDVYSFGVLLLEIIS-------CRKSFDI 371
              T      + DV+S G+ L+E+ +       C+  F++
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 14  GKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+KT   GT  Y+APE    +    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 17  GKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 72
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 73  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 129
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+KT   GT  Y+APE    +    
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 187
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPF 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 36/246 (14%)
Query: 130 GFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTR 189
           GF+  Y+ K I    G G      RC      +E      +  G GSF            
Sbjct: 14  GFYENYEPKEIL---GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF------------ 58
Query: 190 TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 249
              +A  V++L       E   K   ++   + H N+++L    +      LV++ +  G
Sbjct: 59  ---SAEEVQELR------EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG 109
Query: 250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS 309
            L  +L   +  S      I   +   +  LH+     I+H D+KP+NILLDD  N +++
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT 166
Query: 310 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST------ITAKVDVYSFGVLLLEII 363
           DFG +    L+  + ++ ++ GT  Y+APE    S          +VD++S GV++  ++
Sbjct: 167 DFGFS--CQLDPGEKLR-SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
Query: 364 SCRKSF 369
           +    F
Sbjct: 224 AGSPPF 229

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 37/294 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G GS+G V K V+++      AV + K  ++    +GE   K E+ ++ +  HKN+++L+
Sbjct: 14  GEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 231 G--FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF--QIARGLLYLHEDCSS 286
              + +E Q   +V E+   G +   L    +  + +     +  Q+  GL YLH   S 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQ 128
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-ST 345
            I+H DIKP N+LL      +IS  G+A+ L    +       +G+  +  PE      T
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188
Query: 346 ITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-GKLDDLVEGDMEA 403
            +  KVD++S GV L  I +    F+           D  +  + N GK    + GD   
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFE----------GDNIYKLFENIGKGSYAIPGD--- 235
Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM-----LEGVVEVDVPPNPSP 452
                C   L  +    ++ +P+ R ++R++ Q           E  VP  PSP
Sbjct: 236 -----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSP 284

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/268 (21%), Positives = 112/268 (41%), Gaps = 34/268 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   ++     T+       V K   +     ++   E+ +     H+++V   GF
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 233 CDEGQNRLLVYEFLNNGTLASF-----LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            ++     +V E     +L             +  + LR     QI  G  YLH +   +
Sbjct: 84  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLHRN---R 135
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHS 193
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
            +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  ++ +    ++ M  
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM-- 249
Query: 407 IKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                         +Q DP+ RPT+ ++
Sbjct: 250 --------------LQTDPTARPTINEL 263

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD----------RVFQDGEKEFKNEVVVI 218
           KE  GRG   +V + +    + +    AVK +D           V +  E   K   ++ 
Sbjct: 9   KEILGRGVSSVVRRCI---HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
             + H N+++L    +      LV++ +  G L  +L   +  S      I   +   + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
            LH+     I+H D+KP+NILLDD  N +++DFG +    L+  + ++  + GT  Y+AP
Sbjct: 126 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLR-EVCGTPSYLAP 179
Query: 339 EWYRKST------ITAKVDVYSFGVLLLEIISCRKSF 369
           E    S          +VD++S GV++  +++    F
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      KE +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFGLAK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/268 (21%), Positives = 112/268 (41%), Gaps = 34/268 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   ++     T+       V K   +     ++   E+ +     H+++V   GF
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 233 CDEGQNRLLVYEFLNNGTLASF-----LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            ++     +V E     +L             +  + LR     QI  G  YLH +   +
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLHRN---R 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGHS 195
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
            +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  ++ +    ++ M  
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM-- 251
Query: 407 IKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                         +Q DP+ RPT+ ++
Sbjct: 252 --------------LQTDPTARPTINEL 265

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           + E+ ++ + +H  ++++  F D  ++  +V E +  G L   + GN +          +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTA 328
           Q+   + YLHE+    IIH D+KP+N+LL         +I+DFG +K+  L ++  ++T 
Sbjct: 261 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT- 314
Query: 329 IRGTKGYVAPEWYRKSTITA----KVDVYSFGVLLLEIISCRKSF 369
           + GT  Y+APE    S  TA     VD +S GV+L   +S    F
Sbjct: 315 LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 43  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 156
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 212 VDWWALGVLIYEMAAGYPPF 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/268 (21%), Positives = 112/268 (41%), Gaps = 34/268 (12%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   ++     T+       V K   +     ++   E+ +     H+++V   GF
Sbjct: 26  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 85
Query: 233 CDEGQNRLLVYEFLNNGTLASF-----LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            ++     +V E     +L             +  + LR     QI  G  YLH +   +
Sbjct: 86  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLHRN---R 137
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGHS 195
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
            +VDV+S G ++  ++  +  F+   + E Y  +    +   ++  ++ +    ++ M  
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH--INPVAASLIQKM-- 251
Query: 407 IKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                         +Q DP+ RPT+ ++
Sbjct: 252 --------------LQTDPTARPTINEL 265

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   ++     T+       V K   +     ++   E+ +     H+++V   GF
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 233 CDEGQNRLLVYEFLNNGTLASF-----LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            ++     +V E     +L             +  + LR     QI  G  YLH +   +
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLHRN---R 161
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHS 219
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
            +VDV+S G ++  ++  +  F+   + E Y  +    +   ++             +N 
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH-------------INP 266
Query: 407 IKC--VEKLLMVSIWCIQEDPSLRPTMRKV 434
           +    ++K+L       Q DP+ RPT+ ++
Sbjct: 267 VAASLIQKML-------QTDPTARPTINEL 289

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   ++     T+       V K   +     ++   E+ +     H+++V   GF
Sbjct: 48  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 107
Query: 233 CDEGQNRLLVYEFLNNGTLASF-----LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            ++     +V E     +L             +  + LR     QI  G  YLH +   +
Sbjct: 108 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLHRN---R 159
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHS 217
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
            +VDV+S G ++  ++  +  F+   + E Y  +    +   ++             +N 
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH-------------INP 264
Query: 407 IKC--VEKLLMVSIWCIQEDPSLRPTMRKV 434
           +    ++K+L       Q DP+ RPT+ ++
Sbjct: 265 VAASLIQKML-------QTDPTARPTINEL 287

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/270 (21%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G F   ++     T+       V K   +     ++   E+ +     H+++V   GF
Sbjct: 30  GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 89
Query: 233 CDEGQNRLLVYEFLNNGTLASF-----LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            ++     +V E     +L             +  + LR     QI  G  YLH +   +
Sbjct: 90  FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-----QIVLGCQYLHRN---R 141
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           +IH D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   +
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGHS 199
Query: 348 AKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND 406
            +VDV+S G ++  ++  +  F+   + E Y  +    +   ++             +N 
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH-------------INP 246
Query: 407 IKC--VEKLLMVSIWCIQEDPSLRPTMRKV 434
           +    ++K+L       Q DP+ RPT+ ++
Sbjct: 247 VAASLIQKML-------QTDPTARPTINEL 269

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + +       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 65/125 (52%), Gaps = 17/125 (13%)
Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIK 326
           +I  QIA  + +LH   S  ++H D+KP NI        ++ DFGL   +  ++  +T+ 
Sbjct: 168 HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 327 TAIR---------GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
           T +          GTK Y++PE    +  + KVD++S G++L E++    SF  +M E  
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQM-ERV 280
Query: 378 AILTD 382
            I+TD
Sbjct: 281 RIITD 285

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      KE +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFGLAK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 71  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 240 VDWWALGVLIYEMAAGYPPF 259

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ ++ +    F
Sbjct: 219 VDWWALGVLIYQMAAGYPPF 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKNEVVVIGQTHHKNLVR 228
           E GRG++G V K V    + S   +AVK++     + E++    +  VV+  +    +V+
Sbjct: 29  EIGRGAYGSVNKMV---HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 229 LLGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDC 284
             G      +  +  E ++        +++  L       +   I     + L +L E+ 
Sbjct: 86  FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
             +IIH DIKP NILLD   N ++ DFG++  L  + +KT      G + Y+APE    S
Sbjct: 146 --KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GCRPYMAPERIDPS 200
Query: 345 T----ITAKVDVYSFGVLLLEIISCR 366
                   + DV+S G+ L E+ + R
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 36/246 (14%)
Query: 130 GFFFIYKKKWIRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTR 189
           GF+  Y+ K I    G G      RC      +E      +  G GSF            
Sbjct: 14  GFYENYEPKEIL---GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF------------ 58
Query: 190 TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 249
              +A  V++L       E   K   ++   + H N+++L    +      LV++ +  G
Sbjct: 59  ---SAEEVQELR------EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG 109
Query: 250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS 309
            L  +L   +  S      I   +   +  LH+     I+H D+KP+NILLDD  N +++
Sbjct: 110 ELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT 166
Query: 310 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST------ITAKVDVYSFGVLLLEII 363
           DFG +    L+  + ++  + GT  Y+APE    S          +VD++S GV++  ++
Sbjct: 167 DFGFS--CQLDPGEKLR-EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
Query: 364 SCRKSF 369
           +    F
Sbjct: 224 AGSPPF 229

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 40/272 (14%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 17  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 227 VRLLGFCDEGQNRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +RLL + +   + +L+ E +     L  F+         L  +  +Q+   + + H +C 
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG 134
Query: 286 SQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
             ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW R  
Sbjct: 135 --VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYH 188
Query: 345 TITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
               +   V+S G+LL +++      DI    +  I+    F   R            E 
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS---------EC 235
Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            + I+          WC+   PS RPT  ++ 
Sbjct: 236 QHLIR----------WCLALRPSDRPTFEEIQ 257

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIIISKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 160 ALEEATDNFKE--EAGRGSFGIVYK------GVIETTRTSTTAVAVKKLDRVFQDGEKEF 211
           ++E   D+ +   E GRG++G+V K      G I   +     V  ++  R+  D +   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 212 KNEVVVIGQTHHKNLVR------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNL 265
           +        T +  L R       +   D   ++          T+   + G        
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK------- 113
Query: 266 RTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
              IA  I + L +LH   S  +IH D+KP N+L++     ++ DFG++  L  + +K I
Sbjct: 114 ---IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI 168
Query: 326 KTAIRGTKGYVAPEW----YRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
                G K Y+APE       +   + K D++S G+ ++E+   R  +D
Sbjct: 169 DA---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNL 226
           ++ G G+FG+     +   + S   VAVK ++R    GEK     K E++      H N+
Sbjct: 25  KDIGSGNFGVAR---LMRDKQSNELVAVKYIER----GEKIAANVKREIINHRSLRHPNI 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VR         +  +V E+ + G L   +    + S +       Q+  G+ Y H   + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AM 134
Query: 287 QIIHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           Q+ H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE   K 
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLKK 191
Query: 345 TITAKV-DVYSFGVLL 359
               KV DV+S GV L
Sbjct: 192 EYDGKVADVWSCGVTL 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNL 226
           ++ G G+FG+     +   + S   VAVK ++R    GEK     K E++      H N+
Sbjct: 24  KDIGSGNFGVAR---LMRDKQSNELVAVKYIER----GEKIDENVKREIINHRSLRHPNI 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VR         +  +V E+ + G L   +    + S +       Q+  G+ Y H   + 
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AM 133
Query: 287 QIIHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           Q+ H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE   K 
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLKK 190
Query: 345 TITAKV-DVYSFGVLL 359
               KV DV+S GV L
Sbjct: 191 EYDGKVADVWSCGVTL 206

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 124/294 (42%), Gaps = 56/294 (19%)
Query: 173 GRGSFG-IVYKGVIETTRTSTTAVAVKKLDRVFQD-GEKEFKNEVVVIGQTHHKNLVRLL 230
           G GS G +V++G  +        VAVK++   F D    E K   ++     H N++R  
Sbjct: 24  GYGSSGTVVFQGSFQGR-----PVAVKRMLIDFCDIALMEIK---LLTESDDHPNVIRY- 74
Query: 231 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPSWNLRTNIAF-------QIARGLLYLHE 282
            +C E  +R L     L N  L   +        NL+    +       QIA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 283 DCSSQIIHCDIKPQNILL--------DDHYNAR-----ISDFGLAKLLTLNQS--KTIKT 327
             S +IIH D+KPQNIL+        D    A      ISDFGL K L   Q   +    
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 328 AIRGTKGYVAPEWYRKST-------ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
              GT G+ APE   +S        +T  +D++S G +   I+S  K      G++Y+  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH---PFGDKYSRE 247
Query: 381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           ++     +    LD     +M+ ++D   + +   +    I  DP  RPT  KV
Sbjct: 248 SNIIRGIF---SLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    +         A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 71  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    +         A QI     YLH   S  +I
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 240 VDWWALGVLIYEMAAGYPPF 259

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 19  GKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 74
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 75  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 131
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+K    GT  Y+APE    +    
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 189
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPF 210

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    +         A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 45  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    +         A QI     YLH   S  +I
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 158
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 159 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 213
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 214 VDWWALGVLIYEMAAGYPPF 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPSWNLRTNIAFQIARGLLYLHEDCSS 286
                +  N  +V E++  G + S L   G   +P        A QI     YLH   S 
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLH---SL 160
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE       
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 114/262 (43%), Gaps = 40/262 (15%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN--EVVVIGQTHHK 224
             K   G G++G+V      T + +   VA+KK++  F       +   E+ ++    H+
Sbjct: 14  QLKSLLGEGAYGVVCSA---THKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHE 69
Query: 225 NLVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
           N++ +         E  N + + + L    L   +   +    +++  I +Q  R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLRAVKVL 128
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG----YV 336
           H    S +IH D+KP N+L++ + + ++ DFGLA++  +++S    +   G +     +V
Sbjct: 129 H---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMVEFV 183
Query: 337 APEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR 389
           A  WYR   +       +  +DV+S G +L E+   R  F    G +Y       F    
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP---GRDYRHQLLLIFG--- 237
Query: 390 NGKLDDLVEGDMEAMNDIKCVE 411
                  + G   + ND++C+E
Sbjct: 238 -------IIGTPHSDNDLRCIE 252

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 14  GKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+K    GT  Y+APE    +    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 184
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 27  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 86
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 87  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 142
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 199
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 200 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 253
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 254 --DIPFEHDEEIIRGQVFFRQRVSS---------ECQHLIR----------WCLALRPSD 292
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 293 RPTFEEI 299

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 36  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 149
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEIILSKGYNKA 204
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 205 VDWWALGVLIYEMAAGYPPF 224

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 175 GSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-----------KEFKNEVVVIGQTHH 223
           GS+G V  GV     +    VA+K++     DG            K    E+ ++   HH
Sbjct: 33  GSYGAVCAGV----DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 224 KNLVRL----LGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLL 278
            N++ L    + F +   ++L +   L    LA  +    +  S        + I  GL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
            LHE   + ++H D+ P NILL D+ +  I DF LA+  T + +KT          YV  
Sbjct: 149 VLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---------HYVTH 196
Query: 339 EWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
            WYR   +       T  VD++S G ++ E+ + +  F
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 72  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 127
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 184
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 185 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 238
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 239 --DIPFEHDEEIIRGQVFFRQRVSS---------ECQHLIR----------WCLALRPSD 277
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 278 RPTFEEI 284

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 175 GSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-----------KEFKNEVVVIGQTHH 223
           GS+G V  GV     +    VA+K++     DG            K    E+ ++   HH
Sbjct: 33  GSYGAVCAGV----DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 224 KNLVRL----LGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLL 278
            N++ L    + F +   ++L +   L    LA  +    +  S        + I  GL 
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
            LHE   + ++H D+ P NILL D+ +  I DF LA+  T + +KT          YV  
Sbjct: 149 VLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---------HYVTH 196
Query: 339 EWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
            WYR   +       T  VD++S G ++ E+ + +  F
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 72  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 127
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 184
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 185 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 238
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 239 --DIPFEHDEEIIGGQVFFRQRVSS---------ECQHLIR----------WCLALRPSD 277
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 278 RPTFEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 73  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 128
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 185
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 186 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 239
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 240 --DIPFEHDEEIIGGQVFFRQRVSS---------ECQHLIR----------WCLALRPSD 278
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 279 RPTFEEI 285

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 160 GKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 215
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      S +       +I   L YLH +    +
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 273
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +    T+KT   GT  Y+APE    +    
Sbjct: 274 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 331
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 332 AVDWWGLGVVMYEMMCGRLPF 352

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 46/308 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 27  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 86
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+ E         
Sbjct: 87  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQ 142
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 199
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 200 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 253
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 254 --DIPFEHDEEIIRGQVFFRQRVS---------XECQHLIR----------WCLALRPSD 292
Query: 428 RPTMRKVS 435
           RPT  ++ 
Sbjct: 293 RPTFEEIQ 300

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 72  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 127
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 184
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 185 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 238
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 239 --DIPFEHDEEIIGGQVFFRQRVSS---------ECQHLIR----------WCLALRPSD 277
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 278 RPTFEEI 284

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 73  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 128
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 185
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 186 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 239
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 240 --DIPFEHDEEIIGGQVFFRQRVSS---------ECQHLIR----------WCLALRPSD 278
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 279 RPTFEEI 285

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     ++TR       + K + + +     F  E  ++   +   +V+L   
Sbjct: 83  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 142
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIHC 291
             + +   +V E++  G L      NL  ++++    A F  A  +L L    S   IH 
Sbjct: 143 FQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWYRKS----T 345
           D+KP N+LLD   + +++DFG    + +N+   ++  TA+ GT  Y++PE  +       
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 254
Query: 346 ITAKVDVYSFGVLLLEII 363
              + D +S GV L E++
Sbjct: 255 YGRECDWWSVGVFLYEML 272

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+AP           
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPAIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     + ++       + K + + +     F  E  ++   +   +V+L   
Sbjct: 84  GRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 143
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIHC 291
             + +   +V E++  G L      NL  ++++    A F  A  +L L    S  +IH 
Sbjct: 144 FQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHR 198
Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST----IT 347
           D+KP N+LLD H + +++DFG    +         TA+ GT  Y++PE  +         
Sbjct: 199 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGGDGYYG 257
Query: 348 AKVDVYSFGVLLLEIISCRKSF 369
            + D +S GV L E++     F
Sbjct: 258 RECDWWSVGVFLFEMLVGDTPF 279

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 73  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 128
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 185
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 186 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 239
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 240 --DIPFEHDEEIIGGQVFFRQRVS---------XECQHLIR----------WCLALRPSD 278
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 279 RPTFEEI 285

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 157 GKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 212
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      S +       +I   L YLH +    +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 270
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +    T+KT   GT  Y+APE    +    
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 328
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPF 349

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 46/274 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 18  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 77  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 132
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 234
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            E  + I+          WC+   PS RPT  ++
Sbjct: 235 -ECQHLIR----------WCLALRPSDRPTFEEI 257

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     ++TR       + K + + +     F  E  ++   +   +V+L   
Sbjct: 83  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 142
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIHC 291
             + +   +V E++  G L      NL  ++++    A F  A  +L L    S   IH 
Sbjct: 143 FQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 197
Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWYRKS----T 345
           D+KP N+LLD   + +++DFG    + +N+   ++  TA+ GT  Y++PE  +       
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 254
Query: 346 ITAKVDVYSFGVLLLEII 363
              + D +S GV L E++
Sbjct: 255 YGRECDWWSVGVFLYEML 272

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 46/308 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 12  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 71
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 72  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 127
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 184
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 185 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 238
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 239 --DIPFEHDEEIIGGQVFFRQRVS---------XECQHLIR----------WCLALRPSD 277
Query: 428 RPTMRKVS 435
           RPT  ++ 
Sbjct: 278 RPTFEEIQ 285

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           +F ++ G G+FG+     +   + +   VAVK ++R     E   + E++      H N+
Sbjct: 23  DFVKDIGSGNFGV---ARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNI 78
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VR         +  ++ E+ + G L   +    + S +       Q+  G+ Y H   S 
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SM 135
Query: 287 QIIHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           QI H D+K +N LLD     R  I DFG +K   L+     K+ + GT  Y+APE   + 
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLRQ 192
Query: 345 TITAKV-DVYSFGVLL 359
               K+ DV+S GV L
Sbjct: 193 EYDGKIADVWSCGVTL 208

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 46/307 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 13  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 72
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+   L       
Sbjct: 73  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQ 128
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 185
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 186 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 239
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 240 --DIPFEHDEEIIGGQVFFRQRVS---------XECQHLIR----------WCLALRPSD 278
Query: 428 RPTMRKV 434
           RPT  ++
Sbjct: 279 RPTFEEI 285

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 14  GKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+K    GT  Y+APE    +    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 184
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           GRG+FG V     ++TR       + K + + +     F  E  ++   +   +V+L   
Sbjct: 78  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-FQIARGLLYLHEDCSSQIIHC 291
             + +   +V E++  G L      NL  ++++    A F  A  +L L    S   IH 
Sbjct: 138 FQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHR 192
Query: 292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPEWYRKS----T 345
           D+KP N+LLD   + +++DFG    + +N+   ++  TA+ GT  Y++PE  +       
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 249
Query: 346 ITAKVDVYSFGVLLLEII 363
              + D +S GV L E++
Sbjct: 250 YGRECDWWSVGVFLYEML 267

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 46/308 (14%)
Query: 140 IRNSPGDGTVETNLRCFSYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKK 199
           +R +P +    T L     K   E+        G G FG VY G+  +         V+K
Sbjct: 32  LRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 91
Query: 200 LDRVFQDGE----KEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS 253
            DR+   GE         EVV++ +       ++RLL + +   + +L+ E         
Sbjct: 92  -DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQ 147
Query: 254 FLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARI 308
            LF  +     L+  +A    +Q+   + + H +C   ++H DIK +NIL+D +    ++
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKL 204
Query: 309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRK 367
            DFG   LL      T+ T   GT+ Y  PEW R      +   V+S G+LL +++    
Sbjct: 205 IDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG-- 258
Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
             DI    +  I+    F   R            E  + I+          WC+   PS 
Sbjct: 259 --DIPFEHDEEIIRGQVFFRQRVS---------XECQHLIR----------WCLALRPSD 297
Query: 428 RPTMRKVS 435
           RPT  ++ 
Sbjct: 298 RPTFEEIQ 305

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 43  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    +         A QI     YLH   S  +I
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 156
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 212 VDWWALGVLIYEMAAGYPPF 231

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG   K ++   + +    A+K L +   + +D       E  V+  T H  L   
Sbjct: 14  GKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT-A 69
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      +         +I   L YLH   S  +
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 126
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ DIK +N++LD   + +I+DFGL K   ++   T+K    GT  Y+APE    +    
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFC-GTPEYLAPEVLEDNDYGR 184
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPF 205

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 18  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 77  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 132
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 234
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 235 -ECQHLIR----------WCLALRPSDRPTFEEIQ 258

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 17  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 76  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 131
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 132 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 185
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 233
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 234 -ECQHLIR----------WCLALRPSDRPTFEEIQ 257

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 33  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 92  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 147
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 249
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 250 -ECQHLIR----------WCLALRPSDRPTFEEIQ 273

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 32  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 91  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 146
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 147 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 248
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 249 -ECQHLIR----------WCLALRPSDRPTFEEIQ 272

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 16  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 75  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 130
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 131 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 184
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 232
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 233 -ECQHLIR----------WCLALRPSDRPTFEEIQ 256

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 18  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 77  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 132
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 133 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 186
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 234
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 235 -ECQHLIR----------WCLALRPSDRPTFEEIQ 258

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 32  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 91  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 146
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 147 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 200
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVS--------- 247
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 248 XECQHLIR----------WCLALRPSDRPTFEEIQ 272

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 13  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 72  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 229
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 230 -ECQHLIR----------WCLALRPSDRPTFEEIQ 253

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 40  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 99  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 154
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 155 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 208
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVS--------- 255
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 256 XECQHLIR----------WCLALRPSDRPTFEEIQ 280

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 52  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 111 IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 166
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 167 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 220
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVSS-------- 268
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 269 -ECQHLIR----------WCLALRPSDRPTFEEIQ 292

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 112/260 (43%), Gaps = 36/260 (13%)
Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN--EVVVIGQTHHK 224
             K   G G++G+V      T + +   VA+KK++  F       +   E+ ++    H+
Sbjct: 14  QLKSLLGEGAYGVVCSA---THKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHE 69
Query: 225 NLVRLLGFCD----EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
           N++ +         E  N + + + L    L   +   +    +++  I +Q  R +  L
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTLRAVKVL 128
Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR--GTKGYVAP 338
           H    S +IH D+KP N+L++ + + ++ DFGLA+++  + +   +   +  G    VA 
Sbjct: 129 H---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVAT 185
Query: 339 EWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
            WYR   +       +  +DV+S G +L E+   R  F    G +Y       F      
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP---GRDYRHQLLLIFG----- 237
Query: 392 KLDDLVEGDMEAMNDIKCVE 411
                + G   + ND++C+E
Sbjct: 238 -----IIGTPHSDNDLRCIE 252

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 33  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 92  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 147
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVS--------- 248
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 249 XECQHLIR----------WCLALRPSDRPTFEEIQ 273

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 13  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 72  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 128 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIGGQVFFRQRVSS-------- 229
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 230 -ECQHLIR----------WCLALRPSDRPTFEEIQ 253

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + +    A+K LD+      K+ +   NE  +    +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 50/268 (18%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT---HHKNL 226
           ++ G+G +G V+ G     +     VAVK    VF   E+        I QT    H+N+
Sbjct: 43  KQIGKGRYGEVWMG-----KWRGEKVAVK----VFFTTEEASWFRETEIYQTVLMRHENI 93
Query: 227 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           +  +    +G        L+ ++  NG+L  +L      + ++   +A+    GL +LH 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-LKLAYSSVSGLCHLHT 152
Query: 283 DCSS-----QIIHCDIKPQNILLDDHYNARISDFGLA-KLLTLNQSKTIKTAIR-GTKGY 335
           +  S      I H D+K +NIL+  +    I+D GLA K ++      I    R GTK Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 336 VAPEW--------YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 387
           + PE         + +S I A  D+YSFG++L E+   R+     + EEY +        
Sbjct: 213 MPPEVLDESLNRNHFQSYIMA--DMYSFGLILWEV--ARRCVSGGIVEEYQL-------- 260
Query: 388 YRNGKLDDLVEGD--MEAMNDIKCVEKL 413
                  DLV  D   E M +I C++KL
Sbjct: 261 ----PYHDLVPSDPSYEDMREIVCIKKL 284

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 33  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 92  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 147
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +C   ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 148 NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 201
Query: 342 RKSTITAK-VDVYSFGVLLLEII 363
           R      +   V+S G+LL +++
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMV 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++   + S    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT   +APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 112/275 (40%), Gaps = 46/275 (16%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE----KEFKNEVVVIGQTHH--KNL 226
           G G FG VY G+  +         V+K DR+   GE         EVV++ +       +
Sbjct: 13  GSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHE 282
           +RLL + +   + +L+   L        LF  +     L+  +A    +Q+   + + H 
Sbjct: 72  IRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127
Query: 283 DCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
             +  ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  PEW 
Sbjct: 128 --NXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 342 RKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           R      +   V+S G+LL +++      DI    +  I+    F   R           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG----DIPFEHDEEIIRGQVFFRQRVS--------- 228
Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            E  + I+          WC+   PS RPT  ++ 
Sbjct: 229 XECQHLIR----------WCLALRPSDRPTFEEIQ 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 19  GKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 74
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      S +       +I   L YLH +    +
Sbjct: 75  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 132
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +    T+K    GT  Y+APE    +    
Sbjct: 133 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFC-GTPEYLAPEVLEDNDYGR 190
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 191 AVDWWGLGVVMYEMMCGRLPF 211

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 17  GKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 72
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      S +       +I   L YLH +    +
Sbjct: 73  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 130
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +    T+K    GT  Y+APE    +    
Sbjct: 131 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFC-GTPEYLAPEVLEDNDYGR 188
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 189 AVDWWGLGVVMYEMMCGRLPF 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G+G+FG V   ++   + +    A+K L +   V +D       E  V+  + H  L   
Sbjct: 18  GKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT-A 73
Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQI 288
           L +  +  +RL  V E+ N G L   L      S +       +I   L YLH +    +
Sbjct: 74  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNV 131
Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA 348
           ++ D+K +N++LD   + +I+DFGL K   +    T+K    GT  Y+APE    +    
Sbjct: 132 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFC-GTPEYLAPEVLEDNDYGR 189
Query: 349 KVDVYSFGVLLLEIISCRKSF 369
            VD +  GV++ E++  R  F
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPF 210

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 119/259 (45%), Gaps = 20/259 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN------EVVVIGQTHHKNL 226
           G G+FG V+  V +  +     V   K ++V +D   E         E+ ++ +  H N+
Sbjct: 33  GSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 227 VRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +++L  F ++G  +L++ +  +   L +F+  + +    L + I  Q+   + YL     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---L 148
Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             IIH DIK +NI++ + +  ++ DFG A    L + K   T   GT  Y APE    + 
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERGKLFYT-FCGTIEYCAPEVLMGNP 205
Query: 346 ITA-KVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
               +++++S GV L  ++     F ++E   E AI   +      + +L  LV G ++ 
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLV----SKELMSLVSGLLQP 261
Query: 404 MNDIKCVEKLLMVSIWCIQ 422
           + + +   + L+   W  Q
Sbjct: 262 VPERRTTLEKLVTDPWVTQ 280

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           GRG+FG V    +   + +    A+K L++  + +  E   F+ E  V+     K +  L
Sbjct: 83  GRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
                +  N  LV ++   G L + L  F +  P    R    F +A  ++ +       
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR----FYLAEMVIAIDSVHQLH 195
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWYR---- 342
            +H DIKP NIL+D + + R++DFG    L L +  T+++++  GT  Y++PE  +    
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 343 -KSTITAKVDVYSFGVLLLEIISCRKSFDIE 372
            K     + D +S GV + E++     F  E
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 51  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPSWNLRTNIAFQIARGLLYLHEDCSS 286
                +  N  +V E++  G + S L   G   +P        A QI     YLH   S 
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLH---SL 161
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE       
Sbjct: 162 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
              VD ++ GVL+ E+ +    F
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNL-KPSWNLRTNIAFQIARGLLYLHEDCSS 286
                +  N  +V E++  G + S L   G   +P        A QI     YLH   S 
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF---YAAQIVLTFEYLH---SL 160
Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
            +I+ D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE       
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 347 TAKVDVYSFGVLLLEIISCRKSF 369
              VD ++ GVL+ E+ +    F
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E++  G + S L    +         A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+L+D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNL 226
           ++ G G+FG+     +   + S   VAVK ++R    GEK     K E++      H N+
Sbjct: 25  KDIGSGNFGVAR---LMRDKQSNELVAVKYIER----GEKIDENVKREIINHRSLRHPNI 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VR         +  +V E+ + G L   +    + S +       Q+  G+ Y H   + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AM 134
Query: 287 QIIHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           Q+ H D+K +N LLD     R  I  FG +K   L+     K+ + GT  Y+APE   K 
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP--KSTV-GTPAYIAPEVLLKK 191
Query: 345 TITAKV-DVYSFGVLL 359
               KV DV+S GV L
Sbjct: 192 EYDGKVADVWSCGVTL 207

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLG 231
           GRG +  V++ +     T+   V VK L  V    + + K E+ ++       N++ L  
Sbjct: 46  GRGKYSEVFEAI---NITNNEKVVVKILKPV---KKNKIKREIKILENLRGGPNIITLAD 99
Query: 232 FCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
              +  +R   LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIM 153
Query: 290 HCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-T 347
           H D+KP N+++D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +  
Sbjct: 154 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYD 210
Query: 348 AKVDVYSFGVLLLEIISCRKSF 369
             +D++S G +L  +I  ++ F
Sbjct: 211 YSLDMWSLGCMLASMIFRKEPF 232

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK---EFKNEVVVIGQTHHKNL 226
           ++ G G+FG+     +   + S   VAVK ++R    GEK     K E++      H N+
Sbjct: 25  KDIGSGNFGVAR---LMRDKQSNELVAVKYIER----GEKIDENVKREIINHRSLRHPNI 77
Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           VR         +  +V E+ + G L   +    + S +       Q+  G+ Y H   + 
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AM 134
Query: 287 QIIHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           Q+ H D+K +N LLD     R  I  FG +K   L+ S+   T   GT  Y+APE   K 
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH-SQPKDTV--GTPAYIAPEVLLKK 191
Query: 345 TITAKV-DVYSFGVLL 359
               KV DV+S GV L
Sbjct: 192 EYDGKVADVWSCGVTL 207

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   L +L
Sbjct: 51  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   L +L
Sbjct: 51  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    + S       A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    +         A QI     YLH   S  +I
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
            IA  I + L +LH   S  +IH D+KP N+L++     +  DFG++  L  + +K I  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 328 AIRGTKGYVAPEW----YRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
              G K Y APE       +   + K D++S G+  +E+   R  +D
Sbjct: 198 ---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLG 231
           G G++  V   V   +  +    AVK +++           EV  + Q   +KN++ L+ 
Sbjct: 22  GEGAYAKVQGAV---SLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC 291
           F ++     LV+E L  G++ + +      +    + +   +A  L +LH   +  I H 
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLH---TKGIAHR 135
Query: 292 DIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTAIR-----GTKGYVAPEWYRK 343
           D+KP+NIL +        +I DF L   + LN S T  T        G+  Y+APE    
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 344 STITA-----KVDVYSFGVLLLEIISCRKSF 369
            T  A     + D++S GV+L  ++S    F
Sbjct: 196 FTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 32/214 (14%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G+G +G V++G  +    +    + +     F+  E E  N V++     H+N+   
Sbjct: 43  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR--ETELYNTVML----RHENI--- 93
Query: 230 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLH 281
           LGF               L+  +   G+L  +L    L     LR  I   IA GL +LH
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLH 151
Query: 282 EDC-----SSQIIHCDIKPQNILLDDHYNARISDFGLAKL--LTLNQSKTIKTAIRGTKG 334
            +         I H D+K +NIL+  +    I+D GLA +   + NQ         GTK 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 335 YVAPEWYRKSTIT------AKVDVYSFGVLLLEI 362
           Y+APE   ++          +VD+++FG++L E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G+G +G V++G  +    +    + +     F+  E E  N V++     H+N+   
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR--ETELYNTVML----RHENI--- 64
Query: 230 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLH 281
           LGF               L+  +   G+L  +L    L     LR  I   IA GL +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLH 122
Query: 282 EDC-----SSQIIHCDIKPQNILLDDHYNARISDFGLAKL--LTLNQSKTIKTAIRGTKG 334
            +         I H D+K +NIL+  +    I+D GLA +   + NQ         GTK 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 335 YVAPEWYRKSTITA-------KVDVYSFGVLLLEI 362
           Y+APE     TI         +VD+++FG++L E+
Sbjct: 183 YMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G+G +G V++G  +    +    + +     F+  E E  N V++     H+N+   
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR--ETELYNTVML----RHENI--- 64
Query: 230 LGFC-------DEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLH 281
           LGF               L+  +   G+L  +L    L     LR  I   IA GL +LH
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR--IVLSIASGLAHLH 122
Query: 282 EDC-----SSQIIHCDIKPQNILLDDHYNARISDFGLAKL--LTLNQSKTIKTAIRGTKG 334
            +         I H D+K +NIL+  +    I+D GLA +   + NQ         GTK 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 335 YVAPEWYRKSTITA-------KVDVYSFGVLLLEI 362
           Y+APE     TI         +VD+++FG++L E+
Sbjct: 183 YMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 56/305 (18%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E  G+G +G V++G+      +    + +     F+  E E  N V++     H N++  
Sbjct: 14  ECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFR--ETEIYNTVLL----RHDNILGF 67
Query: 230 LGFCDEGQNR----LLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           +      +N      L+  +  +G+L  FL    L+P   LR  +A   A GL +LH + 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALR--LAVSAACGLAHLHVEI 125
Query: 285 -----SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKTAIR-GTKGYVA 337
                   I H D K +N+L+  +    I+D GLA + +       I    R GTK Y+A
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 338 PEWYRKSTIT------AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG 391
           PE   +   T         D+++FG++L EI   R++    + E+Y              
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNGIVEDY------------RP 231
Query: 392 KLDDLVEGD--MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP-- 447
              D+V  D   E M  + CV+          Q+ P++ P       +L G+ ++     
Sbjct: 232 PFYDVVPNDPSFEDMKKVVCVD----------QQTPTI-PNRLAADPVLSGLAQMMRECW 280
Query: 448 -PNPS 451
            PNPS
Sbjct: 281 YPNPS 285

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQTHHKNLVRL 229
           G GSFG V   ++     +    A+K LD+      K+ +   NE  ++   +   L +L
Sbjct: 51  GTGSFGRV---MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                +  N  +V E+   G + S L    +         A QI     YLH   S  +I
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           + D+KP+N+++D     +++DFG AK     + K     + GT  Y+APE          
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 350 VDVYSFGVLLLEIISCRKSF 369
           VD ++ GVL+ E+ +    F
Sbjct: 220 VDWWALGVLIYEMAAGYPPF 239

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQTHHKNLVRLL 230
           GRG+FG V    ++ T        + K + + +     F+ E  V+V G       +  L
Sbjct: 83  GRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC---QWITAL 139
Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            +  + +N L LV ++   G L + L  F +  P    R    F I   +L +       
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR----FYIGEMVLAIDSIHQLH 195
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWYRK--- 343
            +H DIKP N+LLD + + R++DFG    L +N   T+++++  GT  Y++PE  +    
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 344 --STITAKVDVYSFGVLLLEIISCRKSFDIE 372
                  + D +S GV + E++     F  E
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQTHHKNLVRLL 230
           GRG+FG V    ++ T        + K + + +     F+ E  V+V G       +  L
Sbjct: 99  GRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ---WITAL 155
Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            +  + +N L LV ++   G L + L  F +  P    R    F I   +L +       
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR----FYIGEMVLAIDSIHQLH 211
Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR-GTKGYVAPEWYRK--- 343
            +H DIKP N+LLD + + R++DFG    L +N   T+++++  GT  Y++PE  +    
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 344 --STITAKVDVYSFGVLLLEIISCRKSFDIE 372
                  + D +S GV + E++     F  E
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAE 300

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNLV 227
           G+G+FG V+K      R +   VA+KK   V  + EKE        E+ ++    H+N+V
Sbjct: 27  GQGTFGEVFKA---RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 228 RLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
            L+  C       NR      LV++F       L +  L  F    +K    +  N    
Sbjct: 81  NLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---- 136
Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
              GL Y+H +   +I+H D+K  N+L+      +++DFGLA+  +L ++    +     
Sbjct: 137 ---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN----SQPNRY 186
Query: 333 KGYVAPEWYRKSTIT-------AKVDVYSFGVLLLEI 362
              V   WYR   +          +D++  G ++ E+
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNLV 227
           G+G+FG V+K      R +   VA+KK   V  + EKE        E+ ++    H+N+V
Sbjct: 26  GQGTFGEVFKA---RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 228 RLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
            L+  C       NR      LV++F       L +  L  F    +K    +  N    
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---- 135
Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
              GL Y+H +   +I+H D+K  N+L+      +++DFGLA+  +L ++    +     
Sbjct: 136 ---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN----SQPNRY 185
Query: 333 KGYVAPEWYRKSTIT-------AKVDVYSFGVLLLEI 362
              V   WYR   +          +D++  G ++ E+
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 117/308 (37%), Gaps = 57/308 (18%)
Query: 163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVV------ 216
           EA        G+G FG V+ G   T R     VA+K + R    G     + V       
Sbjct: 30  EAEYRLGPLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 217 ----VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAF- 271
               V     H  ++RLL + +  +  +LV E       A  LF  +     L    +  
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 272 ---QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTIKT 327
              Q+   + + H   S  ++H DIK +NIL+D     A++ DFG   LL         T
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYT 196
Query: 328 AIRGTKGYVAPEWYRKSTITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 386
              GT+ Y  PEW  +    A    V+S G+LL +++      DI    +  IL      
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG----DIPFERDQEILE----- 247
Query: 387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV-- 444
                      E    A     C   +      C+   PS RP++ ++  +L+  ++   
Sbjct: 248 ----------AELHFPAHVSPDCCALIRR----CLAPKPSSRPSLEEI--LLDPWMQTPA 291
Query: 445 -DVPPNPS 451
            DVP NPS
Sbjct: 292 EDVPLNPS 299

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNLV 227
           G+G+FG V+K      R +   VA+KK   V  + EKE        E+ ++    H+N+V
Sbjct: 27  GQGTFGEVFKA---RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 228 RLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
            L+  C       NR      LV++F       L +  L  F    +K    +  N    
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---- 136
Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
              GL Y+H +   +I+H D+K  N+L+      +++DFGLA+  +L ++    +     
Sbjct: 137 ---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN----SQPNRY 186
Query: 333 KGYVAPEWYRKSTIT-------AKVDVYSFGVLLLEI 362
              V   WYR   +          +D++  G ++ E+
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNLV 227
           G+G+FG V+K      R +   VA+KK   V  + EKE        E+ ++    H+N+V
Sbjct: 27  GQGTFGEVFKA---RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 228 RLLGFCDEGQ---NR-----LLVYEF-------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
            L+  C       NR      LV++F       L +  L  F    +K    +  N    
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---- 136
Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
              GL Y+H +   +I+H D+K  N+L+      +++DFGLA+  +L ++    +     
Sbjct: 137 ---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN----SQPNRY 186
Query: 333 KGYVAPEWYRKSTIT-------AKVDVYSFGVLLLEI 362
              V   WYR   +          +D++  G ++ E+
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+L+
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVLI 164
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 165 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 221
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 222 LASMIFRKEPF 232

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 17/140 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEV---VVIGQTHHK 224
           E+ G G FG V+K V    R      A+K+  +       E+    EV    V+GQ  H 
Sbjct: 17  EKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HS 71
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYL 280
           ++VR      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 281 HEDCSSQIIHCDIKPQNILL 300
           H   S  ++H DIKP NI +
Sbjct: 132 H---SMSLVHMDIKPSNIFI 148

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 17/140 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEV---VVIGQTHHK 224
           E+ G G FG V+K V    R      A+K+  +       E+    EV    V+GQ  H 
Sbjct: 15  EKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HS 69
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYL 280
           ++VR      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 281 HEDCSSQIIHCDIKPQNILL 300
           H   S  ++H DIKP NI +
Sbjct: 130 H---SMSLVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 17/140 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEV---VVIGQTHHK 224
           E+ G G FG V+K V    R      A+K+  +       E+    EV    V+GQ  H 
Sbjct: 15  EKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HS 69
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYL 280
           ++VR      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 281 HEDCSSQIIHCDIKPQNILL 300
           H   S  ++H DIKP NI +
Sbjct: 130 H---SMSLVHMDIKPSNIFI 146

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 17/140 (12%)
Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEV---VVIGQTHHK 224
           E+ G G FG V+K V    R      A+K+  +       E+    EV    V+GQ  H 
Sbjct: 13  EKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HS 67
Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYL 280
           ++VR      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+
Sbjct: 68  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 281 HEDCSSQIIHCDIKPQNILL 300
           H   S  ++H DIKP NI +
Sbjct: 128 H---SMSLVHMDIKPSNIFI 144

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 164
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 165 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 221
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 222 LASMIFRKEPF 232

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 110 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 163
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 164 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 220
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 221 LASMIFRKEPF 231

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 164
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 165 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 221
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 222 LASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 164
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 165 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 221
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 222 LASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 109 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 162
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 219
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 220 LASMIFRKEPF 230

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 110 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 163
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 164 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 220
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 221 LASMIFRKEPF 231

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           LV+E +NN      L+  L   +++R  + ++I + L Y H   S  I+H D+KP N+++
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-DYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMI 164
Query: 301 D-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVL 358
           D +H   R+ D+GLA+     Q   ++ A R  KG   PE      +    +D++S G +
Sbjct: 165 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVDYQMYDYSLDMWSLGCM 221
Query: 359 LLEIISCRKSF 369
           L  +I  ++ F
Sbjct: 222 LASMIFRKEPF 232
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	455
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-128
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-119
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-116
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-74
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-48
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-29
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-27
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-27
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  372 bits (957), Expect = e-128
 Identities = 121/303 (39%), Positives = 177/303 (58%), Gaps = 14/303 (4%)

Query: 152 NLRCFSYKALEEATDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKLDR-VFQDGE 208
            L+ FS + L+ A+DNF  +   GRG FG VYKG +       T VAVK+L     Q GE
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGE 71

Query: 209 KEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS----WN 264
            +F+ EV +I    H+NL+RL GFC     RLLVY ++ NG++AS L    +      W 
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131

Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
            R  IA   ARGL YLH+ C  +IIH D+K  NILLD+ + A + DFGLAKL+    +  
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-H 190

Query: 325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDI--EMGEEYAILTD 382
           + TA+RGT G++APE+      + K DV+ +GV+LLE+I+ +++FD+     ++  +L D
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

Query: 383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV 442
           W     +  KL+ LV+ D++     + VE+L+ V++ C Q  P  RP M +V +MLEG  
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

Query: 443 EVD 445
             +
Sbjct: 311 LAE 313

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  350 bits (900), Expect = e-119
 Identities = 104/309 (33%), Positives = 159/309 (51%), Gaps = 13/309 (4%)

Query: 143 SPGDGTVETNLRCFSYKALEEATDNFKEEA--GRGSFGIVYKGVIETTRTSTTAVAVKKL 200
                 V           LEEAT+NF  +   G G FG VYKGV+         VA+K+ 
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRR 71

Query: 201 DRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK 260
                 G +EF+ E+  +    H +LV L+GFCDE    +L+Y+++ NG L   L+G+  
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 261 P----SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
           P    SW  R  I    ARGL YLH      IIH D+K  NILLD+++  +I+DFG++K 
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188

Query: 317 LTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
            T      + T ++GT GY+ PE++ K  +T K DVYSFGV+L E++  R +    +  E
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248

Query: 377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
              L +WA + + NG+L+ +V+ ++      + + K    ++ C+      RP+M  V  
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308

Query: 437 MLEGVVEVD 445
            LE  + + 
Sbjct: 309 KLEYALRLQ 317

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  343 bits (882), Expect = e-116
 Identities = 109/309 (35%), Positives = 160/309 (51%), Gaps = 28/309 (9%)

Query: 150 ETNLRCFSYKALEEATDNFKEEA--------GRGSFGIVYKGVIETTRTSTTAVAVKKLD 201
           +T    FS+  L+  T+NF E          G G FG+VYKG +  T      VAVKKL 
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-----TVAVKKLA 63

Query: 202 RVFQD----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 257
            +        +++F  E+ V+ +  H+NLV LLGF  +G +  LVY ++ NG+L   L  
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123

Query: 258 --NLKP-SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA 314
                P SW++R  IA   A G+ +LHE+     IH DIK  NILLD+ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +         + + I GT  Y+APE   +  IT K D+YSFGV+LLEII+   + D    
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 375 EEYAILTDWAFDCYRN-GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
            +   L D   +       ++D ++  M    D   VE +  V+  C+ E  + RP ++K
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 434 VSQMLEGVV 442
           V Q+L+ + 
Sbjct: 297 VQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  234 bits (598), Expect = 6e-74
 Identities = 76/312 (24%), Positives = 126/312 (40%), Gaps = 39/312 (12%)

Query: 156 FSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFK 212
              + L   +   +  E   RG FG V+K  +         VAVK      QD    + +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----VAVKIFPI--QDKQSWQNE 66

Query: 213 NEVVVIGQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPSWNLRTN 268
            EV  +    H+N+++ +G    G +      L+  F   G+L+ FL  N   SWN   +
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCH 125

Query: 269 IAFQIARGLLYLHEDCSSQ-------IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ 321
           IA  +ARGL YLHED           I H DIK +N+LL ++  A I+DFGLA      +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 322 SKTIKTAIRGTKGYVAPE-----WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
           S        GT+ Y+APE        +     ++D+Y+ G++L E+ S   + D  + E 
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 377 YAILTDWA---------FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
                +            +   + K   ++    +    +  + + +     C   D   
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE---ECWDHDAEA 302

Query: 428 RPTMRKVSQMLE 439
           R +   V + + 
Sbjct: 303 RLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  204 bits (522), Expect = 9e-63
 Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 28/286 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKN 225
            KE+ G GSFG V++          + VAVK L       +   EF  EV ++ +  H N
Sbjct: 41  IKEKIGAGSFGTVHRA-----EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHE 282
           +V  +G   +  N  +V E+L+ G+L   L  +    +     R ++A+ +A+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             +  I+H ++K  N+L+D  Y  ++ DFGL++L     +     +  GT  ++APE  R
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLR 212

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 402
                 K DVYSFGV+L E+ + ++ +   +                  K  ++      
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWG-NLN-----PAQVVAAVGFKCKRLEIPRNLNP 266

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
            +         ++    C   +P  RP+   +  +L  +++  VPP
Sbjct: 267 QV-------AAIIEG--CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  199 bits (508), Expect = 1e-60
 Identities = 78/290 (26%), Positives = 137/290 (47%), Gaps = 33/290 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            +E  GRG+FG+V K      +     VA+K+++   +   K F  E+  + + +H N+V
Sbjct: 12  VEEVVGRGAFGVVCKA-----KWRAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIV 64

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDC 284
           +L G C       LV E+   G+L + L G       +     +   Q ++G+ YLH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 285 SSQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +IH D+KP N+LL       +I DFG A  +     +T  T  +G+  ++APE +  
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEG 177

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
           S  + K DV+S+G++L E+I+ RK FD   G  + I     +  +   +   L++   + 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGTRP-PLIKNLPKP 232

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPF 453
           +       + LM    C  +DPS RP+M ++ +++  ++    P    P 
Sbjct: 233 I-------ESLMTR--CWSKDPSQRPSMEEIVKIMTHLMR-YFPGADEPL 272

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (508), Expect = 1e-60
 Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 42/304 (13%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             E  G+G FG   K    T R +   + +K+L R  ++ ++ F  EV V+    H N++
Sbjct: 14  HGEVLGKGCFGQAIKV---THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSS 286
           + +G   + +    + E++  GTL   +        W+ R + A  IA G+ YLH   S 
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SM 127

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS------------KTIKTAIRGTKG 334
            IIH D+   N L+ ++ N  ++DFGLA+L+   ++            +  +  + G   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 335 YVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNG 391
           ++APE    R      KVDV+SFG++L EII    +  D         L    F      
Sbjct: 188 WMAPEMINGRSYDE--KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--LD-- 241

Query: 392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV---VEVDVPP 448
                         +  C      +++ C   DP  RP+  K+   LE +   +   +P 
Sbjct: 242 ---------RYCPPN--CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290

Query: 449 NPSP 452
            P  
Sbjct: 291 GPQL 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  195 bits (497), Expect = 1e-59
 Identities = 80/286 (27%), Positives = 118/286 (41%), Gaps = 41/286 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL----DRVFQDGEKEFKNEVVVIGQTHH 223
            +E  G G FG VY+            VAVK      D       +  + E  +     H
Sbjct: 11  LEEIIGIGGFGKVYRA-----FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
            N++ L G C +  N  LV EF   G L   L G  +   ++  N A QIARG+ YLH++
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDE 124

Query: 284 CSSQIIHCDIKPQNILLD--------DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
               IIH D+K  NIL+          +   +I+DFGLA+       +T K +  G   +
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAW 180

Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
           +APE  R S  +   DV+S+GVLL E+++    F   + +  A+    A +         
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GI-DGLAVAYGVAMNKLA------ 232

Query: 396 LVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
                +   +   C E    LM   W    DP  RP+   +   L 
Sbjct: 233 -----LPIPST--CPEPFAKLMEDCW--NPDPHSRPSFTNILDQLT 269

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (496), Expect = 1e-58
 Identities = 81/349 (23%), Positives = 125/349 (35%), Gaps = 75/349 (21%)

Query: 156 FSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN 213
            +        DN K  E  GRG +G VYKG ++        VAVK          + F N
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-----PVAVKVFS---FANRQNFIN 54

Query: 214 EVVV--IGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGNLKPSWNLR 266
           E  +  +    H N+ R +   +          LLV E+  NG+L  +L  +    W   
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113

Query: 267 TNIAFQIARGLLYLHEDCSS------QIIHCDIKPQNILLDDHYNARISDFGLAKLLT-- 318
             +A  + RGL YLH +          I H D+  +N+L+ +     ISDFGL+  LT  
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 319 ----LNQSKTIKTAIRGTKGYVAPEWYRKS-------TITAKVDVYSFGVLLLEIIS-CR 366
                 +      +  GT  Y+APE    +       +   +VD+Y+ G++  EI   C 
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 367 KSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD--MEAMNDIKCVEKL----------- 413
             F  E   EY +    AF           V      E M  +   EK            
Sbjct: 234 DLFPGESVPEYQM----AF--------QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN 281

Query: 414 ---------LMVSIWCIQEDPSLRPTMRKVSQMLEGVV-EVDVPPNPSP 452
                     +    C  +D   R T +   + +  ++   +   + SP
Sbjct: 282 SLAVRSLKETIED--CWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (483), Expect = 3e-57
 Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 27/278 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKN 225
             +  G GSFG VYKG           VAVK L          + FKNEV V+ +T H N
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           ++  +G+        +V ++    +L   L     K       +IA Q ARG+ YLH   
Sbjct: 82  ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-- 342
           +  IIH D+K  NI L +    +I DFGLA   +          + G+  ++APE  R  
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 343 -KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 401
             +  + + DVY+FG++L E+++ +  +   +     I+        R     DL +   
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVG--RGSLSPDLSKVRS 252

Query: 402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                  C +++  +   C+++    RP+  ++   +E
Sbjct: 253 N------CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (477), Expect = 2e-56
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 43/289 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-------KEFKNEVVVIGQ 220
           ++++ G+G FG+V+KG +   ++    VA+K L     +GE       +EF+ EV ++  
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSV---VAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLY 279
            +H N+V+L G         +V EF+  G L   L     P  W+++  +   IA G+ Y
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 280 LHEDCSSQIIHCDIKPQNILLD-----DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           +  + +  I+H D++  NI L          A+++DFGL++           + + G   
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQ 191

Query: 335 YVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
           ++APE     + + T K D YSF ++L  I++    FD     +   +     +  R   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251

Query: 393 LDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +D             C  +L  ++    C   DP  RP    + + L 
Sbjct: 252 PED-------------CPPRLRNVIEL--CWSGDPKKRPHFSYIVKELS 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (478), Expect = 3e-56
 Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 44/289 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKN 225
             E  G+G FG VY G           VA++ +  +R  +D  K FK EV+   QT H+N
Sbjct: 37  IGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDC 284
           +V  +G C    +  ++       TL S +    +    N    IA +I +G+ YLH   
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS---KTIKTAIRGTKGYVAPEWY 341
           +  I+H D+K +N+  D+     I+DFGL  +  + Q+   +       G   ++APE  
Sbjct: 148 AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 342 RKSTI---------TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK 392
           R+ +          +   DV++ G +  E+ +    F      E  I     +      K
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII-----WQMGTGMK 260

Query: 393 LDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +         ++ I   +++  +++   C   +   RPT  K+  MLE
Sbjct: 261 PN---------LSQIGMGKEISDILLF--CWAFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (458), Expect = 1e-53
 Identities = 61/282 (21%), Positives = 106/282 (37%), Gaps = 37/282 (13%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHK 224
           NF  +      G ++KG     R     + VK L          ++F  E   +    H 
Sbjct: 13  NFLTKLNENHSGELWKG-----RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 225 NLVRLLGFCDE--GQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYL 280
           N++ +LG C      +  L+  ++  G+L + L    N     +     A  +ARG+ +L
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H      I    +  +++++D+   ARIS   +                     +VAPE 
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEA 179

Query: 341 YRKS---TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
            +K    T     D++SF VLL E+++    F  ++     I    A +  R      + 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DL-SNMEIGMKVALEGLR----PTIP 233

Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            G    ++        LM    C+ EDP+ RP    +  +LE
Sbjct: 234 PGISPHVSK-------LMKI--CMNEDPAKRPKFDMIVPILE 266

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  170 bits (433), Expect = 1e-49
 Identities = 74/312 (23%), Positives = 118/312 (37%), Gaps = 65/312 (20%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKN 225
             E  G+G +G V++G           VAVK      +D EK +  E  +       H+N
Sbjct: 12  LLECVGKGRYGEVWRG-----SWQGENVAVKIFSS--RD-EKSWFRETELYNTVMLRHEN 63

Query: 226 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           ++  +      ++      L+  +   G+L  +L             I   IA GL +LH
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLH 122

Query: 282 EDCSSQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTAIRGTKG 334
            +         I H D+K +NIL+  +    I+D GLA +   + NQ         GTK 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 335 YVAPE------WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
           Y+APE               +VD+++FG++L E+     S  I   E+Y       F   
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--EDYKP----PF--- 233

Query: 389 RNGKLDDLVEGD--MEAMNDIKCVEKL-------------------LMVSIWCIQEDPSL 427
                 D+V  D   E M  + CV++                    LM   W   ++PS 
Sbjct: 234 -----YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW--YQNPSA 286

Query: 428 RPTMRKVSQMLE 439
           R T  ++ + L 
Sbjct: 287 RLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (424), Expect = 4e-48
 Identities = 72/310 (23%), Positives = 116/310 (37%), Gaps = 61/310 (19%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKN 225
             ++ G+G +G V+ G     +     VAVK       + E  +  E  +       H+N
Sbjct: 41  MVKQIGKGRYGEVWMG-----KWRGEKVAVKVFFT--TE-EASWFRETEIYQTVLMRHEN 92

Query: 226 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           ++  +    +G        L+ ++  NG+L  +L  +          +A+    GL +LH
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLH 151

Query: 282 EDCSSQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTAIRGTKG 334
            +  S      I H D+K +NIL+  +    I+D GLA       N+         GTK 
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 335 YVAPE------WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
           Y+ PE                 D+YSFG++L E+     S  I   EEY +        Y
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI--VEEYQL-------PY 262

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKL-------------------LMVSIWCIQEDPSLRP 429
            +    D      E M +I C++KL                   LM    C   +P+ R 
Sbjct: 263 HDLVPSDP---SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE--CWAHNPASRL 317

Query: 430 TMRKVSQMLE 439
           T  +V + L 
Sbjct: 318 TALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (423), Expect = 6e-48
 Identities = 69/312 (22%), Positives = 114/312 (36%), Gaps = 65/312 (20%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNE--VVVIGQTHHKN 225
            +E  G+G FG V++G     +     VAVK         E+ +  E  +       H+N
Sbjct: 46  LQESIGKGRFGEVWRG-----KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHEN 97

Query: 226 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           ++  +   ++         LV ++  +G+L  +L      +      +A   A GL +LH
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLH 156

Query: 282 EDCSSQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTAIRGTKG 334
            +         I H D+K +NIL+  +    I+D GLA       +          GTK 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 335 YVAPEWYRKSTITA------KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
           Y+APE    S          + D+Y+ G++  EI        I   E+Y +        Y
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--EDYQL-------PY 267

Query: 389 RNGKLDDLVEGDM--EAMNDIKCVEKL-------------------LMVSIWCIQEDPSL 427
                 DLV  D   E M  + C +KL                   +M    C   + + 
Sbjct: 268 -----YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE--CWYANGAA 320

Query: 428 RPTMRKVSQMLE 439
           R T  ++ + L 
Sbjct: 321 RLTALRIKKTLS 332

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  155 bits (393), Expect = 1e-43
 Identities = 76/287 (26%), Positives = 131/287 (45%), Gaps = 29/287 (10%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           +  + G+G+FG V     +    +T   VAVK+L     D +++F+ E+ ++   H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 227 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           V+  G       Q+  LV E+L +G L  FL  + +   +       + QI +G+ YL  
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG- 144

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVA 337
             S + +H D+  +NIL++   + +I+DFGLAKLL L++   +        I       A
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----A 198

Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           PE    +  + + DV+SFGV+L E+ + C KS       E+  +     D     +L +L
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDVPALSRLLEL 256

Query: 397 VEGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +E    + A     C  ++  LM   W     P  RP+   +   L+
Sbjct: 257 LEEGQRLPAPPA--CPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  155 bits (394), Expect = 2e-43
 Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 41/287 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 226
             E+ GRG+FG V+ G +   R   T VAVK   + +  D + +F  E  ++ Q  H N+
Sbjct: 118 LGEQIGRGNFGEVFSGRL---RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCS 285
           VRL+G C + Q   +V E +  G   +FL     +        +    A G+ YL    S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---S 231

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA----IRGTKGYVAPEWY 341
              IH D+  +N L+ +    +ISDFG+++                 ++ T    APE  
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287

Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD 400
                +++ DV+SFG+LL E  S         G   Y  L+        N +  + VE  
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSL--------GASPYPNLS--------NQQTREFVEKG 331

Query: 401 --MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
             +       C + +  LM   W    +P  RP+   + Q L+ + +
Sbjct: 332 GRLPCPEL--CPDAVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRK 374

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  156 bits (395), Expect = 1e-42
 Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 39/281 (13%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            K + G G +G VY+GV    +  +  VAVK L +      +EF  E  V+ +  H NLV
Sbjct: 224 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +LLG C       ++ EF+  G L  +L    +   +      +A QI+  + YL     
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 336

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWYR 342
              IH ++  +N L+ +++  +++DFGL++L+T +        K  I+ T    APE   
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 392

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 400
            +  + K DV++FGVLL EI +   S        Y  +           ++ +L+E D  
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-------PYPGID--------LSQVYELLEKDYR 437

Query: 401 MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           ME      C EK+  LM + W  Q +PS RP+  ++ Q  E
Sbjct: 438 MERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFE 474

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (381), Expect = 2e-42
 Identities = 68/286 (23%), Positives = 132/286 (46%), Gaps = 26/286 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++    H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 227 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           V+  G C     +N  L+ E+L  G+L  +L  + K   +         QI +G+ YL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG- 131

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVA 337
             + + IH D+  +NIL+++    +I DFGL K+L  ++            I       A
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----A 185

Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           PE   +S  +   DV+SFGV+L E+ +  +       E   ++ +          L +L+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 398 EGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           + +  +   +   C +++  +M   W    + + RP+ R ++  ++
Sbjct: 246 KNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (381), Expect = 5e-42
 Identities = 68/286 (23%), Positives = 132/286 (46%), Gaps = 26/286 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           F ++ G+G+FG V     +  + +T   VAVKKL    ++  ++F+ E+ ++    H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 227 VRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           V+  G C     +N  L+ E+L  G+L  +L  + K   +         QI +G+ YL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG- 162

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVA 337
             + + IH D+  +NIL+++    +I DFGL K+L  ++            I       A
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----A 216

Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           PE   +S  +   DV+SFGV+L E+ +  +       E   ++ +          L +L+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 398 EGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           + +  +   +   C +++  +M   W    + + RP+ R ++  ++
Sbjct: 277 KNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 318

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  147 bits (374), Expect = 3e-41
 Identities = 72/298 (24%), Positives = 128/298 (42%), Gaps = 42/298 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETT-RTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 225
              + G G FG V     +     +   VAVK L      +   + K E+ ++   +H+N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 226 LVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLH 281
           +V+  G C  D G    L+ EFL +G+L  +L  N K   NL+     A QI +G+ YL 
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG 143

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYV 336
              S Q +H D+  +N+L++  +  +I DFGL K +  ++            +       
Sbjct: 144 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY---- 196

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIIS-------CRKSFDIEMGEEYAILTDWAFDCYR 389
           APE   +S      DV+SFGV L E+++           F   +G  +  +T        
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT-------- 248

Query: 390 NGKLDDLVEGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
             +L + ++    +    +  C +++  LM   W  +  PS R + + + +  E +++
Sbjct: 249 VTRLVNTLKEGKRLPCPPN--CPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFEALLK 302

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (373), Expect = 4e-41
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 34/272 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 225
           F  E GRGSF  VYKG+   T   T  VA    +  ++ +   + FK E  ++    H N
Sbjct: 30  FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 226 LVRLLGFC---DEGQNRLLVY-EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           +VR         +G+  +++  E + +GTL ++L         +  +   QI +GL +LH
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 282 EDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
              +  IIH D+K  NI +     + +I D GLA L   + +K +     GT  ++APE 
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM 201

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSF-DIE-MGEEYAILTDWAFDCYRNGKLDDLVE 398
           Y +      VDVY+FG+ +LE+ +    + + +   + Y  +T       +    D +  
Sbjct: 202 Y-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV----KPASFDKVA- 255

Query: 399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT 430
              E    I+           CI+++   R +
Sbjct: 256 -IPEVKEIIE----------GCIRQNKDERYS 276

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (372), Expect = 1e-40
 Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 28/298 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIE-TTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
              + G G FG V     + T   +   VAVK L           +K E+ ++   +H++
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 226 LVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +++  G C      +  LV E++  G+L  +L  +           A QI  G+ YLH  
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLH-- 151

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-----IRGTKGYVAP 338
            +   IH D+  +N+LLD+    +I DFGLAK +                +       AP
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           E  ++       DV+SFGV L E+++ C  S          I            +L +L+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMTVLRLTELL 264

Query: 398 E--GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPS 451
           E    +   +   C  ++  LM + W  + + S RPT   +  +L+ V E      PS
Sbjct: 265 ERGERLPRPDK--CPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  146 bits (371), Expect = 2e-40
 Identities = 71/285 (24%), Positives = 129/285 (45%), Gaps = 41/285 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
            ++  G G  G V  G +         VA+K L   + + ++ +F +E  ++GQ  H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 284
           +RL G    G+  ++V E++ NG+L +FL  +    + +     +   +  G+ YL    
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS--- 168

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE-- 339
               +H D+  +N+L+D +   ++SDFGL+++L  +      T   G K  +   APE  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT--TGGKIPIRWTAPEAI 226

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 398
            +R  +     DV+SFGV++ E+++         GE  Y  +T        N  +   VE
Sbjct: 227 AFRTFSS--ASDVWSFGVVMWEVLAY--------GERPYWNMT--------NRDVISSVE 268

Query: 399 GD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
               + A     C   L  LM+  W   +D + RP   ++  +L+
Sbjct: 269 EGYRLPAPMG--CPHALHQLMLDCW--HKDRAQRPRFSQIVSVLD 309

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (377), Expect = 2e-40
 Identities = 74/282 (26%), Positives = 120/282 (42%), Gaps = 47/282 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKN 225
             +  G+G FG V  G     +     VAVK +    ++    + F  E  V+ Q  H N
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 247

Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           LV+LLG   E +  L +V E++  G+L  +L    +           +  +   + YL  
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 306

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
              +  +H D+  +N+L+ +   A++SDFGL K  +  Q    K  ++ T    APE  R
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 359

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 400
           +   + K DV+SFG+LL EI S         G   Y  +            +   VE   
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSF--------GRVPYPRIP--------LKDVVPRVEKGY 403

Query: 401 -MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
            M+A +   C   +  +M + W    D + RPT  ++ + LE
Sbjct: 404 KMDAPDG--CPPAVYDVMKNCW--HLDAATRPTFLQLREQLE 441

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  145 bits (367), Expect = 6e-40
 Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 46/287 (16%)

Query: 168 FKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 225
             +  G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           + RLLG C       L+ + +  G L  ++  + K +   +   N   QIA+G+ YL + 
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTAIRGTKGYVAPE 339
              +++H D+  +N+L+    + +I+DFGLAKLL   + +      K  I+      A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189

Query: 340 --WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDL 396
              +R  T   + DV+S+GV + E+++         G + Y  +           ++  +
Sbjct: 190 SILHRIYTH--QSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSI 231

Query: 397 VEGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +E    +       C   +  +M   W    D   RP  R++     
Sbjct: 232 LEKGERLPQPPI--CTIDVYMIMRKCW--MIDADSRPKFRELIIEFS 274

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (375), Expect = 1e-39
 Identities = 80/281 (28%), Positives = 128/281 (45%), Gaps = 41/281 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            + + G+G FG V+ G    T    T VA+K L +      + F  E  V+ +  H+ LV
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L     E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+     
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWYR 342
              +H D++  NIL+ ++   +++DFGLA+L+  N+    +  K  I+ T    APE   
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 437

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 400
               T K DV+SFG+LL E+ +  +         Y  +         N ++ D VE    
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 482

Query: 401 MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           M    +  C E L  LM   W  +++P  RPT   +   LE
Sbjct: 483 MPCPPE--CPESLHDLMCQCW--RKEPEERPTFEYLQAFLE 519

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  147 bits (372), Expect = 1e-39
 Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 41/281 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            + + G+G FG V+ G    T    T VA+K L       E  F  E  V+ +  H+ LV
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLV 242

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L     E +   +V E+++ G+L  FL G       L    ++A QIA G+ Y+     
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWYR 342
              +H D++  NIL+ ++   +++DFGLA+L+  N+    +  K  I+ T    APE   
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 354

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD-- 400
               T K DV+SFG+LL E+ +  +         Y  +         N ++ D VE    
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMV--------NREVLDQVERGYR 399

Query: 401 MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           M    +  C E L  LM   W  +++P  RPT   +   LE
Sbjct: 400 MPCPPE--CPESLHDLMCQCW--RKEPEERPTFEYLQAFLE 436

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  142 bits (360), Expect = 3e-39
 Identities = 75/293 (25%), Positives = 116/293 (39%), Gaps = 41/293 (13%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL---DRVFQDGEKEFKNEVVVIGQTHHK 224
             E+ G GSFG+V +G  +     T +VAVK L        +   +F  EV  +    H+
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           NL+RL G         +V E    G+L   L  + +  + L T    A Q+A G+ YL  
Sbjct: 82  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE- 138

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE 339
             S + IH D+  +N+LL      +I DFGL + L  N            K      APE
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPE 194

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 398
             +  T +   D + FGV L E+ +         G+E +  L           ++   ++
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTY--------GQEPWIGLN--------GSQILHKID 238

Query: 399 GD---MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV 446
            +   +    D  C + +  +MV  W     P  RPT   +   L      D+
Sbjct: 239 KEGERLPRPED--CPQDIYNVMVQCW--AHKPEDRPTFVALRDFLLEAQPTDM 287

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  142 bits (359), Expect = 4e-39
 Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 45/293 (15%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 226 LVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           ++ LLG C   +   L+V  ++ +G L +F+      +  ++       Q+A+G+ YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA- 145

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL------TLNQSKTIKTAIRGTKGYV 336
             S + +H D+  +N +LD+ +  +++DFGLA+ +      +++     K  ++      
Sbjct: 146 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199

Query: 337 APE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNGK 392
           A E    +K T   K DV+SFGVLL E+++         G   Y  +  +        G+
Sbjct: 200 ALESLQTQKFTT--KSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQGR 249

Query: 393 LDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                   +       C + L  +M+  W       +RP+  ++   +  +  
Sbjct: 250 R-------LLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  141 bits (357), Expect = 8e-39
 Identities = 79/279 (28%), Positives = 118/279 (42%), Gaps = 41/279 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG V KG     +     VAVK  K +      + E   E  V+ Q  +  +VR++
Sbjct: 26  GSGNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
           G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   S  +H
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-E--ESNFVH 140

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE--WYRKST 345
            D+  +N+LL   + A+ISDFGL+K L  +++     A    K  V   APE   Y K +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPECINYYKFS 198

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD--ME 402
              K DV+SFGVL+ E  S         G++ Y  +           ++  ++E    M 
Sbjct: 199 S--KSDVWSFGVLMWEAFSY--------GQKPYRGMK--------GSEVTAMLEKGERMG 240

Query: 403 AMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
                 C  ++  LM   W    D   RP    V   L 
Sbjct: 241 CPAG--CPREMYDLMNLCW--TYDVENRPGFAAVELRLR 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  141 bits (357), Expect = 8e-39
 Identities = 85/284 (29%), Positives = 133/284 (46%), Gaps = 45/284 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            K + G G +G VY+GV    +  +  VAVK L     +  +EF  E  V+ +  H NLV
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +LLG C       ++ EF+  G L  +L    +   +      +A QI+  + YL     
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---K 129

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPE--W 340
              IH D+  +N L+ +++  +++DFGL++L+T +        K  I+ T    APE   
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLA 185

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
           Y K +I  K DV++FGVLL EI +         G   Y  +           ++ +L+E 
Sbjct: 186 YNKFSI--KSDVWAFGVLLWEIAT--------YGMSPYPGID--------LSQVYELLEK 227

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           D  ME      C EK+  LM + W  Q +PS RP+  ++ Q  E
Sbjct: 228 DYRMERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFE 267

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (355), Expect = 1e-38
 Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 51/284 (17%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKN 225
             +  G+G FG V  G     +     VAVK +    ++    + F  E  V+ Q  H N
Sbjct: 25  LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 75

Query: 226 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           LV+LLG   E +  L +V E++  G+L  +L    +           +  +   + YL  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE--W 340
              +  +H D+  +N+L+ +   A++SDFGL K  +  Q    K  ++ T    APE   
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 187

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
            +K +   K DV+SFG+LL EI S         G   Y  +            +   VE 
Sbjct: 188 EKKFST--KSDVWSFGILLWEIYS--------FGRVPYPRIP--------LKDVVPRVEK 229

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
              M+A +   C   +  +M + W    D ++RP+  ++ + LE
Sbjct: 230 GYKMDAPDG--CPPAVYEVMKNCW--HLDAAMRPSFLQLREQLE 269

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (366), Expect = 1e-38
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 43/282 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            +++ G G FG V+           T VAVK + +      + F  E  V+    H  LV
Sbjct: 192 LEKKLGAGQFGEVWMATYNKH----TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L     + +   ++ EF+  G+L  FL  +      L    + + QIA G+ ++     
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWYR 342
              IH D++  NIL+      +I+DFGLA+++  N+    +  K  I+ T    APE   
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAIN 358

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 400
             + T K DV+SFG+LL+EI++         G   Y  ++        N ++   +E   
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTY--------GRIPYPGMS--------NPEVIRALERGY 402

Query: 401 -MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
            M    +  C E+L  +M+  W  +  P  RPT   +  +L+
Sbjct: 403 RMPRPEN--CPEELYNIMMRCW--KNRPEERPTFEYIQSVLD 440

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  142 bits (361), Expect = 1e-38
 Identities = 68/294 (23%), Positives = 128/294 (43%), Gaps = 47/294 (15%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKN 225
           +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 226 LVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHE 282
           ++ LLG C   +   L+V  ++ +G L +F+      +  ++       Q+A+G+ +L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFL-- 208

Query: 283 DCSSQ-IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA------IRGTKGY 335
             +S+  +H D+  +N +LD+ +  +++DFGLA+ +   +  ++         ++     
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM--- 263

Query: 336 VAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDCYRNG 391
            A E    +K T   K DV+SFGVLL E+++         G   Y  +  +        G
Sbjct: 264 -ALESLQTQKFTT--KSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITVYLLQG 312

Query: 392 KLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           +        +       C + L  +M+  W       +RP+  ++   +  +  
Sbjct: 313 RR-------LLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 355

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (361), Expect = 1e-38
 Identities = 76/285 (26%), Positives = 133/285 (46%), Gaps = 41/285 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
             +  G G FG V  G ++       +VA+K L   + + ++ +F  E  ++GQ  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 284
           +RL G   + +  ++V E++ NG+L SFL  +    + +     +   IA G+ YL    
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS--- 164

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE-- 339
               +H D+  +NIL++ +   ++SDFGL ++L  +      T  RG K  +   +PE  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIPIRWTSPEAI 222

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 398
            YRK T     DV+S+G++L E++S         GE  Y  ++        N  +   V+
Sbjct: 223 AYRKFTS--ASDVWSYGIVLWEVMS--------YGERPYWEMS--------NQDVIKAVD 264

Query: 399 GD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
               +    D  C   L  LM+  W  Q+D + RP   ++  +L+
Sbjct: 265 EGYRLPPPMD--CPAALYQLMLDCW--QKDRNNRPKFEQIVSILD 305

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  139 bits (353), Expect = 1e-38
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 47/290 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             +E G G FG+V  G           VAVK +       E EF  E   + +  H  LV
Sbjct: 12  LLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +  G C +     +V E+++NG L ++L  +            + + +  G+ +L    S
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---S 122

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPE--W 340
            Q IH D+  +N L+D     ++SDFG+ + +  +Q   S   K  ++ +    APE   
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFH 178

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
           Y K +   K DV++FG+L+ E+ S        +G+  Y + T        N ++   V  
Sbjct: 179 YFKYSS--KSDVWAFGILMWEVFS--------LGKMPYDLYT--------NSEVVLKVSQ 220

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
              +   +     + +  +M S W   E P  RPT +++   +E + E D
Sbjct: 221 GHRLYRPHL--ASDTIYQIMYSCW--HELPEKRPTFQQLLSSIEPLREKD 266

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (353), Expect = 2e-38
 Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 47/288 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           F +E G G FG+V+ G       +   VA+K + R     E++F  E  V+ +  H  LV
Sbjct: 12  FVQEIGSGQFGLVHLGYW----LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L G C E     LV EF+ +G L+ +L    +  +   T   +   +  G+ YL     
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL---EE 122

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPE--W 340
           + +IH D+  +N L+ ++   ++SDFG+ + +  +Q   S   K  ++      +PE   
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFS 178

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
           + + +   K DV+SFGVL+ E+ S         G+  Y   +        N ++ + +  
Sbjct: 179 FSRYSS--KSDVWSFGVLMWEVFS--------EGKIPYENRS--------NSEVVEDIST 220

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              +           +  +M   W  +E P  RP   ++ + L  + E
Sbjct: 221 GFRLYKPRL--ASTHVYQIMNHCW--RERPEDRPAFSRLLRQLAEIAE 264

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  140 bits (355), Expect = 4e-38
 Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 46/291 (15%)

Query: 168 FKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKN 225
             +  G G FG V+KGV I    +    V +K ++        +   + ++ IG   H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           +VRLLG C  G +  LV ++L  G+L   +  + + +   +   N   QIA+G+ YL E 
Sbjct: 77  IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE- 133

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT----IKTAIRGTKGYVAPE 339
               ++H ++  +N+LL      +++DFG+A LL  +  +      KT I+      A E
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALE 187

Query: 340 --WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDL 396
              + K T   + DV+S+GV + E+++         G E YA L           ++ DL
Sbjct: 188 SIHFGKYTH--QSDVWSYGVTVWELMTF--------GAEPYAGLR--------LAEVPDL 229

Query: 397 VEGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           +E    +       C   +  +MV  W    D ++RPT ++++     +  
Sbjct: 230 LEKGERLAQPQI--CTIDVYMVMVKCW--MIDENIRPTFKELANEFTRMAR 276

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (353), Expect = 4e-38
 Identities = 73/304 (24%), Positives = 132/304 (43%), Gaps = 56/304 (18%)

Query: 168 FKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L        K+F+ E  ++    H++
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 269
           +V+  G C +G   ++V+E++ +G L  FL  +   +  L                   I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA- 328
           A QIA G++YL    S   +H D+  +N L+  +   +I DFG+++ +       +    
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 329 ---IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTD 382
              IR       PE   YRK T   + DV+SFGV+L EI +         G++ +  L++
Sbjct: 196 MLPIRWM----PPESIMYRKFTT--ESDVWSFGVILWEIFTY--------GKQPWFQLSN 241

Query: 383 W-AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
               +C   G++       +E      C +++  +M+  W  Q +P  R  ++++ ++L 
Sbjct: 242 TEVIECITQGRV-------LERPRV--CPKEVYDVMLGCW--QREPQQRLNIKEIYKILH 290

Query: 440 GVVE 443
            + +
Sbjct: 291 ALGK 294

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 5e-38
 Identities = 64/290 (22%), Positives = 123/290 (42%), Gaps = 41/290 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
                G+G FG+VY G       +    A+K L R+ +  +   F  E +++   +H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 227 VRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           + L+G     +     +  ++ +G L  F+    + +  ++   +   Q+ARG+ YL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA-- 141

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV-----AP 338
              + +H D+  +N +LD+ +  +++DFGLA+ +     +   +  +     +     A 
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLV 397
           E  +    T K DV+SFGVLL E+++         G   Y  +            L   +
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHID--------PFDLTHFL 241

Query: 398 E--GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                +       C + L  +M   W  + DP++RPT R +   +E +V 
Sbjct: 242 AQGRRLPQPEY--CPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVS 287

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (354), Expect = 5e-38
 Identities = 74/286 (25%), Positives = 135/286 (47%), Gaps = 42/286 (14%)

Query: 168 FKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKN 225
            ++  G G FG VYKG+   ++      VA+K L   + + ++ +F  E  ++GQ  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           ++RL G   + +  +++ E++ NG L  FL       +++     +   IA G+ YL   
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA-- 164

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE- 339
            +   +H D+  +NIL++ +   ++SDFGL+++L  +   T  T   G K  +   APE 
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPEA 221

Query: 340 -WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLV 397
             YRK T     DV+SFG+++ E+++         GE  Y  L+        N ++   +
Sbjct: 222 ISYRKFTS--ASDVWSFGIVMWEVMT--------YGERPYWELS--------NHEVMKAI 263

Query: 398 EGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
                +    D  C   +  LM+  W  Q++ + RP    +  +L+
Sbjct: 264 NDGFRLPTPMD--CPSAIYQLMMQCW--QQERARRPKFADIVSILD 305

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (349), Expect = 8e-38
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 47/290 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
           F +E G G FG+V  G           VA+K + +     E EF  E  V+    H+ LV
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQ----YDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           +L G C + +   ++ E++ NG L ++L    +  +  +    +   +   + YL    S
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---S 138

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPE--W 340
            Q +H D+  +N L++D    ++SDFGL++ +  ++   S   K  +R +     PE   
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLM 194

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
           Y K +   K D+++FGVL+ EI S         G+  Y   T        N +  + +  
Sbjct: 195 YSKFSS--KSDIWAFGVLMWEIYSL--------GKMPYERFT--------NSETAEHIAQ 236

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD 445
              +   +     EK+  +M S W   E    RPT + +   +  V++ +
Sbjct: 237 GLRLYRPHL--ASEKVYTIMYSCW--HEKADERPTFKILLSNILDVMDEE 282

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  137 bits (347), Expect = 1e-37
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 44/285 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNL 226
                G G FG VY+GV    +     VAVK        D +++F +E V++    H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 284
           V+L+G  +E +   ++ E    G L  +L  N K S  + T    + QI + + YL    
Sbjct: 76  VKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--- 130

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPE-- 339
           S   +H DI  +NIL+      ++ DFGL++ +       +   +  I+      +PE  
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 398
            +R+ T     DV+ F V + EI+S         G++ +  L         N  +  ++E
Sbjct: 187 NFRRFTT--ASDVWMFAVCMWEILS--------FGKQPFFWLE--------NKDVIGVLE 228

Query: 399 --GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
               +   +   C   L  LM   W    DPS RP   ++   L 
Sbjct: 229 KGDRLPKPDL--CPPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (348), Expect = 2e-37
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 43/284 (15%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             E G G+FG V +GV    R     VA+K L     +   +E   E  ++ Q  +  +V
Sbjct: 15  DIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCS 285
           RL+G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL     
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EE 128

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE--W 340
              +H D+  +N+LL + + A+ISDFGL+K L  + S    TA    K  +   APE   
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECIN 186

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
           +RK +   + DV+S+GV + E +S         G++ Y  +           ++   +E 
Sbjct: 187 FRKFSS--RSDVWSYGVTMWEALS--------YGQKPYKKMK--------GPEVMAFIEQ 228

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
              ME   +  C  +L  LM   W        RP    V Q + 
Sbjct: 229 GKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  136 bits (346), Expect = 2e-37
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 44/285 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
                G G FG V++G+  +      AVA+K       D  + +F  E + + Q  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 284
           V+L+G   E     ++ E    G L SFL    K S +L +    A+Q++  L YL    
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--- 133

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPE-- 339
           S + +H DI  +N+L+  +   ++ DFGL++ +  +    +   K  I+      APE  
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE 398
            +R+ T     DV+ FGV + EI+          G + +  +         N  +   +E
Sbjct: 190 NFRRFTS--ASDVWMFGVCMWEILM--------HGVKPFQGVK--------NNDVIGRIE 231

Query: 399 --GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
               +    +  C   L  LM   W    DPS RP   ++   L 
Sbjct: 232 NGERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 272

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (345), Expect = 3e-37
 Identities = 84/282 (29%), Positives = 127/282 (45%), Gaps = 43/282 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             E  G G FG V+ G         T VAVK L +        F  E  ++ Q  H+ LV
Sbjct: 17  LVERLGAGQFGEVWMGYYNGH----TKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
           RL     + +   ++ E++ NG+L  FL         +    ++A QIA G+ ++     
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTAIRGTKGYVAPEWYR 342
              IH D++  NIL+ D  + +I+DFGLA+L+  N+    +  K  I+ T    APE   
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEGD- 400
             T T K DV+SFG+LL EI++         G   Y  +T        N ++   +E   
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT--------HGRIPYPGMT--------NPEVIQNLERGY 227

Query: 401 -MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
            M   ++  C E+L  LM   W  +E P  RPT   +  +LE
Sbjct: 228 RMVRPDN--CPEELYQLMRLCW--KERPEDRPTFDYLRSVLE 265

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  137 bits (346), Expect = 3e-37
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 52/304 (17%)

Query: 168 FKEEAGRGSFGIVYKGV----IETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           F E  G+G+F  ++KGV     +  +   T V +K LD+  ++  + F     ++ +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPSWNLRTNIAFQIARGLLYL 280
           K+LV   G C  G   +LV EF+  G+L ++L  N   +   W L   +A Q+A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNAR--------ISDFGLAKLLTLNQSKTIKTAIRGT 332
                + +IH ++  +NILL    + +        +SD G++  +        +  I   
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERIPWV 184

Query: 333 KGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYR 389
                PE     K  +    D +SFG  L EI S         G++  + L         
Sbjct: 185 ----PPECIENPK-NLNLATDKWSFGTTLWEICS--------GGDKPLSALD-------- 223

Query: 390 NGKLDDLVEGD--MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVP 447
           + +     E    + A          L+ +      +P  RP+ R + + L  +   D+ 
Sbjct: 224 SQRKLQFYEDRHQLPAPKA--AELANLINNCM--DYEPDHRPSFRAIIRDLNSLFTPDLV 279

Query: 448 PNPS 451
           P  S
Sbjct: 280 PRGS 283

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  136 bits (345), Expect = 3e-37
 Identities = 82/302 (27%), Positives = 130/302 (43%), Gaps = 59/302 (19%)

Query: 168 FKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHK 224
           F EE G   FG VYKG +        T AVA+K L D+      +EF++E ++  +  H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 268
           N+V LLG   + Q   +++ + ++G L  FL      S    T+                
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 269 IAFQIARGLLYLHEDCSSQ-IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
           +  QIA G+ YL    SS  ++H D+  +N+L+ D  N +ISD GL + +       +  
Sbjct: 133 LVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 328 A----IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAIL 380
                IR      APE   Y K +I    D++S+GV+L E+ S         G + Y   
Sbjct: 189 NSLLPIRWM----APEAIMYGKFSI--DSDIWSYGVVLWEVFS--------YGLQPYCGY 234

Query: 381 TDW-AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQM 437
           ++    +  RN ++       +   +D  C   +  LM+  W   E PS RP  + +   
Sbjct: 235 SNQDVVEMIRNRQV-------LPCPDD--CPAWVYALMIECW--NEFPSRRPRFKDIHSR 283

Query: 438 LE 439
           L 
Sbjct: 284 LR 285

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (347), Expect = 3e-37
 Identities = 77/304 (25%), Positives = 136/304 (44%), Gaps = 53/304 (17%)

Query: 168 FKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 224
              E G+GSFG+VY+GV +        T VA+K ++      E+ EF NE  V+ + +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT----------NIAFQIA 274
           ++VRLLG   +GQ  L++ E +  G L S+L        N              +A +IA
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
            G+ YL+   +++ +H D+  +N ++ + +  +I DFG+ + +            +G KG
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----YETDYYRKGGKG 200

Query: 335 YV-----APE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AF 385
            +     +PE       T     DV+SFGV+L EI +        + E+ Y  L++    
Sbjct: 201 LLPVRWMSPESLKDGVFTT--YSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVL 250

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                G L       ++  ++  C + L  LM   W  Q +P +RP+  ++   ++  +E
Sbjct: 251 RFVMEGGL-------LDKPDN--CPDMLFELMRMCW--QYNPKMRPSFLEIISSIKEEME 299

Query: 444 VDVP 447
               
Sbjct: 300 PGFR 303

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  137 bits (348), Expect = 4e-37
 Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 46/287 (16%)

Query: 168 FKEEAGRGSFGIVYKGV-IETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKN 225
             +  G G+FG VYKG+ I         VA+K+L +       KE  +E  V+    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHED 283
           + RLLG C       L+ + +  G L  ++  + K +   +   N   QIA+G+ YL + 
Sbjct: 79  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTAIRGTKGYVAPE 339
              +++H D+  +N+L+    + +I+DFGLAKLL   + +      K  I+      A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189

Query: 340 --WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDL 396
              +R  T   + DV+S+GV + E+++         G + Y  +           ++  +
Sbjct: 190 SILHRIYTH--QSDVWSYGVTVWELMT--------FGSKPYDGIP--------ASEISSI 231

Query: 397 VEGD--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +E    +       C   +  +MV  W    D   RP  R++     
Sbjct: 232 LEKGERLPQPPI--CTIDVYMIMVKCW--MIDADSRPKFRELIIEFS 274

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  136 bits (345), Expect = 5e-37
 Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 36/268 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G+G++GIVY G   + +     +A+K++        +    E+ +     HKN+V+ LG 
Sbjct: 31  GKGTYGIVYAGRDLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 233 CDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
             E     +  E +  G+L++ L   +G LK +         QI  GL YLH    +QI+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144

Query: 290 HCDIKPQNILLDDHY-NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-- 346
           H DIK  N+L++ +    +ISDFG +K L      T      GT  Y+APE   K     
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRGY 202

Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL--VEGDM--E 402
               D++S G  ++E+ + +  F  E+GE  A +       ++ G       +   M  E
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM-------FKVGMFKVHPEIPESMSAE 254

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT 430
           A   I            C + DP  R  
Sbjct: 255 AKAFILK----------CFEPDPDKRAC 272

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  137 bits (346), Expect = 7e-37
 Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 55/299 (18%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
            K E G G+FG V+               VAVK L    +   ++F+ E  ++    H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------IA 270
           +VR  G C EG+  L+V+E++ +G L  FL  +   +  L                  +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA-- 328
            Q+A G++YL        +H D+  +N L+      +I DFG+++ +       +     
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 329 --IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW 383
             IR       PE   YRK T   + DV+SFGV+L EI +         G++ +  L++ 
Sbjct: 222 LPIRWM----PPESILYRKFTT--ESDVWSFGVVLWEIFT--------YGKQPWYQLSNT 267

Query: 384 -AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
            A DC   G+        +E      C  ++  +M   W  Q +P  R +++ V   L+
Sbjct: 268 EAIDCITQGRE-------LERPRA--CPPEVYAIMRGCW--QREPQQRHSIKDVHARLQ 315

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  137 bits (347), Expect = 1e-36
 Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 60/308 (19%)

Query: 168 FKEEAGRGSFGIVYKG----VIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 221
             +  G G FG V       + +        VAVK L     + +  +  +E+ ++    
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 268
            HKN++ LLG C +     ++ E+ + G L  +L     P      +             
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 269 ---IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
                +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +        
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 326 KTA----IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--Y 377
            T     ++      APE  + R  T   + DV+SFGVL+ EI +        +G     
Sbjct: 262 TTNGRLPVKWM----APEALFDRVYTH--QSDVWSFGVLMWEIFT--------LGGSPYP 307

Query: 378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVS 435
            I  +  F   + G         M+   +  C  +L  +M   W     PS RPT +++ 
Sbjct: 308 GIPVEELFKLLKEGHR-------MDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLV 356

Query: 436 QMLEGVVE 443
           + L+ ++ 
Sbjct: 357 EDLDRILT 364

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (343), Expect = 1e-36
 Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 51/299 (17%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 225
             +  G G FG V +G ++    ++  VAVK  KLD   Q   +EF +E   +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 226 LVRLLGFCDEGQNR-----LLVYEFLNNGTLASFL----FGNLKPSWNLRT--NIAFQIA 274
           ++RLLG C E  ++     +++  F+  G L ++L             L+T       IA
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN----QSKTIKTAIR 330
            G+ YL    +   +H D+  +N +L D     ++DFGL+K +       Q +  K  ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 331 GTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFD 386
                 A E    R  T   K DV++FGV + EI +         G   Y  + +   +D
Sbjct: 215 WI----AIESLADRVYTS--KSDVWAFGVTMWEIAT--------RGMTPYPGVQNHEMYD 260

Query: 387 CYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              +G         ++   D  C+++L  +M S W  + DP  RPT   +   LE ++E
Sbjct: 261 YLLHGHR-------LKQPED--CLDELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (343), Expect = 2e-36
 Identities = 71/314 (22%), Positives = 127/314 (40%), Gaps = 60/314 (19%)

Query: 168 FKEEAGRGSFGIVYKG----VIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 221
             +  G G+FG V       + +        VAVK L     + +  +  +E+ ++    
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN------------- 268
            HKN++ LLG C +     ++ E+ + G L  +L     P      +             
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 269 ---IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
                +Q+ARG+ YL    S + IH D+  +N+L+ ++   +I+DFGLA+ +        
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215

Query: 326 KTA----IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--Y 377
            T     ++      APE  + R  T   + DV+SFGVL+ EI +        +G     
Sbjct: 216 TTNGRLPVKWM----APEALFDRVYTH--QSDVWSFGVLMWEIFT--------LGGSPYP 261

Query: 378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVS 435
            I  +  F   + G         M+   +  C  +L  +M   W     PS RPT +++ 
Sbjct: 262 GIPVEELFKLLKEGHR-------MDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLV 310

Query: 436 QMLEGVVEVDVPPN 449
           + L+ ++ +     
Sbjct: 311 EDLDRILTLTTNEE 324

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (342), Expect = 2e-36
 Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 48/298 (16%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKN 225
                G+G FG V +  ++    S   VAVK  K D +     +EF  E   + +  H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 226 LVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPSWNLR------TNIAFQI 273
           + +L+G     + +      +++  F+ +G L +FL  +                    I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN----QSKTIKTAI 329
           A G+ YL    S   IH D+  +N +L +     ++DFGL++ +       Q    K  +
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AFDC 387
           +      A E    +  T   DV++FGV + EI++         G+  YA + +   ++ 
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEIYNY 251

Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              G         ++   +  C+E++  LM   W    DP  RP+   +   LE ++ 
Sbjct: 252 LIGGNR-------LKQPPE--CMEEVYDLMYQCW--SADPKQRPSFTCLRMELENILG 298

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (342), Expect = 2e-36
 Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 53/296 (17%)

Query: 168 FKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 224
                G G+FG VY+G +       S   VAVK L  V  + ++ +F  E ++I + +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGL 277
           N+VR +G   +   R ++ E +  G L SFL           +       ++A  IA G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 278 LYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
            YL     +  IH DI  +N LL        A+I DFG+A+ +            +G   
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCA 205

Query: 335 YV-----APE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AF 385
            +      PE       T   K D +SFGVLL EI S        +G   Y   ++    
Sbjct: 206 MLPVKWMPPEAFMEGIFTS--KTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVL 255

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +   +G         M+   +  C   +  +M   W  Q  P  RP    + + +E
Sbjct: 256 EFVTSGGR-------MDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIE 300

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  139 bits (352), Expect = 6e-36
 Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 40/283 (14%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHKNL 226
                G G FG V++G+  +      AVA+K       D  + +F  E + + Q  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDC 284
           V+L+G   E     ++ E    G L SFL    K S +L +    A+Q++  L YL    
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--- 508

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN---QSKTIKTAIRGTKGYVAPEWY 341
           S + +H DI  +N+L+  +   ++ DFGL++ +  +   ++   K  I+      APE  
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564

Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVE-- 398
                T+  DV+ FGV + EI+          G + +  +         N  +   +E  
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMH--------GVKPFQGVK--------NNDVIGRIENG 608

Query: 399 GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
             +    +  C   L  LM   W    DPS RP   ++   L 
Sbjct: 609 ERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 647

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (339), Expect = 1e-35
 Identities = 75/296 (25%), Positives = 117/296 (39%), Gaps = 53/296 (17%)

Query: 168 FKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 224
                G G+FG VY+G +       S   VAVK L  V  + ++ +F  E ++I + +H+
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGL 277
           N+VR +G   +   R ++ E +  G L SFL           +       ++A  IA G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 278 LYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
            YL     +  IH DI  +N LL        A+I DFG+A+ +            +G   
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCA 246

Query: 335 YV-----APE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDW-AF 385
            +      PE       T   K D +SFGVLL EI S        +G   Y   ++    
Sbjct: 247 MLPVKWMPPEAFMEGIFTS--KTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVL 296

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
           +   +G         M+   +  C   +  +M   W  Q  P  RP    + + +E
Sbjct: 297 EFVTSGGR-------MDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIE 341

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (334), Expect = 2e-35
 Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 55/294 (18%)

Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNLVRLL 230
           GRG FG+V++              A+K++    ++  +E    EV  + +  H  +VR  
Sbjct: 14  GRGGFGVVFEA----KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69

Query: 231 G-FCDEG--------QNRLLVY---EFLNNGTLASFLF---GNLKPSWNLRTNIAFQIAR 275
             + ++           ++ +Y   +      L  ++       +   ++  +I  QIA 
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL----------TLNQSKTI 325
            + +LH   S  ++H D+KP NI        ++ DFGL   +          T   +   
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 385
            T   GTK Y++PE    ++ + KVD++S G++L E++     F  +M            
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----------- 232

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
              R   L D+       +   K   + +MV    +   P  RP       ++E
Sbjct: 233 ---RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ-DMLSPSPMERPE---AINIIE 279

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  132 bits (334), Expect = 2e-35
 Identities = 71/306 (23%), Positives = 124/306 (40%), Gaps = 55/306 (17%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 223
           F +  G G+FG V +          +   VAVK L       E+    +E+ V+    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------- 268
            N+V LLG C  G   L++ E+   G L +FL          +T+               
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 269 ---IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
               ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 326 KTA----IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAI 379
           K      ++      APE       T + DV+S+G+ L E+ S   S    + +  +   
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256

Query: 380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQM 437
                +   + G         M +        ++  +M + W    DP  RPT +++ Q+
Sbjct: 257 ----FYKMIKEGFR-------MLSPEH--APAEMYDIMKTCW--DADPLKRPTFKQIVQL 301

Query: 438 LEGVVE 443
           +E  + 
Sbjct: 302 IEKQIS 307

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  132 bits (333), Expect = 3e-35
 Identities = 58/272 (21%), Positives = 107/272 (39%), Gaps = 28/272 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQTHHKNLVRL 229
           GRG F  VY+            VA+KK+        K       E+ ++ Q +H N+++ 
Sbjct: 41  GRGQFSEVYRAACLLDGV---PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLHEDCS 285
                E     +V E  + G L+  +    K    +          Q+   L ++H   S
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +++H DIKP N+ +      ++ D GL +  +   +    + + GT  Y++PE   ++ 
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLV-GTPYYMSPERIHENG 212

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
              K D++S G LL E+ + +  F  +    Y++                + + D   + 
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KIEQCDYPPLP 259

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM 437
                E+L  +   CI  DP  RP +  V  +
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  131 bits (332), Expect = 3e-35
 Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 55/297 (18%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
                G+G+FG V K             A+KK+    ++      +EV+++   +H+ +V
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRY---YAIKKIRHT-EEKLSTILSEVMLLASLNHQYVV 65

Query: 228 RLLGFCDEGQNRL-------------LVYEFLNNGTLASFL-FGNLKPSWNLRTNIAFQI 273
           R      E +N +             +  E+  NGTL   +   NL    +    +  QI
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR--- 330
              L Y+H   S  IIH D+KP NI +D+  N +I DFGLAK +  +       +     
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 331 ---------GTKGYVAPE-WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL 380
                    GT  YVA E          K+D+YS G++  E+I    S  +E       L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-YPFSTGMERVNILKKL 241

Query: 381 TDWAFDCYRNGKLD---DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                   R+  ++   D  +  M+    I  +  L+         DP+ RP  R +
Sbjct: 242 --------RSVSIEFPPDFDDNKMKVEKKI--IRLLIDH-------DPNKRPGARTL 281

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  133 bits (337), Expect = 3e-35
 Identities = 75/318 (23%), Positives = 132/318 (41%), Gaps = 60/318 (18%)

Query: 168 FKEEAGRGSFGIVYKG----VIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-T 221
             +  G G+FG V       + +      T VAVK L     + +  +  +E+ ++    
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPSWNLR--- 266
            HKN++ LLG C +     ++ E+ + G L  +L              +  P   L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 267 -TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
             + A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +        
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249

Query: 326 KTA----IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--Y 377
            T     ++      APE  + R  T   + DV+SFGVLL EI +        +G     
Sbjct: 250 TTNGRLPVKWM----APEALFDRIYTH--QSDVWSFGVLLWEIFT--------LGGSPYP 295

Query: 378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVS 435
            +  +  F   + G         M+  ++  C  +L  +M   W     PS RPT +++ 
Sbjct: 296 GVPVEELFKLLKEGHR-------MDKPSN--CTNELYMMMRDCW--HAVPSQRPTFKQLV 344

Query: 436 QMLEGVVEVDVPPNPSPF 453
           + L+ +V +        +
Sbjct: 345 EDLDRIVALTSNQEMGYY 362

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  134 bits (339), Expect = 4e-35
 Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 39/281 (13%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKN 225
             K+  G G+ G +    +   R     VAVK++             EV ++ +   H N
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNR----DVAVKRILPEC---FSFADREVQLLRESDEHPN 79

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-NIAFQIARGLLYLHEDC 284
           ++R      + Q + +  E L   TL  ++         L    +  Q   GL +LH   
Sbjct: 80  VIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135

Query: 285 SSQIIHCDIKPQNILL-----DDHYNARISDFGLAKLLTLNQ-SKTIKTAIRGTKGYVAP 338
           S  I+H D+KP NIL+          A ISDFGL K L + + S + ++ + GT+G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 339 EWYRKSTI---TAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKL 393
           E   +      T  VD++S G +   +IS            +   +L   + DC     L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-----L 250

Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                 D+ A   I+            I  DP  RP+ + V
Sbjct: 251 HPEKHEDVIARELIE----------KMIAMDPQKRPSAKHV 281

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  132 bits (334), Expect = 5e-35
 Identities = 70/313 (22%), Positives = 128/313 (40%), Gaps = 65/313 (20%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 224
           +  + G G+FG V++            T VAVK L        + +F+ E  ++ +  + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN---------------- 268
           N+V+LLG C  G+   L++E++  G L  FL      +    ++                
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 269 --------IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
                   IA Q+A G+ YL      + +H D+  +N L+ ++   +I+DFGL++ +   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 321 QSKTIKTA----IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
                       IR       PE  +Y + T   + DV+++GV+L EI S         G
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTT--ESDVWAYGVVLWEIFS--------YG 273

Query: 375 EE-YAILTDW-AFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPT 430
            + Y  +         R+G +       +    +  C  +L  LM   W   + P+ RP+
Sbjct: 274 LQPYYGMAHEEVIYYVRDGNI-------LACPEN--CPLELYNLMRLCW--SKLPADRPS 322

Query: 431 MRKVSQMLEGVVE 443
              + ++L+ + E
Sbjct: 323 FCSIHRILQRMCE 335

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (332), Expect = 5e-35
 Identities = 76/305 (24%), Positives = 127/305 (41%), Gaps = 62/305 (20%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THHKN 225
           F++  G G+FG V K  I+         A+K++       +  +F  E+ V+ +  HH N
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN----------------I 269
           ++ LLG C+      L  E+  +G L  FL  +     +                     
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           A  +ARG+ YL      Q IH D+  +NIL+ ++Y A+I+DFGL        S+  +  +
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------SRGQEVYV 196

Query: 330 RGTKGYV-----APE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAIL 380
           + T G +     A E   Y   T     DV+S+GVLL EI+S        +G      + 
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTT--NSDVWSYGVLLWEIVS--------LGGTPYCGMT 246

Query: 381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQML 438
               ++    G         +E   +  C +++  LM   W  +E P  RP+  ++   L
Sbjct: 247 CAELYEKLPQGYR-------LEKPLN--CDDEVYDLMRQCW--REKPYERPSFAQILVSL 295

Query: 439 EGVVE 443
             ++E
Sbjct: 296 NRMLE 300

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (343), Expect = 7e-35
 Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 43/284 (15%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL-DRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             E G G+FG V +GV    R     VA+K L     +   +E   E  ++ Q  +  +V
Sbjct: 341 DIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCS 285
           RL+G C + +  +LV E    G L  FL G  +  P  N+   +  Q++ G+ YL     
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EE 454

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV---APE--W 340
              +H ++  +N+LL + + A+ISDFGL+K L  + S    TA    K  +   APE   
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECIN 512

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-YAILTDWAFDCYRNGKLDDLVEG 399
           +RK +   + DV+S+GV + E +S         G++ Y  +           ++   +E 
Sbjct: 513 FRKFSS--RSDVWSYGVTMWEALSY--------GQKPYKKMK--------GPEVMAFIEQ 554

Query: 400 D--MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLE 439
              ME   +  C  +L  LM   W        RP    V Q + 
Sbjct: 555 GKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 594

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (329), Expect = 1e-34
 Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 58/307 (18%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 223
             +  GRG+FG V +          +   VAVK L       E     +E+ ++    HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 224 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-------------- 268
            N+V LLG C   G   +++ EF   G L+++L          +                
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 269 --IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 327 TA----IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYA 378
                 ++      APE  + R  TI  + DV+SFGVLL EI S   S    +++ EE  
Sbjct: 208 GDARLPLKWM----APETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259

Query: 379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQ 436
                     + G         M A +      ++   M+  W    +PS RPT  ++ +
Sbjct: 260 -----FCRRLKEG-------TRMRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVE 303

Query: 437 MLEGVVE 443
            L  +++
Sbjct: 304 HLGNLLQ 310

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  132 bits (333), Expect = 2e-34
 Identities = 79/301 (26%), Positives = 118/301 (39%), Gaps = 58/301 (19%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKN 225
             ++  G GS G V        R     VAVK++   F D       E+ ++ ++  H N
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCD---IALMEIKLLTESDDHPN 70

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-------NIAFQIARGLL 278
           ++R        +   +  E L N  L   +        NL+        ++  QIA G+ 
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 279 YLHEDCSSQIIHCDIKPQNILLD-------------DHYNARISDFGLAKLLTLNQS--- 322
           +LH   S +IIH D+KPQNIL+              ++    ISDFGL K L   QS   
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 323 KTIKTAIRGTKGYVAPE-------WYRKSTITAKVDVYSFGVLLLEIISCRKS-FDIEMG 374
             +     GT G+ APE          K  +T  +D++S G +   I+S  K  F  +  
Sbjct: 187 TNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245

Query: 375 EEYAILT-DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
            E  I+   ++ D  +      L+    EA + I             I  DP  RPT  K
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIA---EATDLIS----------QMIDHDPLKRPTAMK 292

Query: 434 V 434
           V
Sbjct: 293 V 293

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (327), Expect = 2e-34
 Identities = 77/315 (24%), Positives = 136/315 (43%), Gaps = 69/315 (21%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQTHHK 224
             +  G G FG V K        R   T VAVK L       E  +  +E  V+ Q +H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR------------------ 266
           ++++L G C +    LL+ E+   G+L  FL  + K                        
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 267 ------TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
                  + A+QI++G+ YL      +++H D+  +NIL+ +    +ISDFGL++ +   
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV--- 200

Query: 321 QSKTIKTAIRGTKGYV-----APE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEM 373
                 + ++ ++G +     A E  +    T   + DV+SFGVLL EI++        +
Sbjct: 201 --YEEDSYVKRSQGRIPVKWMAIESLFDHIYTT--QSDVWSFGVLLWEIVT--------L 248

Query: 374 GEE-YAILTDWAFDCYRNGKLDDLVE--GDMEAMNDIKCVEKL--LMVSIWCIQEDPSLR 428
           G   Y  +           +L +L++    ME  ++  C E++  LM+  W  +++P  R
Sbjct: 249 GGNPYPGIP--------PERLFNLLKTGHRMERPDN--CSEEMYRLMLQCW--KQEPDKR 296

Query: 429 PTMRKVSQMLEGVVE 443
           P    +S+ LE ++ 
Sbjct: 297 PVFADISKDLEKMMV 311

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (328), Expect = 3e-34
 Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 57/307 (18%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 223
           F +  G G+FG V +          +   VAVK L       EK    +E+ ++     H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPSWNLRTN----I 269
           +N+V LLG C  G   L++ E+   G L +FL                +    T      
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA- 328
           + Q+A+G+ +L    S   IH D+  +N+LL + + A+I DFGLA+ +  + +  +K   
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 329 ---IRGTKGYVAPE--WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT 381
              ++      APE  +    T+  + DV+S+G+LL EI S        +G      IL 
Sbjct: 227 RLPVKWM----APESIFDCVYTV--QSDVWSYGILLWEIFS--------LGLNPYPGILV 272

Query: 382 DWAFDCYRNGKLDDLVEGD-MEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQML 438
           +  F          + +G  M         + +  +M + W    +P+ RPT +++   L
Sbjct: 273 NSKF-------YKLVKDGYQMAQPAF--APKNIYSIMQACW--ALEPTHRPTFQQICSFL 321

Query: 439 EGVVEVD 445
           +   + D
Sbjct: 322 QEQAQED 328

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (322), Expect = 6e-34
 Identities = 61/281 (21%), Positives = 111/281 (39%), Gaps = 54/281 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLG- 231
           G G FG V+K      R       +K++        ++ + EV  + +  H N+V   G 
Sbjct: 20  GSGGFGQVFKA---KHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 232 FCDEGQNRL---------------LVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQI 273
           +     +                 +  EF + GTL  ++    G           +  QI
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-ELFEQI 131

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            +G+ Y+H   S ++I+ D+KP NI L D    +I DFGL   L    +   +T  +GT 
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSKGTL 185

Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 393
            Y++PE         +VD+Y+ G++L E++    +   E  + +  L        R+G +
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL--------RDGII 236

Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            D+   D +    ++            + + P  RP   ++
Sbjct: 237 SDIF--DKKEKTLLQ----------KLLSKKPEDRPNTSEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (322), Expect = 1e-33
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 28/215 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL--VR 228
           G G    V++ + E  +      A+K ++    D +    ++NE+  + +    +   +R
Sbjct: 37  GSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L  +    Q   +V E   N  L S+L    ++ P    R +    +   +  +H     
Sbjct: 93  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIH---QH 146

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE------- 339
            I+H D+KP N L+ D    ++ DFG+A  +  + +  +K +  GT  Y+ PE       
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 340 ----WYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
                  KS I+ K DV+S G +L  +   +  F 
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  128 bits (323), Expect = 2e-33
 Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 42/279 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIG--QTHHKNLVR 228
           G G    V++ + E  +      A+K ++    D +    ++NE+  +   Q H   ++R
Sbjct: 18  GSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L  +    Q   +V E   N  L S+L    ++ P    R +    +   +  +H+    
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQ---H 127

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE------- 339
            I+H D+KP N L+ D    ++ DFG+A  +  + +  +K +  GT  Y+ PE       
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 340 ----WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
                  KS I+ K DV+S G +L  +   +  F  ++  + + L       +     + 
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIIDPNH 238

Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            +E       D++    +L     C++ DP  R ++ ++
Sbjct: 239 EIEFPDIPEKDLQ---DVLK---CCLKRDPKQRISIPEL 271

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (322), Expect = 2e-33
 Identities = 67/311 (21%), Positives = 119/311 (38%), Gaps = 60/311 (19%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGEK-EFKNEVVVIGQ-THH 223
           F +  G G+FG V        +    +  VAVK L       E+    +E+ ++ Q   H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--------------- 268
           +N+V LLG C       L++E+   G L ++L    +                       
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 269 --------IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN 320
                    A+Q+A+G+ +L        +H D+  +N+L+      +I DFGLA+ +  +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 321 QSKTIKTA----IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMG 374
            +  ++      ++      APE   +   T K DV+S+G+LL EI S   +    I + 
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281

Query: 375 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMR 432
                     +   +NG         M+        E++  +M S W    D   RP+  
Sbjct: 282 AN-------FYKLIQNGFK-------MDQPFY--ATEEIYIIMQSCW--AFDSRKRPSFP 323

Query: 433 KVSQMLEGVVE 443
            ++  L   + 
Sbjct: 324 NLTSFLGCQLA 334

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (317), Expect = 2e-33
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 34/277 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G GS+G   K   ++       +  K+LD         +   +EV ++ +  H N+VR  
Sbjct: 15  GTGSYGRCQKIRRKSDGKI---LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 231 G-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLHE-- 282
               D     L +V E+   G LAS +    K    L       +  Q+   L   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           D    ++H D+KP N+ LD   N ++ DFGLA++L  + S   KT + GT  Y++PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTPYYMSPEQMN 189

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 402
           + +   K D++S G LL E+ +    F          L        R GK   +     +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKEL----AGKIREGKFRRIPYRYSD 242

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +N+I  + ++L +           RP+   V ++LE
Sbjct: 243 ELNEI--ITRMLNL-------KDYHRPS---VEEILE 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (322), Expect = 4e-33
 Identities = 56/279 (20%), Positives = 114/279 (40%), Gaps = 42/279 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNL--VR 228
           G G    V++ + E  +      A+K ++    D +    ++NE+  + +    +   +R
Sbjct: 65  GSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L  +    Q   +V E   N  L S+L    ++ P    R +    +   +  +H+    
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP--WERKSYWKNMLEAVHTIHQ---H 174

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE------- 339
            I+H D+KP N L+ D    ++ DFG+A  +  + +  +K +  G   Y+ PE       
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 340 ----WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD 395
                  KS I+ K DV+S G +L  +   +  F  ++  + + L       +     + 
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIIDPNH 285

Query: 396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            +E       D++    +L     C++ DP  R ++ ++
Sbjct: 286 EIEFPDIPEKDLQ---DVLK---CCLKRDPKQRISIPEL 318

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  125 bits (315), Expect = 2e-32
 Identities = 60/199 (30%), Positives = 85/199 (42%), Gaps = 19/199 (9%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           +   GRGSFG V++   + T       AVKK+    +    E   E+V         +V 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQ---CAVKKVR--LEVFRVE---ELVACAGLSSPRIVP 114

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           L G   EG    +  E L  G+L   +   G L            Q   GL YLH   + 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPED--RALYYLGQALEGLEYLH---TR 169

Query: 287 QIIHCDIKPQNILLD-DHYNARISDFGLAKLLT---LNQSKTIKTAIRGTKGYVAPEWYR 342
           +I+H D+K  N+LL  D   A + DFG A  L    L +S      I GT+ ++APE   
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 343 KSTITAKVDVYSFGVLLLE 361
                AKVD++S   ++L 
Sbjct: 230 GKPCDAKVDIWSSCCMMLH 248

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (314), Expect = 2e-32
 Identities = 63/311 (20%), Positives = 108/311 (34%), Gaps = 57/311 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLG 231
             G F  VY+     +       A+K+L    ++  +    EV  + + + H N+V+   
Sbjct: 37  AEGGFAFVYEAQDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 232 FC-------DEGQNRLLVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIARGLLY 279
                    D GQ   L+   L  G L  FL      G L     L+  I +Q  R + +
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRAVQH 151

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR--------- 330
           +H      IIH D+K +N+LL +    ++ DFG A  ++     +     R         
Sbjct: 152 MH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 331 -GTKGYVAPE---WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---DW 383
             T  Y  PE    Y    I  K D+++ G +L  +   +  F  E G +  I+      
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKLRIVNGKYSI 268

Query: 384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                +      L+                       +Q +P  R ++ +V   L+ +  
Sbjct: 269 PPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQEIAA 308

Query: 444 VDVPPNPSPFS 454
                  SP +
Sbjct: 309 ARNVNPKSPIT 319

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (310), Expect = 3e-32
 Identities = 59/289 (20%), Positives = 105/289 (36%), Gaps = 60/289 (20%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQ-THHKNL 226
           E+ G G FG V+K V    R      A+K+  +       E+    EV        H ++
Sbjct: 17  EKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLHE 282
           VR      E  + L+  E+ N G+LA  +  N +     +     ++  Q+ RGL Y+H 
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH- 132

Query: 283 DCSSQIIHCDIKPQNILLD-------------------DHYNARISDFGLAKLLTLNQSK 323
             S  ++H DIKP NI +                    +    +I D G    ++  Q +
Sbjct: 133 --SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190

Query: 324 TIKTAIRGTKGYVAPE-WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD 382
                  G   ++A E      T   K D+++  + ++             G+++  +  
Sbjct: 191 E------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--NGDQWHEI-- 240

Query: 383 WAFDCYRNGKLDDLVEGDMEAMND-IKCVEKLLMVSIWCIQEDPSLRPT 430
                 R G+L  + +   +   + +K            I  DP  RP+
Sbjct: 241 ------RQGRLPRIPQVLSQEFTELLK----------VMIHPDPERRPS 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  123 bits (311), Expect = 4e-32
 Identities = 63/265 (23%), Positives = 94/265 (35%), Gaps = 39/265 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQ-THHKNLVRL 229
           G GS+G V+K     ++      AVK+    F+          EV    +   H   VRL
Sbjct: 66  GHGSYGEVFKVR---SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
               +EG    L  E     +L      +G   P   +           L +LH   S  
Sbjct: 123 EQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLH---SQG 177

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+KP NI L      ++ DFGL   L    +        G   Y+APE  + S   
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQGS-YG 233

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM--EAMN 405
              DV+S G+ +LE+    +      GE +  L        R G L       +  E  +
Sbjct: 234 TAADVFSLGLTILEVACNMELPH--GGEGWQQL--------RQGYLPPEFTAGLSSELRS 283

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPT 430
            +             ++ DP LR T
Sbjct: 284 VLV----------MMLEPDPKLRAT 298

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  122 bits (308), Expect = 6e-32
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 12/205 (5%)

Query: 170 EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKN 225
           ++ G G    VY              VA+K +    ++ E   K F+ EV    Q  H+N
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIK----VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +V ++   +E     LV E++   TL+ ++  +   S +   N   QI  G+ + H+   
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--- 129

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            +I+H DIKPQNIL+D +   +I DFG+AK L+   S T    + GT  Y +PE  +   
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFD 370
                D+YS G++L E++     F+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN 213

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (309), Expect = 7e-32
 Identities = 59/291 (20%), Positives = 98/291 (33%), Gaps = 50/291 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G F  V               A+K++    Q   +E + E  +    +H N++RL+ +
Sbjct: 38  GEGGFSYVDLV---EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 233 CDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLRT----NIAFQIARGLLYLHEDC 284
           C   +       L+  F   GTL + +         L       +   I RGL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI-------RGTKGYVA 337
           +    H D+KP NILL D     + D G      ++   + +          R T  Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211

Query: 338 PE---WYRKSTITAKVDVYSFGVLLLEIISCRKSFD--IEMGEEY--AILTDWAF--DCY 388
           PE         I  + DV+S G +L  ++     +D   + G+    A+    +      
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR 271

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +  L  L+                       +  DP  RP +  +   LE
Sbjct: 272 HSSALWQLLN--------------------SMMTVDPHQRPHIPLLLSQLE 302

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  123 bits (310), Expect = 1e-31
 Identities = 37/230 (16%), Positives = 69/230 (30%), Gaps = 21/230 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN 225
                G G+F  VY+        +       +K                +  +  +    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSW-----NLRTNIAFQIARGLLYL 280
            ++           +LV E  + GTL + +              L  + A ++   +  +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNA-----------RISDFGLAKLLTLNQSKTIKTAI 329
           H     +IIH DIKP N +L + +              + D G +  + L    TI TA 
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 379
             T G+   E         ++D +     +  ++          G E   
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  122 bits (309), Expect = 1e-31
 Identities = 58/285 (20%), Positives = 110/285 (38%), Gaps = 43/285 (15%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK---NEVVVIGQ 220
           + +   ++ G GSFG                  +K+++       KE +    EV V+  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQ---YVIKEINISRMS-SKEREESRREVAVLAN 79

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAFQIARG 276
             H N+V+     +E  +  +V ++   G L   +        +    L      QI   
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD--WFVQICLA 137

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           L ++H     +I+H DIK QNI L      ++ DFG+A++L        +  I GT  Y+
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACI-GTPYYL 192

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           +PE         K D+++ G +L E+ + + +F+         L            +  +
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNL------------VLKI 237

Query: 397 VEGDMEAMNDI--KCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           + G    ++      +  L+       + +P  RP+   V+ +LE
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPS---VNSILE 276

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (306), Expect = 2e-31
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 29/217 (13%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 225
              +  G+G+   V++G  + T       A+K  + +      +    E  V+ + +HKN
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 226 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLY 279
           +V+L    +E   R   L+ EF   G+L + L      ++ L  +        +  G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127

Query: 280 LHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           L     + I+H +IKP NI+     D     +++DFG A+ L     +   +   GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181

Query: 336 VAPEWYRKSTI--------TAKVDVYSFGVLLLEIIS 364
           + P+ Y ++ +         A VD++S GV      +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (304), Expect = 4e-31
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 17/198 (8%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
            + G GS GIV     + +      VAVK +D   Q   +   NEVV++    H N+V +
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQ---VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
                 G+   ++ EFL  G L   +    L         IA     + + L YLH   +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---A 159

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH DIK  +ILL      ++SDFG    ++ +  K  K+ + GT  ++APE   +S 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLV-GTPYWMAPEVISRSL 217

Query: 346 ITAKVDVYSFGVLLLEII 363
              +VD++S G++++E++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 9e-31
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 17/198 (8%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDCS 285
           L     G    +V E+L  G+L   +    +         IA    +  + L +LH   S
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLH---S 134

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
           +Q+IH DIK  NILL    + +++DFG    +T  QSK   T + GT  ++APE   +  
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKA 192

Query: 346 ITAKVDVYSFGVLLLEII 363
              KVD++S G++ +E+I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  118 bits (297), Expect = 2e-30
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 21/198 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY       + S   +A+K L +  + + G E + + EV +     H N++RL
Sbjct: 18  GKGKFGNVYLA---REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 285
            G+  +     L+ E+   GT+    +  L+               ++A  L Y H   S
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH---S 127

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            ++IH DIKP+N+LL      +I+DFG +     ++   +     GT  Y+ PE      
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRM 183

Query: 346 ITAKVDVYSFGVLLLEII 363
              KVD++S GVL  E +
Sbjct: 184 HDEKVDLWSLGVLCYEFL 201

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (301), Expect = 4e-30
 Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 29/212 (13%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKN 225
              +  G+G+   V++G  + T       A+K  + +      +    E  V+ + +HKN
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 226 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLY 279
           +V+L    +E   R   L+ EF   G+L + L      ++ L  +        +  G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127

Query: 280 LHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           L     + I+H +IKP NI+     D     +++DFG A+ L     +   +   GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181

Query: 336 VAPEWYRKSTI--------TAKVDVYSFGVLL 359
           + P+ Y ++ +         A VD++S GV  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  115 bits (291), Expect = 1e-29
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 21/196 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 229
           G+G FG VY       + +   +A+K L +  + ++G E + + E+ +     H N++R+
Sbjct: 23  GKGKFGNVYLAR---EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 285
             +  + +   L+ EF   G L    +  L+         +     ++A  L Y H    
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---E 132

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            ++IH DIKP+N+L+      +I+DFG +      + +T+     GT  Y+ PE     T
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKT 188

Query: 346 ITAKVDVYSFGVLLLE 361
              KVD++  GVL  E
Sbjct: 189 HDEKVDLWCAGVLCYE 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (292), Expect = 2e-29
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 18/208 (8%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNLVR 228
           G G    V+    +   R     VAVK L             F+ E       +H  +V 
Sbjct: 21  GFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 229 LL--GFCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +   G   E     L Y   E+++  TL   +      +      +     + L + H+ 
Sbjct: 77  VYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ- 134

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-AIRGTKGYVAPEWYR 342
             + IIH D+KP NI++      ++ DFG+A+ +  + +   +T A+ GT  Y++PE  R
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFD 370
             ++ A+ DVYS G +L E+++    F 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  114 bits (288), Expect = 8e-29
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 17/199 (8%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQ-THHKN 225
            +E GRG F +V +     ++++    A K  K  R  QD   E  +E+ V+        
Sbjct: 34  SKELGRGKFAVVRQC---ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLHED 283
           ++ L    +     +L+ E+   G + S     L    +      +  QI  G+ YLH  
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-- 148

Query: 284 CSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
             + I+H D+KPQNILL       + +I DFG+++ +    +  ++  + GT  Y+APE 
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIM-GTPEYLAPEI 204

Query: 341 YRKSTITAKVDVYSFGVLL 359
                IT   D+++ G++ 
Sbjct: 205 LNYDPITTATDMWNIGIIA 223

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (296), Expect = 1e-28
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 24/211 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 226
            KE  G G FG V + + + T      VA+K+  +      +E +  E+ ++ + +H N+
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 227 VRLLGFCDEGQN------RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARG 276
           V      D  Q        LL  E+   G L  +L    +    L+          I+  
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSA 133

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
           L YLHE   ++IIH D+KP+NI+L         +I D G AK L   Q +     + GT 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV-GTL 187

Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIIS 364
            Y+APE   +   T  VD +SFG L  E I+
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  117 bits (295), Expect = 2e-28
 Identities = 56/294 (19%), Positives = 98/294 (33%), Gaps = 52/294 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL----DRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
             G  G +Y         +   V +K L    D   Q        E   + +  H ++V+
Sbjct: 89  AHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQ---AMAMAERQFLAEVVHPSIVQ 143

Query: 229 LLGFCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +  F +           +V E++   +L       L  +  +      +I   L YLH  
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLHS- 200

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
               +++ D+KP+NI+L +    ++ D G    +           + GT G+ APE  R 
Sbjct: 201 --IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN--SF----GYLYGTPGFQAPEIVRT 251

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
              T   D+Y+ G  L  +     + +   G     L +             L+      
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPEDDPVLKTYDSYGRLLR----- 302

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRP-TMRKVSQMLEGVV-EVDVPPNPSPFSG 455
               + ++            DP  R  T  ++S  L GV+ EV       P  G
Sbjct: 303 ----RAIDP-----------DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPG 341

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (285), Expect = 2e-28
 Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 34/207 (16%)

Query: 244 EFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL 300
           +      L  ++            +  +I  QIA  + +LH   S  ++H D+KP NI  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197

Query: 301 DDHYNARISDFGLAKLLTLNQSK----------TIKTAIRGTKGYVAPEWYRKSTITAKV 350
                 ++ DFGL   +  ++ +             T   GTK Y++PE    +  + KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 351 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 410
           D++S G++L E++    SF  +M E   I+TD      RN K   L        + +  V
Sbjct: 258 DIFSLGLILFELLY---SFSTQM-ERVRIITD-----VRNLKFPLLFTQKYPQEHMM--V 306

Query: 411 EKLLMVSIWCIQEDPSLRPTMRKVSQM 437
           + +L          P+ RP    + + 
Sbjct: 307 QDML-------SPSPTERPEATDIIEN 326

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  113 bits (285), Expect = 2e-28
 Identities = 44/201 (21%), Positives = 87/201 (43%), Gaps = 23/201 (11%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
              E+ GRG FGIV++       +S      K +     D +   K E+ ++    H+N+
Sbjct: 8   MIAEDLGRGEFGIVHRC---VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL------ASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
           + L    +  +  ++++EF++   +      ++F     +    +      Q+   L +L
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QVCEALQFL 118

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           H   S  I H DI+P+NI+     ++  +I +FG A+   L      +        Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAP 172

Query: 339 EWYRKSTITAKVDVYSFGVLL 359
           E ++   ++   D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 2e-28
 Identities = 32/301 (10%), Positives = 67/301 (22%), Gaps = 60/301 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLV-- 227
             G   +V+              A+K         +   +          +   ++    
Sbjct: 71  RVGDRSVVFLVRDVERLED---FALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 228 ----RLLGFCDEGQ--------------------NRLLVYEFLNNGTLASFL-------F 256
               RLL   D                       N LL+    +   L            
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYV 186

Query: 257 GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
                       +  Q+ R    L    S  ++H    P N+ +       + D      
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 317 LTLNQSKTIKTAIRGTKGYVAPEWY--RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG 374
           +      T   A      Y   E+     +T T  ++ +  G+ +  +      F +   
Sbjct: 244 VG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 375 EEYAILTDWAFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
                    +        L       + + +  +  + + L         D   R    +
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL--IGRFL-------NFDRRRRLLPLE 349

Query: 434 V 434
            
Sbjct: 350 A 350

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (287), Expect = 3e-28
 Identities = 58/237 (24%), Positives = 102/237 (43%), Gaps = 26/237 (10%)

Query: 136 KKKWIRNSPGDGTVETNLRCFSYKALEEATDNFK------EEAGRGSFGIVYKGVIETTR 189
           K    + +  D   E   + +  + +E    +        EE G G+FG+V++  +E  +
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR-CVE--K 73

Query: 190 TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 249
            +      K ++  +   +   KNE+ ++ Q HH  L+ L    ++    +L+ EFL+ G
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133

Query: 250 TLASFLFGNLKPSWNLRT-----NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY 304
                LF  +       +     N   Q   GL ++H      I+H DIKP+NI+ +   
Sbjct: 134 E----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 186

Query: 305 NAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
            +   I DFGLA    LN  + +K     T  + APE   +  +    D+++ GVL 
Sbjct: 187 ASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (286), Expect = 3e-28
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 22/199 (11%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR 228
            E  G G FG V+K        +   +A K +       ++E KNE+ V+ Q  H NL++
Sbjct: 94  TEILGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 229 LLGFCDEGQNRLLVYEFLNNGTL------ASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           L    +   + +LV E+++ G L       S+    L            QI  G+ ++H 
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-----LFMKQICEGIRHMH- 204

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
                I+H D+KP+NIL  +    +I   DFGLA+       + +K    GT  ++APE 
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEV 259

Query: 341 YRKSTITAKVDVYSFGVLL 359
                ++   D++S GV+ 
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (284), Expect = 4e-28
 Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 38/214 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR-----------------VFQDGEKEFKNEV 215
            +G F  +               A+KK ++                   +    +FKNE+
Sbjct: 40  NQGKFNKIILC-----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 216 VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRT------ 267
            +I    ++  +   G         ++YE++ N ++  F   F  L  ++          
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
            I   +     Y+H      I H D+KP NIL+D +   ++SDFG ++ +     K IK 
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209

Query: 328 AIRGTKGYVAPE--WYRKSTITAKVDVYSFGVLL 359
           + RGT  ++ PE      S   AKVD++S G+ L
Sbjct: 210 S-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  112 bits (282), Expect = 5e-28
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 220
           +  EE G G F IV K   E  +++    A K     +     +   +E  + EV ++ Q
Sbjct: 15  DIGEELGSGQFAIVKK-CRE--KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H N++ L    +   + +L+ E ++ G L  FL      S    T+   QI  G+ YL
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 281 HEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   + +I H D+KP+NI+L        + ++ DFGLA    +      K    GT  +V
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185

Query: 337 APEWYRKSTITAKVDVYSFGVLL 359
           APE      +  + D++S GV+ 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (284), Expect = 6e-28
 Identities = 35/239 (14%), Positives = 75/239 (31%), Gaps = 59/239 (24%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQ--------- 220
           G+       +   + T  S     V      +R   +  K+ K EV+ +           
Sbjct: 82  GQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 221 ----------------THHKNLVRLLGFCDEGQ--NRLLVYEFLNN------GTLASFLF 256
                              K ++R+     +    +R  +Y  + +        L S   
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 257 GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
            +     + R  +  Q+ R L  LH      ++H  ++P +I+LD      ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 317 LTLNQSKTIKTAIRGTKGYVAPEW-----------YRKSTITAKVDVYSFGVLLLEIIS 364
                    +     ++G+  PE             R++ +T   D ++ G+++  I  
Sbjct: 256 DGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (279), Expect = 6e-28
 Identities = 61/194 (31%), Positives = 99/194 (51%), Gaps = 18/194 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDG-EKEFKNEVVVIGQTHHKNLVRL 229
           G+GSF  VY+     +  +   VA+K +D+  +++ G  +  +NEV +  Q  H +++ L
Sbjct: 20  GKGSFAGVYRA---ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA----FQIARGLLYLHEDCS 285
             + ++     LV E  +NG +  +L   +KP      N A     QI  G+LYLH   S
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH---S 130

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             I+H D+   N+LL  + N +I+DFGLA  L +   K   T + GT  Y++PE   +S 
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYT-LCGTPNYISPEIATRSA 188

Query: 346 ITAKVDVYSFGVLL 359
              + DV+S G + 
Sbjct: 189 HGLESDVWSLGCMF 202

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  111 bits (279), Expect = 9e-28
 Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E+ G+GSFG V+KG+   T+     VA+K +D    +D  ++ + E+ V+ Q     + +
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKV---VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPSWNLRTNIAF---QIARGLLYLHEDC 284
             G   +     ++ E+L  G+    L  G L  +      IA    +I +GL YLH   
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYLH--- 136

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S + IH DIK  N+LL +H   +++DFG+A  LT  Q K   T + GT  ++APE  ++S
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFV-GTPFWMAPEVIKQS 194

Query: 345 TITAKVDVYSFGVLLLEII 363
              +K D++S G+  +E+ 
Sbjct: 195 AYDSKADIWSLGITAIELA 213

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  114 bits (288), Expect = 1e-27
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 20/200 (10%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
           +  EE G G+FG+V++ V E  R +    A K +    +  ++  + E+  +    H  L
Sbjct: 160 DIHEELGTGAFGVVHR-VTE--RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT-----NIAFQIARGLLYLH 281
           V L    ++    +++YEF++ G L    F  +    N  +         Q+ +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
               +  +H D+KP+NI+     +  +   DFGL   L  +  +++K    GT  + APE
Sbjct: 273 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTT-GTAEFAAPE 326

Query: 340 WYRKSTITAKVDVYSFGVLL 359
                 +    D++S GVL 
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (281), Expect = 1e-27
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 220
           +  EE G G F IV K      +++    A K     +     +   +E  + EV ++ Q
Sbjct: 15  DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H N++ L    +   + +L+ E ++ G L  FL      S    T+   QI  G+ YL
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 281 HEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   + +I H D+KP+NI+L        + ++ DFGLA  +        K    GT  +V
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GTPEFV 185

Query: 337 APEWYRKSTITAKVDVYSFGVLL 359
           APE      +  + D++S GV+ 
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  110 bits (277), Expect = 1e-27
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 19/203 (9%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 220
              EE G G F IV K      + +    A K     +L    +   +E  + EV ++ +
Sbjct: 8   EMGEELGSGQFAIVRKC---RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H N++ L    +   + +L+ E ++ G L  FL      + +  T    QI  G+ YL
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 281 HEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   S +I H D+KP+NI+L      +   ++ DFG+A  +        K    GT  +V
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GTPEFV 178

Query: 337 APEWYRKSTITAKVDVYSFGVLL 359
           APE      +  + D++S GV+ 
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  110 bits (278), Expect = 1e-27
 Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 22/207 (10%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKL------DRVFQDGEKEFKNEVVVIGQTHHKN 225
           GRG  G VY+       R     VA+K +      D VF+      + E    G+    +
Sbjct: 43  GRGGMGDVYEAEDTVRERI----VALKLMSETLSSDPVFR---TRMQREARTAGRLQEPH 95

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +V +  F +      +    +N   LA+ L   G L P   +   I  QI   L   H  
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAHAA 153

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
                 H D+KP+NIL+     A + DFG+A   T ++  T      GT  Y+APE + +
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE 209

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFD 370
           S  T + D+Y+   +L E ++    + 
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQ 236

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (277), Expect = 2e-27
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G GS+G VYK + + T      VA+K++    +   +E   E+ ++ Q    ++V+ 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQI---VAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKY 89

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAF---QIARGLLYLHEDCS 285
            G   +  +  +V E+   G+++  +    K    L    IA       +GL YLH    
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH---F 143

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
            + IH DIK  NILL+   +A+++DFG+A  LT   +K   T I GT  ++APE  ++  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-NTVI-GTPFWMAPEVIQEIG 201

Query: 346 ITAKVDVYSFGVLLLEII 363
                D++S G+  +E+ 
Sbjct: 202 YNCVADIWSLGITAIEMA 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (276), Expect = 2e-27
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
            E G G+FG VYK   + T       A K ++   ++  +++  E+ ++    H  +V+L
Sbjct: 25  GELGDGAFGKVYKAKNKETGAL---AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR-TNIAF---QIARGLLYLHEDCS 285
           LG         ++ EF   G + + +    +    L    I     Q+   L +LH   S
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH---S 135

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-----W 340
            +IIH D+K  N+L+    + R++DFG++        K   + I GT  ++APE      
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFI-GTPYWMAPEVVMCET 193

Query: 341 YRKSTITAKVDVYSFGVLLLEII 363
            + +    K D++S G+ L+E+ 
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (276), Expect = 3e-27
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 41/210 (19%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F E  G G+F  V+       R +    A+K + +     +   +NE+ V+ +  H+N+
Sbjct: 12  IFMEVLGSGAFSEVFLV---KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQ 272
           V L    +   +  LV + ++ G L              AS +                Q
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI--------------QQ 114

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAI 329
           +   + YLH    + I+H D+KP+N+L    +++    I+DFGL+K+    Q+  + TA 
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTAC 168

Query: 330 RGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
            GT GYVAPE   +   +  VD +S GV+ 
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  109 bits (275), Expect = 3e-27
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR---------VFQDGEKEFKNEVVVI 218
            KE  GRG   +V +      + +    AVK +D            Q+  +    EV ++
Sbjct: 21  PKEILGRGVSSVVRRC---IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 219 GQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 277
            + + H N+++L    +      LV++ +  G L  +L   +  S      I   +   +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
             LH      I+H D+KP+NILLDD  N +++DFG +    L+  + ++    GT  Y+A
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVC-GTPSYLA 191

Query: 338 PEWYRKSTITA------KVDVYSFGVLL 359
           PE    S          +VD++S GV++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (277), Expect = 4e-27
 Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 20/204 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVK-----KLDRVFQDGEKEFKNEVVVIGQTH 222
             E  G+G F +V +      R +    AVK     K         ++ K E  +     
Sbjct: 28  LCEVIGKGPFSVVRRC---INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLL 278
           H ++V LL          +V+EF++   L   +       +       ++   QI   L 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 279 YLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           Y H    + IIH D+KP  +LL   ++    ++  FG+A  L  +        + GT  +
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRV-GTPHF 199

Query: 336 VAPEWYRKSTITAKVDVYSFGVLL 359
           +APE  ++      VDV+  GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  110 bits (277), Expect = 9e-27
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 40/213 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRLLG 231
           G GSFG+VY+  +  +      VA+KK   V QD  K FKN E+ ++ +  H N+VRL  
Sbjct: 63  GNGSFGVVYQAKLCDSGEL---VAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRY 114

Query: 232 -FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLH 281
            F   G+ +      LV +++   T+        +    L         +Q+ R L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
              S  I H DIKPQN+LLD      ++ DFG AK L   +             Y+   +
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---------SYICSRY 221

Query: 341 YR------KSTI-TAKVDVYSFGVLLLEIISCR 366
           YR       +T  T+ +DV+S G +L E++  +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  109 bits (274), Expect = 1e-26
 Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 45/248 (18%)

Query: 145 GDGT-VETNLRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD 201
           G G+ +  N    + +   +  D F+    AG+G+FG V  G  ++T  S   VA+KK  
Sbjct: 1   GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS---VAIKK-- 55

Query: 202 RVFQDGEKEFKN----EVVVIGQTHHKNLVRLL------GFCDEGQNRL-LVYEFLNNGT 250
            V QD    F+N     +  +   HH N+V+L       G  D     L +V E++ + T
Sbjct: 56  -VIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-T 111

Query: 251 LASFLFGNLKPSWNLRTN----IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA 306
           L        +              FQ+ R +  LH   S  + H DIKP N+L+++    
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170

Query: 307 -RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-------KSTITAKVDVYSFGVL 358
            ++ DFG AK L+ ++             Y+   +YR           T  VD++S G +
Sbjct: 171 LKLCDFGSAKKLSPSEPNV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221

Query: 359 LLEIISCR 366
             E++   
Sbjct: 222 FAEMMLGE 229

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  107 bits (270), Expect = 1e-26
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 14/198 (7%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 224
           + KEE G+G+F +V +      +T+    A K ++  ++     ++ + E  +  +  H 
Sbjct: 9   DVKEELGKGAFSVVRRC---VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           N+VRL     E     LV++ +  G L   +      S    ++   QI   + Y H   
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH--- 122

Query: 285 SSQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           S+ I+H ++KP+N+LL         +++DFGLA  +  N S+       GT GY++PE  
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFA-GTPGYLSPEVL 179

Query: 342 RKSTITAKVDVYSFGVLL 359
           +K   +  VD+++ GV+L
Sbjct: 180 KKDPYSKPVDIWACGVIL 197

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  107 bits (269), Expect = 2e-26
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKN 225
            FK + G G+FG V+       R+S     +K ++    Q   ++ + E+ V+    H N
Sbjct: 25  IFKRKLGSGAFGDVHLV---EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLR----TNIAFQIARGLLYLH 281
           ++++    ++  N  +V E    G L   +         L       +  Q+   L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 282 EDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
              S  ++H D+KP+NIL      H   +I DFGLA+L      +    A  GT  Y+AP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA-GTALYMAP 195

Query: 339 EWYRKSTITAKVDVYSFGVLL 359
           E +++  +T K D++S GV++
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVM 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (268), Expect = 2e-26
 Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 13/196 (6%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             +   GRGS+G V        + +    A KK+ + F +    FK E+ ++    H N+
Sbjct: 12  TLENTIGRGSWGEVKIA---VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           +RL    ++  +  LV E    G L   +        +    I   +   + Y H     
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KL 125

Query: 287 QIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            + H D+KP+N L          ++ DFGLA        K ++T + GT  YV+P+    
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLEG 182

Query: 344 STITAKVDVYSFGVLL 359
                + D +S GV++
Sbjct: 183 L-YGPECDEWSAGVMM 197

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (276), Expect = 2e-26
 Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 35/277 (12%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHH 223
             +   G+GSFG V        + +    AVK + +     +  ++    EV ++ Q  H
Sbjct: 29  KGQRVLGKGSFGEVILC---KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
            N+++L  F ++     LV E    G L   +    + S      I  Q+  G+ Y+H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH-- 143

Query: 284 CSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
             ++I+H D+KP+N+LL       N RI DFGL+       SK +K  I GT  Y+APE 
Sbjct: 144 -KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKI-GTAYYIAPEV 199

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLV 397
              +    K DV+S GV+L  ++S    F+     +    +    + F+  +  K+ +  
Sbjct: 200 LHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE-- 256

Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                A + I+   K+L          PS+R + R  
Sbjct: 257 ----SAKDLIR---KMLTY-------VPSMRISARDA 279

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 3e-26
 Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 34/275 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 225
             ++ G G++G V        + +    A+K +    V      +   EV V+    H N
Sbjct: 41  RVKKLGSGAYGEVLLC---RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           +++L  F ++ +N  LV E    G L   +   +K +      I  Q+  G+ YLH    
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---K 154

Query: 286 SQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             I+H D+KP+N+LL   +     +I DFGL+ +      K +K  + GT  Y+APE  R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPEVLR 211

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCYRNGKLDDLVEG 399
           K     K DV+S GV+L  +++    F    +      +    + FD      + +    
Sbjct: 212 KK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE---- 266

Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
              A + IK   ++L         D   R + ++ 
Sbjct: 267 --GAKDLIK---QMLQF-------DSQRRISAQQA 289

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 3e-26
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVK-----KLDRVFQDGEKE-FKNEVVVIGQ 220
           +  EE G G F +V K      +++    A K     +     +   +E  + EV ++ +
Sbjct: 14  DTGEELGSGQFAVVKKC---REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H N++ L    +   + +L+ E +  G L  FL      +    T    QI  G+ YL
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 281 HEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   S QI H D+KP+NI+L          +I DFGLA  +  +     K    GT  +V
Sbjct: 131 H---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GTPEFV 184

Query: 337 APEWYRKSTITAKVDVYSFGVLL 359
           APE      +  + D++S GV+ 
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  108 bits (271), Expect = 3e-26
 Identities = 49/221 (22%), Positives = 91/221 (41%), Gaps = 52/221 (23%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVIG 219
            K+  GRG   +V +      R +    AVK ++           ++  +  + E  ++ 
Sbjct: 98  PKDVIGRGVSSVVRRC---VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 220 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWN 264
           Q   H +++ L+   +      LV++ +  G L                 +         
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------- 206

Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT 324
                   +   + +LH   ++ I+H D+KP+NILLDD+   R+SDFG +    L   + 
Sbjct: 207 ------RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255

Query: 325 IKTAIRGTKGYVAPEWYRKSTITA------KVDVYSFGVLL 359
           ++    GT GY+APE  + S          +VD+++ GV+L
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (267), Expect = 4e-26
 Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 11/190 (5%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G+G F   ++     T+      A K + +  + +  ++E    E+ +     H+++V  
Sbjct: 24  GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            GF ++     +V E     +L          +         QI  G  YLH    +++I
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 195

Query: 350 VDVYSFGVLL 359
           VDV+S G ++
Sbjct: 196 VDVWSIGCIM 205

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  108 bits (270), Expect = 4e-26
 Identities = 60/335 (17%), Positives = 130/335 (38%), Gaps = 63/335 (18%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQTHHKNLVR 228
            E G G+ G+V+K      + S   +A K +    +     +   E+ V+ + +   +V 
Sbjct: 39  SELGAGNGGVVFKVSH---KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95

Query: 229 LLG-FCDEGQNRLLVY---EFLNNGTLASFL-FGNLKPSWNLRTNIAFQIARGLLYLHED 283
             G F  +G+    +    E ++ G+L   L      P   L   ++  + +GL YL E 
Sbjct: 96  FYGAFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREK 150

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
              +I+H D+KP NIL++     ++ DFG++  L  + + +      GT+ Y++PE  + 
Sbjct: 151 --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQG 204

Query: 344 STITAKVDVYSFGVLLLEI---------ISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           +  + + D++S G+ L+E+            ++   +   +      +        G+  
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 395 DLVEGDMEAMNDI-----KCVEK---LLMVSIW----------CIQEDPSLRPTMRK--- 433
           +    D      I       V +    L   ++          C+ ++P+ R  +++   
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

Query: 434 -------------VSQMLEGVVEVDVPPNPSPFSG 455
                         +  L   + ++ P  P+  +G
Sbjct: 325 HAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAG 359

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  107 bits (269), Expect = 5e-26
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 45/212 (21%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKN 225
             KE+ G GS+ +  +      + +    AVK +D+  +D       E+ ++ +   H N
Sbjct: 25  EVKEDIGVGSYSVCKRC---IHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPN 77

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 271
           ++ L    D+G+   +V E +  G L              AS +               F
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL--------------F 123

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKT 327
            I + + YLH   +  ++H D+KP NIL      +  + RI DFG AK L       + T
Sbjct: 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMT 179

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
               T  +VAPE   +    A  D++S GVLL
Sbjct: 180 PC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 5e-26
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVI 218
              +  G G+ G V        R +   VA++ + +           D     + E+ ++
Sbjct: 138 IMSKTLGSGACGEVKLAF---ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
            + +H  ++++  F D  ++  +V E +  G L   + GN +          +Q+   + 
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 279 YLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           YLH    + IIH D+KP+N+LL   ++    +I+DFG +K+L   ++  ++T   GT  Y
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC-GTPTY 307

Query: 336 VAPE---WYRKSTITAKVDVYSFGVLL 359
           +APE       +     VD +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (270), Expect = 5e-26
 Identities = 37/307 (12%), Positives = 82/307 (26%), Gaps = 77/307 (25%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFKNEVVVIGQT-------- 221
           G+       +   + T  S     V      +R   +  K+ K EV+ +           
Sbjct: 87  GQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 222 --------------HHKNLVRLLGFCDEGQNRLLVYEFL-------NNGTLASFLFGNLK 260
                               +++    + ++  ++  F        N  T    L  +  
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 261 ----PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
                  + R  +  Q+ R L  LH      ++H  ++P +I+LD      ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 317 LTLNQSKTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKS-F- 369
                + +            A           + +T   D ++ G+ +  I  C      
Sbjct: 261 DG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-CADLPNT 318

Query: 370 -DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM-EAMNDIKCVEKLLMVSIWCIQEDPSL 427
            D  +G    I                    ++ + +  +  +E  L       +     
Sbjct: 319 DDAALGGSEWIFRSCK---------------NIPQPVRAL--LEGFL-------RYPKED 354

Query: 428 RPTMRKV 434
           R    + 
Sbjct: 355 RLLPLQA 361

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (270), Expect = 5e-26
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 41/213 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVRLLG 231
           G GSFG+V++  +  +      VA+KK   V QD  K FKN E+ ++    H N+V L  
Sbjct: 49  GNGSFGVVFQAKLVESDE----VAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKA 99

Query: 232 F-----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLYLH 281
           F       + +  L LV E++   T+        K    +         +Q+ R L Y+H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
              S  I H DIKPQN+LLD      ++ DFG AK+L   +             Y+   +
Sbjct: 159 ---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---------SYICSRY 206

Query: 341 YR-------KSTITAKVDVYSFGVLLLEIISCR 366
           YR        +  T  +D++S G ++ E++  +
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 6e-26
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 33/213 (15%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVR 228
           E  G G++G VYKG    T       A+K +D V  D E+E K E+ ++ +  HH+N+  
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQL---AAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 229 LLG-----FCDEGQNRL-LVYEFLNNGTLA----SFLFGNLKPSWNLRTNIAF---QIAR 275
             G           ++L LV EF   G++     +     LK  W     IA+   +I R
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILR 140

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL +LH     ++IH DIK QN+LL ++   ++ DFG++  L     +   T I GT  +
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFI-GTPYW 195

Query: 336 VAPE-----WYRKSTITAKVDVYSFGVLLLEII 363
           +APE         +T   K D++S G+  +E+ 
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (268), Expect = 7e-26
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 42/209 (20%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            + E GRG+  IVY+      + +    A+K L +     +K  + E+ V+ +  H N++
Sbjct: 57  VESELGRGATSIVYRC---KQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNII 111

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQI 273
           +L    +      LV E +  G L              A+                  QI
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--------------QI 157

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
              + YLH    + I+H D+KP+N+L          +I+DFGL+K++       +KT   
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC- 211

Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
           GT GY APE  R      +VD++S G++ 
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  105 bits (264), Expect = 8e-26
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 43/212 (20%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 224
           N     G+GSFG V K      R +    AVK ++              EV ++ +  H 
Sbjct: 25  NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 270
           N+++L    ++  +  +V E    G L              A+ +               
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII-------------- 127

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKT 327
            Q+  G+ Y+H      I+H D+KP+NILL   +   + +I DFGL+      Q+  +K 
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKD 182

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
            I GT  Y+APE  R +    K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  106 bits (266), Expect = 9e-26
 Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 11/190 (5%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G+G F   ++     T+      A K + +  + +  ++E    E+ +     H+++V  
Sbjct: 50  GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
            GF ++     +V E     +L          +         QI  G  YLH    +++I
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H D+K  N+ L++    +I DFGLA  +  +  +  K  + GT  Y+APE   K   + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFE 221

Query: 350 VDVYSFGVLL 359
           VDV+S G ++
Sbjct: 222 VDVWSIGCIM 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  107 bits (269), Expect = 2e-25
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 43/212 (20%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHK 224
           N     G+GSFG V K      R +    AVK ++              EV ++ +  H 
Sbjct: 25  NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 270
           N+++L    ++  +  +V E    G L              A+               I 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------------RII 127

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKT 327
            Q+  G+ Y+H      I+H D+KP+NILL   +   + +I DFGL+      Q+  +K 
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKD 182

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
            I GT  Y+APE  R +    K DV+S GV+L
Sbjct: 183 RI-GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (270), Expect = 2e-25
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR-------------VFQDGEKEFKNE 214
              + G G++G V        +   +  A+K + +               +   +E  NE
Sbjct: 40  KVRKLGSGAYGEVLLC---KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           + ++    H N+++L    ++ +   LV EF   G L   +    K       NI  QI 
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
            G+ YLH      I+H DIKP+NILL   +   N +I DFGL+     ++   ++  + G
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRL-G 210

Query: 332 TKGYVAPEWYRKSTITAKVDVYSFGVLL 359
           T  Y+APE  +K     K DV+S GV++
Sbjct: 211 TAYYIAPEVLKKK-YNEKCDVWSCGVIM 237

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (265), Expect = 2e-25
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 42/211 (19%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 225
            KEE G+G+F +V +      +T+    A K ++  ++     ++ + E  +  +  H N
Sbjct: 33  VKEELGKGAFSVVRRC---VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 271
           +VRL     E     LV++ +  G L              AS                  
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI--------------Q 135

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTA 328
           QI   + Y H   S+ I+H ++KP+N+LL         +++DFGLA  +  N S+     
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 190

Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
             GT GY++PE  +K   +  VD+++ GV+L
Sbjct: 191 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  106 bits (266), Expect = 4e-25
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 41/211 (19%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKN 225
             EE G+G+F +V +        +    A   ++   +     ++ + E  +     H N
Sbjct: 15  LFEELGKGAFSVVRRC---VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAF 271
           +VRL     E  +  L+++ +  G L              AS                  
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI--------------Q 117

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTA 328
           QI   +L+ H      ++H ++KP+N+LL         +++DFGLA  +   Q      A
Sbjct: 118 QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174

Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
             GT GY++PE  RK      VD+++ GV+L
Sbjct: 175 --GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  103 bits (260), Expect = 5e-25
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 52/221 (23%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR--------VFQDGEKEFKNEVVVI 218
              +  G G+ G V        R +   VA+K + +           D     + E+ ++
Sbjct: 13  IMSKTLGSGACGEVKLA---FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWN 264
            + +H  ++++  F D  ++  +V E +  G L                  F        
Sbjct: 70  KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------- 120

Query: 265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQ 321
                 +Q+   + YLH    + IIH D+KP+N+LL   ++    +I+DFG +K+L   +
Sbjct: 121 ------YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169

Query: 322 SKTIKTAIRGTKGYVAPE---WYRKSTITAKVDVYSFGVLL 359
           +  ++T   GT  Y+APE       +     VD +S GV+L
Sbjct: 170 TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (260), Expect = 5e-25
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 43/212 (20%)

Query: 166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHK 224
           D   +  G GSF I  K      + S  A AVK + +     E   + E+  +     H 
Sbjct: 13  DLKDKPLGEGSFSICRKC---VHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHP 66

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIA 270
           N+V+L     +  +  LV E LN G L              AS               I 
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------------YIM 112

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKT 327
            ++   + ++H      ++H D+KP+N+L    +D+   +I DFG A+L   +  + +KT
Sbjct: 113 RKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLL 359
               T  Y APE   ++      D++S GV+L
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (260), Expect = 6e-25
 Identities = 58/243 (23%), Positives = 86/243 (35%), Gaps = 57/243 (23%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVK-----KLDRVFQDGEKEFKNEVVVIGQTH 222
            K   G+GS+G+V   +   TR      A+K     K+ ++     +  K EV ++ + H
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRA---IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL------------------------------A 252
           H N+ RL    ++ Q   LV E  + G L                               
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 253 SFLFGNLKPSWNLRTNIAF----------QIARGLLYLHEDCSSQIIHCDIKPQNILLDD 302
                     +    +             QI   L YLH   +  I H DIKP+N L   
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFST 203

Query: 303 HYNAR--ISDFGLAKLLTLNQSKTIK--TAIRGTKGYVAPE--WYRKSTITAKVDVYSFG 356
           + +    + DFGL+K      +      T   GT  +VAPE       +   K D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 357 VLL 359
           VLL
Sbjct: 264 VLL 266

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 227
            E GRG++G+V K     +      +AVK++       E K    ++ + +        V
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQ---IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69

Query: 228 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTN----IAFQIARGLLY 279
              G    EG     V+   E ++  +L  F    +     +  +    IA  I + L +
Sbjct: 70  TFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH      +IH D+KP N+L++     ++ DFG++  L  + +K       G K Y+APE
Sbjct: 125 LHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDA-GCKPYMAPE 179

Query: 340 ----WYRKSTITAKVDVYSFGVLLLEI 362
                  +   + K D++S G+ ++E+
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIEL 206

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 21/208 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTHHKNLVR 228
           E  G G+  +V        +     VA+K+++    Q    E   E+  + Q HH N+V 
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN-----IAF---QIARGLLYL 280
                       LV + L+ G++   +   +    +         IA    ++  GL YL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTAIRGTKGYV 336
           H    +  IH D+K  NILL +  + +I+DFG++  L      T     KT + GT  ++
Sbjct: 138 H---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWM 193

Query: 337 APE-WYRKSTITAKVDVYSFGVLLLEII 363
           APE   +      K D++SFG+  +E+ 
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELA 221

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (251), Expect = 2e-23
 Identities = 36/213 (16%), Positives = 71/213 (33%), Gaps = 31/213 (14%)

Query: 170 EEAGRG--SFGIVYKGVIETTRTSTTAVAVKK--LDRVFQDGEKEFKNEVVVIGQTHHKN 225
              G+G      V     + T      V V++  L+    +     + E+ V    +H N
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEY---VTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL----FGNLKPSWNLRTNIAF---QIARGLL 278
           +V             +V  F+  G+    +       +         IA+    + + L 
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALD 142

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV-- 336
           Y+H       +H  +K  +IL+       +S       +  +  +  +      K  V  
Sbjct: 143 YIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ-RVVHDFPKYSVKV 198

Query: 337 ----APEWYRKSTI--TAKVDVYSFGVLLLEII 363
               +PE  +++     AK D+YS G+   E+ 
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (250), Expect = 2e-23
 Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 28/205 (13%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 226
            E G GSFG VY             VA+KK+    +      ++   EV  + +  H N 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEV---VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 227 VRLLGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPSWNLRTNIAF---QIARGLLYLH 281
           ++  G         LV E+       L       L+        IA       +GL YLH
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLH 171

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-- 339
              S  +IH D+K  NILL +    ++ DFG A    +  + +      GT  ++APE  
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV----GTPYWMAPEVI 222

Query: 340 -WYRKSTITAKVDVYSFGVLLLEII 363
               +     KVDV+S G+  +E+ 
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 48/219 (21%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 227
           ++  G G+   V          ++   AVK +++           EV ++ Q   H+N++
Sbjct: 18  EDVLGEGAHARVQTC---INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPSWNLRTNIAFQI 273
            L+ F +E     LV+E +  G++              AS               +   +
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDV 120

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           A  L +LH   +  I H D+KP+NIL    +     +I DF L   + LN   +  +   
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 331 -----GTKGYVAPEWYRKSTITAK-----VDVYSFGVLL 359
                G+  Y+APE     +  A       D++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 34/211 (16%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 227
            E GRG++G V K V + +      +AVK++     + E K+   ++ VV+  +    +V
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQ---IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84

Query: 228 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTN------IAFQIARGL 277
           +  G    EG      +   E ++  +   F    +    +          I     + L
Sbjct: 85  QFYGALFREGD----CWICMELMS-TSFDKFY-KYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTAIRGTKGY 335
            +L E+   +IIH DIKP NILLD   N ++ DFG++  L  ++ +++       G + Y
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRPY 191

Query: 336 VAPE----WYRKSTITAKVDVYSFGVLLLEI 362
           +APE       +     + DV+S G+ L E+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 18/194 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V   T  +   VAVK +D     D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A   F Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTAIRGTKGYVAPE-WYRKST 345
           I H DIKP+N+LLD+  N +ISDFGLA +   N + + +     GT  YVAPE   R+  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184

Query: 346 ITAKVDVYSFGVLL 359
               VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 23/200 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR----VFQDGEKEFKNEVVVIGQTHHKNLVR 228
           G GS+G V + +   T       AVK L +       +GE   K E+ ++ +  HKN+++
Sbjct: 14  GEGSYGKVKEVLDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 229 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHE 282
           L+    +E + ++ +V E+   G     +  ++ P        A   F Q+  GL YLH 
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH- 126

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLNQSKTIKTAIRGTKGYVAPEWY 341
             S  I+H DIKP N+LL      +IS  G+A+ L       T +T+ +G+  +  PE  
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIA 183

Query: 342 R--KSTITAKVDVYSFGVLL 359
               +    KVD++S GV L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTL 203

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 25/201 (12%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLV 227
           K+  G G  G V +      R +    A+K L         + + EV    Q +   ++V
Sbjct: 34  KQVLGLGVNGKVLEC---FHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIV 85

Query: 228 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYLH 281
            +L   +   +     L++ E +  G L S +      ++  R    I   I   + +LH
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 282 EDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
              S  I H D+KP+N+L    +     +++DFG AK  T N  +T       T  YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYYVAP 198

Query: 339 EWYRKSTITAKVDVYSFGVLL 359
           E           D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 18/194 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G V   V   T  +   VAVK +D     D  +  K E+ +    +H+N+V+  G
Sbjct: 16  GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSSQ 287
              EG  + L  E+ + G L    F  ++P   +    A   F Q+  G++YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTAIRGTKGYVAPE-WYRKST 345
           I H DIKP+N+LLD+  N +ISDFGLA +    N+ + +     GT  YVAPE   R+  
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184

Query: 346 ITAKVDVYSFGVLL 359
               VDV+S G++L
Sbjct: 185 HAEPVDVWSCGIVL 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 66/314 (21%), Positives = 112/314 (35%), Gaps = 78/314 (24%)

Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDR------VFQDGEKEFKNEVV----VIGQT 221
           G+G FG V+ G     R +    VA+K + R                 EV     V    
Sbjct: 40  GKGGFGTVFAG----HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGL 277
            H  ++RLL + +  +  +LV E          LF  +     L    +   F Q+   +
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
            + H   S  ++H DIK +NIL+D      ++ DFG   LL     +       GT+ Y 
Sbjct: 153 QHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD-GTRVYS 205

Query: 337 APEWYR-KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA-FDCYRNGKLD 394
            PEW            V+S G+LL                 Y ++     F+  +     
Sbjct: 206 PPEWISRHQYHALPATVWSLGILL-----------------YDMVCGDIPFERDQ----- 243

Query: 395 DLVEGDM--------EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ---MLEGVVE 443
           +++E ++        +    I+           C+   PS RP++ ++     M     +
Sbjct: 244 EILEAELHFPAHVSPDCCALIR----------RCLAPKPSSRPSLEEILLDPWMQTPAED 293

Query: 444 VDVPP---NPSPFS 454
           V + P    P+P +
Sbjct: 294 VPLNPSKGGPAPLA 307

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 32/286 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G+G+F  V       T      VA+K +D+  +     ++   EV ++   +H N+V+L 
Sbjct: 24  GKGNFAKVKLARHILTGRE---VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
              +  +   L+ E+ + G +  +L  + +       +   QI   + Y H+     I+H
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-KSTITAK 349
            D+K +N+LLD   N +I+DFG +   T+     +     G   Y APE ++ K     +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGKKYDGPE 194

Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
           VDV+S GV+L  ++S    FD   G+    L     +    GK         +  N +K 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFD---GQNLKEL----RERVLRGKYRIPFYMSTDCENLLK- 246

Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKVSQ---MLEGVVEVDVPPNPSP 452
             + L++       +P  R T+ ++ +   +  G  E ++ P   P
Sbjct: 247 --RFLVL-------NPIKRGTLEQIMKDRWINAGHEEDELKPFVEP 283

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 23/204 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEV-VVIGQTHHKNLV 227
            E G G+ G V+K     T      +AVK++ R     E K    ++ VV+       +V
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGH---VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87

Query: 228 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
           +  G F         V+   E +                  +   +   I + L YL E 
Sbjct: 88  QCFGTFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---- 339
               +IH D+KP NILLD+    ++ DFG++  L  +++K       G   Y+APE    
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDP 198

Query: 340 -WYRKSTITAKVDVYSFGVLLLEI 362
               K     + DV+S G+ L+E+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVEL 222

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.8 bits (241), Expect = 1e-21
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           GRG FG V+       + +    A KKL   R+ +    +    E  ++ + H + +V L
Sbjct: 194 GRGGFGEVF-ACQM--KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
             +  E +  L LV   +N G +   ++   + +   +   A F   QI  GL +LH   
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--- 306

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+KP+N+LLDD  N RISD GLA  L   Q+KT      GT G++APE     
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLLGE 364

Query: 345 TITAKVDVYSFGVLLLEII 363
                VD ++ GV L E+I
Sbjct: 365 EYDFSVDYFALGVTLYEMI 383

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 24/202 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 226
             +  G G  G V +      + +    A+K L         + + EV +  + +   ++
Sbjct: 66  TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 117

Query: 227 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPSWNLR--TNIAFQIARGLLYL 280
           VR++   +         L+V E L+ G L S +      ++  R  + I   I   + YL
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177

Query: 281 HEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
           H   S  I H D+KP+N+L      +   +++DFG AK  T +   ++ T    T  YVA
Sbjct: 178 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPC-YTPYYVA 231

Query: 338 PEWYRKSTITAKVDVYSFGVLL 359
           PE           D++S GV++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 52/250 (20%), Positives = 91/250 (36%), Gaps = 70/250 (28%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-EVVVIGQTHHKNLVR 228
           +  G GSFGIV +     +       A+KK   V QD    +KN E+ ++    H N+++
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKR---FALKK---VLQD--PRYKNRELDIMKVLDHVNIIK 64

Query: 229 LL--------------------GFCDEGQNRLLVYEFLNNGTLASFLFGNL--------- 259
           L+                           N +  +        +   + N+         
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 260 ----KPSWNLRTNI--------AFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNA 306
               K       +I         +Q+ R + ++H   S  I H DIKPQN+L++      
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181

Query: 307 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-------KSTITAKVDVYSFGVLL 359
           ++ DFG AK L  ++             Y+   +YR        +  T  +D++S G + 
Sbjct: 182 KLCDFGSAKKLIPSEPSV---------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 360 LEIISCRKSF 369
            E+I  +  F
Sbjct: 233 GELILGKPLF 242

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 35/212 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V   + + +      VA+KKL R FQ     K    E++++    H+N++ LL
Sbjct: 33  GSGAYGSVCSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 231 ------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
                        +  LV  F+    L   +         ++  + +Q+ +GL Y+H   
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE-KIQ-YLVYQMLKGLKYIH--- 143

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S+ ++H D+KP N+ +++    +I DFGLA+    +   T         GYV   WYR  
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT---------GYVVTRWYRAP 192

Query: 345 TI-------TAKVDVYSFGVLLLEIISCRKSF 369
            +          VD++S G ++ E+++ +  F
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 32/211 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G+ GIV          +   VA+KKL R FQ+    K    E+V++   +HKN++ LL
Sbjct: 34  GSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90

Query: 231 ------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
                    +E Q+  +V E ++   L   +   L     +   + +Q+  G+ +LH   
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE-RMSY-LLYQMLCGIKHLH--- 144

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-- 342
           S+ IIH D+KP NI++      +I DFGLA+    +   T          YV   +YR  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRYYRAP 195

Query: 343 ----KSTITAKVDVYSFGVLLLEIISCRKSF 369
                      VD++S G ++ E+I     F
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.9 bits (236), Expect = 5e-21
 Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G+G FG V        R +    A KKL   R+ +   +    NE  ++ + + + +V L
Sbjct: 193 GKGGFGEVCAC---QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNI--AFQIARGLLYLHEDCSS 286
             +  E ++ L LV   +N G L   ++   +  +     +  A +I  GL  LH     
Sbjct: 250 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RE 305

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI 346
           +I++ D+KP+NILLDDH + RISD GLA  +     +TIK  + GT GY+APE  +    
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPEVVKNERY 362

Query: 347 TAKVDVYSFGVLLLEII 363
           T   D ++ G LL E+I
Sbjct: 363 TFSPDWWALGCLLYEMI 379

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 25/200 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR------VFQDGEKEFKNEVVVIGQTHHK-- 224
           G G FG VY G+  +       VA+K +++                 EVV++ +      
Sbjct: 52  GSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNN-GTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLH 281
            ++RLL + +   + +L+ E       L  F+   G L+    L  +  +Q+   + + H
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE--ELARSFFWQVLEAVRHCH 166

Query: 282 EDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
              +  ++H DIK +NIL+D +    ++ DFG   LL   +         GT+ Y  PEW
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD-GTRVYSPPEW 219

Query: 341 YR-KSTITAKVDVYSFGVLL 359
            R          V+S G+LL
Sbjct: 220 IRYHRYHGRSAAVWSLGILL 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.5 bits (230), Expect = 6e-21
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 29/213 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR--VFQDGEKEFKN------EVVVIGQTHHK 224
           G G+FG V+  V +        V VK + +  V +D   E         E+ ++ +  H 
Sbjct: 33  GSGAFGFVWTAVDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARGLL 278
           N++++L   +      LV E   +G     LF        L     L + I  Q+   + 
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDE--PLASYIFRQLVSAVG 144

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YL       IIH DIK +NI++ + +  ++ DFG A  L   + K   T   GT  Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEYCAP 198

Query: 339 EWYR-KSTITAKVDVYSFGVLLLEIISCRKSFD 370
           E          +++++S GV L  ++     F 
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 55/222 (24%), Positives = 86/222 (38%), Gaps = 43/222 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE--FKN---------EVVVIGQT 221
             GS+G V  GV     +    VA+K++     DG       +         E+ ++   
Sbjct: 31  SSGSYGAVCAGV----DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86

Query: 222 HHKNLVRLL-----GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRTN-IAFQIA 274
           HH N++ L                LV E +   T LA  +                + I 
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQYFMYHIL 144

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
            GL  LH    + ++H D+ P NILL D+ +  I DF LA+  T + +KT          
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---------H 192

Query: 335 YVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           YV   WYR   +       T  VD++S G ++ E+ + +  F
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 34/220 (15%)

Query: 163 EATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ 220
              D+++   + GRG +  V++ +  T       V VK L  V    +K+ K E+ ++  
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILEN 86

Query: 221 -THHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 277
                N++ L     D       LV+E +NN      L+  L    ++R  + ++I + L
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDY-DIRFYM-YEILKAL 143

Query: 278 LYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
            Y H   S  I+H D+KP N+++D +H   R+ D+GLA+     Q              V
Sbjct: 144 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---------VRV 191

Query: 337 APEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
           A  +++   +          +D++S G +L  +I  ++ F
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 35/289 (12%), Positives = 74/289 (25%), Gaps = 56/289 (19%)

Query: 170 EEAGRGSFGIVYKGVIETT-RTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKN 225
              G       ++ +     R     VA+  +D      +   +E  +  + + +     
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQ----VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 226 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           + R+L         L+V E++  G+L      +  P   +R      +A      H    
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHR--- 147

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
           + +      P  +         +S  G   L                   +         
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------ 179

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEGDMEA 403
              + D+   G  L  ++  R                 D A        +D  +   + A
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSP 452
           +       + +       Q D  +R     ++ M +     D      P
Sbjct: 239 V-----AARSV-------QGDGGIRSASTLLNLMQQATAVADRTEVLGP 275

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 21/201 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEF-KNEVVVIGQTHHKNLVRL 229
           G GSF  V          ++   A+K L+   + ++ +  +   E  V+ +  H   V+L
Sbjct: 39  GEGSFSTVVLA---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 230 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHED 283
              F D+   +L     +  NG L       ++   +       F   +I   L YLH  
Sbjct: 96  YFTFQDD--EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSALEYLH-- 147

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
               IIH D+KP+NILL++  + +I+DFG AK+L+    +    +  GT  YV+PE   +
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 344 STITAKVDVYSFGVLLLEIIS 364
            +     D+++ G ++ ++++
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 37/218 (16%)

Query: 166 DNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 217
           + ++   + G GS+G+V+K    +T +     VA+KK     +  +          E+ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQI----VAIKK---FLESEDDPVIKKIALREIRM 55

Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIAR 275
           + Q  H NLV LL      +   LV+E+ ++ T+   L  +    P   ++ +I +Q  +
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQ 113

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
            + + H       IH D+KP+NIL+  H   ++ DFG A+LLT                 
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--------SDYYDDE 162

Query: 336 VAPEWYR------KSTI-TAKVDVYSFGVLLLEIISCR 366
           VA  WYR        T     VDV++ G +  E++S  
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.0 bits (219), Expect = 9e-20
 Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 13/191 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG V  G  + T      VAVK L+R      D   + K E+  +    H ++++L
Sbjct: 20  GVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                   +  +V E+++ G L  ++  + +        +  QI   + Y H      ++
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVV 133

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKSTITA 348
           H D+KP+N+LLD H NA+I+DFGL+ +++    + ++T+  G+  Y APE    +     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRLYAGP 190

Query: 349 KVDVYSFGVLL 359
           +VD++S GV+L
Sbjct: 191 EVDIWSCGVIL 201

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 48/226 (21%)

Query: 169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR-------------------------- 202
           K+E G+GS+G+V     E   T     A+K L +                          
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 203 VFQDGEKEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLK 260
             +   ++   E+ ++ +  H N+V+L+    D  ++ L +V+E +N G +       LK
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLK 132

Query: 261 PSWNLRTNIA---F-QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL 316
           P   L  + A   F  + +G+ YLH     +IIH DIKP N+L+ +  + +I+DFG++  
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 317 LTLNQSKTIKTAIRGTKGYVAPE---WYRKSTITAKVDVYSFGVLL 359
              + +    T   GT  ++APE     RK      +DV++ GV L
Sbjct: 187 FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 60/225 (26%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V   V   T      VA+KKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 34  GSGAYGAVCSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 231 ------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNIAF 271
                    D+  +  LV  F             L    +   ++               
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY--------------- 135

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           Q+ +GL Y+H   ++ IIH D+KP N+ +++    +I DFGLA+    +   T       
Sbjct: 136 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT------- 183

Query: 332 TKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
             GYV   WYR   +       T  VD++S G ++ E+I+ +  F
Sbjct: 184 --GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G+ GIV          +   VA+KKL R FQ+    K    E+V++   +HKN++ LL
Sbjct: 71  GSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 231 ------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC 284
                    +E Q+  LV E ++   L   +   L       + + +Q+  G+ +LH   
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH--ERMSYLLYQMLCGIKHLH--- 181

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR-- 342
           S+ IIH D+KP NI++      +I DFGLA+    +   T          YV   +YR  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTRYYRAP 232

Query: 343 ----KSTITAKVDVYSFGVLLLEIISCRKSF 369
                      VD++S G ++ E++  +  F
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 35/211 (16%)

Query: 141 RNSPGDGTVETNLRCFSYKALEEATDNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAV 197
            +S G      NL         ++ + ++     G GS+G+V K    +T R     VA+
Sbjct: 7   HHSSGVDLGTENLYF-------QSMEKYENLGLVGEGSYGMVMKCRNKDTGRI----VAI 55

Query: 198 KKLDRVFQDGEKE-FKN----EVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 252
           KK     +  + +  K     E+ ++ Q  H+NLV LL  C + +   LV+EF+++ T+ 
Sbjct: 56  KK---FLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TIL 111

Query: 253 SFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF 311
             L        + +     FQI  G+ + H   S  IIH DIKP+NIL+      ++ DF
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDF 168

Query: 312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
           G A+ L                  VA  WYR
Sbjct: 169 GFARTLAAP--------GEVYDDEVATRWYR 191

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 77/241 (31%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE------------KEFKNEVVVIGQ 220
           G+G++GIV+K +   T      VAVKK+   FQ+               E          
Sbjct: 18  GKGAYGIVWKSIDRRTGEV---VAVKKIFDAFQNSTDAQRTFREIMILTELSG------- 67

Query: 221 THHKNLVRLLG-FCDEGQNRL-LVYEF----LNNGTLASFLFGNLKPSWNLRTN------ 268
             H+N+V LL     +    + LV+++    L+                 +R N      
Sbjct: 68  --HENIVNLLNVLRADNDRDVYLVFDYMETDLHA---------------VIRANILEPVH 110

Query: 269 ---IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
              + +Q+ + + YLH   S  ++H D+KP NILL+   + +++DFGL++     +  T 
Sbjct: 111 KQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 326 KTAIRGTK-------------GYVAPEWYR-------KSTITAKVDVYSFGVLLLEIISC 365
              +   +              YVA  WYR        +  T  +D++S G +L EI+  
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

Query: 366 R 366
           +
Sbjct: 228 K 228

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 89.6 bits (222), Expect = 3e-19
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 19/199 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEF----KNEVVVIGQTHHKNL 226
           GRG FG VY G  +    +    A+K L   R+     +      +  + ++       +
Sbjct: 198 GRGGFGEVY-GCRK--ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 227 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           V +  +     ++L  + + +N G L   L  +   S       A +I  GL ++H   +
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---N 310

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKS 344
             +++ D+KP NILLD+H + RISD GLA   +  +         GT GY+APE   +  
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGV 366

Query: 345 TITAKVDVYSFGVLLLEII 363
              +  D +S G +L +++
Sbjct: 367 AYDSSADWFSLGCMLFKLL 385

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 51/231 (22%), Positives = 100/231 (43%), Gaps = 44/231 (19%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN---EVVVIGQTHHKNLVRL 229
           G GS+G V +   +  +     VA+KK+ RVF+D   + K    E+ ++ + +H ++V++
Sbjct: 62  GTGSYGHVCEAYDKLEKRV---VAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKV 117

Query: 230 LGFC----DEGQNRL-LVYEFLNNGT-LASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
           L        E  + L +V E     +         +  +      + + +  G+ Y+H  
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH-- 173

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK---------- 333
            S+ I+H D+KP N L++   + ++ DFGLA+ +   ++   +  I   +          
Sbjct: 174 -SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

Query: 334 ---------GYVAPEWYR-------KSTITAKVDVYSFGVLLLEIISCRKS 368
                    G+V   WYR       +   T  +DV+S G +  E+++  K 
Sbjct: 233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 61/225 (27%), Positives = 91/225 (40%), Gaps = 60/225 (26%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G++G V       T      VAVKKL R FQ     K    E+ ++    H+N++ LL
Sbjct: 38  GSGAYGSVCAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 231 ------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNIAF 271
                    +E  +  LV                L +  +   ++               
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY--------------- 139

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRG 331
           QI RGL Y+H   S+ IIH D+KP N+ +++    +I DFGLA+        T       
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMT------- 187

Query: 332 TKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
             GYVA  WYR   I          VD++S G ++ E+++ R  F
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 46/226 (20%), Positives = 92/226 (40%), Gaps = 51/226 (22%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G++G+V     + T      VA+KK+   F           E+ ++    H+N++ + 
Sbjct: 20  GEGAYGVVCSATHKPTGEI---VAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIF 75

Query: 231 -----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
                   +      ++ E              L++  +  F++               Q
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------------Q 120

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGT 332
             R +  LH    S +IH D+KP N+L++ + + ++ DFGLA+++  + +   +   + +
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 333 K--GYVAPEWYR-------KSTITAKVDVYSFGVLLLEIISCRKSF 369
               +VA  WYR        +  +  +DV+S G +L E+   R  F
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 21/195 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G G+FG V  G  E T      VAVK L+R      D   + + E+  +    H ++++L
Sbjct: 25  GVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCS 285
                   +  +V E+++ G L  ++  N +    L    +   F QI  G+ Y H    
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCH---R 134

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKS 344
             ++H D+KP+N+LLD H NA+I+DFGL+ +++    + ++T+  G+  Y APE    + 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 191

Query: 345 TITAKVDVYSFGVLL 359
               +VD++S GV+L
Sbjct: 192 YAGPEVDIWSSGVIL 206

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G G+FG+      + T+     VAVK ++R     E   + E++      H N+VR    
Sbjct: 29  GSGNFGVARLMRDKLTKEL---VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEV 84

Query: 233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA---F-QIARGLLYLHEDCSSQI 288
                +  ++ E+ + G L   +    +       + A   F Q+  G+ Y H   S QI
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCH---SMQI 137

Query: 289 IHCDIKPQNILLDDHY--NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKST 345
            H D+K +N LLD       +I DFG +K   L+     K+ + GT  Y+APE   R+  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPEVLLRQEY 194

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFD 370
                DV+S GV L  ++     F+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 52/235 (22%), Positives = 95/235 (40%), Gaps = 57/235 (24%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           GRGS+G VY    + T  +   VA+KK++R+F+D    K    E+ ++ +     ++RL 
Sbjct: 35  GRGSYGYVYLAYDKNTEKN---VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 231 G-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPSWNLRTNIA----------FQIA 274
                +   +     +V E     + L              +T I           + + 
Sbjct: 92  DLIIPDDLLKFDELYIVLEIA--DSDLKKLF----------KTPIFLTEEHIKTILYNLL 139

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK- 333
            G  ++H    S IIH D+KP N LL+   + ++ DFGLA+ +   +   I   +   + 
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 334 -------------GYVAPEWYR-------KSTITAKVDVYSFGVLLLEIISCRKS 368
                         +V   WYR       +   T  +D++S G +  E+++  +S
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.9 bits (206), Expect = 5e-18
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 23/160 (14%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 218
           + +   E+ G G++G+VYK       T     A+KK   +  + E E        E+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKK---IRLEKEDEGIPSTTIREISIL 54

Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 275
            +  H N+V+L       +  +LV+E L+   L   L    G L+     ++    Q+  
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESV-TAKS-FLLQLLN 111

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
           G+ Y H     +++H D+KPQN+L++     +I+DFGLA+
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           G GSFG V       T+     VA+K + R      D     + E+  +    H ++++L
Sbjct: 18  GEGSFGKVKLATHYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
                   + ++V E+   G L  ++    + + +       QI   + Y H     +I+
Sbjct: 75  YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIV 130

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE-WYRKSTITA 348
           H D+KP+N+LLDD+ N +I+DFGL+ ++T      +KT+  G+  Y APE    K     
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVINGKLYAGP 187

Query: 349 KVDVYSFGVLLLEIISCRKSFD 370
           +VDV+S G++L  ++  R  FD
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFD 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 23/160 (14%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVVI 218
           + ++  E+ G G++G+VYK      R     VA+K+   +  D E E        E+ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKR---IRLDAEDEGIPSTAIREISLL 73

Query: 219 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIAR 275
            + HH N+V L+      +   LV+EF+    L   L      L+ S  ++    +Q+ R
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLR 130

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
           G+ + H     +I+H D+KPQN+L++     +++DFGLA+
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 41/221 (18%)

Query: 166 DNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 217
             ++  E+ G G++G V+K    ET       VA+K++ R+  D + E        E+ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI----VALKRV-RL--DDDDEGVPSSALREICL 54

Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARG 276
           + +  HKN+VRL       +   LV+EF +   L  +           +  +  FQ+ +G
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY- 335
           L + H   S  ++H D+KPQN+L++ +   ++++FGLA+   +             + Y 
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-----------VRCYS 159

Query: 336 --VAPEWYR-------KSTITAKVDVYSFGVLLLEIISCRK 367
             V   WYR           +  +D++S G +  E+ +  +
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.9 bits (208), Expect = 9e-18
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 37/221 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLL 230
           G+GSFG V   +++   T    A+      +  +  E      E+ ++    H  LV L 
Sbjct: 24  GKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 231 G-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLL 278
             F DE    + +V + L  G L           ++L+ N+ F          ++   L 
Sbjct: 82  YSFQDEE--DMFMVVDLLLGGDL----R------YHLQQNVHFKEETVKLFICELVMALD 129

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           YL    + +IIH D+KP NILLD+H +  I+DF +A +L     +T  T + GTK Y+AP
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAP 183

Query: 339 EWYRKSTI---TAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
           E +        +  VD +S GV   E++  R+ + I     
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 21/160 (13%)

Query: 166 DNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 217
           +NF+  E+ G G++G+VYK     T       VA+KK+ R+  D E E        E+ +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV----VALKKI-RL--DTETEGVPSTAIREISL 55

Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIAR 275
           + + +H N+V+LL          LV+EFL+   L  F+  +      L    +  FQ+ +
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
           GL + H   S +++H D+KPQN+L++     +++DFGLA+
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 29/202 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G+GSFG V+     +   +    A+K L    +        K E  ++ + +H  +V+L 
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH 92

Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLY 279
            +  + + +L L+ +FL  G L    F        L   + F          ++A  L +
Sbjct: 93  -YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAELALALDH 141

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH   S  II+ D+KP+NILLD+  + +++DFGL+K    ++ K    +  GT  Y+APE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAPE 196

Query: 340 WYRKSTITAKVDVYSFGVLLLE 361
              +   T   D +SFGVL+ E
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFE 218

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 28/165 (16%)

Query: 166 DNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKN-----EVVV 217
           D ++   + G G++G VYK +   T  T    VA+K++ R+  + E+E        EV +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNET----VAIKRI-RL--EHEEEGVPGTAIREVSL 86

Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIAR 275
           + +  H+N++ L           L++E+  N  L  ++    ++     +++   +Q+  
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR-VIKS-FLYQLIN 143

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR-----ISDFGLAK 315
           G+ + H   S + +H D+KPQN+LL     +      I DFGLA+
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 47/228 (20%)

Query: 164 ATDNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--- 217
           AT  ++   E G G++G VYK     +       VA+K + RV           + +   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHF----VALKSV-RV--PNGGGGGGGLPISTV 59

Query: 218 --------IGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWN 264
                   +    H N+VRL+        + + ++ LV+E ++   L ++L     P   
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118

Query: 265 LRT--NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
             T  ++  Q  RGL +LH   ++ I+H D+KP+NIL+      +++DFGLA++ +   +
Sbjct: 119 AETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175

Query: 323 KTIKTAIRGTKGYVAPEWYRK------STITAKVDVYSFGVLLLEIIS 364
            T           V   WYR       ST    VD++S G +  E+  
Sbjct: 176 LTPV---------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 51/227 (22%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-------------KE 210
             ++   E G G++G V+K      +     VA+K++ RV    E             + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRH 67

Query: 211 FKNEVVVIGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSW 263
            +          H N+VRL         + + +L LV+E ++   L ++L          
Sbjct: 68  LE-------TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119

Query: 264 NLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK 323
               ++ FQ+ RGL +LH   S +++H D+KPQNIL+      +++DFGLA++ +   + 
Sbjct: 120 ETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176

Query: 324 TIKTAIRGTKGYVAPEWYRK------STITAKVDVYSFGVLLLEIIS 364
           T           V   WYR       S+    VD++S G +  E+  
Sbjct: 177 TSV---------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 51/227 (22%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G  G+V+  V          VA+KK+  V  D +  K    E+ +I +  H N+V++ 
Sbjct: 20  GCGGNGLVFSAVDNDCDKR---VAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVF 74

Query: 231 --------------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRTN----IAF 271
                         G   E  +  +V E++   T LA+ L         L         +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG-----PLLEEHARLFMY 127

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIK-TAI 329
           Q+ RGL Y+H   S+ ++H D+KP N+ ++ +    +I DFGLA+++  + S     +  
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-- 182

Query: 330 RGTKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
                 +  +WYR   +       T  +D+++ G +  E+++ +  F
Sbjct: 183 ----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 22/202 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           GRG+F  V   V++  +T     A+K +    + + GE   F+ E  V+     + + +L
Sbjct: 70  GRGAFSEVA--VVKMKQTGQV-YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             F  + +N L LV E+   G L + L  FG   P+   R  +A +I   +  +H     
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVH---RL 181

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE------- 339
             +H DIKP NILLD   + R++DFG    L  + +     A+ GT  Y++PE       
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGG 240

Query: 340 WYRKSTITAKVDVYSFGVLLLE 361
                +   + D ++ GV   E
Sbjct: 241 GPGTGSYGPECDWWALGVFAYE 262

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.3 bits (201), Expect = 9e-17
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 26/203 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           GRG+FG V   V++         A+K L    + +  E   F+ E  V+     K +  L
Sbjct: 83  GRGAFGEVA--VVKLKNADKV-FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 230 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHED 283
              F D+  N L LV ++   G L + L    K    L   +A F   ++   +  +H  
Sbjct: 140 HYAFQDD--NNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIAIDSVH-- 192

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE---- 339
                +H DIKP NIL+D + + R++DFG    L  + +     A+ GT  Y++PE    
Sbjct: 193 -QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250

Query: 340 -WYRKSTITAKVDVYSFGVLLLE 361
               K     + D +S GV + E
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYE 273

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 25/180 (13%)

Query: 268 NIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 327
             +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K 
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS--FDIEMGEEYAILTDWAF 385
             R    ++APE       T + DV+SFGVLL EI S   S    +++ EE         
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLK 310

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKL--LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           +  R           M A +      ++   M+  W    +PS RPT  ++ + L  +++
Sbjct: 311 EGTR-----------MRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEHLGNLLQ 355

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 12/153 (7%)

Query: 168 FKEEAGRGSFGIVYKGVIE--TTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQ-THH 223
             +  GRG+FG V +          +   VAVK L       E +   +E+ ++    HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 224 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
            N+V LLG C   G   +++ EF   G L+++L        + R        +G  +   
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
                 I  D+K +   +    ++  S F   K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 56/225 (24%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G++G+V        +     VA+KK+   F+     +    E+ ++ +  H+N++ + 
Sbjct: 36  GEGAYGMVCSAYDNLNKVR---VAIKKIS-PFEHQTYCQRTLREIKILLRFRHENIIGIN 91

Query: 231 -----GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPSWNLRTNIAFQ 272
                   ++ ++  +V +              L+N  +  FL+               Q
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY---------------Q 136

Query: 273 IARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK-TAIRG 331
           I RGL Y+H   S+ ++H D+KP N+LL+   + +I DFGLA++   +   T   T    
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---- 189

Query: 332 TKGYVAPEWYRKSTI-------TAKVDVYSFGVLLLEIISCRKSF 369
              YVA  WYR   I       T  +D++S G +L E++S R  F
Sbjct: 190 --EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 46/217 (21%), Positives = 90/217 (41%), Gaps = 36/217 (16%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLG 231
           GRG++G VYK   +  +      A+K+++     G       E+ ++ +  H N++ L  
Sbjct: 30  GRGTYGHVYKAKRKDGKDDKD-YALKQIEG---TGISMSACREIALLRELKHPNVISLQK 85

Query: 232 -FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTN---------IAFQIARGLLYL 280
            F      ++ L++++  +  L   +  +     N +           + +QI  G+ YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNAR----ISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           H   ++ ++H D+KP NIL+      R    I+D G A+L        +K         V
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP----LKPLADLDPVVV 197

Query: 337 APEWYR-------KSTITAKVDVYSFGVLLLEIISCR 366
              WYR           T  +D+++ G +  E+++  
Sbjct: 198 TF-WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 27/164 (16%)

Query: 166 DNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKN--------E 214
             ++  +  G G F  VYK     T +     VA+KK+ ++      E K+        E
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQI----VAIKKI-KL--GHRSEAKDGINRTALRE 62

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAF 271
           + ++ +  H N++ LL       N  LV++F+    L   +      L PS +++     
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YML 119

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
              +GL YLH      I+H D+KP N+LLD++   +++DFGLAK
Sbjct: 120 MTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 22/163 (13%)

Query: 164 ATDNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKEFKN----EVV 216
           ++  FK  E+ G G++  VYKG+   T       VA+K++ ++  D E+   +    E+ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVY----VALKEV-KL--DSEEGTPSTAIREIS 55

Query: 217 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPSWNLRT--NIAF 271
           ++ +  H+N+VRL           LV+EF++N     + S   GN      L       +
Sbjct: 56  LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA 314
           Q+ +GL + H    ++I+H D+KPQN+L++     ++ DFGLA
Sbjct: 116 QLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 21/159 (13%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKN----EVVVIG 219
           + +   ++ G G++  VYKG  + T      VA+K++    ++G          EV ++ 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDN---LVALKEIRLEHEEG---APCTAIREVSLLK 55

Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARG 276
              H N+V L       ++  LV+E+L+   L  +L      +    N++    FQ+ RG
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-FLFQLLRG 112

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK 315
           L Y H     +++H D+KPQN+L+++    +++DFGLA+
Sbjct: 113 LAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLL 230
           G+G+FG V   +++   T    A+ + K + +    E      E  V+  + H  L  L 
Sbjct: 157 GKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLY 279
            +  +  +RL  V E+ N G L           ++L     F          +I   L Y
Sbjct: 215 -YSFQTHDRLCFVMEYANGGEL----------FFHLSRERVFSEDRARFYGAEIVSALDY 263

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH + +  +++ D+K +N++LD   + +I+DFGL K   +    T+KT   GT  Y+APE
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT-FCGTPEYLAPE 319

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
               +     VD +  GV++ E++  R  F 
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 33/220 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFK-----NEVVVIGQTH-- 222
           G G F  V+        T    VA+K         +  E E K     N+     +    
Sbjct: 28  GWGHFSTVWLAKDMVNNT---HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 223 HKNLVRLLG-FCDEGQNRL---LVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARG 276
             ++++LL  F  +G N +   +V+E L    L + +         L     I+ Q+  G
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDD------HYNARISDFGLAKLLTLNQSKTIKTAIR 330
           L Y+H  C   IIH DIKP+N+L++           +I+D G A     + + +I+    
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ---- 197

Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
            T+ Y +PE    +      D++S   L+ E+I+    F+
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 52/226 (23%), Positives = 101/226 (44%), Gaps = 45/226 (19%)

Query: 166 DNFK--EEAGRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVFQDGEKE-FKN----EVVV 217
             ++   + G+G+FG V+K    +T +     VA+KK+  +  + EKE F      E+ +
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQK----VALKKV-LM--ENEKEGFPITALREIKI 69

Query: 218 IGQTHHKNLVRLLGFCDEGQNRL--------LVYEFLNNGTLASFL-FGNLKPSWNLRTN 268
           +    H+N+V L+  C    +          LV++F  +  LA  L    +K + +    
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 128

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           +   +  GL Y+H    ++I+H D+K  N+L+      +++DFGLA+  +L ++      
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS----- 180

Query: 329 IRGTKGY---VAPEWYR-------KSTITAKVDVYSFGVLLLEIIS 364
                 Y   V   WYR       +      +D++  G ++ E+ +
Sbjct: 181 --QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 19/198 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           GRG+FG V   ++    T     A+K L    + +  +   F  E  ++   +   +V+L
Sbjct: 78  GRGAFGEVQ--LVRHKSTRKV-YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 230 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
              F D+    L +V E++  G L + +     P    R   A ++   L  +H   S  
Sbjct: 135 FYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMG 188

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
            IH D+KP N+LLD   + +++DFG    +         TA+ GT  Y++PE  +     
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 247

Query: 348 AK----VDVYSFGVLLLE 361
                  D +S GV L E
Sbjct: 248 GYYGRECDWWSVGVFLYE 265

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 31/211 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQTHHKNLVRLL 230
           G+G+FG V   ++    T    A+ + + + +    E      E  V+  T H  L  L 
Sbjct: 14  GKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 231 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIARGLLY 279
            +  +  +RL  V E+ N G L    F      ++L     F          +I   L Y
Sbjct: 72  -YAFQTHDRLCFVMEYANGGEL----F------FHLSRERVFTEERARFYGAEIVSALEY 120

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH   S  +++ DIK +N++LD   + +I+DFGL K   ++   T+KT   GT  Y+APE
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT-FCGTPEYLAPE 175

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFD 370
               +     VD +  GV++ E++  R  F 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 43/206 (20%), Positives = 76/206 (36%), Gaps = 53/206 (25%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 226
             +  G G  G V +      + +    A+K L         + + EV +  + +   ++
Sbjct: 22  TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 73

Query: 227 VRLLGFCDEGQNR----LLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARG 276
           VR++   +         L+V E L+ G     LF      G+   +    + I   I   
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 277 LLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
           + YLH   S  I H D+KP+N+L      +   +++DFG AK  T              +
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------GE 173

Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLL 359
            Y               D++S GV++
Sbjct: 174 KY-----------DKSCDMWSLGVIM 188

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 22/196 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G GSFG V    +   + S    A+K L   +V +  + E   NE  ++   +   LV+L
Sbjct: 50  GTGSFGRVM---LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDCS 285
                +  N  +V E++  G +    F +L+         A F   QI     YLH   S
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---S 159

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +I+ D+KP+N+L+D     +++DFG AK +   + +T  T + GT   +APE      
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRT-WT-LCGTPEALAPEIILSKG 214

Query: 346 ITAKVDVYSFGVLLLE 361
               VD ++ GVL+ E
Sbjct: 215 YNKAVDWWALGVLIYE 230

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 21/199 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEF---KNEVVVIGQTHHKNLV 227
           G+G +G V++    T   +    A+K L    + ++  K+    K E  ++ +  H  +V
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIV 84

Query: 228 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHE 282
            L+ +  +   +L L+ E+L+ G L    F  L+       + A F   +I+  L +LH 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLH- 138

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
                II+ D+KP+NI+L+   + +++DFGL K    + + T  T   GT  Y+APE   
Sbjct: 139 --QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HT-FCGTIEYMAPEILM 194

Query: 343 KSTITAKVDVYSFGVLLLE 361
           +S     VD +S G L+ +
Sbjct: 195 RSGHNRAVDWWSLGALMYD 213

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEF--KNEVVVIGQT-HHKNLV 227
           G G++G V+     +   +    A+K L    + Q  +     + E  V+        LV
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122

Query: 228 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHE 282
            L  +  + + +L L+ +++N G L    F +L        +       +I   L +LH 
Sbjct: 123 TLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHLH- 176

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE--W 340
                II+ DIK +NILLD + +  ++DFGL+K    ++++       GT  Y+AP+   
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVR 233

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIE 372
              S     VD +S GVL+ E+++    F ++
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 26/198 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKE-FKNEVVVIGQTHHKNLVRL 229
           G GSFG V+   +  +R +    A+K L  + V +  + E   +E +++    H  ++R+
Sbjct: 15  GTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 230 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHED 283
            G F D    ++ ++ +++  G L    F  L+ S      +A F   ++   L YLH  
Sbjct: 72  WGTFQDA--QQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLH-- 123

Query: 284 CSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
            S  II+ D+KP+NILLD + + +I+DFG AK        T  T + GT  Y+APE    
Sbjct: 124 -SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVT-YT-LCGTPDYIAPEVVST 177

Query: 344 STITAKVDVYSFGVLLLE 361
                 +D +SFG+L+ E
Sbjct: 178 KPYNKSIDWWSFGILIYE 195

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 22/220 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQ-THHKNLVRL 229
           G+GSFG V   +     T    AV V K D + QD + E    E  ++    +H  L +L
Sbjct: 32  GKGSFGKVM--LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
              C +  +RL  V EF+N G L      +++ S       A F   +I   L++LH   
Sbjct: 90  F-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFLH--- 141

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+K  N+LLD   + +++DFG+ K    N   T      GT  Y+APE  ++ 
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEILQEM 199

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 382
                VD ++ GVLL E++     F+ E  ++   AIL D
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQ-THHKNLVRL 229
           G+GSFG V   +          AV V +   + +  E++   +E  V+ +   H  LV L
Sbjct: 47  GKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
             F  +  ++L  V +++N G L    F +L+         A F   +IA  L YLH   
Sbjct: 105 H-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLH--- 156

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  I++ D+KP+NILLD   +  ++DFGL K    + S T  +   GT  Y+APE   K 
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVLHKQ 214

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFD 370
                VD +  G +L E++     F 
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFY 240

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 22/220 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQ-THHKNLVRL 229
           G+GSFG V   + E   T    AV + K D V QD + E    E  V+        L +L
Sbjct: 29  GKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
              C +  +RL  V E++N G L      +++     +   A F   +IA GL +L    
Sbjct: 87  H-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 138

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  II+ D+K  N++LD   + +I+DFG+ K    +   T KT   GT  Y+APE     
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEIIAYQ 196

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 382
                VD ++FGVLL E+++ +  F+ E  +E   +I+  
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 22/220 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQ-THHKNLVRL 229
           G+GSFG V   + E   T    AV + K D V QD + E    E  V+        L +L
Sbjct: 350 GKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
              C +  +RL  V E++N G L      +++     +   A F   +IA GL +L    
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 459

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
           S  II+ D+K  N++LD   + +I+DFG+ K    +   T KT   GT  Y+APE     
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KT-FCGTPDYIAPEIIAYQ 517

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 382
                VD ++FGVLL E+++ +  F+ E  +E   +I+  
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.1 bits (175), Expect = 9e-14
 Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEF----KNEVVVIGQTHHKNL 226
           G+GSFG V+   +   + +    A+K L  D V  D + E     K   V+     H  L
Sbjct: 26  GKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR--VLSLAWEHPFL 80

Query: 227 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIAF----------QIAR 275
             +     + +  L  V E+LN G L           +++++   F          +I  
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGDL----M------YHIQSCHKFDLSRATFYAAEIIL 129

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGY 335
           GL +LH   S  I++ D+K  NILLD   + +I+DFG+ K   L  +KT      GT  Y
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDY 184

Query: 336 VAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTD 382
           +APE          VD +SFGVLL E++  +  F  +  EE  ++I  D
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 9e-14
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 20/212 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQ-THHKNLVRL 229
           GRGS+  V   ++   +T    A+ V K + V  D + ++ + E  V  Q ++H  LV L
Sbjct: 18  GRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
              C + ++RL  V E++N G L      +++    L    A F   +I+  L YLH   
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLH--- 127

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+K  N+LLD   + +++D+G+ K        T  +   GT  Y+APE  R  
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGE 185

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                VD ++ GVL+ E+++ R  FDI    +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 20/212 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTT-AVAVKKLDRVFQDGEKEF-KNEVVVIGQ-THHKNLVRL 229
           GRGS+  V   ++   +T    A+ V K + V  D + ++ + E  V  Q ++H  LV L
Sbjct: 61  GRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 230 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPSWNLRTNIA-F---QIARGLLYLHEDC 284
              C + ++RL  V E++N G L      +++    L    A F   +I+  L YLHE  
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLHE-- 171

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
              II+ D+K  N+LLD   + +++D+G+ K        T  +   GT  Y+APE  R  
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGE 228

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                VD ++ GVL+ E+++ R  FDI    +
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 39/208 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 227
           G+GSFG V K            VA+K      R  +   +E +    +    + +  N++
Sbjct: 106 GKGSFGQVVKAYDHKVHQH---VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 228 RLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
            +L             E    N   +YE +       F       S  L    A  I + 
Sbjct: 163 HMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGF-------SLPLVRKFAHSILQC 212

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLNQSKTIKTAIRGTKG 334
           L  LH    ++IIHCD+KP+NILL     +  ++ DFG +      + + + T I+ ++ 
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQ-SRF 264

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEI 362
           Y APE    +     +D++S G +L E+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAEL 292

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 47/210 (22%), Positives = 76/210 (36%), Gaps = 63/210 (30%)

Query: 223 HKNLVRLLG-FCDEGQN---RLLVYEFL--NNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
            + +V+LL  F   G N     +V+E L  +             P   ++  I  Q+ +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK-IIQQVLQG 158

Query: 277 LLYLHEDCSSQIIHCDIKPQNILL--DDHY------------------------------ 304
           L YLH  C  +IIH DIKP+NILL  ++ Y                              
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 305 -----------------NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
                              +I+D G A  +  + ++ I+     T+ Y + E    S   
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYN 271

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEEY 377
              D++S   +  E+ +    F+   GEEY
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEY 301

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 19/198 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 227
           G+GSFG V K      +     VA+K            + E +    +          +V
Sbjct: 63  GKGSFGQVVKAYDRVEQEW---VAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCS 285
            L        +  LV+E L+   L   L        +L      A Q+   LL+L     
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-E 177

Query: 286 SQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK 343
             IIHCD+KP+NILL +   +  +I DFG +        + I   I+ ++ Y +PE    
Sbjct: 178 LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ-SRFYRSPEVLLG 232

Query: 344 STITAKVDVYSFGVLLLE 361
                 +D++S G +L+E
Sbjct: 233 MPYDLAIDMWSLGCILVE 250

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 20/152 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG +  G    T      VA+K   +         E++    +        + ++ 
Sbjct: 18  GCGNFGELRLGKNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVY 71

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSSQI 288
            F   G+   +V E L  G     LF     +++L+T   IA Q+   + Y+H   S  +
Sbjct: 72  YFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNL 126

Query: 289 IHCDIKPQNILLDDHYNAR-----ISDFGLAK 315
           I+ D+KP+N L+    N       I DF LAK
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.3 bits (145), Expect = 3e-10
 Identities = 34/229 (14%), Positives = 59/229 (25%), Gaps = 67/229 (29%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKL--------DRVFQDGEKEFKNEVVV------- 217
           G G FG V++          T VA+K +        +   Q   +E   E+++       
Sbjct: 29  GEGVFGEVFQT-----IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83

Query: 218 --IGQTHHKNLVRLLGFC------------------------------DEGQNRLLVYEF 245
                   +  + L                                   +     +V EF
Sbjct: 84  SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143

Query: 246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN 305
              G     +   L  S     +I  Q+   L         +  H D+   N+LL     
Sbjct: 144 EFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200

Query: 306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGY-VAPEWYRKSTITAKVDVY 353
            ++      K  T+            + G  V+   Y  S +     V 
Sbjct: 201 KKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 32/164 (19%), Positives = 67/164 (40%), Gaps = 26/164 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTA-----VAVK------KLDRVFQDGEKEFKNEVVVIGQT 221
            R + GI+Y+    +T T  +       ++K      +L       ++  K   V   + 
Sbjct: 51  TRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKK 110

Query: 222 HHKNLV----RLLGF-CDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRT--NIAFQI 273
            +   +      +GF   + + R LV   L  G  L S L  + K   + R+   +A ++
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACRL 168

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI--SDFGLAK 315
              L +LH    ++ +H ++  +NI +D    +++  + +G A 
Sbjct: 169 LDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 20/152 (13%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK--KLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G GSFG++++G           VA+K             E++   ++ G T    +  + 
Sbjct: 19  GEGSFGVIFEGTNLLNNQ---QVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVY 72

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSSQI 288
            F  EG + +LV + L  G     L       ++++T    A Q+   +  +H      +
Sbjct: 73  YFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 127

Query: 289 IHCDIKPQNILLDDHYNAR-----ISDFGLAK 315
           ++ DIKP N L+    +       + DFG+ K
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 33/170 (19%), Positives = 63/170 (37%), Gaps = 31/170 (18%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 227
           G G+FG V + +    +     VAVK    +DR  +    E +    +           V
Sbjct: 23  GEGAFGKVVECI--DHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 228 RLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
           ++L + +         E  G +    Y+F+       F         +    +A+QI + 
Sbjct: 81  QMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPF-------RLDHIRKMAYQICKS 130

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
           + +LH    +++ H D+KP+NIL          +  + +      +  IK
Sbjct: 131 VNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 44/225 (19%), Positives = 83/225 (36%), Gaps = 57/225 (25%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFK--NEVVVIGQTHHKNLV 227
           G G+FG V +  ++  R  +  VA+K    + +  +    E     ++    + +    V
Sbjct: 28  GEGTFGKVVE-CLDHARGKSQ-VALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCV 85

Query: 228 RLLGFCDE-----------GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARG 276
            +  + +            G+N    +EFL       +             ++A+Q+   
Sbjct: 86  LMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPY-------PLPHVRHMAYQLCHA 135

Query: 277 LLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK---------- 326
           L +LHE   +Q+ H D+KP+NIL  +     + +   +      ++ +I+          
Sbjct: 136 LRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 327 ----TAIRGTKGYVAPE------WYRKSTITAKVDVYSFGVLLLE 361
               T I  T+ Y  PE      W          DV+S G +L E
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 47/234 (20%), Positives = 72/234 (30%), Gaps = 71/234 (30%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK---KLDRVFQDGEKEFK-----NEVVVIGQTHHK 224
           G G+FG V        +      AVK    + +  +  + E                ++ 
Sbjct: 44  GDGTFGRVLLCQHIDNKKY---YAVKVVRNIKKYTRSAKIEADILKKIQN----DDINNN 96

Query: 225 NLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
           N+V+  G            E  G +   +YE +       F                 +I
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGF-------HIEDIKLYCIEI 146

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIR- 330
            + L YL +     + H D+KP+NILLDD Y  +                     T I+ 
Sbjct: 147 LKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 331 ---G--------------TKGYVAPE------WYRKSTITAKVDVYSFGVLLLE 361
              G              T+ Y APE      W          D++SFG +L E
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 40/149 (26%), Positives = 58/149 (38%), Gaps = 16/149 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLG 231
           G GSFG +Y G           VA+K      +    +   E  +         +  +  
Sbjct: 18  GSGSFGDIYLGTDIAAG---EEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRW 72

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSSQII 289
              EG   ++V E L  G     LF      ++L+T   +A Q+   + Y+H   S   I
Sbjct: 73  CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 127

Query: 290 HCDIKPQNILL---DDHYNARISDFGLAK 315
           H D+KP N L+          I DFGLAK
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 42/149 (28%), Positives = 61/149 (40%), Gaps = 16/149 (10%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLG 231
           G GSFG +Y G    T      VA+K  +   +    +   E  +         +  +  
Sbjct: 16  GSGSFGEIYLGTNIQTNE---EVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQIARGLLYLHEDCSSQII 289
           F  EG   +LV + L  G     LF       +L+T   +A Q+   + ++H   S   +
Sbjct: 71  FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFL 125

Query: 290 HCDIKPQNILLDDHYNAR---ISDFGLAK 315
           H DIKP N L+     A    I DFGLAK
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 34/164 (20%), Positives = 61/164 (37%), Gaps = 29/164 (17%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLD-----------RVFQD-GEKEFKNEVVVIGQ 220
           G G FG++Y     T +    A  V K++           + +Q   +K+   + +   Q
Sbjct: 46  GSGGFGLIYLA-FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 221 THHKNLVRLLGF----CDEGQNRLLVYEFLNNGT-LASFLFGNLKPSWNLRT--NIAFQI 273
             +  +    G           R +V E L  G  L      N        T   +  ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFK--KSTVLQLGIRM 160

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI--SDFGLAK 315
              L Y+H    ++ +H DIK  N+LL      ++  +D+GL+ 
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 29/164 (17%), Positives = 66/164 (40%), Gaps = 26/164 (15%)

Query: 173 GRGSFGIVYKGVIETTRTSTTA--VAVKKL----------DRVFQD-GEKEFKNEVVVIG 219
           G+G FG +Y   + ++ +  +     VK             + +Q   + E   + +   
Sbjct: 44  GQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTR 103

Query: 220 QTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPSWNLRT--NIAFQI 273
           +  +  + +  G     +N    R ++ +    G+    ++      ++ +T   ++ +I
Sbjct: 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI--SDFGLAK 315
              L Y+H     + +H DIK  N+LL+     ++   D+GLA 
Sbjct: 162 LDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 3e-07
 Identities = 68/525 (12%), Positives = 139/525 (26%), Gaps = 169/525 (32%)

Query: 4   GYNKELFDFHE--VKNIDWPQ-SDYER--FK----------PYNEVQCKNSCLSDCFC-- 46
            Y   L  F +  V N D     D  +                         L       
Sbjct: 17  QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR--LFWTLLSK 74

Query: 47  ----AAVIFED---DSCCFKKLPLSNGMTDSRITSKAFIKYKNK--GDDPP----SVPRP 93
                    E+    +  F   P+        + ++ +I+ +++   D+      +V R 
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRL 134

Query: 94  PDPDDKKKRKMMNA--TGSVLL------GSSVFVNFAMVC---GVGLGFFF-IYKKKWI- 140
             P  K ++ ++      +VL+      G +       VC    V     F I+   W+ 
Sbjct: 135 -QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA--LDVCLSYKVQCKMDFKIF---WLN 188

Query: 141 ---RNSPGDGTVETNLRCF----SYKALEEATDN---------------FKEEAGRGSFG 178
               NSP           +    ++ +  + + N                K +       
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 179 I---VY-KGVIE----------TTR----------TSTTAVAVKKLDRVFQDGE------ 208
           +   V                 TTR           +TT +++          E      
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308

Query: 209 -------KEFKNEVVVIGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL---FG 257
                  ++   EV+    T +   + ++     +G      ++ +N   L + +     
Sbjct: 309 KYLDCRPQDLPREVL----TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364

Query: 258 NLKPSWNLRTN-----IAFQ----IARGLL--------------YLHEDCSSQIIHCDIK 294
            L+P+   R       + F     I   LL               +++     ++    K
Sbjct: 365 VLEPA-EYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

Query: 295 PQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITA-KVDVY 353
              I +   Y        L   + L     +  +I     Y  P+ +    +    +D Y
Sbjct: 423 ESTISIPSIY--------LELKVKLENEYALHRSIVDH--YNIPKTFDSDDLIPPYLDQY 472

Query: 354 SFGVL---LLEIISCRKSFDIEMGEEYAILTDWAFDCYR--NGKL 393
            +  +   L          +IE  E   +      D +R    K+
Sbjct: 473 FYSHIGHHL---------KNIEHPERMTLFRMVFLD-FRFLEQKI 507

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 9e-06
 Identities = 48/305 (15%), Positives = 88/305 (28%), Gaps = 74/305 (24%)

Query: 158 YKALEEATDNFKEEA-----GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFK 212
           Y  L +A    +        G    G   K        +  A+ V    +V    + +  
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG---K--------TWVALDVCLSYKV----QCKMD 181

Query: 213 NEV--VVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIA 270
            ++  + +   +      +L    E   +LL Y+   N T  S    N+K    LR +  
Sbjct: 182 FKIFWLNLKNCNSPET--VL----EMLQKLL-YQIDPNWTSRSDHSSNIK----LRIHSI 230

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD-FGL-AKLLTLNQSKTIKTA 328
               R LL      +  ++          L +  NA+  + F L  K+L   + K +   
Sbjct: 231 QAELRRLLKSKPYENCLLV----------LLNVQNAKAWNAFNLSCKILLTTRFKQVTDF 280

Query: 329 IRGTKGYVAPEWYRKSTIT--------AKV----------DVYSFGVLLLEIISCRKSFD 370
           +           +   T+T         K           +V +     L II+      
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340

Query: 371 IEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM--------NDIKCVEKLLMVSIWC-- 420
           +   + +  +            L+ L   +   M                LL + IW   
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL-IWFDV 399

Query: 421 IQEDP 425
           I+ D 
Sbjct: 400 IKSDV 404

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 5e-05
 Identities = 39/282 (13%), Positives = 79/282 (28%), Gaps = 72/282 (25%)

Query: 181 YKGVIETTRTSTTAVAVKKLD-RVFQDGEKE-FKNEVV--VIGQTHHKNLVRLLGFCDEG 236
           YK ++     +     V   D +  QD  K     E +  +I      +    L +    
Sbjct: 18  YKDILSVFEDAF----VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73

Query: 237 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDIK 294
           +   +V +F+      ++ F  L             + R  +   +     +Q+      
Sbjct: 74  KQEEMVQKFVEEVLRINYKF--LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV----FA 127

Query: 295 PQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV---- 350
             N+     Y           LL L  +K +   I G  G        K+ +   V    
Sbjct: 128 KYNVSRLQPYLKLRQ-----ALLELRPAKNV--LIDGVLG------SGKTWVALDVCLSY 174

Query: 351 ---DVYSFGVLLLEIISCRKSFDI-EM------------------GEEYAILTDWAFD-- 386
                  F +  L + +C     + EM                       +         
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234

Query: 387 ----CYRNGK-----LDDLVEGDMEAMN--DIKCVEKLLMVS 417
                 +  +     L + V+ + +A N  ++ C  K+L+ +
Sbjct: 235 RRLLKSKPYENCLLVLLN-VQ-NAKAWNAFNLSC--KILLTT 272

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	455
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.52
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.45
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.23
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.88
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.74
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.7
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.66
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.0
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.97
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.96
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.87
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.76
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.59
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.32
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.24
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.88
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.19
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.09
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.74
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	86.21
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.19
2ll3_A	82	Micronemal protein 4; cell adhesion; NMR {Toxoplas	85.44
3hms_A	101	Hepatocyte growth factor; HGF/SF, hormone/growth f	82.77

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-60  Score=453.24  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=217.3

Q ss_pred             HHHHHHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC
Q 037780          160 ALEEATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG  236 (455)
Q Consensus       160 ~l~~~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  236 (455)
                      ++..++..|.++||+|+||+||+|.+..  ....++.||||+++... ....++|.+|+.++++++|||||+++|+|.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            3444556788999999999999999853  22456889999996543 33457899999999999999999999999999


Q ss_pred             CeEEEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          237 QNRLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      +..+||||||++|+|.++|...                ..++|.+++.|+.|||+||+|||+.   +||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            9999999999999999999642                3589999999999999999999964   99999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAI  379 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~  379 (455)
                      ++++++||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||......+   
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---  255 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---  255 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999997765444333355679999999999999999999999999999999999 899997654321   


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                          +...+..+....         .+.+++..+.+++..||+.||++||||.+|++.|+....
T Consensus       256 ----~~~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          256 ----VVEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             ----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             ----HHHHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence                222233332221         122456789999999999999999999999999987543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-59  Score=451.93  Aligned_cols=259  Identities=25%  Similarity=0.446  Sum_probs=207.5

Q ss_pred             hhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.++||+|+||+||+|.+..  ...++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            355789999999999999863  234578999999987666667889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEe
Q 037780          245 FLNNGTLASFLFGN---------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS  309 (455)
Q Consensus       245 ~~~~gsL~~~l~~~---------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  309 (455)
                      ||++|+|.++++..               ..++|.+++.|+.|||+||+|||+.   +|+||||||+||||++++++||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence            99999999999653               3589999999999999999999954   99999999999999999999999


Q ss_pred             eccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHh
Q 037780          310 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCY  388 (455)
Q Consensus       310 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  388 (455)
                      |||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+       +...+
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~i  273 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDCI  273 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HHHHH
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence            9999997765544433355679999999999999999999999999999999999 999997654321       11222


Q ss_pred             hcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       389 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ..+...         ..+..++..+.+++..||+.||++||||.||++.|+.+.+.
T Consensus       274 ~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 TQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            222211         11223567889999999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.8e-60  Score=448.01  Aligned_cols=258  Identities=24%  Similarity=0.479  Sum_probs=214.2

Q ss_pred             hhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.++||+|+||+||+|.+..  ...++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            456889999999999999863  224578899999987666667889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          245 FLNNGTLASFLFGN-------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                      ||++|+|.++|+..             ..++|.+++.|+.|||+||+|||+.   +|+||||||+||||++++++||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence            99999999999653             4689999999999999999999964   9999999999999999999999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......+       +...+..
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~i~~  245 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQ  245 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHc
Confidence            99987655444333344569999999999999999999999999999999999 999997654321       2222233


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      +....         .+..++.++.+++..||+.||++||||.+|++.|+++.+
T Consensus       246 ~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          246 GRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            32211         122356788999999999999999999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-57  Score=428.49  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=200.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .|.++||+|+||+||+|.+.      ..||||.++...  .+..+.|.+|+.++++++|||||+++|+|.+ +..+||||
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEEC------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            46688999999999999864      248999886432  3345679999999999999999999999865 56899999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||++|+|.++|+.. ..++|.+++.|+.|||+||+|||+.   +||||||||+||||++++++||+|||+|+........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999764 6799999999999999999999964   9999999999999999999999999999976644433


Q ss_pred             cccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .......||+.|||||++.+   +.++.++|||||||+||||+||+.||.......      .+...+..+..    .+.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~----~p~  258 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA----SPD  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----CCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----CCC
Confidence            33355679999999999864   468999999999999999999999997544321      11222222211    111


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      +. ..+.+++..+.+++..||+.||++||||.+|++.|+.+.
T Consensus       259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            11 112235678899999999999999999999999998654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-55  Score=414.81  Aligned_cols=247  Identities=27%  Similarity=0.418  Sum_probs=199.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec----CCeEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~  240 (455)
                      .|.++||+|+||+||+|.+.   ..+..||+|++....  ....+.|.+|+.++++++|||||++++++.+    ....+
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC---CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            35678999999999999987   456789999986432  3335679999999999999999999999865    34579


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||||||++|+|.+++.....+++..+..|+.||+.||+|||++ .++|+||||||+||||+ .++.+||+|||+|+....
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999999999888999999999999999999999965 23499999999999998 479999999999986543


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ..    ....+||+.|||||++.+ .++.++|||||||+||||+||+.||.......      .+...+..+......+ 
T Consensus       185 ~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~~~~-  252 (290)
T 3fpq_A          185 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFD-  252 (290)
T ss_dssp             TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGGG-
T ss_pred             Cc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCCCCC-
Confidence            22    245679999999999865 69999999999999999999999997543211      1222222222211111 


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ...+.++.+++..||+.||++|||+.|+++
T Consensus       253 -------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   112356889999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-56  Score=434.46  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=213.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEecccccc-ccHHHHHHHHHHHcccCC-CCceeeeeeEecC-CeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEG-QNR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~-~~~  239 (455)
                      .+.+.++||+|+||+||+|.+...+  ...+.||||++..... ...++|.+|+.+|.+++| ||||+++|+|.+. +..
T Consensus        65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~  144 (353)
T 4ase_A           65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  144 (353)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence            4456678999999999999987543  3457899999976433 335679999999999965 8999999999764 568


Q ss_pred             EEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          240 LLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      ++|||||++|+|.++|+..                ..++|.+++.|+.|||+||+|||+.   +||||||||+|||++++
T Consensus       145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK  221 (353)
T ss_dssp             EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCC
Confidence            9999999999999999642                3479999999999999999999954   99999999999999999


Q ss_pred             CcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHH
Q 037780          304 YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  382 (455)
                      +.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||.......      
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------  295 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------  295 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------
Confidence            9999999999998765554444455679999999999999999999999999999999998 999997644321      


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+...+..+....         .+..++.++.+++..||+.||++||||.+|++.|+.+++
T Consensus       296 ~~~~~i~~g~~~~---------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          296 EFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            1222333332211         122345678999999999999999999999999988754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.7e-55  Score=417.53  Aligned_cols=266  Identities=21%  Similarity=0.277  Sum_probs=200.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC----eEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lv  242 (455)
                      .+.++||+|+||+||+|.+.     ++.||||+++... .....+..|+..+.+++|||||+++|+|.+++    ..+||
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~~-----g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            34578999999999999873     6789999997532 22223455677778899999999999997654    57999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ||||++|+|.++|+. ..++|..+.+|+.|+++||+|||+++     .++|+||||||+||||++++++||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999975 46899999999999999999999652     458999999999999999999999999999876


Q ss_pred             cCCCCcc--ccccccccCcccccccccCC------CCCCCCCeecHHHHHHHHHhCCCCCCccccchh--------hhhH
Q 037780          318 TLNQSKT--IKTAIRGTKGYVAPEWYRKS------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AILT  381 (455)
Q Consensus       318 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--------~~~~  381 (455)
                      .......  ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+........        ....
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            5443221  12345799999999998754      467899999999999999999988754332110        0011


Q ss_pred             HHHHHHhhcCcccccccccccc-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          382 DWAFDCYRNGKLDDLVEGDMEA-MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .........+..    ++.+.. ..+.+.++.+.+++.+||+.||++||||.+|++.|+.+.+
T Consensus       239 ~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            112222222211    111111 1233567889999999999999999999999999988653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.4e-55  Score=421.52  Aligned_cols=248  Identities=25%  Similarity=0.353  Sum_probs=207.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.++||+|+||+||+|...   .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVR---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEeecCcCeEEEEEEEC---CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            345578999999999999987   45788999999766555667799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      |++|+|.+++.. ..+++.++..|+.||+.||+|||++   +|+||||||+||||+.++++||+|||+|+.+......  
T Consensus       153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~--  226 (346)
T 4fih_A          153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  226 (346)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred             CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence            999999999965 5689999999999999999999965   9999999999999999999999999999977544332  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      ....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+.       ...+..+....+       ..
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~~~~-------~~  292 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPPRL-------KN  292 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSSCCCC-------SC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCCCCC-------Cc
Confidence            2456899999999999999999999999999999999999999976543211       111122111111       11


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+..+.+++..||+.||++|||+.|+++
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1234567899999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.5e-55  Score=419.02  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=199.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.++||+|+||+||+|+..   .+++.||||+++...  ....+.|.+|+.++++++|||||++++++.+++..||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKST---EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             EEEEEEC------CEEEEEET---TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            456688999999999999986   457889999986542  233567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++|+|.++|...  ..+++.+.+.|+.||+.||+|||+.   +|+||||||+||||+.++++||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999999644  4578999999999999999999964   99999999999999999999999999998765322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                        ......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+      ... .+..+....+     
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~-~i~~~~~~~~-----  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVL-KIISGSFPPV-----  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHH-HHHHTCCCCC-----
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHH-HHHcCCCCCC-----
Confidence              12245679999999999999999999999999999999999999997654321      111 1222222111     


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          +...+..+.+++..||+.||++|||+.|+++
T Consensus       246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1224567899999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.8e-54  Score=415.17  Aligned_cols=256  Identities=22%  Similarity=0.236  Sum_probs=205.3

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.++||+|+||+||+|++.   ..++.||||+++....     +.+|+.++++++|||||++++++.+++..|||||||+
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~---~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDK---QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             EEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             eCcEeccCCCeEEEEEEEC---CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            4467999999999999987   4578899999965322     2469999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccCCCCcc--
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLNQSKT--  324 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~--  324 (455)
                      +|+|.++|.....+++.++..|+.||+.||+|||   +.+|+||||||+||||+.++ ++||+|||+|+.+.......  
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            9999999988889999999999999999999999   45999999999999999987 69999999999876443211  


Q ss_pred             -ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 -IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                       .....+||+.|||||++.+..++.++|||||||+||||+||+.||.........   .   .. ..+...      . .
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i-~~~~~~------~-~  276 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---L---KI-ASEPPP------I-R  276 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---H---HH-HHSCCG------G-G
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---H---HH-HcCCCC------c-h
Confidence             123457999999999999999999999999999999999999999765442211   1   11 111110      0 0


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC----cCCCCCC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV----VEVDVPP  448 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~----~~~~~p~  448 (455)
                      ..+...+..+.+++..||+.||.+|||+.|+++.|...    ..+..|+
T Consensus       277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw  325 (336)
T 4g3f_A          277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW  325 (336)
T ss_dssp             GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred             hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence            11223467788999999999999999999999877653    3344554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-54  Score=412.03  Aligned_cols=246  Identities=22%  Similarity=0.282  Sum_probs=209.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|+..   .+++.||||.+++.   .....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~---~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cEEEEEEecccCeEEEEEEEC---CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            566789999999999999987   45788999998643   233456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++.+...++.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999999888999999999999999999999965   999999999999999999999999999998765544


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .......+||+.|||||++.+..++.++||||+||+||||+||+.||......+       +...+..+...        
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~--------  252 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEYD--------  252 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--------
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence            444456789999999999999999999999999999999999999997654321       11122222221        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV  434 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v  434 (455)
                        .+...+.++.+++..||+.||++|||+.|+
T Consensus       253 --~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          253 --FPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             --CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             --CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence              111234678899999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.7e-54  Score=422.00  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .+.++||+|+||.||+|...   .+++.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus       154 ~~~~~iG~G~fG~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          154 DNFIKIGEGSTGIVCIATVR---SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             EEEEEEEECSSCEEEEEEET---TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EeeeEeccCcCcEEEEEEEC---CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            34568999999999999987   457889999997665556677999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      ++|+|.+++.. ..+++.++..|+.||+.||+|||++   +|+||||||+||||+.++.+||+|||+|+.+......  .
T Consensus       231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~--~  304 (423)
T 4fie_A          231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R  304 (423)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--B
T ss_pred             CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--c
Confidence            99999999865 4689999999999999999999965   9999999999999999999999999999977544332  2


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...+||+.|||||++.+..|+.++|||||||+||||++|+.||......+       +...+..+....+     .  ..
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~~~~-----~--~~  370 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDNLPPRL-----K--NL  370 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSCCCCC-----S--CT
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCCCC-----c--cc
Confidence            45679999999999999999999999999999999999999997554321       1111222211111     1  11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...+..+.+++..||+.||++|||+.|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            123567889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.1e-53  Score=395.69  Aligned_cols=244  Identities=25%  Similarity=0.356  Sum_probs=191.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||+++...   ....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHT---TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECT---TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            556789999999999999876   457889999986432   23356799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+ +|+|.+++.....+++.+...++.||+.||+|||++   +|+||||||+|||+++++++||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence            9999 689999998888999999999999999999999965   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                         .....||+.|+|||++.+..+ +.++||||+||+||||+||+.||.......       ..+.+..+...       
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~~~~-------  230 (275)
T 3hyh_A          168 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNGVYT-------  230 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-------
T ss_pred             ---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence               244679999999999998876 579999999999999999999997544321       11222222211       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         .+...+..+.+++..||+.||++|||+.|+++
T Consensus       231 ---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 ---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               01123467889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.9e-54  Score=407.37  Aligned_cols=249  Identities=24%  Similarity=0.270  Sum_probs=199.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|+...++..++.||||.++...  ......+.+|+.++++++|||||++++++.+++..|+||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            567789999999999999986655677899999986532  223446889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++.++..++.||+.||+|||++   +|+||||||+|||+++++++||+|||+|+........
T Consensus       106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            9999999999999888999999999999999999999964   9999999999999999999999999999875443322


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        ....+||+.|||||++.+..++.++|||||||+||||+||+.||......+.       ...+.++...         
T Consensus       183 --~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~~---------  244 (304)
T 3ubd_A          183 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTMILKAKLG---------  244 (304)
T ss_dssp             --CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC---------
T ss_pred             --ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHHHHcCCCC---------
Confidence              2456799999999999999999999999999999999999999986543221       1111122111         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTM-----RKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~~v~~  436 (455)
                       .+...+.++.+++..||+.||++|||+     +|+++
T Consensus       245 -~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 -MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             111235678899999999999999994     56664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.9e-51  Score=386.66  Aligned_cols=247  Identities=22%  Similarity=0.353  Sum_probs=185.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCC-------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-------  237 (455)
                      +.+.+.||+|+||+||+|+..   .+++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEET---TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             CEEeeEEecCCCeEEEEEEEC---CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            345678999999999999986   4568899999865433 33467999999999999999999999986544       


Q ss_pred             -----eEEEEEEeCCCCCHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEe
Q 037780          238 -----NRLLVYEFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS  309 (455)
Q Consensus       238 -----~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  309 (455)
                           ..|+||||+++|+|.+++.....   .++..++.|+.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                 36899999999999999987643   45677889999999999999964   99999999999999999999999


Q ss_pred             eccCcccccCCCCcc----------ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh
Q 037780          310 DFGLAKLLTLNQSKT----------IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI  379 (455)
Q Consensus       310 Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~  379 (455)
                      |||+|+.........          ..+..+||+.|||||++.+..++.++|||||||+||||++   ||......    
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~----  233 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER----  233 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH----
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH----
Confidence            999999775433211          1134579999999999999999999999999999999997   77532211    


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       .. .............         .......+.+++.+||+.||++|||+.|+++
T Consensus       234 -~~-~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 -VR-TLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HH-HHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HH-HHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00 1111122222111         1123345678999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-48  Score=377.73  Aligned_cols=272  Identities=35%  Similarity=0.632  Sum_probs=236.8

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      +.+.||+|+||+||+|.+.    ++..||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  118 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME  118 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred             ccceeecCCCeeEEEEEEC----CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence            3467999999999999864    467899999877666667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          248 NGTLASFLFGNL----KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       248 ~gsL~~~l~~~~----~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +|+|.+++....    .++|..++.|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred             CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999997643    589999999999999999999964   9999999999999999999999999999875543333


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .......||+.|+|||++.+..++.++||||||+++|||+||+.||....+.+......|.......+.+...+++.+..
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD  275 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred             ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence            22244568999999999998899999999999999999999999998776655556667777777777778888877776


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCCC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV  446 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~~  446 (455)
                      ....+.+..+.+++..||+.||++|||+.+|++.|+.+..+..
T Consensus       276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            6777889999999999999999999999999999998766543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.9e-49  Score=379.80  Aligned_cols=285  Identities=42%  Similarity=0.724  Sum_probs=243.3

Q ss_pred             cccccCHHHHHHHHHhhh--hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCcee
Q 037780          152 NLRCFSYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVR  228 (455)
Q Consensus       152 ~~~~~~~~~l~~~t~~f~--~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  228 (455)
                      ....|++.++...+.+|.  +.||+|+||.||+|...    ++..||||++..... .....+.+|+.++++++||||++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence            456789999998888775  67999999999999753    577899999875432 22346899999999999999999


Q ss_pred             eeeeEecCCeEEEEEEeCCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          229 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       229 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      +++++...+..++||||+++|+|.+++...    ..++|..+..|+.|++.||+|||+.+..+|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            999999999999999999999999999764    3489999999999999999999976666999999999999999999


Q ss_pred             cEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc--chhhhhHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG--EEYAILTD  382 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~--~~~~~~~~  382 (455)
                      .+||+|||+++.......... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ........
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  250 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD  250 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred             CEEeccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence            999999999987754443322 445699999999999988999999999999999999999999964321  23344566


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      |............+.+..+........+..+.+++..||+.||.+|||+.+|++.|++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            77777777778888888887778888999999999999999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-49  Score=388.48  Aligned_cols=265  Identities=21%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec------CC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQ  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~  237 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||++....  ....+.+.+|+.+|++++|||||++++++..      .+
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~---~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRR---LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             eEEEEEEecccCeEEEEEEEC---CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            456689999999999999987   457899999996543  2334668899999999999999999998753      46


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..|||||||+ |+|.+++.....+++..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            7899999995 68999999989999999999999999999999954   9999999999999999999999999999876


Q ss_pred             cCCC--CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          318 TLNQ--SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       318 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      ....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....   +..........
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~p~~~  285 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGTPSPA  285 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCCGG
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCCChH
Confidence            4332  12222456899999999998775 569999999999999999999999986554221111   11110000000


Q ss_pred             -----------ccccccc-ccCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          395 -----------DLVEGDM-EAMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       395 -----------~~~~~~l-~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                                 ..+.... ....+     ......+.+++..||+.||++|||+.|+++  .+.+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence                       0000000 00000     012457889999999999999999999986  3544

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.5e-48  Score=376.26  Aligned_cols=200  Identities=22%  Similarity=0.331  Sum_probs=170.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.++||+|+||+||+|+.+.....++.||+|++...  .....+.+|+++|.++ +|||||++++++.+.++.++|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            45567899999999999998654456789999998653  3456788999999998 69999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++.   .+++.+...++.|++.||+|||+.   +|+||||||+|||++.+ +.+||+|||+|+........
T Consensus       101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            999999999984   589999999999999999999964   99999999999999877 79999999999865433211


Q ss_pred             --------------------------cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccc
Q 037780          324 --------------------------TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEM  373 (455)
Q Consensus       324 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~  373 (455)
                                                ...+..+||++|+|||++.+. .++.++||||+||++|||+||+.||....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                      011335699999999999775 58999999999999999999999996544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-47  Score=395.37  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=206.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|...   .+++.||+|.+........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~---~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            456788999999999999987   45678999999766555567799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC--CcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH--YNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |++|+|.++|... ..+++.++..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+|+.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999999654 6789999999999999999999965   99999999999999854  8999999999998764432


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ...+||+.|+|||++.+..++.++||||+||+||||++|+.||......+.       ...+..+... +.+.   
T Consensus       313 ~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~~-~~~~---  378 (573)
T 3uto_A          313 V---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN-MDDS---  378 (573)
T ss_dssp             E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCC-CCSG---
T ss_pred             e---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCCC-CCcc---
Confidence            2   445799999999999999999999999999999999999999976554221       1111222111 0011   


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .....+..+.+|+..||+.||.+|||+.|+++
T Consensus       379 --~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          379 --AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              01123567889999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-47  Score=391.28  Aligned_cols=246  Identities=24%  Similarity=0.262  Sum_probs=198.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHH---HHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFK---NEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.||+|+||+||+|...   .+++.||+|++++..   ......+.   .++.+++.++|||||++++++.+.+..|
T Consensus       192 ~i~k~LG~G~fG~V~la~~~---~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             EEEEEEecccCeEEEEEEEC---CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            45578999999999999987   457899999986431   22233333   4467778889999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |||||++||+|.++|.....+++..+..++.||+.||+|||   +.+||||||||+||||+.+|++||+|||+|+.+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            99999999999999998889999999999999999999999   559999999999999999999999999999877544


Q ss_pred             CCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ..    ...+||+.|||||++.. ..|+.++|+||+||+||||++|+.||..........+    .........      
T Consensus       346 ~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i----~~~i~~~~~------  411 (689)
T 3v5w_A          346 KP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAV------  411 (689)
T ss_dssp             CC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH----HHHHHHCCC------
T ss_pred             CC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhhcCCCC------
Confidence            32    34679999999999975 5799999999999999999999999976543221111    111111111      


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                          ..+...+..+.+++..||+.||.+|++     +.+|++
T Consensus       412 ----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                111224567889999999999999998     577664

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.7e-47  Score=364.25  Aligned_cols=260  Identities=28%  Similarity=0.432  Sum_probs=199.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|..     .+..||||++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        39 y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            34557899999999999976     35679999986543  233467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          244 EFLNNGTLASFLFGNLK---PSWNLRTNIAFQIARGLLYLHEDCSSQ--IIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~---~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ||+++|+|.+++.....   +++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999987653   89999999999999999999954   6  9999999999999999999999999998654


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      .....  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      ..........    
T Consensus       191 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~------~~~~~~~~~~----  258 (309)
T 3p86_A          191 STFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV------AAVGFKCKRL----  258 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHHHHSCCCC----
T ss_pred             ccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCCC----
Confidence            33221  13456999999999999999999999999999999999999999765432211      1110111111    


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNP  450 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~~p~~p  450 (455)
                           ..+...+..+.+++..||+.+|.+|||+.++++.|+.+.+-..||.+
T Consensus       259 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~  305 (309)
T 3p86_A          259 -----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN  305 (309)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred             -----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence                 11123456788999999999999999999999999998776555444

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=363.16  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=209.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|.+.   .++..+|+|++........+.|.+|+.++.+++||||+++++++.+++..++||||
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHR---ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEET---TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeccceecCCCCEEEEEEEEC---CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            345678999999999999986   35678999998766666677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++.. ...+++.+++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999986 57789999999999999999999965   99999999999999999999999999998765433211


Q ss_pred             c------------cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          325 I------------KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       325 ~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      .            .....||+.|+|||.+.+..++.++||||||+++|||++|..|+............          .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~  235 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------N  235 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------C
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------h
Confidence            0            11456999999999999999999999999999999999999998754432111000          0


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .....+    ...+...+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus       236 ~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          236 VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            000000    01112234568899999999999999999999999987643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.9e-47  Score=364.64  Aligned_cols=261  Identities=23%  Similarity=0.416  Sum_probs=212.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|.+..++..+..||||++.... ....+.|.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  130 (325)
T 3kul_A           51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE  130 (325)
T ss_dssp             EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred             eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence            344578999999999999998776677889999997542 3345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++... ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred             CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence            99999999999654 6789999999999999999999965   9999999999999999999999999999877544322


Q ss_pred             c-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          324 T-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       324 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      . ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......       ....+..+..        
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~--------  272 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYR--------  272 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC--------
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCC--------
Confidence            1 1123346788999999998899999999999999999999 999997554322       1111112111        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                       ...+...+..+.+++..||+.||.+|||+.+|++.|+.+.+.+
T Consensus       273 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          273 -LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence             1112234578899999999999999999999999999876544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.7e-46  Score=366.97  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=211.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc----CCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT----RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  239 (455)
                      +.+.+.||+|+||.||+|.+...    ...+..||||.+.... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  162 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  162 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence            44567899999999999998532    2356789999997543 23356799999999999 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          240 LLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      ++||||+++|+|.+++....                .+++..++.++.||+.||+|||+.   +|+||||||+|||++.+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCC
Confidence            99999999999999997542                478999999999999999999965   99999999999999999


Q ss_pred             CcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHH
Q 037780          304 YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  382 (455)
                      +.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+.     
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-----  314 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-----  314 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence            9999999999987654433332244567889999999999999999999999999999999 9999976543221     


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                        ...+..+...         ..+...+..+.+++..||+.+|.+|||+.++++.|+.++.
T Consensus       315 --~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          315 --FKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --HHHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              1112222111         1122345678999999999999999999999999998654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-45  Score=351.23  Aligned_cols=279  Identities=39%  Similarity=0.648  Sum_probs=226.5

Q ss_pred             cccccCHHHHHHHHHhhhh--------hcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHc
Q 037780          152 NLRCFSYKALEEATDNFKE--------EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIG  219 (455)
Q Consensus       152 ~~~~~~~~~l~~~t~~f~~--------~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~  219 (455)
                      ....|++.++.+++.+|.+        .||+|+||.||+|..     .+..+|||++....    ....+.+.+|+.+++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~   85 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA   85 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----CCceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence            4578999999999999974        499999999999985     35689999986432    233567999999999


Q ss_pred             ccCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 037780          220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQ  296 (455)
Q Consensus       220 ~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~  296 (455)
                      +++||||+++++++.+.+..++||||+++++|.+++..   ...++|..++.|+.|++.||.|||+.   +|+||||||+
T Consensus        86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~  162 (307)
T 2nru_A           86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA  162 (307)
T ss_dssp             HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred             hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHH
Confidence            99999999999999999999999999999999999864   35689999999999999999999965   9999999999


Q ss_pred             CEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch
Q 037780          297 NILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE  376 (455)
Q Consensus       297 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~  376 (455)
                      ||++++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  241 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ  241 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence            99999999999999999987654433333344569999999998865 58999999999999999999999997654322


Q ss_pred             hhhhHHHHHHHhh-cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          377 YAILTDWAFDCYR-NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       377 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .  +..+...... ...+...+++.+. ......+..+.+++..||+.+|.+|||+.+|++.|+++.
T Consensus       242 ~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          242 L--LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             B--TTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             H--HHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1  1111111111 1223334444332 235567889999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.7e-46  Score=353.47  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBT---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeeeccCCCeEEEEEEEC---CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            344578999999999999865   45788999998766666677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++... .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......... 
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-  173 (297)
T 3fxz_A           99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-  173 (297)
T ss_dssp             CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB-
T ss_pred             CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc-
Confidence            9999999999754 689999999999999999999965   99999999999999999999999999998765443322 


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .......+.. .+       ..
T Consensus       174 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~-~~-------~~  238 (297)
T 3fxz_A          174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL-------QN  238 (297)
T ss_dssp             -CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CC-------SC
T ss_pred             -CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC-CC-------CC
Confidence             445699999999999999999999999999999999999999975543211      1111111111 01       11


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +...+..+.+++..||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            2234567889999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.6e-45  Score=354.09  Aligned_cols=261  Identities=25%  Similarity=0.343  Sum_probs=214.3

Q ss_pred             ccccCHHHHHHHHHhh------------hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc
Q 037780          153 LRCFSYKALEEATDNF------------KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ  220 (455)
Q Consensus       153 ~~~~~~~~l~~~t~~f------------~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~  220 (455)
                      ...++++++..++..+            .+.||+|+||.||+|...   .+++.||||++........+.+.+|+.++++
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~---~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK---HSGRQVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC---CCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            3568999999888642            346999999999999986   3578899999976666667789999999999


Q ss_pred             cCCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       221 l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      ++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.   +|+||||||+|||+
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            9999999999999999999999999999999999864 5689999999999999999999964   99999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL  380 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~  380 (455)
                      +.++.+||+|||+++.........  ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----  248 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----  248 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred             CCCCcEEEeeeeeeeecccCcccc--ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence            999999999999998765433221  34569999999999999999999999999999999999999997544321    


Q ss_pred             HHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ....+.......+.       .....+..+.+++..||+.||++|||+.++++
T Consensus       249 ---~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          249 ---AMKRLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ---HHHHHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               11111111111110       11123567889999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.9e-46  Score=362.26  Aligned_cols=268  Identities=28%  Similarity=0.361  Sum_probs=206.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC----eEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~l  241 (455)
                      +.+.+.||+|+||+||+|...     +..||||++.... .....+..|+.++.+++||||+++++++....    ..++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhheecccCceEEEEEEEC-----CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            345678999999999999864     5789999986543 33445677999999999999999999998744    4699


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------SSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      ||||+++|+|.+++... .++|..++.|+.|++.||+|||+.+       +.+|+||||||+|||++.++.+||+|||++
T Consensus       100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            99999999999999664 5899999999999999999999421       129999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccC-----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhH--------
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRK-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT--------  381 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~--------  381 (455)
                      +...............||+.|+|||++.+     ..++.++||||||+++|||+||+.||............        
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            87765444333344679999999999976     35667899999999999999999999765432211111        


Q ss_pred             -HHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          382 -DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       382 -~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       ...............+..   .......+..+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             011111111111111111   01123467789999999999999999999999999987653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-46  Score=367.20  Aligned_cols=259  Identities=24%  Similarity=0.439  Sum_probs=199.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|.+......+..||||++.... ....++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            345578999999999999987555567889999997543 3345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++.+++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       127 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            99999999999765 4789999999999999999999965   9999999999999999999999999999876544322


Q ss_pred             cc-cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          324 TI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       324 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. .....+|..|+|||++.+..++.++||||||+++|||++ |+.||.......       ....+..+.         
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~---------  267 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGY---------  267 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTE---------
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence            11 122335788999999999999999999999999999998 999997544321       111111111         


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ....+...+..+.+++..||+.+|.+|||+.+|+++|+.+..
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            111122346788999999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-45  Score=350.03  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=207.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++...   ..+..||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDT---ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEEC---CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            445678999999999999876   356789999985432   23346789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            99999999999998888899999999999999999999965   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      ... ....||+.|+|||.+.+..++.++||||||+++|||+||+.||........      ........ .....     
T Consensus       167 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~~~-----  233 (294)
T 4eqm_A          167 TQT-NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VPNVT-----  233 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CCCHH-----
T ss_pred             ccc-CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CCCcc-----
Confidence            221 345699999999999999999999999999999999999999976543211      11111111 11110     


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcCcCCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-TMRKVSQMLEGVVEVD  445 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~~v~~~L~~~~~~~  445 (455)
                      .......+..+.+++..||+.||.+|| +++++.+.|+.+....
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            011122456789999999999999998 9999999999876544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.6e-46  Score=364.22  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=209.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCe-EE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN-RL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~-~~  240 (455)
                      +.+.+.||+|+||.||+|.+..  ....++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+. .+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            3445789999999999999764  335678999999975432 3346799999999999 79999999999987654 89


Q ss_pred             EEEEeCCCCCHHHHhcCCCC------------------------------------------------------------
Q 037780          241 LVYEFLNNGTLASFLFGNLK------------------------------------------------------------  260 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------  260 (455)
                      +||||+++|+|.+++.....                                                            
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999976532                                                            


Q ss_pred             ------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCc
Q 037780          261 ------PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG  334 (455)
Q Consensus       261 ------~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  334 (455)
                            +++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...............||+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence                  88999999999999999999965   999999999999999999999999999987655443333345668999


Q ss_pred             ccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHH
Q 037780          335 YVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL  413 (455)
Q Consensus       335 y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  413 (455)
                      |+|||++.+..++.++||||||+++|||+| |+.||........      ....+..+.....         +......+
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~l  325 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA---------PDYTTPEM  325 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCCC---------CTTCCHHH
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCCC---------CCCCCHHH
Confidence            999999999999999999999999999998 9999976543221      1122222211111         11234678


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          414 LMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       414 ~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+++..||+.||.+|||+.+|++.|+.+++
T Consensus       326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            899999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-46  Score=358.00  Aligned_cols=267  Identities=24%  Similarity=0.413  Sum_probs=207.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  241 (455)
                      .+.+.+.||+|+||+||+|.+.. ....+..||||++........+.+.+|+.++.+++||||+++++++...  ...++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   90 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL   90 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence            44566889999999999998642 2246789999999876666667899999999999999999999998553  46899


Q ss_pred             EEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+++++|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.....
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            99999999999999765 4589999999999999999999964   9999999999999999999999999999876543


Q ss_pred             CCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch---------hhhhHHHHHHHhhc
Q 037780          321 QSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE---------YAILTDWAFDCYRN  390 (455)
Q Consensus       321 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~---------~~~~~~~~~~~~~~  390 (455)
                      ... .......+|..|+|||.+.+..++.++||||||+++|||+||..|+.....+.         ...........+..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            321 11233457788999999999999999999999999999999999986432210         00011111111111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      +.         ....+...+..+.+++..||+.||++|||+.++++.|+.+.+
T Consensus       248 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          248 NG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            11         111223456789999999999999999999999999988653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-45  Score=357.63  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCC-CceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRT-STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|.+..++. ....||+|.+.... ....+.|.+|+.++++++||||++++++|..+. .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            4455789999999999999864432 23357899885432 345678999999999999999999999998764 78999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++.. ...+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            99999999999976 46789999999999999999999965   999999999999999999999999999988765544


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ........+|..|+|||++.+..++.++||||||+++|||+| |+.||.........       ..+..+..        
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~--------  237 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER--------  237 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC--------
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCC--------
Confidence            333344557889999999999999999999999999999999 99999765443211       11111111        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       ...+...+..+.+++..||+.+|.+|||+.++++.|+.+..
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 -LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             11122345678899999999999999999999999987543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.1e-46  Score=367.71  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=207.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|.+.   .++..||||.+..... .....|.+|+.++++++||||+++++++...+..++|||
T Consensus       116 ~~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          116 LVLGEQIGRGNFGEVFSGRLR---ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eEEeeEeccCCCCeEEEEEEe---cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            345678999999999999986   3567899999875432 233568999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999764 4689999999999999999999965   9999999999999999999999999999865433222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .......++..|+|||.+....++.++||||||+++|||+| |+.||.......       ....+..+...        
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--------  334 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRL--------  334 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCC--------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence            11122335778999999998899999999999999999998 999997654321       11222222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                       ..+..++..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       335 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          335 -PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence             112224567889999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=362.98  Aligned_cols=262  Identities=28%  Similarity=0.410  Sum_probs=213.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC----CCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||+||+|......    ..+..||||++.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  149 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP  149 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence            4456688999999999999986432    345689999987543 23346799999999999 99999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 037780          239 RLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD  302 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  302 (455)
                      .++||||+++|+|.+++....                .+++..++.|+.|++.||+|||+.   +|+||||||+|||+++
T Consensus       150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  226 (382)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcC
Confidence            999999999999999997543                489999999999999999999965   9999999999999999


Q ss_pred             CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhH
Q 037780          303 HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT  381 (455)
Q Consensus       303 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~  381 (455)
                      ++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+     
T Consensus       227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-----  301 (382)
T 3tt0_A          227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-----  301 (382)
T ss_dssp             TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred             CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999987765443333344567899999999999999999999999999999999 999997554321     


Q ss_pred             HHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          382 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                        ....+..+....         .+...+..+.+++..||+.+|++|||+.+|++.|+.+....
T Consensus       302 --~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          302 --LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             --HHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             --HHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence              122222222111         11224567899999999999999999999999999876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.7e-45  Score=353.01  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=204.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHI---LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            345678999999999999986   356789999986542  234566889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++....... 
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  169 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-  169 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence            9999999999998888899999999999999999999965   999999999999999999999999999987654332 


Q ss_pred             cccccccccCcccccccccCCCCC-CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                        .....||+.|+|||++.+..++ .++|||||||++|||++|+.||.......       ....+..+...        
T Consensus       170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~~--------  232 (328)
T 3fe3_A          170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKYR--------  232 (328)
T ss_dssp             --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------
T ss_pred             --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC--------
Confidence              2446799999999999888765 79999999999999999999997654322       11111222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .+...+..+.+++..||+.||.+|||+.++++
T Consensus       233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              11123467889999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=363.51  Aligned_cols=259  Identities=28%  Similarity=0.397  Sum_probs=207.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||+||+|.+..  ....+..||||++... .......+.+|+.++++++||||+++++++......++
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  151 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  151 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence            44566889999999999999754  2245678999998643 23445679999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeec
Q 037780          242 VYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDF  311 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Df  311 (455)
                      ||||+++|+|.+++...       ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++   .+||+||
T Consensus       152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence            99999999999999653       3589999999999999999999965   999999999999999555   5999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||......+       ....+..
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i~~  301 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTS  301 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHT
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc
Confidence            99986543332222234568999999999999999999999999999999998 999997654322       1112222


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      +...         ..+...+..+.+++..||+.+|.+|||+.+|++.|+.+.
T Consensus       302 ~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          302 GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            2111         111234567889999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-45  Score=346.07  Aligned_cols=255  Identities=24%  Similarity=0.398  Sum_probs=209.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||+|...    ++..||+|.+.... ...+++.+|+.++.+++||||+++++++.+....++|||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             heeeeeeeccCCCceEEEEEec----CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            3455678999999999999875    45679999997543 345779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++... ..+++..++.|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999999765 4589999999999999999999965   9999999999999999999999999999876544332


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .. ....+|+.|+|||.+.+..++.++||||||++++||+| |+.||........       ......+...        
T Consensus       161 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~--------  224 (268)
T 3sxs_A          161 SS-VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-------VLKVSQGHRL--------  224 (268)
T ss_dssp             EC-CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTCCC--------
T ss_pred             cc-cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-------HHHHHcCCCC--------
Confidence            22 33456788999999998899999999999999999999 9999975543221       1111111110        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                       ..+...+..+.+++..||+.+|.+|||+.++++.|+.+.+.
T Consensus       225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence             01112346788999999999999999999999999987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-45  Score=373.53  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=211.8

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.+.+.||+|+||.||+|.+..   .+..||||.+.... ...++|.+|+.++++++||||++++++|......++||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            344566889999999999999873   46789999997543 34678999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          244 EFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       244 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||+++|+|.+++...  ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999999753  5689999999999999999999965   99999999999999999999999999998765433


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ... .....++..|+|||++....++.++||||||++||||+| |+.||........       ...+..+.        
T Consensus       373 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~--------  436 (495)
T 1opk_A          373 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDY--------  436 (495)
T ss_dssp             EEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTTC--------
T ss_pred             eee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC--------
Confidence            221 133456789999999998899999999999999999999 9999976543221       11112211        


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       ....+..++..+.+++..||+.||.+|||+.+|++.|+.+.+
T Consensus       437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             111222346788999999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-45  Score=356.51  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=211.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|......  ..+..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  128 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL  128 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence            345578999999999999987432  345889999997543 23356799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 037780          243 YEFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI  298 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  298 (455)
                      |||+++|+|.+++...                        ..+++.+++.|+.|+++||.|||+.   +|+||||||+||
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI  205 (343)
T 1luf_A          129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  205 (343)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence            9999999999999753                        5689999999999999999999965   999999999999


Q ss_pred             EEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchh
Q 037780          299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  377 (455)
Q Consensus       299 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~  377 (455)
                      |++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ 
T Consensus       206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-  284 (343)
T 1luf_A          206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-  284 (343)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred             EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-
Confidence            999999999999999987654332222234568999999999998899999999999999999999 999997544321 


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                            ....+..+.....         +...+..+.+++..||+.+|.+|||+.+|++.|+++.+-
T Consensus       285 ------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          285 ------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             ------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             ------HHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence                  1122223322111         123456789999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-45  Score=345.11  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=207.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|...    ++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ceeeheecCCCccEEEEEEec----CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            445678999999999999975    45679999997543 3457799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999999654 5689999999999999999999965   99999999999999999999999999998765432211


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                       .....+|+.|+|||.+.+..++.++||||||++++||++ |+.||........       ...+..+..         .
T Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~~~---------~  226 (269)
T 4hcu_A          164 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFR---------L  226 (269)
T ss_dssp             -TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCC---------C
T ss_pred             -ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcCcc---------C
Confidence             133457888999999998899999999999999999999 9999976543211       111111110         0


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ..+...+..+.+++..||+.+|.+|||+.++++.|+++.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            1111235678899999999999999999999999998654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.2e-45  Score=350.47  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=211.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|.....  ..++..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            34557899999999999998532  2456889999997543 23446789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCE
Q 037780          243 YEFLNNGTLASFLFGNL------------------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNI  298 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  298 (455)
                      |||+++++|.+++....                        .+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence            99999999999997643                        278999999999999999999965   999999999999


Q ss_pred             EEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchh
Q 037780          299 LLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  377 (455)
Q Consensus       299 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~  377 (455)
                      ++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999987755443333344557889999999998889999999999999999999 9999976544321


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                             ...+..+...         ..+...+..+.+++..||+.||.+|||+.++++.|+++..
T Consensus       262 -------~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          262 -------FNLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             -------HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   1112222111         1122345788999999999999999999999999988653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.8e-45  Score=347.06  Aligned_cols=257  Identities=24%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||.||+|.+..+...+..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   94 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   94 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence            3456688999999999999987665567889999986543 233567999999999999999999999984 45789999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            999999999999765 4689999999999999999999964   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ... ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   .    ..+..+....      
T Consensus       172 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~----~~i~~~~~~~------  237 (281)
T 1mp8_A          172 YKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I----GRIENGERLP------  237 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----HHHHTTCCCC------
T ss_pred             ccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---H----HHHHcCCCCC------
Confidence            211 23446789999999998899999999999999999997 9999976544321   1    1111211111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                         .+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          238 ---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               11234577889999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-45  Score=351.05  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=213.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.+.||+|+||.||+|.+..  ....+..||||.+..... ...+.+.+|+.++.++ +||||+++++++...+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            34566889999999999999753  334678899999975432 3356799999999999 9999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 037780          241 LVYEFLNNGTLASFLFGNL------------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD  302 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  302 (455)
                      +||||+++|+|.+++....                  .+++..++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence            9999999999999997543                  489999999999999999999965   9999999999999999


Q ss_pred             CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhH
Q 037780          303 HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT  381 (455)
Q Consensus       303 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~  381 (455)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........    
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----  256 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----  256 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH----
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH----
Confidence            99999999999988765544333344567889999999998899999999999999999999 9999976543211    


Q ss_pred             HHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          382 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                        .......+..         ...+...+..+.+++..||+.||.+|||+.++++.|+++.+
T Consensus       257 --~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          257 --FYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             --HHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence              1111111111         11112245678999999999999999999999999998653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-45  Score=354.63  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=210.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.+.||+|+||.||+|.....  ...+..||||.+.... ....+.+.+|+.++.++ +||||+++++++...+..+
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  125 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  125 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence            345567899999999999998532  2356789999987532 23456799999999999 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 037780          241 LVYEFLNNGTLASFLFGNL-----------------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQN  297 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  297 (455)
                      +||||+++|+|.+++....                       .+++..++.|+.|++.||+|||+.   +|+||||||+|
T Consensus       126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~N  202 (344)
T 1rjb_A          126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  202 (344)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhh
Confidence            9999999999999997643                       378999999999999999999965   99999999999


Q ss_pred             EEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccch
Q 037780          298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  376 (455)
Q Consensus       298 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~  376 (455)
                      ||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            9999999999999999987765544333345568899999999998899999999999999999998 999997654322


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      .      ....+..+...         ..+...+..+.+++..||+.||.+|||+.+|++.|+.+...
T Consensus       283 ~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          283 N------FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             H------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             H------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            1      11222222111         11122357789999999999999999999999999986543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.6e-45  Score=369.69  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=207.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...+.+.||+|+||+||+|.+.    .+..||||++.... ...+.|.+|+.++++++||||+++++++. .+..++|||
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             HeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3455678999999999999985    45779999997543 45778999999999999999999999986 567899999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++|+|.+++...  ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            99999999999764  3689999999999999999999965   999999999999999999999999999987653221


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      . ......+|..|+|||++....++.++||||||++||||+| |+.||......+.       ...+..+..        
T Consensus       340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~--------  403 (454)
T 1qcf_A          340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGYR--------  403 (454)
T ss_dssp             H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHHHTCC--------
T ss_pred             e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence            1 1133446789999999998899999999999999999999 9999975543221       111122211        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                       ...+..++..+.+++..||+.||++|||+.+|++.|+.+...
T Consensus       404 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          404 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence             011223467889999999999999999999999999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.7e-45  Score=351.95  Aligned_cols=252  Identities=28%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||.+..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceeeeEEecCCCEEEEEEEEC---CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            345578999999999999886   3567899999864322 234568999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999999999999888899999999999999999999964   99999999999999999999999999998765443333


Q ss_pred             ccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...     +......  .      
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~-----~~~~~~~--~------  228 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-----WKEKKTY--L------  228 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH-----HHTTCTT--S------
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH-----Hhccccc--C------
Confidence            3345679999999999987765 77999999999999999999999765432111 111     1111100  0      


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .........+.+++..||+.||.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0111235677899999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.3e-45  Score=353.52  Aligned_cols=260  Identities=22%  Similarity=0.378  Sum_probs=194.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE---
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR---  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~---  239 (455)
                      .+.+.+.||+|+||+||+|.+..++.....||||.+...  .....+.+.+|+.++++++||||+++++++......   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            345568899999999999998755444458999998654  234457799999999999999999999999877665   


Q ss_pred             ---EEEEEeCCCCCHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEee
Q 037780          240 ---LLVYEFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD  310 (455)
Q Consensus       240 ---~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  310 (455)
                         ++|+||+++|+|.+++...      ..+++..++.|+.|++.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence               9999999999999998643      2689999999999999999999965   999999999999999999999999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhh
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+.
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~  253 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------YNYLI  253 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHH
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-------HHHHh
Confidence            999987654443333234457889999999999999999999999999999999 9999976544221       11111


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+...         ..+...+..+.+++..||+.||.+|||+.++++.|++++.
T Consensus       254 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          254 GGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11111         1122345678999999999999999999999999998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-44  Score=349.45  Aligned_cols=246  Identities=23%  Similarity=0.265  Sum_probs=203.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||++...   .+++.||+|.+...   .......+.+|+.++.+++||||+++++++...+..++|
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            345578999999999999986   45678999998653   233456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999999999998888899999999999999999999965   999999999999999999999999999986433222


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......       ....+..+...        
T Consensus       161 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~--------  223 (337)
T 1o6l_A          161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIR--------  223 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------
T ss_pred             c--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence            1  144579999999999999999999999999999999999999997544321       11111111111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                        .+...+..+.+++..||+.||.+||     ++.+|++
T Consensus       224 --~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence              1112356788999999999999999     8999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-44  Score=352.48  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=204.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc------cHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      +.+.+.||+|+||+||++...   .++..+|+|.+......      ..+.+.+|+.++.+++||||+++++++.+....
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~---~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eEEeeEEeeCcCEEEEEEEEC---CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            456688999999999999986   35678999998654321      356799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----cEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~  315 (455)
                      ++||||+++|+|.+++.....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|||+++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999998888899999999999999999999965   999999999999998877    79999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.       ...+..+... 
T Consensus       168 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~~-  236 (361)
T 2yab_A          168 EIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAVSYD-  236 (361)
T ss_dssp             ECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCC-
T ss_pred             EcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCC-
Confidence            76543221   345699999999999998999999999999999999999999976543221       1111122111 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      + ++..    ....+..+.+++..||+.||.+|||+.++++
T Consensus       237 ~-~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 F-DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C-Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0 0000    0123467889999999999999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=346.92  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=204.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc------ccHHHHHHHHHHHcccCCCCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||.||++...   .++..+|+|.+.....      ...+.+.+|+.++.+++||||+++++++.+...
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEET---TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ceEeceEEeeCCCeEEEEEEEC---CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            4566788999999999999986   3567899999865322      135779999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----cEEEeeccCc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGLA  314 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a  314 (455)
                      .++||||+++++|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999998888899999999999999999999964   999999999999999887    8999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      +........   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+..       ..+......
T Consensus       166 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~  235 (326)
T 2y0a_A          166 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANVSAVNYE  235 (326)
T ss_dssp             EECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHTCCC
T ss_pred             eECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHHhcCCC
Confidence            876543221   3456999999999999889999999999999999999999999755432111       111111110


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ....     .....+..+.+++..||+.||.+|||+.++++
T Consensus       236 -~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 -FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -CCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -cCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0000     00123467889999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.6e-45  Score=344.25  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||+||++...    ++..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             HHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            3445688999999999999875    45679999997543 345779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++.. ...+++..++.|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            9999999999976 46789999999999999999999965   9999999999999999999999999999876433221


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      . .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........       ...+..+..         
T Consensus       177 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~---------  239 (283)
T 3gen_A          177 S-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLR---------  239 (283)
T ss_dssp             S-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTCC---------
T ss_pred             c-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-------HHHHhcccC---------
Confidence            1 133457788999999998899999999999999999998 9999976543221       111111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ...+......+.+++..||+.+|.+|||+.++++.|+++.+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            01111234678899999999999999999999999987653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.8e-44  Score=341.11  Aligned_cols=261  Identities=18%  Similarity=0.207  Sum_probs=208.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||.+....  ....+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEeecCCEEEEEEEEC---CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            345678999999999999975   457899999986432  334688999999999 79999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc-----EEEeeccCccccc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN-----ARISDFGLAKLLT  318 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~  318 (455)
                      |+ +++|.+++... ..+++..++.|+.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999864 46899999999999999999999   459999999999999987776     9999999998766


Q ss_pred             CCCCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          319 LNQSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       319 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            443221     123456999999999999999999999999999999999999999875432222111111111111111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ..+.         ...+..+.+++..||+.+|++|||+.+|++.|+++.+.
T Consensus       243 ~~~~---------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          243 RELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHH---------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            1110         12356889999999999999999999999999986643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.6e-44  Score=346.10  Aligned_cols=257  Identities=18%  Similarity=0.179  Sum_probs=204.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||+||+|...   .+++.||||.+....  ....+.+|+.+++++ +||||+++++++...+..++||||
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNL---YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEET---TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEeeccCCceEEEEEEC---CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            45578999999999999975   457899999986432  234688999999999 999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc-----EEEeeccCcccccC
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN-----ARISDFGLAKLLTL  319 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~~  319 (455)
                      + +++|.+++.. ...+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++....
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9 9999999976 46899999999999999999999965   9999999999999999887     99999999987654


Q ss_pred             CCCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          320 NQSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       320 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      .....     ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........................
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  242 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE  242 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence            33221     1134569999999999999999999999999999999999999998654332211111111110000000


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .+     .    ...+ .+.+++..||+.+|.+||++.+|.+.|+++.
T Consensus       243 ~~-----~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          243 VL-----C----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HH-----T----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HH-----h----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            00     0    0123 8899999999999999999999999997643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-44  Score=365.22  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=202.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|.+.    ....||||.+.... ...++|.+|+.++++++||||+++++++.+ +..++||||
T Consensus       186 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          186 LRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             EEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ceeeeeecCCCCeEEEEEEEC----CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            445678999999999999986    34679999997543 346789999999999999999999999976 678999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.+++...  ..+++..++.|+.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            9999999999753  5689999999999999999999964   9999999999999999999999999999876543222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      . .....+|..|+|||.+....++.++||||||++||||+| |+.||......+       +...+..+..         
T Consensus       337 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---------  399 (452)
T 1fmk_A          337 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---------  399 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------
T ss_pred             c-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------
Confidence            1 133457889999999998899999999999999999999 999997554321       1112222211         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                      ...+..++..+.+++..||+.||++|||+.+|++.|+.+....
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            1112234678899999999999999999999999999976543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=339.56  Aligned_cols=266  Identities=20%  Similarity=0.266  Sum_probs=208.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCC--eEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++|
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEEC---CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            345678999999999999987   346789999987543 334567889999999999999999999987765  77999


Q ss_pred             EEeCCCCCHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCcEEEeeccCcc
Q 037780          243 YEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAK  315 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~  315 (455)
                      |||+++++|.+++....   .+++..++.|+.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999997653   389999999999999999999965   99999999999999    888899999999998


Q ss_pred             cccCCCCccccccccccCccccccccc--------CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYR--------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      ........   ....||+.|+|||++.        +..++.++||||||+++|||+||+.||.........  .......
T Consensus       165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~  239 (319)
T 4euu_A          165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (319)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred             ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence            76544322   3356999999999886        567899999999999999999999999754432111  1111122


Q ss_pred             hhc---Ccccccc-----------ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          388 YRN---GKLDDLV-----------EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       388 ~~~---~~~~~~~-----------~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ...   ..+..+.           ...............+.+++..||+.||++|||+.|+++...+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            111   1111000           000111234567888999999999999999999999999987644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.5e-45  Score=351.96  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=203.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCC-ceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTS-TTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|.+..++.. ...|++|.+.... ......+.+|+.++++++||||+++++++. ++..++|+|
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            4557899999999999998754322 2348888875432 233456788999999999999999999986 456889999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            99999999999775 5789999999999999999999965   9999999999999999999999999999987655444


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .......+|..|+|||++.+..++.++||||||+++|||+| |+.||........       ...+..+....       
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~-------  237 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERLA-------  237 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBCC-------
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCCC-------
Confidence            33355668889999999998999999999999999999999 9999986543221       11122221111       


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                        .+...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus       238 --~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 --QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             --CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             --CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              111133467789999999999999999999999987643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=341.12  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=205.9

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE-EEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR-LLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~-~lv~e~~  246 (455)
                      .+.||+|+||+||+|.+..+......+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            4679999999999999887666777899999875433 3456799999999999999999999999876665 9999999


Q ss_pred             CCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC--c
Q 037780          247 NNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS--K  323 (455)
Q Consensus       247 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~  323 (455)
                      .+++|.+++.. ...+++..++.|+.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.......  .
T Consensus       106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (298)
T 3pls_A          106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV  182 (298)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred             cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence            99999999977 46789999999999999999999965   999999999999999999999999999986543321  1


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCC-CccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSF-DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+ .......   +    ......+...        
T Consensus       183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~----~~~~~~~~~~--------  247 (298)
T 3pls_A          183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---L----THFLAQGRRL--------  247 (298)
T ss_dssp             CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---H----HHHHHTTCCC--------
T ss_pred             ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---H----HHHhhcCCCC--------
Confidence            1123445789999999999999999999999999999999965554 3322221   1    1111111110        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       ..+...+..+.+++..||+.||.+|||+.++++.|+.+.+
T Consensus       248 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          248 -PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             1112235678999999999999999999999999998654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-44  Score=346.65  Aligned_cols=250  Identities=24%  Similarity=0.297  Sum_probs=183.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|+||+||++...   .+++.||||++...   ....+.+|+.++.++. ||||+++++++.+....++||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHK---KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEET---TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEEC---CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            56999999999999986   35688999998643   4567889999999997 99999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeeccCcccccCCCCccc
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      |+|.+++.....+++.++..|+.|++.||+|||+.   +|+||||||+|||++.++   .+||+|||+++........  
T Consensus        91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--  165 (325)
T 3kn6_A           91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--  165 (325)
T ss_dssp             CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence            99999999888999999999999999999999965   999999999999998765   8999999999866543222  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+....      ....
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence            1345689999999999999999999999999999999999999976543211111122222233332210      0000


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+..+.+++..||+.||.+|||+.++++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0123567899999999999999999999884

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-44  Score=362.73  Aligned_cols=245  Identities=27%  Similarity=0.394  Sum_probs=201.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC-eEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-NRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~  245 (455)
                      .+.+.||+|+||.||+|.+.     +..||||.++...  ..+.|.+|+.++++++||||+++++++.+.. ..++||||
T Consensus       196 ~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEET-----TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             EEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            34578999999999999874     5689999997543  4578999999999999999999999987665 78999999


Q ss_pred             CCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.+++....  .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            99999999997643  379999999999999999999965   99999999999999999999999999998543221  


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                         ....++..|+|||.+.+..++.++||||||++||||+| |+.||......+.       ...+..+..         
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~---------  404 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK---------  404 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTCC---------
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence               22357889999999999999999999999999999999 9999976543221       111222211         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ...+..++..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1112235678899999999999999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=357.91  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=204.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.+.||+|+||+||++...   .++..+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~---~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKV---LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEET---TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             CeEEEEEeccCCCeEEEEEEEC---CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4556688999999999999876   457889999986533  23345689999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCcEEEeeccCcccccC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTL  319 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~  319 (455)
                      |||+++|+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++   +++.+||+|||+++....
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999999999888999999999999999999999965   999999999999998   567899999999987654


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......       ....+..+.... ..+
T Consensus       166 ~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~-~~~  235 (444)
T 3soa_A          166 EQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDF-PSP  235 (444)
T ss_dssp             TCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC-CTT
T ss_pred             CCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCC-Ccc
Confidence            3322  134579999999999999899999999999999999999999997554321       112222222211 111


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .     ....+..+.+++..||+.||.+|||+.++++
T Consensus       236 ~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 E-----WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             T-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             c-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0     1123567889999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=346.52  Aligned_cols=248  Identities=20%  Similarity=0.292  Sum_probs=203.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||++...   .++..+|+|.+... ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~---~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             eEeeeEEecCCCeEEEEEEEC---CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            345678999999999999986   45688999998643 33456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--CCcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +++++|.+++... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++.......
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999765 4789999999999999999999965   9999999999999997  78999999999987754332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||........       ...+..+....  .... 
T Consensus       160 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~--~~~~-  226 (321)
T 1tki_A          160 F---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYTF--DEEA-  226 (321)
T ss_dssp             E---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCCC--CHHH-
T ss_pred             c---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-------HHHHHcCCCCC--Chhh-
Confidence            1   345689999999999988899999999999999999999999976543211       11111111110  0000 


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ....+..+.+++..||+.||.+|||+.++++
T Consensus       227 ---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          227 ---FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0123567889999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-44  Score=344.71  Aligned_cols=259  Identities=26%  Similarity=0.407  Sum_probs=198.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe-----
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-----  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----  238 (455)
                      +.+.+.||+|+||.||+|........+..||+|.+....  ....+.+.+|+.++++++||||+++++++.+.+.     
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            345578999999999999988666667899999986442  2334679999999999999999999999987653     


Q ss_pred             EEEEEEeCCCCCHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeecc
Q 037780          239 RLLVYEFLNNGTLASFLF------GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFG  312 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~------~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  312 (455)
                      .++|+||+++++|.+++.      ....+++..++.|+.|++.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecC
Confidence            499999999999999983      34678999999999999999999994   599999999999999999999999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      +++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........       ......+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~  265 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------YDYLLHG  265 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTT
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-------HHHHHcC
Confidence            9987654433222234457889999999999999999999999999999999 8899876543221       1111111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ...         ..+...+..+.+++..||+.+|.+|||+.++++.|+++.+
T Consensus       266 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          266 HRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             CCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111         1112345678999999999999999999999999998653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=355.02  Aligned_cols=258  Identities=26%  Similarity=0.469  Sum_probs=197.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|.+..+......||||.+.... ....+.|.+|+.++++++||||+++++++.. .+..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            34578999999999999987655456789999986543 2345779999999999999999999998754 457899999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++..++.++.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus       172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999999765 5689999999999999999999965   9999999999999999999999999999866433221


Q ss_pred             c--ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          324 T--IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       324 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .  ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+.   .    ..+..+...      
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~----~~~~~~~~~------  315 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T----VYLLQGRRL------  315 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---H----HHHHTTCCC------
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---H----HHHHcCCCC------
Confidence            1  1133457889999999999999999999999999999999 6777765443221   1    111112111      


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                         ..+...+..+.+++..||+.+|.+|||+.++++.|+.+..
T Consensus       316 ---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          316 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1112245678999999999999999999999999988653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8e-44  Score=351.89  Aligned_cols=248  Identities=24%  Similarity=0.314  Sum_probs=198.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...   .+++.+|+|++....   ......+..|..++.++ +||||+++++++.+.+..++
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~---~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLK---KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            345678999999999999987   456889999987542   22234588899999887 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|..++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999999999998888899999999999999999999965   99999999999999999999999999998633222


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccch--hhhhHHHHHHHhhcCcccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .........+.+..+...     
T Consensus       208 ~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----  280 (396)
T 4dc2_A          208 DT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----  280 (396)
T ss_dssp             CC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-----
T ss_pred             Cc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-----
Confidence            21  245679999999999999999999999999999999999999997543211  111112222222222211     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                           .+......+.+++..||+.||.+||++
T Consensus       281 -----~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 -----IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                 111235678899999999999999996

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=349.58  Aligned_cols=268  Identities=16%  Similarity=0.165  Sum_probs=202.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-----------cHHHHHHHHHHHcccCCCCceeeeeeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-----------GEKEFKNEVVVIGQTHHKNLVRLLGFC  233 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~g~~  233 (455)
                      .+.+.+.||+|+||.||+|....+...+..+|+|+.......           ....+.+|+..+..++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            345668899999999999999865556788999998654321           123467788999999999999999999


Q ss_pred             ec----CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC--cEE
Q 037780          234 DE----GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY--NAR  307 (455)
Q Consensus       234 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~k  307 (455)
                      ..    ....++||||+ +++|.+++.....+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++  .+|
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEE
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEE
Confidence            87    77899999999 999999998877899999999999999999999965   999999999999999887  999


Q ss_pred             EeeccCcccccCCCCc-----cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH
Q 037780          308 ISDFGLAKLLTLNQSK-----TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD  382 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~  382 (455)
                      |+|||+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~  271 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV--Q  271 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH--H
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH--H
Confidence            9999999876433211     11134569999999999999899999999999999999999999996533221111  1


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ......... +...+...   ......+..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus       272 ~~~~~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          272 TAKTNLLDE-LPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHT-TTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHhhccc-ccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111111111 11110000   001124568999999999999999999999999998754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-43  Score=336.84  Aligned_cols=250  Identities=27%  Similarity=0.460  Sum_probs=199.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-------HHHHHHHHHHHcccCCCCceeeeeeEecCCe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-------EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  238 (455)
                      +.+.+.||+|+||+||+|.+.   .++..||+|++.......       .+.+.+|+.++.+++||||+++++++.+.. 
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLV---KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEET---TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             ceehhccccCCceeEEEEEEc---CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            455678999999999999986   356789999986433221       167899999999999999999999997665 


Q ss_pred             EEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCEEEcCCCc-----EEEee
Q 037780          239 RLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQ--IIHCDIKPQNILLDDHYN-----ARISD  310 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~D  310 (455)
                       ++||||+++++|.+++... ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999998888654 5789999999999999999999954   6  999999999999988776     99999


Q ss_pred             ccCcccccCCCCccccccccccCccccccccc--CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHh
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR--KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY  388 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  388 (455)
                      ||+++.....     .....||+.|+|||.+.  ...++.++||||||+++|||++|+.||..........    .....
T Consensus       173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF----INMIR  243 (287)
T ss_dssp             CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH----HHHHH
T ss_pred             CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH----HHHHh
Confidence            9999754432     13456899999999983  4567899999999999999999999997654432111    11111


Q ss_pred             hcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       389 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ..+...         ..+...+..+.+++..||+.||.+|||+.++++.|+++
T Consensus       244 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EEGLRP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HSCCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ccCCCC---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111111         11223457889999999999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-44  Score=337.61  Aligned_cols=251  Identities=31%  Similarity=0.437  Sum_probs=192.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc----ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ----DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||+|.+.     +..+|||.+.....    ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             eeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            345678999999999999863     57799999865322    234678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--------CCcEEEeeccC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD--------HYNARISDFGL  313 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Dfg~  313 (455)
                      ||||+++++|.+++. ...+++..++.++.|++.||+|||+....+|+||||||+||+++.        ++.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999999985 457899999999999999999999762233999999999999986        77899999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ++.......    ....||+.|+|||.+.+..++.++||||||+++++|++|+.||........      ....... ..
T Consensus       163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~-~~  231 (271)
T 3dtc_A          163 AREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMN-KL  231 (271)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTS-CC
T ss_pred             ccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcC-CC
Confidence            986654322    234689999999999988999999999999999999999999976443211      1111111 11


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                              ....+...+..+.+++..||+.+|.+|||+.++++.|+.+
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 --------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    1111223456789999999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=340.91  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=195.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|...     ++.||||++...  ...+.|.+|+.++++++||||+++++++.+  ..++||||
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-----TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             eeeeeEeecCCCceEEEEEEC-----CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            345678999999999999874     567999998643  345779999999999999999999999874  47899999


Q ss_pred             CCCCCHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc-EEEeeccCcccccCCC
Q 037780          246 LNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLNQ  321 (455)
Q Consensus       246 ~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~  321 (455)
                      +++++|.+++....   .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            99999999998654   4689999999999999999999643368999999999999998886 7999999997654322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                           ....||+.|+|||++.+..++.++||||||+++|||++|+.||..........    .. ....+.....     
T Consensus       161 -----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~-----  225 (307)
T 2eva_A          161 -----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MW-AVHNGTRPPL-----  225 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HH-HHHTTCCCCC-----
T ss_pred             -----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HH-HHhcCCCCCc-----
Confidence                 23458999999999999999999999999999999999999997544322111    11 1111211111     


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                          ....+..+.+++..||+.||.+|||+.++++.|+.+.+
T Consensus       226 ----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          226 ----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                11235678899999999999999999999999987543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-43  Score=338.53  Aligned_cols=261  Identities=23%  Similarity=0.313  Sum_probs=198.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc--cCCCCceeeeeeEec----CCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDE----GQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~----~~~~  239 (455)
                      +.+.+.||+|+||+||+|..     ++..||||++...   ....+..|.+++..  ++||||+++++++..    ....
T Consensus        10 y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            44567899999999999986     3678999998643   34556666666666  799999999998654    3457


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      ++||||+++|+|.+++.. ..+++..++.|+.|++.||+|||...     +.+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999954 57899999999999999999999321     349999999999999999999999999999


Q ss_pred             ccccCCCCcc--ccccccccCcccccccccCC------CCCCCCCeecHHHHHHHHHhC----------CCCCCccccch
Q 037780          315 KLLTLNQSKT--IKTAIRGTKGYVAPEWYRKS------TITAKVDVYSFGVLLLEIISC----------RKSFDIEMGEE  376 (455)
Q Consensus       315 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg----------~~p~~~~~~~~  376 (455)
                      +.........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8765443321  11234699999999999876      456799999999999999999          77876543321


Q ss_pred             hhhhHHHHHHHhh-cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          377 YAILTDWAFDCYR-NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       377 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      .. . ........ ......+..    .......+..+.+++..||+.||++|||+.+|++.|+++
T Consensus       241 ~~-~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PS-F-EDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CC-H-HHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc-h-hhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11 1 11111111 111111111    112235678999999999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.1e-45  Score=365.05  Aligned_cols=249  Identities=20%  Similarity=0.229  Sum_probs=199.0

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.||+|+||+||+|...   ..++.+|+|++....   ......+.+|..++.+++||||+++++++.+.+..++||||
T Consensus        79 ~~~LG~G~fG~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey  155 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLK---NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY  155 (437)
T ss_dssp             EEEEEECSSEEEEEEEET---TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEeCCCEEEEEEEEc---CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence            467999999999999987   356889999986422   12223488999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++|+|.+++.. ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+++.........
T Consensus       156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            999999999987 57899999999999999999999954   99999999999999999999999999998765443322


Q ss_pred             ccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      . ....||+.|+|||++.     ...++.++|||||||++|||++|+.||......+..      ...+....  .+..+
T Consensus       233 ~-~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~--~~~~p  303 (437)
T 4aw2_A          233 S-SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKE--RFQFP  303 (437)
T ss_dssp             C-CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTHHH--HCCCC
T ss_pred             c-ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------Hhhhhccc--cccCC
Confidence            1 3457999999999987     567899999999999999999999999865432211      11111000  00000


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSL--RPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~~v~~  436 (455)
                      ..    .......+.+++..||..+|++  ||++.++++
T Consensus       304 ~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          304 TQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            00    0113567888999999888887  999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-44  Score=343.42  Aligned_cols=254  Identities=28%  Similarity=0.417  Sum_probs=209.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||+||+|.+.   ..+..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEG---GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ceeEEeecCCCCceeEEEeEec---CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3455678999999999999987   34678999998754 3346779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++...  ..+++..++.|+.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999753  5589999999999999999999965   999999999999999999999999999987664433


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.........       ..+...         .
T Consensus       167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-------~~~~~~---------~  229 (288)
T 3kfa_A          167 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKD---------Y  229 (288)
T ss_dssp             EE-ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTT---------C
T ss_pred             cc-ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcc---------C
Confidence            22 234557889999999998899999999999999999999 99999765432211       111111         1


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ....+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            11112234578899999999999999999999999998754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.9e-44  Score=350.01  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=211.0

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccC----CCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCC
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  237 (455)
                      ..+.+.+.||+|+||.||+|.+....    ..+..||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            34556688999999999999985321    356789999997543 23456789999999999 8999999999999999


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      ..++||||+++|+|.+++....                .+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence            9999999999999999997653                389999999999999999999965   999999999999999


Q ss_pred             CCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhh
Q 037780          302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL  380 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~  380 (455)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+    
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----  267 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----  267 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH----
Confidence            999999999999987665443322234457889999999988889999999999999999999 999997544322    


Q ss_pred             HHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                         ....+..+....         .+...+..+.+++..||+.+|.+|||+.++++.|+++...
T Consensus       268 ---~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          268 ---LFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ---HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence               111222221111         1123456789999999999999999999999999987543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=348.09  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=203.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++...   ..++.+|+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKN---DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            445678999999999999986   456789999986432   33456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  170 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ  170 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence            99999999999999888999999999999999999999965   999999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                         .....||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.    ..+.....      
T Consensus       171 ---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~~------  237 (384)
T 4fr4_A          171 ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTVV------  237 (384)
T ss_dssp             ---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCCC------
T ss_pred             ---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhccc------
Confidence               244679999999999864   45899999999999999999999999755432221111    11111111      


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT-MRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~~v~~  436 (455)
                          ..+...+..+.+++..||+.||.+||+ +.+|.+
T Consensus       238 ----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 ----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                111224567899999999999999999 666654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-43  Score=348.01  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=204.8

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+.+.+.||+|+||.||+|...   .++..+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEEC---CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34566788999999999999986   456789999986532  2334678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeeccCccccc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDFGLAKLLT  318 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~  318 (455)
                      ||||+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++   .+||+|||++....
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999998888899999999999999999999965   999999999999998654   59999999998765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      .....   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......       ....+..+.... ..
T Consensus       183 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~-~~  251 (362)
T 2bdw_A          183 DSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-PS  251 (362)
T ss_dssp             TCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-CT
T ss_pred             CCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC-Cc
Confidence            43221   34569999999999999899999999999999999999999997544321       111222222110 00


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +.     ....+..+.+++..||+.||.+|||+.++++
T Consensus       252 ~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          252 PE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             TG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00     1123567889999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=340.98  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=193.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------------------------ccHHHHHHHHHHHc
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------------------------DGEKEFKNEVVVIG  219 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  219 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||.+.....                          ...+.+.+|+.+++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNE---NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEET---TTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             eEEEeEEeecCCEEEEEEEEC---CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            445678999999999999876   4578899999864321                          11346899999999


Q ss_pred             ccCCCCceeeeeeEec--CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 037780          220 QTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQN  297 (455)
Q Consensus       220 ~l~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  297 (455)
                      +++||||+++++++.+  ....++||||+++++|.+++. ...+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  167 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN  167 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence            9999999999999986  567899999999999988754 45789999999999999999999965   99999999999


Q ss_pred             EEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCC---CCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST---ITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       298 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      ||++.++.+||+|||+++........  .....||+.|+|||.+.+..   .+.++||||||+++|||++|+.||.....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999876543322  13456999999999997765   47789999999999999999999975432


Q ss_pred             chhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          375 EEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..       ....+.......        ......+..+.+++..||+.||++|||+.++++
T Consensus       246 ~~-------~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 MC-------LHSKIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HH-------HHHHHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH-------HHHHHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            11       111111111110        011123567899999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.5e-44  Score=339.42  Aligned_cols=256  Identities=25%  Similarity=0.363  Sum_probs=204.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|.+..+...+..||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++|||
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e   92 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME   92 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence            345678999999999999988665567789999987542 33456799999999999999999999998654 5689999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            99999999999764 5689999999999999999999964   9999999999999999999999999999876543322


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .. ....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.........       ..+..+...        
T Consensus       170 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-------~~~~~~~~~--------  233 (281)
T 3cc6_A          170 KA-SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGDRL--------  233 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-------HHHHHTCCC--------
T ss_pred             cc-ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-------HHHhcCCCC--------
Confidence            21 33457889999999988899999999999999999998 99999754432211       111111111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                       ..+...+..+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence             011123567889999999999999999999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.4e-44  Score=345.80  Aligned_cols=244  Identities=25%  Similarity=0.358  Sum_probs=201.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   ..+..||+|.+....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHY---KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            345678999999999999986   356789999986432   22345789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+ +|+|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||++........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            9999 789999998888899999999999999999999965   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .   ....||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||........               ...+.... 
T Consensus       164 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~-  224 (336)
T 3h4j_B          164 L---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCV-  224 (336)
T ss_dssp             T---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSC-
T ss_pred             c---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCC-
Confidence            2   34569999999999988776 6899999999999999999999975443211               00111100 


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ...+...+..+.+++..||+.||.+|||+.++++
T Consensus       225 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 -YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             0112224567889999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=349.74  Aligned_cols=246  Identities=24%  Similarity=0.296  Sum_probs=197.1

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      .+.||+|+||.||+|...   .++..||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~---~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEET---ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEECC-----CEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceEEecCcCEEEEEEEEc---CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            356999999999999886   35678999999765555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE--cCCCcEEEeeccCcccccCCCCccc
Q 037780          249 GTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL--DDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       249 gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      ++|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++........  
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--  245 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--  245 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence            9999988654 5689999999999999999999965   99999999999999  57789999999999876544322  


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      ...... .... +....     
T Consensus       246 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~-~~~~-~~~~~-----  311 (373)
T 2x4f_A          246 -KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILA-CRWD-LEDEE-----  311 (373)
T ss_dssp             -CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-TCCC-SCSGG-----
T ss_pred             -ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-ccCC-CChhh-----
Confidence             334699999999999988999999999999999999999999976543211      111111 1110 00000     


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......+.+++..||+.||.+|||+.++++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123567899999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=346.08  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=200.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCC-ceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTS-TTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|.+..++.. ...|++|.+... .....+.+.+|+.++.+++||||+++++++.... .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence            34557899999999999998754322 234688887543 3345678999999999999999999999998765 78999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++.. ...+++..++.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            99999999999976 46789999999999999999999965   999999999999999999999999999987755443


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........       ..+..+..        
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~~--------  237 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGER--------  237 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCC--------
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCC--------
Confidence            333344557889999999999999999999999999999999 99999765543211       11111111        


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       ...+...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus       238 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          238 -LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             11122245678899999999999999999999999988664

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=350.14  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.+.||+|+||+||++...   .+++.||||++...   .......+..|..++..+ +||||+++++++.+.+..+
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVK---ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEc---CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3456688999999999999987   35678999998653   223456688999999988 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||||+++|+|.+++.....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.....
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999998888899999999999999999999965   9999999999999999999999999999864332


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ...  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+...      
T Consensus       178 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~------  242 (353)
T 3txo_A          178 GVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVV------  242 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------
T ss_pred             Ccc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC------
Confidence            221  244679999999999998899999999999999999999999997654322       11111122111      


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTM------RKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~------~~v~~  436 (455)
                          .+......+.+++..||+.||.+||++      .++++
T Consensus       243 ----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 ----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                111234678899999999999999998      66654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-43  Score=336.63  Aligned_cols=260  Identities=20%  Similarity=0.246  Sum_probs=198.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|...   .+++.||+|++....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEET---TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeeeEecCCCCeEEEEEEEC---CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            45578999999999999986   356789999986433  2234678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |++++.+..+......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  157 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence            998755555555567899999999999999999999965   9999999999999999999999999999876533222 


Q ss_pred             ccccccccCcccccccccCCC-CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---ccc---ccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLD---DLV  397 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~  397 (455)
                       .....||+.|+|||.+.+.. ++.++||||||+++|||++|..|+........  ............   ...   ...
T Consensus       158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcccc
Confidence             13456899999999997765 79999999999999999998888643332111  111111111110   000   000


Q ss_pred             cc---------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          398 EG---------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       398 ~~---------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +.         .............+.+++..||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00         0000111134567889999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.8e-44  Score=375.22  Aligned_cols=251  Identities=29%  Similarity=0.414  Sum_probs=203.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      ++||+|+||.||+|.+... ..++.||||+++....  ...++|.+|+.++.+++|||||++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCC-CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            3699999999999987644 3568899999975432  335789999999999999999999999964 56889999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc-ccc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIK  326 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~  326 (455)
                      +|+|.+++.....+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999999888999999999999999999999965   9999999999999999999999999999876544321 112


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      ....+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+       +...+..+....         .
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~  593 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG---------C  593 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------C
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------C
Confidence            33457889999999999999999999999999999999 999997654422       222222222111         1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      +..++..+.+++..||+.||++|||+.+|++.|+++
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            223467899999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=349.65  Aligned_cols=249  Identities=25%  Similarity=0.327  Sum_probs=204.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|...   .++..+|+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCEEEEEEEEC---CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            456678999999999999986   35678999998765545566799999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--CCcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +++|+|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999765 4789999999999999999999965   9999999999999974  57799999999987654432


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....||+.|+|||++.+..++.++|||||||++|||++|+.||........      .. .+......  .+    
T Consensus       207 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~-~i~~~~~~--~~----  270 (387)
T 1kob_A          207 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQ-NVKRCDWE--FD----  270 (387)
T ss_dssp             E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HH-HHHHCCCC--CC----
T ss_pred             e---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HH-HHHhCCCC--CC----
Confidence            2   334699999999999999999999999999999999999999976543211      11 11111111  00    


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......+..+.+++..||+.||.+|||+.++++
T Consensus       271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0111123567899999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.2e-45  Score=345.39  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCC----CceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRT----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.+.||+|+||+||+|....++.    ....||+|.+........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            34566789999999999999875432    13579999997766666788999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc--------EEEeec
Q 037780          241 LVYEFLNNGTLASFLFGNLK-PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN--------ARISDF  311 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Df  311 (455)
                      +||||+++++|.+++..... +++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.        +||+||
T Consensus        89 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             EEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            99999999999999987644 89999999999999999999965   9999999999999998887        999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      |++......      ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+........      .......
T Consensus       166 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~~~~~~  233 (289)
T 4fvq_A          166 GISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KLQFYED  233 (289)
T ss_dssp             CSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHT
T ss_pred             cccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HHHHhhc
Confidence            998754321      23458899999999987 6789999999999999999996554433222111      0011111


Q ss_pred             -CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          391 -GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       391 -~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       ....            ...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus       234 ~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          234 RHQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             TCCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             cCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             1111            0113457889999999999999999999999998765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-44  Score=349.09  Aligned_cols=271  Identities=24%  Similarity=0.353  Sum_probs=209.7

Q ss_pred             hhhhhcCcCCCccEEEEEEec-cCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lv  242 (455)
                      .+.+.||+|+||+||++.+.. ....++.||||++..... ...+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            456789999999999997643 334678999999975432 3356799999999999999999999999874  578999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++... .+++..++.|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            9999999999999765 489999999999999999999965   999999999999999999999999999987764432


Q ss_pred             c-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh--------hhhHHHHHHHhhcCcc
Q 037780          323 K-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--------AILTDWAFDCYRNGKL  393 (455)
Q Consensus       323 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~  393 (455)
                      . .......+|..|+|||.+.+..++.++||||||+++|||+||+.||........        .............+  
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  267 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG--  267 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT--
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc--
Confidence            2 122344588899999999998999999999999999999999999865332100        00001111111111  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNP  450 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~~p~~p  450 (455)
                             .....+...+..+.+++..||+.||.+|||+.++++.|+.+.+.-..+.|
T Consensus       268 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          268 -------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             -------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence                   11122234567899999999999999999999999999987654433333

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-44  Score=349.35  Aligned_cols=259  Identities=26%  Similarity=0.401  Sum_probs=209.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCC--CceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRT--STTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||+|....++.  ....||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  127 (333)
T 2i1m_A           48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV  127 (333)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence            4456789999999999999865432  345799999875432 3456799999999999 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEE
Q 037780          242 VYEFLNNGTLASFLFG--------------NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR  307 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~--------------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  307 (455)
                      ||||+++|+|.+++..              ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence            9999999999999864              24579999999999999999999965   999999999999999999999


Q ss_pred             EeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHH
Q 037780          308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFD  386 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  386 (455)
                      |+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |..||........      ...
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~  278 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYK  278 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------HHH
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------HHH
Confidence            999999987655444333344567889999999998899999999999999999999 9999976543221      111


Q ss_pred             HhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       387 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ....+...         ..+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       279 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          279 LVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            11111110         111123567889999999999999999999999998753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=369.52  Aligned_cols=250  Identities=28%  Similarity=0.428  Sum_probs=202.2

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      +||+|+||.||+|.+...+ .+..||||+++... ....++|.+|+.++++++|||||+++++|.. +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSS-CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            6999999999999987543 46789999997643 3356789999999999999999999999976 5689999999999


Q ss_pred             CHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc-ccc
Q 037780          250 TLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKT  327 (455)
Q Consensus       250 sL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  327 (455)
                      +|.+++... ..+++..++.|+.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++......... ...
T Consensus       421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            999999754 5689999999999999999999965   99999999999999999999999999998765433221 112


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...+|+.|+|||++.+..++.++|||||||+||||+| |+.||......+       +...+..+...         ..+
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~---------~~p  561 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---------ECP  561 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCC---------CCC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCC
Confidence            2346789999999998999999999999999999998 999998655432       11222222211         112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ..++..+.+++..||+.+|.+|||+.+|++.|+.+
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            23567899999999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=344.54  Aligned_cols=255  Identities=25%  Similarity=0.452  Sum_probs=199.3

Q ss_pred             hhhcCcCCCccEEEEEEeccC-CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          169 KEEAGRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .+.||+|+||+||+|....+. ..+..||||.+.... ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            357999999999999987442 235679999987543 233457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc-
Q 037780          247 NNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-  324 (455)
Q Consensus       247 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-  324 (455)
                      ++++|.+++... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......... 
T Consensus       129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  205 (333)
T 1mqb_A          129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY  205 (333)
T ss_dssp             TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred             CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccccc
Confidence            999999999764 6789999999999999999999965   99999999999999999999999999998765433221 


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....+..+...         
T Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~---------  269 (333)
T 1mqb_A          206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRL---------  269 (333)
T ss_dssp             -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC---------
T ss_pred             ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCcC---------
Confidence            1122346789999999998899999999999999999999 999997544321       11122222110         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ..+...+..+.+++..||+.+|.+||++.++++.|+.+.
T Consensus       270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            112234567899999999999999999999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=339.84  Aligned_cols=243  Identities=25%  Similarity=0.315  Sum_probs=202.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++...   .+++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            345678999999999999986   456789999986432   23456788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc-
Confidence            999999999999998888999999999999999999999   4599999999999999999999999999998754321 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......      .... +..+...        
T Consensus       161 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~-i~~~~~~--------  221 (318)
T 1fot_A          161 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEK-ILNAELR--------  221 (318)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHHCCCC--------
T ss_pred             ----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCCC--------
Confidence                34569999999999999999999999999999999999999997544321      1111 1111111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                        .+......+.+++..||+.||.+||     ++.++++
T Consensus       222 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence              1112346788999999999999999     8888874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-44  Score=348.85  Aligned_cols=267  Identities=24%  Similarity=0.367  Sum_probs=211.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEe--cCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~--~~~~~~l  241 (455)
                      .+.+.+.||+|+||.||++.+.. +...+..||||++........+.+.+|+.++++++||||+++++++.  +....++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            34566789999999999998643 23467899999998765566677999999999999999999999886  4556899


Q ss_pred             EEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+++++|.+++.. ...+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            9999999999999976 35689999999999999999999964   9999999999999999999999999999876544


Q ss_pred             CCcc-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh--------hHHHHHHHhhcC
Q 037780          321 QSKT-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--------LTDWAFDCYRNG  391 (455)
Q Consensus       321 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~--------~~~~~~~~~~~~  391 (455)
                      .... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||.....+....        ...........+
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            3221 2233458889999999998889999999999999999999999986543211000        001111111111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                               .....+...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus       261 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          261 ---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             ---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     1112233456789999999999999999999999999998654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.3e-44  Score=340.07  Aligned_cols=258  Identities=26%  Similarity=0.468  Sum_probs=201.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEe-cCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCD-EGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|.+..+......+|+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            455789999999999999876555667799999875433 33467999999999999999999999864 4567899999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++..++.|+.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++........
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            99999999999764 5689999999999999999999965   9999999999999999999999999999876543321


Q ss_pred             --cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          324 --TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       324 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                        .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.........       .....+...      
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~------  251 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRRL------  251 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-------HHHHTTCCC------
T ss_pred             ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhcCCCC------
Confidence              11234557889999999999999999999999999999999 55566543332111       111111110      


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                         ..+...+..+.+++..||+.+|.+|||+.++++.|+.+..
T Consensus       252 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          252 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1111235678999999999999999999999999998654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.9e-44  Score=349.15  Aligned_cols=250  Identities=23%  Similarity=0.287  Sum_probs=192.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||++...   ..++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDK---LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEET---TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEeccCCCEEEEEEEEC---CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            556788999999999999986   456789999997543 2346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc--EEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN--ARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.+++.....+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++....... 
T Consensus        98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-  173 (361)
T 3uc3_A           98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  173 (361)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC-
Confidence            99999999998888899999999999999999999964   9999999999999987766  99999999975432221 


Q ss_pred             cccccccccCcccccccccCCCCCCC-CCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAK-VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                        .....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||........  .......... ...        .
T Consensus       174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~-~~~--------~  240 (361)
T 3uc3_A          174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILS-VKY--------S  240 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHT-TCC--------C
T ss_pred             --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhc-CCC--------C
Confidence              133469999999999988877665 8999999999999999999976543211  1111111111 111        0


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......+..+.+++..||+.||.+|||+.++++
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0111123467889999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-43  Score=339.16  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=196.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|...    +++.||+|++.....  .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            345678999999999999874    477899999864322  23467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++ +|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            99985 777777654 5689999999999999999999965   999999999999999999999999999987653322


Q ss_pred             ccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc---cccc--
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LDDL--  396 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--  396 (455)
                      .  .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+..   ...........   ....  
T Consensus       175 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          175 S--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGGTT
T ss_pred             c--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhhhc
Confidence            2  134568999999999876 56899999999999999999999999765543221   11111111100   0000  


Q ss_pred             -----------cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 -----------VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 -----------~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                 ...............++.+++..||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                       0000000000113457889999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-44  Score=342.06  Aligned_cols=248  Identities=23%  Similarity=0.257  Sum_probs=193.4

Q ss_pred             HHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHccc-CCCCceeeeeeEecC
Q 037780          160 ALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG  236 (455)
Q Consensus       160 ~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~  236 (455)
                      ++....+.+.++||+|+||+||+|.+.   .+++.||||++.....  .....+..|+..+.++ +||||+++++++.++
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSK---EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEET---TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             chhhhheeeeheeccCCCeEEEEEEEC---CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            344455666688999999999999986   3578899999864322  2234455666666665 899999999999999


Q ss_pred             CeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          237 QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      +..++||||+ +++|.+++... ..++|..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999999999 67888887653 5699999999999999999999965   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ........   ....||++|+|||++.+ .++.++||||||+++|||++|..|+.....          ...+..+....
T Consensus       206 ~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~  271 (311)
T 3p1a_A          206 ELGTAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPP  271 (311)
T ss_dssp             ECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCH
T ss_pred             ecccCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCc
Confidence            76543322   34569999999999876 789999999999999999999776643211          11112221111


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..        .......+.+++..||+.||++|||+.++++
T Consensus       272 ~~--------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 EF--------TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cc--------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            00        1123567899999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.6e-44  Score=344.89  Aligned_cols=260  Identities=27%  Similarity=0.382  Sum_probs=209.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCC-eEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ-NRL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~-~~~  240 (455)
                      +.+.+.||+|+||+||+|.+..  ....++.||||.+..... ...+.+.+|+.++.++ +||||+++++++...+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            4456789999999999998764  234678999999975433 2345789999999999 7999999999987755 589


Q ss_pred             EEEEeCCCCCHHHHhcCCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          241 LVYEFLNNGTLASFLFGNLK----------------PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      +||||+++++|.+++.....                +++..++.++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence            99999999999999976543                78999999999999999999965   999999999999999999


Q ss_pred             cEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDW  383 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  383 (455)
                      .+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.||........      
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------  259 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------  259 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH------
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH------
Confidence            999999999987655443333344568899999999999999999999999999999998 9999975543211      


Q ss_pred             HHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          384 AFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       384 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ....+..+....         .+......+.+++..||+.||.+|||+.+|++.|+.+.+
T Consensus       260 ~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          260 FCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhccCccCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111222221111         111235678899999999999999999999999987653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.1e-44  Score=349.37  Aligned_cols=269  Identities=15%  Similarity=0.173  Sum_probs=204.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEecccccccc-----------HHHHHHHHHHHcccCCCCceeeee
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVFQDG-----------EKEFKNEVVVIGQTHHKNLVRLLG  231 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~g  231 (455)
                      .+.+.+.||+|+||+||+|.+..+.  ..++.||||.+.......           ...+..|+..+..++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            3456688999999999999987542  135789999986543211           123445666778889999999999


Q ss_pred             eEecC----CeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCC
Q 037780          232 FCDEG----QNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD--DHY  304 (455)
Q Consensus       232 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~  304 (455)
                      ++...    ...++||||+ +++|.+++... ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++  .++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence            98764    4579999999 99999999765 6799999999999999999999965   999999999999999  889


Q ss_pred             cEEEeeccCcccccCCCCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh
Q 037780          305 NARISDFGLAKLLTLNQSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI  379 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~  379 (455)
                      .+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||++||||+||+.||........  
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--  269 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--  269 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--
Confidence            99999999998765432211     11334599999999999999999999999999999999999999985443211  


Q ss_pred             hHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .......... ..+..++++.+.   ....+..+.+++..||+.+|.+||++.+|++.|+++.+
T Consensus       270 ~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          270 YVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             HHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            1111111111 122223332221   11235688999999999999999999999999987554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=348.00  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=192.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCC--CCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...    ++..||||++....  ....+.+.+|+.++.+++|  +||+++++++...+..++
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            345678999999999999864    46789999986432  2334678999999999986  999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||| +.+++|.+++.....+++.++..|+.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||+++......
T Consensus        87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999 56889999999888999999999999999999999965   999999999999997 5789999999998776544


Q ss_pred             CccccccccccCcccccccccC-----------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRK-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      .........||+.|+|||++.+           ..++.++||||||+++|||++|+.||.......     ........ 
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~-  235 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIID-  235 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHC-
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHHHhc-
Confidence            4333345679999999999864           678899999999999999999999997543211     11111111 


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                              +......+......+.+++..||+.||.+|||+.++++
T Consensus       236 --------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          236 --------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             --------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                    11111111122457889999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.9e-44  Score=337.95  Aligned_cols=252  Identities=32%  Similarity=0.478  Sum_probs=205.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||+|...    ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             hhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            3445678999999999999875    45679999987543 346789999999999999999999999864 56899999


Q ss_pred             eCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++....  .+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999997653  789999999999999999999965   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .. .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+       ....+..+...       
T Consensus       165 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~-------  229 (279)
T 1qpc_A          165 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYRM-------  229 (279)
T ss_dssp             EC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-------
T ss_pred             cc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcccCC-------
Confidence            21 133457889999999988889999999999999999999 999997544321       11111222110       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                        ..+...+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus       230 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence              111234568899999999999999999999999999854

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-43  Score=339.13  Aligned_cols=265  Identities=25%  Similarity=0.383  Sum_probs=207.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  241 (455)
                      +.+.+.||+|+||.||+|.+.. +...+..||+|++.... ......+.+|+.++.+++||||+++++++...  ...++
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  102 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL  102 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence            4556789999999999998642 23467899999987432 33457799999999999999999999999876  66899


Q ss_pred             EEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+++++|.+++.. ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            9999999999999954 46789999999999999999999965   9999999999999999999999999999877644


Q ss_pred             CCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccc--------hhhhhHHHHHHHhhcC
Q 037780          321 QSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE--------EYAILTDWAFDCYRNG  391 (455)
Q Consensus       321 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~  391 (455)
                      ... .......||..|+|||.+.+..++.++||||||+++|||+||+.|+......        ............+..+
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence            322 2223456888999999999999999999999999999999999986533210        0000111111111111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .         ....+...+..+.+++..||+.||.+|||+.++++.|+.++
T Consensus       260 ~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          260 K---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1         11112234578999999999999999999999999998764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-43  Score=333.66  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=205.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||+||+|...   ..+..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQK---GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeC---CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3455678999999999999986   3467899999977666667889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+++++|.+++.....+++..++.|+.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            999999999998888899999999999999999999965   99999999999999   788999999999998765433


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..   ....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+       ....+..+.... .... 
T Consensus       164 ~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~~~-  230 (277)
T 3f3z_A          164 MM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFTF-PEKD-  230 (277)
T ss_dssp             CB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-CHHH-
T ss_pred             ch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC-Cchh-
Confidence            22   345689999999998654 8999999999999999999999997654321       111112221110 0000 


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          ....+..+.+++..||+.||.+|||+.++++
T Consensus       231 ----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 ----WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0023567889999999999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.7e-44  Score=347.33  Aligned_cols=251  Identities=24%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-----cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  238 (455)
                      ..+.+.+.||+|+||+||+|...   .+++.||||.+....     ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINR---ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeeEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            45667789999999999999886   356789999985321     1245779999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc---EEEeec
Q 037780          239 RLLVYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDF  311 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df  311 (455)
                      .++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+||
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence            99999999999998887542    4589999999999999999999965   9999999999999987655   999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      |+++........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......        ....+..+
T Consensus       178 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~i~~~  247 (351)
T 3c0i_A          178 GVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--------LFEGIIKG  247 (351)
T ss_dssp             TTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--------HHHHHHHT
T ss_pred             cceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH--------HHHHHHcC
Confidence            999876543321  23456999999999999999999999999999999999999999754221        11111222


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....  .+..    ....+..+.+++..||+.||.+|||+.++++
T Consensus       248 ~~~~--~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYKM--NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC--Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2110  0000    0113467889999999999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-43  Score=343.23  Aligned_cols=248  Identities=25%  Similarity=0.317  Sum_probs=199.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...   .+++.+|+|++....   ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLK---KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             eEEEEEEEecCCeEEEEEEEC---CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            345678999999999999986   456889999997542   22345688999999988 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999998878899999999999999999999964   99999999999999999999999999998643222


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh--hhhHHHHHHHhhcCcccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY--AILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..........+..+...     
T Consensus       165 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----  237 (345)
T 3a8x_A          165 DT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----  237 (345)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred             Cc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence            21  2446799999999999999999999999999999999999999975322110  01111222222222211     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                           .+......+.+++..||+.||.+||++
T Consensus       238 -----~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 -----IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 111235678899999999999999996

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.3e-44  Score=334.50  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=201.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC--CeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG--QNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~l  241 (455)
                      +.+.+.||+|+||.||+|.+.     +..+|||.+....  ....+.|.+|+.++++++||||+++++++.+.  ...++
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             hHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            445678999999999999974     5679999986542  33456799999999999999999999999887  77899


Q ss_pred             EEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          242 VYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||||+++|+|.+++....  .+++..++.|+.|++.||+|||+. ...++||||||+||+++.++.++|+|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999998765  589999999999999999999954 22299999999999999999999999998764322


Q ss_pred             CCCccccccccccCcccccccccCCCCCC---CCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITA---KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                             ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||........      .......+...  
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~--  230 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEGLRP--  230 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSCCCC--
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcCCCC--
Confidence                   2345899999999998765554   79999999999999999999975443211      11111222111  


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                             ..+...+..+.+++..||+.||++|||+.++++.|+.+.+
T Consensus       231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 -------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                   1112345678999999999999999999999999988653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-43  Score=338.42  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=190.0

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||+||+|...   .++..||+|++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNK---TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             -------------CEEEEEECS---SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEEC---CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3456688999999999999876   456889999986443 233467899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          244 EFLNNGTLASFLFGN------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       244 e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ||++ ++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 5999988642      4589999999999999999999964   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---Ccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKL  393 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  393 (455)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+..   .........   ...
T Consensus       159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLW  233 (317)
T ss_dssp             TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTC
T ss_pred             CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHh
Confidence            533221  1344689999999998764 6899999999999999999999999865543211   111111100   000


Q ss_pred             ccc---c--ccc------------cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDL---V--EGD------------MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~---~--~~~------------l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...   .  .+.            +...........+.+++..||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000   0  000            000001123457899999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-43  Score=337.69  Aligned_cols=261  Identities=20%  Similarity=0.211  Sum_probs=199.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .+++.||+|.+......   ..+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDT---VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEEcCCCCeeEEEEEEc---CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            445678999999999999976   35688999998754322   236789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +||+++++|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            99999999999998878899999999999999999999965   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      ... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......       .....+..... ..      
T Consensus       190 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~~------  254 (309)
T 2h34_A          190 TQL-GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-RP------  254 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-CG------
T ss_pred             ccc-cccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-Cc------
Confidence            221 3456899999999999999999999999999999999999999754321       11111111110 00      


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcCcCCCCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-TMRKVSQMLEGVVEVDVP  447 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~~v~~~L~~~~~~~~p  447 (455)
                      .......+..+.+++..||+.||++|| |+.++++.|+...+...+
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            011122356788999999999999999 999999999987665433

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-43  Score=336.84  Aligned_cols=255  Identities=29%  Similarity=0.412  Sum_probs=205.5

Q ss_pred             hhhh-hcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKE-EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~-~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+ .||+|+||+||+|.+... ..+..||||.+.....  ...+++.+|+.++.+++||||+++++++ ..+..++||
T Consensus        19 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           19 TLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhccCccccccCeeeEeeeecCC-CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            3445 899999999999977543 3578899999875432  2356799999999999999999999999 567789999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus        97 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (291)
T 1xbb_A           97 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  173 (291)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             EeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence            9999999999999888899999999999999999999965   9999999999999999999999999999876544332


Q ss_pred             c-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          324 T-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       324 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....+..+....      
T Consensus       174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~------  240 (291)
T 1xbb_A          174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG------  240 (291)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC------
T ss_pred             ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC------
Confidence            1 1122346789999999988889999999999999999999 999997654322       112222222111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                         .+...+..+.+++..||+.||.+|||+.+|++.|+++.
T Consensus       241 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          241 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               12234578899999999999999999999999998754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.9e-44  Score=346.06  Aligned_cols=245  Identities=27%  Similarity=0.348  Sum_probs=202.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||+|...   .+++.||+|.++...   ......+..|..++.++ +||||+++++++.+.+..++
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            345678999999999999986   457889999986532   33456688899999887 99999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999999998878899999999999999999999965   99999999999999999999999999998643322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+...       
T Consensus       173 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~-------  236 (345)
T 1xjd_A          173 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF-------  236 (345)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred             Cc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence            22  245679999999999999999999999999999999999999997654321       11111111110       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR-KVS  435 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-~v~  435 (455)
                         .+......+.+++..||+.||.+||++. +|+
T Consensus       237 ---~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 ---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               1112356788999999999999999997 665

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-43  Score=341.20  Aligned_cols=267  Identities=22%  Similarity=0.286  Sum_probs=200.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCe----
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN----  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~----  238 (455)
                      +.+.+.||+|+||.||++...   .+++.||||++.....   .....+.+|+.++.+++||||+++++++.....    
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDL---RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             EEEEEEEccCCCEEEEEEEEC---CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            455688999999999999976   4578899999975432   224568999999999999999999999876543    


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++||||+++++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence            499999999999999998888899999999999999999999965   99999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          319 LNQSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       319 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......      ...............
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPSA  241 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCHHH
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCccc
Confidence            43222 11234568999999999999999999999999999999999999997654321      111222221111000


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHHhcCcCCCCCCCCC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS-QMLEGVVEVDVPPNPS  451 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~-~~L~~~~~~~~p~~p~  451 (455)
                             .....+..+.+++..||+.||.+||+..+++ +.|........|+.|.
T Consensus       242 -------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~  289 (311)
T 3ork_A          242 -------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK  289 (311)
T ss_dssp             -------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred             -------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence                   0112356788999999999999999766544 5565554444444333

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.4e-44  Score=342.90  Aligned_cols=269  Identities=23%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.||+|+||+||+|...   .++..||||++..........+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus        19 ~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINL---ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG   95 (316)
T ss_dssp             CCCCCCSSEEEEEEECS---SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             ceecCCceEEEEEEEEc---CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence            56999999999999875   45678999999766556677899999999985 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc---EEEeeccCcccccCCCC---
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQS---  322 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~~~---  322 (455)
                      ++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||+++.......   
T Consensus        96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~  172 (316)
T 2ac3_A           96 GSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP  172 (316)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred             CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence            99999998888899999999999999999999965   9999999999999998776   99999999986543211   


Q ss_pred             --ccccccccccCcccccccccC-----CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhh--------hhHHHHHHH
Q 037780          323 --KTIKTAIRGTKGYVAPEWYRK-----STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTDWAFDC  387 (455)
Q Consensus       323 --~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--------~~~~~~~~~  387 (455)
                        ........||+.|+|||++..     ..++.++||||||+++|||++|+.||.........        .........
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (316)
T 2ac3_A          173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES  252 (316)
T ss_dssp             ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred             ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence              111123458999999999875     56889999999999999999999999765432100        000111122


Q ss_pred             hhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCcCCCCCCCC
Q 037780          388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVDVPPNP  450 (455)
Q Consensus       388 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~~~~~p~~p  450 (455)
                      +..+... +.....     ...+..+.+++..||+.||.+|||+.++++  .+.+.......|.|
T Consensus       253 i~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~  311 (316)
T 2ac3_A          253 IQEGKYE-FPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP  311 (316)
T ss_dssp             HHHCCCC-CCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----------
T ss_pred             HhccCcc-cCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCc
Confidence            2222211 000000     113467899999999999999999999997  45554433333333

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-43  Score=341.82  Aligned_cols=259  Identities=27%  Similarity=0.467  Sum_probs=209.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|....  ....+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  106 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  106 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence            4556889999999999998763  123467899999975432 3345689999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeecc
Q 037780          243 YEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFG  312 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  312 (455)
                      |||+++|+|.+++...          ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence            9999999999998642          4568999999999999999999965   99999999999999999999999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      +++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....+..+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~  256 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEG  256 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHHTT
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------HHHHHHcC
Confidence            9987654433322234457889999999998899999999999999999999 899987544321       11222222


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .....         +...+..+.+++..||+.||.+|||+.++++.|++..+
T Consensus       257 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          257 GLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            22111         12345678899999999999999999999999988654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=346.53  Aligned_cols=248  Identities=26%  Similarity=0.342  Sum_probs=188.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|...   ..++.||||.+....  ..+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQK---GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEeeCCCEEEEEEEEC---CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            345678999999999999986   346789999987532  346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +++++|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++.......
T Consensus       130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            99999999999888899999999999999999999965   9999999999999975   88999999999987653322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........      ....+...... ...+   
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~-~~~~---  273 (349)
T 2w4o_A          207 ---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYY-FISP---  273 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCC-CCTT---
T ss_pred             ---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCc-cCCc---
Confidence               1345689999999999998999999999999999999999999975443211      11111222111 1111   


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .....+..+.+++..||+.||++|||+.++++
T Consensus       274 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          274 --WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11124567889999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=341.62  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=199.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------ccHHHHHHHHHHHcccCCCCceeeeeeEecCC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  237 (455)
                      +.+.+.||+|+||+||+|...   .++..||||.+.....        .....+.+|+.++++++||||+++++++.+.+
T Consensus        26 y~~~~~lG~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           26 YSTMSPLGSGAFGFVWTAVDK---EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             EEEEEECSSSSSCSEEEEEET---TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             eEEEeEEEecCCEEEEEEEEC---CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            344567999999999999876   4578899999865421        12335788999999999999999999999999


Q ss_pred             eEEEEEEeCCCC-CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          238 NRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       238 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ..++||||+.+| +|.+++.....+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            999999999777 9999999888999999999999999999999965   999999999999999999999999999987


Q ss_pred             ccCCCCccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      .......   ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......                 ..
T Consensus       180 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~~  239 (335)
T 3dls_A          180 LERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------EA  239 (335)
T ss_dssp             CCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------TT
T ss_pred             CCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------hh
Confidence            6543322   34569999999999988776 789999999999999999999996422110                 00


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ...      .+...+..+.+++..||+.||.+|||+.++++.
T Consensus       240 ~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 AIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000      011135678899999999999999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-43  Score=331.47  Aligned_cols=252  Identities=28%  Similarity=0.393  Sum_probs=204.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||.||+|...   .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEEC---CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3455678999999999999876   356789999986432 234567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999999999998888899999999999999999999965   9999999999999999999999999999876543322


Q ss_pred             cccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ..     .+......  .     
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~-----~~~~~~~~--~-----  228 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS-----DWKEKKTY--L-----  228 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HH-----HHHTTCTT--S-----
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HH-----Hhhhcccc--c-----
Confidence            22244568999999999987765 77999999999999999999999765432111 11     11111100  0     


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       .........+.+++..||+.||.+|||+.++++
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             001123567889999999999999999999876

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4e-43  Score=342.44  Aligned_cols=243  Identities=24%  Similarity=0.243  Sum_probs=203.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++...   .++..||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEeecCcCcEEEEEEEC---CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            345578999999999999986   356789999986432   23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence            99999999999998878899999999999999999999964   99999999999999999999999999998765322 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||++.+..++.++||||||+++|||++|+.||.......       ....+..+...        
T Consensus       196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~--------  256 (350)
T 1rdq_E          196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR--------  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------
T ss_pred             ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence                34569999999999999999999999999999999999999997554321       11122222211        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                        .+...+..+.+++..||+.||.+||+     +.+|++
T Consensus       257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence              11123567889999999999999998     888774

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-43  Score=341.59  Aligned_cols=250  Identities=22%  Similarity=0.258  Sum_probs=195.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.+.+.||+|+||.||++........++.+|+|++....    ......+.+|+.++++++||||+++++++...+..+
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            3456688999999999999986555578899999987542    223456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            9999999999999998888899999999999999999999965   9999999999999999999999999999864432


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ...  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .... ..+...      
T Consensus       175 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i-~~~~~~------  239 (327)
T 3a62_A          175 GTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKI-LKCKLN------  239 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHH-HHTCCC------
T ss_pred             Ccc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HhCCCC------
Confidence            221  1345699999999999998999999999999999999999999976543211      1111 111110      


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                          .+......+.+++..||+.||.+||     ++.++++
T Consensus       240 ----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          240 ----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                1112356788999999999999999     6777765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-44  Score=335.25  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=207.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||++...    ++..||+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             eeeeeEecCCCceeEEEEEec----CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            345678999999999999975    45679999997643 3457899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999999765 5689999999999999999999965   99999999999999999999999999998764322111


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                       .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......       ....+..+...         
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~~~~---------  224 (267)
T 3t9t_A          162 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL---------  224 (267)
T ss_dssp             -TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC---------
T ss_pred             -cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcCCcC---------
Confidence             133457889999999998889999999999999999999 899997544321       11111222110         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ..+...+..+.+++..||+.+|.+|||+.++++.|+++.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1111235678899999999999999999999999988654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=340.87  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=202.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEe----cCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD----EGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~----~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...   .+++.||||++........+.+.+|+.++++++||||+++++++.    .....++
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGL---HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEET---TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEec---CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            456688999999999999976   356889999987655556678999999999999999999999986    3447899


Q ss_pred             EEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          242 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      |+||+++|+|.+++..    ...+++..++.|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999875    46789999999999999999999965   9999999999999999999999999998765


Q ss_pred             cCCCCcc-------ccccccccCcccccccccCCC---CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH
Q 037780          318 TLNQSKT-------IKTAIRGTKGYVAPEWYRKST---ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       318 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      .......       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||........ .+.    ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA----LA  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH----HH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh----HH
Confidence            4221110       012234799999999987553   68999999999999999999999964221111 010    00


Q ss_pred             hhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       388 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ... .        .........+..+.+++..||+.||.+|||+.++++.|+.+...
T Consensus       260 ~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQN-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hhc-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            111 0        00111122356789999999999999999999999999987643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=335.35  Aligned_cols=261  Identities=25%  Similarity=0.309  Sum_probs=197.7

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-----ccHHHHHHHHHHHcccC---CCCceeeeeeEe
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-----DGEKEFKNEVVVIGQTH---HKNLVRLLGFCD  234 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~g~~~  234 (455)
                      ...+.+.+.||+|+||+||+|...   .+++.||||++.....     .....+.+|+.++++++   ||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDP---HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECT---TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            344566788999999999999875   3568899999864321     12346777887777765   999999999997


Q ss_pred             cCC-----eEEEEEEeCCCCCHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEE
Q 037780          235 EGQ-----NRLLVYEFLNNGTLASFLFGNLK--PSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR  307 (455)
Q Consensus       235 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  307 (455)
                      ...     ..++||||+. ++|.+++.....  +++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            755     4789999997 599999987644  89999999999999999999965   899999999999999999999


Q ss_pred             EeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH
Q 037780          308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      |+|||+++........   ....||+.|+|||++.+..++.++||||||+++|||++|+.||.........   ......
T Consensus       161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~  234 (308)
T 3g33_A          161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDL  234 (308)
T ss_dssp             ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHH
T ss_pred             EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHH
Confidence            9999999876533322   4456899999999999999999999999999999999999999765542211   111111


Q ss_pred             hhc---Ccccccc---ccccc--cCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          388 YRN---GKLDDLV---EGDME--AMN-----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       388 ~~~---~~~~~~~---~~~l~--~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...   .......   .....  ...     ..+..+.+.+++..||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            111   0000000   00000  000     0123567889999999999999999999885

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-43  Score=344.60  Aligned_cols=246  Identities=25%  Similarity=0.305  Sum_probs=202.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...   .+++.||+|.+...   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            445678999999999999986   35688999998653   223456788999999988 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            999999999999998878899999999999999999999965   99999999999999999999999999998643222


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+...       
T Consensus       176 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~-------  239 (353)
T 2i0e_A          176 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNVA-------  239 (353)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred             cc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence            21  244679999999999999999999999999999999999999997654321       11111111111       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                         .+...+..+.+++..||+.||.+||+     +.+|++
T Consensus       240 ---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 ---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               11124567889999999999999996     466654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6e-44  Score=367.53  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=207.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.++||+|+||.||+|.+.    ....||||++.... ...++|.+|+.+|++++|+||+++++++.+ +..++||||
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhheecccCCCeEEEEEEEC----CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            445678999999999999986    34679999997543 346789999999999999999999999976 678999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.+++...  ..+++.+++.|+.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence            9999999999753  5689999999999999999999965   9999999999999999999999999999876532211


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                       ......++..|+|||.+....++.++||||||++||||+| |+.||......+       +...+..+...        
T Consensus       420 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~--------  483 (535)
T 2h8h_A          420 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM--------  483 (535)
T ss_dssp             -TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCCC--------
T ss_pred             -cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence             1123446789999999998899999999999999999999 999997554321       11122222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                       ..+..++..+.+++..||+.||++|||+.+|+++|+.+....
T Consensus       484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence             112234678899999999999999999999999999976543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-43  Score=350.44  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=193.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccC--CCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...    .+..||||++....  ....+.+.+|+.++.+++  ||||+++++++...+..++
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            445678999999999999864    46789999986432  334567999999999996  5999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||| +.+++|.+++.....+++..+..|+.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++......
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999 5688999999988889999999999999999999994   5999999999999996 5799999999998776544


Q ss_pred             CccccccccccCcccccccccC-----------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRK-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      .........||+.|+|||++.+           ..++.++|||||||+||||++|+.||.......     .........
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~~~~~  283 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIIDP  283 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHCT
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHHHhCc
Confidence            3333345679999999999865           368899999999999999999999997543211     111111111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .         .....+......+.+++..||+.||.+|||+.++++
T Consensus       284 ~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          284 N---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             T---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1         111111112457889999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-43  Score=337.09  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=194.4

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+.+.+.||+|+||+||+|...      ..+|+|.+....  ....+.|.+|+.++++++||||+++++++ .....++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEc------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            34556688999999999999753      248999886433  23346799999999999999999999965 4556899


Q ss_pred             EEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          242 VYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||||+++++|.+++... ..+++..++.|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999999654 6789999999999999999999965   9999999999999999999999999999866543


Q ss_pred             CCccccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ..........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.......      ........+......
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcch
Confidence            3322224456999999999986   5678889999999999999999999997654321      112222222221111


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ..     .....+..+.+++..||+.+|.+|||+.++++.|+.+.+
T Consensus       248 ~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 SK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11     112345789999999999999999999999999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=333.60  Aligned_cols=251  Identities=28%  Similarity=0.430  Sum_probs=204.0

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      .||+|+||.||+|.+.... .+..||||.+.... ....+.+.+|+.++.+++||||+++++++ ..+..++||||++++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             cccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            7999999999999875432 56789999997643 33456799999999999999999999999 556789999999999


Q ss_pred             CHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc-ccc
Q 037780          250 TLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKT  327 (455)
Q Consensus       250 sL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  327 (455)
                      +|.+++... ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......... ...
T Consensus        95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  171 (287)
T 1u59_A           95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  171 (287)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence            999999754 5689999999999999999999965   99999999999999999999999999998775443221 112


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+       ....+..+...         ..+
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~~~~---------~~~  235 (287)
T 1u59_A          172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM---------ECP  235 (287)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC---------CCC
T ss_pred             cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcCCcC---------CCC
Confidence            3346889999999988889999999999999999999 999997654322       11122222211         112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ...+..+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus       236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            234578899999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=336.82  Aligned_cols=262  Identities=24%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|...   .++..||+|++.....  ...+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNR---DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEeeEEeecCCeEEEEEEeC---CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            45578999999999999986   3467899998855432  224668899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..|+.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  158 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-  158 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence            999999999998888899999999999999999999965   9999999999999999999999999999876533221 


Q ss_pred             ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH--------HHHhhcCcc-c
Q 037780          325 IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA--------FDCYRNGKL-D  394 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~-~  394 (455)
                       .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........        ...+..... .
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence             134568999999999876 57899999999999999999999999766543221111000        001111100 0


Q ss_pred             cccccccccCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+.......     ...+..+.+++..||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000000     123556889999999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.8e-43  Score=336.99  Aligned_cols=247  Identities=21%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCC-------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ-------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~-------  237 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEET---TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             CceeeEecCCCCeEEEEEEEc---CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            345578999999999999986   356789999986433 334577999999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEeCCCCCHHHHhcCCC---CCCHH
Q 037780          238 --------------------------------------------------NRLLVYEFLNNGTLASFLFGNL---KPSWN  264 (455)
Q Consensus       238 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~---~~~~~  264 (455)
                                                                        ..++||||+++++|.+++....   ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999998753   34677


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc----------cccccccccCc
Q 037780          265 LRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK----------TIKTAIRGTKG  334 (455)
Q Consensus       265 ~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~  334 (455)
                      .++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            8899999999999999965   9999999999999999999999999999877654221          11133569999


Q ss_pred             ccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHH
Q 037780          335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLL  414 (455)
Q Consensus       335 y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  414 (455)
                      |+|||.+.+..++.++||||||+++|||++|..|+....         ..............         .......+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~~~~~~---------~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNLKFPLL---------FTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTTCCCHH---------HHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhccCCCcc---------cccCChhHH
Confidence            999999999999999999999999999999877642111         01111111111111         123446678


Q ss_pred             HHHHhcccCCCCCCCCHHHHHH
Q 037780          415 MVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       415 ~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +++..||+.||.+|||+.++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.2e-43  Score=336.97  Aligned_cols=251  Identities=25%  Similarity=0.325  Sum_probs=205.2

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc------cHHHHHHHHHHHcccCCCCceeeeeeEecCC
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  237 (455)
                      ..+.+.+.||+|+||.||++...   .++..+|+|.+......      ..+.+.+|+.++.+++||||+++++++.+.+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccEEEeeEeeecCCEEEEEEEEC---CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34566789999999999999986   35678999998653321      3577999999999999999999999999999


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----cEEEeeccC
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGL  313 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~  313 (455)
                      ..++||||+++++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999998888899999999999999999999965   999999999999999888    799999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ++........   ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.      . ..+.....
T Consensus       166 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~-~~i~~~~~  235 (321)
T 2a2a_A          166 AHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L-ANITSVSY  235 (321)
T ss_dssp             CEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H-HHHHTTCC
T ss_pred             ceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------H-HHHHhccc
Confidence            9876543221   345689999999999999999999999999999999999999975543211      1 11111111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .  .++..    ....+..+.+++..||+.||.+|||+.++++
T Consensus       236 ~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 D--FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             C--CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             c--cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0  00000    0113467889999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-42  Score=350.89  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=205.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHE---LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEET---TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            345678999999999999986   356789999986432   22346789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            9999999999999988889999999999999999999994   5999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .   ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......       ....+..+...       
T Consensus       172 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~-------  234 (476)
T 2y94_A          172 L---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIFY-------  234 (476)
T ss_dssp             B---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCCC-------
T ss_pred             c---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCcC-------
Confidence            1   34569999999999988765 689999999999999999999997554321       11112222111       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                         .+......+.+++..||+.||.+|||+.++++  .+..
T Consensus       235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence               01123457889999999999999999999996  4544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.2e-43  Score=345.65  Aligned_cols=266  Identities=15%  Similarity=0.159  Sum_probs=200.1

Q ss_pred             HhhhhhcCcC--CCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRG--SFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G--~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|  +||+||+|...   .++..||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYK---PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEc---CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4566889999  99999999987   357889999986543  2334668899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          242 VYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||||+++|+|.+++...  ..+++..+..|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999765  6789999999999999999999965   999999999999999999999999999875432


Q ss_pred             CCC-----ccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh--hHHHHHHHhhc
Q 037780          320 NQS-----KTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTDWAFDCYRN  390 (455)
Q Consensus       320 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~  390 (455)
                      ...     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..........  +..........
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            211     111123468999999999987  578999999999999999999999997644321110  00000000000


Q ss_pred             ------------------Ccccccccc---------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          391 ------------------GKLDDLVEG---------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       391 ------------------~~~~~~~~~---------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                                        .........         .............+.+++..||+.||++|||+.++++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                              000000000         00000112235678999999999999999999999853

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.8e-44  Score=353.79  Aligned_cols=249  Identities=19%  Similarity=0.237  Sum_probs=198.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.||+|+||+||++...   .++..+|+|++....   ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus        73 ~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           73 VVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             EEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEcCCCEEEEEEEEC---CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3467999999999999987   356789999986421   2233458899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++|+|.+++.. ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.........
T Consensus       150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            9999999999965 4689999999999999999999964   99999999999999999999999999998765433221


Q ss_pred             ccccccccCcccccccccCCC----CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKST----ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                       .....||+.|+|||++.+..    ++.++|||||||+||||++|+.||........      ...... +.. .+..+ 
T Consensus       226 -~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~-~~~-~~~~p-  295 (410)
T 3v8s_A          226 -CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMN-HKN-SLTFP-  295 (410)
T ss_dssp             -CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-HHH-HCCCC-
T ss_pred             -ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHh-ccc-cccCC-
Confidence             13567999999999997665    78999999999999999999999976543211      111111 000 00000 


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSL--RPTMRKVSQM  437 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPt~~~v~~~  437 (455)
                          .....+..+.+++..||+.+|.+  ||++.+|++.
T Consensus       296 ----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          296 ----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                01123567889999999999988  9999999963

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-43  Score=356.38  Aligned_cols=247  Identities=23%  Similarity=0.262  Sum_probs=194.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++...   .++..||||++...   .......+.+|+.++.+++||||+++++++...+..++|
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEK---ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cEEeEEEeeCcCEEEEEEEEc---CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            344578999999999999986   45788999998643   223345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            99999999999998888899999999999999999999951  4899999999999999999999999999986433222


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....||+.|+|||++.+..++.++||||||++||||++|+.||........       ...+..+...        
T Consensus       305 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~~--------  367 (446)
T 4ejn_A          305 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEIR--------  367 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC--------
T ss_pred             c--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHHhCCCC--------
Confidence            1  2446799999999999999999999999999999999999999976543221       1111111111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                        .+......+.+++..||+.||.+||     |+.++++
T Consensus       368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              1112346788999999999999999     9999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-44  Score=345.88  Aligned_cols=265  Identities=25%  Similarity=0.414  Sum_probs=209.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEec-cCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC--eEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET-TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv  242 (455)
                      +.+.+.||+|+||.||++.+.. ....+..||||++........+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            4456789999999999998642 23467899999998766666678999999999999999999999987654  67999


Q ss_pred             EEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +||+++++|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            9999999999999765 5689999999999999999999964   99999999999999999999999999998776443


Q ss_pred             Ccc-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh---------hhhHHHHHHHhhcC
Q 037780          322 SKT-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY---------AILTDWAFDCYRNG  391 (455)
Q Consensus       322 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~---------~~~~~~~~~~~~~~  391 (455)
                      ... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.....+..         ..........+..+
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            221 11234577889999999988899999999999999999999998764321100         00111111111111


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .         ....+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       280 ~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          280 G---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1         11112234678999999999999999999999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-43  Score=338.11  Aligned_cols=259  Identities=21%  Similarity=0.324  Sum_probs=197.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .++..||+|++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACL---LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEET---TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eEEEEeecCCCCceEEEEEEc---CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            455678999999999999976   356789999986422   23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          243 YEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864    46789999999999999999999965   99999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      .....  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........    . ....+..+...... 
T Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~~~~~~-  259 (310)
T 2wqm_A          188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----S-LCKKIEQCDYPPLP-  259 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----H-HHHHHHTTCSCCCC-
T ss_pred             CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----H-HHHHhhcccCCCCc-
Confidence            43221  1334689999999999999999999999999999999999999975432211    1 11122222221111 


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                             ....+..+.+++..||+.||.+|||+.+|++.|+.+....
T Consensus       260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence                   1123567889999999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-43  Score=343.10  Aligned_cols=243  Identities=25%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +...+.||+|+||+||+|...   .++..||||++.....   ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeeeeEEccCCCEEEEEEEEc---cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            344578999999999999876   4578899999864322   2335689999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |||++ |+|.+++. ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            99997 67877775 456789999999999999999999965   9999999999999999999999999999876432 


Q ss_pred             CccccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                           ....||+.|+|||++.   ...++.++||||||+++|||++|+.||.......      ......... ....  
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~~-~~~~--  273 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SPAL--  273 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CCCC--
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcC-CCCC--
Confidence                 2346899999999984   5678999999999999999999999997544321      111111111 1111  


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                            .....+..+.+++..||+.||++|||+.++++
T Consensus       274 ------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          274 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                  11123567889999999999999999999985

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-43  Score=341.30  Aligned_cols=260  Identities=25%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             CHHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-----ccccHHHHHHHHHHHcccCCCCceeeee
Q 037780          157 SYKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-----FQDGEKEFKNEVVVIGQTHHKNLVRLLG  231 (455)
Q Consensus       157 ~~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~g  231 (455)
                      +..++. ..+.+.+.||+|+||+||+|...   .++..+|+|.+...     .....+.+.+|+.++++++||||+++++
T Consensus        20 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           20 SLLELQ-KKYHLKGAIGQGSYGVVRVAIEN---QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             CHHHHH-HHEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhh-hheeecceeeecCCeEEEEEEEC---CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            344433 34566789999999999999876   45678999988543     2344577999999999999999999999


Q ss_pred             eEecCCeEEEEEEeCCCCCHHHHhcC----------------------------------------CCCCCHHHHHHHHH
Q 037780          232 FCDEGQNRLLVYEFLNNGTLASFLFG----------------------------------------NLKPSWNLRTNIAF  271 (455)
Q Consensus       232 ~~~~~~~~~lv~e~~~~gsL~~~l~~----------------------------------------~~~~~~~~~~~i~~  271 (455)
                      ++.+.+..++||||+++|+|.+++..                                        ...+++..++.|+.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            99999999999999999999999852                                        11225677888999


Q ss_pred             HHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC--cEEEeeccCcccccCCCCcc--ccccccccCcccccccccC--CC
Q 037780          272 QIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY--NARISDFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWYRK--ST  345 (455)
Q Consensus       272 ~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~  345 (455)
                      |++.||+|||+.   +|+||||||+|||++.++  .+||+|||+++.........  ......||+.|+|||.+.+  ..
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            999999999965   999999999999998776  89999999998764322211  1234569999999999865  67


Q ss_pred             CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCC
Q 037780          346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDP  425 (455)
Q Consensus       346 ~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p  425 (455)
                      ++.++||||||+++|||++|+.||......+.      ..........  ...+.     .......+.+++..||+.||
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCT
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCCh
Confidence            89999999999999999999999976543221      1111111110  00110     11235678899999999999


Q ss_pred             CCCCCHHHHHH
Q 037780          426 SLRPTMRKVSQ  436 (455)
Q Consensus       426 ~~RPt~~~v~~  436 (455)
                      .+|||+.++++
T Consensus       320 ~~Rps~~~~l~  330 (345)
T 3hko_A          320 DERFDAMRALQ  330 (345)
T ss_dssp             TTSCCHHHHHH
T ss_pred             hHCCCHHHHhc
Confidence            99999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.2e-43  Score=332.17  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=195.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|...    .+..+|+|++....  ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             hhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            45678999999999999873    46789999986432  2234678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++ +|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9986 898888754 6789999999999999999999965   9999999999999999999999999999876533221


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc---ccc---c
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK---LDD---L  396 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~  396 (455)
                        .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.  + ...........   ...   .
T Consensus       157 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--L-MRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHHHHHCCCCTTTSTTGGGS
T ss_pred             --cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHHCCCChhhchhhhcc
Confidence              1334689999999998764 589999999999999999999999976543221  1 11111111100   000   0


Q ss_pred             --cccccc-------cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 --VEGDME-------AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 --~~~~l~-------~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .++...       ..........+.+++..||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000000       0001123567889999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-43  Score=342.57  Aligned_cols=261  Identities=28%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ..+.+.+.||+|+||.||+|.+..  ....+..||||.+... ......++.+|+.++.+++||||+++++++.+....+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            345567889999999999998643  2245678999999643 2344567999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEee
Q 037780          241 LVYEFLNNGTLASFLFGN-------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISD  310 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~D  310 (455)
                      +||||+++++|.+++...       ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence            999999999999999754       3488999999999999999999965   9999999999999994   45699999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhh
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......       ....+.
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~  259 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVT  259 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHH
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHHHh
Confidence            999986544333222234457899999999988899999999999999999998 999997544321       111222


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+....         .+...+..+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus       260 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          260 SGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            221111         112245678899999999999999999999999987543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-42  Score=330.69  Aligned_cols=262  Identities=19%  Similarity=0.204  Sum_probs=204.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeE-ecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||.+....  ...++.+|+.++.+++|++++..+.++ ...+..++|||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEEccCCCeEEEEEEEc---CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            345578999999999999975   457899999986533  234689999999999998877766665 56777899999


Q ss_pred             eCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCcccccCC
Q 037780          245 FLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       245 ~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+ +++|.+++. ....+++..++.++.|++.||+|||+.   +|+||||||+|||+   ++++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 999999997 356799999999999999999999965   99999999999999   48889999999999876654


Q ss_pred             CCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          321 QSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       321 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ....     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........................
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            3211     11345699999999999999999999999999999999999999986443221111111111110000000


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                      +         ....+..+.+++..||+.||.+|||+.+|++.|+.+....
T Consensus       242 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          242 L---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             H---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            0         0123467899999999999999999999999999865433

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.3e-43  Score=340.19  Aligned_cols=257  Identities=29%  Similarity=0.454  Sum_probs=203.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.+.||+|+||.||+|....++ ....+++|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCC-cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            3456788999999999999987432 12245999886432 33455689999999999 899999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcE
Q 037780          243 YEFLNNGTLASFLFGNL----------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNA  306 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  306 (455)
                      |||+++++|.+++....                .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997654                689999999999999999999964   99999999999999999999


Q ss_pred             EEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHH
Q 037780          307 RISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAF  385 (455)
Q Consensus       307 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  385 (455)
                      ||+|||+++........   ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......       ..
T Consensus       182 kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY  251 (327)
T ss_dssp             EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred             EEcccCcCccccccccc---cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence            99999999754322211   23457889999999988889999999999999999998 999997554321       11


Q ss_pred             HHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ..+..+..         ...+...+..+.+++..||+.+|.+|||+.++++.|+.+.+.
T Consensus       252 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          252 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            12222211         111223456789999999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-42  Score=329.04  Aligned_cols=244  Identities=26%  Similarity=0.360  Sum_probs=199.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   .++..+|+|.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeeEEecCCCeEEEEEEEc---cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            344578999999999999886   456789999985432   22356789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++.....+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence            9999999999999888889999999999999999999994   5999999999999999999999999999865443222


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........       ..+.....         
T Consensus       165 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~---------  224 (279)
T 3fdn_A          165 ----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRVEF---------  224 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCC---------
T ss_pred             ----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-------HHHHhCCC---------
Confidence                3346899999999999999999999999999999999999999755432211       11111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ..+......+.+++..||+.||.+|||+.++++
T Consensus       225 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             011123467889999999999999999999996

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=328.01  Aligned_cols=245  Identities=26%  Similarity=0.388  Sum_probs=180.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||+|...   .++..||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.+..++|+
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESI---HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeeecCCCceEEEEEEEc---cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            44578999999999999875   356789999986432   223467999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++++|.+++... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999875 6789999999999999999999965   999999999999999999999999999987653322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      ..  ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........               ........ 
T Consensus       168 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~-  229 (278)
T 3cok_A          168 KH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY-  229 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC-
T ss_pred             cc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc-
Confidence            21  2356899999999999888999999999999999999999999754432110               00111111 


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       230 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 -EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             111223567889999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-42  Score=331.09  Aligned_cols=261  Identities=19%  Similarity=0.202  Sum_probs=202.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeE-ecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFC-DEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~-~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||+||+|...   ..++.||||.+....  ....+.+|+.++.+++|++++..++++ ...+..++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEc---CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            3456688999999999999976   357889999865432  223588999999999998877777766 6677889999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||+ +++|.+++.. ...+++..++.++.|++.||+|||+.   +|+||||||+|||+   ++++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 9999999974 56799999999999999999999965   99999999999999   7899999999999987654


Q ss_pred             CCCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          320 NQSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       320 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      .....     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            43211     1134568999999999999999999999999999999999999998654422222111111111000000


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+         ....+..+.+++..||+.+|++|||+.+|++.|+++.+
T Consensus       241 ~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          241 VL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            00         01124678999999999999999999999999988654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-43  Score=334.68  Aligned_cols=259  Identities=26%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|.+.........||||.+....   ....+.+.+|+.++.+++||||+++++++.... .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            455678999999999999986554455679999986532   234567999999999999999999999998765 8899


Q ss_pred             EEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      +||+++++|.+++... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  175 (291)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence            9999999999999764 5689999999999999999999965   99999999999999999999999999998765443


Q ss_pred             Ccc-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          322 SKT-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......      ........+...     
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~-----  244 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERL-----  244 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCC-----
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCCCC-----
Confidence            321 1233457889999999998889999999999999999999 999997654321      111111111110     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                          ......+..+.+++..||+.||.+|||+.++++.|+++..
T Consensus       245 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          245 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                1112345788999999999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=343.61  Aligned_cols=263  Identities=17%  Similarity=0.173  Sum_probs=203.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCC-----CceEEEEEeccccccccHHHHHHHHHHHcccCCCCcee------------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRT-----STTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVR------------  228 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------------  228 (455)
                      +.+.+.||+|+||.||+|....+..     .+..||+|.+...     +.+.+|+.++.+++||||++            
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            4566889999999999999875321     4678999998643     35889999999999999988            


Q ss_pred             ---eeeeEec-CCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 037780          229 ---LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD  302 (455)
Q Consensus       229 ---l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  302 (455)
                         +++++.. +...++||||+ +++|.+++...  ..+++..++.|+.|++.||.|||+.   +|+||||||+|||++.
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence               5677765 67889999999 99999999876  7899999999999999999999965   9999999999999999


Q ss_pred             CC--cEEEeeccCcccccCCCCc-----cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccc
Q 037780          303 HY--NARISDFGLAKLLTLNQSK-----TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGE  375 (455)
Q Consensus       303 ~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~  375 (455)
                      ++  .+||+|||+++........     .......||+.|+|||.+.+..++.++||||||++||||++|+.||......
T Consensus       195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            98  9999999999876543221     1113346999999999999989999999999999999999999999865432


Q ss_pred             hhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          376 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ... +....... .. ....+......   ....+..+.+++..||+.||.+|||+.+|++.|+++.+
T Consensus       275 ~~~-~~~~~~~~-~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          275 TED-IMKQKQKF-VD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             HHH-HHHHHHHH-HH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHH-HHHHHHhc-cC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            211 11111111 11 11111111110   11234678999999999999999999999999998654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=345.63  Aligned_cols=268  Identities=20%  Similarity=0.270  Sum_probs=209.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCC--eEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ--NRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~--~~~lv  242 (455)
                      +.+.+.||+|+||+||+|.+.   .++..||||++.... ....+.+.+|+.++++++||||+++++++....  ..++|
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHK---KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             eEEEEEEEcCCCeEEEEEEEC---CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            345678999999999999986   356789999987543 234567889999999999999999999998765  77999


Q ss_pred             EEeCCCCCHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCcEEEeeccCcc
Q 037780          243 YEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLAK  315 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~  315 (455)
                      |||+++|+|.+++....   .+++..++.|+.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997643   389999999999999999999965   99999999999999    788889999999998


Q ss_pred             cccCCCCccccccccccCcccccccccC--------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHH
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRK--------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  387 (455)
                      ........   ....||+.|+|||++.+        ..++.++||||||+++|||++|+.||.........  .......
T Consensus       165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~  239 (396)
T 4eut_A          165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (396)
T ss_dssp             ECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred             EccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence            76543321   34569999999999865        56788999999999999999999999754332111  1112222


Q ss_pred             hhcCc---cccc---cc------cc--cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          388 YRNGK---LDDL---VE------GD--MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       388 ~~~~~---~~~~---~~------~~--l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      .....   +..+   ..      ..  ............+.+++..||+.||++|||+.++++.++.+++.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            21111   1000   00      00  11122356778899999999999999999999999999886653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-43  Score=344.71  Aligned_cols=244  Identities=27%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHH-HcccCCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVV-IGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...   .++..+|+|++.....   .....+..|..+ ++.++||||+++++++.+.+..++
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHK---AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEET---TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEc---CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            456688999999999999986   3567899999865432   233456777776 577899999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++......
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            999999999999998888899999999999999999999964   99999999999999999999999999998643322


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+       ....+..+...       
T Consensus       194 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~-------  257 (373)
T 2r5t_A          194 ST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-------MYDNILNKPLQ-------  257 (373)
T ss_dssp             CC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-------HHHHHHHSCCC-------
T ss_pred             Cc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhcccC-------
Confidence            21  245679999999999999999999999999999999999999997654321       11111111111       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV  434 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v  434 (455)
                         .+......+.+++..||+.||.+||++.+.
T Consensus       258 ---~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          258 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             ---CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             ---CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence               011234678899999999999999998543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-42  Score=329.48  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=195.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||+||++...   .++..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEER---SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heeecceeccCCCeEEEEEEEc---cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            4566789999999999999876   356789999986543 334578999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCccc
Q 037780          244 EFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKL  316 (455)
Q Consensus       244 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~  316 (455)
                      ||+++++|.+++..    ...+++..++.|+.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999999854    36789999999999999999999964   99999999999999   4567899999999987


Q ss_pred             ccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          317 LTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       317 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      .......   ....||+.|+|||.+. ..++.++||||||+++|||++|+.||.........       ...........
T Consensus       177 ~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~  245 (285)
T 3is5_A          177 FKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-------QKATYKEPNYA  245 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCCC
T ss_pred             cCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-------hhhccCCcccc
Confidence            6543222   3456899999999885 56899999999999999999999999765432211       11111111000


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..       .......+.+++..||+.||++|||+.++++
T Consensus       246 ~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 VE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00       0012467889999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-42  Score=330.42  Aligned_cols=247  Identities=27%  Similarity=0.420  Sum_probs=197.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec----CCeEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~  240 (455)
                      .+.+.||+|+||+||+|...   ..+..||+|.+....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~---~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EeeeeccCCCCeEEEEeEec---CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34567999999999999886   356789999886432  3345679999999999999999999998865    45689


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  319 (455)
                      +||||+++++|.+++.....+++..++.|+.|++.||.|||+. ..+|+||||||+||+++ +++.+||+|||++.....
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999998878899999999999999999999954 12399999999999998 889999999999976543


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ...    ....||+.|+|||.+. +.++.++||||||+++|+|++|+.||........      .......+......+ 
T Consensus       185 ~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~-  252 (290)
T 1t4h_A          185 SFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFD-  252 (290)
T ss_dssp             TSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCGGGG-
T ss_pred             ccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCccccC-
Confidence            322    3456899999999886 4589999999999999999999999975433211      111222221111111 


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ...+..+.+++..||+.||.+|||+.++++
T Consensus       253 -------~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          253 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   112357889999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.5e-43  Score=338.33  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||+|...   .++..||+|++.....  ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           27 YENLGLVGEGSYGMVMKCRNK---DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             EEEEEEGGGGTTSSEEEEEET---TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             heeeeEEeecCCEEEEEEEEC---CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            345578999999999999986   3567899999854332  23456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            9999999999988888899999999999999999999965   9999999999999999999999999999876543221


Q ss_pred             cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH--------HHHHHhhcCc-c
Q 037780          324 TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCYRNGK-L  393 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~-~  393 (455)
                        .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.............        .....+.... .
T Consensus       181 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          181 --YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             --cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence              1345689999999999775 78999999999999999999999997655422111000        0001111110 1


Q ss_pred             ccccccccccCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....+.......     ...++.+.+++..||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111111111     123578999999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-42  Score=338.05  Aligned_cols=250  Identities=24%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.+.||+|+||.||++...   .++..+|+|.+.....    .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHK---ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3455678999999999999986   4578899999965433    245688888888 7999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC----CcEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH----YNARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~~~  319 (455)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||+.   +|+||||||+|||+.++    +.+||+|||+++....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            9999999999999888899999999999999999999965   99999999999998543    3599999999987654


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      .....  ....||+.|+|||++.+..++.++|||||||++|||++|+.||..........    ....+..+....    
T Consensus       173 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~~----  242 (342)
T 2qr7_A          173 ENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFSL----  242 (342)
T ss_dssp             TTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCCC----
T ss_pred             CCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCccc----
Confidence            33221  34568999999999988889999999999999999999999997543221111    122222232211    


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        ........+..+.+++..||+.||++|||+.++++
T Consensus       243 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 --SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00111224567889999999999999999999885

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-42  Score=328.85  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=201.7

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc------ccHHHHHHHHHHHcccCCCCceeeeeeEecCC
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~  237 (455)
                      ..+.+.+.||+|+||.||++...   .++..+|+|.+.....      ...+.+.+|+.++++++||||+++++++.+..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK---GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhHHhhcccCceEEEEEEEc---CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence            34566788999999999999986   3467899998864321      13678999999999999999999999999999


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----cEEEeeccC
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGL  313 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~  313 (455)
                      ..++||||+++++|.+++.....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++    .+||+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999999998878899999999999999999999964   999999999999999877    899999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      +.........   ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........       ...+.....
T Consensus       159 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~  228 (283)
T 3bhy_A          159 AHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------LTNISAVNY  228 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC
T ss_pred             ceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------HHHhHhccc
Confidence            9876543221   334589999999999988999999999999999999999999976543211       111111111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .  .....    ....+..+.+++..||+.||.+|||+.++++
T Consensus       229 ~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 D--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             C--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0  00000    0123467889999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-42  Score=328.00  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||+|...   .++..||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHK---TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhcCcCCeEEEEEEEc---CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            345578999999999999986   356789999986432  233467889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc---EEEeeccCcccccCC
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLN  320 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~  320 (455)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||++......
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999999999998888899999999999999999999965   9999999999999987665   999999999876543


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ...   ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......       ....+..+.... ..+ 
T Consensus       162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~-~~~-  229 (284)
T 3kk8_A          162 EAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-PSP-  229 (284)
T ss_dssp             CBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-CTT-
T ss_pred             ccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC-Cch-
Confidence            322   34568999999999999999999999999999999999999997544321       111112221111 110 


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          .....+..+.+++..||+.||++|||+.++++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          230 ----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                01123567889999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=340.57  Aligned_cols=254  Identities=21%  Similarity=0.281  Sum_probs=185.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEe--------cC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCD--------EG  236 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~--------~~  236 (455)
                      +.+.+.||+|+||.||+|...   ..+..||||++........+.+.+|+.++.++. ||||+++++++.        ..
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDV---GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEET---TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             EEEEEEEccCCceEEEEEEEC---CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            455688999999999999986   356789999986655556677999999999996 999999999983        34


Q ss_pred             CeEEEEEEeCCCCCHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          237 QNRLLVYEFLNNGTLASFLFG---NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ...++|+||+. |+|.+++..   ...+++..++.|+.|++.||+|||+. ..+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            45799999995 799888864   46799999999999999999999954 12299999999999999999999999999


Q ss_pred             cccccCCCCcc----------ccccccccCcccccccc---cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh
Q 037780          314 AKLLTLNQSKT----------IKTAIRGTKGYVAPEWY---RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL  380 (455)
Q Consensus       314 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~  380 (455)
                      ++.........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||.......    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence            98765432211          01134589999999998   56678999999999999999999999996433211    


Q ss_pred             HHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                                     +................+.+++..||+.||.+|||+.++++.|+.+..
T Consensus       261 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          261 ---------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                           000000001111123457889999999999999999999999988654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=340.63  Aligned_cols=251  Identities=18%  Similarity=0.197  Sum_probs=200.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEeccccccccHHHHHHHHHHHcccC---CCCceeeeeeEecCCeEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~  240 (455)
                      +.+.+.||+|+||+||+|....  ....++.||||++...   ...++..|+.++.+++   |+|++++++++...+..+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~  143 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV  143 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence            4455789999999999996432  1246788999998753   3556778888888776   999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----------CC
Q 037780          241 LVYEFLNNGTLASFLF-----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-----------HY  304 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----------~~  304 (455)
                      +||||+++|+|.+++.     ....++|..++.|+.|++.||+|||+   .+|+||||||+|||++.           ++
T Consensus       144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccC
Confidence            9999999999999997     35679999999999999999999995   59999999999999998           89


Q ss_pred             cEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHH
Q 037780          305 NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWA  384 (455)
Q Consensus       305 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  384 (455)
                      .+||+|||+++.+.............||++|+|||++.+..++.++|||||||++|||+||+.||........       
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------  293 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------  293 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------
Confidence            9999999999865533333333556799999999999999999999999999999999999999864332110       


Q ss_pred             HHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHhcCcC
Q 037780          385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLR-PTMRKVSQMLEGVVE  443 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R-Pt~~~v~~~L~~~~~  443 (455)
                             .    +.......   ...+.+.+++..|++.+|.+| |++.++.+.|++..+
T Consensus       294 -------~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          294 -------K----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             -------E----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -------e----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                   0    11111111   124567788889999999999 788888888877543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=331.75  Aligned_cols=269  Identities=22%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc--CCCCceeeeeeEecC----
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT--HHKNLVRLLGFCDEG----  236 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~g~~~~~----  236 (455)
                      ...+.+.+.||+|+||.||+|...     +..||||++...   ....+..|.+++...  +||||+++++++...    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            345566789999999999999873     678999998543   234455566665554  899999999999877    


Q ss_pred             CeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          237 QNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                      ...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+     ..+|+||||||+|||++.++.+||+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            6889999999999999999654 6899999999999999999999431     229999999999999999999999999


Q ss_pred             cCcccccCCCCccc--cccccccCcccccccccCCCCCCC------CCeecHHHHHHHHHhC----------CCCCCccc
Q 037780          312 GLAKLLTLNQSKTI--KTAIRGTKGYVAPEWYRKSTITAK------VDVYSFGVLLLEIISC----------RKSFDIEM  373 (455)
Q Consensus       312 g~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gv~l~el~tg----------~~p~~~~~  373 (455)
                      |+++..........  .....||+.|+|||++.+...+.+      +||||||+++|||+||          +.||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            99987654332211  123469999999999987766665      9999999999999999          55554432


Q ss_pred             cchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          374 GEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                      .....  ..................   .......++..+.+++..||+.||.+|||+.+|++.|+.+.+..
T Consensus       267 ~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          267 PSDPS--YEDMREIVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CSSCC--HHHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CCCCc--hhhhHHHHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            21111  111111111111111111   11112367888999999999999999999999999999876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.8e-43  Score=337.92  Aligned_cols=259  Identities=20%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|...   .++..||||++.....  ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDT---VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEecCCeEEEEEEEC---CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            445678999999999999876   4578999999864432  22456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-----CCCcEEEeeccCccccc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-----DHYNARISDFGLAKLLT  318 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Dfg~a~~~~  318 (455)
                      ||++ |+|.+++.....+++..++.|+.|++.||+|||+.   +|+||||||+|||++     +++.+||+|||+++...
T Consensus       113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9998 49999999888899999999999999999999965   999999999999994     55569999999998765


Q ss_pred             CCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---Cccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLD  394 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  394 (455)
                      ......  ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  .. .......   ....
T Consensus       189 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          189 IPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FK-IFEVLGLPDDTTWP  263 (329)
T ss_dssp             -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCTTTST
T ss_pred             Cccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HH-HHHHhCCCchhhhh
Confidence            332221  344689999999999875 4899999999999999999999999765432211  11 1111000   0000


Q ss_pred             -------------cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 -------------DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 -------------~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                   ......+...........+.+++..||+.||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                         000000000001113467889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=349.82  Aligned_cols=248  Identities=20%  Similarity=0.213  Sum_probs=197.2

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.||+|+||.||++...   .+++.||+|++.+..   ......+.+|..++.+++||||+++++++.+.+..++||||
T Consensus        66 ~~~lG~G~fG~V~~~~~~---~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~  142 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMK---QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY  142 (412)
T ss_dssp             EEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence            467999999999999986   457889999986432   12234588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++|+|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.........
T Consensus       143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence            9999999999764 4789999999999999999999964   99999999999999999999999999998765443321


Q ss_pred             ccccccccCccccccccc-------CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR-------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                       .....||+.|+|||++.       ...++.++|||||||++|||++|+.||......+..      ........  .+.
T Consensus       220 -~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~--~~~  290 (412)
T 2vd5_A          220 -SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY------GKIVHYKE--HLS  290 (412)
T ss_dssp             -CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTHHH--HCC
T ss_pred             -cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH------HHHHhccc--CcC
Confidence             13457999999999987       457899999999999999999999999765432211      11110000  000


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLR---PTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R---Pt~~~v~~  436 (455)
                      .+..    ....+..+.+++..||. +|.+|   |++.++++
T Consensus       291 ~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          291 LPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0100    11235678999999999 99998   68998875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.9e-43  Score=332.37  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=201.8

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec--------
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--------  235 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--------  235 (455)
                      ..+...+.||+|+||.||+|...   .+++.||+|++....    +.+.+|+.++.+++||||+++++++..        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHR---IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEET---TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             cccceeeeeccCCceEEEEEEEc---CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34455678999999999999986   356789999986532    357789999999999999999998854        


Q ss_pred             --------CCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc
Q 037780          236 --------GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN  305 (455)
Q Consensus       236 --------~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  305 (455)
                              ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+|+||||+||++++++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                    44579999999999999999643  6789999999999999999999965   9999999999999999999


Q ss_pred             EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH
Q 037780          306 ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF  385 (455)
Q Consensus       306 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  385 (455)
                      +||+|||++.........   ....||+.|+|||.+.+..++.++||||||+++|||++|..|+....         ...
T Consensus       161 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHH
T ss_pred             EEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHH
Confidence            999999999876543322   33468999999999999999999999999999999999998864211         111


Q ss_pred             HHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCCC
Q 037780          386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDV  446 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~~  446 (455)
                      ..+..+.+..            ..+..+.+++..||+.||.+|||+.++++.|+.+...+.
T Consensus       229 ~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 TDLRDGIISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHTTCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHhhcccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            1122222111            123567899999999999999999999999988765443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-42  Score=332.78  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ..+.+.+.||+|+||+||++...   .+++.||+|.+..........+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQR---LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEEC---CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            34556688999999999999976   356789999997654445567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCcccccCC
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+||++   ++++.+||+|||+++.....
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999999998878899999999999999999999965   99999999999999   78899999999999765432


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ....+..+... ..   
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~-~~---  227 (304)
T 2jam_A          163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE-FE---  227 (304)
T ss_dssp             T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC-CC---
T ss_pred             c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC-CC---
Confidence            1    133458999999999999999999999999999999999999997544321       11112222111 00   


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGV  441 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~  441 (455)
                        .......+..+.+++..||+.||.+|||+.++++  .+.+.
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          228 --SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             --TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             --ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence              0111123567899999999999999999999986  45543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-42  Score=327.20  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=205.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .++..||+|.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREK---QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceeeheecCCCCeEEEEEEEc---CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            445678999999999999986   356789999985432   22356799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++.....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence            9999999999999887889999999999999999999994   5999999999999999999999999999876543221


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........       ...+.....         
T Consensus       170 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~---------  229 (284)
T 2vgo_A          170 ----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNVDL---------  229 (284)
T ss_dssp             ----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC---------
T ss_pred             ----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhcccc---------
Confidence                335689999999999999999999999999999999999999976543211       111111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~  442 (455)
                       ..+...+..+.+++..||+.||.+|||+.++++  .+....
T Consensus       230 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 -KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence             011123467889999999999999999999986  555433

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-42  Score=346.70  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=191.4

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--------cccHHHHHHHHHHHcccCCCCceeeeeeEec
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE  235 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  235 (455)
                      ..+.+.+.||+|+||+||+|...   .++..||||.+....        ......+.+|+.++++++||||+++++++..
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFER---KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             ccEEEEeEEeeCCCeEEEEEEEC---CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34556688999999999999987   456789999986432        1112348899999999999999999999854


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEeecc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARISDFG  312 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg  312 (455)
                       +..++||||+++|+|.+++.....+++..+..|+.|++.||+|||+.   +|+||||||+|||++.++   .+||+|||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence             56899999999999999999888999999999999999999999965   999999999999997544   59999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      +++.......   .....||+.|+|||++.+   ..++.++||||||+++|+|++|+.||........  +    ...+.
T Consensus       288 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~i~  358 (419)
T 3i6u_A          288 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQIT  358 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHHHH
T ss_pred             cceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHHHh
Confidence            9987654322   134569999999999853   5678899999999999999999999975433211  1    11112


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+.......  .    ....+..+.+++..||+.||.+|||+.++++
T Consensus       359 ~~~~~~~~~--~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          359 SGKYNFIPE--V----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TTCCCCCHH--H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCch--h----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            222111000  0    0123567899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=337.12  Aligned_cols=267  Identities=26%  Similarity=0.361  Sum_probs=193.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHH--HcccCCCCceeeeeeEe-----cCCe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVV--IGQTHHKNLVRLLGFCD-----EGQN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~g~~~-----~~~~  238 (455)
                      +.+.+.||+|+||.||+|..     .+..||||++...   ....+..|.++  +..++||||+++++.+.     ....
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           15 LKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hheeeecccCCCeEEEEEEE-----CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            34567899999999999976     4678999998643   23344444444  55689999999998553     2335


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEeCCCCCCEEEcCCCcEEEeecc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------SSQIIHCDIKPQNILLDDHYNARISDFG  312 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~kl~Dfg  312 (455)
                      .++||||+++|+|.+++.... .++..+..|+.|++.||+|||+.+      ..+|+||||||+|||++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            789999999999999996544 489999999999999999999431      1299999999999999999999999999


Q ss_pred             CcccccCCCC------ccccccccccCcccccccccC-------CCCCCCCCeecHHHHHHHHHhCCCCCCcccc-chhh
Q 037780          313 LAKLLTLNQS------KTIKTAIRGTKGYVAPEWYRK-------STITAKVDVYSFGVLLLEIISCRKSFDIEMG-EEYA  378 (455)
Q Consensus       313 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~-~~~~  378 (455)
                      +++.......      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.|+..... ....
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987654321      111124469999999999976       4567899999999999999999877643322 1110


Q ss_pred             hh----------HHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          379 IL----------TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       379 ~~----------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ..          ................+..  ........+..+.+++..||+.||++|||+.++++.|+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            00          0011111111111111111  111233467789999999999999999999999999998654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.5e-42  Score=340.55  Aligned_cols=244  Identities=23%  Similarity=0.282  Sum_probs=188.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc-cCCCCceeeeeeEec----CCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLGFCDE----GQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~e  244 (455)
                      +.||+|+||+||++...   .++..||||++..     ...+.+|+.++.+ .+||||+++++++..    ....++|||
T Consensus        68 ~~LG~G~~g~V~~~~~~---~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             EEEEEETTEEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             ceeeeccCeEEEEEEEC---CCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            57999999999999986   4567899999853     2457788888754 589999999998865    567899999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTL  319 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  319 (455)
                      |+++|+|.+++...  ..+++..+..|+.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++....
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            99999999999875  3589999999999999999999964   9999999999999997   78999999999986553


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ...   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ....+..+... +..+
T Consensus       217 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~-~~~~  289 (400)
T 1nxk_A          217 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYE-FPNP  289 (400)
T ss_dssp             -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCC-CCTT
T ss_pred             CCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCccc-CCCc
Confidence            322   1345689999999999999999999999999999999999999976543211100   01111112111 0000


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           .....+..+.+++..||+.||.+|||+.++++
T Consensus       290 -----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          290 -----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 01124567899999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-42  Score=340.55  Aligned_cols=258  Identities=23%  Similarity=0.281  Sum_probs=198.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-----CCCceeeeeeEecCCeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----HKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~g~~~~~~~~  239 (455)
                      .+.+.++||+|+||+||+|...   .++..||||++... ......+..|+.++.+++     ||||+++++++...+..
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~  111 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHI---DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM  111 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred             EEEEEEEEcccCCeEEEEEEEC---CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence            3445688999999999999986   35678999998643 334566788999999986     99999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---------------
Q 037780          240 LLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---------------  302 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---------------  302 (455)
                      ++||||+ +++|.+++....  .+++..+..|+.|++.||+|||+.   +|+||||||+|||++.               
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999 999999997653  589999999999999999999954   9999999999999975               


Q ss_pred             ----------CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcc
Q 037780          303 ----------HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIE  372 (455)
Q Consensus       303 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~  372 (455)
                                ++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                      7899999999998654322     3356899999999999999999999999999999999999999765


Q ss_pred             ccchhhhhHHH---------HHHHhhcCccccccccc-cc-----cCCCH---------------HHHHHHHHHHHhccc
Q 037780          373 MGEEYAILTDW---------AFDCYRNGKLDDLVEGD-ME-----AMNDI---------------KCVEKLLMVSIWCIQ  422 (455)
Q Consensus       373 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-l~-----~~~~~---------------~~~~~~~~l~~~cl~  422 (455)
                      ...+.......         ........ ....++.. ..     .....               ...+.+.+++..||+
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            43221111100         00000000 00000000 00     00000               012567899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 037780          423 EDPSLRPTMRKVSQ  436 (455)
Q Consensus       423 ~~p~~RPt~~~v~~  436 (455)
                      .||.+|||+.|+++
T Consensus       342 ~dP~~Rpta~elL~  355 (360)
T 3llt_A          342 IDPTLRPSPAELLK  355 (360)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.2e-43  Score=330.30  Aligned_cols=246  Identities=27%  Similarity=0.390  Sum_probs=194.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecC-CeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-QNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||++...     +..||||.+...  ...+.+.+|+.++.+++||||+++++++.+. +..++|||
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             ceEEeEEecCCCceEEEEEEc-----CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            445678999999999999863     678999998753  3456799999999999999999999997654 47899999


Q ss_pred             eCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++++|.+++....  .+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999999997653  378999999999999999999965   99999999999999999999999999998654322 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                          ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||........       ...+..+...       
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~~-------  233 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYKM-------  233 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTCCC-------
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCCC-------
Confidence                22347889999999998899999999999999999998 9999975543221       1111121111       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                        ..+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus       234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          234 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence              112234578899999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.2e-43  Score=343.39  Aligned_cols=262  Identities=19%  Similarity=0.289  Sum_probs=202.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||++...   .++..||+|++.... ....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~---~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceeeeeecCCCCeEEEEEEEC---CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            344578999999999999986   456789999986542 3335679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++++|.+++.....+++..+..|+.+++.||+|||+.  .+|+||||||+|||++.++.+||+|||++........  
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  187 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  187 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc--
Confidence            999999999998888899999999999999999999952  2799999999999999999999999999976543221  


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHH---------HHHH--------
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW---------AFDC--------  387 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~---------~~~~--------  387 (455)
                        ....||+.|+|||++.+..++.++||||||+++|||++|+.||..............         ....        
T Consensus       188 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          188 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             --cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence              335689999999999999999999999999999999999999976543221110000         0000        


Q ss_pred             ------hhcCcccc----ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          388 ------YRNGKLDD----LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       388 ------~~~~~~~~----~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                            .......+    +.............+..+.+++..||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  00000000    00000011111123567899999999999999999999885

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-42  Score=328.65  Aligned_cols=245  Identities=21%  Similarity=0.329  Sum_probs=203.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+.+.||+|+||.||++...   ..+..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDA---DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEeecCCEEEEEEEEC---CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45578999999999999986   346789999986432   234567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      ||+++++|.+++.....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999999999998878899999999999999999999965   9999999999999999999999999999876533222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                        .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.       ...+..+...         
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~---------  233 (294)
T 2rku_A          172 --KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEYS---------  233 (294)
T ss_dssp             --BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCCC---------
T ss_pred             --cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhhccCC---------
Confidence              1345689999999999988899999999999999999999999976543211       1111111110         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       .+......+.+++..||+.||++|||+.++++
T Consensus       234 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          234 -IPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             01123457889999999999999999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-42  Score=346.07  Aligned_cols=259  Identities=24%  Similarity=0.265  Sum_probs=191.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecC------C
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  237 (455)
                      +.+.+.||+|+||+||+|...   ..++.||||++...  .....+.+.+|+.++++++||||+++++++...      .
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             eEEEEEeecCCCeEEEEEEEC---CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            445678999999999999886   45688999999654  233456789999999999999999999999654      4


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +.++||||++++ |.+.+..  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            679999999765 6666543  489999999999999999999965   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh-hHH--------------
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI-LTD--------------  382 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~-~~~--------------  382 (455)
                      .....   .....||++|+|||++.+..++.++|||||||+|+||++|+.||......+... +..              
T Consensus       215 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          215 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             --CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             CCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            54322   244679999999999999999999999999999999999999997654321110 000              


Q ss_pred             -HHHHHhhcCc------cccccccccccC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          383 -WAFDCYRNGK------LDDLVEGDMEAM---NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       383 -~~~~~~~~~~------~~~~~~~~l~~~---~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ..........      ........+...   ........+.+++..||+.||++|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0001111000      000000000000   01122567899999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-43  Score=340.76  Aligned_cols=255  Identities=21%  Similarity=0.250  Sum_probs=203.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      +.+.+.||+|+||.||++....+...++.||||++....    ....+.+.+|+.++.++ +||||+++++++...+..+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            455688999999999999986555578899999986532    22345678899999999 6999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  212 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  212 (355)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence            9999999999999998888899999999999999999999965   9999999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ..... ....||+.|+|||++.+  ..++.++||||||++||||++|+.||........  ........... .      
T Consensus       213 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~-~------  282 (355)
T 1vzo_A          213 ETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS-E------  282 (355)
T ss_dssp             GGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC-C------
T ss_pred             CCCcc-cCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhcc-C------
Confidence            32222 34569999999999985  3478899999999999999999999975443211  11111111111 0      


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQM  437 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~~  437 (455)
                          ...+......+.+++..||+.||.+||     |+.++++.
T Consensus       283 ----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          283 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                011123456788999999999999999     89999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-42  Score=343.21  Aligned_cols=261  Identities=23%  Similarity=0.368  Sum_probs=187.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccC-CCCceeeeeeEecCC--eEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQ--NRL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~--~~~  240 (455)
                      +.+.+.||+|+||.||+|.+.   ..++.||||++....  ......+.+|+.++.++. ||||+++++++...+  ..+
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDR---RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             EEEEEC-------CEEEEEET---TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             eEEEEEeeeCCCeEEEEEEEC---CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            445678999999999999886   456789999985432  234456889999999997 999999999997544  689


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||||++ ++|..++.. ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            9999997 589998865 4789999999999999999999954   9999999999999999999999999999865421


Q ss_pred             C-------------------CccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh
Q 037780          321 Q-------------------SKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL  380 (455)
Q Consensus       321 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~  380 (455)
                      .                   .....+...||++|+|||++.+ ..++.++|||||||+++||++|+.||.......... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-  241 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE-  241 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence            1                   1111234579999999999876 678999999999999999999999997655322111 


Q ss_pred             HHHHHHHhhcCcccc---c--------c----------cccccc------------CCCHHHHHHHHHHHHhcccCCCCC
Q 037780          381 TDWAFDCYRNGKLDD---L--------V----------EGDMEA------------MNDIKCVEKLLMVSIWCIQEDPSL  427 (455)
Q Consensus       381 ~~~~~~~~~~~~~~~---~--------~----------~~~l~~------------~~~~~~~~~~~~l~~~cl~~~p~~  427 (455)
                        .+...+.......   +        +          ......            .........+.+++..||+.||.+
T Consensus       242 --~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          242 --RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             --HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             --HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence              0111100000000   0        0          000000            000022457889999999999999


Q ss_pred             CCCHHHHHHH
Q 037780          428 RPTMRKVSQM  437 (455)
Q Consensus       428 RPt~~~v~~~  437 (455)
                      |||+.++++.
T Consensus       320 R~t~~e~l~H  329 (388)
T 3oz6_A          320 RISANDALKH  329 (388)
T ss_dssp             SCCHHHHTTS
T ss_pred             CCCHHHHhCC
Confidence            9999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.2e-42  Score=331.89  Aligned_cols=272  Identities=21%  Similarity=0.299  Sum_probs=208.3

Q ss_pred             HHHHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcc--cCCCCceeeeeeEec
Q 037780          158 YKALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ--THHKNLVRLLGFCDE  235 (455)
Q Consensus       158 ~~~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~g~~~~  235 (455)
                      ..+.....+.+.+.||+|+||.||+|..     .++.||||.+...   ....+..|.+++..  ++||||+++++++..
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3444455667778999999999999987     3678999998643   35667888888887  789999999999988


Q ss_pred             CC----eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCCEEEcCCCcE
Q 037780          236 GQ----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDIKPQNILLDDHYNA  306 (455)
Q Consensus       236 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~  306 (455)
                      ..    ..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||...     +.+|+||||||+|||++.++++
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            76    78999999999999999965 46899999999999999999999311     3489999999999999999999


Q ss_pred             EEeeccCcccccCCCCcc--ccccccccCcccccccccCC------CCCCCCCeecHHHHHHHHHhC----------CCC
Q 037780          307 RISDFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWYRKS------TITAKVDVYSFGVLLLEIISC----------RKS  368 (455)
Q Consensus       307 kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg----------~~p  368 (455)
                      ||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998765443211  12345699999999998765      344789999999999999999          677


Q ss_pred             CCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          369 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      |........ .... ....+.......-+..   .....+.+..+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus       267 ~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          267 YYDLVPSDP-SVEE-MRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             TTTTSCSSC-CHHH-HHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCcCcc-cHHH-HHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            765432111 1111 1122211111111110   01233577889999999999999999999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-42  Score=333.86  Aligned_cols=265  Identities=20%  Similarity=0.245  Sum_probs=196.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec-------
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-------  235 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-------  235 (455)
                      .+.+.+.||+|+||+||+|...   .+++.||+|++....  ......+.+|+.++.+++||||+++++++..       
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEET---TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ceeEEEEEecCCCcEEEEEEEC---CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            3455678999999999999986   356789999985432  2234578899999999999999999999877       


Q ss_pred             -CCeEEEEEEeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          236 -GQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       236 -~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                       .+..++||||+++ +|.+.+.. ...+++..++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence             4468999999986 66666654 46799999999999999999999965   999999999999999999999999999


Q ss_pred             cccccCCCCc--cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          314 AKLLTLNQSK--TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       314 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      ++........  .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9876532221  11234568999999998876 45899999999999999999999999865543222111111110010


Q ss_pred             Cccccccccc--------cccCCC-HH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLVEGD--------MEAMND-IK------CVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~~~~--------l~~~~~-~~------~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..........        ...... .+      ....+.+++..||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1000000000        000000 01      1345789999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-42  Score=365.43  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=205.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|.+..++..+..||||++.... ....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEE
Confidence            445577999999999999997666667889999986543 2334679999999999999999999999854 56899999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            99999999999755 4689999999999999999999965   9999999999999999999999999999876543322


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .. ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.       ...+..+....       
T Consensus       548 ~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------~~~i~~~~~~~-------  612 (656)
T 2j0j_A          548 KA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERLP-------  612 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHHTCCCC-------
T ss_pred             ec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCCCC-------
Confidence            21 33457889999999998899999999999999999997 9999975543211       11111221111       


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                        .+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus       613 --~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          613 --MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              11234578899999999999999999999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.1e-42  Score=351.70  Aligned_cols=247  Identities=26%  Similarity=0.311  Sum_probs=201.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.||+|+||.||+|...   .+++.||+|++...   .......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~---~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  264 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT  264 (576)
T ss_dssp             EEEEEEEETTEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEeeCCCEEEEEEEEC---CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            4467999999999999986   35788999998643   22345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++|+|.+++....  .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus       265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            999999999997653  489999999999999999999965   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..+...+.....         
T Consensus       342 ~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~---------  406 (576)
T 2acx_A          342 I---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPE---------  406 (576)
T ss_dssp             E---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCC---------
T ss_pred             c---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcccc---------
Confidence            1   3457999999999999989999999999999999999999999865432111   111111111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                       ..+...+..+.+++..||+.||.+||     ++.+|++
T Consensus       407 -~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 -EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             11122356789999999999999999     6788874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.8e-42  Score=324.96  Aligned_cols=245  Identities=26%  Similarity=0.346  Sum_probs=195.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      ..||+|+||.||+|...   .++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus        28 ~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  104 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDL---SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG  104 (295)
T ss_dssp             CEEEECSSSEEEEEEET---TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             EEEeecCcEEEEEEEEC---CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence            37999999999999976   356789999987665555678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcccccCCCCccc
Q 037780          250 TLASFLFGN---LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       250 sL~~~l~~~---~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +|.+++...   ..+++..+..++.|++.||.|||+.   +++|+||||+||+++. ++.+||+|||+++........  
T Consensus       105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--  179 (295)
T 2clq_A          105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--  179 (295)
T ss_dssp             EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred             CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence            999999754   3567899999999999999999965   9999999999999997 899999999999876533221  


Q ss_pred             cccccccCcccccccccCCC--CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          326 KTAIRGTKGYVAPEWYRKST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .....||+.|+|||++.+..  ++.++||||||+++|+|++|+.||..........     .........     +    
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~-----~----  245 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-----FKVGMFKVH-----P----  245 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-----HHHHHHCCC-----C----
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-----Hhhcccccc-----c----
Confidence            13456899999999987653  7899999999999999999999997543321110     000000000     0    


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..+...+..+.+++..||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111224567889999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.6e-42  Score=329.16  Aligned_cols=245  Identities=26%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      ...+.||+|+||.||+|...   ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           25 TKLEKIGKGSFGEVFKGIDN---RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEET---TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHhhhhcccCCeEEEEEEEC---CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            44578999999999999876   356789999986443 33457899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.......... 
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-  176 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-  176 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB-
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccccc-
Confidence            999999999864 5689999999999999999999965   99999999999999999999999999998765433221 


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........       ......+....     .    
T Consensus       177 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~-----~----  239 (303)
T 3a7i_A          177 -NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-------LFLIPKNNPPT-----L----  239 (303)
T ss_dssp             -CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCCCC-----C----
T ss_pred             -CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-------HHHhhcCCCCC-----C----
Confidence             345689999999999999999999999999999999999999975443211       11111111111     1    


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....+..+.+++..||+.||.+|||+.++++
T Consensus       240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1123467889999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.8e-42  Score=334.85  Aligned_cols=246  Identities=21%  Similarity=0.324  Sum_probs=203.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||++...   ..+..+|+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDA---DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            345578999999999999986   356789999986432   23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++.....+++.+++.|+.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            99999999999998878899999999999999999999965   999999999999999999999999999987653322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.       ...+..+...        
T Consensus       197 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~--------  259 (335)
T 2owb_A          197 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEYS--------  259 (335)
T ss_dssp             C--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCC--------
T ss_pred             c--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHhcCCCC--------
Confidence            2  1345689999999999998899999999999999999999999976543211       1111111110        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .+......+.+++..||+.||++|||+.++++
T Consensus       260 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 --IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              01123456889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.7e-42  Score=348.66  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=198.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.+.||+|+||+||+|...   ..+..+|+|++....  ......+.+|+.++++++||||+++++++.+....++|
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDK---VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEET---TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEEC---CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4566788999999999999986   356789999986532  33456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CcEEEeeccCcccccC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTL  319 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~  319 (455)
                      |||+++|+|.+++.....+++..+..|+.|++.||+|||+.   +|+||||||+|||++.+   +.+||+|||+++....
T Consensus       115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            99999999999998888899999999999999999999965   99999999999999764   4599999999987654


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ....   ....||+.|+|||++. ..++.++|||||||++|+|++|+.||......+       ....+..+.... ..+
T Consensus       192 ~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~-~~~  259 (494)
T 3lij_A          192 QKKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF-DSP  259 (494)
T ss_dssp             TBCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-CSG
T ss_pred             Cccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC-Cch
Confidence            3321   3456999999999986 569999999999999999999999997654422       112222222111 011


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..     ...+..+.+++..||+.+|.+|||+.++++
T Consensus       260 ~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 EW-----KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GG-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hc-----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            00     123567889999999999999999999884

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.7e-42  Score=360.63  Aligned_cols=245  Identities=25%  Similarity=0.313  Sum_probs=202.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv  242 (455)
                      .+.+.||+|+||.||+|...   .+++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus       344 ~~~~~LG~G~fG~V~~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          344 NFLMVLGKGSFGKVMLSERK---GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             EEEEESSBTTTBCEEEEEES---SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             EEEEEEccCCCEEEEEEEEC---CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            34467999999999999987   35678999998643   233456788999999988 799999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..++.|+.||+.||+|||+.   +|+||||||+||||+.++++||+|||+++.......
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            99999999999998888899999999999999999999965   999999999999999999999999999986433322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....||+.|+|||++.+..++.++|||||||+||||++|+.||......+       ....+..+..         
T Consensus       498 ~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~---------  559 (674)
T 3pfq_A          498 T--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV---------  559 (674)
T ss_dssp             C--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCC---------
T ss_pred             c--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC---------
Confidence            2  245679999999999999999999999999999999999999998654321       1111122211         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTM-----RKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~-----~~v~~  436 (455)
                       ..+......+.+++..||+.||.+||++     .+|++
T Consensus       560 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence             1112345678999999999999999998     66653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=327.34  Aligned_cols=248  Identities=23%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||.||+|...   .++..||+|.+...  .....+.+|+.++.+++||||+++++++...+..++|||
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHK---ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             CEEEEEECC----CEEEEEEET---TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhheeeccCCCeEEEEEEEC---CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3445678999999999999886   35678999998653  345679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++++|.+++. ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999986 456789999999999999999999964   9999999999999999999999999999876543222


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .  ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........      .. ....+......      
T Consensus       182 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~~~------  246 (314)
T 3com_A          182 R--NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IF-MIPTNPPPTFR------  246 (314)
T ss_dssp             B--CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH-HHHHSCCCCCS------
T ss_pred             c--CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HH-HHhcCCCcccC------
Confidence            1  345689999999999998999999999999999999999999975443211      11 11111111110      


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       .+...+..+.+++..||+.||.+|||+.++++
T Consensus       247 -~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 -KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             11223567889999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.9e-42  Score=347.61  Aligned_cols=250  Identities=26%  Similarity=0.332  Sum_probs=203.1

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      ..+.+.+.||+|+||+||++...   .++..||||++....  ......+.+|+.++++++||||+++++++.+....++
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEET---TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEEC---CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            45667789999999999999986   356789999985432  3346779999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCcEEEeeccCccccc
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLT  318 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~  318 (455)
                      |+||+++|+|.+++.....+++..+..|+.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++...
T Consensus        99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999998888899999999999999999999965   999999999999995   55679999999998765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ....   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+       ....+..+...... 
T Consensus       176 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~-  243 (486)
T 3mwu_A          176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFDL-  243 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSCS-
T ss_pred             CCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCCC-
Confidence            4322   134569999999999875 58999999999999999999999997654321       11122222221100 


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +     .....+..+.+++..||+.+|.+|||+.++++
T Consensus       244 ~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          244 P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0     01123567889999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.4e-42  Score=331.25  Aligned_cols=253  Identities=24%  Similarity=0.323  Sum_probs=200.2

Q ss_pred             HHHHhhh-hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCe
Q 037780          163 EATDNFK-EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       163 ~~t~~f~-~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  238 (455)
                      ...+.+. +.||+|+||.||+|...   .+++.||+|.+....  ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISK---STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3334444 78999999999999986   456789999986532  23467899999999999 46999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccC
Q 037780          239 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGL  313 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~  313 (455)
                      .++||||+++|+|.+++...  ..+++..++.|+.|++.||+|||+.   +|+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999999654  6789999999999999999999965   9999999999999998   78999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ++........   ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..       ..+.....
T Consensus       181 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~  250 (327)
T 3lm5_A          181 SRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-------LNISQVNV  250 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC
T ss_pred             ccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-------HHHHhccc
Confidence            9876543221   3356999999999999999999999999999999999999999765432211       01111111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      .      ............+.+++..||+.||.+|||+.++++.
T Consensus       251 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          251 D------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             C------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             c------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0      0001111245678899999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.3e-43  Score=329.46  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=200.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEe--cCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~--~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...   .+++.+|+|.+....  ....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRK---SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             eeeehhccCCCCcEEEEEEEC---CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            345578999999999999986   356789999986432  234567999999999999999999999874  4668899


Q ss_pred             EEEeCCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          242 VYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ||||+++++|.+++...    ..+++..++.|+.|++.||+|||+..  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999643    45899999999999999999999751  1129999999999999999999999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ........  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......       ....+..+....
T Consensus       165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~~  235 (279)
T 2w5a_A          165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR  235 (279)
T ss_dssp             HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC
T ss_pred             eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhccccc
Confidence            76543221  133468999999999998899999999999999999999999997654321       112222232221


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      +         +...+..+.+++..||+.||.+|||+.+|++.+..
T Consensus       236 ~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          236 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             C---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            1         11245678999999999999999999999987754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-42  Score=349.46  Aligned_cols=250  Identities=26%  Similarity=0.326  Sum_probs=205.5

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ..+.+.+.||+|+||+||++...   ..+..||||++....   ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDK---ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEEC---CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45666788999999999999986   456789999985432   335677999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCcccc
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLL  317 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~  317 (455)
                      +|+||+++|+|.+++.....+++..+..|+.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            9999999999999999888999999999999999999999965   99999999999999   56789999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ......   ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+       ....+..+......
T Consensus       180 ~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~  248 (484)
T 3nyv_A          180 EASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFEL  248 (484)
T ss_dssp             CCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCCS
T ss_pred             cccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCCC
Confidence            543321   34569999999999865 68999999999999999999999997654321       11222222221100


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       +     .....+..+.+++..||+.+|.+|||+.++++
T Consensus       249 -~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 -P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence             0     01123567889999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=335.43  Aligned_cols=264  Identities=21%  Similarity=0.308  Sum_probs=194.3

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-HHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      .+.+.||+|+||+||+|...   .++..||+|++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSK---LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             EEEEEEcCCCCEEEEEEEEC---CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            44578999999999999986   356789999986433211 12456799999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      ++ |+|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence            97 5888888654 5689999999999999999999964   9999999999999999999999999999865433221 


Q ss_pred             ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---Ccccccccc-
Q 037780          325 IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLDDLVEG-  399 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-  399 (455)
                       .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...   ........   ......... 
T Consensus       157 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          157 -YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGCH
T ss_pred             -cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhchhhhcch
Confidence             134468999999999876 568999999999999999999999998655432211   11111111   011111000 


Q ss_pred             --------ccccC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCc
Q 037780          400 --------DMEAM----NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV  442 (455)
Q Consensus       400 --------~l~~~----~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~  442 (455)
                              .....    ........+.+++..||+.||.+|||+.|+++  .+.++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                    00000    00123457889999999999999999999987  455443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-42  Score=345.50  Aligned_cols=193  Identities=24%  Similarity=0.393  Sum_probs=153.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec-----CCe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-----GQN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-----~~~  238 (455)
                      +.+.+.||+|+||+||+|...   .++..||||++....  ....+.+.+|+.++.+++||||+++++++..     ...
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDK---LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             EEECCC-------CEEEEEEC---C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             eEEeeEeeecCCeEEEEEEEC---CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            456688999999999999987   456789999986532  2234678999999999999999999999843     357


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++||||+ +++|.+++.....+++..+..|+.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            89999998 579999998888899999999999999999999964   99999999999999999999999999998765


Q ss_pred             CCCCc-------------------------cccccccccCcccccccc-cCCCCCCCCCeecHHHHHHHHHhC
Q 037780          319 LNQSK-------------------------TIKTAIRGTKGYVAPEWY-RKSTITAKVDVYSFGVLLLEIISC  365 (455)
Q Consensus       319 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg  365 (455)
                      .....                         ...+...||++|+|||++ ....++.++|||||||+||||++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            32211                         112445689999999976 556799999999999999999993

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-42  Score=330.14  Aligned_cols=258  Identities=23%  Similarity=0.338  Sum_probs=182.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++.... ....+++.+|+.++.+++||||+++++++...+..++|||
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCA---PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhheeccccceEEEEEEEC---CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            445678999999999999875   346789999986432 2345678999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          245 FLNNGTLASFLFG--------NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       245 ~~~~gsL~~~l~~--------~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      |+++++|.+++..        ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            9999999999863        45689999999999999999999965   999999999999999999999999999986


Q ss_pred             ccCCCC---ccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          317 LTLNQS---KTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       317 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ......   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........      ...... .
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~-~  243 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQN-D  243 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHTS-S
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhcc-C
Confidence            643321   111133568999999999876 56899999999999999999999999765432211      111111 1


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .................+..+.+++..||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111000000111123467889999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.1e-42  Score=336.30  Aligned_cols=248  Identities=24%  Similarity=0.366  Sum_probs=199.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------ccHHHHHHHHHHHccc-CCCCceeeeeeEecCC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQ  237 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~  237 (455)
                      .+.+.||+|+||.||+|.+.   .++..||||.+.....        ...+.+.+|+.++.++ +||||+++++++....
T Consensus        97 ~~~~~lg~G~~g~Vy~a~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           97 DPKDVIGRGVSSVVRRCVHR---ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             ccceEEecCCCEEEEEEEEC---CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            33468999999999999986   3567899998864321        1135688999999999 7999999999999999


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||+|||++...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            9999999999999999998878899999999999999999999965   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccC------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRK------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      ......   ....||+.|+|||++.+      ..++.++||||||+++|||++|+.||.......       ....+..+
T Consensus       251 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-------~~~~i~~~  320 (365)
T 2y7j_A          251 EPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-------MLRMIMEG  320 (365)
T ss_dssp             CTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHT
T ss_pred             CCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhC
Confidence            543322   34569999999999863      358889999999999999999999997543211       11111222


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .... ..+..     ...+..+.+++..||+.||.+|||+.++++
T Consensus       321 ~~~~-~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          321 QYQF-SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCCC-CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCC-CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1110 00000     012456889999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=334.96  Aligned_cols=260  Identities=24%  Similarity=0.295  Sum_probs=194.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  237 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||++....  ....+.+.+|+.++++++||||+++++++....      
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             EEEEEEC------CEEEEEET---TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             EEEeEEeeecCCeEEEEEEEC---CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            445678999999999999986   456789999985432  223467899999999999999999999997653      


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            469999999 8899999876 5689999999999999999999964   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC-----
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----  391 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  391 (455)
                      ....     ....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||..........   .........     
T Consensus       179 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          179 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGTPPAEFV  250 (367)
T ss_dssp             CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHH
T ss_pred             cccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHH
Confidence            5322     34568999999999877 679999999999999999999999997654321110   000000000     


Q ss_pred             -------------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCc
Q 037780          392 -------------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV  442 (455)
Q Consensus       392 -------------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~  442 (455)
                                   .+.......... ........+.+++..||+.||.+|||+.++++  .+++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                         000000001110 01123567889999999999999999999987  455543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3e-43  Score=347.30  Aligned_cols=235  Identities=14%  Similarity=0.137  Sum_probs=183.4

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHH---HHHcccCCCCceeee-------eeEe
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEV---VVIGQTHHKNLVRLL-------GFCD  234 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~l~-------g~~~  234 (455)
                      +.+.||+|+||+||+|.+.   .++..||||++...   .....+.+.+|+   ..+++++|||||+++       +++.
T Consensus        77 ~~~~lG~G~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           77 RGTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEETTEEEEEEEC----CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             EcceeecCCCEEEEEEEEC---CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            3578999999999999975   35678999998632   233457799999   566666899999998       5555


Q ss_pred             cCC-----------------eEEEEEEeCCCCCHHHHhcCCCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 037780          235 EGQ-----------------NRLLVYEFLNNGTLASFLFGNLKP-------SWNLRTNIAFQIARGLLYLHEDCSSQIIH  290 (455)
Q Consensus       235 ~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~i~~~ia~~l~~LH~~~~~~ivH  290 (455)
                      ..+                 ..++||||+ +|+|.+++.....+       ++..++.|+.|++.||+|||+.   +|+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            443                 278999999 68999999764333       3588899999999999999965   9999


Q ss_pred             eCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCC-----------CCCCCCCeecHHHHH
Q 037780          291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-----------TITAKVDVYSFGVLL  359 (455)
Q Consensus       291 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv~l  359 (455)
                      |||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||+|
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999986432     1134457 999999999887           899999999999999


Q ss_pred             HHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          360 LEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       360 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      |||++|+.||........               ...+... .     ...+..+.+++..||+.||.+|||+.++++
T Consensus       304 ~elltg~~Pf~~~~~~~~---------------~~~~~~~-~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGG---------------SEWIFRS-C-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CC---------------SGGGGSS-C-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccc---------------hhhhhhh-c-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999975433211               1111110 0     123467889999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.5e-42  Score=328.93  Aligned_cols=249  Identities=20%  Similarity=0.312  Sum_probs=196.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||.||+|...   .++..+|+|.+........+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNK---ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEET---TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             eeecceeccCCCeEEEEEEEc---CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            345678999999999999986   35678999998776666678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++++|.+++.. ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--
Confidence            999999999865 46789999999999999999999965   999999999999999999999999998764322111  


Q ss_pred             ccccccccCcccccccc-----cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          325 IKTAIRGTKGYVAPEWY-----RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ......||+.|+|||++     ....++.++||||||+++|+|++|+.||.......      ...... .+.....   
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~---  242 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIA-KSDPPTL---  242 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCC---
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHh-ccCCccc---
Confidence            11234589999999998     46678999999999999999999999997554321      111111 1111111   


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          ..+...+..+.+++..||+.||.+|||+.++++
T Consensus       243 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 ----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                112233567889999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-41  Score=344.23  Aligned_cols=258  Identities=18%  Similarity=0.214  Sum_probs=203.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC-CCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||.||+|...   ..+..||||.+.....  ..++..|+.++..++| +++..+..++...+..++|||
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEET---TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEEEeeCCCEEEEEEEEC---CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            345678999999999999976   3567899998764332  3458899999999987 455566667778888999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE---cCCCcEEEeeccCcccccCC
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      |+ +++|.+++.. ...+++..++.|+.||+.||+|||+.   +|+||||||+||||   +.++.+||+|||+++.....
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 9999999974 56799999999999999999999965   99999999999999   68899999999999876654


Q ss_pred             CCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          321 QSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       321 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ....     ......||+.|+|||.+.+..++.++||||||++||||++|+.||..............+........+..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            3221     11245699999999999999999999999999999999999999986554322222111111111111111


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      +..         ..+.++.+++..||+.+|++||++.+|+++|+.+
T Consensus       240 l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          240 LCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             Hhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            111         1356889999999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.8e-42  Score=324.21  Aligned_cols=241  Identities=23%  Similarity=0.323  Sum_probs=195.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~l  241 (455)
                      .+.+.+.||+|+||+||+|...   .++..||+|.+....  .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKR---LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEc---CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3445678999999999999986   356789999986532  33456788999999999 99999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC--------------
Q 037780          242 VYEFLNNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH--------------  303 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--------------  303 (455)
                      ||||+++++|.+++...    ..+++..++.|+.|++.||+|||+.   +|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999764    6789999999999999999999965   99999999999999844              


Q ss_pred             -----CcEEEeeccCcccccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchh
Q 037780          304 -----YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  377 (455)
Q Consensus       304 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~  377 (455)
                           ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++++|++|..++.....   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                 479999999998765432      23489999999999766 567899999999999999999987643211   


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ...+..+....+         +...+..+.+++..||+.||.+|||+.++++
T Consensus       237 -------~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -------WHEIRQGRLPRI---------PQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHTTCCCCC---------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHcCCCCCC---------CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   111222222211         1123567889999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=322.55  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=197.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHcccCCCCceeeeeeE--ecCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHHKNLVRLLGFC--DEGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~g~~--~~~~~~  239 (455)
                      +.+.+.||+|+||.||++...   .++..+|+|.+....    ......+.+|+.++++++||||+++++++  .+....
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDS---ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBT---TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             eeEeeEEecCCCeEEEEEEEC---CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            345678999999999999875   456789999986532    23456799999999999999999999998  445678


Q ss_pred             EEEEEeCCCCCHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          240 LLVYEFLNNGTLASFLFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ++||||++++ |.+++..  ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999887 6666654  46789999999999999999999965   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCC--CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKST--ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      .............||+.|+|||.+.+..  .+.++||||||+++|||++|+.||.......       ....+..+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~-  231 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGSYA-  231 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCC-
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCCCC-
Confidence            5433333334456899999999987643  4779999999999999999999997544221       11122222111 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                               .+......+.+++.+||+.||.+|||+.++++  .+.+
T Consensus       232 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          232 ---------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             ---------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             ---------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence                     11123567889999999999999999999996  4554

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-41  Score=347.58  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-------------ccHHHHHHHHHHHcccCCCCceeeeee
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-------------DGEKEFKNEVVVIGQTHHKNLVRLLGF  232 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~g~  232 (455)
                      +.+.++||+|+||+||+|...   ..+..+|+|.+.....             ...+.+.+|+.++++++||||++++++
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEK---NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEET---TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eEEEeEecccCCeEEEEEEEC---CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            445688999999999999986   3567899999864321             234678999999999999999999999


Q ss_pred             EecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC---cEEEe
Q 037780          233 CDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY---NARIS  309 (455)
Q Consensus       233 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~  309 (455)
                      +.+....++||||+++|+|.+++.....+++..+..|+.|++.||+|||+.   +|+||||||+|||++.++   .+||+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999999999998888899999999999999999999965   999999999999998775   69999


Q ss_pred             eccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          310 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       310 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      |||+++........   ....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+       ....+.
T Consensus       192 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~  260 (504)
T 3q5i_A          192 DFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKKVE  260 (504)
T ss_dssp             CCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             ECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH
Confidence            99999876543322   3456999999999986 468999999999999999999999998654322       112222


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+....... .     ....+..+.+++..||+.||.+|||+.++++
T Consensus       261 ~~~~~~~~~-~-----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          261 KGKYYFDFN-D-----WKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HCCCCCCHH-H-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCCCCcc-c-----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            222110000 0     0113467899999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-41  Score=321.02  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=194.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||.+....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQ---LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEeeecCCCCeEEEEEEEC---CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            345678999999999999986   356789999986432   23456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999998878899999999999999999999965   999999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .   ....||+.|+|||.+.+..+ +.++||||||+++++|++|+.||.......       ....+..+...       
T Consensus       167 ~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~-------  229 (276)
T 2h6d_A          167 L---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVFY-------  229 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred             e---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCccc-------
Confidence            1   33458999999999987765 689999999999999999999997543321       11112222110       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         .+......+.+++..||+.||.+|||+.++++
T Consensus       230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               01123467889999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=332.33  Aligned_cols=261  Identities=24%  Similarity=0.290  Sum_probs=196.7

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-----cHHHHHHHHHHHcccCCCCceeeeeeEecCCeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      .+.+.+.||+|+||.||+|...   .++..||||++......     ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECS---SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             ccEEEeEEeecCCEEEEEEEEC---CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3455678999999999999876   35678999998643221     124688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          240 LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ++||||+++ +|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999986 888888765 4689999999999999999999965   99999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---ccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLD  394 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  394 (455)
                      .....  .....||+.|+|||.+.+. .++.++||||||+++|||++|..||........  + ..........   ...
T Consensus       164 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~-~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          164 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQWP  238 (346)
T ss_dssp             SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTSS
T ss_pred             CCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHHcCCCChhhhh
Confidence            43222  1345689999999998764 588999999999999999999999876543211  1 1111111110   000


Q ss_pred             cc---ccc---ccccCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          395 DL---VEG---DMEAMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       395 ~~---~~~---~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                      ..   .+.   ......+     ......+.+++..||+.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00   000   0000000     1234678999999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.6e-41  Score=345.60  Aligned_cols=241  Identities=27%  Similarity=0.337  Sum_probs=196.9

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.||+|+||.||++...   .+++.||+|++....   ......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus       191 ~~LG~G~fG~Vy~a~~~---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMK---ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEECSSSEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEeeCCCeEEEEEEEC---CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            46999999999999986   356889999986432   234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          247 NNGTLASFLFGN----LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       247 ~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            999999998753    4689999999999999999999965   999999999999999999999999999987654432


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .. ....+..+..         
T Consensus       345 ~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~-~~~~i~~~~~---------  410 (543)
T 3c4z_A          345 K--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE-LKQRVLEQAV---------  410 (543)
T ss_dssp             C--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HH-HHHHHHHCCC---------
T ss_pred             c--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HH-HHHHHhhccc---------
Confidence            2  13457999999999999999999999999999999999999999765431110  11 1111111111         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTM  431 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~  431 (455)
                       ..+...+..+.+++..||+.||.+||++
T Consensus       411 -~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 -TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             -CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence             1112345678899999999999999976

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.7e-41  Score=327.42  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=196.7

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------ccHHHHHHHHHHHcccCCCCceeeeeeEec
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------DGEKEFKNEVVVIGQTHHKNLVRLLGFCDE  235 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~g~~~~  235 (455)
                      ..+.+.+.||+|+||.||+|...   .++..||||.+.....        .....+.+|+.++++++||||+++++++..
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFER---KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hceeEeeEEecCCCEEEEEEEEc---CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            45566789999999999999986   3568899999864321        122458899999999999999999999876


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc---EEEeecc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDFG  312 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg  312 (455)
                      .+ .++||||+++++|.+++.....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.   +||+|||
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            55 899999999999999999888999999999999999999999965   9999999999999987665   9999999


Q ss_pred             CcccccCCCCccccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      +++.......   .....||+.|+|||++.   ...++.++||||||+++|+|++|+.||........  +.    ..+.
T Consensus       163 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~----~~~~  233 (322)
T 2ycf_A          163 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQIT  233 (322)
T ss_dssp             TCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HH----HHHH
T ss_pred             cceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HH----HHHH
Confidence            9987653221   13456899999999874   56789999999999999999999999975443211  11    1111


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+.....  +..    ....+..+.+++..||+.||.+|||+.++++
T Consensus       234 ~~~~~~~--~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKYNFI--PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCCCCC--HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCccccC--chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            2211110  000    0123567889999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.8e-41  Score=339.00  Aligned_cols=199  Identities=26%  Similarity=0.408  Sum_probs=165.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC-----C
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----Q  237 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~  237 (455)
                      .+.+.+.||+|+||.||+|...   .++..||||++....  ....+.+.+|+.++++++||||+++++++...     .
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDK---NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CEEEEEEEeecCCEEEEEEEEC---CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3456688999999999999986   456889999996532  23346789999999999999999999999766     5


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++||||+. ++|.+++.....+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            7899999986 59999999888899999999999999999999965   9999999999999999999999999999876


Q ss_pred             cCCCCc--------------------cccccccccCcccccccc-cCCCCCCCCCeecHHHHHHHHHhCCCCCC
Q 037780          318 TLNQSK--------------------TIKTAIRGTKGYVAPEWY-RKSTITAKVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       318 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                      ......                    ...+...||++|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            543221                    112456799999999986 55679999999999999999998655553

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.1e-42  Score=326.47  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=183.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||++...   .+++.||+|++.....  ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHV---PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             hhhHHhcCCCCCeEEEEEEec---CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            345678999999999999986   4578899999865422  22233555666688899999999999999999999999


Q ss_pred             EeCCCCCHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          244 EFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       244 e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||++ |+|.+++.    ....+++..++.|+.|++.||+|||+.  .+|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9997 48877764    357899999999999999999999952  3899999999999999999999999999987654


Q ss_pred             CCCccccccccccCcccccccc----cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWY----RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ....   ....||+.|+|||++    .+..++.++||||||+++|||++|+.||........     ........... .
T Consensus       163 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~-~  233 (290)
T 3fme_A          163 DVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEPSP-Q  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHHHSCCC-C
T ss_pred             cccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHhccCCC-C
Confidence            3322   234689999999996    556789999999999999999999999975332211     11111111111 1


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                              ......+..+.+++..||+.||++|||+.++++
T Consensus       234 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 --------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                    111123567899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.2e-42  Score=338.37  Aligned_cols=250  Identities=11%  Similarity=0.043  Sum_probs=178.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHccc--CCCCceeee-------eeEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQT--HHKNLVRLL-------GFCD  234 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------g~~~  234 (455)
                      .+.+.||+|+||+||+|.+.   .+++.||||++.....   ...+.+.+|+.++..+  +||||++++       +++.
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDV---ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeccCCCCEEEEEEEEC---CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45678999999999999986   3568999999976432   2345677885444444  699987754       3433


Q ss_pred             cC-----------------CeEEEEEEeCCCCCHHHHhcCC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEE
Q 037780          235 EG-----------------QNRLLVYEFLNNGTLASFLFGN-LKPSWNLR------TNIAFQIARGLLYLHEDCSSQIIH  290 (455)
Q Consensus       235 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~------~~i~~~ia~~l~~LH~~~~~~ivH  290 (455)
                      ..                 ...++||||++ |+|.+++... ..+++..+      +.|+.|++.||+|||+.   +|+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence            22                 34799999999 8999999763 34566666      78889999999999965   9999


Q ss_pred             eCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCC
Q 037780          291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKS  368 (455)
Q Consensus       291 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p  368 (455)
                      |||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||||||+||||+||+.|
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998664321     13457799999999987  6799999999999999999999999


Q ss_pred             CCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          369 FDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      |..........        +.....................+..+.+++..||+.||++|||+.++++
T Consensus       293 f~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          293 FGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            98664321110        0000000011111111111234678899999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-41  Score=323.94  Aligned_cols=249  Identities=23%  Similarity=0.300  Sum_probs=201.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---------cccHHHHHHHHHHHcccC-CCCceeeeeeEec
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---------QDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~  235 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||.+....         ....+.+.+|+.++.++. ||||+++++++..
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cceeeeecCCCceEEEEEEEc---CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            344578999999999999986   356889999986432         122456889999999995 9999999999999


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ....++||||+++++|.+++.....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence            999999999999999999998888899999999999999999999965   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccccCccccccccc------CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYR------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ........   ....||+.|+|||.+.      ...++.++||||||+++|||++|+.||.......       ....+.
T Consensus       173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~  242 (298)
T 1phk_A          173 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM  242 (298)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             hcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHHHHh
Confidence            76543322   3356899999999885      4568899999999999999999999997544321       111111


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+.... ..     ......+..+.+++..||+.||.+|||+.++++
T Consensus       243 ~~~~~~-~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 SGNYQF-GS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HTCCCC-CT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCCccc-Cc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            221110 00     011234567899999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.7e-41  Score=323.11  Aligned_cols=255  Identities=21%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEec--CCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE--GQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~--~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||.+..   ...+.+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             eEEEEEecccCCeEEEEEEEC---CCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            445678999999999999876   3567899999864   33567999999999997 9999999999987  6678999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  321 (455)
                      |||+++++|.+++.   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++......
T Consensus       112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999985   478999999999999999999965   999999999999999776 89999999998765443


Q ss_pred             CccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHH--------HHHHHhhcCc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTD--------WAFDCYRNGK  392 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  392 (455)
                      ..   ....||..|+|||.+.+ ..++.++||||||+++|||++|+.||......... +..        .....+....
T Consensus       186 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          186 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTT
T ss_pred             cc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhc
Confidence            32   33468999999999877 67899999999999999999999999644332111 100        0001111100


Q ss_pred             cc--------------cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          393 LD--------------DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       393 ~~--------------~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..              ..................+.+++..||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00              000000111112224678899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-41  Score=329.90  Aligned_cols=254  Identities=19%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccccc-----------------HHHHHHHHHHHcccCCCCcee
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-----------------EKEFKNEVVVIGQTHHKNLVR  228 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~  228 (455)
                      +.+.+.||+|+||.||+|..     ++..||+|.+.......                 .+.+.+|+.++.+++||||++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             eEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            44567899999999999987     46889999986432211                 178999999999999999999


Q ss_pred             eeeeEecCCeEEEEEEeCCCCCHHHH------hcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          229 LLGFCDEGQNRLLVYEFLNNGTLASF------LFG--NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       229 l~g~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      +++++.+.+..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+  ..+|+|+||||+||++
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            99999999999999999999999999      665  5778999999999999999999996  1499999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCC-CCCC-CCCeecHHHHHHHHHhCCCCCCccccchhh
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITA-KVDVYSFGVLLLEIISCRKSFDIEMGEEYA  378 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~  378 (455)
                      +.++.+||+|||++.......    .....||+.|+|||.+.+. .++. ++||||||+++|||++|+.||........ 
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred             cCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence            999999999999998765431    2345689999999999877 6666 99999999999999999999986544111 


Q ss_pred             hhHHHHHHHhhcCccccccc------ccc---ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          379 ILTDWAFDCYRNGKLDDLVE------GDM---EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~------~~l---~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           ....+..+......+      +..   ........+..+.+++..||+.||.+|||+.++++
T Consensus       261 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 -----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 111222222111000      000   00001234567899999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-41  Score=335.22  Aligned_cols=254  Identities=23%  Similarity=0.284  Sum_probs=191.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec----------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----------  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----------  235 (455)
                      +.+.+.||+|+||+||+|...   .++..||||++.....    ...+|+.++++++||||+++++++..          
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~---~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDI---ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEET---TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             EEEEEEEEeccCEEEEEEEEC---CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            445678999999999999986   4568899999864322    23479999999999999999999843          


Q ss_pred             ----------------------------CCeEEEEEEeCCCCCHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 037780          236 ----------------------------GQNRLLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHED  283 (455)
Q Consensus       236 ----------------------------~~~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~~LH~~  283 (455)
                                                  ....++||||+++ +|.+.+.    ....+++..+..++.|+++||+|||  
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--  158 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH--  158 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence                                        3347899999984 7666654    4678999999999999999999999  


Q ss_pred             CCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHH
Q 037780          284 CSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLE  361 (455)
Q Consensus       284 ~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~e  361 (455)
                       +.+|+||||||+|||++ .++.+||+|||+++........   ....||+.|+|||.+.+. .++.++||||||+++||
T Consensus       159 -~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          159 -SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             -TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             -HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence             45999999999999998 6899999999999876544322   334689999999998765 58999999999999999


Q ss_pred             HHhCCCCCCccccchhhhhHHHHHHHhhc----------C-----ccccccccccccCCCHHHHHHHHHHHHhcccCCCC
Q 037780          362 IISCRKSFDIEMGEEYAILTDWAFDCYRN----------G-----KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPS  426 (455)
Q Consensus       362 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~-----~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~  426 (455)
                      |++|+.||......+..  ...+ .....          .     ....+.........+...+..+.+++..||+.||.
T Consensus       235 ll~g~~pf~~~~~~~~~--~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQL--VRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHSSCSSCCSSHHHHH--HHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHhCCCCCCCCChHHHH--HHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999865542211  1111 10000          0     01111111111111222456789999999999999


Q ss_pred             CCCCHHHHHH
Q 037780          427 LRPTMRKVSQ  436 (455)
Q Consensus       427 ~RPt~~~v~~  436 (455)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-41  Score=326.53  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=191.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccC--CCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||.||++...    ++..||||.+....  ....+.+.+|+.++.+++  |+||+++++++...+..++
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            345678999999999999864    46789999986432  334567899999999997  5999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||| +.+++|.+++.....+++..++.|+.|+++||.|||+.   +|+||||||+|||+++ +.+||+|||+++......
T Consensus       106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            999 66889999999888899999999999999999999965   9999999999999975 899999999998776544


Q ss_pred             CccccccccccCcccccccccC-----------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRK-----------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      .........||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.......     .........
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~  255 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIIDP  255 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHCT
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHHhc
Confidence            3322234568999999999865           467889999999999999999999997543321     111111111


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..         ....+......+.+++..||+.||.+|||+.++++
T Consensus       256 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          256 NH---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             TS---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cc---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11         11111112467889999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-41  Score=339.53  Aligned_cols=196  Identities=24%  Similarity=0.324  Sum_probs=168.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc------CCCCceeeeeeEecCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT------HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~g~~~~~~~~  239 (455)
                      +.+.+.||+|+||+||+|...   ..+..||||++... .....++.+|+.++..+      +|+||+++++++......
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~---~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDH---KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             EEEEEEcccCccEEEEEEEEC---CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            455688999999999999876   35688999999753 23345677888888877      577999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc--EEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN--ARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~  315 (455)
                      ++||||+. ++|.+++...  ..+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 6899988765  3589999999999999999999965   9999999999999999887  9999999997


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      ......     ....||+.|+|||++.+..++.++|||||||+||||+||+.||.....
T Consensus       251 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          251 YEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             ETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            654322     334689999999999999999999999999999999999999976554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.3e-41  Score=333.07  Aligned_cols=261  Identities=22%  Similarity=0.258  Sum_probs=198.9

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC--------CCCceeeeeeEe-
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH--------HKNLVRLLGFCD-  234 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~g~~~-  234 (455)
                      ..+.+.+.||+|+||+||+|...   .+++.||||++... ....+.+.+|+.++++++        |+||+++++++. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDI---QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEec---CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            34566788999999999999876   45788999999743 334567899999999985        788999999987 


Q ss_pred             ---cCCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-----
Q 037780          235 ---EGQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-----  304 (455)
Q Consensus       235 ---~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----  304 (455)
                         .....++||||+ +++|.+++...  ..+++..++.|+.||+.||+|||++  .+|+||||||+|||++.++     
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhh
Confidence               566889999999 55665655433  5689999999999999999999953  2899999999999999775     


Q ss_pred             --------------------------------------------cEEEeeccCcccccCCCCccccccccccCccccccc
Q 037780          305 --------------------------------------------NARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW  340 (455)
Q Consensus       305 --------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  340 (455)
                                                                  .+||+|||+++......     ....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence                                                        79999999998765432     33468999999999


Q ss_pred             ccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh---HHHHHHHhh--------cCc-----------cccccc
Q 037780          341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL---TDWAFDCYR--------NGK-----------LDDLVE  398 (455)
Q Consensus       341 ~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~--------~~~-----------~~~~~~  398 (455)
                      +.+..++.++|||||||+||||+||+.||...........   .........        .+.           ...+..
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            9999999999999999999999999999976554321111   111111100        000           000000


Q ss_pred             cc---------cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GD---------MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~---------l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..         .....+......+.+++.+||+.||.+|||+.++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00         001224566788999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=327.19  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=191.4

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEec------CCeE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE------GQNR  239 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~------~~~~  239 (455)
                      .+.+.||+|+||.||+|...   .+++.||||.+.... .....+.+|+.++.++ +||||+++++++..      .+..
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~  102 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHV---KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL  102 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred             EEEEEeccCCCEEEEEEEEC---CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence            34578999999999999986   356789999986542 3456799999999999 89999999999976      4678


Q ss_pred             EEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          240 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ++||||+++++|.+++...  ..+++..++.|+.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++...
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            9999999999999999764  5789999999999999999999965   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ......  .....||+.|+|||++.     +..++.++||||||+++|+|++|+.||........      ... .....
T Consensus       180 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~  250 (326)
T 2x7f_A          180 DRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFL-IPRNP  250 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHSC
T ss_pred             CcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHH-hhcCc
Confidence            533221  13346899999999986     56789999999999999999999999975443211      111 11111


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          393 LDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       393 ~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .....        ....+..+.+++..||+.||.+|||+.++++
T Consensus       251 ~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          251 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111        1123567889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.2e-41  Score=324.69  Aligned_cols=260  Identities=21%  Similarity=0.302  Sum_probs=200.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC------ceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN------LVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||+||+|....  .++..||||.+... ....+.+.+|+.++.+++|+|      ++++++++...+.
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             ceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35566889999999999998732  35688999998653 234567889999999987765      9999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--------------
Q 037780          239 RLLVYEFLNNGTLASFLFGNL--KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD--------------  302 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------------  302 (455)
                      .++||||+ +++|.+++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999997654  688999999999999999999965   9999999999999987              


Q ss_pred             -----CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh
Q 037780          303 -----HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  377 (455)
Q Consensus       303 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~  377 (455)
                           ++.+||+|||+++......     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 6689999999998654322     334689999999999999999999999999999999999999986554322


Q ss_pred             hhhHHHHHH-----HhhcCccccc---------------------cccc-cccCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 037780          378 AILTDWAFD-----CYRNGKLDDL---------------------VEGD-MEAMNDIKCVEKLLMVSIWCIQEDPSLRPT  430 (455)
Q Consensus       378 ~~~~~~~~~-----~~~~~~~~~~---------------------~~~~-l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt  430 (455)
                      .........     .+........                     ..+. ..........+.+.+++..||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            111111000     0000000000                     0000 001122345788999999999999999999


Q ss_pred             HHHHHH
Q 037780          431 MRKVSQ  436 (455)
Q Consensus       431 ~~~v~~  436 (455)
                      +.|+++
T Consensus       323 ~~ell~  328 (339)
T 1z57_A          323 LREALK  328 (339)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-40  Score=328.46  Aligned_cols=259  Identities=24%  Similarity=0.260  Sum_probs=188.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  237 (455)
                      +.+.+.||+|+||.||+|...   ..+..||||++....  ....+.+.+|+.++++++||||+++++++....      
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             eeEeeeeEecCCEEEEEEEEC---CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            445678999999999999876   456889999986532  233467889999999999999999999997654      


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++||||+++ +|.+++.  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            78999999975 7888875  3588999999999999999999965   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhh----------------H
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL----------------T  381 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~----------------~  381 (455)
                      .....   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........                .
T Consensus       178 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          178 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            53321   1345689999999999999999999999999999999999999976543211000                0


Q ss_pred             HHHHHHhhcCc------ccccccccccc---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          382 DWAFDCYRNGK------LDDLVEGDMEA---MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       382 ~~~~~~~~~~~------~~~~~~~~l~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ...........      +..........   .........+.+++..||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            00000000000      00000000000   001223678899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=329.31  Aligned_cols=255  Identities=27%  Similarity=0.386  Sum_probs=196.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||.||+|...      ..+|+|.+....  ....+.+.+|+.++.+++||||+++++++.+.+..++|+
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWH------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEES------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             eEEeeEeccCCceEEEEEEEc------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            345678999999999999874      238999886432  223456888999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++++|.+++.... .+++..++.|+.|++.||+|||+.   +++||||||+||+++ ++.+||+|||+++.......
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999999998754 789999999999999999999965   999999999999998 67999999999876542211


Q ss_pred             ---ccccccccccCcccccccccC---------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          323 ---KTIKTAIRGTKGYVAPEWYRK---------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       323 ---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                         ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||........       ......
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~  257 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-------IWQMGT  257 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-------HHHHHT
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHhcc
Confidence               111133458999999999864         3578899999999999999999999976543211       111122


Q ss_pred             CccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       391 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                      +.......        ...+..+.+++..||+.||.+|||+.+++++|+.+.+..
T Consensus       258 ~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          258 GMKPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             TCCCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCCCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            21111111        113456889999999999999999999999999976543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=334.86  Aligned_cols=260  Identities=20%  Similarity=0.322  Sum_probs=179.9

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEe--cCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD--EGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~  247 (455)
                      ++||+|+||+||+|...++ ..+..||||++...  .....+.+|+.++++++||||+++++++.  .....++||||+.
T Consensus        27 ~~lG~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           27 CKVGRGTYGHVYKAKRKDG-KDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             CCCC-----EEEEEEESSS-SCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             cEeeecCCeEEEEEEEccC-CCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            4799999999999997643 25678999999753  23457889999999999999999999994  4678999999997


Q ss_pred             CCCHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----cCCCcEEEeeccCc
Q 037780          248 NGTLASFLFGN---------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL----DDHYNARISDFGLA  314 (455)
Q Consensus       248 ~gsL~~~l~~~---------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a  314 (455)
                      + +|.+++...         ..+++..++.|+.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            4 787777421         2589999999999999999999965   99999999999999    77899999999999


Q ss_pred             ccccCCCCc-cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchh------hhhHHHHHH
Q 037780          315 KLLTLNQSK-TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY------AILTDWAFD  386 (455)
Q Consensus       315 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~------~~~~~~~~~  386 (455)
                      +........ .......||+.|+|||++.+. .++.++|||||||+||||++|+.||........      .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            876543221 112345689999999998874 589999999999999999999999975443110      001111111


Q ss_pred             HhhcC---cccccc-------------ccccccCC--------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          387 CYRNG---KLDDLV-------------EGDMEAMN--------DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       387 ~~~~~---~~~~~~-------------~~~l~~~~--------~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+...   .+..+.             ........        .......+.+++..||+.||.+|||+.|+++
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11100   000000             00000000        0001356789999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.8e-41  Score=329.94  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=179.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecC------C
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------Q  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~  237 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++....  ....+.+.+|+.++++++||||+++++++...      .
T Consensus        31 y~~~~~lG~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             EEEEEECC----CCEEEEEET---TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             eEEeeEEeecCCeEEEEEEEC---CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            345678999999999999876   457889999986532  23456788999999999999999999998654      5


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      ..++|+|++ +++|.+++.. ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            679999999 7899998865 5789999999999999999999954   9999999999999999999999999999875


Q ss_pred             cCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc----
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK----  392 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  392 (455)
                      ....     ....||+.|+|||++.+ ..++.++|||||||+++||++|+.||..........   .+........    
T Consensus       183 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~p~~~~~  254 (367)
T 2fst_X          183 ADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELL  254 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHHHH
T ss_pred             cccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHHH
Confidence            4321     34568999999999877 678999999999999999999999997654322111   1111100000    


Q ss_pred             -------cccccccccc-cCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          393 -------LDDLVEGDME-AMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       393 -------~~~~~~~~l~-~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ....+..... ....     ......+.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                   0000000000 0000     012456889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-40  Score=316.15  Aligned_cols=251  Identities=26%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      ...+.+.+.||+|+||.||+|...   .+++.||+|.+....  ......+.+|+.++++++||||+++++++.+.+..+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDR---ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEc---CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345566788999999999999986   356789999986432  234678999999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC---CcEEEeeccCcccc
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH---YNARISDFGLAKLL  317 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~  317 (455)
                      +|+||+++++|.+++.....+++..++.++.|++.||.|||+.   +++|+||||+||+++.+   +.+||+|||++...
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            9999999999999998778899999999999999999999965   99999999999999754   46999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ......   ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.......       ....+..+......
T Consensus       175 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~  243 (287)
T 2wei_A          175 QQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFDL  243 (287)
T ss_dssp             CCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCCS
T ss_pred             cCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCCCc
Confidence            543322   23358999999999865 48999999999999999999999997654321       11222222221100


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      . .     ....+..+.+++..||+.+|.+|||+.++++
T Consensus       244 ~-~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          244 P-Q-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             G-G-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h-h-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0 0     0123567889999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.8e-41  Score=329.36  Aligned_cols=260  Identities=22%  Similarity=0.280  Sum_probs=197.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecC-----CeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  239 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++..... .....+.+|+.++.+++||||+++++++...     ...
T Consensus        29 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           29 YTNLSYIGEGAYGMVCSAYDN---LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             EEEEEEeecCCCeEEEEEEEC---CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            455678999999999999876   4578899999875332 2346789999999999999999999998654     368


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||+. ++|.+++.. ..+++..+..|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            99999997 599998865 4689999999999999999999965   999999999999999999999999999987654


Q ss_pred             CCCcc-ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc---
Q 037780          320 NQSKT-IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD---  394 (455)
Q Consensus       320 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  394 (455)
                      ..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...   ............   
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQEDLN  257 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCHHHHH
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCHHHHH
Confidence            33221 1234579999999998754 458999999999999999999999997655422111   111100000000   


Q ss_pred             ------------cccccccc--cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 ------------DLVEGDME--AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ------------~~~~~~l~--~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                  ........  ..........+.+++..||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                        00000000  0000112457889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.5e-41  Score=329.43  Aligned_cols=266  Identities=21%  Similarity=0.238  Sum_probs=186.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCe-------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-------  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-------  238 (455)
                      +.+.+.||+|+||+||+|...   .++..||||++.... .....+.+++..+..++||||+++++++.....       
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           25 FQVERMAGQGTFGTVQLGKEK---STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             EEEC----------CEEEEET---TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             eEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            344578999999999999986   356789999985432 233457788889999999999999999865433       


Q ss_pred             EEEEEEeCCCCCHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCc
Q 037780          239 RLLVYEFLNNGTLA---SFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLA  314 (455)
Q Consensus       239 ~~lv~e~~~~gsL~---~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a  314 (455)
                      .++||||++++.+.   .++.....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||+|||++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            78999999875332   3334567889999999999999999999932 349999999999999996 899999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHH--------
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF--------  385 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------  385 (455)
                      +........   ....||+.|+|||++.+. .++.++||||||+++|||++|+.||..........  ....        
T Consensus       180 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~  254 (360)
T 3e3p_A          180 KKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EIVRVLGCPSRE  254 (360)
T ss_dssp             BCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHH
T ss_pred             eecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HHHHHcCCCCHH
Confidence            876544332   334689999999998655 48999999999999999999999998655422111  1110        


Q ss_pred             --HHhhc-Ccccccccc------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcC
Q 037780          386 --DCYRN-GKLDDLVEG------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGV  441 (455)
Q Consensus       386 --~~~~~-~~~~~~~~~------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~  441 (455)
                        ..+.. .......+.      .............+.+++..||+.||.+|||+.++++  .+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence              00000 000000000      0000111224678999999999999999999999986  35543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.4e-41  Score=335.65  Aligned_cols=255  Identities=25%  Similarity=0.306  Sum_probs=189.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecC----C--eE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG----Q--NR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~----~--~~  239 (455)
                      +.+.+.||+|+||.||+|.+.   ..+..||||++....    ..+.+|++++++++||||+++++++...    +  ..
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~---~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEEC---CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            345678999999999999986   346789999986432    2245799999999999999999988432    2  35


Q ss_pred             EEEEEeCCCCCHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-CcEEEeeccCc
Q 037780          240 LLVYEFLNNGTLASFLF----GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-YNARISDFGLA  314 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a  314 (455)
                      ++||||+++ +|.+.+.    ....+++..++.++.||++||+|||+   .+|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 5555543    45788999999999999999999994   599999999999999955 67899999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHH-------
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-------  386 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------  386 (455)
                      +........   ....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+.  +...+..       
T Consensus       205 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          205 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTRE  279 (420)
T ss_dssp             EECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred             hhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            876543322   335689999999998764 789999999999999999999999986543221  1111110       


Q ss_pred             Hhh--cCcccccccccccc-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          387 CYR--NGKLDDLVEGDMEA-----MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       387 ~~~--~~~~~~~~~~~l~~-----~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+.  .........+....     .........+.+++.+||+.||.+|||+.|+++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            000  00111111111110     011123567899999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.8e-40  Score=324.36  Aligned_cols=198  Identities=27%  Similarity=0.335  Sum_probs=168.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CC-----CceeeeeeEecCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HK-----NLVRLLGFCDEGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~g~~~~~~~~  239 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||++... .....++..|+.++..++ |+     +++++.+++...+..
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDR---VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             EEEEEEEeecCCEEEEEEEEc---CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            445678999999999999886   45688999999743 233566788999888885 44     499999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCCcEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD--DHYNARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~  315 (455)
                      ++||||++ ++|.+++...  ..+++..+..|+.|++.||.|||.+ ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            99999996 5999998765  4689999999999999999999953 45899999999999994  57889999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMG  374 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~  374 (455)
                      ......     ....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       210 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          210 QLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             ETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            765332     335689999999999999999999999999999999999999986554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=324.15  Aligned_cols=259  Identities=21%  Similarity=0.271  Sum_probs=189.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEe------------
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCD------------  234 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~------------  234 (455)
                      ...+.||+|+||.||+|...   ..++.||+|++........+.+.+|+.++++++||||+++++++.            
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDN---DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             EEEEECC-----CEEEEEET---TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             eEEEEeccCCCeEEEEEEEC---CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            44578999999999999986   356889999987665556678999999999999999999999873            


Q ss_pred             --cCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeec
Q 037780          235 --EGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDF  311 (455)
Q Consensus       235 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Df  311 (455)
                        +....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ +++.+||+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence              4467899999998 699999864 5689999999999999999999965   999999999999997 5679999999


Q ss_pred             cCcccccCCCCc-cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          312 GLAKLLTLNQSK-TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       312 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      |+++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...   .......
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~  242 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ---LILESIP  242 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHSC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcC
Confidence            999876533221 11133457999999998865 678999999999999999999999998655321110   0000000


Q ss_pred             c----------Cccccccccccc-cCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 N----------GKLDDLVEGDME-AMN-----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~----------~~~~~~~~~~l~-~~~-----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .          ..+...+..... ...     ....+..+.+++..||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0          000000000000 000     0123567899999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-40  Score=330.45  Aligned_cols=255  Identities=24%  Similarity=0.277  Sum_probs=189.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC------eE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------NR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~  239 (455)
                      +.+.+.||+|+||+||+|...    ....+|+|++.....    ...+|+.++++++||||+++++++....      ..
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~----~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLV----ESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEET----TTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEEC----CCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            456688999999999999986    334488888754322    2346999999999999999999985443      37


Q ss_pred             EEEEEeCCCCCHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASFL---FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~  315 (455)
                      ++||||++++.+....   .....+++..++.++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8999999876544333   2357789999999999999999999964   999999999999999 79999999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHH--------
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD--------  386 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------  386 (455)
                      ........   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+..  ......        
T Consensus       191 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          191 ILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVLGTPSREQ  265 (394)
T ss_dssp             ECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHH
T ss_pred             cccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence            76543322   345689999999998765 5899999999999999999999999865542211  111100        


Q ss_pred             --H----hhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          387 --C----YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       387 --~----~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .    +.....................+..+.+++..||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence              0    0000111111110111111124568899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.4e-41  Score=329.26  Aligned_cols=254  Identities=23%  Similarity=0.270  Sum_probs=185.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-----------cHHHHHHHHHHHcccCCCCceeeeeeEec-
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-----------GEKEFKNEVVVIGQTHHKNLVRLLGFCDE-  235 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~g~~~~-  235 (455)
                      +.+.||+|+||.||+|...    .+..||||++......           ..+.+.+|+.++.+++||||+++++++.. 
T Consensus        26 ~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           26 VQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             EEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             EeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            3478999999999999864    4788999998643221           12679999999999999999999999843 


Q ss_pred             ----CCeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEee
Q 037780          236 ----GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD  310 (455)
Q Consensus       236 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  310 (455)
                          ....++||||++ |+|.+++... ..+++..+..|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence                346799999998 5777777654 5789999999999999999999965   999999999999999999999999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ||+++........   ....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+..   ........
T Consensus       178 fg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~  251 (362)
T 3pg1_A          178 FNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL---NKIVEVVG  251 (362)
T ss_dssp             TTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred             cCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcC
Confidence            9999855433222   34568999999999876 67899999999999999999999999865432111   01111000


Q ss_pred             cC-------------------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NG-------------------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~-------------------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..                   ........... .........+.+++..||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCChHHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            00                   00000000000 001122456889999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.2e-41  Score=323.33  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=174.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHH-HHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVV-VIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||+|...   .+++.||||++..... ....++..|+. +++.++||||+++++++...+..++|||
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHK---PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEET---TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hehheeccCCCEEEEEEEEc---CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            34578999999999999986   3578899999865432 23345556665 7788899999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          245 FLNNGTLASFLFG-----NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       245 ~~~~gsL~~~l~~-----~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      |+++ +|.+++..     ...+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++....
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            9985 88777753     56789999999999999999999952  2899999999999999999999999999987654


Q ss_pred             CCCccccccccccCcccccccc----cCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWY----RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ....   ....||+.|+|||++    .+..++.++||||||+++|||++|+.||........     ... ....+....
T Consensus       179 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~-~~~~~~~~~  249 (327)
T 3aln_A          179 SIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT-QVVKGDPPQ  249 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-CCCCSCCCC
T ss_pred             cccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHH-HHhcCCCCC
Confidence            3221   234689999999998    456789999999999999999999999975332100     000 000111111


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                           +...........+.+++..||+.||.+|||+.++++
T Consensus       250 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 -----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                 111111224567899999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.9e-41  Score=329.63  Aligned_cols=255  Identities=22%  Similarity=0.279  Sum_probs=192.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeE----
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNR----  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~----  239 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..    
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             EEEEeEEecCCCeEEEEEEEC---CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            345578999999999999986   457889999987542  22346789999999999999999999999877755    


Q ss_pred             --EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          240 --LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       240 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                        ++||||+. ++|.+++.  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence              99999997 68888874  3489999999999999999999965   9999999999999999999999999999865


Q ss_pred             cCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC-----
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----  391 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  391 (455)
                      ....     ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+...   .........     
T Consensus       195 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~  266 (371)
T 4exu_A          195 DAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEFV  266 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHH
T ss_pred             ccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCcHHHH
Confidence            4322     34568999999999877 678999999999999999999999997654321110   000000000     


Q ss_pred             ------cc----cccccccccc--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          392 ------KL----DDLVEGDMEA--MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       392 ------~~----~~~~~~~l~~--~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                            ..    ..+.......  .........+.+++..||+.||++|||+.++++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                  00    0000000000  0001235678999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.1e-40  Score=326.14  Aligned_cols=267  Identities=21%  Similarity=0.268  Sum_probs=199.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-----------CCCceeeeeeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----------HKNLVRLLGFC  233 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~~  233 (455)
                      .+.+.+.||+|+||+||+|...   .+++.||||.+... ......+.+|+.++.+++           |+||+++++++
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEec---CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            4556788999999999999876   45788999998743 234567889999999886           89999999998


Q ss_pred             ecCC----eEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc------
Q 037780          234 DEGQ----NRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD------  301 (455)
Q Consensus       234 ~~~~----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~------  301 (455)
                      ...+    ..++||||+ +++|.+++...  ..+++..+..|+.|++.||+|||+.  .+|+||||||+|||++      
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCc
Confidence            7654    789999999 89999999753  5589999999999999999999952  2899999999999994      


Q ss_pred             CCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhH
Q 037780          302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT  381 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~  381 (455)
                      ..+.+||+|||+++......     ....||+.|+|||++.+..++.++||||||+++|||+||+.||............
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            44589999999998765432     3346899999999999999999999999999999999999999865432111111


Q ss_pred             HHHHHHhh-cCc---------------------cccccccc---------cccCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 037780          382 DWAFDCYR-NGK---------------------LDDLVEGD---------MEAMNDIKCVEKLLMVSIWCIQEDPSLRPT  430 (455)
Q Consensus       382 ~~~~~~~~-~~~---------------------~~~~~~~~---------l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt  430 (455)
                      ........ .+.                     ...+....         .....+......+.+++..||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111000 000                     00000000         011234567889999999999999999999


Q ss_pred             HHHHHH--HHhcCcC
Q 037780          431 MRKVSQ--MLEGVVE  443 (455)
Q Consensus       431 ~~~v~~--~L~~~~~  443 (455)
                      +.++++  .+.+...
T Consensus       328 ~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          328 AGGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHHTCGGGTTCTT
T ss_pred             HHHHhhChhhhcccC
Confidence            999997  4555443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-40  Score=316.75  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=188.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec----------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----------  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----------  235 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNA---LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             chhhheeccCCcEEEEEEEEc---CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            445678999999999999976   35678999998643 3345679999999999999999999998865          


Q ss_pred             ---CCeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeec
Q 037780          236 ---GQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDF  311 (455)
Q Consensus       236 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  311 (455)
                         ....++||||+++++|.+++... ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence               35679999999999999999754 4678899999999999999999965   9999999999999999999999999


Q ss_pred             cCcccccCCCC------------ccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh
Q 037780          312 GLAKLLTLNQS------------KTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA  378 (455)
Q Consensus       312 g~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~  378 (455)
                      |+++.......            ........||+.|+|||.+.+. .++.++||||||+++|||++   ||......  .
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~  235 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--V  235 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--H
Confidence            99987643210            1111345689999999999764 68999999999999999998   44422111  0


Q ss_pred             hhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         . ....+.....      ..........+..+.+++..||+.||.+|||+.++++
T Consensus       236 ---~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          236 ---N-ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---H-HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---H-HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               1 1111111111      0111122234567889999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-40  Score=323.91  Aligned_cols=263  Identities=20%  Similarity=0.282  Sum_probs=197.0

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecC-----CeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~  239 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHK---PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             eEEeeEEcCCCCeEEEEEEEC---CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            345578999999999999986   457889999986432 23345688999999999999999999988654     678


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            99999997 689998865 5689999999999999999999965   999999999999999999999999999987653


Q ss_pred             CCCcc--------ccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc
Q 037780          320 NQSKT--------IKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN  390 (455)
Q Consensus       320 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  390 (455)
                      .....        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..........   ........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~  241 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIGT  241 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCC
Confidence            32211        1123468999999998764 678999999999999999999999998654322111   11111000


Q ss_pred             Cc----cccc---------------cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          391 GK----LDDL---------------VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       391 ~~----~~~~---------------~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                      ..    ....               ....+.. .....+..+.+++..||+.||++|||+.++++  .+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            00    0000               0000000 00123567889999999999999999999987  4554

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.8e-41  Score=324.79  Aligned_cols=238  Identities=24%  Similarity=0.406  Sum_probs=196.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc------cHHHHHHHHHHHcccC--CCCceeeeeeEecCC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQ  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~  237 (455)
                      +.+.+.||+|+||.||+|...   .+++.||||.+......      ....+.+|+.++.+++  |+|++++++++...+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEET---TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             eEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            456688999999999999876   45688999998654221      2245778999999996  599999999999999


Q ss_pred             eEEEEEEeCCC-CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcc
Q 037780          238 NRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAK  315 (455)
Q Consensus       238 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~  315 (455)
                      ..++|+|++.+ ++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+|||++ +++.+||+|||+++
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999986 89999998888899999999999999999999964   999999999999999 78999999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      .......    ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....            . ..+...
T Consensus       199 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~-~~~~~~  261 (320)
T 3a99_A          199 LLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I-IRGQVF  261 (320)
T ss_dssp             ECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H-HHCCCC
T ss_pred             ccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------h-hccccc
Confidence            7654322    33568999999999987665 6789999999999999999999964321            0 001100


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                .....+..+.+++..||+.||.+|||+.+|++
T Consensus       262 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          262 ----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      01123467889999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.4e-40  Score=319.73  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=195.5

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHccc---CCCCceeeeeeEe-----c
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQT---HHKNLVRLLGFCD-----E  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~g~~~-----~  235 (455)
                      +.+.+.||+|+||.||+|....  .++..||+|++.....  .....+.+|+.+++++   +||||+++++++.     .
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             eeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            3456789999999999998742  2467899999864322  1223566777777766   8999999999987     5


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccC
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGL  313 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~  313 (455)
                      ....++||||++ |+|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence            567899999998 6999998764  4489999999999999999999965   999999999999999999999999999


Q ss_pred             cccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC--
Q 037780          314 AKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG--  391 (455)
Q Consensus       314 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  391 (455)
                      ++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ...........  
T Consensus       167 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~  240 (326)
T 1blx_A          167 ARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGE  240 (326)
T ss_dssp             CCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCG
T ss_pred             cccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCc
Confidence            987653221   2345689999999999998999999999999999999999999986543221   11111111100  


Q ss_pred             -cccc-------ccc---cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 -KLDD-------LVE---GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 -~~~~-------~~~---~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       ....       ...   ...........+..+.+++..||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0000       000   00000111224567889999999999999999999995

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.2e-40  Score=320.52  Aligned_cols=250  Identities=21%  Similarity=0.235  Sum_probs=170.7

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec----CCeEEEEEEe
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRLLVYEF  245 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~  245 (455)
                      +.||+|+||+||+|...   .+++.||||++...    .....+....+..++||||+++++++..    ....++||||
T Consensus        35 ~~lG~G~~g~V~~~~~~---~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  107 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHR---RTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC  107 (336)
T ss_dssp             EEEEEETTEEEEEEEET---TTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             eeeeeCCCeEEEEEEEC---CCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence            45999999999999987   35678999998642    2222333344566799999999999876    4458999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccCC
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLN  320 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~  320 (455)
                      +++|+|.+++...  ..+++.+++.|+.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~  184 (336)
T 3fhr_A          108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN  184 (336)
T ss_dssp             CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence            9999999999765  3689999999999999999999965   9999999999999986   455999999999865533


Q ss_pred             CCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      ..    ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..........   ........+..      .
T Consensus       185 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~------~  251 (336)
T 3fhr_A          185 AL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY------G  251 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------C
T ss_pred             cc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc------c
Confidence            22    33468999999999988899999999999999999999999997544321100   00000000100      0


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCc
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVV  442 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~  442 (455)
                      .........+..+.+++..||+.||.+|||+.++++  .+.+..
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            000111234567899999999999999999999997  555543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=322.79  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=192.2

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe-----
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-----  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----  238 (455)
                      +.+.+.||+|+||.||+|...   .++..||||++....  ....+.+.+|+.++++++||||+++++++.....     
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDK---RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             EEEeeeEecCCCeEEEEEEEC---CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            345578999999999999986   457889999986532  2234678999999999999999999999987654     


Q ss_pred             -EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          239 -RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       239 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                       .++||||++ ++|.+++..  .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence             499999997 688888743  489999999999999999999965   9999999999999999999999999999865


Q ss_pred             cCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC-----
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG-----  391 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  391 (455)
                      ....     ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........   ..........     
T Consensus       177 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          177 DAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTEFV  248 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH---HHHHHHHCBCCHHHH
T ss_pred             CCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence            4321     33468999999999877 67899999999999999999999999765432111   0011000000     


Q ss_pred             -------------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 -------------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 -------------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                   .+......... .........+.+++..||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                         00000000000 011134678899999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6e-40  Score=320.44  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=197.6

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC------ceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN------LVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||+||+|....+  .+..||+|.+... ....+.+.+|+.++.+++|++      ++.+.+++...+.
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            455678899999999999997633  2478999998653 234567889999999998766      8999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE----------------
Q 037780          239 RLLVYEFLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL----------------  300 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----------------  300 (455)
                      .++||||+ +++|.+++...  ..+++..++.|+.|++.||+|||+   .+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 66676666544  478999999999999999999994   599999999999999                


Q ss_pred             ---cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchh
Q 037780          301 ---DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY  377 (455)
Q Consensus       301 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~  377 (455)
                         +.++.+||+|||+++......     ....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               668899999999998654322     334689999999999999999999999999999999999999986554321


Q ss_pred             hhhHHHHHH-----HhhcCcccc-ccccc---------------------cccCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 037780          378 AILTDWAFD-----CYRNGKLDD-LVEGD---------------------MEAMNDIKCVEKLLMVSIWCIQEDPSLRPT  430 (455)
Q Consensus       378 ~~~~~~~~~-----~~~~~~~~~-~~~~~---------------------l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt  430 (455)
                      .........     .+....... .....                     ............+.+++..||+.||.+|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            111110000     000000000 00000                     001112344668999999999999999999


Q ss_pred             HHHHHH
Q 037780          431 MRKVSQ  436 (455)
Q Consensus       431 ~~~v~~  436 (455)
                      +.++++
T Consensus       328 ~~e~l~  333 (355)
T 2eu9_A          328 LAEALL  333 (355)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.6e-40  Score=329.12  Aligned_cols=245  Identities=27%  Similarity=0.311  Sum_probs=184.0

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      .+.||+|+||+||.+...    +++.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus        20 ~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSF----QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEECSTTCEEEEEES----SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             cCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            367999999999865432    5789999998643   345678999999886 89999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC-------------CcEE
Q 037780          248 NGTLASFLFGNLKP-------SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH-------------YNAR  307 (455)
Q Consensus       248 ~gsL~~~l~~~~~~-------~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~k  307 (455)
                       |+|.+++......       ++..++.|+.||+.||+|||+.   +|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999765432       2334578999999999999964   99999999999999754             4899


Q ss_pred             EeeccCcccccCCCCcc--ccccccccCcccccccccC-------CCCCCCCCeecHHHHHHHHHh-CCCCCCccccchh
Q 037780          308 ISDFGLAKLLTLNQSKT--IKTAIRGTKGYVAPEWYRK-------STITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEY  377 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~  377 (455)
                      |+|||+++.........  ......||++|+|||++.+       ..++.++|||||||++|||+| |+.||........
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            99999999876543221  1134569999999999865       568999999999999999999 9999975443221


Q ss_pred             hhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          378 AILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .    ..     .+...   .+......+...+..+.+++.+||+.||.+|||+.+|++
T Consensus       249 ~----i~-----~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 N----II-----RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H----HH-----HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H----Hh-----cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1    01     11110   011122234456788999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=322.38  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=191.6

Q ss_pred             HHHHHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc------cHHHHHHHHHHHccc----CCCCceee
Q 037780          160 ALEEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQT----HHKNLVRL  229 (455)
Q Consensus       160 ~l~~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l  229 (455)
                      +.....+.+.+.||+|+||.||+|...   .++..||||.+......      ....+.+|+.++.++    +|+||+++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRL---TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECT---TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEc---cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            334445666789999999999999875   35678999998654321      223466789999888    89999999


Q ss_pred             eeeEecCCeEEEEEEe-CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEE
Q 037780          230 LGFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNAR  307 (455)
Q Consensus       230 ~g~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k  307 (455)
                      ++++...+..++|+|+ +.+++|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+||+++ +++.+|
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999999 78999999998888899999999999999999999965   999999999999999 899999


Q ss_pred             EeeccCcccccCCCCccccccccccCcccccccccCCCCC-CCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHH
Q 037780          308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT-AKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD  386 (455)
Q Consensus       308 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  386 (455)
                      |+|||+++.......    ....||..|+|||++.+..+. .++||||||+++|||++|+.||.....            
T Consensus       181 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------  244 (312)
T 2iwi_A          181 LIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------  244 (312)
T ss_dssp             ECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred             EEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------
Confidence            999999987654332    345689999999998876664 589999999999999999999964221            


Q ss_pred             HhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       387 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      . .....          ..+......+.+++..||+.||++|||+.++++
T Consensus       245 ~-~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 I-LEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             H-HHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             H-hhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 00000          011123467889999999999999999999997

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=318.40  Aligned_cols=248  Identities=21%  Similarity=0.318  Sum_probs=176.2

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||.||+|...   .++..||||++......  ..+.+.++..+++.++||||+++++++.+.+..++|||
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFR---KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             EEEEEC------CEEEEEET---TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccceeeecCCeeEEEEEEe---cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            44578999999999999986   35678999998654322  22335555567888899999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+ ++.+..+... ...+++..++.++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.........
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK  181 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence            99 5566555543 46789999999999999999999951  28999999999999999999999999999766543221


Q ss_pred             cccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                         ....||+.|+|||++.     ...++.++||||||+++|||++|+.||.......     ........ +....+..
T Consensus       182 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~~~~~~~  252 (318)
T 2dyl_A          182 ---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQ-EEPPLLPG  252 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHH-SCCCCCCS
T ss_pred             ---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhc-cCCCCCCc
Confidence               3346899999999984     4568899999999999999999999997533211     11111111 11111110


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ....+..+.+++..||+.||.+|||+.++++
T Consensus       253 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          253 -------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   1123467889999999999999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-39  Score=337.15  Aligned_cols=265  Identities=26%  Similarity=0.310  Sum_probs=200.3

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEec------CC
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQ  237 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~  237 (455)
                      .+.+.+.||+|+||+||+|...   .++..||||++... .....+.+.+|+.++.+++||||+++++++..      ++
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~---~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQ---DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCT---TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CeEEEEEEeeCCCeEEEEEEEC---CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            4667789999999999999875   35678999998653 23345679999999999999999999998765      67


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc---EEEeec
Q 037780          238 NRLLVYEFLNNGTLASFLFGNL---KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN---ARISDF  311 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Df  311 (455)
                      ..++||||+++|+|.+++....   .+++..++.|+.+++.||+|||+.   +|+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999997643   689999999999999999999964   9999999999999997765   999999


Q ss_pred             cCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC
Q 037780          312 GLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       312 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      |++.........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......     .|.......+
T Consensus       169 G~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~  240 (676)
T 3qa8_A          169 GYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKS  240 (676)
T ss_dssp             CCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC---
T ss_pred             cccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhccc
Confidence            999876543322   34569999999999999999999999999999999999999997543211     0000000000


Q ss_pred             c----ccccccc------c--cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHH-----HHHHHhcCcC
Q 037780          392 K----LDDLVEG------D--MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK-----VSQMLEGVVE  443 (455)
Q Consensus       392 ~----~~~~~~~------~--l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~-----v~~~L~~~~~  443 (455)
                      .    .......      .  .........+..+.+++..||+.||.+|||+.+     +.+.++.+.+
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0    0000000      0  011123346788999999999999999999977     4455554433

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=321.31  Aligned_cols=244  Identities=25%  Similarity=0.313  Sum_probs=181.2

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEEeC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      ..+.||+|+||+||....    .+++.||||++.....   ..+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus        28 ~~~~LG~G~~G~V~~~~~----~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGM----FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEECGGGCEEEEEE----SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCeeecCcCEEEEEEEE----eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            346899999999654333    2567899999865332   2356899999999 7999999999999999999999999


Q ss_pred             CCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----CCcEEEeeccCcccccCC
Q 037780          247 NNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-----HYNARISDFGLAKLLTLN  320 (455)
Q Consensus       247 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~  320 (455)
                      . |+|.+++.... ...+..+..|+.|++.||.|||+.   +|+||||||+|||++.     ...+||+|||+++.....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            6 59999997653 455566788999999999999965   9999999999999953     336889999999876543


Q ss_pred             CCc-cccccccccCccccccccc---CCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          321 QSK-TIKTAIRGTKGYVAPEWYR---KSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       321 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ... .......||++|+|||++.   ...++.++|||||||++|||+| |+.||........       .......... 
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~~~-  248 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGACSLD-  248 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCCCCT-
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccCCcc-
Confidence            221 2224467999999999997   4567889999999999999999 9999864433211       1111111111 


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..      .........+.+++..||+.||.+|||+.+|++
T Consensus       249 ~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11      112234566889999999999999999999983

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-39  Score=339.22  Aligned_cols=239  Identities=22%  Similarity=0.288  Sum_probs=189.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe-----
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN-----  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~-----  238 (455)
                      .+.+.+.||+|+||+||+|.+...  +++.||||++.... ......+.+|+.++.+++||||+++++++...+.     
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            345667899999999999998632  46789999986432 2344578999999999999999999999987665     


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++||||+++++|.+++..  .++|.+++.|+.||+.||.|||+.   +|+||||||+|||++.+ .+||+|||+++...
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            6999999999999998755  789999999999999999999965   99999999999999986 99999999998765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ..      ....||++|+|||++.+.. +.++||||||++|++|++|..|+.......                   +. 
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~~-  285 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------LP-  285 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------CC-
T ss_pred             cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------cc-
Confidence            32      3346999999999987654 889999999999999999998876422110                   00 


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHhcC
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT-MRKVSQMLEGV  441 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-~~~v~~~L~~~  441 (455)
                         ...........+.+++..||+.||.+||+ ++++.+.|.++
T Consensus       286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence               00011123467889999999999999995 56666666553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.9e-38  Score=298.02  Aligned_cols=228  Identities=12%  Similarity=0.048  Sum_probs=180.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|...   ..++.||||.+......   ..+.+.+|+..+.+++||||+++++++.+.+..++|
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDT---ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEET---TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEEcccCCeEEEEEEec---CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            455678999999999999986   35788999999754332   236799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++++|.+++...  ....+..+|+.|++.||+|||+.   +|+||||||+|||++.++.+||++++          
T Consensus       110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            9999999999999653  35567888999999999999965   99999999999999999999998543          


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                                  |++       .++.++||||||+++|||+||+.||...........            ..........
T Consensus       175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~~  223 (286)
T 3uqc_A          175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQPI  223 (286)
T ss_dssp             ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCBC
T ss_pred             ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCCC
Confidence                        333       368899999999999999999999986544211000            0000000000


Q ss_pred             --cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          403 --AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       403 --~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                        .......+..+.+++..||+.||.+| |+.++++.|+.+..
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence              00011245678999999999999999 99999999988554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.7e-37  Score=294.94  Aligned_cols=230  Identities=23%  Similarity=0.300  Sum_probs=177.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHH-cccCCCCceeeeeeEec----CCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVI-GQTHHKNLVRLLGFCDE----GQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~g~~~~----~~~~~lv~e  244 (455)
                      +.||+|+||.||++...   .++..||+|.+..     ...+.+|+.++ +..+||||+++++++..    ....++|||
T Consensus        24 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e   95 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   95 (299)
T ss_dssp             EEEEEETTEEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cccccCCCeEEEEEEEc---CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence            56999999999999986   3567899999853     34577888888 55699999999999876    667899999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTL  319 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  319 (455)
                      |+++|+|.+++...  ..+++..++.|+.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||++.... 
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-  171 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-  171 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence            99999999999765  3689999999999999999999964   9999999999999998   7889999999986432 


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                                             +..++.++||||||+++|||++|+.||.........           ......+...
T Consensus       172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~  217 (299)
T 3m2w_A          172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMG  217 (299)
T ss_dssp             -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTT
T ss_pred             -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhc
Confidence                                   234678999999999999999999999754332100           0000111111


Q ss_pred             ccccCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCcCCC
Q 037780          400 DMEAMN--DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVEVD  445 (455)
Q Consensus       400 ~l~~~~--~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~~~~  445 (455)
                      ......  ....+..+.+++..||+.||.+|||+.++++  .+.+....+
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            000000  0123567899999999999999999999997  455544433

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-37  Score=311.00  Aligned_cols=233  Identities=14%  Similarity=0.112  Sum_probs=174.5

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCC-CCceeee---------e----
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHH-KNLVRLL---------G----  231 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~l~---------g----  231 (455)
                      .+.||+|+||+||+|.+.   .+++.||||++.....   ...+.|.+|+.++..++| +|.....         .    
T Consensus        83 ~~~LG~G~fG~Vy~a~~~---~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQ---ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEETTEEEEEEEET---TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             ecccccCCCEEEEEEEec---CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            467999999999999986   3567899999873322   235679999999999987 3221111         1    


Q ss_pred             --------eEec-----CCeEEEEEEeCCCCCHHHHhc------C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 037780          232 --------FCDE-----GQNRLLVYEFLNNGTLASFLF------G-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHC  291 (455)
Q Consensus       232 --------~~~~-----~~~~~lv~e~~~~gsL~~~l~------~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  291 (455)
                              ++..     ....+++|+++ +++|.+++.      . ...+++..++.|+.|+++||+|||+.   +|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr  235 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT  235 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence                    1111     12346677655 689998884      1 34568889999999999999999954   99999


Q ss_pred             CCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccc----------cCCCCCCCCCeecHHHHHHH
Q 037780          292 DIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY----------RKSTITAKVDVYSFGVLLLE  361 (455)
Q Consensus       292 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gv~l~e  361 (455)
                      ||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||++||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999999865433     134457 999999999          55668899999999999999


Q ss_pred             HHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          362 IISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       362 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                      |+||+.||........               ...+....      ...++.+.+++..||+.||++|||+.+++
T Consensus       310 lltg~~Pf~~~~~~~~---------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          310 IWCADLPNTDDAALGG---------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHSSCCCCTTGGGSC---------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHCCCCCCCcchhhh---------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999975443211               11111110      01246789999999999999999976654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.6e-37  Score=300.04  Aligned_cols=242  Identities=14%  Similarity=0.114  Sum_probs=180.7

Q ss_pred             HHHHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--------cccHHHHHHHHHHHcccC---------CCC
Q 037780          163 EATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--------QDGEKEFKNEVVVIGQTH---------HKN  225 (455)
Q Consensus       163 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~n  225 (455)
                      ...+.+.+.||+|+||+||+|+.     +++.||||++....        ....+.+.+|+.++++++         |||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            34566778999999999999986     35889999997542        223477899999998886         666


Q ss_pred             ceeeeee-----------------Eec-------------CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHH
Q 037780          226 LVRLLGF-----------------CDE-------------GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR  275 (455)
Q Consensus       226 iv~l~g~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~  275 (455)
                      ++++.+.                 +.+             .+..++||||+++|++.+.+.+ ..+++..++.|+.||+.
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence            6666554                 332             6789999999999977666644 56899999999999999


Q ss_pred             HHHHHH-hCCCCCeEEeCCCCCCEEEcCCC--------------------cEEEeeccCcccccCCCCccccccccccCc
Q 037780          276 GLLYLH-EDCSSQIIHCDIKPQNILLDDHY--------------------NARISDFGLAKLLTLNQSKTIKTAIRGTKG  334 (455)
Q Consensus       276 ~l~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  334 (455)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+|||+++....       ....||+.
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence            999999 65   899999999999999887                    899999999987653       23469999


Q ss_pred             ccccccccCCCCCCCCCeecHHHH-HHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCCHHHHHHH
Q 037780          335 YVAPEWYRKSTITAKVDVYSFGVL-LLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKL  413 (455)
Q Consensus       335 y~aPE~~~~~~~~~~~Dv~s~Gv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  413 (455)
                      |+|||++.+.. +.++||||++++ .+++++|..||.....     +...............    ..........+..+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----LHYLTDKMLKQMTFKT----KCNTPAMKQIKRKI  312 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----HHHHHHHHHHTCCCSS----CCCSHHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-----hhHHHHhhhhhhccCc----ccchhhhhhcCHHH
Confidence            99999998766 889999998777 6778889998742110     0000111111111110    00011123467889


Q ss_pred             HHHHHhcccCCCCCCCCHHHHH
Q 037780          414 LMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       414 ~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                      .+++..||+.|     |+.|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999966     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.1e-32  Score=279.55  Aligned_cols=186  Identities=18%  Similarity=0.108  Sum_probs=130.8

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc----------cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----------QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  239 (455)
                      .++.|++|.+..+...   -.+..+++|.+....          ....++|.+|+++|+++ .|+||+++++++++++..
T Consensus       241 ~~~~~~~~~h~~~rr~---~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~  317 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRY---FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG  317 (569)
T ss_dssp             C-C--------CCEEE---EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred             ccccCCcccccccccc---cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence            4566777766654433   135678999885431          12345799999999999 799999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ||||||++|++|.++|.....++..   +|+.||+.||+|+|++   +||||||||+||||++++++||+|||+|+....
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999999988888754   4899999999999965   999999999999999999999999999987754


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCC
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS  368 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p  368 (455)
                      .....  ....||++|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~~~~--~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSWP--TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCccc--cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            43322  44679999999999965 467789999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.8e-28  Score=251.68  Aligned_cols=184  Identities=18%  Similarity=0.245  Sum_probs=146.4

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc--------cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEE
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--------GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  240 (455)
                      .+.||+|+||+||+|..     .+..+++|+.......        ..+.+.+|++++++++||||+++..++...+..+
T Consensus       341 ~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             -------CCEEEEEEEC-----SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             CCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            35799999999999953     3567888876432111        1345899999999999999998777777888889


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +||||+++++|.+++..        +..|+.|+++||.|||+.   +|+||||||+|||+++  ++||+|||+++.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999999976        568999999999999965   9999999999999999  9999999999987643


Q ss_pred             CCcc-----ccccccccCcccccccccC--CCCCCCCCeecHHHHHHHHHhCCCCCC
Q 037780          321 QSKT-----IKTAIRGTKGYVAPEWYRK--STITAKVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       321 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                      ....     ......||+.|+|||++..  ..|+.++|+||..+-.++-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            3221     1235679999999999987  568888999999999999888877663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=4e-24  Score=201.55  Aligned_cols=141  Identities=14%  Similarity=0.093  Sum_probs=113.3

Q ss_pred             hhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc------------------ccHHHHHHHHHHHcccCCCCceeee
Q 037780          169 KEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ------------------DGEKEFKNEVVVIGQTHHKNLVRLL  230 (455)
Q Consensus       169 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~  230 (455)
                      .+.||+|+||.||+|...    ++..||+|.+.....                  .....+.+|+.++++++  | +++.
T Consensus        95 ~~~iG~G~~g~Vy~~~~~----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             EEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             cCEeccCCCceEEEEEeC----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            378999999999999972    568899999864321                  12456899999999999  5 6777


Q ss_pred             eeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEee
Q 037780          231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISD  310 (455)
Q Consensus       231 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  310 (455)
                      +++.. +..++||||+++++|.+ +..      .....++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence            76544 55699999999999998 422      23457999999999999954   999999999999999 99999999


Q ss_pred             ccCcccccCCCCccccccccccCcccccccccC
Q 037780          311 FGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRK  343 (455)
Q Consensus       311 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  343 (455)
                      ||+++.               +..+.|||++..
T Consensus       236 FG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          236 FPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             CTTCEE---------------TTSTTHHHHHHH
T ss_pred             CCCCeE---------------CCCCCHHHHHHH
Confidence            999863               345788888743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=4.7e-20  Score=171.47  Aligned_cols=136  Identities=17%  Similarity=0.121  Sum_probs=104.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceE--EEEEeccccccc------------------------cHHHHHHHHHHHccc
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLDRVFQD------------------------GEKEFKNEVVVIGQT  221 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  221 (455)
                      +.+.||+|+||.||+|...   .++..  ||||.+......                        ....+.+|+..+.++
T Consensus        51 i~~~ig~G~~g~Vy~a~~~---~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGV---FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEE---ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             hCCEEeecceEEEEEEEEc---CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            4467999999999999984   24667  999986432111                        113688999999999


Q ss_pred             CCCCc--eeeeeeEecCCeEEEEEEeCCC-C----CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEeCC
Q 037780          222 HHKNL--VRLLGFCDEGQNRLLVYEFLNN-G----TLASFLFGNLKPSWNLRTNIAFQIARGLLYLH-EDCSSQIIHCDI  293 (455)
Q Consensus       222 ~h~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dl  293 (455)
                      +|+++  ..++++    ...+|||||+.+ |    +|.++...   .++.....++.|++.+|.||| +.   +|+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence            98864  333332    356899999942 4    77776543   234567889999999999999 54   9999999


Q ss_pred             CCCCEEEcCCCcEEEeeccCccccc
Q 037780          294 KPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       294 k~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ||+|||+++  .++|+|||+|....
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETT
T ss_pred             CHHHEEEcC--cEEEEECcccccCC
Confidence            999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=3.5e-17  Score=158.47  Aligned_cols=137  Identities=12%  Similarity=0.043  Sum_probs=94.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--------------ccHHH--------HHHHHHHHcccCCC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--------------DGEKE--------FKNEVVVIGQTHHK  224 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h~  224 (455)
                      .+.+.||.|+||.||+|...    +++.||||.++....              .....        ...|...|.++.+.
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            35567999999999999864    578899998653210              00111        23455555555443


Q ss_pred             CceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC
Q 037780          225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY  304 (455)
Q Consensus       225 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  304 (455)
                      ++.-..-+..  ...+|||||+++++|..+...      .....++.|++.+|.|||+.   +||||||||.|||+++++
T Consensus       174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred             CCCCCeeeec--cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence            3211111111  123799999999988765421      23456889999999999965   999999999999998877


Q ss_pred             ----------cEEEeeccCccccc
Q 037780          305 ----------NARISDFGLAKLLT  318 (455)
Q Consensus       305 ----------~~kl~Dfg~a~~~~  318 (455)
                                .+.|+||+-+....
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CcccccccccceEEEEeCCcccCC
Confidence                      38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=9e-12  Score=115.55  Aligned_cols=139  Identities=15%  Similarity=0.053  Sum_probs=108.0

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEeC
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +...++.|+.+.||+...     .+..+++|............+.+|+.+++.+. +.++.++++++...+..++||||+
T Consensus        18 ~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             EEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             eEeeccCCCCCeEEEEEC-----CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            345678888899999863     24679999986432223346889999999884 677889999999888999999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC------------------------------------------  284 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------  284 (455)
                      +|.+|.+.+.     +......++.+++++|+.||+..                                          
T Consensus        93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            9999988642     12234578899999999999710                                          


Q ss_pred             --------------CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 --------------SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 --------------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                                    ...++|+|++|.||+++++....|+||+.+..
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                          14589999999999998766677999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=5.8e-11  Score=109.70  Aligned_cols=129  Identities=15%  Similarity=0.063  Sum_probs=96.0

Q ss_pred             CcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeeeEecCCeEEEEEEeCCCCC
Q 037780          173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLNNGT  250 (455)
Q Consensus       173 G~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs  250 (455)
                      +.|..+.||+....    ++..+++|.....   ....+..|+.++..+.+.+  +.+++++...++..++||||++|.+
T Consensus        29 ~gg~~~~v~~~~~~----~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~  101 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQ----GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD  101 (264)
T ss_dssp             CTTSSCEEEEEECT----TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCCCceEEEEecC----CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence            35566999998642    4566899986543   2245788999999886545  4568888888888999999999988


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 037780          251 LASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC----------------------------------------------  284 (455)
Q Consensus       251 L~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------------  284 (455)
                      |.  ...   .+   ...++.++++.|+.||+..                                              
T Consensus       102 l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          102 LL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            84  211   11   2367788888899998631                                              


Q ss_pred             ---------CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 ---------SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 ---------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                               ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     11299999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=4e-10  Score=109.48  Aligned_cols=141  Identities=16%  Similarity=0.191  Sum_probs=105.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecc--ccc-cccHHHHHHHHHHHcccC--CCCceeeeeeEecC---CeEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVF-QDGEKEFKNEVVVIGQTH--HKNLVRLLGFCDEG---QNRLL  241 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~---~~~~l  241 (455)
                      +.|+.|.++.||+....     +..+++|+..  ... ......+.+|+.+++.+.  +.++.++++++.+.   +..++
T Consensus        44 ~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EECCC-CCSCEEEEECS-----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            46899999999998753     3467888765  221 122346888999999987  45678889988776   45799


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------------------------------------  284 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------  284 (455)
                      ||||++|..+.+..  ...++..++..++.++++.|+.||+..                                     
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999998875421  234678888999999999999999731                                     


Q ss_pred             ------------------CCCeEEeCCCCCCEEEcCCCc--EEEeeccCcccc
Q 037780          285 ------------------SSQIIHCDIKPQNILLDDHYN--ARISDFGLAKLL  317 (455)
Q Consensus       285 ------------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~  317 (455)
                                        ...++|+|+++.||+++.++.  +.|+||+.+..-
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              256999999999999997753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=2.9e-10  Score=107.84  Aligned_cols=185  Identities=19%  Similarity=0.159  Sum_probs=119.8

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCC--ceeeeeeEecCC---eEEEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKN--LVRLLGFCDEGQ---NRLLVYE  244 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lv~e  244 (455)
                      .++.|....||+..        ..+++|.....  .....+.+|..++..+. +..  +.+++......+   ..|+|||
T Consensus        27 ~~~~G~~n~v~~v~--------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN--------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             EEEECSSEEEEEST--------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             ecCCCCcceEEEEC--------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            47889999998752        34788875432  33567899999998883 333  334444443333   3478999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC----------------------------------------  284 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------  284 (455)
                      +++|.+|.+...  ..++..++..++.++++.|+.||+..                                        
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988865332  34567778888999999999998611                                        


Q ss_pred             ---------------CCCeEEeCCCCCCEEEcC--CCcEEEeeccCcccccCCCCccccc------------cccccCcc
Q 037780          285 ---------------SSQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLNQSKTIKT------------AIRGTKGY  335 (455)
Q Consensus       285 ---------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~------------~~~gt~~y  335 (455)
                                     ...++|+|++|.||++++  +..+.|+||+.+..-.+........            ......+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                           135899999999999998  5668899999987543211000000            00000111


Q ss_pred             cc-cccccCCCCCCCCCeecHHHHHHHHHhCCCCC
Q 037780          336 VA-PEWYRKSTITAKVDVYSFGVLLLEIISCRKSF  369 (455)
Q Consensus       336 ~a-PE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~  369 (455)
                      .. |+....  .....+.|+++.++|.+.+|..+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 222111  112357899999999999998775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.45  E-value=1e-06  Score=81.60  Aligned_cols=135  Identities=18%  Similarity=0.143  Sum_probs=95.7

Q ss_pred             cCcCCCc-cEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          172 AGRGSFG-IVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       172 lG~G~fg-~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      +..|..| .||+....   .++..+.+|+-..   .....+..|...|+.+. +-.+-++++++.+.+..++|||++++.
T Consensus        32 ~~~G~S~~~v~rl~~~---~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGK---PNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECC---TTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEec---CCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445555 58886644   2455688887543   23456888999988874 334678889999999999999999998


Q ss_pred             CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 037780          250 TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC---------------------------------------------  284 (455)
Q Consensus       250 sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------------  284 (455)
                      ++.+.....    ...+..+..++++.|+-||+..                                             
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887754321    2233456666777777777421                                             


Q ss_pred             ----------CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 ----------SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 ----------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                                ...++|+|+.+.||+++++..+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      11379999999999999887778999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.31  E-value=3.5e-06  Score=79.62  Aligned_cols=134  Identities=18%  Similarity=0.187  Sum_probs=92.4

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCC---CceeeeeeEe-cCCeEEEEEEeC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK---NLVRLLGFCD-EGQNRLLVYEFL  246 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~  246 (455)
                      .++.|....||+.        +..+++|.-..  ......+..|..+|..+.+.   .+.+++.++. ..+..++|||++
T Consensus        26 ~l~~G~~n~v~~v--------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           26 SLGEGFRNYAILV--------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEECSSEEEEEE--------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             ecCCCcceeEEEE--------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            4677888889886        23477777422  23356789999999999753   2556666664 455678999999


Q ss_pred             CCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 037780          247 NNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED-------------------------------------------  283 (455)
Q Consensus       247 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~-------------------------------------------  283 (455)
                      +|.+|.....  ..++..++..++.++++.|+.||+.                                           
T Consensus        96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            9988876321  1234455556666666666666642                                           


Q ss_pred             --------------CCCCeEEeCCCCCCEEEcC---CCc-EEEeeccCccc
Q 037780          284 --------------CSSQIIHCDIKPQNILLDD---HYN-ARISDFGLAKL  316 (455)
Q Consensus       284 --------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~a~~  316 (455)
                                    ....++|+|++|.||+++.   ++. ..|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          1335799999999999997   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=2.6e-06  Score=82.21  Aligned_cols=147  Identities=9%  Similarity=0.089  Sum_probs=88.1

Q ss_pred             hhc-CcCCCccEEEEEEeccC---CCceEEEEEeccccc---cccHHHHHHHHHHHcccCC---CCceeeeeeEecC---
Q 037780          170 EEA-GRGSFGIVYKGVIETTR---TSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQTHH---KNLVRLLGFCDEG---  236 (455)
Q Consensus       170 ~~l-G~G~fg~Vy~~~~~~~~---~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~g~~~~~---  236 (455)
                      +.| +.|....+|+.......   .++..+++|.-....   ......+..|+.++..+..   ..+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            346 88888999987653100   014567888764322   0012457788888888843   3466788887665   


Q ss_pred             CeEEEEEEeCCCCCHHHHhc---CC---CCCCHHHHHHHHHHHHH-----------------------------------
Q 037780          237 QNRLLVYEFLNNGTLASFLF---GN---LKPSWNLRTNIAFQIAR-----------------------------------  275 (455)
Q Consensus       237 ~~~~lv~e~~~~gsL~~~l~---~~---~~~~~~~~~~i~~~ia~-----------------------------------  275 (455)
                      ...++||||++|..+.+.+.   ..   ..++..++..++.++++                                   
T Consensus       106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV  185 (357)
T ss_dssp             SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred             CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence            35689999999876543210   00   01122222222222222                                   


Q ss_pred             -------------------HHHHHHhCC-------CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          276 -------------------GLLYLHEDC-------SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       276 -------------------~l~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                                         .+.+|.+..       ...++|+|+.+.||+++++..+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence                               233343221       35789999999999999655578999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.03  E-value=1.3e-05  Score=78.48  Aligned_cols=75  Identities=17%  Similarity=0.140  Sum_probs=47.5

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-------ccHHHHHHHHHHHcccCC--CCce-eeeeeEecCCeE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-------DGEKEFKNEVVVIGQTHH--KNLV-RLLGFCDEGQNR  239 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~l~g~~~~~~~~  239 (455)
                      +.||.|.++.||++....   .+..++||.......       .....+..|.+++..+..  +..+ +++.+  +.+..
T Consensus        36 ~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             EECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence            468999999999997542   346789997543211       123456778888887742  3333 45543  34456


Q ss_pred             EEEEEeCCCC
Q 037780          240 LLVYEFLNNG  249 (455)
Q Consensus       240 ~lv~e~~~~g  249 (455)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.88  E-value=0.00017  Score=68.67  Aligned_cols=137  Identities=18%  Similarity=0.205  Sum_probs=78.5

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC--CCceeeee------eEecCCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLG------FCDEGQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g------~~~~~~~~~lv  242 (455)
                      .|+.|..+.||+....    + ..+++|+....    ...+..|..++..+..  -.+.+++.      +....+..+++
T Consensus        39 ~l~gG~~n~~~~v~~~----~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           39 VIQGNQMALVWKVHTD----S-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             ECC----CEEEEEEET----T-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eccccccCcEEEEEeC----C-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            3666778899998753    2 34888887642    2334455555555531  12333332      12345678999


Q ss_pred             EEeCCCCCHH-----H---------HhcC----C--C--------CCCHHHHH---------------------------
Q 037780          243 YEFLNNGTLA-----S---------FLFG----N--L--------KPSWNLRT---------------------------  267 (455)
Q Consensus       243 ~e~~~~gsL~-----~---------~l~~----~--~--------~~~~~~~~---------------------------  267 (455)
                      +||++|..+.     .         .++.    .  .        ...|....                           
T Consensus       110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  189 (346)
T 2q83_A          110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL  189 (346)
T ss_dssp             EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence            9999986542     0         1111    0  0        11343211                           


Q ss_pred             ----HHHHHHHHHHHHHHh----------CCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          268 ----NIAFQIARGLLYLHE----------DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       268 ----~i~~~ia~~l~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                          .+...+.+++.+|++          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                011123345666663          1256899999999999998888999999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.74  E-value=0.00016  Score=68.12  Aligned_cols=134  Identities=18%  Similarity=0.154  Sum_probs=88.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC---CCCceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.|+.|....+|+...     ++..+++|.-...   ....+..|...|+.+.   ...+.++++++...+..++||||+
T Consensus        42 ~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEECCSSSSEEEEEES-----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             EEeCCccceeeeEEEE-----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            3589999999999763     2456788876432   3566889999888884   356788888888888899999999


Q ss_pred             CCCCHHH-----------HhcCCC----------------------CCCHHHHH---HHHH----------------HHH
Q 037780          247 NNGTLAS-----------FLFGNL----------------------KPSWNLRT---NIAF----------------QIA  274 (455)
Q Consensus       247 ~~gsL~~-----------~l~~~~----------------------~~~~~~~~---~i~~----------------~ia  274 (455)
                      ++..+..           .|+...                      .-+|....   ++..                .+.
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9876421           112110                      11455322   1111                111


Q ss_pred             HH-HHHHHh-CCCCCeEEeCCCCCCEEEcCCCcEEEeecc
Q 037780          275 RG-LLYLHE-DCSSQIIHCDIKPQNILLDDHYNARISDFG  312 (455)
Q Consensus       275 ~~-l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  312 (455)
                      .- ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 223321 2256799999999999999887 8899973

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.70  E-value=0.00011  Score=68.58  Aligned_cols=74  Identities=18%  Similarity=0.213  Sum_probs=52.2

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCC---CceeeeeeEecCCeEEEEEEeC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHK---NLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      +.+|.|..+.||+..+.    +++.+.+|+-..........|..|...|+.+...   .+.+++++.    ..++||||+
T Consensus        21 ~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l   92 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELA----DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV   92 (288)
T ss_dssp             EEEEEETTEEEEEEEET----TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred             EecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence            45899999999999885    6678999987544333445688899988888422   234445442    247899999


Q ss_pred             CCCCH
Q 037780          247 NNGTL  251 (455)
Q Consensus       247 ~~gsL  251 (455)
                      +++..
T Consensus        93 ~~~~~   97 (288)
T 3f7w_A           93 DERPP   97 (288)
T ss_dssp             CCCCC
T ss_pred             cccCC
Confidence            87653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.66  E-value=0.00016  Score=71.24  Aligned_cols=80  Identities=9%  Similarity=0.015  Sum_probs=48.4

Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCC---CCCCCCCeecHHHHHHH
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS---TITAKVDVYSFGVLLLE  361 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gv~l~e  361 (455)
                      ...++|+|++|.|||++.++ ++|+||+.+..-.+...... ....-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            56899999999999999876 99999998875432211000 000012346666655311   11123445577777777


Q ss_pred             HHhCC
Q 037780          362 IISCR  366 (455)
Q Consensus       362 l~tg~  366 (455)
                      ..+++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.0026  Score=60.32  Aligned_cols=33  Identities=30%  Similarity=0.313  Sum_probs=28.4

Q ss_pred             CCCeEEeCCCCCCEEEcCC----CcEEEeeccCcccc
Q 037780          285 SSQIIHCDIKPQNILLDDH----YNARISDFGLAKLL  317 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~  317 (455)
                      ...++|+|+.+.||+++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4579999999999999875    68999999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.00  E-value=0.0014  Score=64.63  Aligned_cols=76  Identities=13%  Similarity=0.191  Sum_probs=48.8

Q ss_pred             hhcCcCCCccEEEEEEeccC----CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCc-eeeeeeEecCCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e  244 (455)
                      +.|+.|....||+....+..    ..+..+++|+....  .....+..|..++..+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            45788888999999765211    12456788876331  122456689999888854444 466666543    28999


Q ss_pred             eCCCCCH
Q 037780          245 FLNNGTL  251 (455)
Q Consensus       245 ~~~~gsL  251 (455)
                      |+++.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.97  E-value=0.0021  Score=62.10  Aligned_cols=141  Identities=18%  Similarity=0.263  Sum_probs=81.7

Q ss_pred             hcCcCCCccEEEEEEecc----CCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCc-eeeeeeEecCCeEEEEEEe
Q 037780          171 EAGRGSFGIVYKGVIETT----RTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~  245 (455)
                      .|..|-...+|+.....+    ..++..+++|+-... ........+|..+++.+...++ .++++++.++    +|+||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence            466777888999876421    113456888875322 2345567789999988853333 4566665442    99999


Q ss_pred             CCCCCHHHH-----------------hcCC-----CCCC--HHHHHHHHHHHH-------------------HHHHHHHh
Q 037780          246 LNNGTLASF-----------------LFGN-----LKPS--WNLRTNIAFQIA-------------------RGLLYLHE  282 (455)
Q Consensus       246 ~~~gsL~~~-----------------l~~~-----~~~~--~~~~~~i~~~ia-------------------~~l~~LH~  282 (455)
                      ++|..|..-                 |+..     ....  |.+..++..++.                   +.+..|.+
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            987654311                 1111     1222  444444444332                   12333321


Q ss_pred             ----C-CCCCeEEeCCCCCCEEEcCC----CcEEEeeccCccc
Q 037780          283 ----D-CSSQIIHCDIKPQNILLDDH----YNARISDFGLAKL  316 (455)
Q Consensus       283 ----~-~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~  316 (455)
                          . ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 23468999999999999876    7899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.96  E-value=0.0015  Score=61.11  Aligned_cols=127  Identities=17%  Similarity=0.207  Sum_probs=71.4

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCc-eeeeeeEecCCeEEEEEEeC-C
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFL-N  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~  247 (455)
                      +.|+.|....+|+.         ..+++|+-...... .....+|..++..+....+ .++++++  .+.-++++||+ +
T Consensus        24 ~~l~gG~tN~~~~~---------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           24 LERLGGLTNLVFRA---------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             EEEESCSSEEEEEE---------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eEcCCcccccccee---------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            45788888999987         23777776432111 1123467777777653333 3555443  33457899999 5


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE---------------------------------------------  282 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~---------------------------------------------  282 (455)
                      +.+|......       .+..++.++++.|+-||+                                             
T Consensus        92 g~~l~~~~~~-------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           92 AQTMSPEKFK-------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             CEECCHHHHH-------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             CccCCHhhHh-------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            5444210000       000112222222222221                                             


Q ss_pred             -----CCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          283 -----DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       283 -----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                           .....++|+|+.+.||+ .+++.+.++||..+..
T Consensus       165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                 12345899999999999 6667889999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.87  E-value=0.0029  Score=59.64  Aligned_cols=139  Identities=12%  Similarity=0.105  Sum_probs=77.8

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeee------EecCCeEEEE
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGF------CDEGQNRLLV  242 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~------~~~~~~~~lv  242 (455)
                      .|+.|....+|+....    ++ .+++|.....  .....+..|+.++..+....  +.+++..      ....+..+++
T Consensus        29 ~i~~G~~n~~~~v~~~----~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTT----KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EECC---EEEEEEEES----SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             ccCCCcccceEEEEeC----Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            4677877889988653    22 5778887542  12234566777777764322  2333321      1223567899


Q ss_pred             EEeCCCCCHHH-----H---------hcC---C---CC------CCHHHHHH------------HHHHHHHHHHHHHhC-
Q 037780          243 YEFLNNGTLAS-----F---------LFG---N---LK------PSWNLRTN------------IAFQIARGLLYLHED-  283 (455)
Q Consensus       243 ~e~~~~gsL~~-----~---------l~~---~---~~------~~~~~~~~------------i~~~ia~~l~~LH~~-  283 (455)
                      ++|++|..+..     +         ++.   .   ..      ..|.....            +...+.+.++++++. 
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99999865321     0         111   0   10      12433111            111244455666532 


Q ss_pred             ---CCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          284 ---CSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       284 ---~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                         ....++|+|+++.||+++++....|+||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               235799999999999999876668999997753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.76  E-value=0.0067  Score=57.24  Aligned_cols=137  Identities=12%  Similarity=0.047  Sum_probs=77.6

Q ss_pred             cCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCC--ceeeeee-----EecCCeEEEEEE
Q 037780          172 AGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKN--LVRLLGF-----CDEGQNRLLVYE  244 (455)
Q Consensus       172 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lv~e  244 (455)
                      |+ |....||+....    ++..+++|..... ......+..|..++..+....  +.+++..     ....+..+++++
T Consensus        34 l~-g~~n~~y~v~~~----~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           34 LN-SYENRVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EC-CSSSEEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             ec-CcccceEEEEcC----CCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            55 777889986542    3456889987532 123456777888887774322  3444443     122445688999


Q ss_pred             eCCCCCHH-----HH---------hc----CC-----CCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 037780          245 FLNNGTLA-----SF---------LF----GN-----LKPSWNLR----TNI---------------AFQIARGLLYLHE  282 (455)
Q Consensus       245 ~~~~gsL~-----~~---------l~----~~-----~~~~~~~~----~~i---------------~~~ia~~l~~LH~  282 (455)
                      |++|..+.     ..         ++    ..     ...++...    ..+               ...+.+.++.+.+
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875432     11         11    00     11222211    001               1111122333332


Q ss_pred             C----CCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          283 D----CSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       283 ~----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      .    ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1    245689999999999999 4 899999988754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.59  E-value=0.0026  Score=55.65  Aligned_cols=103  Identities=13%  Similarity=0.021  Sum_probs=66.8

Q ss_pred             CCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcccc
Q 037780          248 NGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK  326 (455)
Q Consensus       248 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  326 (455)
                      .-||.+.|.. +.+++++++|.++.|.+..|.-+-.. ..+ ..+=+.|..|++..+|.+...+ ..+.           
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            3479999875 57899999999999999998776211 011 1333457899999999988764 1110           


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS  368 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p  368 (455)
                         .....+.|||... ...+.+.=|||+|++||.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0122466888763 3446778899999999998874443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.53  E-value=0.005  Score=59.32  Aligned_cols=77  Identities=13%  Similarity=0.098  Sum_probs=42.2

Q ss_pred             hhcCcCCCccEEEEEEeccC-----CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCc-eeeeeeEecCCeEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTR-----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~  243 (455)
                      +.|+.|....+|+....+..     ..+..+++|........ ..+...|..++..+...++ .++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            35778888899998764210     01246777775432211 1123567888877754443 3555544  2  26899


Q ss_pred             EeCCCCCH
Q 037780          244 EFLNNGTL  251 (455)
Q Consensus       244 e~~~~gsL  251 (455)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.32  E-value=0.0084  Score=59.51  Aligned_cols=74  Identities=14%  Similarity=0.081  Sum_probs=44.7

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCc-eeeeeeEecCCeEEEEEEeCCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +.|+.|-...+|+....+   .+..+++|+....... .-+-..|..++..+...++ .++++++.  +  .+|+||+++
T Consensus       114 ~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMS---KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETT---TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECC---CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            457888889999987642   1356778775432211 1112578888888865555 46666663  2  259999987


Q ss_pred             CCH
Q 037780          249 GTL  251 (455)
Q Consensus       249 gsL  251 (455)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.29  E-value=0.043  Score=52.03  Aligned_cols=32  Identities=25%  Similarity=0.364  Sum_probs=28.2

Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.88  E-value=0.13  Score=50.24  Aligned_cols=140  Identities=16%  Similarity=0.154  Sum_probs=80.2

Q ss_pred             hcCcCCCccEEEEEEeccCCC----ceEEEEEeccccccccHHHHHHHHHHHcccCCCCc-eeeeeeEecCCeEEEEEEe
Q 037780          171 EAGRGSFGIVYKGVIETTRTS----TTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL-VRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~  245 (455)
                      .+..|-...+|+........+    +..+++++-..... ..-+..+|..+++.+...++ .++++.+.    -++|+||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            467788889999887532111    46678877543221 11123567888877753333 34554332    2689999


Q ss_pred             CCCCCHHH-------H----------hcC------------CCCC-CHHHHHHHHHH-------------------HHHH
Q 037780          246 LNNGTLAS-------F----------LFG------------NLKP-SWNLRTNIAFQ-------------------IARG  276 (455)
Q Consensus       246 ~~~gsL~~-------~----------l~~------------~~~~-~~~~~~~i~~~-------------------ia~~  276 (455)
                      ++|..|..       .          |+.            ...+ -|.+...+..+                   +...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            99865421       0          010            1111 24443333322                   1223


Q ss_pred             HHHHHhC---------------------CCCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          277 LLYLHED---------------------CSSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       277 l~~LH~~---------------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      +.+|.+.                     ....++|+|+.+.||+ ++++.+.++||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            3343311                     1345899999999999 8888999999998864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.19  E-value=0.73  Score=40.29  Aligned_cols=85  Identities=12%  Similarity=0.085  Sum_probs=62.8

Q ss_pred             CCCCceeeeeeEecCCeEEEEEEeCCCC-CHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEeCCCCCCEE
Q 037780          222 HHKNLVRLLGFCDEGQNRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLL-YLHEDCSSQIIHCDIKPQNIL  299 (455)
Q Consensus       222 ~h~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~dlk~~Nil  299 (455)
                      .||.+  -...-.+.+...+.|+--+++ ++. .+   ...+...+++++..++.... +++     .-+|--|+|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence            57777  444557777777778765443 333 33   45678899999999888776 555     5688899999999


Q ss_pred             EcCCCcEEEeeccCcccc
Q 037780          300 LDDHYNARISDFGLAKLL  317 (455)
Q Consensus       300 l~~~~~~kl~Dfg~a~~~  317 (455)
                      +|.++.++|.-.|+-..+
T Consensus       117 f~~~~~p~i~hRGi~~~l  134 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL  134 (219)
T ss_dssp             ECTTCCEEESCCEETTTB
T ss_pred             EeCCCcEEEEEcCCcccC
Confidence            999999999877765433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.09  E-value=0.3  Score=30.60  Aligned_cols=8  Identities=0%  Similarity=-0.056  Sum_probs=3.2

Q ss_pred             ehhhHHHH
Q 037780          107 ATGSVLLG  114 (455)
Q Consensus       107 ~~~~~~~~  114 (455)
                      ++.+++.|
T Consensus        13 IA~gVVgG   20 (44)
T 2ks1_B           13 IATGMVGA   20 (44)
T ss_dssp             STHHHHHH
T ss_pred             EEeehhHH
Confidence            33444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.74  E-value=0.56  Score=40.88  Aligned_cols=115  Identities=10%  Similarity=0.092  Sum_probs=78.4

Q ss_pred             CCCCceeeeeeEecCCeEEEEEEeCCCC-CHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          222 HHKNLVRLLGFCDEGQNRLLVYEFLNNG-TLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       222 ~h~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      .||+++.. .+-.+.+...+.|+.-+++ ++..    -...+...+++++..|+....+++     .-+|--|.|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence            57888866 4556666666666654322 2222    245678899999999999887776     45888999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCC
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFD  370 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~  370 (455)
                      +.++.+++.=.|+-..+.+...                        +...=.-.+=+++..+++++..|+
T Consensus       113 ~~~~~p~i~~RGik~~l~P~~~------------------------~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVDPLPV------------------------SEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTBSCCCC------------------------CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCCCCCCC------------------------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999987776543332211                        111112245678889999988875

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=86.21  E-value=0.96  Score=27.32  Aligned_cols=9  Identities=0%  Similarity=-0.156  Sum_probs=3.9

Q ss_pred             hHHHHHHHH
Q 037780          110 SVLLGSSVF  118 (455)
Q Consensus       110 ~~~~~~~~~  118 (455)
                      +.++|+++.
T Consensus        11 GaIAGiVvG   19 (38)
T 2k1k_A           11 GEIVAVIFG   19 (38)
T ss_dssp             HHHHHHHHH
T ss_pred             CceeeeehH
Confidence            344444443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.19  E-value=0.093  Score=52.04  Aligned_cols=62  Identities=6%  Similarity=0.023  Sum_probs=18.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEE------Eeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAV------KKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCD  234 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~  234 (455)
                      .+.++||   ||.||+|.+..+   ...|||      |......  .+....|.+|..++...+|||+++.++|..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~---~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKK---HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhccccccc---CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456777   999999998632   346777      6654322  223346888999999999999999988764

>2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M*

Probab=85.44  E-value=0.63  Score=33.58  Aligned_cols=33  Identities=15%  Similarity=0.410  Sum_probs=27.0

Q ss_pred             cccCHHhHHHhhccCCceeeeeecC--Ccceeecc
Q 037780           29 KPYNEVQCKNSCLSDCFCAAVIFED--DSCCFKKL   61 (455)
Q Consensus        29 ~~~~~~~C~~~Cl~~C~C~a~~~~~--~~c~~~~~   61 (455)
                      ...++++|+..|+.+=.|.+|.|+.  ..|.++..
T Consensus        28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~   62 (82)
T 2ll3_A           28 RASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG   62 (82)
T ss_dssp             ECSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred             cCCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence            4468999999999999999999963  45776654

>3hms_A Hepatocyte growth factor; HGF/SF, hormone/growth factor, disulfide bond, glycoprotein, kringle, pyrrolidone carboxylic acid, serine protea homolog; 1.70A {Homo sapiens} SCOP: g.10.1.1 PDB: 3hmt_A 2hgf_A 3hmr_A

Probab=82.77  E-value=0.63  Score=35.05  Aligned_cols=55  Identities=20%  Similarity=0.409  Sum_probs=39.2

Q ss_pred             CCCCccceeEEEeeCCCCCCCcc----ccccccCHHhHHHhhccCC----ceeeeeec--CCcce
Q 037780            3 QGYNKELFDFHEVKNIDWPQSDY----ERFKPYNEVQCKNSCLSDC----FCAAVIFE--DDSCC   57 (455)
Q Consensus         3 ~~~~~~~~~f~~~~~~~~p~~~~----~~~~~~~~~~C~~~Cl~~C----~C~a~~~~--~~~c~   57 (455)
                      -+..+...+|.+-+++.|-..+.    ......+.++|.+.|.++=    .|.||.|.  +-.|.
T Consensus         8 ~~~~~~L~~y~kTeg~~L~~~~~~~~~~~~~~~s~eeCA~kC~~~~~~~F~CRAF~y~~k~q~C~   72 (101)
T 3hms_A            8 RKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCL   72 (101)
T ss_dssp             ---CCCGGGEEEEEEEEEEECCTTCCCEEEECSCHHHHHHHHHHCTTCSSCCCEEEEETTTTEEE
T ss_pred             CCCCcHHHHhhhcCCeEEeccCCCccceeeccCCHHHHHHHHHhccCCCcceeeeEEecCCCcEE
Confidence            34566788898888887765432    2445578999999999963    79999995  34675

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	455
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-68
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-59
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-59
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-57
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (552), Expect = 6e-68
 Identities = 71/304 (23%), Positives = 134/304 (44%), Gaps = 34/304 (11%)

Query: 156 FSYKALEEATDNFKEEA-----------GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF 204
           F+++   EA   F +E            G G FG V  G ++        VA+K L   +
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 205 -QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-S 262
            +   ++F +E  ++GQ  H N++ L G   +    +++ EF+ NG+L SFL  N    +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 263 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS 322
                 +   IA G+ YL +      +H D+  +NIL++ +   ++SDFGL++ L  + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 323 K---TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI 379
               T     +    + APE  +    T+  DV+S+G+++ E++S  +            
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233

Query: 380 LTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                +    N  + + +E D      + C   L  + + C Q+D + RP   ++   L+
Sbjct: 234 -----YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

Query: 440 GVVE 443
            ++ 
Sbjct: 289 KMIR 292

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 8e-68
 Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 23/276 (8%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             +  G GSFG VYKG          AV +  +        + FKNEV V+ +T H N++
Sbjct: 12  VGQRIGSGSFGTVYKG----KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             +G+    Q   +V ++    +L   L     K       +IA Q A+G+ YLH     
Sbjct: 68  LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS-- 124

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---K 343
            IIH D+K  NI L +    +I DFGLA + +          + G+  ++APE  R   K
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
           +  + + DVY+FG++L E+++ +  +      +   +       Y +  L  +       
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLSPDLSKVRSN---- 237

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                C + +  +   C+++    RP   ++   +E
Sbjct: 238 -----CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 1e-63
 Identities = 77/274 (28%), Positives = 122/274 (44%), Gaps = 27/274 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             E  G G FG V+ G           VAVK L +        F  E  ++ Q  H+ LV
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTK----VAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
           RL     +     ++ E++ NG+L  FL     +K + N   ++A QIA G+ ++ E   
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
              IH D++  NIL+ D  + +I+DFGLA+L+  N+    +   +    + APE     T
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGT 186

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            T K DV+SFG+LL EI++  +                 +    N ++   +E     + 
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVR 231

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
              C E+L  +   C +E P  RPT   +  +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 6e-63
 Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 23/293 (7%)

Query: 162 EEATDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNEVVVIGQ 220
                +F E  GRG FG VY G +          AVK L+R+   GE  +F  E +++  
Sbjct: 25  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84

Query: 221 THHKNLVRLLGFCDEGQNR-LLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLL 278
             H N++ LLG C   +   L+V  ++ +G L +F+      P+         Q+A+G  
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-- 142

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTAIRGTKGYV 336
            +    S + +H D+  +N +LD+ +  +++DFGLA+ +   +  ++  KT  +    ++
Sbjct: 143 -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           A E  +    T K DV+SFGVLL E+++       ++        D      +  +L   
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQ- 255

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPN 449
                       C + L  V + C      +RP+  ++   +  +    +  +
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 28/288 (9%)

Query: 159 KALEEATDNFK---EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE-KEFKNE 214
           K L    DN      E G G+FG V +GV    +     VA+K L +  +  + +E   E
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMRE 59

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQI 273
             ++ Q  +  +VRL+G C + +  +LV E    G L  FL G  +    +    +  Q+
Sbjct: 60  AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGT 332
           + G+ YL E      +H D+  +N+LL + + A+ISDFGL+K L  + S  T ++A +  
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 333 KGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKS-FDIEMGEEYAILTDWAFDCYRNG 391
             + APE       +++ DV+S+GV + E +S  +  +    G E              G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228

Query: 392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           K  +             C  +L  +   C       RP    V Q + 
Sbjct: 229 KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 9e-62
 Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V+ G           VA+K +       E++F  E  V+ +  H  L
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDK----VAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 285
           V+L G C E     LV+EF+ +G L+ +L       +      +   +  G+ YL E C 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
             +IH D+  +N L+ ++   ++SDFG+ + +  +Q  T  T  +    + +PE +  S 
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 178

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            ++K DV+SFGVL+ E+ S  K                 ++   N ++ + +        
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYK 223

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
                  +  +   C +E P  RP   ++ + L  + E
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-61
 Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 25/274 (9%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
            F +E G G FG+V  G           VA+K +       E EF  E  V+    H+ L
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYD----VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 285
           V+L G C + +   ++ E++ NG L ++L              +   +   + YL     
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
              +H D+  +N L++D    ++SDFGL++ +  +   T     +    +  PE    S 
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            ++K D+++FGVL+ EI S  K                 ++ + N +  + +   +    
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                EK+  +   C  E    RPT + +   + 
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 3e-60
 Identities = 71/316 (22%), Positives = 126/316 (39%), Gaps = 47/316 (14%)

Query: 157 SYKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTT--AVAVKKLDR-VFQDGEKEF 211
              +LE   +N +   + G G+FG V++              VAVK L      D + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 212 KNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---------- 261
           + E  ++ +  + N+V+LLG C  G+   L++E++  G L  FL                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 262 --------------SWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNAR 307
                         S   +  IA Q+A G+ YL E      +H D+  +N L+ ++   +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 308 ISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRK 367
           I+DFGL++ +                 ++ PE    +  T + DV+++GV+L EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 368 SFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSL 427
                M  E            R+G +    E          C  +L  +   C  + P+ 
Sbjct: 241 QPYYGMAHE------EVIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPAD 285

Query: 428 RPTMRKVSQMLEGVVE 443
           RP+   + ++L+ + E
Sbjct: 286 RPSFCSIHRILQRMCE 301

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-60
 Identities = 54/304 (17%), Positives = 120/304 (39%), Gaps = 39/304 (12%)

Query: 161 LEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG-EKEFKNEVVV 217
           +E   D+F+   E G G+ G+V+K   + +      +A K +    +     +   E+ V
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGL---VMARKLIHLEIKPAIRNQIIRELQV 57

Query: 218 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 277
           + + +   +V   G         +  E ++ G+L   L    +    +   ++  + +GL
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            YL E     I+H D+KP NIL++     ++ DFG++  L  + + +      GT+ Y++
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMS 171

Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL---------TDWAFDCY 388
           PE  + +  + + D++S G+ L+E+   R        +E  ++          +      
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW------------------CIQEDPSLRPT 430
             G+       D      I  +   ++                      C+ ++P+ R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 431 MRKV 434
           ++++
Sbjct: 292 LKQL 295

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-60
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 23/270 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG V KG  +  +   T VAVK L     D     E   E  V+ Q  +  +VR++
Sbjct: 16  GSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
           G C E ++ +LV E    G L  +L  N          +  Q++ G+ YL E   S  +H
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVH 130

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTAIRGTKGYVAPEWYRKSTITAK 349
            D+  +N+LL   + A+ISDFGL+K L  +++    +T  +    + APE       ++K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 350 VDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKC 409
            DV+SFGVL+ E  S  +                 +   +  ++  ++E          C
Sbjct: 191 SDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPAGC 235

Query: 410 VEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             ++  +   C   D   RP    V   L 
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-59
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 39/298 (13%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLDR-VFQDGEKEFKNEVVVIGQ-THH 223
           F +  G G+FG V +        S  A  VAVK L         +   +E+ V+    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------------------SWNL 265
            N+V LLG C  G   L++ E+   G L +FL                            
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 266 RTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
             + ++Q+A+G+ +L    S   IH D+  +NILL      +I DFGLA+ +  + +  +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 385
           K   R    ++APE       T + DV+S+G+ L E+ S   S                 
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYP 249

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
               + K   +++     ++      ++  +   C   DP  RPT +++ Q++E  + 
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 5e-59
 Identities = 56/298 (18%), Positives = 113/298 (37%), Gaps = 29/298 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            +E  G+G FG V++G     +     VAVK      ++     + E+       H+N++
Sbjct: 7   LQESIGKGRFGEVWRG-----KWRGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 60

Query: 228 RLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHED 283
             +   ++         LV ++  +G+L  +L      +      +A   A GL +LH +
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHME 119

Query: 284 C-----SSQIIHCDIKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTAIRGTKGYV 336
                    I H D+K +NIL+  +    I+D GLA       +          GTK Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 337 APEWY------RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEY----AILTDWAFD 386
           APE        +      + D+Y+ G++  EI        I    +      + +D + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 387 CYRNGKLDDLVEGDM-EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
             R    +  +  ++       + +  +  +   C   + + R T  ++ + L  + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-59
 Identities = 69/339 (20%), Positives = 132/339 (38%), Gaps = 51/339 (15%)

Query: 135 YKKKW----IRNSPGDGTVETNLRCFSY-KALEEATDNFK--EEAGRGSFGIVYKGVIET 187
           Y+ +     +  S  +     + R + Y    E   +N +  +  G G+FG V       
Sbjct: 1   YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYG 60

Query: 188 TRTSTTA--VAVKKLDRVFQDGEKE-FKNEVVVIGQ-THHKNLVRLLGFCDEGQNRLLVY 243
              +  +  VAVK L       E+E   +E+ ++ Q   H+N+V LLG C       L++
Sbjct: 61  ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120

Query: 244 EFLNNGTLASFLFGNLKP-----------------------SWNLRTNIAFQIARGLLYL 280
           E+   G L ++L    +                        ++      A+Q+A+G+ +L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
                   +H D+  +N+L+      +I DFGLA+ +  + +  ++   R    ++APE 
Sbjct: 181 E---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
             +   T K DV+S+G+LL EI S   +    +  +                   L++  
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--------------KLIQNG 283

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +        E++ ++   C   D   RP+   ++  L 
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-58
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 27/283 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
            + + G+G FG V+ G    T   TT VA+K L        + F  E  V+ +  H+ LV
Sbjct: 21  LEVKLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPS--WNLRTNIAFQIARGLLYLHEDCS 285
           +L       +   +V E+++ G+L  FL G            ++A QIA G+ Y+     
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
              +H D++  NIL+ ++   +++DFGLA+L+  N+  T +   +    + APE      
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR 190

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            T K DV+SFG+LL E+ +  +                 +    N ++ D VE       
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMPC 235

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP 448
             +C E L  +   C +++P  RPT   +   LE       P 
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-58
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 33/277 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             +  G+G FG V  G     +     VAVK +        + F  E  V+ Q  H NLV
Sbjct: 11  LLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63

Query: 228 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--SWNLRTNIAFQIARGLLYLHEDC 284
           +LLG   E +  L +V E++  G+L  +L    +     +     +  +   + YL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
            +  +H D+  +N+L+ +   A++SDFGL K  +     + +   +    + APE  R+ 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 175

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             + K DV+SFG+LL EI S  +     +  +              G   D  +G     
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG----- 224

Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV 441
               C   +  V   C   D ++RP+  ++ + LE +
Sbjct: 225 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (485), Expect = 3e-58
 Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 25/279 (8%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL 226
             K + G G +G VY+GV +        VAVK L     + E EF  E  V+ +  H NL
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPSWNLRTNIAFQIARGLLYLHEDC 284
           V+LLG C       ++ EF+  G L  +L      + S  +   +A QI+  + YL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
               IH D+  +N L+ +++  +++DFGL++L+T   + T     +    + APE    +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM 404
             + K DV++FGVLL EI +   S                +      ++ +L+E D    
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRME 236

Query: 405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
               C EK+  +   C Q +PS RP+  ++ Q  E + +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-57
 Identities = 65/286 (22%), Positives = 127/286 (44%), Gaps = 24/286 (8%)

Query: 173 GRGSFGIVYKGVIETTRTST-TAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G FG VYKG+++T+       VA+K L   + +    +F  E  ++GQ  H N++RL 
Sbjct: 16  GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 75

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSSQII 289
           G   + +  +++ E++ NG L  FL       S      +   IA G+ YL        +
Sbjct: 76  GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YV 132

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-AIRGTKGYVAPEWYRKSTITA 348
           H D+  +NIL++ +   ++SDFGL+++L  +   T  T   +    + APE       T+
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 192

Query: 349 KVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIK 408
             DV+SFG+++ E+++  +                 +    N ++   +         + 
Sbjct: 193 ASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAINDGFRLPTPMD 237

Query: 409 CVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPPNPSPFS 454
           C   +  + + C Q++ + RP    +  +L+ ++    P +    +
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR--APDSLKTLA 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 7e-57
 Identities = 62/269 (23%), Positives = 107/269 (39%), Gaps = 20/269 (7%)

Query: 173 GRGSFGIVYKGV-IETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLL 230
           G G+FG VYKG+ I         VA+K+L         KE  +E  V+    + ++ RLL
Sbjct: 18  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 77

Query: 231 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIH 290
           G C     +L+         L                N   QIA+G+ YL      +++H
Sbjct: 78  GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVH 134

Query: 291 CDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKV 350
            D+  +N+L+    + +I+DFGLAKLL   + +      +    ++A E       T + 
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194

Query: 351 DVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCV 410
           DV+S+GV + E+++                    +D     ++  ++E          C 
Sbjct: 195 DVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGERLPQPPICT 239

Query: 411 EKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             + M+ + C   D   RP  R++     
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-56
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 30/274 (10%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD--RVFQDGEKEFKNEVVVIGQTHHKN 225
           F  E GRGSF  VYKG+      +T  VA  +L   ++ +   + FK E  ++    H N
Sbjct: 13  FDIEIGRGSFKTVYKGLD---TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 226 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
           +VR            +  +LV E + +GTL ++L         +  +   QI +GL +LH
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 282 EDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
                 IIH D+K  NI +     + +I D GLA L   + +K     + GT  ++APE 
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEM 184

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
           Y +      VDVY+FG+ +LE+ +    +                          +  G 
Sbjct: 185 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTSGV 229

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
             A  D   + ++  +   CI+++   R +++ +
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 40/295 (13%)

Query: 167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQ-THHK 224
            F++  G G+FG V K  I+         A+K++     +D  ++F  E+ V+ +  HH 
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNLRTN 268
           N++ LLG C+      L  E+  +G L  FL  +                   S     +
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
            A  +ARG+ YL      Q IH D+  +NIL+ ++Y A+I+DFGL++     +    KT 
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 185

Query: 329 IRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCY 388
            R    ++A E    S  T   DV+S+GVLL EI+S   +                +   
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------YCGM 230

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              +L + +         + C +++  +   C +E P  RP+  ++   L  ++E
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 2e-56
 Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 33/281 (11%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQT 221
           ++++     G GS+G   K   ++       +  K+LD         +   +EV ++ + 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGK---ILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 222 HHKNLVRLLGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKP----SWNLRTNIAFQIAR 275
            H N+VR      +  N  L  V E+   G LAS +    K            +  Q+  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 276 GLLYLHE--DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
            L   H   D    ++H D+KP N+ LD   N ++ DFGLA++L  + S     A  GT 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178

Query: 334 GYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL 393
            Y++PE   + +   K D++S G LL E+ +    F     +E            R GK 
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF 231

Query: 394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
             +     + +N+      ++      +      RP++ ++
Sbjct: 232 RRIPYRYSDELNE------IIT---RMLNLKDYHRPSVEEI 263

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 22/278 (7%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-FKNEVVVIGQTHHKNL 226
                G G FG V++G+  +      AVA+K       D  +E F  E + + Q  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCS 285
           V+L+G   E     ++ E    G L SFL               A+Q++  L YL     
Sbjct: 71  VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128

Query: 286 SQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST 345
              +H DI  +N+L+  +   ++ DFGL++ +  + +    +  +    ++APE      
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185

Query: 346 ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN 405
            T+  DV+ FGV + EI+         +                NG+   +         
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPMPPN------ 233

Query: 406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
              C   L  +   C   DPS RP   ++   L  ++E
Sbjct: 234 ---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-56
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 24/273 (8%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD-RVFQDGEKEFKNEVVVIGQTH 222
           +++   +  G G++G V   V   T     AVAVK +D +   D  +  K E+ +    +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLN 61

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHE 282
           H+N+V+  G   EG  + L  E+ + G L   +  ++            Q+  G++YLH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 120

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
                I H DIKP+N+LLD+  N +ISDFGLA +   N  + +   + GT  YVAPE  +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 343 KSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM 401
           +       VDV+S G++L  +++    +D +  +     +DW            +   D 
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKI---DS 234

Query: 402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
             +  +             + E+PS R T+  +
Sbjct: 235 APLALLH----------KILVENPSARITIPDI 257

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-56
 Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 25/281 (8%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 220
            + +  E+ G GSFG+V +G  +     T +VAVK L        +   +F  EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLY 279
             H+NL+RL G       + +V E    G+L   L  +         +  A Q+A G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAP 338
           L        IH D+  +N+LL      +I DFGL + L  N     ++   +    + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 398
           E  +  T +   D + FGV L E+ +  +   I +     IL     +  R  + +D   
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEGERLPRPED--- 239

Query: 399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
                     C + +  V + C    P  RPT   +   L 
Sbjct: 240 ----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 6e-55
 Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 38/277 (13%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 220
           ++F+     G+G FG VY    + ++     +A+K L +        E + + EV +   
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSH 62

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H N++RL G+  +     L+ E+   GT+   L    K           ++A  L Y 
Sbjct: 63  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S ++IH DIKP+N+LL      +I+DFG +     ++  T+     GT  Y+ PE 
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEM 175

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLV 397
                   KVD++S GVL  E +  +  F+    +E    I   ++ F  +      DL+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235

Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                                  ++ +PS RP +R+V
Sbjct: 236 S--------------------RLLKHNPSQRPMLREV 252

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 61/273 (22%), Positives = 97/273 (35%), Gaps = 33/273 (12%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE---KEFKNEVVVIGQTHHKNL 226
            E G GSFG VY             VA+KK+    +      ++   EV  + +  H N 
Sbjct: 21  REIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
           ++  G         LV E+                       +     +GL YLH   S 
Sbjct: 78  IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 287 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR---K 343
            +IH D+K  NILL +    ++ DFG A ++    S        GT  ++APE      +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDE 188

Query: 344 STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA 403
                KVDV+S G+  +E+   +                  F+      L  + + +  A
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSALYHIAQNESPA 233

Query: 404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ 436
           +      E        C+Q+ P  RPT   + +
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 6e-54
 Identities = 63/267 (23%), Positives = 118/267 (44%), Gaps = 27/267 (10%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL 229
           E+ G+G+ G VY  +   T      VA+++++   Q  ++   NE++V+ +  + N+V  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQ---EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQII 289
           L     G    +V E+L  G+L   +             +  +  + L +LH   S+Q+I
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 290 HCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAK 349
           H DIK  NILL    + +++DFG    +T  QSK   + + GT  ++APE   +     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196

Query: 350 VDVYSFGVLLLEIISCRKSF--DIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMNDI 407
           VD++S G++ +E+I     +  +  +   Y I T+   +     KL           + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA------IFRDFL 250

Query: 408 KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                       C+  D   R + +++
Sbjct: 251 N----------RCLDMDVEKRGSAKEL 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 8e-53
 Identities = 57/278 (20%), Positives = 108/278 (38%), Gaps = 30/278 (10%)

Query: 165 TDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH 222
            D ++   E G G+FG VYK   + T       A K +D   ++  +++  E+ ++    
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSV---LAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLH 281
           H N+V+LL       N  ++ EF   G + + +    +P + +    +  Q    L YLH
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW- 340
               ++IIH D+K  NIL     + +++DFG++   T    +    +  GT  ++APE  
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVV 182

Query: 341 ----YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
                +      K DV+S G+ L+E+                             +   L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTL 235

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            +         +           C++++   R T  ++
Sbjct: 236 AQPS-------RWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 9e-53
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 31/289 (10%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTT--AVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHK 224
              E G+GSFG+VY+GV +          VA+K ++         EF NE  V+ + +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 225 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIA 274
           ++VRLLG   +GQ  L++ E +  G L S+L               PS +    +A +IA
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
            G+ YL    +++ +H D+  +N ++ + +  +I DFG+ + +                 
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD 394
           +++PE  +    T   DV+SFGV+L EI +  +     +  E              G L 
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLL 254

Query: 395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
           D  +          C + L  +   C Q +P +RP+  ++   ++  +E
Sbjct: 255 DKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-51
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 40/299 (13%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTST----TAVAVKKLDR-VFQDGEKEFKNEVVVIGQ-T 221
             +  G G+FG V                T VAVK L     +    +  +E+ ++    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNL 265
            HKN++ LLG C +     ++ E+ + G L  +L     P                S   
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 266 RTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 325
             + A+Q+ARG+ YL    S + IH D+  +N+L+ +    +I+DFGLA+ +        
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAF 385
            T  R    ++APE       T + DV+SFGVLL EI +   S    +  E        F
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELF 247

Query: 386 DCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV 444
              + G   D             C  +L M+   C    PS RPT +++ + L+ +V +
Sbjct: 248 KLLKEGHRMDKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-51
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 38/297 (12%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTA--VAVKKLDR-VFQDGEKEFKNEVVVIGQT-HH 223
             +  GRG+FG V +        + T   VAVK L         +   +E+ ++    HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 224 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKP----------------SWNLR 266
            N+V LLG C   G   +++ EF   G L+++L                      +    
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 267 TNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 326
              +FQ+A+G+ +L    S + IH D+  +NILL +    +I DFGLA+ +  +     K
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD 386
              R    ++APE       T + DV+SFGVLL EI S   S    +  +     +    
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCR 248

Query: 387 CYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE 443
             + G      +             ++    + C   +PS RPT  ++ + L  +++
Sbjct: 249 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 4e-48
 Identities = 55/279 (19%), Positives = 106/279 (37%), Gaps = 28/279 (10%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 220
           ++FK  +  G GSF  V       T       A+K L++   + ++       E  V+ +
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSRE---YAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H   V+L     + +       +  NG L  ++                +I   L YL
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H      IIH D+KP+NILL++  + +I+DFG AK+L+    +    +  GT  YV+PE 
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
             + +     D+++ G ++ ++++    F               F      + D   +  
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYDFPEKFF 234

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
            +A + ++            +  D + R    ++     
Sbjct: 235 PKARDLVE----------KLLVLDATKRLGCEEMEGYGP 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (420), Expect = 7e-48
 Identities = 60/273 (21%), Positives = 110/273 (40%), Gaps = 31/273 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
             EE G G+FG+V++     T  +    A K +    +  ++  + E+  +    H  LV
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHEDCSS 286
            L    ++    +++YEF++ G L   +       S +       Q+ +GL ++HE+   
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144

Query: 287 QIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKS 344
             +H D+KP+NI+     +  +   DFGL   L     K       GT  + APE     
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGK 200

Query: 345 TITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNGKLDDLVEGDM 401
            +    D++S GVL   ++S    F  E  +E    + + DW  D      + +      
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE------ 254

Query: 402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           +  + I+            +  DP+ R T+ + 
Sbjct: 255 DGKDFIR----------KLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (407), Expect = 5e-46
 Identities = 63/274 (22%), Positives = 108/274 (39%), Gaps = 27/274 (9%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH 223
           D +   EE G G+FG+V++ V + T         K ++  +   +   KNE+ ++ Q HH
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHH 85

Query: 224 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYLHE 282
             L+ L    ++    +L+ EFL+ G L   +       S     N   Q   GL ++H 
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 144

Query: 283 DCSSQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
                I+H DIKP+NI+ +    + +   DFGLA  L       I      T  + APE 
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEI 199

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
             +  +    D+++ GVL   ++S    F  E   E            +    +   +  
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEFDEDAF 252

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                + K     +      +Q++P  R T+   
Sbjct: 253 SSVSPEAK---DFIK---NLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 1e-45
 Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 28/283 (9%)

Query: 158 YKALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR-VFQDGEKEFKNE 214
           +K  E+  D +   +  G G+F  V     + T+     VA+K + +   +  E   +NE
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQK---LVAIKCIAKKALEGKEGSMENE 57

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIA 274
           + V+ +  H N+V L    + G +  L+ + ++ G L   +      +    + + FQ+ 
Sbjct: 58  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117

Query: 275 RGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKG 334
             + YLH+                 LD+     ISDFGL+K+       ++ +   GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPG 174

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE--YAILT-DWAFDCYRNG 391
           YVAPE   +   +  VD +S GV+   ++     F  E   +    IL  ++ FD     
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234

Query: 392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            + D       A + I+            +++DP  R T  + 
Sbjct: 235 DISD------SAKDFIR----------HLMEKDPEKRFTCEQA 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 52/278 (18%), Positives = 114/278 (41%), Gaps = 28/278 (10%)

Query: 162 EEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIG 219
           +E  + +   E+ GRG FGIV++ V  +++ +      K +     D +   K E+ ++ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTD-QVLVKKEISILN 56

Query: 220 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLL 278
              H+N++ L    +  +  ++++EF++   +   +  +    +     +   Q+   L 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTAIRGTKGYV 336
           +LH   S  I H DI+P+NI+     ++   I +FG A+ L    +  +   +     Y 
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYY 170

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           APE ++   ++   D++S G L+  ++S    F  E  ++         +   N +    
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTFD 223

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            E   E   +       +      + ++   R T  + 
Sbjct: 224 EEAFKEISIEAM---DFVD---RLLVKERKSRMTASEA 255

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (387), Expect = 6e-43
 Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 33/279 (11%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVI-- 218
           ++F      GRG FG VY      T       A+K LD+     + GE    NE +++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKM---YAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 219 -GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGL 277
                   +V +            + + +N G L   L  +   S       A +I  GL
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 278 LYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
            ++H      +++ D+KP NILLD+H + RISD GLA       SK    A  GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173

Query: 338 PEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           PE  +K     +  D +S G +L +++     F     ++   +            ++  
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELP 229

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
                E  + ++            +Q D + R       
Sbjct: 230 DSFSPELRSLLE----------GLLQRDVNRRLGCLGRG 258

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 8e-43
 Identities = 71/273 (26%), Positives = 108/273 (39%), Gaps = 31/273 (11%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDR---VFQDGEKEFKNEVVVIGQ 220
           ++F   +  G+GSFG V+    + T       A+K L +   +  D  +    E  V+  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSL 58

Query: 221 T-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
              H  L  +       +N   V E+LN G L   +    K   +  T  A +I  GL +
Sbjct: 59  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           LH      I++ D+K  NILLD   + +I+DFG+ K   L  +K       GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173

Query: 340 WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG 399
                     VD +SFGVLL E++  +  F  +  EE        F   R          
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFYPRWL 226

Query: 400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR 432
           + EA + +                +P  R  +R
Sbjct: 227 EKEAKDLLV----------KLFVREPEKRLGVR 249

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (378), Expect = 1e-42
 Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 40/287 (13%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLD---------RVFQDGEKEFKNE 214
           +N++  E  GRG   +V + + + T       AVK +D            Q+  +    E
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 59

Query: 215 VVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQI 273
           V ++ +   H N+++L    +      LV++ +  G L  +L   +  S      I   +
Sbjct: 60  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 274 ARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTK 333
              +  LH      I+H D+KP+NILLDD  N +++DFG +  L   +       + GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 334 GYVAPEWYR------KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDC 387
            Y+APE               +VD++S GV++  +++    F      +  ++       
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLMLRMIMSG 230

Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                  +  +      + +             +   P  R T  + 
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS----------RFLVVQPQKRYTAEEA 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 58/291 (19%), Positives = 110/291 (37%), Gaps = 36/291 (12%)

Query: 165 TDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIG 219
           +D ++  E  G G    V+             VAVK L             F+ E     
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 220 QTHHKNLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIAR 275
             +H  +V +          G    +V E+++  TL   +      +      +     +
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 276 GLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-AIRGTKG 334
            L +      + IIH D+KP NI++      ++ DFG+A+ +  + +   +T A+ GT  
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 335 YVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA---ILTDWAFDCYRNG 391
           Y++PE  R  ++ A+ DVYS G +L E+++    F  +     A   +  D      R+ 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

Query: 392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP-TMRKVSQMLEGV 441
            L                ++ +++     + ++P  R  T  ++   L  V
Sbjct: 240 GLSAD-------------LDAVVL---KALAKNPENRYQTAAEMRADLVRV 274

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 52/281 (18%), Positives = 90/281 (32%), Gaps = 26/281 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
              + G GSFG +Y G           VA+K      +    +   E  +         +
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEE---VAIKLECV--KTKHPQLHIESKIYKMMQGGVGI 65

Query: 228 RLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             + +C  EG   ++V E L       F F + K S      +A Q+   + Y+H   S 
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122

Query: 287 QIIHCDIKPQNIL---LDDHYNARISDFGLAKLLTLNQSKTI-----KTAIRGTKGYVAP 338
             IH D+KP N L           I DFGLAK     ++           + GT  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 339 EWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE 398
             +     + + D+ S G +L+        +            +   +   +  ++ L +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
           G                   +C       +P    + Q+  
Sbjct: 243 GYPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFR 274

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (369), Expect = 6e-41
 Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 39/278 (14%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 220
            +F+     G GSFG V+              A+K L +         +   +E +++  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRY---YAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             H  ++R+ G   + Q   ++ +++  G L S L  + +    +    A ++   L YL
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H      II+ D+KP+NILLD + + +I+DFG AK +       +   + GT  Y+APE 
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSF--DIEMGEEYAILT-DWAFDCYRNGKLDDLV 397
                    +D +SFG+L+ E+++    F     M     IL  +  F  + N  + DL+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232

Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
                                  I  D S R    +  
Sbjct: 233 SR--------------------LITRDLSQRLGNLQNG 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-40
 Identities = 62/282 (21%), Positives = 105/282 (37%), Gaps = 25/282 (8%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE-----FKNEVVVIGQTHHKNLV 227
           G G F  VYK   + T      VA+KK+    +   K+        E+ ++ +  H N++
Sbjct: 7   GEGQFATVYKARDKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
            LL       N  LV++F+           +L  + +          +GL YLH+     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 120

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKST-I 346
           I+H D+KP N+LLD++   +++DFGLAK  +        T    T+ Y APE    +   
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 347 TAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYRNGKLDDL 396
              VD+++ G +L E++                 I           W   C     +   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 397 VEGDMEAMNDIKCVEKLLMVSI-WCIQEDPSLRPTMRKVSQM 437
               +   +        L+  I      +P  R T  +  +M
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 61/278 (21%), Positives = 103/278 (37%), Gaps = 44/278 (15%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKL------DRVFQDGEKEFKNEVVVIGQ- 220
                G G FG VY G+  +       VA+K +      D            EVV++ + 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 221 -THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLL 278
            +    ++RLL + +   + +L+ E                     L  +  +Q+   + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 279 YLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
           + H      ++H DIK +NIL+D +    ++ DFG   LL      T+ T   GT+ Y  
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSP 177

Query: 338 PEWYR-KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           PEW R          V+S G+LL +++     F+    +E  I     F    + +   L
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHL 234

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           +                     WC+   PS RPT  ++
Sbjct: 235 IR--------------------WCLALRPSDRPTFEEI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-39
 Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 33/272 (12%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNLVRLLG 231
           G G  G V +   + T+      A+K L         + + EV +  + +   ++VR++ 
Sbjct: 21  GLGINGKVLQIFNKRTQEK---FALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72

Query: 232 FCD----EGQNRLLVYEFLNNGTLASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCS 285
             +      +  L+V E L+ G L S +   G+   +    + I   I   + YLH   S
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 286 SQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
             I H D+KP+N+L          +++DFG AK  T + S T       T  YVAPE   
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLG 186

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME 402
                   D++S GV++  ++     F          ++       R G+ +       E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
              ++K    L+      ++ +P+ R T+ + 
Sbjct: 244 VSEEVK---MLIR---NLLKTEPTQRMTITEF 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 53/285 (18%), Positives = 106/285 (37%), Gaps = 24/285 (8%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQT 221
           + +   E+ G G++G+VYK       T     A+KK+    +D         E+ ++ + 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKIRLEKEDEGIPSTTIREISILKEL 57

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            H N+V+L       +  +LV+E L+                    +   Q+  G+ Y H
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
           +     ++H D+KPQN+L++     +I+DFGLA+   +   K     I            
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173

Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDL 396
                +  +D++S G +  E+++    F      +     + IL       + N      
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 397 VEGDMEAMNDIKCVEKLLMVSI-------WCIQEDPSLRPTMRKV 434
            + +      +     L  +           ++ DP+ R T ++ 
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (354), Expect = 4e-39
 Identities = 44/283 (15%), Positives = 90/283 (31%), Gaps = 28/283 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-THHKNL 226
                G GSFG++++G           VA+K   R  +    + ++E            +
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQ---VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 227 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSS 286
             +  F  EG + +LV + L             K S       A Q+   +  +H     
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120

Query: 287 QIIHCDIKPQNILLDDHYN-----ARISDFGLAKLLTLNQSKTI-----KTAIRGTKGYV 336
            +++ DIKP N L+    +       + DFG+ K      +K       K  + GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 337 APEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           +   +     + + D+ + G + +  +     +            +   +  ++  L +L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE 439
             G           E+      +         P    +  +  
Sbjct: 241 CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-38
 Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 31/294 (10%)

Query: 164 ATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVV-- 217
           A   ++   E G G++G V+K      +     VA+K++      +        EV V  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 218 -IGQTHHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIA 270
            +    H N+VRL   C     D      LV+E ++                     ++ 
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 271 FQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           FQ+ RGL +LH      ++H D+KPQNIL+      +++DFGLA++ +    +   T++ 
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 176

Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWA 384
            T  Y APE   +S+    VD++S G +  E+   +  F      +        I     
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 385 FDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSI----WCIQEDPSLRPTMRKV 434
            D  R+  L         A    K V  +  +       C+  +P+ R +    
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 9e-38
 Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 32/277 (11%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE------KEFKNEVVVIGQT 221
             EE G G F +V K   ++T       A K + +            ++ + EV ++ + 
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            H N++ L    +   + +L+ E +  G L  FL      +    T    QI  G   ++
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VY 127

Query: 282 EDCSSQIIHCDIKPQNILLDDH----YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVA 337
              S QI H D+KP+NI+L D        +I DFGLA  +           I GT  +VA
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 184

Query: 338 PEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV 397
           PE      +  + D++S GV+   ++S    F  +  +E                 +   
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFED 237

Query: 398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
           E         K     +      + +DP  R T++  
Sbjct: 238 EYFSNTSALAK---DFIR---RLLVKDPKKRMTIQDS 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 9e-38
 Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 29/304 (9%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLG 231
           G G++G+V        +     VA+KK+     Q   +    E+ ++ +  H+N++ +  
Sbjct: 17  GEGAYGMVCSAYDNVNKV---RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 232 FCDEGQNRLLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHEDCSSQI 288
                    +   +L    + + L+  LK    S +      +QI RGL Y+H   S+ +
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130

Query: 289 IHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTAIRGTKGYVAPE-WYRKSTI 346
           +H D+KP N+LL+   + +I DFGLA++   +       T    T+ Y APE        
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 347 TAKVDVYSFGVLLLEIISCRKSFDIEMGEE-----YAILTDWAFDCYRNGKLDDLVEGDM 401
           T  +D++S G +L E++S R  F  +   +       IL   + +              +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 402 EAMNDIKCVEKLLMVSI---------WCIQEDPSLRPTMRKVSQ---MLEGVVEVDVPPN 449
              +  K     L  +            +  +P  R  + +      + +     D P  
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA 310

Query: 450 PSPF 453
            +PF
Sbjct: 311 EAPF 314

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-37
 Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 26/287 (9%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKL--DRVFQDGEKEFKNEVVVIGQT 221
           +NF+  E+ G G++G+VYK   + T      VA+KK+  D   +        E+ ++ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58

Query: 222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-SWNLRTNIAFQIARGLLYL 280
           +H N+V+LL          LV+EFL+           L      L  +  FQ+ +GL + 
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H      ++H D+KPQN+L++     +++DFGLA+           T    T  Y APE 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRAPEI 173

Query: 341 YRKS-TITAKVDVYSFGVLLLEIISCRKSFD----------IEMGEEYAILTDWAFDCYR 389
                  +  VD++S G +  E+++ R  F           I           W      
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 390 NGKLDDLVEGDMEAMNDI--KCVEKLLMVSIWCIQEDPSLRPTMRKV 434
                   +   +  + +     E    +    +  DP+ R + +  
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-35
 Identities = 52/293 (17%), Positives = 107/293 (36%), Gaps = 34/293 (11%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDG--EKEFKNEVVVIGQTHHKNLV 227
            + G+G+FG V+K     T      VA+KK+    +          E+ ++    H+N+V
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQK---VALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 228 RLLGFCDEGQNR--------LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLY 279
            L+  C    +          LV++F  +          +K + +    +   +  GL  
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL-- 130

Query: 280 LHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS--KTIKTAIRGTKGYVA 337
            +    ++I+H D+K  N+L+      +++DFGLA+  +L ++      T    T  Y  
Sbjct: 131 -YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 338 PEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIE--------MGEEYAILTDWAFDCY 388
           PE           +D++  G ++ E+ +                + +    +T   +   
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 389 RNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW-------CIQEDPSLRPTMRKV 434
            N +L + +E        +K   K  +   +        +  DP+ R      
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 3e-35
 Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 34/284 (11%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGF 232
           G GSFG+VY+  +  +      VA+KK+ +     ++    E+ ++ +  H N+VRL  F
Sbjct: 29  GNGSFGVVYQAKLCDSGE---LVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 233 CDEGQNR------LLVYEFLNNGTLASFLFGNLKP---SWNLRTNIAFQIARGLLYLHED 283
                 +       LV +++           +               +Q+ R L Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139

Query: 284 CSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYR 342
            S  I H DIKPQN+LLD D    ++ DFG AK L   + +   + I           + 
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFG 196

Query: 343 KSTITAKVDVYSFGVLLLEIISCRKSFDIE------------MGEEYAILTDWAFDCYRN 390
            +  T+ +DV+S G +L E++  +  F  +            +G             Y  
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 391 GKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKV 434
            K   +       +   +   + + +    ++  P+ R T  + 
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 6e-35
 Identities = 48/280 (17%), Positives = 106/280 (37%), Gaps = 22/280 (7%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD--GEKEFKNEVVVIGQTHHKNLV 227
           E+ G G++G V+K     T      VA+K++     D         E+ ++ +  HKN+V
Sbjct: 8   EKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 228 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQ 287
           RL       +   LV+EF +      F   N      +  +  FQ+ +GL + H      
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121

Query: 288 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTIT 347
           ++H D+KPQN+L++ +   ++++FGLA+   +         +           +     +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYS 180

Query: 348 AKVDVYSFGVLLLEIISCRKSFDIEMGEE------YAILTDWAFDCYRNGKLDDLVEGDM 401
             +D++S G +  E+ +  +        +      + +L     + + +       +   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 402 EAMNDIKCVEKLLMVSI-------WCIQEDPSLRPTMRKV 434
                   V  +  ++          ++ +P  R +  + 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-34
 Identities = 58/273 (21%), Positives = 98/273 (35%), Gaps = 30/273 (10%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKNEVVVIGQ 220
           ++F   +  G+G+FG V     + T       A+K L +     +D       E  V+  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRY---YAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
           T H  L  L            V E+ N G L   L      +         +I   L   
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL--- 118

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
               S  +++ DIK +N++LD   + +I+DFGL K    + +        GT  Y+APE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
              +     VD +  GV++ E++  R  F  +  E         F+     ++       
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIRFPRTLS 229

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
            EA + +             +++DP  R     
Sbjct: 230 PEAKSLLA----------GLLKKDPKQRLGGGP 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (317), Expect = 3e-33
 Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 33/275 (12%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKE---FKNEVVVIGQ 220
           D F   +  G GSFG V     + +       A+K LD+      K+     NE  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGN---HYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 221 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
            +   LV+L     +  N  +V E++  G + S L    + S       A QI     YL
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           H   S  +I+ D+KP+N+L+D     +++DFG AK     + K     + GT   +APE 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209

Query: 341 YRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD 400
                    VD ++ GVL+ E+ +    F  +   +        ++   +GK+       
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFS 262

Query: 401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS 435
            +  + ++            +Q D + R    K  
Sbjct: 263 SDLKDLLR----------NLLQVDLTKRFGNLKNG 287

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-32
 Identities = 59/277 (21%), Positives = 105/277 (37%), Gaps = 26/277 (9%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIG 219
           +NF+  +  G G++G V+     +   +    A+K L +          +  + E  V+ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 220 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLL 278
                  LV L           L+ +++N G L + L    + + +       +I   L 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 279 YLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAP 338
           +LH+     II+ DIK +NILLD + +  ++DFGL+K               GT  Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAP 199

Query: 339 EWYR--KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL 396
           +  R   S     VD +S GVL+ E+++    F ++  +                +    
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256

Query: 397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRK 433
            E    A + I+            + +DP  R     
Sbjct: 257 QEMSALAKDLIQ----------RLLMKDPKKRLGCGP 283

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 5e-31
 Identities = 74/322 (22%), Positives = 123/322 (38%), Gaps = 40/322 (12%)

Query: 159 KALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNE 214
           K   E    ++  +  G G++G V   V   T      VA+KKL R FQ     K    E
Sbjct: 11  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA---KVAIKKLYRPFQSELFAKRAYRE 67

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPSWNLRTN 268
           + ++    H+N++ LL      +         LV  F+  GT    L  + K   +    
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQF 125

Query: 269 IAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTA 328
           + +Q+ +GL Y+H      IIH D+KP N+ +++    +I DFGLA+     Q+ +  T 
Sbjct: 126 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTG 177

Query: 329 IRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIE------------MGE 375
              T+ Y APE        T  VD++S G ++ E+I+ +  F                G 
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 376 EYAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSI--WCIQEDPSLRPTMRK 433
             A              +  L E + +    I      L V++    +  D   R T  +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 434 VSQM--LEGVVEVDVPPNPSPF 453
                  E + + +  P    +
Sbjct: 298 ALAHPYFESLHDTEDEPQVQKY 319

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (293), Expect = 4e-30
 Identities = 58/297 (19%), Positives = 115/297 (38%), Gaps = 43/297 (14%)

Query: 166 DNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQ-TH 222
           D+++   + GRG +  V++ +  T       V VK L  V    +K+ K E+ ++     
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVK---KKKIKREIKILENLRG 88

Query: 223 HKNLVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYL 280
             N++ L     +  +R   LV+E +NN             +        ++I + L Y 
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYC 145

Query: 281 HEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPE 339
           H      I+H D+KP N+++D +H   R+ D+GLA+     Q   ++     ++ +  PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPE 199

Query: 340 -WYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAIL-------TDWAFDCYRNG 391
                      +D++S G +L  +I  ++ F         ++       T+  +D     
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 392 KLD-DLVEGDMEAMNDIKCVEKLLMVSIW-------------CIQEDPSLRPTMRKV 434
            ++ D    D+   +  K  E+ +                   ++ D   R T R+ 
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-29
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)

Query: 170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNEVVVIGQTHHKNLV 227
           +  G G+ GIV          +   VA+KKL R FQ+    K    E+V++   +HKN++
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 228 RLLGFC------DEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH 281
            LL         +E Q+  LV E ++            +      + + +Q+  G+ +LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH 136

Query: 282 EDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWY 341
                 IIH D+KP NI++      +I DFGLA+      +  + T    T+ Y APE  
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 190

Query: 342 RKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEE 376
                   VD++S G ++ E++  +  F      +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-28
 Identities = 67/322 (20%), Positives = 119/322 (36%), Gaps = 38/322 (11%)

Query: 159 KALEEATDNFK--EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGE--KEFKNE 214
           K + E  + ++     G G++G V       T      VAVKKL R FQ     K    E
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---RVAVKKLSRPFQSIIHAKRTYRE 67

Query: 215 VVVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNI 269
           + ++    H+N++ LL      +     N + +   L    L + +    K + +    +
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFL 126

Query: 270 AFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAI 329
            +QI RGL Y+H      IIH D+KP N+ +++    +I DFGLA       +    T  
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGY 178

Query: 330 RGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIE-MGEEYAILTDWAFDC 387
             T+ Y APE           VD++S G ++ E+++ R  F      ++  ++       
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIW-------------CIQEDPSLRPTMRKV 434
                     E     +  +  + K+   +++              +  D   R T  + 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

Query: 435 SQM--LEGVVEVDVPPNPSPFS 454
                     + D  P   P+ 
Sbjct: 299 LAHAYFAQYHDPDDEPVADPYD 320

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (255), Expect = 9e-25
 Identities = 44/233 (18%), Positives = 82/233 (35%), Gaps = 23/233 (9%)

Query: 168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV 227
              + G G F  V+        T    VA+K +    +   +  ++E+ ++ + +  +  
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTH---VAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72

Query: 228 RLLGFCDEGQNRLLVY----------------EFLNNGTLASFLFGNLKPSWNLRTNIAF 271
           +          +LL +                    N       + +          I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 272 QIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTAIR 330
           Q+  GL Y+H  C   IIH DIKP+N+L++       +    +A L          T   
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 331 GTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDW 383
            T+ Y +PE    +      D++S   L+ E+I+    F+ + G  Y    D 
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 2e-19
 Identities = 28/201 (13%), Positives = 57/201 (28%), Gaps = 30/201 (14%)

Query: 173 GRGSFGIVYKGVIETTRTSTTAVAVK----------KLDRVFQDGEKEFKNEVVVIGQTH 222
           G G    V+    E          VK          K+      G+  F    +   +  
Sbjct: 9   GEGKESAVFNCYSEKFGE----CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 223 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTN--IAFQIARGLLYL 280
            + L +L G           Y +  N  L   +         +     +   I   +   
Sbjct: 65  FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 281 HEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEW 340
           +      I+H D+   N+L+ +     I DF  +  +     + I              +
Sbjct: 120 YHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILE----RDVRNIITY 171

Query: 341 YRKSTITAKVDVYSFGVLLLE 361
           + ++    + D+ S    +L+
Sbjct: 172 FSRTY-RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	455
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.89
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.72
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.62
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.37
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.87
d2qj2a1	91	Hepatocyte growth factor {Human (Homo sapiens) [Ta	86.2

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-57  Score=427.77  Aligned_cols=271  Identities=24%  Similarity=0.430  Sum_probs=211.8

Q ss_pred             cccCHHHHHHHHHhhh-----------hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHccc
Q 037780          154 RCFSYKALEEATDNFK-----------EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT  221 (455)
Q Consensus       154 ~~~~~~~l~~~t~~f~-----------~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l  221 (455)
                      ..++|+++.+++.+|.           +.||+|+||+||+|.+..++.....||||++.... ....++|.+|+.+|+++
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            4578888899998885           35999999999999997665566789999986543 33456799999999999


Q ss_pred             CCCCceeeeeeEecCCeEEEEEEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEE
Q 037780          222 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILL  300 (455)
Q Consensus       222 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  300 (455)
                      +|||||+++|+|.+++..++||||+++|+|.+++... ..++|.+++.|+.||++||+|||+.   +|+||||||+||||
T Consensus        85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl  161 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV  161 (299)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence            9999999999999999999999999999999988764 5789999999999999999999964   99999999999999


Q ss_pred             cCCCcEEEeeccCcccccCCCCccc---cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccch
Q 037780          301 DDHYNARISDFGLAKLLTLNQSKTI---KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  376 (455)
Q Consensus       301 ~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~  376 (455)
                      +.++++||+|||+++..........   .....||+.|+|||.+.++.++.++|||||||+||||+| |+.||......+
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~  241 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD  241 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999997765433221   123457999999999999999999999999999999998 899997554321


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                             +...+..+..         ...+.+.+..+.+++.+||+.||++||||.+|++.|+.+++
T Consensus       242 -------~~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         242 -------VINAIEQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                   1111222211         11223356788999999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=411.59  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=197.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .+.++||+|+||+||+|.+.    ++..||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEET----TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46688999999999999985    4567999999754 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          247 NNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       247 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      ++|+|.+++... ..++|..++.|+.|+|.||+|||+.   +|+||||||+|||+++++.+||+|||+++..........
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            999999998765 6689999999999999999999965   999999999999999999999999999987654433222


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhC-CCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISC-RKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                       ....||+.|+|||++.+..++.++|||||||+||||+|+ ++|+......+       +...+..+...         .
T Consensus       160 -~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~~---------~  222 (263)
T d1sm2a_         160 -TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFRL---------Y  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-------HHHHHHHTCCC---------C
T ss_pred             -cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHhcCCC---------C
Confidence             345689999999999999999999999999999999995 55554332211       11122222111         1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .+..++.++.+++..||+.||++||||++|++.|+++.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            112235678999999999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-55  Score=415.05  Aligned_cols=256  Identities=28%  Similarity=0.412  Sum_probs=211.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.++||+|+||+||+|.+.   ..+..||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++|||
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEG---GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEC---CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3455688999999999999987   346789999997543 346789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++|+|.+++...  ..++|..++.|+.||+.||+|||+.   +|+||||||+||||++++++||+|||+|+.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999999643  6789999999999999999999965   999999999999999999999999999998765443


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      ... ....||+.|+|||++.+..++.++|||||||++|||++|..|+.......      .+.+.+..+..         
T Consensus       171 ~~~-~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~~---------  234 (287)
T d1opja_         171 TAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYR---------  234 (287)
T ss_dssp             EEE-TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCC---------
T ss_pred             eee-ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcCCC---------
Confidence            322 44568999999999999999999999999999999999777664333211      11222222211         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      ...+...++.+.+++..||+.||++||||.+|++.|+.+.+
T Consensus       235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11222346789999999999999999999999999988654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-55  Score=407.99  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=200.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|.+.      ..||||+++..  .....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             EEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            45678999999999999753      24999998643  34456789999999999999999999999865 56899999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..++|..++.|+.||++||+|||+.   +|+||||||+||||+.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999754 6699999999999999999999964   9999999999999999999999999999887654443


Q ss_pred             cccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGD  400 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (455)
                      .......||+.|+|||++.+   ..++.++|||||||+||||+||+.||........      +......+...    +.
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~----p~  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLS----PD  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCC----CC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCC----Cc
Confidence            33355679999999999864   3578999999999999999999999976543221      12222222211    11


Q ss_pred             cccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          401 MEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       401 l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      +. ..+.+.++.+.+++.+||+.||++||||.+|++.|+.+.+
T Consensus       231 ~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 LS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             GG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11 1122346789999999999999999999999999998654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=406.36  Aligned_cols=250  Identities=29%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCC
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN  247 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~  247 (455)
                      ++||+|+||+||+|.+..++ .++.||||+++...  ....++|.+|+.++++++|||||+++|+|.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            46999999999999986543 56889999986432  2234679999999999999999999999965 46789999999


Q ss_pred             CCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc-cc
Q 037780          248 NGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IK  326 (455)
Q Consensus       248 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~  326 (455)
                      +|+|.+++.....++|.+++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            999999999989999999999999999999999964   99999999999999999999999999999775443322 22


Q ss_pred             ccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          327 TAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       327 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+       +...+..+....         .
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~---------~  231 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG---------C  231 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------C
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------C
Confidence            34568999999999999999999999999999999998 899997654321       122223332111         1


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      +...+..+.+++.+||+.||++||||.+|+++|+.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            22346788999999999999999999999998875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=404.20  Aligned_cols=251  Identities=28%  Similarity=0.385  Sum_probs=203.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||+++... .+..+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNR---VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            345688999999999999987   356789999986543 2334568999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++|+|.+++.....+++.+++.|+.|++.||+|||+.   +|+||||||+|||+++++++||+|||+|+.........
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            999999999999888999999999999999999999964   99999999999999999999999999999876554433


Q ss_pred             ccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      .....+||+.|+|||++.+..+ +.++|||||||+||||+||+.||..........      ..........        
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~~--------  226 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYL--------  226 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTTS--------
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCCC--------
Confidence            3356779999999999988776 578999999999999999999997654322110      0111111100        


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ......+..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011123467789999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-55  Score=408.21  Aligned_cols=251  Identities=31%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.++||+|+||+||+|.+.    ++..||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             eEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            445688999999999999975    45789999997543 456789999999999999999999998865 567999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.+++...  ..++|..++.|+.||++||.|||+.   +|+||||||+||||++++.+||+|||+|+........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999999988654  3689999999999999999999964   9999999999999999999999999999987654332


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEA  403 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  403 (455)
                      . .....||+.|+|||++.+..++.++|||||||+||||+||..|+.......      .+...+..+...         
T Consensus       166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i~~~~~~---------  229 (272)
T d1qpca_         166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRM---------  229 (272)
T ss_dssp             C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCC---------
T ss_pred             c-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCC---------
Confidence            2 244568999999999999999999999999999999999665554322211      111222222111         


Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          404 MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       404 ~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      ..+...++.+.+++.+||+.||++||||.+|+++|+..
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            11223456789999999999999999999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=400.05  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=206.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.++||+|+||+||+|...   .+++.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDV---ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBT---TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            445678999999999999876   45788999999766555677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          246 LNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       246 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      +++|+|.+++.. ..+++.++..|+.||+.||+|||+.   +|+||||||+|||++.++++||+|||+|+.+....... 
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~-  173 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-  173 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB-
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccccc-
Confidence            999999998865 4689999999999999999999964   99999999999999999999999999999775443322 


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMN  405 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  405 (455)
                       ....||+.|+|||++.+..++.++|||||||++|||+||+.||.......      ........+... +       ..
T Consensus       174 -~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~~-~-------~~  238 (293)
T d1yhwa1         174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPE-L-------QN  238 (293)
T ss_dssp             -CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSCC-C-------SS
T ss_pred             -cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCCC-C-------CC
Confidence             44579999999999999999999999999999999999999997544321      111122222111 1       11


Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          406 DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       406 ~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +...+..+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2234577889999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=401.60  Aligned_cols=249  Identities=29%  Similarity=0.439  Sum_probs=204.6

Q ss_pred             hcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeCCCC
Q 037780          171 EAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG  249 (455)
Q Consensus       171 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g  249 (455)
                      +||+|+||+||+|.+..++ ++..||||.++... ....++|.+|+++|++++|||||+++|+|.. +..++||||+++|
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g   93 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG   93 (285)
T ss_dssp             EEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             EEecccCeEEEEEEEecCC-CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence            5999999999999886443 45689999997543 3345779999999999999999999999865 5689999999999


Q ss_pred             CHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc-ccc
Q 037780          250 TLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKT  327 (455)
Q Consensus       250 sL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  327 (455)
                      +|.+++... ..+++.+++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus        94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (285)
T d1u59a_          94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  170 (285)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence            999998654 6799999999999999999999964   99999999999999999999999999999876543322 223


Q ss_pred             cccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccCCC
Q 037780          328 AIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAMND  406 (455)
Q Consensus       328 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  406 (455)
                      ...||+.|+|||++.++.++.++|||||||++|||+| |+.||......+       +...+..+....         .+
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p  234 (285)
T d1u59a_         171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME---------CP  234 (285)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCC---------CC
T ss_pred             ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CC
Confidence            4568999999999999999999999999999999998 999997654322       122233332221         12


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhc
Q 037780          407 IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEG  440 (455)
Q Consensus       407 ~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~  440 (455)
                      ...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2345788999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=402.80  Aligned_cols=260  Identities=25%  Similarity=0.439  Sum_probs=201.9

Q ss_pred             hhhhhcCcCCCccEEEEEEeccC-CCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTR-TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.||+|+||+||+|.+..+. .....||||++.... .....+|.+|+.++++++|||||+++|++.+.+..++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            34578999999999999987543 233579999986543 2334579999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+.+++|.+++... ..++|.+++.|+.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++........
T Consensus        90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            99999999987654 6799999999999999999999964   9999999999999999999999999999976544322


Q ss_pred             c-ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 T-IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      . ......||+.|+|||++.+..++.++|||||||+||||+||..|+.......      .+...+..+..         
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~---------  231 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFR---------  231 (283)
T ss_dssp             -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC---------
T ss_pred             ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH------HHHHHHhccCC---------
Confidence            2 2234568999999999999999999999999999999999766654333211      11222222211         


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEV  444 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~  444 (455)
                      ...+...+..+.+++.+||+.||++||||.+|+++|+.+++.
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            112223567889999999999999999999999999987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=395.06  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=210.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEeC
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL  246 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~  246 (455)
                      .|.++||+|+||+||+|+++    ++..||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             EEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            46789999999999999975    56789999997643 34678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCccc
Q 037780          247 NNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKTI  325 (455)
Q Consensus       247 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  325 (455)
                      ++|+|.+++... ..+++..+++|+.|+++||+|||+.   +|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            999999997654 6789999999999999999999964   999999999999999999999999999987665443322


Q ss_pred             cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccccC
Q 037780          326 KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDMEAM  404 (455)
Q Consensus       326 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  404 (455)
                       ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+       +...+.++...         .
T Consensus       159 -~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~---------~  221 (258)
T d1k2pa_         159 -VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRL---------Y  221 (258)
T ss_dssp             -CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCC---------C
T ss_pred             -cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCC---------C
Confidence             44568999999999999999999999999999999998 899997655432       11222222111         1


Q ss_pred             CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          405 NDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       405 ~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                      .+...++.+.+++..||+.||++|||+++|++.|.++
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1223456889999999999999999999999998653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=410.43  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=208.9

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCC--CceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRT--STTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~  240 (455)
                      ...+.+.||+|+||+||+|.+.....  ....||||++.... ......|.+|+.++.++ +|||||++++++.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            34566889999999999999875432  24579999986432 33456799999999998 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 037780          241 LVYEFLNNGTLASFLFGN-----------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQN  297 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  297 (455)
                      +||||+++|+|.++|+..                       ..++|..++.|+.||+.||+|||+.   +|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence            999999999999999754                       2479999999999999999999964   99999999999


Q ss_pred             EEEcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccch
Q 037780          298 ILLDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEE  376 (455)
Q Consensus       298 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~  376 (455)
                      ||++.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||+||||+| |+.||.......
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999998766555444455678999999999999999999999999999999998 899997544322


Q ss_pred             hhhhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHh
Q 037780          377 YAILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLE  439 (455)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~  439 (455)
                      .      ....+..+..         ...+...++.+.+++..||+.||++||||+||++.|.
T Consensus       275 ~------~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 N------FYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             H------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H------HHHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1      1222222211         1112234578999999999999999999999999995

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=395.22  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=206.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   .+++.||+|++...   .....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREK---QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecCCCcEEEEEEEC---CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            456688999999999999987   35678999998642   233456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..+..|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence            99999999999998888999999999999999999999964   999999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||++.+..++.++|||||||+||||++|+.||......+       ....+..+...        
T Consensus       162 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~--------  222 (263)
T d2j4za1         162 ----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFT--------  222 (263)
T ss_dssp             ----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCC--------
T ss_pred             ----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence                34569999999999999999999999999999999999999997654322       11112222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .+...++.+.+++..||+.||++|||+.|+++
T Consensus       223 --~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence              11123567889999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=396.88  Aligned_cols=247  Identities=27%  Similarity=0.420  Sum_probs=199.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec----CCeEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE----GQNRL  240 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~  240 (455)
                      .|.++||+|+||+||+|.+.   .++..||+|++....  ....+.|.+|++++++++|||||++++++.+    ....+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~---~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT---ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC---CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45678999999999999986   356789999986532  3334679999999999999999999999864    34679


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc-CCCcEEEeeccCcccccC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTL  319 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~  319 (455)
                      +||||+++|+|.+++.....+++..++.|+.||++||+|||++ ..+|+||||||+|||++ +++.+||+|||+++....
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999999998888999999999999999999999965 33499999999999996 578999999999986543


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ...    ....||+.|+|||++.+ .++.++|||||||+||||++|+.||.......      ...+.+..+......+ 
T Consensus       168 ~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~~~-  235 (270)
T d1t4ha_         168 SFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFD-  235 (270)
T ss_dssp             TSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGGG-
T ss_pred             Ccc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCcccC-
Confidence            322    34679999999999865 59999999999999999999999997543221      1222222222211111 


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                             ...+.++.+++.+||+.||++|||+.|+++
T Consensus       236 -------~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                   112456889999999999999999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=401.48  Aligned_cols=259  Identities=28%  Similarity=0.416  Sum_probs=203.1

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...+.+.||+|+||+||+|++.    +...||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~----~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             HEEEeeEEeeCCCeEEEEEEEC----CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            3566788999999999999986    3457999999754 3456789999999999999999999999855 56799999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |+++|+|..++...  ..++|.+++.|+.||+.||+|||+.   +|+||||||+|||||.++++||+|||+++.......
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999999998753  5789999999999999999999965   999999999999999999999999999987654433


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .. .....||+.|+|||++..+.++.++||||||++||||+||..|+.......  .    ....+..+...        
T Consensus       169 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~----~~~~i~~~~~~--------  233 (285)
T d1fmka3         169 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--E----VLDQVERGYRM--------  233 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTTCCC--------
T ss_pred             ee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--H----HHHHHHhcCCC--------
Confidence            22 244568999999999999999999999999999999999766654433211  1    11112222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVDVPP  448 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~~p~  448 (455)
                       ..+...++++.+++.+||+.||++||||.+|+++|+.......|+
T Consensus       234 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         234 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             -CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence             112234568899999999999999999999999999866554443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=398.64  Aligned_cols=247  Identities=22%  Similarity=0.280  Sum_probs=203.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||++...   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            556789999999999999986   35678999998642   233456799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999999999888999999999999999999999954   999999999999999999999999999998765444


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      ........||+.|+|||++.+..++.++|||||||+||||+||+.||.......       ....+..+...        
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~--------  228 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYD--------  228 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCCC--------
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCCC--------
Confidence            333345679999999999999999999999999999999999999998654321       11112222211        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVS  435 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~  435 (455)
                        .+...+..+.+++..||+.||++|||++|++
T Consensus       229 --~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         229 --FPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             --CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             --CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence              1112356788999999999999999999863

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-53  Score=398.41  Aligned_cols=249  Identities=22%  Similarity=0.305  Sum_probs=204.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.++||+|+||+||+|...   .++..||||+++.......+.|.+|++++++++|||||++++++.+.+..++||||
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNK---ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEeEEEeeCCCcEEEEEEEC---CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            345678999999999999987   35678999999776666667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          246 LNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       246 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      +++|+|.+++.+ ...+++.++..|+.||+.||.|||+.   +|+||||||+|||++.++++||+|||+|+.......  
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--
Confidence            999999999765 46799999999999999999999965   999999999999999999999999999976543221  


Q ss_pred             ccccccccCccccccccc-----CCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          325 IKTAIRGTKGYVAPEWYR-----KSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ......||+.|+|||++.     +..++.++|||||||+||||+||+.||......+.      .... ..+....+   
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i-~~~~~~~~---  235 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKI-AKSEPPTL---  235 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHH-HHSCCCCC---
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHH-HcCCCCCC---
Confidence            123467999999999984     45688999999999999999999999976544221      1111 11111111   


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                          ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                112234578899999999999999999999976

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=394.02  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=192.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec--CCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--GQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~l  241 (455)
                      +++.+.||+|+||+||+|+..   .+++.||||.+....  ....+.+.+|++++++++|||||++++++.+  ++..++
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRK---SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            445688999999999999987   356789999986543  2334568999999999999999999999865  456899


Q ss_pred             EEEeCCCCCHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          242 VYEFLNNGTLASFLFG----NLKPSWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ||||+++|+|.+++..    ...+++..++.|+.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999863    467999999999999999999999752  2359999999999999999999999999999


Q ss_pred             cccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDD  395 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (455)
                      ........  .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+       +...+..+....
T Consensus       163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~  233 (269)
T d2java1         163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR  233 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC
T ss_pred             ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence            87543322  244679999999999999999999999999999999999999997654321       122223333322


Q ss_pred             ccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          396 LVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       396 ~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +         +...++++.+++.+||+.||.+|||+.|+++
T Consensus       234 ~---------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C---------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1         1124567899999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-52  Score=398.45  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=211.0

Q ss_pred             hhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      ++.++||+|+||+||+|+..+  ...+++.||||+++.... +..++|.+|+.++++++||||++++++|...+..++||
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            456789999999999999874  234668899999975433 33567999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhcCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEE
Q 037780          244 EFLNNGTLASFLFGN------------------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNIL  299 (455)
Q Consensus       244 e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  299 (455)
                      ||+++|+|.++++..                        ..++|..++.|+.|++.||+|||+.   +|+||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence            999999999998642                        2478999999999999999999954   9999999999999


Q ss_pred             EcCCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCC-CCCCccccchhh
Q 037780          300 LDDHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYA  378 (455)
Q Consensus       300 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~  378 (455)
                      +|.++++||+|||+|+...........+...||+.|+|||.+.+..++.++|||||||+||||++|. +||......+  
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e--  250 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE--  250 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH--
Confidence            9999999999999998765544443334566899999999999999999999999999999999986 5666544322  


Q ss_pred             hhHHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          379 ILTDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                           +...+.++.....         +...+.++.+++..||+.+|++||||.+|+++|+++.+
T Consensus       251 -----~~~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         251 -----VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             -----HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -----HHHHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 1122333333221         12345678999999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=407.82  Aligned_cols=262  Identities=19%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.++||+|+||+||+|...   .++..||+|+++... ......+.+|+.+|++++|||||+++++|.+.++.++|||
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHK---PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEET---TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            344578999999999999986   457899999986543 3335679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+++|+|.+++.+...+++..+..++.|++.||.|||+.  .+|+||||||+|||+++++++||+|||+|+.......  
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~--  160 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--  160 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc--
Confidence            999999999998888899999999999999999999952  3799999999999999999999999999987643322  


Q ss_pred             ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhH-HHHHHHh--------hcC----
Q 037780          325 IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT-DWAFDCY--------RNG----  391 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~--------~~~----  391 (455)
                        ....||+.|+|||++.+..++.++||||+||++|||++|+.||............ .......        ..+    
T Consensus       161 --~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         161 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             -----CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             --ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence              3457999999999999999999999999999999999999999765432211100 0000000        000    


Q ss_pred             ----------cccccc----ccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 ----------KLDDLV----EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ----------~~~~~~----~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                                ...+..    ............+.++.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                      000000    000000001112457889999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-52  Score=396.44  Aligned_cols=244  Identities=23%  Similarity=0.277  Sum_probs=201.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +...++||+|+||+||+|+..   .++..||||+++....   ...+.+.+|+.++++++|||||++++++.+++..++|
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDV---RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEeeEEEecCCCeEEEEEEEC---CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            445578999999999999986   4578899999865432   2335689999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|..++.....+++.+++.|+.||+.||.|||+.   +|+||||||+|||++.++++||+|||+|+.....  
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            99999999998888888899999999999999999999965   9999999999999999999999999999865432  


Q ss_pred             ccccccccccCcccccccccC---CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRK---STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                          ....||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......      ...... .+....+.  
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~-~~~~~~~~--  235 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNESPALQ--  235 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCCS--
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCCCCCC--
Confidence                33569999999999864   468999999999999999999999997544321      111111 11111111  


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                            +...++.+.+++..||+.||.+|||+.++++
T Consensus       236 ------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                  1123567899999999999999999999975

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=396.62  Aligned_cols=259  Identities=25%  Similarity=0.450  Sum_probs=206.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e  244 (455)
                      +|.++||+|+||+||+|.+..++.....||||+++.. .....++|.+|++++++++|||||+++|++.+ +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            5677899999999999999765545567999999753 33445779999999999999999999999875 458899999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+++|+|.+++... ..+++..++.++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||+++........
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999998765 567899999999999999999995   49999999999999999999999999999977544332


Q ss_pred             c--ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          324 T--IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       324 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      .  ......||+.|+|||.+.+..++.++||||||++||||+||+.||.......  .+.    ..+..+....      
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~----~~i~~g~~~~------  254 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT----VYLLQGRRLL------  254 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCCCC------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH----HHHHcCCCCC------
Confidence            2  2234568999999999999999999999999999999999888876433211  111    1122222111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                         .+...++.+.+++..||+.||++||||.||++.|+++.+
T Consensus       255 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               112245678999999999999999999999999988654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=395.31  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=199.8

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc-ccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      .+++.+.||+|+||+||+|.+..++..+..||||.++.... ...+.|.+|+.++++++|||||+++|++. .+..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence            34566889999999999999887666678899999865433 33467999999999999999999999996 46789999


Q ss_pred             EeCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+++|+|.+++.. ...+++..++.++.||++||.|||+.   +|+||||||+||++++++.+||+|||+++.......
T Consensus        87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            99999999998765 45789999999999999999999964   999999999999999999999999999987654433


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ... ....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+.       ...+..+....      
T Consensus       164 ~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-------~~~i~~~~~~~------  229 (273)
T d1mp8a_         164 YKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERLP------  229 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCCC------
T ss_pred             eec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCCC------
Confidence            222 44568999999999999999999999999999999998 8999976554321       11222222111      


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                         .+...+..+.+++..||+.||++|||+.+|++.|+.+++
T Consensus       230 ---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         230 ---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               122345789999999999999999999999999987653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-52  Score=392.88  Aligned_cols=253  Identities=24%  Similarity=0.354  Sum_probs=192.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||.+.... ......+.+|+.++++++|||||++++++.+++..++|||
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDK---RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEET---TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEeeccCeEEEEEEEC---CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            566789999999999999876   356789999986543 2334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+++|+|.+++.....+++..+..|+.||+.||+|||+.   +|+||||||+|||+.   +++.+||+|||+++......
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            999999999999888999999999999999999999964   999999999999994   57899999999998765433


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..   ....||+.|+|||++.+..++.++|||||||+||||++|+.||.......       ....+..+...      .
T Consensus       165 ~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~------~  228 (307)
T d1a06a_         165 VL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE------F  228 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC------C
T ss_pred             ee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC------C
Confidence            22   34569999999999999999999999999999999999999997654321       11111222211      0


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                      ........+..+.+++..||+.||++|||+.|+++  .+.+
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            01111234567899999999999999999999987  3544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-52  Score=387.82  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=200.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|.+.........||||++...   ..+..++|.+|+.++++++|||||+++|+|.+ ...++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence            35567899999999999998766556678999998653   23345679999999999999999999999976 467899


Q ss_pred             EEeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |||+++|+|.+++... ..+++..++.++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            9999999999887654 5799999999999999999999964   99999999999999999999999999999876554


Q ss_pred             Cccc-cccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          322 SKTI-KTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       322 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      .... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||......+.      .......+...     
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~~-----  234 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERL-----  234 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCCC-----
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCCCC-----
Confidence            3322 234457889999999999999999999999999999998 8999975543221      12222222111     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                          ..+...+..+.+++.+||+.||++||||.+|.+.|++.
T Consensus       235 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 ----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                11223456789999999999999999999999999753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=395.75  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=202.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCC-CceEEEEEecccc-ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRT-STTAVAVKKLDRV-FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVY  243 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~  243 (455)
                      +.+.+.||+|+||+||+|.+..++. ....||+|+++.. .....++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            4456789999999999999864432 2346899998643 344567899999999999999999999999875 567888


Q ss_pred             EeCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          244 EFLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       244 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      ||+.+|+|.+++... ..+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            999999999887654 6789999999999999999999964   999999999999999999999999999998766554


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ........||+.|+|||++.++.++.++|||||||+||||+| |+.||......+.       ...+..+...       
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-------~~~i~~~~~~-------  232 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERL-------  232 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------HHHHHHTCCC-------
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCCC-------
Confidence            444345678999999999999999999999999999999999 8889876544321       1122222111       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                        ..+..++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       233 --~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence              11223457889999999999999999999999988764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=395.31  Aligned_cols=261  Identities=26%  Similarity=0.371  Sum_probs=201.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC--CCceEEEEEeccccc-cccHHHHHHHHHHHccc-CCCCceeeeeeEecC-CeE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR--TSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEG-QNR  239 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~-~~~  239 (455)
                      .+.+.++||+|+||.||+|.+....  .+++.||||+++... ....+.+..|...+.++ +|+||+.+++++.+. ...
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence            3456688999999999999987532  345789999997543 33456688888888887 689999999998665 468


Q ss_pred             EEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCC
Q 037780          240 LLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDH  303 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  303 (455)
                      ++||||+++|+|.+++...                ..++|.+++.++.||++||.|||+.   +|+||||||+||||+++
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence            9999999999999999643                3478999999999999999999954   99999999999999999


Q ss_pred             CcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCC-CCCCccccchhhhhHH
Q 037780          304 YNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTD  382 (455)
Q Consensus       304 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~~~  382 (455)
                      +++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||.......      
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------  244 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------  244 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------
Confidence            999999999998776555444445567999999999999999999999999999999999964 5776443321      


Q ss_pred             HHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          383 WAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .....+..+.....         +...+.++.+++.+||+.||++|||+.+|++.|+++++
T Consensus       245 ~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            12222333322211         12245678999999999999999999999999998754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-52  Score=384.38  Aligned_cols=245  Identities=27%  Similarity=0.412  Sum_probs=195.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEec-CCeEEEEEEe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE-GQNRLLVYEF  245 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~  245 (455)
                      .|.+.||+|+||.||+|.+.     +..||||+++..  ...++|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             EEeEEEecCCCeEEEEEEEC-----CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            46688999999999999974     567999999653  345789999999999999999999999865 4568999999


Q ss_pred             CCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          246 LNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       246 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      +++|+|.+++...  ..++|..+++|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++......  
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            9999999999754  358999999999999999999995   499999999999999999999999999998654332  


Q ss_pred             cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                         ....+|..|+|||++.+..++.++||||||+++|||+| |+.||.......   +.    ..+.++....       
T Consensus       158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~~i~~~~~~~-------  220 (262)
T d1byga_         158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKMD-------  220 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCCCC-------
T ss_pred             ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC-------
Confidence               33458899999999999999999999999999999998 788876544322   11    1122222211       


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                        .+...+.++.+++.+||+.||.+||||.+|+++|+.+.
T Consensus       221 --~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         221 --APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence              12234567889999999999999999999999998753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=391.45  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=204.7

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc-ccccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-FQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.++||+|+||+||+|.+..++ ....||||+++.. .....++|.+|+++|.++ +|||||+++|+|.+++..++|||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e   91 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   91 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence            45678999999999999987543 3346889988543 333456799999999998 79999999999999999999999


Q ss_pred             eCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEE
Q 037780          245 FLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARI  308 (455)
Q Consensus       245 ~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  308 (455)
                      |+++|+|.++|+..                ..++|.++++++.||++||.|||+.   +|+||||||+|||++.++.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence            99999999999654                5789999999999999999999965   9999999999999999999999


Q ss_pred             eeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCC-CCCccccchhhhhHHHHHHH
Q 037780          309 SDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRK-SFDIEMGEEYAILTDWAFDC  387 (455)
Q Consensus       309 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~  387 (455)
                      +|||+++........   ....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+       +...
T Consensus       169 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~~  238 (309)
T d1fvra_         169 ADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK  238 (309)
T ss_dssp             CCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHH
T ss_pred             ccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHHH
Confidence            999999865433322   33468999999999999999999999999999999999765 565433221       1222


Q ss_pred             hhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcCCC
Q 037780          388 YRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVEVD  445 (455)
Q Consensus       388 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~~~  445 (455)
                      +.++..         ...+...++++.+++.+||+.||++||||.+|++.|+++.+..
T Consensus       239 i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         239 LPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             GGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            222211         1112234678999999999999999999999999999876543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.2e-51  Score=393.63  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=207.2

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      .+.+.+.||+|+||+||+|...   .++..||||++........+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~---~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTER---ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEET---TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            3566789999999999999986   4578899999977655566779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD--DHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+++|+|.+++.. ...+++..+..|+.||+.||.|||+.   +|+||||||+|||++  .++.+||+|||+++......
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999864 46799999999999999999999964   999999999999996  46789999999998776443


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ..   ....||+.|+|||++.+..++.++|||||||++|||+||+.||......+.      . ..+..+... ...   
T Consensus       181 ~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~-~~i~~~~~~-~~~---  246 (350)
T d1koaa2         181 SV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------L-RNVKSCDWN-MDD---  246 (350)
T ss_dssp             CE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H-HHHHHTCCC-SCC---
T ss_pred             cc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------H-HHHHhCCCC-CCc---
Confidence            32   345799999999999999999999999999999999999999976543221      1 111111111 000   


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                        ......++.+.+++..||+.||++|||+.|+++.
T Consensus       247 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0111235678899999999999999999999873

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=393.46  Aligned_cols=261  Identities=25%  Similarity=0.397  Sum_probs=213.4

Q ss_pred             HHHhhhhhcCcCCCccEEEEEEec--cCCCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCeE
Q 037780          164 ATDNFKEEAGRGSFGIVYKGVIET--TRTSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       164 ~t~~f~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~  239 (455)
                      ....+.+.||+|+||.||+|++..  ....++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            345667899999999999999864  235678999999975433 3445799999999999 699999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc
Q 037780          240 LLVYEFLNNGTLASFLFGNL------------------KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD  301 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  301 (455)
                      ++||||+++|+|.++++...                  .+++..++.|+.||++||+|||++   +++||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            99999999999999986432                  589999999999999999999965   999999999999999


Q ss_pred             CCCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhh
Q 037780          302 DHYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAIL  380 (455)
Q Consensus       302 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~  380 (455)
                      .++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+| |.+|+......+.   
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999998776555444456779999999999999999999999999999999999 5555544333211   


Q ss_pred             HHHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          381 TDWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                         +...+..+..         ...+...+..+.+++.+||+.||.+||||.+|+++|++.+
T Consensus       257 ---~~~~i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         257 ---FYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ---HHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence               1222222211         1112234577899999999999999999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-50  Score=392.32  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=206.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      +.+.+.||+|+||+||+|...   .++..||||+++.........+.+|+.++++++|||||++++++.+++..++||||
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEK---ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            556789999999999999986   45788999999766555566789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc--CCCcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD--DHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +++|+|.+++... ..+++.+++.|+.||+.||+|||+.   +|+||||||+||||+  .++.+||+|||+|+.......
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999987665 4689999999999999999999964   999999999999998  678999999999998765433


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....||+.|+|||++.+..++.++|||||||+||||+||+.||........       ...+..+...      ..
T Consensus       185 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~~------~~  248 (352)
T d1koba_         185 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE------FD  248 (352)
T ss_dssp             E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCC------CC
T ss_pred             e---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC------CC
Confidence            2   345699999999999999999999999999999999999999976543221       1111222111      00


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......+..+.+++..||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111224567889999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=388.20  Aligned_cols=260  Identities=28%  Similarity=0.394  Sum_probs=209.5

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccC----CCceEEEEEecccccc-ccHHHHHHHHHHHccc-CCCCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVFQ-DGEKEFKNEVVVIGQT-HHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||.||+|....+.    ..+..||||+++.... ....++.+|...+.++ +|||||+++++|.+++.
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            3455688999999999999976543    3346899999976543 3346789999999998 79999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC
Q 037780          239 RLLVYEFLNNGTLASFLFGN----------------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD  302 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  302 (455)
                      .++||||+++|+|.+++...                ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence            99999999999999999644                3589999999999999999999965   9999999999999999


Q ss_pred             CCcEEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHh-CCCCCCccccchhhhhH
Q 037780          303 HYNARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIIS-CRKSFDIEMGEEYAILT  381 (455)
Q Consensus       303 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~t-g~~p~~~~~~~~~~~~~  381 (455)
                      ++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+| |+.||......      
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~------  244 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------  244 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH------
Confidence            99999999999998766554444455679999999999999999999999999999999998 78888654432      


Q ss_pred             HHHHHHhhcCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          382 DWAFDCYRNGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                       .+...+..+.....         +...+..+.+++.+||+.||++|||+.||+++|++++.
T Consensus       245 -~~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         245 -ELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -HHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence             12233333322111         12245678999999999999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-51  Score=384.48  Aligned_cols=250  Identities=25%  Similarity=0.318  Sum_probs=205.4

Q ss_pred             HHhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc------cccHHHHHHHHHHHcccCCCCceeeeeeEecCCe
Q 037780          165 TDNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF------QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQN  238 (455)
Q Consensus       165 t~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  238 (455)
                      .+.+.+.||+|+||+||+|...   .+++.||||+++...      ....+.|.+|+.+|++++|||||++++++.+.+.
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~---~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CEEEeEEEecCCCeEEEEEEEC---CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3556788999999999999986   456789999986432      1235779999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC----cEEEeeccCc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY----NARISDFGLA  314 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a  314 (455)
                      .++||||+++|+|.+++.....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999998888999999999999999999999965   999999999999998776    4999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      +........   ....||+.|+|||++.+..++.++|||||||+||||+||+.||......+.       ...+..+...
T Consensus       165 ~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~~  234 (293)
T d1jksa_         165 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNYE  234 (293)
T ss_dssp             EECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCCC
T ss_pred             hhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcCCC
Confidence            876543322   345689999999999999999999999999999999999999986543221       1111222111


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      . ..     ......+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~-~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 F-ED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C-CH-----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-Cc-----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 00     001123467889999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=384.69  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=211.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEecc--CCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETT--RTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      ..+.+.||+|+||+||+|.+...  ...+..||||+++... ......|.+|+.++++++|||||+++|+|...+..++|
T Consensus        22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv  101 (308)
T d1p4oa_          22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  101 (308)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence            34567899999999999998632  1245789999997543 23345689999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeecc
Q 037780          243 YEFLNNGTLASFLFGN----------LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFG  312 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg  312 (455)
                      |||+++|+|.+++...          ..++|..+..|+.|+++||.|||+.   +|+||||||+|||+++++++||+|||
T Consensus       102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecc
Confidence            9999999999998532          4578999999999999999999964   99999999999999999999999999


Q ss_pred             CcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCC-CCCCccccchhhhhHHHHHHHhhcC
Q 037780          313 LAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCR-KSFDIEMGEEYAILTDWAFDCYRNG  391 (455)
Q Consensus       313 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~  391 (455)
                      +++...............||+.|+|||.+.+..++.++||||||++||||+||+ .||......+       ....+.++
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~i~~~  251 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEG  251 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHHTT
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhC
Confidence            999876555444445556899999999999999999999999999999999985 6665443221       11222233


Q ss_pred             ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCcC
Q 037780          392 KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVVE  443 (455)
Q Consensus       392 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~~  443 (455)
                      .....         +...+..+.+++..||+.+|++||||.+|+++|++.++
T Consensus       252 ~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         252 GLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            22211         12245689999999999999999999999999998755

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-50  Score=383.47  Aligned_cols=246  Identities=23%  Similarity=0.263  Sum_probs=206.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||.||+|+..   .+++.||||++++.   .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~---~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREK---ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            455688999999999999986   45789999998643   233457789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|.+++.....+++...+.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.......
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999889999999999999999999999954   999999999999999999999999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .  ....+||+.|+|||++.+..++.++||||+||+||||++|+.||......+       .......+.+.        
T Consensus       161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~~--------  223 (337)
T d1o6la_         161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIR--------  223 (337)
T ss_dssp             C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------
T ss_pred             c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCCC--------
Confidence            2  245679999999999999999999999999999999999999998655422       11222222211        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                        .+...+.++.+++..||+.||.+||+     +.++++
T Consensus       224 --~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              11223567889999999999999995     777765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=378.59  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=198.9

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCC----eEEEEE
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRLLVY  243 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lv~  243 (455)
                      +.+.||+|+||+||+|++     .+..||||+++... .....+..|+..+.+++|||||+++++|.+.+    ..++||
T Consensus         7 l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-----TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEE-----CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            457899999999999986     36789999986432 11222344666667889999999999997654    578999


Q ss_pred             EeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          244 EFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       244 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      ||+++|+|.+++++. .++|..++.++.|+|.||+|||+..     ..+|+||||||+||||+.++++||+|||+++...
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            999999999999764 6899999999999999999999531     3699999999999999999999999999999775


Q ss_pred             CCCCcc--ccccccccCcccccccccCC------CCCCCCCeecHHHHHHHHHhCCCCCCccccchhh--------hhHH
Q 037780          319 LNQSKT--IKTAIRGTKGYVAPEWYRKS------TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYA--------ILTD  382 (455)
Q Consensus       319 ~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~--------~~~~  382 (455)
                      ......  ......||+.|+|||++.+.      .++.++|||||||+||||+||..|+.........        ....
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            443221  22346799999999998754      2677999999999999999999887543321100        0111


Q ss_pred             HHHHHhhcCccccccccccc-cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          383 WAFDCYRNGKLDDLVEGDME-AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      ........+..    .+.+. .....+.+..+.+++.+||+.||++||||.||++.|+.+.
T Consensus       240 ~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         240 EMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            22222222221    11111 1113346778999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.2e-50  Score=380.49  Aligned_cols=243  Identities=25%  Similarity=0.330  Sum_probs=204.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +.+.+.||+|+||+||+|+..   .+++.||||+++..   .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~---~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSR---HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecCcCcEEEEEEEC---CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            445688999999999999986   45788999998643   233457799999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      |||+++|+|..++.....+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            999999999999999999999999999999999999999   4599999999999999999999999999998765432 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||++.+..++.++|||||||+||||+||+.||......+       ....+..+...        
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~--------  219 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAELR--------  219 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHCCCC--------
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-------HHHHHHcCCCC--------
Confidence                34679999999999999999999999999999999999999997654322       11111222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                        .+...+..+.+++.+||+.||.+||     |++++++
T Consensus       220 --~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              1112346788999999999999996     8999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=378.64  Aligned_cols=260  Identities=22%  Similarity=0.282  Sum_probs=199.9

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc-----cHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD-----GEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.||+|+||+||+|.+.   .+++.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus         4 ~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDK---NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEETTEEEEEEECS---SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             eEeccCcCeEEEEEEEC---CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            57999999999999976   35678999998643321     12468899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+.++++..+......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            999998888887788899999999999999999999964   99999999999999999999999999998765443322


Q ss_pred             ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---cccccc---
Q 037780          325 IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLDDLV---  397 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---  397 (455)
                        ....||+.|+|||++... .++.++|||||||++|||+||+.||......+..   ....+.....   ......   
T Consensus       158 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         158 --THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             --CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSST
T ss_pred             --cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccc
Confidence              345699999999998654 5799999999999999999999999765542211   1111111100   000000   


Q ss_pred             cc-ccc--cCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhc
Q 037780          398 EG-DME--AMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEG  440 (455)
Q Consensus       398 ~~-~l~--~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~  440 (455)
                      .. ...  ...+     ....+.+.+++.+||+.||++|||+.|+++  .+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            00 000  0000     122467899999999999999999999987  4654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-49  Score=371.39  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=203.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc---------cHHHHHHHHHHHcccC-CCCceeeeeeEec
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD---------GEKEFKNEVVVIGQTH-HKNLVRLLGFCDE  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~g~~~~  235 (455)
                      +.+.+.||+|+||+||+|+..   .+++.+|||+++.....         ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~---~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHK---PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CEEceEEecCcCeEEEEEEEC---CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            345678999999999999876   45789999998653211         1245889999999997 9999999999999


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ++..++||||+++|+|.+++.....+++.+++.++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence            999999999999999999998888999999999999999999999965   99999999999999999999999999999


Q ss_pred             cccCCCCccccccccccCcccccccccC------CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhh
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRK------STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYR  389 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  389 (455)
                      ........   ....||+.|+|||++.+      ..++.++||||+||+|+||++|+.||.......       ....+.
T Consensus       159 ~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~  228 (277)
T d1phka_         159 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM  228 (277)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             EccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHH
Confidence            87653322   44579999999999853      346889999999999999999999998654322       112222


Q ss_pred             cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          390 NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       390 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .+... ..     .......++++.+++.+||+.||++|||+.||++
T Consensus       229 ~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            22221 11     1111234578899999999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.8e-49  Score=370.40  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=201.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc---ccHHHHHHHHHHHcccCCCCceeeeeeEecCC----e
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ---DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----N  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~  238 (455)
                      +.+.+.||+|+||+||+|...   .+++.||||.++....   .....|.+|+.++++++|||||++++++...+    .
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDL---RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             eEEeEEEeeCCCeEEEEEEEC---CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            456788999999999999986   4578999999965432   23456999999999999999999999987644    3


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++||||+++++|.+++.....+++.+++.|+.||+.||+|||+.   +|+||||||+|||++.++..+|+|||.++...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence            789999999999999998888999999999999999999999964   99999999999999999999999999987654


Q ss_pred             CCCCc-cccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccc
Q 037780          319 LNQSK-TIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLV  397 (455)
Q Consensus       319 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (455)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+      ........+..... 
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~~~-  235 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPS-  235 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCGG-
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCCCc-
Confidence            33221 22244579999999999999999999999999999999999999997654321      12222232221110 


Q ss_pred             ccccccCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHhcC
Q 037780          398 EGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRP-TMRKVSQMLEGV  441 (455)
Q Consensus       398 ~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-t~~~v~~~L~~~  441 (455)
                            ......+..+.+++.+||+.||.+|| |++++++.|.++
T Consensus       236 ------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         236 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                  11112456788999999999999999 899999988764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.8e-49  Score=381.15  Aligned_cols=247  Identities=24%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc---cccHHHHHH---HHHHHcccCCCCceeeeeeEecCCeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF---QDGEKEFKN---EVVVIGQTHHKNLVRLLGFCDEGQNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~g~~~~~~~~  239 (455)
                      +.+.+.||+|+||.||+|+..   .+++.||||++....   ......+.+   |+.+++.++|||||++++++.+.+..
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~---~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKA---DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             CeeeeEEecCCCeEEEEEEEC---CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            345678999999999999986   356889999985421   122333444   47778888999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccC
Q 037780          240 LLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL  319 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~  319 (455)
                      ++||||+++|+|.+++.....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999999998888899999999999999999999964   999999999999999999999999999987664


Q ss_pred             CCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ...    ....||+.|+|||++.. ..++.++|||||||+||||+||+.||..........    ..........     
T Consensus       160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~~-----  226 (364)
T d1omwa3         160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMAV-----  226 (364)
T ss_dssp             SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCCC-----
T ss_pred             Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCC-----
Confidence            432    34569999999999875 468999999999999999999999997654432211    1111111110     


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                           ..+...+..+.+++..||+.||.+|||     ++++++
T Consensus       227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 011123567899999999999999999     577764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=376.37  Aligned_cols=246  Identities=28%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHc-ccCCCCceeeeeeEecCCeEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIG-QTHHKNLVRLLGFCDEGQNRLL  241 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~~~~~~l  241 (455)
                      +.+.+.||+|+||+||+|+..   .+++.||||+++..   .....+.+..|..++. .++|||||++++++.+++..++
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~---~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFK---KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEEC---CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            456789999999999999987   45789999998643   2334456777777765 6899999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCC
Q 037780          242 VYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       242 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      ||||+++|+|.+++.....+++.+++.++.||+.||+|||+.   +|+||||||+|||+++++++||+|||+++......
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            999999999999999888899999999999999999999965   99999999999999999999999999998765433


Q ss_pred             CccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccccc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDM  401 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  401 (455)
                      ...  ....||+.|+|||++.+..++.++|||||||++|||+||+.||.......       +...+..+...       
T Consensus       158 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~-------  221 (320)
T d1xjda_         158 AKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF-------  221 (320)
T ss_dssp             CCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-------
T ss_pred             ccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC-------
Confidence            322  44679999999999999999999999999999999999999998655322       11222222211       


Q ss_pred             ccCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 037780          402 EAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR-KVSQ  436 (455)
Q Consensus       402 ~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~-~v~~  436 (455)
                         .+...+..+.+++..||+.||++|||+. ++++
T Consensus       222 ---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 ---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               1112356789999999999999999995 6753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-48  Score=378.13  Aligned_cols=243  Identities=24%  Similarity=0.243  Sum_probs=204.3

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc---ccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV---FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv  242 (455)
                      +++.+.||+|+||.||+|...   .+++.||||+++..   .....+.+.+|+.+|++++|||||++++++.+....++|
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~---~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEeecCcCcEEEEEEEC---CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            455688999999999999986   45678999998642   223456789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +||+.+|+|..++.....+++..++.|+.||+.||.|||+.   +|+||||||+|||++.++++||+|||+|+...... 
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            99999999999998888999999999999999999999954   99999999999999999999999999998765332 


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                          ....||+.|+|||++.+..++.++|||||||+||||+||+.||.......       ....+..+...        
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~~--------  256 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVR--------  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--------
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCCCC--------
Confidence                34569999999999999999999999999999999999999997554321       11111222111        


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRP-----TMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RP-----t~~~v~~  436 (455)
                        .+...+..+.+++..||+.||.+|+     |++++++
T Consensus       257 --~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              1112456788999999999999994     8999985

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=373.79  Aligned_cols=248  Identities=20%  Similarity=0.285  Sum_probs=202.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYEF  245 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~  245 (455)
                      |.+.+.||+|+||+||+|...   .++..||||.++... .....+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~---~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVET---SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             eEEEEEEecCCCeEEEEEEEC---CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            456688999999999999987   356789999997643 3345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC--CCcEEEeeccCcccccCCCC
Q 037780          246 LNNGTLASFLFGNL-KPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLNQS  322 (455)
Q Consensus       246 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~  322 (455)
                      +++|+|.+++.... .+++.++..|+.||+.||.|||+.   +|+||||||+|||++.  ...+||+|||+++.......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999998764 789999999999999999999964   9999999999999985  45899999999987654332


Q ss_pred             ccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccccccc
Q 037780          323 KTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEGDME  402 (455)
Q Consensus       323 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  402 (455)
                      .   ....+|+.|+|||.+.+..++.++||||+||++|+|++|+.||......+       ....+..+... +....  
T Consensus       160 ~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~~-~~~~~--  226 (321)
T d1tkia_         160 F---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT-FDEEA--  226 (321)
T ss_dssp             E---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC-CCHHH--
T ss_pred             c---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-CChhh--
Confidence            2   34568999999999999999999999999999999999999997655321       11111112111 00000  


Q ss_pred             cCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          403 AMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       403 ~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                         ....+.++.+++..||+.||++|||+.|+++
T Consensus       227 ---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 ---FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0013457889999999999999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-48  Score=371.87  Aligned_cols=244  Identities=23%  Similarity=0.280  Sum_probs=193.3

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHccc-CCCCceeeeeeEec----CCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQT-HHKNLVRLLGFCDE----GQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e  244 (455)
                      +.||+|+||+||+|...   .+++.||||+++.     ...+.+|+.++.++ +|||||++++++.+    ....++|||
T Consensus        18 ~~lG~G~fg~Vy~a~~~---~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE   89 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNK---RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   89 (335)
T ss_dssp             EEEEECSSCEEEEEEET---TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             EEeeeccCeEEEEEEEC---CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence            45999999999999986   3567899999854     34578899987655 89999999999865    456899999


Q ss_pred             eCCCCCHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC---CCcEEEeeccCcccccC
Q 037780          245 FLNNGTLASFLFGN--LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTL  319 (455)
Q Consensus       245 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~  319 (455)
                      ||++|+|.+++...  ..+++.+++.|+.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++....
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence            99999999999764  4689999999999999999999954   9999999999999985   56799999999987665


Q ss_pred             CCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcccccccc
Q 037780          320 NQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVEG  399 (455)
Q Consensus       320 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (455)
                      ....   ....||+.|+|||++.+..++.++|||||||+||+|+||+.||..........   ........+...     
T Consensus       167 ~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~~-----  235 (335)
T d2ozaa1         167 HNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYE-----  235 (335)
T ss_dssp             CCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS-----
T ss_pred             CCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCCC-----
Confidence            4332   34569999999999999999999999999999999999999997554321100   001111111100     


Q ss_pred             ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          400 DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       400 ~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                       .........+.++.+++..||+.||++|||+.|+++
T Consensus       236 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         236 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             000111234678999999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=361.70  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=198.0

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...++||+|+||+||+|...   .+++.||||+++...  ....+.+.+|+.++++++|||||++++++.++++.++|||
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNK---LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEET---TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EeccEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            34578999999999999986   356789999986432  2235679999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCc
Q 037780          245 FLNNGTLASFLFG-NLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSK  323 (455)
Q Consensus       245 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~  323 (455)
                      |+.++.+...... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            9976555444333 46789999999999999999999965   9999999999999999999999999999876543322


Q ss_pred             cccccccccCcccccccccCCC-CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc---Cccc---cc
Q 037780          324 TIKTAIRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN---GKLD---DL  396 (455)
Q Consensus       324 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~  396 (455)
                        .....||+.|+|||.+.... ++.++|||||||++|+|++|+.||......+.  +. ........   ....   ..
T Consensus       159 --~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~-~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         159 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LF-RIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             --TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH-HHHHHHCCCCTTTSTTGGGS
T ss_pred             --ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HH-HHHHhcCCCchhhccccccc
Confidence              24457999999999877655 57899999999999999999999976543221  11 11111000   0000   00


Q ss_pred             cccc--c-c-cCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcC
Q 037780          397 VEGD--M-E-AMND-----IKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGV  441 (455)
Q Consensus       397 ~~~~--l-~-~~~~-----~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~  441 (455)
                      .+..  . . ...+     ......+.+++.+||+.||++|||+.|+++-  ++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            0000  0 0 0000     1224678899999999999999999999873  6543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=364.74  Aligned_cols=238  Identities=24%  Similarity=0.403  Sum_probs=195.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccc------cHHHHHHHHHHHcccC--CCCceeeeeeEecCC
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQD------GEKEFKNEVVVIGQTH--HKNLVRLLGFCDEGQ  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~  237 (455)
                      +.+.+.||+|+||+||+|+..   .+++.||||++......      ....+.+|+.++++++  |||||++++++.+.+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRV---SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             EEEeEEEeeCCCeEEEEEEEC---CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            456688999999999999986   35688999998643211      1234678999999986  899999999999999


Q ss_pred             eEEEEEEeCCC-CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-CCcEEEeeccCcc
Q 037780          238 NRLLVYEFLNN-GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-HYNARISDFGLAK  315 (455)
Q Consensus       238 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~  315 (455)
                      ..++||||+.+ +++.+++.....+++..++.++.|++.||+|||+.   +|+||||||+|||++. ++.+||+|||+|+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence            99999999976 68889988888999999999999999999999954   9999999999999985 4799999999998


Q ss_pred             cccCCCCccccccccccCcccccccccCCCC-CCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccc
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRKSTI-TAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLD  394 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (455)
                      .......    ....||+.|+|||++.+..+ +.++|||||||+||||+||+.||.....             ...+...
T Consensus       160 ~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~~~  222 (273)
T d1xwsa_         160 LLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQVF  222 (273)
T ss_dssp             ECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCCC
T ss_pred             ecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------HhhcccC
Confidence            7543322    34579999999999987765 5679999999999999999999974321             0111110


Q ss_pred             cccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          395 DLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       395 ~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                        .        +...+.++.+++.+||+.||++|||++|+++
T Consensus       223 --~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         223 --F--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --C--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --C--------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              1        1123467889999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-47  Score=359.66  Aligned_cols=258  Identities=22%  Similarity=0.274  Sum_probs=198.5

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...++||+|+||+||+|.+.    +++.||||++....  ....+.+.+|+.+|++++|||||++++++...+..++++|
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             eeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            34578999999999999874    56789999986542  3335789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      |+.++.+..+......+++..+..|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence            999988888888888999999999999999999999964   99999999999999999999999999998765433221


Q ss_pred             ccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---c---cccc-
Q 037780          325 IKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---K---LDDL-  396 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~-  396 (455)
                        ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+..   ..........   .   .... 
T Consensus       158 --~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         158 --THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCChhhccchhhhh
Confidence              344689999999998754 5789999999999999999999999765432211   1111111000   0   0000 


Q ss_pred             --------cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          397 --------VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       397 --------~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                              ..+.............+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0000000111123467889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=357.26  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=193.7

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHccc---CCCCceeeeeeEec-----
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQT---HHKNLVRLLGFCDE-----  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----  235 (455)
                      +.+.++||+|+||+||+|.+..+  .++.||||++....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             EEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            44567899999999999987532  35779999986432  22233466777776665   79999999999853     


Q ss_pred             CCeEEEEEEeCCCCCHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCc
Q 037780          236 GQNRLLVYEFLNNGTLASFLF-GNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLA  314 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a  314 (455)
                      ....++++||++++++..... ....+++...+.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence            346799999999988765544 446789999999999999999999965   9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhc-C--
Q 037780          315 KLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRN-G--  391 (455)
Q Consensus       315 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~--  391 (455)
                      +.......   .....||+.|+|||++.+..++.++||||+||++|||+||+.||......+...   ........ .  
T Consensus       164 ~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~  237 (305)
T d1blxa_         164 RIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGEE  237 (305)
T ss_dssp             CCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCGG
T ss_pred             hhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCchh
Confidence            86543322   245679999999999999999999999999999999999999998655422111   11111000 0  


Q ss_pred             cc------ccccc----cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          392 KL------DDLVE----GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       392 ~~------~~~~~----~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..      .....    ............+.+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00      00000    00000011123467889999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=354.12  Aligned_cols=265  Identities=18%  Similarity=0.215  Sum_probs=196.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccc--ccccHHHHHHHHHHHcccCCCCceeeeeeEec--------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV--FQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE--------  235 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--------  235 (455)
                      +.+.++||+|+||+||+|++.   .+++.||||++...  .....+++.+|+.+|++++|||++++++.+..        
T Consensus        12 Y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          12 YEKLAKIGQGTFGEVFKARHR---KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             EEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            345678999999999999986   45789999998543  23345678999999999999999999998855        


Q ss_pred             CCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          236 GQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       236 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ....++||||++++++..+......++....+.|+.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence            346799999999988888877778899999999999999999999954   99999999999999999999999999998


Q ss_pred             cccCCCCc--cccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc
Q 037780          316 LLTLNQSK--TIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK  392 (455)
Q Consensus       316 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  392 (455)
                      ........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......................
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            76543321  122335699999999998765 689999999999999999999999976554322211111110000000


Q ss_pred             ccccccc--------ccccCCCH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          393 LDDLVEG--------DMEAMNDI-------KCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       393 ~~~~~~~--------~l~~~~~~-------~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      .......        ........       .....+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0000000        00000000       11345678999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-46  Score=352.69  Aligned_cols=259  Identities=19%  Similarity=0.171  Sum_probs=194.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceee-eeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRL-LGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|.+.   .+++.||||.+....  ...++..|++++++++|+|++.. .++..+++..++|||
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDI---AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEET---TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEeEEEeeCCCcEEEEEEEC---CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            456788999999999999986   356789999876532  23458899999999987776555 455577888899999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEc---CCCcEEEeeccCcccccCCC
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLNQ  321 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~  321 (455)
                      |+.++.+..+......+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+......
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            995544444445567899999999999999999999964   999999999999986   45579999999999875443


Q ss_pred             Ccc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccc
Q 037780          322 SKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDL  396 (455)
Q Consensus       322 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (455)
                      ...     ......||+.|+|||.+.+..++.++|||||||++|||+||+.||..........................+
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence            221     123457999999999999999999999999999999999999999765543221111111110000001100


Q ss_pred             cccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcC
Q 037780          397 VEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGV  441 (455)
Q Consensus       397 ~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~  441 (455)
                               ....+.++.+++..||+.+|++||++.++.+.|+.+
T Consensus       241 ---------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         241 ---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ---------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ---------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                     012356789999999999999999999999988764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-45  Score=346.99  Aligned_cols=259  Identities=18%  Similarity=0.203  Sum_probs=203.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC-CCceeeeeeEecCCeEEEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e  244 (455)
                      +.+.+.||+|+||+||+|++.   .+++.||||.+....  ....+.+|++.+..++| +|++.+++++.++...++|||
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNL---LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEET---TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            456688999999999999986   457889999885432  23457889999999975 899999999999999999999


Q ss_pred             eCCCCCHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcC-----CCcEEEeeccCccccc
Q 037780          245 FLNNGTLASFLFGN-LKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDD-----HYNARISDFGLAKLLT  318 (455)
Q Consensus       245 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~  318 (455)
                      |+ +++|.+++... ..+++.++..|+.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            98 78999988654 57899999999999999999999   559999999999999974     5789999999999765


Q ss_pred             CCCCcc-----ccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCcc
Q 037780          319 LNQSKT-----IKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKL  393 (455)
Q Consensus       319 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  393 (455)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..............+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            432211     123457999999999999999999999999999999999999999865543222211111111111111


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHhcCc
Q 037780          394 DDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQMLEGVV  442 (455)
Q Consensus       394 ~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~L~~~~  442 (455)
                      .++.         ...++++.+++..|+..+|++||+++.+.+.|+++.
T Consensus       238 ~~l~---------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         238 RELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhc---------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1111         113467889999999999999999999999887754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=356.20  Aligned_cols=258  Identities=24%  Similarity=0.272  Sum_probs=191.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCceeeeeeEecC------CeE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG------QNR  239 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~  239 (455)
                      ++..++||+|+||+||+|++.   .+++.||||++.....    .+.+|+.+|++++||||+++++++...      ...
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLC---DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             cEeeeEEeeCcCeEEEEEEEC---CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            344578999999999999987   4578899999865432    235799999999999999999998542      347


Q ss_pred             EEEEEeCCCCCHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcc
Q 037780          240 LLVYEFLNNGTLASF---LFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAK  315 (455)
Q Consensus       240 ~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~  315 (455)
                      ++||||++++.+...   ......+++.+++.|+.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            899999987654443   335678999999999999999999999   45999999999999999775 89999999998


Q ss_pred             cccCCCCccccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhH---------HHHH
Q 037780          316 LLTLNQSKTIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILT---------DWAF  385 (455)
Q Consensus       316 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~---------~~~~  385 (455)
                      ........   ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.....         .+..
T Consensus       172 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            76544332   34569999999998765 57899999999999999999999999765532211100         0001


Q ss_pred             HHhh---cCccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          386 DCYR---NGKLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       386 ~~~~---~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ....   .......................+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1000   00111111111111111224567889999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-46  Score=354.80  Aligned_cols=254  Identities=21%  Similarity=0.229  Sum_probs=204.9

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc----cccHHHHHHHHHHHcccCC-CCceeeeeeEecCCeEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF----QDGEKEFKNEVVVIGQTHH-KNLVRLLGFCDEGQNRL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~  240 (455)
                      +.+.++||+|+||+||+|+......+++.||||.++...    ....+.+.+|+.++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            567789999999999999987666678999999986432    2234568899999999976 89999999999999999


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      +|+||+.+|+|.+++.....++......++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+...
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            9999999999999999888889999999999999999999954   9999999999999999999999999999876544


Q ss_pred             CCccccccccccCcccccccccCC--CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCccccccc
Q 037780          321 QSKTIKTAIRGTKGYVAPEWYRKS--TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGKLDDLVE  398 (455)
Q Consensus       321 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (455)
                      ..... ....|++.|+|||.+.+.  .++.++|||||||+||||++|+.||..........   ...........     
T Consensus       183 ~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~~~-----  253 (322)
T d1vzoa_         183 ETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSEP-----  253 (322)
T ss_dssp             GGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHCCC-----
T ss_pred             ccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcccCCC-----
Confidence            33322 445699999999998754  46889999999999999999999997665432111   11111111111     


Q ss_pred             cccccCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 037780          399 GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPT-----MRKVSQ  436 (455)
Q Consensus       399 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt-----~~~v~~  436 (455)
                           ..+...+.++.+++..||+.||.+|||     ++|+++
T Consensus       254 -----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 -----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                 112234678899999999999999995     788875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-45  Score=343.46  Aligned_cols=260  Identities=20%  Similarity=0.250  Sum_probs=202.6

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCCeEEEEEE
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e  244 (455)
                      ...++||+|+||+||+|++.   .+++.||||+++...  ......+.+|+.++++++||||+++++++.+....++|+|
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNR---ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEET---TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EeeeEEecCcCeEEEEEEEC---CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            44578999999999999986   456789999985432  2345789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCCCCcc
Q 037780          245 FLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLNQSKT  324 (455)
Q Consensus       245 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  324 (455)
                      ++.+++|..++.....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.++.........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            999999999998889999999999999999999999965   99999999999999999999999999998765443322


Q ss_pred             ccccccccCcccccccccCCC-CCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC---ccc---ccc
Q 037780          325 IKTAIRGTKGYVAPEWYRKST-ITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG---KLD---DLV  397 (455)
Q Consensus       325 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~  397 (455)
                        ....+++.|+|||.+.... ++.++|||||||++|||++|+.||........  ....+.......   ...   ...
T Consensus       159 --~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcc
Confidence              3345788999999887665 68999999999999999999999754332111  111111111100   000   000


Q ss_pred             c---------cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          398 E---------GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       398 ~---------~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      +         ..............+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         00001111233467889999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=352.63  Aligned_cols=265  Identities=21%  Similarity=0.251  Sum_probs=192.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc-cccHHHHHHHHHHHcccCCCCceeeeeeEecCC----eEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF-QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ----NRL  240 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~  240 (455)
                      +...++||+|+||+||+|+..   .+++.||||+++... ....+.+++|+.+|++++|||++++++++....    ..+
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~---~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDN---VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             EEEEEECC---CCCEEEEEET---TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             eEEEEEEeeccCeEEEEEEEC---CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            345578999999999999976   457889999997543 233567899999999999999999999986543    234


Q ss_pred             EEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccccCC
Q 037780          241 LVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLN  320 (455)
Q Consensus       241 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~  320 (455)
                      ++++|+.+|+|.+++... .+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            555667799999999654 689999999999999999999965   9999999999999999999999999999876544


Q ss_pred             CCc-cccccccccCcccccccccC-CCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcCc------
Q 037780          321 QSK-TIKTAIRGTKGYVAPEWYRK-STITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNGK------  392 (455)
Q Consensus       321 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  392 (455)
                      ... .......||+.|+|||.+.. ..++.++||||+||+++||++|+.||.......................      
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            322 12244569999999999855 4678899999999999999999999976543221111100000000000      


Q ss_pred             --cccc--cccccccCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 037780          393 --LDDL--VEGDMEAMN----DIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM  437 (455)
Q Consensus       393 --~~~~--~~~~l~~~~----~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~  437 (455)
                        ....  ..+......    ......++.+++.+||+.||++|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0000  000000000    00123468899999999999999999999973

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=352.55  Aligned_cols=264  Identities=23%  Similarity=0.282  Sum_probs=192.6

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEecCC------
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDEGQ------  237 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------  237 (455)
                      +...++||+|+||+||+|...   .+++.||||+++...  ....+.+.+|+.+|++++|||||+++++|...+      
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDG---RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             EEEEEEC------CEEEEEET---TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             EEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            445578999999999999986   357889999997532  233467899999999999999999999997654      


Q ss_pred             eEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCcccc
Q 037780          238 NRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLL  317 (455)
Q Consensus       238 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~  317 (455)
                      +.++||||+ +.+|..+.. ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence            569999999 567777664 45789999999999999999999964   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHH-----HhhcC
Q 037780          318 TLNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFD-----CYRNG  391 (455)
Q Consensus       318 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~  391 (455)
                      ....     +...||+.|+|||.+.+. .++.++||||+||+++||++|+.||.................     .+...
T Consensus       172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            5432     345699999999998764 578999999999999999999999976543221110000000     00000


Q ss_pred             ----------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--HhcCcC
Q 037780          392 ----------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQM--LEGVVE  443 (455)
Q Consensus       392 ----------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~~--L~~~~~  443 (455)
                                .........+.. ........+.+++.+||+.||++|||+.|+++.  ++++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             cchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                      000000000110 011234567899999999999999999999973  665443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-43  Score=340.17  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=194.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEec--CCeEEEE
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDE--GQNRLLV  242 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~--~~~~~lv  242 (455)
                      +.+.++||+|+||+||+|+..   .+++.||||+++..   ..+++.+|+.+|.+++ ||||+++++++..  ....++|
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~---~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINI---TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEEC---CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            456688999999999999976   45789999998643   3567899999999995 9999999999874  4568999


Q ss_pred             EEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCC-cEEEeeccCcccccCCC
Q 037780          243 YEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLNQ  321 (455)
Q Consensus       243 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~  321 (455)
                      |||+++++|..+.   +.+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+|+......
T Consensus       111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999998764   4689999999999999999999954   999999999999998655 69999999998766443


Q ss_pred             CccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh--hHH-----HHHHHhhcCcc
Q 037780          322 SKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI--LTD-----WAFDCYRNGKL  393 (455)
Q Consensus       322 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~--~~~-----~~~~~~~~~~~  393 (455)
                      ..   ....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..........  +..     ...........
T Consensus       185 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             cc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            32   345689999999998765 47999999999999999999999997654422110  000     00000000000


Q ss_pred             ------ccccc--------cccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          394 ------DDLVE--------GDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       394 ------~~~~~--------~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                            .....        .............++.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00000        00011111223567889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=342.50  Aligned_cols=258  Identities=24%  Similarity=0.269  Sum_probs=186.1

Q ss_pred             hhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccc--cccHHHHHHHHHHHcccCCCCceeeeeeEec------CCe
Q 037780          167 NFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVF--QDGEKEFKNEVVVIGQTHHKNLVRLLGFCDE------GQN  238 (455)
Q Consensus       167 ~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~------~~~  238 (455)
                      ...++||+|+||+||+|++.   .+++.||||++....  ....+.+.+|+.++++++|||||++++++..      ..+
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~---~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDA---VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             EEEEECSCC--CEEEEEEET---TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             EEEEEeecCcCeEEEEEEEC---CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            34578999999999999986   357889999996543  2334568999999999999999999999853      468


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .++||||+.++++..+ .  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+++...
T Consensus        97 ~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence            8999999977655544 3  4579999999999999999999954   99999999999999999999999999988765


Q ss_pred             CCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh----------------hHH
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI----------------LTD  382 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~----------------~~~  382 (455)
                      .....   ....+|+.|+|||++.+..+++++||||+||+++||++|+.||..........                ...
T Consensus       171 ~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         171 TSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             ccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            43322   44568999999999999999999999999999999999999997554311100                000


Q ss_pred             HHHHHhhcCc------ccccccccccc---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 037780          383 WAFDCYRNGK------LDDLVEGDMEA---MNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ  436 (455)
Q Consensus       383 ~~~~~~~~~~------~~~~~~~~l~~---~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~  436 (455)
                      ..........      ...........   .........+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0111111100      00011011100   112234678899999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=344.01  Aligned_cols=262  Identities=24%  Similarity=0.288  Sum_probs=193.8

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc--ccHHHHHHHHHHHcccCCCCceeeeeeEecC-----Ce
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ--DGEKEFKNEVVVIGQTHHKNLVRLLGFCDEG-----QN  238 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~  238 (455)
                      +...++||+|+||+||+|+..   .+++.||||+++....  ...+.+.+|+.+|++++|||+|++++++...     ..
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDT---KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEET---TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             eEEEEEEecCCCeEEEEEEEC---CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            445578999999999999876   4578999999975432  2345788999999999999999999998633     34


Q ss_pred             EEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEeeccCccccc
Q 037780          239 RLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARISDFGLAKLLT  318 (455)
Q Consensus       239 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~  318 (455)
                      .+++++|+.+|+|.+++.. ..+++..+..|+.||+.||+|||+.   +|+||||||+|||++.++.+|++|||++....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence            4667788889999999855 4689999999999999999999964   99999999999999999999999999997654


Q ss_pred             CCCCccccccccccCcccccccccCC-CCCCCCCeecHHHHHHHHHhCCCCCCccccchhhhhHHHHHHHhhcC------
Q 037780          319 LNQSKTIKTAIRGTKGYVAPEWYRKS-TITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAILTDWAFDCYRNG------  391 (455)
Q Consensus       319 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------  391 (455)
                      ...     ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........   ........      
T Consensus       173 ~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         173 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELLK  244 (348)
T ss_dssp             GGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHHT
T ss_pred             ccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChHHhh
Confidence            322     345689999999987665 468899999999999999999999976543221111   00000000      


Q ss_pred             ------------ccccccccccccCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HHhcCcC
Q 037780          392 ------------KLDDLVEGDMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMRKVSQ--MLEGVVE  443 (455)
Q Consensus       392 ------------~~~~~~~~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~~v~~--~L~~~~~  443 (455)
                                  .........+... .......+.+++.+||+.||.+|||+.|+++  .+.+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                        0000000000000 0112456789999999999999999999997  5655433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-38  Score=309.87  Aligned_cols=276  Identities=21%  Similarity=0.250  Sum_probs=194.1

Q ss_pred             HhhhhhcCcCCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-----------CCCceeeeeeEe
Q 037780          166 DNFKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-----------HKNLVRLLGFCD  234 (455)
Q Consensus       166 ~~f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~~~  234 (455)
                      +.+.++||+|+||+||+|+..   .+++.||||+++... ...+.+.+|+.++++++           |+||+++++++.
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~---~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDM---VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEET---TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC---CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            556789999999999999986   457899999997542 23456888999888875           578999998875


Q ss_pred             c--CCeEEEEEEeCCCCCH-HHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCc----
Q 037780          235 E--GQNRLLVYEFLNNGTL-ASFL--FGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYN----  305 (455)
Q Consensus       235 ~--~~~~~lv~e~~~~gsL-~~~l--~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~----  305 (455)
                      .  ....+++++++..+.. ....  .....+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.    
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            4  3456677777655432 2222  344678899999999999999999996  258999999999999986653    


Q ss_pred             --EEEeeccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHHHHHHhCCCCCCccccchhhh----
Q 037780          306 --ARISDFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLLLEIISCRKSFDIEMGEEYAI----  379 (455)
Q Consensus       306 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l~el~tg~~p~~~~~~~~~~~----  379 (455)
                        ++++|||.+.......     ....||+.|+|||.+....++.++||||+||+++||++|+.||..........    
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              9999999998654322     33569999999999999999999999999999999999999997544321111    


Q ss_pred             hHHHHHH-------HhhcC----------cc-cccccc---------ccccCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 037780          380 LTDWAFD-------CYRNG----------KL-DDLVEG---------DMEAMNDIKCVEKLLMVSIWCIQEDPSLRPTMR  432 (455)
Q Consensus       380 ~~~~~~~-------~~~~~----------~~-~~~~~~---------~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPt~~  432 (455)
                      +......       ....+          .. ..+...         .............+.+++..||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1111100       00000          00 000000         001122345678899999999999999999999


Q ss_pred             HHHHH--Hhc---CcCCCCCCCCCC
Q 037780          433 KVSQM--LEG---VVEVDVPPNPSP  452 (455)
Q Consensus       433 ~v~~~--L~~---~~~~~~p~~p~~  452 (455)
                      |+++.  +++   ..++..|+.|..
T Consensus       324 e~L~Hp~f~~~~~~~~~~~p~~~~~  348 (362)
T d1q8ya_         324 GLVNHPWLKDTLGMEEIRVPDRELY  348 (362)
T ss_dssp             HHHTCGGGTTCTTCTTCCCTTSCTT
T ss_pred             HHhcCcccCCCCCcccCCCCCcccC
Confidence            99873  543   234445554443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=3e-24  Score=188.43  Aligned_cols=168  Identities=14%  Similarity=0.117  Sum_probs=118.5

Q ss_pred             hhhhcCcCCCccEEEEEEeccCCCceEEEEEecccccc------------------ccHHHHHHHHHHHcccCCCCceee
Q 037780          168 FKEEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRVFQ------------------DGEKEFKNEVVVIGQTHHKNLVRL  229 (455)
Q Consensus       168 f~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l  229 (455)
                      +.++||+|+||+||+|.+.    +++.||||.++....                  .....+..|...+.++.|.+++..
T Consensus         4 vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~   79 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV   79 (191)
T ss_dssp             EEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             hCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence            4578999999999999874    567899998643110                  011335678889999999999988


Q ss_pred             eeeEecCCeEEEEEEeCCCCCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCEEEcCCCcEEEe
Q 037780          230 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPSWNLRTNIAFQIARGLLYLHEDCSSQIIHCDIKPQNILLDDHYNARIS  309 (455)
Q Consensus       230 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  309 (455)
                      +++..    .+++|||+++..+..       ++......++.|++++|+|||+.   +|+||||||+|||++++ .++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            76632    379999998876543       23445667999999999999964   99999999999999976 58999


Q ss_pred             eccCcccccCCCCccccccccccCcccccccccCCCCCCCCCeecHHHHH
Q 037780          310 DFGLAKLLTLNQSKTIKTAIRGTKGYVAPEWYRKSTITAKVDVYSFGVLL  359 (455)
Q Consensus       310 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv~l  359 (455)
                      |||+|+............   ..... -.+.+ ...|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~~~l~---rd~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWREILE---RDVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHHHHHH---HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHH---HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            999997654332211100   00000 01122 35678899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.41  E-value=1.3e-06  Score=78.14  Aligned_cols=132  Identities=16%  Similarity=0.067  Sum_probs=91.9

Q ss_pred             CCCccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccC-CCCceeeeeeEecCCeEEEEEEeCCCCCHHH
Q 037780          175 GSFGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLAS  253 (455)
Q Consensus       175 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~  253 (455)
                      ++.+.||+...     ++..+.+|+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+
T Consensus        25 ~s~~~v~rv~~-----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          25 MSPAKVYKLVG-----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             CSSSEEEEEEC-----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             CCCCcEEEEEe-----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            33468998753     34557888876554444455778888877764 4345677888888889999999999988876


Q ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 037780          254 FLFGNLKPSWNLRTNIAFQIARGLLYLHEDC-------------------------------------------------  284 (455)
Q Consensus       254 ~l~~~~~~~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------------  284 (455)
                      .....     .....++.++++.++.||+..                                                 
T Consensus       100 ~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         100 EYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             HTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             ccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            54221     113335556666666666421                                                 


Q ss_pred             -------CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 -------SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 -------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                             ...++|+|+.|.||+++++...-|+||+.+..
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                   12378999999999999877778999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.89  E-value=2.2e-05  Score=69.43  Aligned_cols=130  Identities=15%  Similarity=0.094  Sum_probs=81.1

Q ss_pred             cCcCC-CccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCC--CCceeeeeeEecCCeEEEEEEeCCC
Q 037780          172 AGRGS-FGIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLNN  248 (455)
Q Consensus       172 lG~G~-fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~  248 (455)
                      +..|. ...||+....    .+..+.+|......   ...+..|...++.+..  -.+.+++++..+++..++||+++++
T Consensus        18 ~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ----GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEECT----TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEeC----CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            33444 3578987653    44557778754432   2346778887777643  3356678888888889999999988


Q ss_pred             CCHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 037780          249 GTLASFLFGNLKPSWNLRTNIAFQIARGLLYLH-----------------------------------------------  281 (455)
Q Consensus       249 gsL~~~l~~~~~~~~~~~~~i~~~ia~~l~~LH-----------------------------------------------  281 (455)
                      .++.+..     ..   ...++.++++.|+-||                                               
T Consensus        91 ~~~~~~~-----~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          91 QDLLSSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             EETTTSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccccc-----cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            6653311     00   1111222222333333                                               


Q ss_pred             ----hCC----CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          282 ----EDC----SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       282 ----~~~----~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                          +..    ...++|+|+.|.||+++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                211    22379999999999999887778999997753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.72  E-value=3.9e-05  Score=72.66  Aligned_cols=76  Identities=16%  Similarity=0.136  Sum_probs=46.0

Q ss_pred             hhcCcCCCccEEEEEEeccCCCceEEEEEecccc-------ccccHHHHHHHHHHHcccC-C--CCceeeeeeEecCCeE
Q 037780          170 EEAGRGSFGIVYKGVIETTRTSTTAVAVKKLDRV-------FQDGEKEFKNEVVVIGQTH-H--KNLVRLLGFCDEGQNR  239 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~niv~l~g~~~~~~~~  239 (455)
                      +.||.|....||+....   .+++.++||.-...       ..........|.+.|..+. +  ..+.+++.+  +.+..
T Consensus        32 ~eig~G~~N~vfrV~~~---~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~  106 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQ---EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  106 (392)
T ss_dssp             EECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             EEeCCCceEeEEEEEeC---CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCC
Confidence            46899999999998765   23567888864321       1112234556777777663 2  234445544  34456


Q ss_pred             EEEEEeCCCCC
Q 037780          240 LLVYEFLNNGT  250 (455)
Q Consensus       240 ~lv~e~~~~gs  250 (455)
                      ++|||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            89999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.62  E-value=0.002  Score=58.76  Aligned_cols=132  Identities=14%  Similarity=0.078  Sum_probs=75.1

Q ss_pred             ccEEEEEEeccCCCceEEEEEeccccccccHHHHHHHHHHHcccCCCCc--eeeee-----eEecCCeEEEEEEeCCCCC
Q 037780          178 GIVYKGVIETTRTSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNL--VRLLG-----FCDEGQNRLLVYEFLNNGT  250 (455)
Q Consensus       178 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lv~e~~~~gs  250 (455)
                      -.||+....    ++..+++|..+.. ....+++..|...+..+....+  +..+.     ........+.++++++|..
T Consensus        36 N~vy~v~~~----dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcC----CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            368888764    5677889886543 3346678888888888753322  11111     2344566789999987643


Q ss_pred             HH-----HHh---------c----CC-----CCCCHH-------------------HHHHHHHHHHHHHHHHHh----CC
Q 037780          251 LA-----SFL---------F----GN-----LKPSWN-------------------LRTNIAFQIARGLLYLHE----DC  284 (455)
Q Consensus       251 L~-----~~l---------~----~~-----~~~~~~-------------------~~~~i~~~ia~~l~~LH~----~~  284 (455)
                      +.     .+-         +    ..     ...++.                   .+..+...+.+.++.+..    ..
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence            21     110         0    00     111211                   111122222233333322    22


Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCccc
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAKL  316 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~  316 (455)
                      ..++||+|+.+.|||++++  ..+.||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4578999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.37  E-value=0.0043  Score=58.09  Aligned_cols=76  Identities=13%  Similarity=0.181  Sum_probs=48.5

Q ss_pred             hhcCcCCCccEEEEEEeccC----CCceEEEEEeccccccccHHHHHHHHHHHcccCCCCce-eeeeeEecCCeEEEEEE
Q 037780          170 EEAGRGSFGIVYKGVIETTR----TSTTAVAVKKLDRVFQDGEKEFKNEVVVIGQTHHKNLV-RLLGFCDEGQNRLLVYE  244 (455)
Q Consensus       170 ~~lG~G~fg~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e  244 (455)
                      +.|+.|-.=.+|+.......    .....+.++... . ........+|..+++.+.-.++. ++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            45788888899998876432    123345555543 2 22334566788888888644554 67777653    58999


Q ss_pred             eCCCCCH
Q 037780          245 FLNNGTL  251 (455)
Q Consensus       245 ~~~~gsL  251 (455)
                      |+++..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.87  E-value=0.22  Score=44.12  Aligned_cols=31  Identities=23%  Similarity=0.336  Sum_probs=27.8

Q ss_pred             CCCeEEeCCCCCCEEEcCCCcEEEeeccCcc
Q 037780          285 SSQIIHCDIKPQNILLDDHYNARISDFGLAK  315 (455)
Q Consensus       285 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~  315 (455)
                      ..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5679999999999999998777899999875

>d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Hairpin loop containing domain-like
superfamily: Hairpin loop containing domain-like
family: Hairpin loop containing domain
domain: Hepatocyte growth factor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.20  E-value=0.21  Score=35.31  Aligned_cols=53  Identities=21%  Similarity=0.413  Sum_probs=36.0

Q ss_pred             ccceeEEEeeCCCCCCCccccc----cccCHHhHHHhhccCC----ceeeeeec--CCcceee
Q 037780            7 KELFDFHEVKNIDWPQSDYERF----KPYNEVQCKNSCLSDC----FCAAVIFE--DDSCCFK   59 (455)
Q Consensus         7 ~~~~~f~~~~~~~~p~~~~~~~----~~~~~~~C~~~Cl~~C----~C~a~~~~--~~~c~~~   59 (455)
                      +....|.+.+++.|...+...+    ...+.++|...|+++=    .|.+|.|.  +..|.+.
T Consensus         2 ~~L~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls   64 (91)
T d2qj2a1           2 NTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWF   64 (91)
T ss_dssp             CCGGGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEE
T ss_pred             chhHhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEECCCCeEEEc
Confidence            3466788888887765543222    2248999999999844    59999984  3456543